data_3ncm_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 3ncm _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.0 t . . . . . 0 N--CA 1.502 2.146 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.49 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 7.6 mmt -114.33 116.84 29.61 Favored 'General case' 0 N--CA 1.507 2.386 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.137 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -75.37 115.16 14.72 Favored 'General case' 0 N--CA 1.504 2.248 0 CA-C-O 120.9 0.381 . . . . 0.0 110.479 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.5 ptpt -127.22 163.71 23.28 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.649 0.738 . . . . 0.0 111.529 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 32.36 76.97 0.04 OUTLIER 'General case' 0 N--CA 1.517 2.901 0 C-N-CA 124.266 1.026 . . . . 0.0 113.49 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -145.03 78.45 12.48 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.812 -0.555 . . . . 0.0 110.916 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -64.37 104.39 0.51 Allowed 'Trans proline' 0 N--CA 1.492 1.412 0 N-CA-C 108.532 -1.372 . . . . 0.0 108.532 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.441 ' CB ' ' HD3' ' A' ' 10' ' ' PRO . 0.5 OUTLIER -50.92 -69.69 0.28 Allowed Pre-proline 0 N--CA 1.509 2.5 0 CA-C-O 116.625 -1.655 . . . . 0.0 112.802 -176.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.441 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.6 Cg_endo -72.62 96.72 0.84 Allowed 'Trans proline' 0 N--CA 1.498 1.741 0 CA-C-N 121.69 1.639 . . . . 0.0 111.518 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -101.3 177.5 4.91 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 120.951 -1.093 . . . . 0.0 110.319 178.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -158.57 125.16 4.72 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.897 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -123.17 -170.65 2.15 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.953 -0.467 . . . . 0.0 109.876 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -104.67 143.86 32.51 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.617 0.722 . . . . 0.0 111.519 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -60.27 125.0 22.0 Favored 'General case' 0 N--CA 1.508 2.431 0 O-C-N 121.965 -0.459 . . . . 0.0 111.049 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.29 22.24 68.32 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 110.889 -0.885 . . . . 0.0 110.889 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -110.21 164.44 12.65 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 118.714 1.257 . . . . 0.0 110.61 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.43 98.62 8.98 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 177.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.78 165.82 11.4 Favored 'General case' 0 N--CA 1.497 1.925 0 C-N-CA 120.121 -0.631 . . . . 0.0 111.991 -177.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 85.1 t -138.94 139.68 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 40.9 mt -95.47 115.62 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 178.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.406 ' HA ' ' CE2' ' A' ' 57' ' ' TYR . 47.4 t -76.9 118.19 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-O 121.544 0.687 . . . . 0.0 110.507 -177.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.1 t -160.08 87.11 0.78 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.03 142.11 28.17 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 119.946 -0.702 . . . . 0.0 109.269 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.3 t -147.7 129.28 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.49 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 60.1 t -92.71 78.28 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.2 m -79.45 164.62 23.82 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.9 t -42.13 -80.52 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.224 0 CA-C-N 118.283 0.492 . . . . 0.0 111.607 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -170.69 -63.43 0.0 OUTLIER Pre-proline 0 N--CA 1.515 2.786 0 CA-C-O 117.658 -1.163 . . . . 0.0 111.467 177.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.84 -53.29 2.77 Favored 'Trans proline' 0 CA--C 1.563 1.97 0 CA-C-N 120.1 1.071 . . . . 0.0 112.805 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.71 -162.94 0.03 OUTLIER 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 120.516 0.811 . . . . 0.0 112.666 -178.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -170.16 -165.67 0.49 Allowed 'General case' 0 N--CA 1.518 2.936 0 O-C-N 121.849 -0.532 . . . . 0.0 110.403 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.5 tt -100.82 162.79 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.1 mt -125.23 126.77 71.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -90.44 110.65 21.75 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.0 tttt . . . . . 0 N--CA 1.502 2.131 0 O-C-N 121.941 -0.475 . . . . 0.0 110.594 -179.001 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.506 2.364 0 CA-C-O 120.993 0.425 . . . . 0.0 110.052 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.8 mm -58.27 -18.75 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.825 0 O-C-N 121.807 -0.558 . . . . 0.0 111.87 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.3 mp -93.2 -20.71 20.19 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.47 -0.769 . . . . 0.0 111.531 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 42.2 pttt -98.97 -37.89 9.21 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.531 -0.731 . . . . 0.0 109.802 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt 48.61 55.19 9.41 Favored 'General case' 0 N--CA 1.509 2.513 0 CA-C-O 121.581 0.705 . . . . 0.0 111.766 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -53.11 171.3 0.07 Allowed 'General case' 0 N--CA 1.513 2.682 0 O-C-N 121.755 -0.591 . . . . 0.0 110.876 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.6 t -66.9 -19.41 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.467 0 O-C-N 122.007 -0.433 . . . . 0.0 110.996 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 10.0 ptt-85 -115.64 45.7 1.64 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.504 -0.747 . . . . 0.0 112.1 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -145.28 105.33 4.04 Favored 'General case' 0 N--CA 1.506 2.346 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 177.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 45.2 mt -126.0 102.45 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.5 t -73.37 129.04 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 29.8 mt -82.71 167.6 18.05 Favored 'General case' 0 N--CA 1.509 2.498 0 CA-C-O 121.358 0.599 . . . . 0.0 112.143 -178.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.4 p -61.63 -22.02 64.89 Favored 'General case' 0 N--CA 1.509 2.496 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.985 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 52.4 p30 -91.49 18.85 6.76 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.749 -0.595 . . . . 0.0 111.337 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.8 m120 66.88 34.44 5.4 Favored 'General case' 0 N--CA 1.517 2.921 0 O-C-N 121.534 -0.728 . . . . 0.0 112.832 178.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.406 ' CE2' ' HA ' ' A' ' 22' ' ' VAL . 3.7 m-85 -103.06 166.03 10.67 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 177.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 15.2 tp -119.51 97.19 5.53 Favored 'General case' 0 N--CA 1.519 2.993 0 C-N-CA 119.371 -0.932 . . . . 0.0 111.505 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.67 95.39 3.97 Favored 'General case' 0 N--CA 1.502 2.166 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.857 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.441 HG22 HD11 ' A' ' 60' ' ' ILE . 99.4 mt -87.04 119.74 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 177.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 32.9 tpt85 -80.3 117.39 21.03 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-O 121.324 0.583 . . . . 0.0 110.638 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.26 -39.59 2.75 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.464 ' O ' HG21 ' A' ' 63' ' ' ILE . 2.8 tp 42.3 73.59 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.776 0 CA-C-O 122.16 0.981 . . . . 0.0 112.581 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 37.5 mmtt -59.8 150.61 27.71 Favored 'General case' 0 N--CA 1.51 2.573 0 O-C-N 121.377 -0.827 . . . . 0.0 111.661 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.7 ttmt -62.52 -17.59 60.11 Favored 'General case' 0 N--CA 1.506 2.374 0 O-C-N 122.087 -0.383 . . . . 0.0 111.213 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.8 t -89.32 -15.95 32.23 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.651 -0.656 . . . . 0.0 111.127 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -92.47 15.03 14.98 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.502 -0.748 . . . . 0.0 111.536 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -96.73 160.98 14.07 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.422 -0.798 . . . . 0.0 109.283 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 154.99 -99.4 0.19 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.371 -1.491 . . . . 0.0 109.371 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.8 m -151.05 101.35 2.87 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 122.016 -0.696 . . . . 0.0 111.988 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -82.17 131.74 35.24 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.1 tpp85 -98.11 117.02 31.53 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 120.087 -0.645 . . . . 0.0 111.212 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 14.4 m -79.43 129.84 34.85 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 177.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -128.03 88.63 2.79 Favored 'General case' 0 N--CA 1.502 2.15 0 CA-C-N 118.581 0.628 . . . . 0.0 110.265 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.47 111.11 3.84 Favored Glycine 0 N--CA 1.504 3.178 0 N-CA-C 107.915 -2.074 . . . . 0.0 107.915 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.2 ttm180 . . . . . 0 N--CA 1.502 2.165 0 CA-C-O 121.959 0.885 . . . . 0.0 113.366 -177.109 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 N--CA 1.501 2.122 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -167.76 176.19 6.49 Favored 'General case' 0 N--CA 1.508 2.475 0 O-C-N 121.455 -0.778 . . . . 0.0 112.692 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -168.13 155.95 8.45 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -93.16 120.53 33.55 Favored 'General case' 0 N--CA 1.51 2.55 0 O-C-N 121.713 -0.617 . . . . 0.0 111.796 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.6 mp -106.04 119.47 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -85.11 130.84 34.54 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.1 t -123.25 128.76 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 54.7 mt -121.07 142.29 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.7 p . . . . . 0 N--CA 1.5 2.056 0 CA-C-O 117.876 -1.059 . . . . 0.0 110.469 179.726 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.4 t . . . . . 0 N--CA 1.5 2.059 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.479 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 7.3 mmm -96.56 113.92 25.53 Favored 'General case' 0 N--CA 1.506 2.354 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.907 -178.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -72.13 115.06 10.91 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.22 158.01 35.11 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 121.323 0.582 . . . . 0.0 110.354 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 38.88 70.92 0.18 Allowed 'General case' 0 N--CA 1.518 2.954 0 C-N-CA 123.374 0.67 . . . . 0.0 112.151 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.03 72.01 72.69 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.748 -0.595 . . . . 0.0 111.258 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -65.09 102.07 0.43 Allowed 'Trans proline' 0 N--CA 1.49 1.323 0 N-CA-C 108.886 -1.236 . . . . 0.0 108.886 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.446 ' CB ' ' HD3' ' A' ' 10' ' ' PRO . 0.4 OUTLIER -54.28 -68.3 0.51 Allowed Pre-proline 0 N--CA 1.508 2.461 0 CA-C-O 116.782 -1.58 . . . . 0.0 112.25 -177.636 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.446 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.4 Cg_endo -72.43 90.5 0.79 Allowed 'Trans proline' 0 N--CA 1.496 1.676 0 CA-C-N 121.52 1.579 . . . . 0.0 111.353 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -100.85 173.93 6.27 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 120.785 -1.197 . . . . 0.0 110.352 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -157.16 122.88 4.71 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.803 -0.561 . . . . 0.0 111.003 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -117.16 -170.09 1.78 Allowed 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.963 -0.46 . . . . 0.0 110.552 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -103.31 140.45 37.4 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.862 0.839 . . . . 0.0 111.907 -178.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -60.79 126.96 29.32 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.822 -0.548 . . . . 0.0 111.017 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.07 21.82 72.83 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.418 ' O ' HG23 ' A' ' 63' ' ' ILE . 18.2 tp10 -110.91 161.5 15.77 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 118.652 1.226 . . . . 0.0 111.018 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -79.79 95.8 6.11 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 177.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.66 169.68 9.86 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.851 -177.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 84.5 t -142.98 141.3 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.0 mt -96.36 114.4 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 178.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.41 ' HA ' ' CE2' ' A' ' 57' ' ' TYR . 38.8 t -75.51 118.33 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 CA-C-O 121.477 0.656 . . . . 0.0 110.735 -176.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.9 t -163.61 80.49 0.44 Allowed 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.06 146.21 32.06 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.4 t -148.88 133.84 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 60.6 t -94.88 88.49 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -88.29 140.2 29.72 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.0 t -97.97 30.57 3.0 Favored 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -177.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.442 ' HB3' ' HD2' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -161.79 170.41 8.12 Favored Pre-proline 0 N--CA 1.513 2.693 0 O-C-N 120.896 -1.127 . . . . 0.0 111.12 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.435 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 4.0 Cg_exo -49.81 -47.93 21.32 Favored 'Trans proline' 0 N--CA 1.502 1.973 0 C-N-CA 121.639 1.559 . . . . 0.0 114.491 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 29' ' ' LEU . 4.5 Cg_exo -52.66 -170.02 0.01 OUTLIER 'Trans proline' 0 N--CA 1.506 2.235 0 CA-C-N 120.044 1.051 . . . . 0.0 112.896 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -168.93 -156.21 0.16 Allowed 'General case' 0 N--CA 1.522 3.154 0 O-C-N 120.381 -1.45 . . . . 0.0 111.634 -176.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.5 tt -88.02 143.04 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 O-C-N 121.897 -0.502 . . . . 0.0 111.906 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.6 mp -109.47 130.44 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 177.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.436 ' CE2' ' HB2' ' A' ' 58' ' ' LEU . 79.3 m95 -90.28 110.61 21.66 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.0 mttt . . . . . 0 N--CA 1.501 2.1 0 CA-C-O 121.394 0.616 . . . . 0.0 111.199 -178.76 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.6 m . . . . . 0 N--CA 1.507 2.394 0 CA-C-O 120.757 0.313 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 79.6 mt -59.27 -17.33 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.87 0 O-C-N 121.754 -0.591 . . . . 0.0 111.803 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.8 mp -89.47 -25.22 21.59 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.599 -0.688 . . . . 0.0 110.55 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.0 pttt -98.6 -38.87 8.97 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.756 -0.59 . . . . 0.0 109.655 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.5 mmmt 47.06 55.64 7.79 Favored 'General case' 0 N--CA 1.51 2.55 0 CA-C-O 121.399 0.618 . . . . 0.0 111.959 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.8 169.46 0.07 Allowed 'General case' 0 N--CA 1.515 2.778 0 O-C-N 121.792 -0.567 . . . . 0.0 111.116 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 31.4 m -63.54 -21.59 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.591 0 O-C-N 121.985 -0.447 . . . . 0.0 111.649 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 16.4 ptt-85 -113.67 48.5 1.06 Allowed 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.648 -0.658 . . . . 0.0 111.747 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -144.73 102.97 3.87 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.553 -0.717 . . . . 0.0 109.895 178.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 48.0 mm -127.74 114.05 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 t -80.13 146.64 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 24.6 mt -102.71 162.99 12.48 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 121.244 0.545 . . . . 0.0 111.605 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 81.8 p -59.88 -20.58 57.96 Favored 'General case' 0 N--CA 1.51 2.552 0 O-C-N 122.098 -0.376 . . . . 0.0 111.689 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 38.5 p-10 -91.36 17.74 8.06 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.662 -0.649 . . . . 0.0 111.736 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.1 m120 70.21 29.54 3.67 Favored 'General case' 0 N--CA 1.52 3.046 0 O-C-N 121.635 -0.666 . . . . 0.0 111.931 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.41 ' CE2' ' HA ' ' A' ' 22' ' ' VAL . 4.3 m-85 -103.18 159.92 15.11 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.436 ' HB2' ' CE2' ' A' ' 35' ' ' TRP . 26.9 tp -120.85 100.81 7.3 Favored 'General case' 0 N--CA 1.514 2.743 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.814 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -75.48 103.47 5.62 Favored 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 120.759 -0.377 . . . . 0.0 111.244 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 99.8 mt -95.53 114.09 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 177.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -74.59 115.55 14.28 Favored 'General case' 0 N--CA 1.503 2.175 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.229 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.04 -39.02 2.89 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.45 ' O ' HG21 ' A' ' 63' ' ' ILE . 1.9 tp 42.92 71.79 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.843 0 CA-C-O 122.256 1.027 . . . . 0.0 112.241 -178.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.1 mtpp -63.32 158.01 21.46 Favored 'General case' 0 N--CA 1.506 2.374 0 O-C-N 121.59 -0.694 . . . . 0.0 112.333 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -62.02 -23.63 66.56 Favored 'General case' 0 N--CA 1.508 2.441 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.933 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.7 p -83.78 -16.56 44.24 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.74 -0.6 . . . . 0.0 111.015 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.91 -19.47 25.77 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.704 -0.623 . . . . 0.0 111.042 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -67.6 150.1 49.23 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.445 -0.785 . . . . 0.0 109.916 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 166.31 -111.69 0.46 Allowed Glycine 0 N--CA 1.498 2.822 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.4 m -144.57 101.59 3.7 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.941 -0.74 . . . . 0.0 110.034 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -82.16 133.52 35.27 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -94.64 117.94 30.92 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 120.002 -0.679 . . . . 0.0 111.143 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 85' ' ' PHE . 12.0 m -80.3 120.82 24.87 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 177.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.82 82.59 1.97 Allowed 'General case' 0 N--CA 1.509 2.512 0 CA-C-N 118.962 0.801 . . . . 0.0 110.556 -179.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.61 100.79 0.29 Allowed Glycine 0 N--CA 1.508 3.493 0 N-CA-C 108.779 -1.729 . . . . 0.0 108.779 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 25.1 ttp85 . . . . . 0 N--CA 1.497 1.917 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -177.322 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 . . . . . 0 N--CA 1.499 2.016 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.402 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 39.0 p90 -159.51 178.38 9.95 Favored 'General case' 0 N--CA 1.504 2.248 0 CA-C-N 119.773 1.17 . . . . 0.0 113.752 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -171.3 159.61 5.83 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -102.39 118.15 36.25 Favored 'General case' 0 N--CA 1.512 2.656 0 O-C-N 121.795 -0.566 . . . . 0.0 110.773 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.9 mp -101.99 119.73 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.06 112.83 21.63 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -179.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.9 t -106.74 133.26 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.13 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.9 mt -124.64 158.53 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.499 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 42.2 t . . . . . 0 N--CA 1.505 2.281 0 N-CA-C 110.383 -0.229 . . . . 0.0 110.383 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.402 ' CG ' ' HB ' ' A' ' 26' ' ' VAL . 25.6 ptm -119.29 122.87 42.87 Favored 'General case' 0 N--CA 1.509 2.485 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 177.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -73.71 136.87 43.75 Favored 'General case' 0 N--CA 1.511 2.603 0 O-C-N 122.031 -0.418 . . . . 0.0 111.992 -176.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -136.47 158.15 45.11 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 121.424 0.631 . . . . 0.0 110.823 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 32.93 84.1 0.02 OUTLIER 'General case' 0 N--CA 1.521 3.103 0 C-N-CA 123.998 0.919 . . . . 0.0 113.347 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -145.19 80.86 10.81 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.7 -0.625 . . . . 0.0 111.23 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -67.07 105.3 0.96 Allowed 'Trans proline' 0 N--CA 1.49 1.32 0 N-CA-C 108.693 -1.31 . . . . 0.0 108.693 178.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.427 ' CB ' ' HD3' ' A' ' 10' ' ' PRO . 0.4 OUTLIER -57.88 -67.25 0.95 Allowed Pre-proline 0 N--CA 1.507 2.415 0 CA-C-O 116.905 -1.521 . . . . 0.0 111.828 -177.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.427 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.6 Cg_endo -71.46 92.02 0.68 Allowed 'Trans proline' 0 N--CA 1.493 1.445 0 CA-C-N 121.32 1.507 . . . . 0.0 111.604 178.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -101.27 166.31 10.83 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.068 -1.02 . . . . 0.0 110.141 178.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -152.37 120.62 6.3 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 120.196 -0.601 . . . . 0.0 111.844 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -116.12 -172.03 2.1 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 122.028 -0.42 . . . . 0.0 110.056 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 62.2 tttt -101.2 140.77 35.04 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.477 0.656 . . . . 0.0 111.468 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -59.52 122.17 13.37 Favored 'General case' 0 N--CA 1.51 2.541 0 O-C-N 121.99 -0.443 . . . . 0.0 111.041 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.26 21.97 59.71 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.415 ' O ' HG23 ' A' ' 63' ' ' ILE . 14.3 tt0 -111.76 164.43 13.06 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 118.738 1.269 . . . . 0.0 110.628 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -82.81 99.85 9.95 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -101.62 171.06 7.78 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.772 -177.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 84.5 t -141.96 141.26 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 19.0 mt -95.18 112.35 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.413 ' HA ' ' CE2' ' A' ' 57' ' ' TYR . 43.6 t -74.1 121.49 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.546 -176.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.6 t -164.85 93.56 0.64 Allowed 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.95 142.53 27.67 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.9 t -144.41 138.2 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 C-N-CA 120.311 -0.556 . . . . 0.0 109.541 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.402 ' HB ' ' CG ' ' A' ' 3' ' ' MET . 90.0 t -106.08 79.46 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.8 m -84.37 169.38 14.67 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.4 t -45.46 -76.31 0.02 OUTLIER 'General case' 0 N--CA 1.521 3.091 0 O-C-N 121.689 -0.632 . . . . 0.0 111.458 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -173.04 -62.52 0.0 OUTLIER Pre-proline 0 N--CA 1.518 2.953 0 CA-C-O 117.832 -1.08 . . . . 0.0 111.987 177.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.19 -53.31 3.13 Favored 'Trans proline' 0 CA--C 1.562 1.909 0 CA-C-N 119.939 1.014 . . . . 0.0 112.897 -179.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -62.48 -163.63 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.745 0 CA-C-N 119.275 0.777 . . . . 0.0 112.676 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -170.25 -166.37 0.53 Allowed 'General case' 0 N--CA 1.519 3.001 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.203 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.413 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 15.1 tt -97.61 161.11 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 122.065 -0.397 . . . . 0.0 110.056 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 90.4 mt -126.3 124.69 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.414 ' CE2' ' HB2' ' A' ' 58' ' ' LEU . 78.2 m95 -87.56 105.95 17.67 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 24.9 tttt . . . . . 0 N--CA 1.497 1.896 0 O-C-N 122.052 -0.405 . . . . 0.0 110.617 -178.654 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.6 m . . . . . 0 N--CA 1.506 2.325 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 50.6 mt -60.51 -18.62 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.68 0 O-C-N 121.877 -0.515 . . . . 0.0 111.173 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.0 mp -91.73 -20.94 21.02 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.608 -0.682 . . . . 0.0 110.975 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -98.88 -38.14 9.14 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt 48.35 56.69 7.1 Favored 'General case' 0 N--CA 1.508 2.463 0 CA-C-O 121.508 0.671 . . . . 0.0 111.649 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -50.57 173.71 0.02 OUTLIER 'General case' 0 N--CA 1.516 2.842 0 O-C-N 121.895 -0.503 . . . . 0.0 111.421 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.3 m -61.33 -18.47 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.636 0 O-C-N 121.882 -0.511 . . . . 0.0 111.804 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -126.05 48.33 2.12 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.6 -0.687 . . . . 0.0 112.337 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -144.47 106.47 4.32 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 121.56 -0.712 . . . . 0.0 109.689 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 65.8 mt -128.05 106.84 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.3 t -75.67 136.73 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.287 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.5 mt -91.16 165.26 13.58 Favored 'General case' 0 N--CA 1.506 2.338 0 CA-C-O 121.309 0.576 . . . . 0.0 111.724 -178.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.8 p -60.55 -21.22 62.29 Favored 'General case' 0 N--CA 1.511 2.576 0 O-C-N 122.114 -0.366 . . . . 0.0 111.453 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 40.4 p-10 -90.57 17.23 7.72 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.627 -0.671 . . . . 0.0 111.505 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.5 m120 69.38 31.58 3.79 Favored 'General case' 0 N--CA 1.516 2.856 0 O-C-N 121.594 -0.691 . . . . 0.0 111.846 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.413 ' CE2' ' HA ' ' A' ' 22' ' ' VAL . 4.3 m-85 -102.41 166.03 10.78 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 177.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.414 ' HB2' ' CE2' ' A' ' 35' ' ' TRP . 18.5 tp -123.62 99.92 6.54 Favored 'General case' 0 N--CA 1.515 2.818 0 C-N-CA 119.333 -0.947 . . . . 0.0 111.808 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.28 101.5 6.29 Favored 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 120.805 0.336 . . . . 0.0 111.107 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 97.6 mt -92.78 115.97 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.51 115.24 17.12 Favored 'General case' 0 N--CA 1.505 2.302 0 CA-C-O 121.299 0.571 . . . . 0.0 111.306 -178.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.31 -38.81 2.95 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 179.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.453 ' O ' HG21 ' A' ' 63' ' ' ILE . 1.7 tp 41.47 72.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.846 0 CA-C-O 121.995 0.903 . . . . 0.0 112.624 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -62.72 155.37 26.72 Favored 'General case' 0 N--CA 1.509 2.508 0 O-C-N 121.391 -0.818 . . . . 0.0 111.687 -178.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 33.9 tttt -62.82 -21.45 65.92 Favored 'General case' 0 N--CA 1.51 2.542 0 O-C-N 122.119 -0.363 . . . . 0.0 110.772 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 50.7 p -85.17 -13.97 48.39 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.79 -0.569 . . . . 0.0 111.106 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.88 -6.38 48.83 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.607 -0.683 . . . . 0.0 111.452 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.04 172.74 13.38 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-N 119.005 0.82 . . . . 0.0 110.067 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 145.33 -108.16 0.46 Allowed Glycine 0 N--CA 1.496 2.646 0 N-CA-C 108.991 -1.643 . . . . 0.0 108.991 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.7 m -143.17 100.99 3.74 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 122.041 -0.682 . . . . 0.0 111.418 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -83.72 129.46 34.95 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 29.4 ttp180 -94.84 119.21 33.03 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.324 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 5.5 m -81.88 124.12 29.44 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 177.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -125.12 89.94 3.15 Favored 'General case' 0 N--CA 1.503 2.201 0 CA-C-N 118.995 0.816 . . . . 0.0 111.021 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 33' ' ' ILE . . . -69.44 107.89 2.28 Favored Glycine 0 N--CA 1.502 3.045 0 N-CA-C 107.336 -2.306 . . . . 0.0 107.336 178.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 . . . . . 0 N--CA 1.502 2.159 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -176.603 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.2 m120 . . . . . 0 N--CA 1.504 2.239 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -163.01 -175.94 4.62 Favored 'General case' 0 N--CA 1.503 2.19 0 C-N-CA 119.551 -0.86 . . . . 0.0 112.979 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 9.1 tttt -167.6 162.27 14.12 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -106.71 110.5 22.7 Favored 'General case' 0 N--CA 1.51 2.531 0 O-C-N 121.764 -0.585 . . . . 0.0 111.0 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.6 mp -95.74 120.13 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 10.6 tm0? -91.63 113.53 25.82 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.046 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.7 t -104.75 143.33 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.931 -0.481 . . . . 0.0 109.967 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 68.4 mt -134.95 139.92 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.311 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 8.4 p . . . . . 0 N--CA 1.5 2.045 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.76 179.725 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 45.3 t . . . . . 0 N--CA 1.504 2.256 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.416 ' CG ' ' HB ' ' A' ' 26' ' ' VAL . 17.1 ptm -119.09 123.31 44.13 Favored 'General case' 0 N--CA 1.508 2.456 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -74.17 133.29 42.74 Favored 'General case' 0 N--CA 1.511 2.606 0 CA-C-O 120.974 0.416 . . . . 0.0 112.045 -176.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.37 163.38 30.15 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-O 121.367 0.603 . . . . 0.0 111.093 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.5 t30 27.78 70.24 0.06 Allowed 'General case' 0 N--CA 1.523 3.205 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -135.76 82.85 37.09 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.736 -0.603 . . . . 0.0 110.619 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -65.44 110.0 1.51 Allowed 'Trans proline' 0 N--CA 1.491 1.366 0 N-CA-C 109.02 -1.185 . . . . 0.0 109.02 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.476 ' OG1' ' HD3' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -60.64 -59.05 15.09 Favored Pre-proline 0 N--CA 1.502 2.151 0 CA-C-O 117.113 -1.422 . . . . 0.0 112.161 -177.777 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.476 ' HD3' ' OG1' ' A' ' 9' ' ' THR . 1.4 Cg_endo -80.11 91.44 1.17 Allowed 'Trans proline' 0 CA--C 1.554 1.488 0 CA-C-N 121.055 1.413 . . . . 0.0 111.557 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -101.38 173.5 6.41 Favored 'General case' 0 N--CA 1.509 2.504 0 O-C-N 120.973 -1.079 . . . . 0.0 110.521 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -158.37 121.13 3.76 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.783 -0.573 . . . . 0.0 111.478 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -116.68 -170.02 1.74 Allowed 'General case' 0 N--CA 1.503 2.203 0 O-C-N 122.06 -0.4 . . . . 0.0 109.943 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -103.48 137.52 41.46 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.527 0.68 . . . . 0.0 111.444 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -61.08 116.67 4.71 Favored 'General case' 0 N--CA 1.508 2.466 0 CA-C-O 121.051 0.453 . . . . 0.0 110.333 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.13 22.46 29.96 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -117.48 165.41 13.56 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 118.567 1.183 . . . . 0.0 111.085 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -80.62 99.85 8.34 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 177.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.29 165.85 11.49 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.968 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 99.2 t -141.68 139.47 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 177.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 42.6 mt -97.15 113.47 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 178.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.401 ' HA ' ' CE2' ' A' ' 57' ' ' TYR . 48.4 t -76.43 117.47 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 CA-C-O 121.558 0.694 . . . . 0.0 110.401 -177.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.3 t -157.94 91.26 1.11 Allowed 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.01 138.95 31.0 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -178.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.3 t -143.87 131.11 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 C-N-CA 120.283 -0.567 . . . . 0.0 109.476 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.416 ' HB ' ' CG ' ' A' ' 3' ' ' MET . 93.3 t -97.63 83.21 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.8 m -84.62 171.18 12.65 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 177.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.5 t -46.18 -81.49 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.091 0 O-C-N 121.594 -0.691 . . . . 0.0 111.261 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -165.93 -64.01 0.01 OUTLIER Pre-proline 0 N--CA 1.514 2.758 0 CA-C-O 117.706 -1.14 . . . . 0.0 111.752 177.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.13 -53.07 2.76 Favored 'Trans proline' 0 CA--C 1.563 1.939 0 CA-C-N 120.189 1.103 . . . . 0.0 113.013 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -61.14 -163.83 0.03 OUTLIER 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 120.549 0.832 . . . . 0.0 113.108 -178.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -168.97 -162.81 0.39 Allowed 'General case' 0 N--CA 1.517 2.915 0 O-C-N 121.966 -0.459 . . . . 0.0 109.768 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.0 tt -101.23 167.35 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.879 -0.513 . . . . 0.0 110.195 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.7 mt -131.89 134.35 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.423 ' CE2' ' HB2' ' A' ' 58' ' ' LEU . 85.4 m95 -95.9 114.88 26.64 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.5 tttt . . . . . 0 N--CA 1.503 2.213 0 O-C-N 121.814 -0.554 . . . . 0.0 111.129 -178.72 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.3 m . . . . . 0 N--CA 1.505 2.323 0 CA-C-O 121.192 0.52 . . . . 0.0 109.663 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.41 HG22 HD11 ' A' ' 43' ' ' ILE . 47.8 mm -58.35 -19.36 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.795 0 O-C-N 121.867 -0.52 . . . . 0.0 111.558 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.2 mp -93.03 -22.78 18.94 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.478 -0.764 . . . . 0.0 111.126 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 31.2 pttt -97.96 -38.57 9.34 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.4 mmmt 49.14 54.86 10.22 Favored 'General case' 0 N--CA 1.507 2.395 0 CA-C-O 121.487 0.66 . . . . 0.0 111.726 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.75 161.47 0.74 Allowed 'General case' 0 N--CA 1.514 2.764 0 O-C-N 121.731 -0.605 . . . . 0.0 110.916 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.9 m -58.42 -21.1 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.666 0 O-C-N 121.909 -0.494 . . . . 0.0 111.876 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.1 ptp85 -111.53 46.11 1.14 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.78 -0.575 . . . . 0.0 111.633 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -146.24 106.36 4.02 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.72 -0.613 . . . . 0.0 109.836 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 81.1 mt -129.03 107.5 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.1 t -74.94 139.32 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 43.1 mt -94.82 167.84 11.18 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 121.224 0.535 . . . . 0.0 111.963 -178.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.4 p -61.76 -23.22 66.03 Favored 'General case' 0 N--CA 1.509 2.484 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.072 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 35.6 p-10 -90.03 16.93 7.49 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.659 -0.651 . . . . 0.0 111.414 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.5 m120 69.43 32.18 3.55 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 121.558 -0.714 . . . . 0.0 112.283 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.401 ' CE2' ' HA ' ' A' ' 22' ' ' VAL . 4.0 m-85 -103.24 157.97 16.64 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.423 ' HB2' ' CE2' ' A' ' 35' ' ' TRP . 17.8 tp -114.13 98.92 7.26 Favored 'General case' 0 N--CA 1.517 2.897 0 C-N-CA 119.487 -0.885 . . . . 0.0 111.624 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -76.97 98.96 5.1 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 120.325 -0.55 . . . . 0.0 111.075 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 98.2 mt -89.58 119.56 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 177.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.2 tpt85 -81.45 114.12 19.98 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-O 121.443 0.639 . . . . 0.0 111.247 -178.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.17 -36.73 3.75 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.427 ' O ' HG21 ' A' ' 63' ' ' ILE . 3.1 tp 42.3 93.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.826 0 CA-C-N 118.14 0.97 . . . . 0.0 112.237 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -80.36 154.68 27.59 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.377 -0.827 . . . . 0.0 112.004 -177.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.7 tttm -62.04 -25.07 67.45 Favored 'General case' 0 N--CA 1.509 2.517 0 O-C-N 122.174 -0.329 . . . . 0.0 111.002 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 56.3 p -82.22 -16.62 48.98 Favored 'General case' 0 N--CA 1.505 2.325 0 O-C-N 121.848 -0.532 . . . . 0.0 110.978 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.88 -12.42 36.26 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.622 -0.674 . . . . 0.0 111.732 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -73.42 142.87 46.92 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.385 -0.822 . . . . 0.0 109.792 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 171.85 -104.27 0.2 Allowed Glycine 0 N--CA 1.498 2.792 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.4 m -147.77 102.13 3.39 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 122.055 -0.674 . . . . 0.0 110.45 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -81.97 139.61 34.46 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.8 ttt180 -102.46 116.79 33.34 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.02 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 7.0 m -79.04 133.43 36.81 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 177.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -133.71 91.58 2.86 Favored 'General case' 0 N--CA 1.504 2.243 0 CA-C-N 118.711 0.687 . . . . 0.0 110.452 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.36 109.6 2.96 Favored Glycine 0 N--CA 1.504 3.185 0 N-CA-C 107.631 -2.187 . . . . 0.0 107.631 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 5.9 ttm180 . . . . . 0 N--CA 1.505 2.284 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -176.962 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.2 m120 . . . . . 0 N--CA 1.505 2.292 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -164.83 -178.6 5.34 Favored 'General case' 0 N--CA 1.506 2.348 0 C-N-CA 119.723 -0.791 . . . . 0.0 112.937 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.9 mttm -168.72 159.52 9.9 Favored 'General case' 0 N--CA 1.505 2.294 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -103.66 112.75 25.82 Favored 'General case' 0 N--CA 1.512 2.642 0 O-C-N 121.847 -0.533 . . . . 0.0 110.644 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.8 mp -98.85 115.23 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -82.87 110.87 18.24 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 44.4 t -105.54 135.69 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.032 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.1 mp -124.71 159.76 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.503 2.205 0 CA-C-O 117.937 -1.03 . . . . 0.0 110.35 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 43.3 t . . . . . 0 N--CA 1.502 2.129 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.485 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 0.8 OUTLIER -108.31 112.89 25.58 Favored 'General case' 0 N--CA 1.507 2.42 0 C-N-CA 120.251 -0.579 . . . . 0.0 109.56 179.289 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -69.91 120.43 15.63 Favored 'General case' 0 N--CA 1.504 2.242 0 CA-C-O 120.926 0.393 . . . . 0.0 110.485 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.0 pttt -130.92 161.55 31.63 Favored 'General case' 0 N--CA 1.502 2.133 0 CA-C-O 121.624 0.726 . . . . 0.0 111.068 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 32.55 72.38 0.08 Allowed 'General case' 0 N--CA 1.518 2.942 0 C-N-CA 124.213 1.005 . . . . 0.0 113.31 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -136.5 80.79 37.87 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.739 -0.601 . . . . 0.0 110.972 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -66.08 102.32 0.54 Allowed 'Trans proline' 0 N--CA 1.491 1.378 0 N-CA-C 108.455 -1.402 . . . . 0.0 108.455 178.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.45 ' CB ' ' HD3' ' A' ' 10' ' ' PRO . 0.3 OUTLIER -53.15 -67.82 0.53 Allowed Pre-proline 0 N--CA 1.509 2.5 0 CA-C-O 116.732 -1.604 . . . . 0.0 112.401 -177.219 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.45 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.4 Cg_endo -74.88 95.14 0.96 Allowed 'Trans proline' 0 N--CA 1.498 1.749 0 CA-C-N 121.54 1.586 . . . . 0.0 111.123 178.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -100.49 179.51 4.42 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.96 -1.087 . . . . 0.0 110.389 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -159.61 124.68 4.06 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.852 -0.53 . . . . 0.0 111.921 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -124.18 -169.04 1.89 Allowed 'General case' 0 N--CA 1.505 2.315 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.0 tttt -106.04 137.18 44.41 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.598 0.713 . . . . 0.0 111.542 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -62.18 115.87 4.5 Favored 'General case' 0 N--CA 1.508 2.471 0 CA-C-O 121.105 0.478 . . . . 0.0 110.168 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.0 22.4 23.12 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -118.3 165.31 14.0 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 118.371 1.086 . . . . 0.0 110.851 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -83.3 99.34 9.94 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 177.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.26 169.07 9.38 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.315 0.579 . . . . 0.0 112.197 -177.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 88.5 t -142.01 141.05 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.2 mt -97.01 114.18 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 178.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.405 ' HA ' ' CE2' ' A' ' 57' ' ' TYR . 46.8 t -75.41 120.41 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.64 -176.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.0 t -162.4 89.91 0.71 Allowed 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.88 142.88 27.28 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.0 t -147.34 132.61 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.485 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 48.9 t -93.63 75.54 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.1 m -77.6 163.96 25.78 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.5 t -45.44 -83.58 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.145 0 O-C-N 121.895 -0.503 . . . . 0.0 111.189 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -167.06 -64.37 0.01 OUTLIER Pre-proline 0 N--CA 1.513 2.712 0 CA-C-O 117.61 -1.186 . . . . 0.0 111.686 177.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -59.6 -53.15 3.61 Favored 'Trans proline' 0 CA--C 1.563 1.969 0 CA-C-N 120.235 1.12 . . . . 0.0 112.682 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.73 -163.73 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 120.601 0.867 . . . . 0.0 112.611 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -169.94 -168.76 0.79 Allowed 'General case' 0 N--CA 1.518 2.95 0 O-C-N 121.932 -0.48 . . . . 0.0 110.283 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 tt -97.52 164.24 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 86.6 mt -129.34 129.66 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.433 ' CE2' ' HB2' ' A' ' 58' ' ' LEU . 84.6 m95 -91.95 101.03 13.59 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.8 tttt . . . . . 0 N--CA 1.5 2.068 0 CA-C-O 121.065 0.46 . . . . 0.0 110.493 -179.134 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.1 m . . . . . 0 N--CA 1.509 2.494 0 CA-C-O 120.77 0.319 . . . . 0.0 110.618 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.3 mm -58.91 -17.76 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.757 0 O-C-N 121.578 -0.702 . . . . 0.0 111.679 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.9 mp -92.53 -22.47 19.53 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.48 -0.762 . . . . 0.0 110.986 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.6 pttt -98.03 -42.27 7.57 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.574 -0.704 . . . . 0.0 109.635 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 20.1 mmmt 46.37 56.49 6.28 Favored 'General case' 0 N--CA 1.51 2.55 0 CA-C-O 121.457 0.646 . . . . 0.0 112.038 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -52.19 169.58 0.07 Allowed 'General case' 0 N--CA 1.515 2.798 0 O-C-N 121.694 -0.628 . . . . 0.0 110.968 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.8 m -61.99 -19.25 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.638 0 O-C-N 121.975 -0.453 . . . . 0.0 111.893 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.1 ptt-85 -116.93 46.49 1.65 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.678 -0.639 . . . . 0.0 111.703 -179.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -143.8 102.99 4.0 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.609 -0.682 . . . . 0.0 109.501 178.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 71.3 mt -128.17 113.22 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.4 t -78.62 127.37 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 65.1 mt -78.82 165.51 23.47 Favored 'General case' 0 N--CA 1.508 2.473 0 CA-C-O 121.224 0.535 . . . . 0.0 112.169 -177.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.2 p -60.16 -21.59 61.84 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 122.196 -0.315 . . . . 0.0 111.505 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -91.39 19.04 6.42 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.676 -0.64 . . . . 0.0 111.526 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.0 m120 68.11 31.48 5.38 Favored 'General case' 0 N--CA 1.516 2.851 0 O-C-N 121.661 -0.649 . . . . 0.0 112.145 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.405 ' CE2' ' HA ' ' A' ' 22' ' ' VAL . 4.0 m-85 -102.12 165.21 11.28 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.433 ' HB2' ' CE2' ' A' ' 35' ' ' TRP . 21.9 tp -120.65 98.68 6.14 Favored 'General case' 0 N--CA 1.517 2.908 0 C-N-CA 119.341 -0.944 . . . . 0.0 112.008 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.18 104.97 6.96 Favored 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.991 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 98.9 mt -96.56 113.63 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 177.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -77.08 115.95 17.32 Favored 'General case' 0 N--CA 1.503 2.224 0 CA-C-O 121.394 0.616 . . . . 0.0 111.287 -178.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.53 -37.02 3.65 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.409 HG22 ' O ' ' A' ' 63' ' ' ILE . 3.6 tp 40.11 84.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.521 3.095 0 CA-C-O 122.133 0.968 . . . . 0.0 112.44 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 45.6 mttt -75.99 160.08 30.2 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 121.631 -0.668 . . . . 0.0 112.151 -178.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.8 tttm -60.86 -25.6 66.79 Favored 'General case' 0 N--CA 1.51 2.564 0 O-C-N 122.022 -0.424 . . . . 0.0 110.974 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 63.9 p -80.14 -16.9 53.92 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 121.859 -0.525 . . . . 0.0 111.56 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.25 -29.47 26.46 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.51 -0.743 . . . . 0.0 110.509 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -61.72 140.68 58.17 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.884 -0.51 . . . . 0.0 111.18 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 169.06 -101.39 0.17 Allowed Glycine 0 N--CA 1.497 2.765 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.3 m -151.23 100.6 2.77 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 122.079 -0.659 . . . . 0.0 110.382 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -81.64 140.05 34.63 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.2 ttm-85 -102.44 121.09 41.64 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 120.059 -0.656 . . . . 0.0 111.511 -179.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 9.8 m -86.1 130.1 34.64 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 177.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -131.38 90.47 2.87 Favored 'General case' 0 N--CA 1.506 2.331 0 CA-C-N 118.783 0.719 . . . . 0.0 110.526 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.2 106.27 1.74 Allowed Glycine 0 N--CA 1.504 3.208 0 N-CA-C 107.827 -2.109 . . . . 0.0 107.827 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 . . . . . 0 N--CA 1.504 2.24 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -177.12 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.8 m120 . . . . . 0 N--CA 1.498 1.952 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -161.9 -179.25 7.02 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 120.009 -0.676 . . . . 0.0 112.221 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.0 mttt -165.76 160.39 17.11 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -104.17 113.36 26.86 Favored 'General case' 0 N--CA 1.511 2.612 0 O-C-N 121.896 -0.502 . . . . 0.0 110.213 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.0 mp -100.89 116.74 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -82.96 122.09 27.84 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 44.6 t -116.01 126.5 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.16 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 71.0 mt -115.68 155.75 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.499 1.975 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.71 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 48.4 t . . . . . 0 N--CA 1.504 2.243 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.3 mtp -114.81 106.56 14.33 Favored 'General case' 0 N--CA 1.513 2.698 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -66.38 119.16 11.11 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.959 -0.463 . . . . 0.0 110.747 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.87 156.2 45.44 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-O 121.578 0.704 . . . . 0.0 110.558 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.6 t30 39.13 87.75 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.051 0 C-N-CA 123.404 0.682 . . . . 0.0 112.193 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -143.04 61.36 10.32 Favored Pre-proline 0 N--CA 1.497 1.917 0 C-N-CA 119.91 -0.716 . . . . 0.0 112.332 -178.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -64.68 93.34 0.2 Allowed 'Trans proline' 0 N--CA 1.494 1.506 0 N-CA-C 107.972 -1.588 . . . . 0.0 107.972 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.493 ' OG1' ' HD3' ' A' ' 10' ' ' PRO . 18.3 p -53.04 -42.79 92.53 Favored Pre-proline 0 N--CA 1.508 2.472 0 CA-C-O 117.343 -1.313 . . . . 0.0 113.631 -176.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.493 ' HD3' ' OG1' ' A' ' 9' ' ' THR . 1.6 Cg_endo -82.83 86.55 1.46 Allowed 'Trans proline' 0 CA--C 1.548 1.203 0 CA-C-N 120.785 1.316 . . . . 0.0 111.051 -177.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -100.16 171.17 7.97 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 121.15 -0.969 . . . . 0.0 111.068 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -155.92 119.9 4.48 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 122.089 -0.382 . . . . 0.0 110.975 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -116.28 -171.09 1.93 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.871 -0.518 . . . . 0.0 110.196 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.0 tttm -103.68 139.58 38.76 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.492 0.663 . . . . 0.0 111.633 -178.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -59.83 125.83 25.2 Favored 'General case' 0 N--CA 1.508 2.442 0 O-C-N 121.767 -0.583 . . . . 0.0 110.815 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.24 22.04 66.16 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -113.59 160.9 18.06 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-N 118.829 1.314 . . . . 0.0 111.094 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -78.29 98.38 5.91 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.39 174.0 6.49 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.125 0.488 . . . . 0.0 111.875 -177.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 85.9 t -145.57 141.52 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 21.9 mt -95.95 116.77 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.411 ' HA ' ' CE2' ' A' ' 57' ' ' TYR . 55.6 t -75.98 121.02 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 CA-C-O 121.446 0.641 . . . . 0.0 111.42 -176.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.8 t -165.2 93.75 0.61 Allowed 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.4 139.11 31.03 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.044 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.8 t -147.08 131.95 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.2 t -94.09 74.06 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.1 m -76.18 165.93 24.2 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.1 t -47.65 -82.75 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.085 0 O-C-N 121.877 -0.515 . . . . 0.0 111.206 -179.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -166.59 -63.22 0.01 OUTLIER Pre-proline 0 N--CA 1.513 2.694 0 CA-C-O 117.661 -1.161 . . . . 0.0 111.696 178.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.22 -53.19 3.2 Favored 'Trans proline' 0 CA--C 1.561 1.852 0 CA-C-N 120.203 1.108 . . . . 0.0 112.503 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -63.45 -164.58 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.715 0 CA-C-N 119.211 0.754 . . . . 0.0 112.51 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -171.79 -164.5 0.32 Allowed 'General case' 0 N--CA 1.52 3.037 0 O-C-N 121.925 -0.484 . . . . 0.0 110.206 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 18.8 tt -103.49 136.32 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 122.038 -0.414 . . . . 0.0 110.069 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.0 mp -100.79 130.03 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.434 ' CE2' ' HB2' ' A' ' 58' ' ' LEU . 74.7 m95 -89.73 107.34 19.04 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 48.2 mttt . . . . . 0 N--CA 1.496 1.841 0 O-C-N 122.02 -0.425 . . . . 0.0 110.618 -178.732 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.506 2.332 0 CA-C-O 120.877 0.37 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 77.9 mt -60.61 -16.87 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.829 0 O-C-N 121.943 -0.473 . . . . 0.0 111.658 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.3 mp -91.43 -22.29 20.52 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.469 -0.769 . . . . 0.0 110.731 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.5 pttt -98.55 -36.43 9.91 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.71 -0.619 . . . . 0.0 109.411 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.4 mmmt 47.92 55.0 9.19 Favored 'General case' 0 N--CA 1.507 2.379 0 CA-C-O 121.405 0.622 . . . . 0.0 112.035 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.52 169.39 0.13 Allowed 'General case' 0 N--CA 1.513 2.685 0 O-C-N 121.705 -0.622 . . . . 0.0 110.81 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.7 m -63.78 -16.02 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.612 0 O-C-N 121.891 -0.506 . . . . 0.0 111.872 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.5 ptt-85 -120.07 45.05 2.27 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.585 -0.697 . . . . 0.0 111.956 -178.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -145.49 101.59 3.6 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.56 -0.712 . . . . 0.0 110.418 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.401 HG22 HD11 ' A' ' 51' ' ' ILE . 49.9 mm -125.96 113.79 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.5 t -80.02 139.4 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 31.8 mt -92.92 165.51 12.85 Favored 'General case' 0 N--CA 1.506 2.327 0 CA-C-O 121.335 0.588 . . . . 0.0 112.0 -178.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.1 p -61.09 -21.25 63.51 Favored 'General case' 0 N--CA 1.509 2.493 0 O-C-N 122.097 -0.377 . . . . 0.0 111.212 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 46.5 p-10 -89.67 16.97 6.99 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.573 -0.704 . . . . 0.0 111.503 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.6 m120 68.14 31.49 5.33 Favored 'General case' 0 N--CA 1.517 2.896 0 O-C-N 121.559 -0.713 . . . . 0.0 112.278 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.411 ' CE2' ' HA ' ' A' ' 22' ' ' VAL . 4.2 m-85 -103.68 165.64 10.91 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 177.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.434 ' HB2' ' CE2' ' A' ' 35' ' ' TRP . 23.4 tp -121.48 99.42 6.46 Favored 'General case' 0 N--CA 1.516 2.833 0 C-N-CA 119.404 -0.918 . . . . 0.0 111.901 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -76.0 105.16 6.89 Favored 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.089 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.5 mt -95.26 115.08 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.45 113.32 12.72 Favored 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.642 -177.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.66 -35.12 4.69 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 178.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.454 ' O ' HG21 ' A' ' 63' ' ' ILE . 3.1 tp 41.07 76.65 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.519 2.98 0 CA-C-N 118.15 0.975 . . . . 0.0 112.116 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.6 mtpp -59.65 147.63 36.74 Favored 'General case' 0 N--CA 1.508 2.444 0 O-C-N 121.411 -0.805 . . . . 0.0 111.769 -178.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.2 tttt -62.22 -17.46 58.34 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 122.23 -0.294 . . . . 0.0 111.037 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.8 p -90.81 -16.72 27.82 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.6 -0.688 . . . . 0.0 111.116 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.2 12.44 20.13 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.573 -0.704 . . . . 0.0 112.039 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.78 160.93 14.73 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.33 -0.856 . . . . 0.0 109.368 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 157.12 -98.68 0.18 Allowed Glycine 0 N--CA 1.495 2.625 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.7 m -153.67 102.49 2.55 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 117.52 0.66 . . . . 0.0 111.292 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -82.38 139.38 34.09 Favored 'General case' 0 N--CA 1.506 2.33 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.9 ttp180 -101.25 119.61 39.01 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.282 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 37.8 m -79.56 127.85 32.66 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 177.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.71 85.11 2.35 Favored 'General case' 0 N--CA 1.505 2.321 0 CA-C-N 119.312 0.96 . . . . 0.0 110.549 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.88 105.12 1.31 Allowed Glycine 0 N--CA 1.504 3.231 0 N-CA-C 107.688 -2.165 . . . . 0.0 107.688 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 34.4 ttp85 . . . . . 0 N--CA 1.497 1.905 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -176.823 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 N--CA 1.499 1.994 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -159.2 176.07 12.66 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 119.544 -0.862 . . . . 0.0 112.9 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.8 mttp -165.74 158.68 15.49 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -96.92 138.52 34.34 Favored 'General case' 0 N--CA 1.506 2.351 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.212 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 46.4 mm -121.04 104.73 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -71.17 113.32 8.09 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 43.5 t -110.72 132.48 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.621 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 71.7 mt -124.76 143.83 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.365 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.503 2.194 0 CA-C-O 118.043 -0.98 . . . . 0.0 110.863 -179.96 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 44.3 t . . . . . 0 N--CA 1.5 2.06 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.47 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 12.0 mmt -110.16 123.14 49.21 Favored 'General case' 0 N--CA 1.51 2.54 0 O-C-N 121.85 -0.531 . . . . 0.0 111.868 -178.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -77.26 122.11 24.62 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 120.927 0.394 . . . . 0.0 110.585 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.4 ' HG2' HG21 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -132.83 157.06 45.96 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 40.17 70.67 0.22 Allowed 'General case' 0 N--CA 1.517 2.913 0 C-N-CA 123.178 0.591 . . . . 0.0 111.956 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -130.16 71.47 82.22 Favored Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.599 -0.688 . . . . 0.0 111.017 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -64.52 108.36 1.01 Allowed 'Trans proline' 0 N--CA 1.492 1.406 0 N-CA-C 109.161 -1.13 . . . . 0.0 109.161 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.445 ' CB ' ' HD3' ' A' ' 10' ' ' PRO . 0.3 OUTLIER -63.2 -69.18 0.63 Allowed Pre-proline 0 N--CA 1.503 2.189 0 CA-C-O 116.767 -1.587 . . . . 0.0 111.5 -178.101 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.445 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.4 Cg_endo -71.52 88.34 0.75 Allowed 'Trans proline' 0 N--CA 1.492 1.432 0 CA-C-N 121.392 1.533 . . . . 0.0 111.706 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -100.66 169.45 9.02 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 120.99 -1.069 . . . . 0.0 109.192 177.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -157.01 122.35 4.64 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.708 -0.62 . . . . 0.0 111.277 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -115.21 -173.78 2.38 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.948 -0.47 . . . . 0.0 110.033 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -102.54 140.51 36.72 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.536 0.684 . . . . 0.0 111.404 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -60.16 117.78 5.55 Favored 'General case' 0 N--CA 1.51 2.535 0 O-C-N 121.985 -0.447 . . . . 0.0 110.855 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.27 22.05 36.25 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -113.81 159.69 19.52 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 118.465 1.132 . . . . 0.0 111.465 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -79.55 100.31 7.7 Favored 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 177.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -101.86 168.61 9.32 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.59 0.709 . . . . 0.0 112.386 -177.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 98.6 t -144.16 137.33 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 178.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 53.7 mt -93.89 115.85 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 178.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.416 ' HA ' ' CE2' ' A' ' 57' ' ' TYR . 43.0 t -76.41 115.49 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-O 121.492 0.663 . . . . 0.0 110.903 -176.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.1 t -161.16 81.38 0.62 Allowed 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.37 147.74 30.92 Favored 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.878 -178.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.7 t -147.64 137.73 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.47 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 25.8 t -97.7 88.95 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.52 138.58 31.66 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.7 t -94.86 14.76 20.46 Favored 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -177.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 17.3 mt -140.59 168.18 15.37 Favored Pre-proline 0 N--CA 1.503 2.22 0 O-C-N 121.164 -0.96 . . . . 0.0 111.677 -178.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -48.2 -47.37 19.82 Favored 'Trans proline' 0 N--CA 1.502 2.029 0 C-N-CA 121.616 1.544 . . . . 0.0 114.516 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -55.13 -165.43 0.01 OUTLIER 'Trans proline' 0 N--CA 1.504 2.116 0 CA-C-N 120.004 1.037 . . . . 0.0 112.794 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -169.65 -157.29 0.16 Allowed 'General case' 0 N--CA 1.518 2.935 0 O-C-N 120.556 -1.34 . . . . 0.0 111.02 -176.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.442 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 20.2 tt -78.98 166.75 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.876 -0.515 . . . . 0.0 110.796 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.44 HG22 HD11 ' A' ' 34' ' ' ILE . 38.2 mm -128.85 128.51 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.436 ' CE2' ' HB2' ' A' ' 58' ' ' LEU . 81.5 m95 -93.89 99.18 11.58 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 120.191 -0.604 . . . . 0.0 109.44 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.4 tttm . . . . . 0 N--CA 1.497 1.892 0 O-C-N 121.922 -0.486 . . . . 0.0 110.285 -179.217 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.7 m . . . . . 0 N--CA 1.51 2.527 0 CA-C-O 120.897 0.38 . . . . 0.0 110.342 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 50.6 mt -59.24 -17.24 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.812 0 O-C-N 121.746 -0.596 . . . . 0.0 111.651 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.7 mp -90.82 -23.27 20.64 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.504 -0.748 . . . . 0.0 110.882 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 53.9 pttt -97.89 -37.06 9.96 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.696 -0.627 . . . . 0.0 109.595 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm 46.49 55.26 7.72 Favored 'General case' 0 N--CA 1.51 2.529 0 CA-C-O 121.335 0.588 . . . . 0.0 112.229 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.3 163.71 0.55 Allowed 'General case' 0 N--CA 1.515 2.778 0 O-C-N 121.657 -0.652 . . . . 0.0 110.736 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.8 m -58.6 -20.77 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.779 0 O-C-N 121.868 -0.52 . . . . 0.0 111.823 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 16.8 ptt-85 -113.95 46.05 1.38 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.757 -0.59 . . . . 0.0 111.684 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -146.25 108.33 4.39 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.67 -0.644 . . . . 0.0 110.138 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 71.6 mt -130.85 107.8 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 t -74.76 134.17 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.0 mt -89.23 160.43 16.94 Favored 'General case' 0 N--CA 1.505 2.307 0 CA-C-O 121.223 0.535 . . . . 0.0 111.364 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 90.5 p -60.2 -19.74 55.56 Favored 'General case' 0 N--CA 1.508 2.459 0 O-C-N 122.091 -0.381 . . . . 0.0 111.194 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 49.8 p-10 -91.87 19.21 6.81 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.673 -0.642 . . . . 0.0 111.653 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.2 m120 70.51 29.68 3.36 Favored 'General case' 0 N--CA 1.524 3.23 0 O-C-N 121.615 -0.678 . . . . 0.0 112.681 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.416 ' CE2' ' HA ' ' A' ' 22' ' ' VAL . 4.6 m-85 -105.74 157.85 17.15 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.436 ' HB2' ' CE2' ' A' ' 35' ' ' TRP . 20.5 tp -115.61 98.94 6.99 Favored 'General case' 0 N--CA 1.517 2.912 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.164 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -75.96 100.18 4.78 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.099 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.429 HD11 HG22 ' A' ' 60' ' ' ILE . 88.3 mt -92.1 120.72 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 177.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -83.71 114.59 21.69 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 121.299 0.571 . . . . 0.0 111.308 -178.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 100.25 -37.32 3.62 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 178.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.1 tp 38.21 97.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.139 0 CA-C-O 121.862 0.839 . . . . 0.0 112.8 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.7 mmtp -90.7 150.02 21.82 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.26 -0.9 . . . . 0.0 111.172 -178.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.6 ptmt -59.48 -28.25 66.84 Favored 'General case' 0 N--CA 1.512 2.637 0 O-C-N 122.002 -0.436 . . . . 0.0 110.271 178.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.3 t -72.12 -14.97 61.98 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.897 -0.502 . . . . 0.0 110.603 178.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -99.12 -6.48 28.25 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.638 -0.664 . . . . 0.0 111.579 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -71.94 162.21 29.8 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.319 -0.863 . . . . 0.0 109.144 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 155.02 -111.97 0.51 Allowed Glycine 0 N--CA 1.496 2.691 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 16.9 m -143.62 99.16 3.37 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 122.108 -0.642 . . . . 0.0 110.867 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -79.3 133.47 36.63 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -95.4 119.41 33.85 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.671 -0.812 . . . . 0.0 111.5 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 9.1 m -81.97 129.15 34.69 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 177.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -132.36 85.99 2.29 Favored 'General case' 0 N--CA 1.507 2.409 0 CA-C-N 119.155 0.889 . . . . 0.0 110.791 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 33' ' ' ILE . . . -58.55 103.6 0.38 Allowed Glycine 0 N--CA 1.508 3.492 0 N-CA-C 108.507 -1.837 . . . . 0.0 108.507 178.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.8 ttm-85 . . . . . 0 N--CA 1.499 1.984 0 CA-C-O 122.255 1.026 . . . . 0.0 113.752 -176.744 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.7 m120 . . . . . 0 N--CA 1.505 2.3 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -160.63 175.5 12.59 Favored 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 119.507 -0.877 . . . . 0.0 112.918 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 8.1 mttp -166.58 154.8 10.21 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -99.66 114.01 26.82 Favored 'General case' 0 N--CA 1.51 2.559 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.007 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.418 ' N ' ' CD1' ' A' ' 88' ' ' ILE . 2.1 mp -102.45 123.38 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -91.96 120.32 32.51 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 48.3 t -107.73 140.53 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 C-N-CA 120.658 -0.417 . . . . 0.0 109.907 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 32.2 mm -126.18 147.52 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.41 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 N--CA 1.502 2.174 0 CA-C-O 117.962 -1.018 . . . . 0.0 108.553 179.456 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 48.0 t . . . . . 0 N--CA 1.502 2.139 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.481 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 3.1 mmt -112.54 110.65 20.96 Favored 'General case' 0 N--CA 1.509 2.494 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.242 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -69.35 115.41 8.58 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 122.114 -0.366 . . . . 0.0 110.901 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.34 160.33 32.52 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 121.723 0.773 . . . . 0.0 111.283 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 32.92 79.39 0.03 OUTLIER 'General case' 0 N--CA 1.52 3.049 0 C-N-CA 123.975 0.91 . . . . 0.0 113.35 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -142.1 78.68 16.89 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.726 -0.609 . . . . 0.0 111.103 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -66.62 104.48 0.79 Allowed 'Trans proline' 0 N--CA 1.489 1.263 0 N-CA-C 108.535 -1.371 . . . . 0.0 108.535 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.483 ' OG1' ' HD3' ' A' ' 10' ' ' PRO . 0.2 OUTLIER -55.46 -61.03 6.8 Favored Pre-proline 0 N--CA 1.505 2.304 0 CA-C-O 116.974 -1.489 . . . . 0.0 112.361 -177.586 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.483 ' HD3' ' OG1' ' A' ' 9' ' ' THR . 1.4 Cg_endo -78.66 93.75 1.09 Allowed 'Trans proline' 0 N--CA 1.493 1.443 0 CA-C-N 121.134 1.441 . . . . 0.0 111.552 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -101.2 172.17 7.16 Favored 'General case' 0 N--CA 1.508 2.445 0 O-C-N 120.911 -1.118 . . . . 0.0 109.864 178.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -148.47 125.72 11.51 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.822 -0.549 . . . . 0.0 111.587 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -127.14 -165.54 1.48 Allowed 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.07 147.59 52.64 Favored 'General case' 0 N--CA 1.517 2.897 0 CA-C-O 121.92 0.866 . . . . 0.0 111.906 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -57.96 130.47 46.68 Favored 'General case' 0 N--CA 1.507 2.411 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.209 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.3 17.8 77.34 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -109.38 155.11 21.64 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 119.182 1.491 . . . . 0.0 111.434 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -79.77 98.54 7.06 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -104.69 169.49 8.42 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.626 0.727 . . . . 0.0 112.586 -177.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 87.9 t -144.53 140.82 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 48.5 mt -96.84 114.95 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 178.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.4 t -75.5 119.35 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 CA-C-O 121.61 0.719 . . . . 0.0 110.842 -176.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.6 t -161.71 89.01 0.72 Allowed 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.41 138.77 31.14 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.193 -179.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.4 t -147.04 126.55 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.481 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 48.1 t -90.87 77.76 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.5 m -78.74 165.85 23.13 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 t -43.96 -85.51 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.177 0 O-C-N 121.753 -0.592 . . . . 0.0 111.443 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 mt -165.48 -63.06 0.01 OUTLIER Pre-proline 0 N--CA 1.512 2.657 0 CA-C-O 117.677 -1.154 . . . . 0.0 111.52 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.55 -53.37 2.88 Favored 'Trans proline' 0 CA--C 1.564 1.987 0 CA-C-N 120.102 1.072 . . . . 0.0 112.524 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.68 -163.66 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 120.541 0.827 . . . . 0.0 112.418 -179.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -171.75 -166.15 0.42 Allowed 'General case' 0 N--CA 1.518 2.937 0 O-C-N 121.861 -0.525 . . . . 0.0 110.304 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.9 tt -99.54 147.98 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 78.0 mt -111.23 127.3 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.418 ' CE2' ' HB2' ' A' ' 58' ' ' LEU . 76.8 m95 -89.9 109.69 20.69 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.0 tttm . . . . . 0 N--CA 1.502 2.146 0 CA-C-O 121.072 0.463 . . . . 0.0 110.572 -178.561 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.7 m . . . . . 0 N--CA 1.51 2.527 0 CA-C-O 121.054 0.454 . . . . 0.0 110.494 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 66.8 mt -60.56 -15.7 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.781 0 O-C-N 121.817 -0.552 . . . . 0.0 111.768 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.9 mp -90.68 -21.79 21.46 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.527 -0.733 . . . . 0.0 110.666 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.1 pttt -97.77 -35.48 10.53 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.598 -0.689 . . . . 0.0 109.733 178.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.1 mmmt 46.35 56.5 6.25 Favored 'General case' 0 N--CA 1.509 2.525 0 CA-C-O 121.382 0.61 . . . . 0.0 112.134 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -50.32 171.59 0.03 OUTLIER 'General case' 0 N--CA 1.516 2.84 0 O-C-N 121.732 -0.605 . . . . 0.0 111.491 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.5 t -65.57 -14.9 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.539 0 O-C-N 121.952 -0.468 . . . . 0.0 111.415 -179.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -115.85 -4.6 12.09 Favored 'General case' 0 N--CA 1.506 2.364 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -94.14 115.22 27.48 Favored 'General case' 0 N--CA 1.503 2.182 0 CA-C-N 119.075 0.852 . . . . 0.0 110.616 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.2 mp -137.19 106.25 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 t -73.74 128.18 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.6 mt -81.93 166.84 19.53 Favored 'General case' 0 N--CA 1.506 2.357 0 CA-C-O 121.377 0.608 . . . . 0.0 112.022 -178.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.6 p -60.66 -21.69 63.07 Favored 'General case' 0 N--CA 1.509 2.51 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.229 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 42.1 p-10 -91.55 19.03 6.61 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.665 -0.647 . . . . 0.0 111.403 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.5 m120 66.63 32.72 6.91 Favored 'General case' 0 N--CA 1.515 2.798 0 O-C-N 121.627 -0.67 . . . . 0.0 112.223 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -101.69 168.34 9.53 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.418 ' HB2' ' CE2' ' A' ' 35' ' ' TRP . 17.1 tp -121.43 96.99 5.3 Favored 'General case' 0 N--CA 1.517 2.912 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.621 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.4 104.2 6.8 Favored 'General case' 0 N--CA 1.502 2.174 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.919 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.435 HD11 HG22 ' A' ' 60' ' ' ILE . 96.5 mt -97.55 101.37 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 177.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.35 114.77 7.91 Favored 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 121.252 0.549 . . . . 0.0 110.97 -178.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.418 ' O ' HG21 ' A' ' 63' ' ' ILE . . . 101.39 -34.18 5.87 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 109.971 -1.251 . . . . 0.0 109.971 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.418 HG21 ' O ' ' A' ' 62' ' ' GLY . 1.8 tp 32.92 92.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.523 3.212 0 CA-C-N 117.925 0.863 . . . . 0.0 113.251 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm -74.23 148.25 41.72 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.697 -0.627 . . . . 0.0 110.834 -178.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -63.4 -19.13 64.42 Favored 'General case' 0 N--CA 1.508 2.455 0 C-N-CA 120.571 -0.451 . . . . 0.0 110.711 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.1 t -83.76 -12.85 55.15 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.441 -0.787 . . . . 0.0 111.105 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.43 11.03 36.36 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.49 -0.756 . . . . 0.0 111.571 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -88.0 152.73 21.83 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.286 -0.884 . . . . 0.0 109.533 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 163.95 -106.15 0.27 Allowed Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.2 m -146.51 103.85 3.71 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 122.156 -0.614 . . . . 0.0 110.654 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -83.61 128.72 34.74 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.4 tpp180 -91.77 118.37 30.62 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.179 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 85' ' ' PHE . 5.1 m -83.77 122.59 28.86 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 177.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -123.27 88.27 2.89 Favored 'General case' 0 N--CA 1.506 2.349 0 CA-C-N 118.738 0.699 . . . . 0.0 110.643 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.7 103.03 0.9 Allowed Glycine 0 N--CA 1.503 3.161 0 N-CA-C 107.653 -2.179 . . . . 0.0 107.653 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 . . . . . 0 N--CA 1.5 2.054 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -176.808 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.9 m120 . . . . . 0 N--CA 1.503 2.208 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.405 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 42.7 p90 -162.06 -179.21 6.93 Favored 'General case' 0 N--CA 1.503 2.191 0 C-N-CA 119.612 -0.835 . . . . 0.0 113.142 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.6 mttt -167.16 161.54 14.64 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -103.27 112.35 25.18 Favored 'General case' 0 N--CA 1.51 2.545 0 O-C-N 121.782 -0.574 . . . . 0.0 111.221 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.0 mp -97.06 115.62 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -85.22 117.27 24.06 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 42.7 t -111.05 135.27 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 CA-C-O 121.058 0.456 . . . . 0.0 110.045 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 47.7 mt -121.76 135.02 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.7 t . . . . . 0 N--CA 1.504 2.27 0 CA-C-O 118.308 -0.853 . . . . 0.0 109.782 -179.289 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.2 t . . . . . 0 N--CA 1.503 2.204 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.51 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 4.7 mmt -111.38 116.86 31.66 Favored 'General case' 0 N--CA 1.51 2.556 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.142 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -73.44 119.63 17.94 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 122.039 -0.413 . . . . 0.0 110.485 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -132.82 160.15 37.73 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 121.495 0.664 . . . . 0.0 111.076 -179.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 33.31 88.85 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.107 0 C-N-CA 124.013 0.925 . . . . 0.0 113.423 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -157.25 81.23 3.27 Favored Pre-proline 0 N--CA 1.495 1.806 0 C-N-CA 120.084 -0.646 . . . . 0.0 111.55 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -64.97 105.61 0.69 Allowed 'Trans proline' 0 N--CA 1.492 1.416 0 N-CA-C 108.588 -1.351 . . . . 0.0 108.588 177.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.438 ' CB ' ' HD3' ' A' ' 10' ' ' PRO . 0.2 OUTLIER -53.88 -66.91 0.71 Allowed Pre-proline 0 N--CA 1.508 2.468 0 CA-C-O 116.91 -1.519 . . . . 0.0 112.245 -177.593 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.438 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.4 Cg_endo -73.13 92.47 0.82 Allowed 'Trans proline' 0 N--CA 1.495 1.591 0 CA-C-N 121.242 1.479 . . . . 0.0 110.978 178.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -100.18 173.05 6.8 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 120.917 -1.114 . . . . 0.0 110.192 178.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -155.1 125.3 6.72 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.937 -0.477 . . . . 0.0 111.304 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -122.98 -169.73 1.98 Allowed 'General case' 0 N--CA 1.504 2.246 0 O-C-N 122.025 -0.422 . . . . 0.0 110.04 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -106.05 138.65 41.87 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.578 0.704 . . . . 0.0 111.507 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -60.13 126.6 28.13 Favored 'General case' 0 N--CA 1.509 2.498 0 O-C-N 121.717 -0.614 . . . . 0.0 110.739 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.36 21.14 62.96 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -112.85 161.63 16.72 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 118.811 1.306 . . . . 0.0 111.31 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.88 98.66 7.2 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 177.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -101.56 169.02 9.12 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 120.15 -0.62 . . . . 0.0 112.109 -177.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 84.1 t -142.23 140.68 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 178.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 43.9 mt -96.62 115.34 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.419 ' HA ' ' CE2' ' A' ' 57' ' ' TYR . 57.3 t -76.41 116.98 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 CA-C-O 121.355 0.598 . . . . 0.0 110.536 -177.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.2 t -160.67 89.82 0.83 Allowed 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.53 141.56 28.52 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.5 t -147.11 129.18 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.51 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 26.4 t -90.41 75.17 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.8 m -79.53 162.22 25.52 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 178.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 t -43.18 -85.04 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.25 0 O-C-N 121.844 -0.535 . . . . 0.0 111.433 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.3 mt -166.77 -63.56 0.01 OUTLIER Pre-proline 0 N--CA 1.512 2.658 0 CA-C-O 117.747 -1.121 . . . . 0.0 111.1 177.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -59.65 -53.37 3.39 Favored 'Trans proline' 0 CA--C 1.565 2.05 0 CA-C-N 120.113 1.076 . . . . 0.0 112.347 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -61.02 -165.65 0.04 OUTLIER 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 120.685 0.923 . . . . 0.0 112.358 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -170.64 -161.3 0.23 Allowed 'General case' 0 N--CA 1.523 3.197 0 C-N-CA 120.134 -0.626 . . . . 0.0 111.045 -179.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.2 tt -111.3 137.39 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.978 -0.451 . . . . 0.0 110.249 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 70.6 mt -94.56 129.98 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -94.66 103.46 15.39 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.181 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.6 tptm . . . . . 0 N--CA 1.497 1.888 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 177.54 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.8 m . . . . . 0 N--CA 1.508 2.437 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.9 mm -57.7 -18.92 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.778 0 O-C-N 121.889 -0.507 . . . . 0.0 111.854 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.8 mp -89.05 -25.34 22.0 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.581 -0.699 . . . . 0.0 110.767 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.5 pttt -98.67 -39.82 8.49 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.775 -0.578 . . . . 0.0 109.957 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.5 mmmt 47.75 55.01 9.05 Favored 'General case' 0 N--CA 1.511 2.623 0 CA-C-O 121.593 0.711 . . . . 0.0 111.569 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.15 169.47 0.17 Allowed 'General case' 0 N--CA 1.511 2.61 0 O-C-N 121.724 -0.61 . . . . 0.0 110.81 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 29.4 m -62.55 -20.55 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.534 0 O-C-N 122.052 -0.405 . . . . 0.0 111.601 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.9 ptp85 -113.51 46.6 1.25 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.735 -0.603 . . . . 0.0 112.055 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -144.93 107.02 4.31 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.685 -0.634 . . . . 0.0 109.778 178.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 66.3 mt -128.93 104.82 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.1 t -73.95 132.16 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.9 mt -85.91 166.66 15.79 Favored 'General case' 0 N--CA 1.508 2.431 0 O-C-N 121.786 -0.571 . . . . 0.0 111.699 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.8 p -61.57 -21.43 64.3 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 122.204 -0.31 . . . . 0.0 111.137 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -90.93 18.15 6.99 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.614 -0.679 . . . . 0.0 111.46 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.0 m120 67.98 32.54 5.03 Favored 'General case' 0 N--CA 1.517 2.899 0 O-C-N 121.596 -0.69 . . . . 0.0 112.189 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.419 ' CE2' ' HA ' ' A' ' 22' ' ' VAL . 4.0 m-85 -102.75 162.79 12.64 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 177.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 17.4 tp -118.2 98.37 6.26 Favored 'General case' 0 N--CA 1.517 2.913 0 C-N-CA 119.276 -0.97 . . . . 0.0 111.591 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.01 97.98 4.82 Favored 'General case' 0 N--CA 1.501 2.12 0 C-N-CA 120.391 -0.523 . . . . 0.0 110.84 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.0 mt -89.09 119.64 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.0 tpp180 -80.14 115.43 19.69 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 121.369 0.604 . . . . 0.0 110.707 -178.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.04 -33.28 5.87 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.9 tp 37.85 72.02 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.521 3.108 0 CA-C-N 118.155 0.978 . . . . 0.0 112.861 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.6 mtpp -62.77 158.34 18.96 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 121.751 -0.593 . . . . 0.0 112.187 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 45.2 tttt -62.35 -24.14 67.18 Favored 'General case' 0 N--CA 1.509 2.521 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.908 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 48.0 p -82.86 -15.91 49.67 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.894 -0.504 . . . . 0.0 111.056 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -88.69 -21.67 23.78 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.672 -0.642 . . . . 0.0 110.998 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -66.74 151.14 48.03 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.519 -0.738 . . . . 0.0 110.312 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 164.24 -115.73 0.66 Allowed Glycine 0 N--CA 1.498 2.787 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.6 m -138.4 100.55 4.14 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.94 -0.741 . . . . 0.0 110.431 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -83.22 135.68 34.69 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.6 ttm105 -103.81 119.61 39.28 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.749 -0.78 . . . . 0.0 111.003 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 19.6 m -78.51 122.64 26.12 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 177.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -121.43 84.26 2.21 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 121.216 0.532 . . . . 0.0 110.695 -178.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.44 117.27 8.74 Favored Glycine 0 N--CA 1.504 3.178 0 N-CA-C 108.062 -2.015 . . . . 0.0 108.062 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.6 ttp180 . . . . . 0 N--CA 1.498 1.938 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -177.315 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 N--CA 1.499 2.016 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -167.26 174.96 7.68 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.538 -0.726 . . . . 0.0 112.556 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -166.71 155.1 10.2 Favored 'General case' 0 N--CA 1.503 2.221 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -91.78 120.38 32.45 Favored 'General case' 0 N--CA 1.512 2.669 0 O-C-N 121.839 -0.538 . . . . 0.0 111.933 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.1 mp -102.91 120.51 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -87.69 114.81 24.66 Favored 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 32.5 t -107.96 133.88 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.07 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 74.0 mt -125.62 156.72 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.498 1.937 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.578 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 62.3 t . . . . . 0 N--CA 1.505 2.297 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.414 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 11.5 mmm -107.52 114.72 28.9 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 122.032 -0.418 . . . . 0.0 109.953 -178.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -68.45 119.2 12.55 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.935 -0.478 . . . . 0.0 109.892 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.2 pttt -129.43 161.54 30.14 Favored 'General case' 0 N--CA 1.503 2.201 0 CA-C-O 121.693 0.758 . . . . 0.0 111.482 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 32.85 51.39 0.26 Allowed 'General case' 0 N--CA 1.517 2.917 0 C-N-CA 124.134 0.974 . . . . 0.0 113.243 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -116.64 81.89 12.02 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.725 -0.61 . . . . 0.0 110.645 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -65.54 107.33 1.01 Allowed 'Trans proline' 0 N--CA 1.491 1.373 0 N-CA-C 109.142 -1.138 . . . . 0.0 109.142 178.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.451 ' CB ' ' HD3' ' A' ' 10' ' ' PRO . 0.3 OUTLIER -60.19 -67.84 0.93 Allowed Pre-proline 0 N--CA 1.505 2.311 0 CA-C-O 116.802 -1.57 . . . . 0.0 110.985 -178.336 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.451 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.5 Cg_endo -73.8 89.63 0.99 Allowed 'Trans proline' 0 CA--C 1.559 1.739 0 CA-C-N 121.385 1.53 . . . . 0.0 110.67 177.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -98.44 178.65 4.96 Favored 'General case' 0 N--CA 1.508 2.45 0 O-C-N 120.675 -1.266 . . . . 0.0 110.193 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -159.38 124.53 4.13 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 120.294 -0.562 . . . . 0.0 112.03 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -122.54 -165.21 1.26 Allowed 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.49 137.43 53.2 Favored 'General case' 0 N--CA 1.514 2.765 0 CA-C-O 121.734 0.778 . . . . 0.0 110.941 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -55.32 140.2 40.23 Favored 'General case' 0 N--CA 1.511 2.604 0 O-C-N 121.707 -0.62 . . . . 0.0 111.352 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.13 12.27 81.59 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -106.93 157.47 17.76 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 119.332 1.566 . . . . 0.0 111.821 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -80.07 95.15 6.11 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 176.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.09 169.73 9.2 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.191 0.519 . . . . 0.0 112.204 -176.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 85.3 t -139.75 140.73 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 27.7 mt -93.17 115.64 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 105.969 -1.864 . . . . 0.0 105.969 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.423 ' HA ' ' CE2' ' A' ' 57' ' ' TYR . 48.1 t -77.54 119.68 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 CA-C-O 121.446 0.641 . . . . 0.0 110.618 -176.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.6 t -161.33 92.18 0.89 Allowed 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.04 145.43 25.09 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 -179.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.6 t -146.42 119.92 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.414 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 21.2 t -75.9 73.46 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 178.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.4 m -84.09 157.24 21.82 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.6 t -47.46 -79.4 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.078 0 O-C-N 121.762 -0.586 . . . . 0.0 111.385 -178.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -172.94 -61.02 0.0 OUTLIER Pre-proline 0 N--CA 1.514 2.758 0 CA-C-O 117.918 -1.039 . . . . 0.0 111.018 177.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.09 -53.97 3.13 Favored 'Trans proline' 0 CA--C 1.563 1.935 0 CA-C-N 119.7 0.928 . . . . 0.0 112.634 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -61.99 -166.41 0.05 OUTLIER 'Trans proline' 0 N--CA 1.501 1.936 0 CA-C-N 119.322 0.794 . . . . 0.0 111.545 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -170.7 -164.93 0.4 Allowed 'General case' 0 N--CA 1.518 2.966 0 O-C-N 121.7 -0.625 . . . . 0.0 110.078 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.9 tt -105.1 158.22 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.992 -0.443 . . . . 0.0 110.023 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 68.8 mt -125.58 118.89 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.45 ' CE2' ' HB2' ' A' ' 58' ' ' LEU . 83.0 m95 -81.6 102.15 10.46 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.2 tttt . . . . . 0 N--CA 1.499 1.978 0 CA-C-O 121.222 0.534 . . . . 0.0 110.906 -178.785 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.5 m . . . . . 0 N--CA 1.509 2.519 0 CA-C-O 120.792 0.33 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 73.5 mt -59.79 -16.6 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.83 0 O-C-N 121.624 -0.673 . . . . 0.0 111.656 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.6 mp -91.45 -23.39 20.02 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.433 -0.792 . . . . 0.0 110.732 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -97.86 -38.95 9.24 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.697 -0.627 . . . . 0.0 109.379 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 17.5 mmmt 46.35 55.55 7.27 Favored 'General case' 0 N--CA 1.51 2.559 0 CA-C-O 121.438 0.637 . . . . 0.0 112.228 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.33 165.76 0.33 Allowed 'General case' 0 N--CA 1.513 2.688 0 O-C-N 121.782 -0.574 . . . . 0.0 111.106 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.5 m -58.85 -20.88 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.699 0 O-C-N 122.018 -0.426 . . . . 0.0 111.856 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 5.0 ptt-85 -115.79 47.22 1.39 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.791 -0.568 . . . . 0.0 111.886 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -146.26 101.56 3.51 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.645 -0.659 . . . . 0.0 109.796 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 62.5 mt -125.92 113.42 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.4 t -79.49 128.05 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.5 mt -80.56 164.1 23.19 Favored 'General case' 0 N--CA 1.506 2.354 0 CA-C-O 121.195 0.521 . . . . 0.0 111.601 -178.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 96.6 p -60.0 -20.63 58.76 Favored 'General case' 0 N--CA 1.511 2.618 0 O-C-N 122.139 -0.351 . . . . 0.0 111.336 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.7 p-10 -91.19 19.44 5.87 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.721 -0.612 . . . . 0.0 111.43 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.8 m120 66.64 32.87 6.81 Favored 'General case' 0 N--CA 1.515 2.806 0 O-C-N 121.607 -0.683 . . . . 0.0 112.165 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.423 ' CE2' ' HA ' ' A' ' 22' ' ' VAL . 3.9 m-85 -103.4 168.82 8.92 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.45 ' HB2' ' CE2' ' A' ' 35' ' ' TRP . 18.0 tp -124.77 98.47 5.72 Favored 'General case' 0 N--CA 1.515 2.788 0 C-N-CA 119.29 -0.964 . . . . 0.0 112.241 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.79 100.16 3.96 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 120.77 0.319 . . . . 0.0 110.825 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 97.3 mt -92.7 110.9 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 178.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.27 113.89 9.8 Favored 'General case' 0 N--CA 1.504 2.261 0 CA-C-O 121.386 0.612 . . . . 0.0 111.343 -178.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.36 -38.3 3.15 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.404 ' O ' HG21 ' A' ' 63' ' ' ILE . 1.5 tp 41.84 67.24 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.927 0 CA-C-O 122.145 0.974 . . . . 0.0 112.544 -178.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.5 mttm -58.35 157.38 8.71 Favored 'General case' 0 N--CA 1.51 2.557 0 CA-C-O 121.398 0.618 . . . . 0.0 112.611 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.8 ttmm -62.06 -21.81 65.24 Favored 'General case' 0 N--CA 1.509 2.486 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.97 178.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.1 p -83.78 -18.86 36.31 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.802 -0.561 . . . . 0.0 110.96 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.75 -5.7 56.72 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.653 -0.655 . . . . 0.0 111.607 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -81.7 137.01 35.46 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 119.006 0.821 . . . . 0.0 109.619 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 176.97 -111.39 0.33 Allowed Glycine 0 N--CA 1.499 2.863 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.0 m -138.8 104.1 5.0 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 122.034 -0.686 . . . . 0.0 110.708 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -86.8 135.89 33.19 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -93.72 118.62 31.65 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.21 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 85' ' ' PHE . 3.4 m -86.48 91.33 8.51 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 178.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -91.53 88.45 6.78 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.842 -0.536 . . . . 0.0 109.929 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.47 96.3 0.82 Allowed Glycine 0 N--CA 1.5 2.95 0 N-CA-C 107.311 -2.315 . . . . 0.0 107.311 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.7 ttm180 . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 122.031 0.919 . . . . 0.0 113.198 -176.921 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.9 m120 . . . . . 0 N--CA 1.507 2.401 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.427 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 36.1 p90 -161.1 171.93 17.68 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.534 -0.729 . . . . 0.0 112.4 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.9 mttp -165.78 159.0 15.7 Favored 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -103.94 121.29 42.81 Favored 'General case' 0 N--CA 1.512 2.662 0 O-C-N 121.757 -0.589 . . . . 0.0 110.756 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.8 mp -105.46 121.49 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -85.26 111.46 19.87 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.7 t -104.73 127.75 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.097 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 72.2 mt -117.17 159.71 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.501 2.092 0 CA-C-O 117.922 -1.037 . . . . 0.0 110.496 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 49.0 t . . . . . 0 N--CA 1.501 2.105 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.469 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 17.8 mmm -112.53 111.22 21.89 Favored 'General case' 0 N--CA 1.506 2.371 0 C-N-CA 120.501 -0.479 . . . . 0.0 110.475 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -70.91 116.5 11.28 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 122.041 -0.412 . . . . 0.0 110.841 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -124.8 155.3 39.6 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 121.531 0.681 . . . . 0.0 110.133 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 41.85 86.04 0.02 OUTLIER 'General case' 0 N--CA 1.52 3.044 0 C-N-CA 123.073 0.549 . . . . 0.0 111.803 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -131.95 62.9 66.62 Favored Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 121.696 -0.627 . . . . 0.0 112.155 -178.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -66.28 89.83 0.26 Allowed 'Trans proline' 0 N--CA 1.494 1.543 0 N-CA-C 108.162 -1.514 . . . . 0.0 108.162 177.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.49 ' OG1' ' HD3' ' A' ' 10' ' ' PRO . 13.6 p -59.47 -43.34 95.89 Favored Pre-proline 0 N--CA 1.508 2.459 0 CA-C-O 117.382 -1.294 . . . . 0.0 113.156 -177.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.49 ' HD3' ' OG1' ' A' ' 9' ' ' THR . 1.7 Cg_endo -81.8 82.88 2.23 Favored 'Trans proline' 0 CA--C 1.549 1.251 0 CA-C-N 120.651 1.268 . . . . 0.0 111.332 -177.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -100.73 170.52 8.29 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.163 -0.96 . . . . 0.0 110.978 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -155.3 124.34 6.2 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 122.002 -0.436 . . . . 0.0 110.996 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -122.49 -169.59 1.93 Allowed 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.912 -0.493 . . . . 0.0 109.778 179.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -115.96 145.61 42.79 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.479 0.657 . . . . 0.0 111.67 -178.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -61.44 121.24 12.18 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 121.947 -0.471 . . . . 0.0 110.399 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.35 20.61 51.6 Favored Glycine 0 N--CA 1.497 2.714 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -179.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -112.37 158.1 20.22 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 118.619 1.21 . . . . 0.0 111.212 -179.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -80.45 98.09 7.38 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 177.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -102.9 165.5 11.0 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 120.169 -0.612 . . . . 0.0 112.398 -177.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.8 t -140.0 143.26 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 178.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 47.1 mt -99.96 113.24 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 178.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.4 t -73.22 120.15 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 CA-C-O 121.513 0.673 . . . . 0.0 111.057 -176.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.0 t -165.09 93.12 0.6 Allowed 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.15 140.79 29.11 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.314 -179.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.7 t -148.83 133.24 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.469 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 59.5 t -99.85 78.71 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.8 m -79.23 165.71 22.95 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.9 t -43.56 -82.31 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.19 0 O-C-N 121.899 -0.501 . . . . 0.0 111.509 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -167.73 -63.27 0.01 OUTLIER Pre-proline 0 N--CA 1.513 2.708 0 CA-C-O 117.778 -1.106 . . . . 0.0 111.661 177.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.1 -53.13 3.32 Favored 'Trans proline' 0 CA--C 1.563 1.939 0 CA-C-N 120.107 1.074 . . . . 0.0 112.676 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -62.57 -163.98 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.794 0 CA-C-N 119.268 0.774 . . . . 0.0 112.634 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -169.95 -160.13 0.22 Allowed 'General case' 0 N--CA 1.519 3.017 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.21 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.7 tt -107.98 145.19 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.924 -0.485 . . . . 0.0 110.036 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.0 mt -104.59 130.43 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.436 ' HB2' ' CG2' ' A' ' 42' ' ' VAL . 55.8 m95 -96.02 119.37 34.38 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.217 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.6 tptt . . . . . 0 N--CA 1.498 1.935 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.274 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.436 ' CG2' ' HB2' ' A' ' 35' ' ' TRP . 8.4 m . . . . . 0 N--CA 1.505 2.307 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.6 mm -57.95 -19.41 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.683 0 O-C-N 122.028 -0.42 . . . . 0.0 111.796 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.9 mp -90.59 -24.96 20.41 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.562 -0.711 . . . . 0.0 110.843 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 41.6 pttt -99.03 -39.97 8.26 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.665 -0.647 . . . . 0.0 109.802 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm 49.6 54.51 10.89 Favored 'General case' 0 N--CA 1.509 2.523 0 CA-C-O 121.464 0.649 . . . . 0.0 111.744 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -53.49 164.21 0.53 Allowed 'General case' 0 N--CA 1.514 2.771 0 O-C-N 121.698 -0.626 . . . . 0.0 110.715 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.8 m -60.83 -21.0 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.728 0 O-C-N 121.943 -0.473 . . . . 0.0 111.767 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.8 ptt-85 -100.87 -8.89 22.14 Favored 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -93.47 107.61 19.43 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-N 118.852 0.751 . . . . 0.0 110.272 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 71.7 mt -128.64 105.68 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.9 t -75.17 131.51 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 37.8 mt -84.15 168.1 16.11 Favored 'General case' 0 N--CA 1.508 2.452 0 CA-C-O 121.172 0.511 . . . . 0.0 111.717 -178.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 55.3 p -61.58 -22.87 65.58 Favored 'General case' 0 N--CA 1.509 2.522 0 O-C-N 122.182 -0.324 . . . . 0.0 111.074 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 50.9 p-10 -91.25 18.42 7.03 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.825 -0.547 . . . . 0.0 111.345 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.3 m120 66.82 34.63 5.38 Favored 'General case' 0 N--CA 1.515 2.795 0 O-C-N 121.542 -0.724 . . . . 0.0 112.406 178.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -102.67 159.21 15.66 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.412 ' HB2' ' CE2' ' A' ' 35' ' ' TRP . 17.8 tp -114.01 98.31 6.9 Favored 'General case' 0 N--CA 1.515 2.815 0 C-N-CA 119.353 -0.939 . . . . 0.0 112.026 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.76 101.42 7.57 Favored 'General case' 0 N--CA 1.503 2.205 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.088 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.429 HD11 HG22 ' A' ' 60' ' ' ILE . 91.1 mt -93.58 102.43 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 177.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -68.98 114.19 7.05 Favored 'General case' 0 N--CA 1.506 2.371 0 CA-C-O 121.24 0.543 . . . . 0.0 111.378 -178.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 100.4 -34.8 5.26 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 110.079 -1.209 . . . . 0.0 110.079 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.9 tp 35.98 95.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.13 0 CA-C-N 118.001 0.901 . . . . 0.0 113.205 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -72.88 146.78 45.93 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.626 -0.671 . . . . 0.0 111.116 -178.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -63.28 -18.71 63.87 Favored 'General case' 0 N--CA 1.51 2.545 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.676 178.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 58.5 p -86.14 -16.43 37.94 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.422 -0.798 . . . . 0.0 110.859 179.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -93.18 17.45 11.02 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.601 -0.687 . . . . 0.0 111.479 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -95.72 145.03 25.62 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.581 -0.699 . . . . 0.0 109.737 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 169.6 -105.36 0.22 Allowed Glycine 0 N--CA 1.497 2.757 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.0 m -142.89 101.38 3.83 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.99 -0.712 . . . . 0.0 111.277 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -83.11 127.55 33.69 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.0 ttt180 -95.71 122.21 38.23 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 120.087 -0.645 . . . . 0.0 111.407 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 65.1 m -79.85 127.34 32.11 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 177.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -126.16 84.63 2.29 Favored 'General case' 0 N--CA 1.506 2.344 0 CA-C-N 119.245 0.929 . . . . 0.0 110.36 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.09 102.35 0.71 Allowed Glycine 0 N--CA 1.506 3.307 0 N-CA-C 107.898 -2.081 . . . . 0.0 107.898 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 . . . . . 0 N--CA 1.497 1.919 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -176.814 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 . . . . . 0 N--CA 1.503 2.186 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -159.47 -178.2 6.96 Favored 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 119.419 -0.912 . . . . 0.0 113.429 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -168.24 163.18 13.07 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -104.22 144.86 31.03 Favored 'General case' 0 N--CA 1.511 2.58 0 O-C-N 121.771 -0.581 . . . . 0.0 111.442 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 50.8 mm -126.48 106.24 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -72.52 101.1 2.89 Favored 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 25.7 t -100.25 133.51 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.438 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 72.8 mt -119.68 144.72 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 43.5 t . . . . . 0 N--CA 1.505 2.281 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.625 -179.176 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 62.4 t . . . . . 0 N--CA 1.504 2.266 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.44 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 61.4 mmm -104.16 120.21 40.63 Favored 'General case' 0 N--CA 1.509 2.484 0 O-C-N 121.831 -0.543 . . . . 0.0 110.741 -178.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -78.1 113.59 16.18 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 122.053 -0.404 . . . . 0.0 110.192 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.6 ptpt -127.61 165.93 19.02 Favored 'General case' 0 N--CA 1.503 2.182 0 CA-C-O 121.748 0.785 . . . . 0.0 112.235 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 31.26 80.27 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.959 0 C-N-CA 124.442 1.097 . . . . 0.0 113.226 179.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -154.4 81.44 4.48 Favored Pre-proline 0 N--CA 1.489 1.505 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.864 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.6 105.49 0.63 Allowed 'Trans proline' 0 N--CA 1.491 1.339 0 N-CA-C 108.58 -1.354 . . . . 0.0 108.58 178.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.446 ' CB ' ' HD3' ' A' ' 10' ' ' PRO . 0.2 OUTLIER -51.41 -64.6 1.31 Allowed Pre-proline 0 N--CA 1.509 2.481 0 CA-C-O 117.139 -1.41 . . . . 0.0 111.909 -177.563 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.446 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.6 Cg_endo -74.6 90.56 1.03 Allowed 'Trans proline' 0 CA--C 1.557 1.67 0 CA-C-N 120.974 1.384 . . . . 0.0 110.545 177.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -99.03 177.04 5.36 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 120.805 -1.185 . . . . 0.0 110.2 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -159.81 121.29 3.22 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.855 -0.528 . . . . 0.0 111.856 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -116.2 -169.89 1.7 Allowed 'General case' 0 N--CA 1.504 2.259 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -103.43 137.12 41.95 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.553 0.692 . . . . 0.0 111.524 -178.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -61.06 113.97 2.85 Favored 'General case' 0 N--CA 1.509 2.484 0 O-C-N 121.897 -0.502 . . . . 0.0 110.539 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.16 23.33 22.61 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.526 -1.029 . . . . 0.0 110.526 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -117.88 164.83 14.46 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 118.335 1.068 . . . . 0.0 110.998 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -80.47 99.31 7.95 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 177.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.77 167.44 10.77 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.454 0.645 . . . . 0.0 112.119 -177.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 87.5 t -143.72 133.84 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 178.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 42.1 mt -90.35 115.18 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 178.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.407 ' HA ' ' CE2' ' A' ' 57' ' ' TYR . 54.4 t -74.83 120.99 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.852 -176.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -162.19 91.74 0.8 Allowed 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.59 140.6 29.6 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.5 t -146.35 124.0 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.44 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 45.3 t -82.45 77.51 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.1 m -87.47 154.64 20.48 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.6 t -43.88 -85.69 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.255 0 O-C-N 121.919 -0.488 . . . . 0.0 112.294 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.2 mt -165.4 -62.51 0.01 OUTLIER Pre-proline 0 N--CA 1.51 2.555 0 CA-C-O 117.711 -1.137 . . . . 0.0 111.24 178.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -59.4 -53.45 3.46 Favored 'Trans proline' 0 CA--C 1.561 1.864 0 CA-C-N 120.091 1.068 . . . . 0.0 112.307 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -62.91 -170.07 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.668 0 CA-C-N 119.286 0.781 . . . . 0.0 111.467 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -171.17 -165.41 0.41 Allowed 'General case' 0 N--CA 1.519 2.979 0 O-C-N 121.767 -0.583 . . . . 0.0 109.647 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.3 tt -99.11 161.03 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 66.2 mt -128.74 121.04 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.406 ' CE2' ' HB2' ' A' ' 58' ' ' LEU . 83.5 m95 -85.51 113.13 21.53 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 120.49 -0.484 . . . . 0.0 109.778 -179.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 50.9 mttt . . . . . 0 N--CA 1.502 2.16 0 O-C-N 121.79 -0.569 . . . . 0.0 111.539 -178.929 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.6 m . . . . . 0 N--CA 1.509 2.491 0 CA-C-O 121.022 0.439 . . . . 0.0 110.695 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 71.1 mt -59.43 -18.08 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.769 0 O-C-N 121.711 -0.618 . . . . 0.0 111.738 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.4 mp -92.57 -21.35 20.14 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.455 -0.778 . . . . 0.0 111.119 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 42.8 pttt -98.06 -37.43 9.75 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.633 -0.667 . . . . 0.0 109.233 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.4 mmmt 48.05 54.75 9.65 Favored 'General case' 0 N--CA 1.509 2.493 0 CA-C-O 121.421 0.629 . . . . 0.0 111.824 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -51.83 168.29 0.09 Allowed 'General case' 0 N--CA 1.515 2.789 0 O-C-N 121.867 -0.521 . . . . 0.0 110.943 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.8 m -61.16 -18.77 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.689 0 O-C-N 121.976 -0.452 . . . . 0.0 111.799 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 29.6 ptt-85 -121.26 46.82 1.96 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.728 -0.607 . . . . 0.0 111.973 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -145.36 106.97 4.23 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.574 -0.704 . . . . 0.0 110.156 178.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 82.7 mt -129.66 107.99 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.0 t -76.17 131.66 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.5 mt -85.02 164.43 18.25 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.909 -0.494 . . . . 0.0 111.49 -178.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.3 p -62.03 -20.68 64.19 Favored 'General case' 0 N--CA 1.509 2.48 0 O-C-N 122.102 -0.374 . . . . 0.0 110.812 178.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 50.3 p30 -88.17 13.58 11.06 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.721 -0.612 . . . . 0.0 111.528 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.3 m120 71.09 33.94 1.94 Allowed 'General case' 0 N--CA 1.518 2.968 0 O-C-N 121.547 -0.72 . . . . 0.0 112.493 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.407 ' CE2' ' HA ' ' A' ' 22' ' ' VAL . 5.3 m-85 -106.0 163.77 12.5 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 177.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.406 ' HB2' ' CE2' ' A' ' 35' ' ' TRP . 18.1 tp -118.07 97.54 5.86 Favored 'General case' 0 N--CA 1.519 3.005 0 C-N-CA 119.381 -0.928 . . . . 0.0 111.218 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.39 99.49 4.16 Favored 'General case' 0 N--CA 1.501 2.081 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.763 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 92.6 mt -90.75 118.95 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 177.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.8 tpt85 -81.2 113.06 19.09 Favored 'General case' 0 N--CA 1.501 2.092 0 CA-C-O 121.29 0.566 . . . . 0.0 111.012 -178.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.55 -37.28 3.6 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.418 ' O ' HG21 ' A' ' 63' ' ' ILE . 3.2 tp 41.6 94.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.521 3.08 0 CA-C-N 118.126 0.963 . . . . 0.0 112.253 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.2 mttm -86.87 157.45 19.53 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 121.233 -0.917 . . . . 0.0 112.693 -177.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.6 tttp -61.68 -27.38 68.65 Favored 'General case' 0 N--CA 1.508 2.453 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.12 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.5 t -81.11 -11.74 59.41 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 121.896 -0.503 . . . . 0.0 111.601 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.64 -17.54 20.31 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.534 -0.729 . . . . 0.0 111.482 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -68.75 148.28 50.58 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.36 -0.837 . . . . 0.0 109.933 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 167.01 -107.15 0.28 Allowed Glycine 0 N--CA 1.496 2.695 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.9 m -145.26 104.2 3.92 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 122.023 -0.692 . . . . 0.0 110.864 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -85.44 138.02 32.53 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -97.42 120.29 37.52 Favored 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.447 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 85' ' ' PHE . 2.9 m -87.31 105.73 17.45 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -104.63 85.97 2.41 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.298 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.29 87.96 0.25 Allowed Glycine 0 N--CA 1.499 2.899 0 N-CA-C 107.674 -2.17 . . . . 0.0 107.674 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.706 0.765 . . . . 0.0 112.967 -176.961 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 N--CA 1.504 2.266 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.43 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 35.4 p90 -164.12 176.69 9.04 Favored 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.2 pttt -170.53 167.13 8.17 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -105.54 123.96 48.77 Favored 'General case' 0 N--CA 1.513 2.677 0 O-C-N 121.801 -0.562 . . . . 0.0 111.703 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.9 mp -104.85 119.24 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -83.54 114.83 21.79 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.5 t -108.52 132.92 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.235 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 50.2 mt -121.95 159.25 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.498 1.943 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.699 179.749 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 44.5 t . . . . . 0 N--CA 1.505 2.276 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.49 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 12.5 mmt -119.85 116.23 25.44 Favored 'General case' 0 N--CA 1.507 2.396 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.803 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -72.88 115.71 12.5 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 122.118 -0.364 . . . . 0.0 111.101 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -124.49 156.56 37.05 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.566 0.698 . . . . 0.0 110.357 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 41.07 81.82 0.03 OUTLIER 'General case' 0 N--CA 1.518 2.94 0 C-N-CA 123.479 0.712 . . . . 0.0 111.919 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -131.92 68.54 80.49 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.711 -0.618 . . . . 0.0 111.68 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -67.12 88.85 0.31 Allowed 'Trans proline' 0 N--CA 1.492 1.397 0 N-CA-C 107.966 -1.59 . . . . 0.0 107.966 177.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.42 ' CB ' ' HD3' ' A' ' 10' ' ' PRO . 0.6 OUTLIER -48.69 -68.27 0.34 Allowed Pre-proline 0 N--CA 1.509 2.496 0 CA-C-O 116.795 -1.574 . . . . 0.0 113.069 -176.702 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.42 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.5 Cg_endo -71.31 93.88 0.66 Allowed 'Trans proline' 0 N--CA 1.497 1.686 0 CA-C-N 121.516 1.577 . . . . 0.0 111.441 178.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -101.0 173.98 6.22 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.02 -1.05 . . . . 0.0 110.26 178.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -158.79 120.39 3.45 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.238 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -116.72 -169.76 1.69 Allowed 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.945 -0.472 . . . . 0.0 109.94 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -102.01 137.46 40.25 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.597 0.713 . . . . 0.0 111.705 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -60.79 118.78 7.07 Favored 'General case' 0 N--CA 1.508 2.444 0 O-C-N 121.964 -0.46 . . . . 0.0 110.494 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.3 23.54 37.01 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -118.26 165.17 14.14 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 118.412 1.106 . . . . 0.0 110.867 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.71 97.74 8.08 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 178.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.19 169.96 9.23 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.729 -177.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.2 t -142.88 140.76 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 178.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 20.8 mt -96.02 113.32 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 178.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.403 ' HA ' ' CE2' ' A' ' 57' ' ' TYR . 45.2 t -73.66 122.04 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.21 -176.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -164.92 89.81 0.5 Allowed 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.6 141.3 28.64 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.056 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.3 t -148.16 132.08 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.49 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 53.8 t -95.32 78.57 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.6 m -81.52 163.48 22.65 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 178.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 t -43.04 -85.06 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.329 0 O-C-N 121.825 -0.547 . . . . 0.0 111.582 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -167.29 -63.15 0.01 OUTLIER Pre-proline 0 N--CA 1.514 2.768 0 CA-C-O 117.707 -1.14 . . . . 0.0 111.663 177.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -59.76 -53.23 3.45 Favored 'Trans proline' 0 CA--C 1.564 1.999 0 CA-C-N 120.209 1.11 . . . . 0.0 112.446 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.55 -164.4 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 120.55 0.833 . . . . 0.0 112.185 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -171.12 -166.69 0.49 Allowed 'General case' 0 N--CA 1.519 3.019 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.443 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 15.1 tt -97.96 165.45 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 81.1 mt -128.65 133.9 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.439 ' CE2' ' HB2' ' A' ' 58' ' ' LEU . 82.7 m95 -97.55 115.49 27.95 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.7 tttt . . . . . 0 N--CA 1.505 2.3 0 CA-C-O 121.334 0.588 . . . . 0.0 111.295 -178.623 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.7 m . . . . . 0 N--CA 1.507 2.421 0 CA-C-O 120.831 0.348 . . . . 0.0 110.626 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.5 mm -58.44 -18.41 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.806 0 O-C-N 121.623 -0.673 . . . . 0.0 111.77 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.4 mp -91.66 -23.02 19.96 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.527 -0.733 . . . . 0.0 111.133 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -98.9 -42.28 7.23 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.753 -0.592 . . . . 0.0 110.034 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt 48.05 56.91 6.65 Favored 'General case' 0 N--CA 1.509 2.499 0 CA-C-O 121.492 0.663 . . . . 0.0 111.892 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -50.9 170.14 0.04 OUTLIER 'General case' 0 N--CA 1.517 2.893 0 O-C-N 121.689 -0.632 . . . . 0.0 111.506 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 36.0 m -63.21 -19.5 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.64 0 O-C-N 122.054 -0.404 . . . . 0.0 111.985 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.1 ptp85 -109.42 0.16 19.23 Favored 'General case' 0 N--CA 1.506 2.349 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -99.33 106.1 18.16 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.35 -0.844 . . . . 0.0 110.562 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 74.5 mt -129.64 110.49 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.5 t -77.62 137.88 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 45.0 mt -89.97 167.44 12.8 Favored 'General case' 0 N--CA 1.505 2.321 0 CA-C-O 121.387 0.613 . . . . 0.0 112.01 -178.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.7 p -60.92 -22.41 64.33 Favored 'General case' 0 N--CA 1.51 2.554 0 O-C-N 122.137 -0.352 . . . . 0.0 111.229 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 35.5 p-10 -91.29 18.54 6.92 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.735 -0.603 . . . . 0.0 111.48 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.6 m120 67.48 33.21 5.3 Favored 'General case' 0 N--CA 1.516 2.86 0 O-C-N 121.544 -0.722 . . . . 0.0 111.999 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.403 ' CE2' ' HA ' ' A' ' 22' ' ' VAL . 4.1 m-85 -103.06 163.84 11.97 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 177.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.439 ' HB2' ' CE2' ' A' ' 35' ' ' TRP . 20.8 tp -120.11 100.6 7.3 Favored 'General case' 0 N--CA 1.516 2.859 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.968 -179.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.69 105.32 9.9 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.328 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.4 mt -97.47 102.81 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 177.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -67.55 118.17 10.49 Favored 'General case' 0 N--CA 1.506 2.33 0 CA-C-O 121.155 0.503 . . . . 0.0 111.221 -178.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.57 -39.14 2.85 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.414 HG22 ' O ' ' A' ' 63' ' ' ILE . 2.8 tp 40.13 85.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.52 3.042 0 CA-C-O 122.023 0.916 . . . . 0.0 112.308 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.2 mtpt -68.95 151.28 46.74 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 121.548 -0.72 . . . . 0.0 111.347 -178.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.24 -17.99 63.06 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 122.15 -0.344 . . . . 0.0 110.956 179.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.0 t -90.98 -12.37 36.11 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.551 -0.718 . . . . 0.0 111.246 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.81 14.71 18.51 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.454 -0.779 . . . . 0.0 111.532 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.41 148.07 23.56 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.416 -0.802 . . . . 0.0 109.946 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 169.52 -102.1 0.18 Allowed Glycine 0 N--CA 1.498 2.769 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.6 m -148.38 100.76 3.18 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 122.025 -0.691 . . . . 0.0 110.994 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -80.76 133.41 35.64 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.8 tpt180 -96.32 116.56 29.22 Favored 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.651 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 7.1 m -79.29 132.89 36.6 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -134.82 91.13 2.72 Favored 'General case' 0 N--CA 1.503 2.178 0 CA-C-N 118.719 0.69 . . . . 0.0 110.724 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.76 121.21 10.56 Favored Glycine 0 N--CA 1.501 3.03 0 N-CA-C 107.598 -2.201 . . . . 0.0 107.598 178.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 . . . . . 0 N--CA 1.503 2.188 0 CA-C-N 118.308 1.054 . . . . 0.0 113.581 -177.251 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.8 m120 . . . . . 0 N--CA 1.501 2.124 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -161.37 -177.92 6.31 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.797 -0.761 . . . . 0.0 112.035 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.5 tptp -169.17 166.07 10.87 Favored 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -111.03 112.86 24.98 Favored 'General case' 0 N--CA 1.51 2.544 0 CA-C-O 121.071 0.462 . . . . 0.0 110.46 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.2 mp -101.07 118.99 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -83.52 127.32 33.63 Favored 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 40.7 t -121.11 132.7 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 O-C-N 121.808 -0.558 . . . . 0.0 109.905 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 72.1 mt -126.05 146.34 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 N--CA 1.501 2.103 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.714 -179.768 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.5 m . . . . . 0 N--CA 1.504 2.272 0 CA-C-O 121.335 0.588 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.483 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 0.7 OUTLIER -87.8 106.81 18.33 Favored 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.907 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -67.13 119.9 12.83 Favored 'General case' 0 N--CA 1.506 2.346 0 CA-C-O 120.812 0.339 . . . . 0.0 110.738 -178.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.2 pttt -135.13 163.84 29.03 Favored 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 121.88 0.847 . . . . 0.0 112.26 -179.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 28.59 95.58 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.134 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 179.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -164.82 84.0 1.16 Allowed Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.953 -0.467 . . . . 0.0 111.154 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -65.2 106.04 0.77 Allowed 'Trans proline' 0 N--CA 1.492 1.392 0 N-CA-C 108.419 -1.416 . . . . 0.0 108.419 177.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.44 ' CB ' ' HD3' ' A' ' 10' ' ' PRO . 0.2 OUTLIER -51.04 -65.64 0.88 Allowed Pre-proline 0 N--CA 1.508 2.45 0 CA-C-O 116.91 -1.519 . . . . 0.0 112.594 -177.02 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.44 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.4 Cg_endo -75.1 94.55 0.96 Allowed 'Trans proline' 0 N--CA 1.495 1.59 0 CA-C-N 121.182 1.458 . . . . 0.0 111.019 178.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -99.96 179.35 4.53 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 120.949 -1.095 . . . . 0.0 110.276 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -160.6 121.75 2.99 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.825 -0.547 . . . . 0.0 111.82 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -118.95 -170.95 2.01 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.929 -0.482 . . . . 0.0 109.988 178.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.1 tttp -102.33 135.95 43.04 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.505 0.669 . . . . 0.0 111.339 -178.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -60.66 112.42 2.0 Allowed 'General case' 0 N--CA 1.508 2.47 0 O-C-N 121.929 -0.482 . . . . 0.0 110.533 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.02 23.89 16.42 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.423 ' O ' HG23 ' A' ' 63' ' ' ILE . 18.3 tt0 -118.4 165.79 13.44 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-N 118.397 1.099 . . . . 0.0 110.676 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -81.72 98.98 8.68 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 177.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.03 166.67 10.92 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 120.24 -0.584 . . . . 0.0 112.116 -177.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 89.6 t -141.19 139.7 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 178.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 42.7 mt -95.38 119.11 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 106.563 -1.644 . . . . 0.0 106.563 178.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.41 ' HA ' ' CE2' ' A' ' 57' ' ' TYR . 54.1 t -78.59 118.87 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 CA-C-O 121.415 0.626 . . . . 0.0 110.922 -176.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.6 t -159.91 91.56 0.97 Allowed 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.12 138.29 31.64 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.103 -179.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.6 t -147.51 124.17 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.483 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 29.0 t -85.51 75.01 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.4 m -75.48 158.22 32.9 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.5 t -40.45 -77.97 0.02 OUTLIER 'General case' 0 N--CA 1.525 3.323 0 CA-C-N 118.158 0.435 . . . . 0.0 111.597 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.2 mt -173.27 -63.47 0.0 OUTLIER Pre-proline 0 N--CA 1.515 2.789 0 CA-C-O 117.719 -1.134 . . . . 0.0 111.064 177.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.13 -53.35 3.13 Favored 'Trans proline' 0 CA--C 1.564 1.98 0 CA-C-N 120.105 1.073 . . . . 0.0 112.473 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -62.11 -164.83 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 120.503 0.802 . . . . 0.0 112.558 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -170.34 -167.37 0.61 Allowed 'General case' 0 N--CA 1.519 3.003 0 O-C-N 121.921 -0.487 . . . . 0.0 110.434 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.8 tt -103.59 139.42 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.0 mp -102.13 130.57 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.426 ' CE2' ' HB2' ' A' ' 58' ' ' LEU . 72.3 m95 -92.68 114.78 27.43 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt . . . . . 0 N--CA 1.501 2.115 0 O-C-N 121.903 -0.498 . . . . 0.0 111.035 -178.981 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.7 m . . . . . 0 N--CA 1.507 2.387 0 CA-C-O 121.282 0.563 . . . . 0.0 109.739 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 58.5 mt -60.94 -17.48 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.718 0 O-C-N 121.964 -0.46 . . . . 0.0 111.423 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.1 mp -90.08 -23.64 21.35 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.473 -0.767 . . . . 0.0 110.451 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -99.06 -35.45 10.03 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.721 -0.612 . . . . 0.0 109.544 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.5 mmmt 49.27 54.85 10.25 Favored 'General case' 0 N--CA 1.506 2.351 0 CA-C-O 121.359 0.6 . . . . 0.0 111.978 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.0 167.24 0.12 Allowed 'General case' 0 N--CA 1.517 2.888 0 O-C-N 121.895 -0.503 . . . . 0.0 110.729 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.9 m -60.81 -19.38 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.741 0 O-C-N 121.874 -0.516 . . . . 0.0 111.843 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 25.6 ptt-85 -118.52 45.41 2.04 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.676 -0.64 . . . . 0.0 111.915 -179.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -146.51 104.84 3.8 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.604 -0.685 . . . . 0.0 109.752 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 76.1 mt -129.87 108.32 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.7 t -74.65 140.88 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.0 mt -95.49 169.59 9.95 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.821 -0.549 . . . . 0.0 111.899 -178.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.6 p -61.88 -23.11 66.09 Favored 'General case' 0 N--CA 1.509 2.521 0 O-C-N 122.183 -0.323 . . . . 0.0 111.007 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 44.6 p-10 -88.19 15.15 7.93 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.768 -0.582 . . . . 0.0 111.412 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.6 m120 68.13 33.47 4.43 Favored 'General case' 0 N--CA 1.516 2.834 0 O-C-N 121.577 -0.702 . . . . 0.0 112.023 179.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.41 ' CE2' ' HA ' ' A' ' 22' ' ' VAL . 3.8 m-85 -102.85 166.83 10.25 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.426 ' HB2' ' CE2' ' A' ' 35' ' ' TRP . 19.2 tp -120.83 98.03 5.81 Favored 'General case' 0 N--CA 1.519 2.991 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.666 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -75.65 101.11 4.85 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.917 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 95.5 mt -92.12 115.37 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 177.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -77.58 112.23 14.16 Favored 'General case' 0 N--CA 1.505 2.298 0 CA-C-O 121.521 0.677 . . . . 0.0 111.467 -178.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 100.16 -36.44 4.12 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 179.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.435 ' O ' HG21 ' A' ' 63' ' ' ILE . 2.6 tp 41.77 74.47 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.519 3.003 0 CA-C-O 122.249 1.024 . . . . 0.0 112.454 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.9 mmtp -62.8 158.6 18.39 Favored 'General case' 0 N--CA 1.509 2.483 0 O-C-N 121.488 -0.758 . . . . 0.0 112.336 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.3 tptt -61.97 -24.55 67.08 Favored 'General case' 0 N--CA 1.51 2.557 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.833 178.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.3 t -83.61 -15.1 50.31 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.773 -0.579 . . . . 0.0 111.109 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -94.12 11.09 31.22 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.635 -0.666 . . . . 0.0 111.595 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -98.74 137.3 37.55 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.275 -0.891 . . . . 0.0 109.593 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 174.7 -106.37 0.22 Allowed Glycine 0 N--CA 1.499 2.886 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.3 m -143.33 102.2 3.93 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.946 -0.737 . . . . 0.0 110.901 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -83.61 132.55 34.89 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.7 tpp85 -96.42 118.18 32.4 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.459 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 9.0 m -81.04 126.4 31.38 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 177.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -125.26 87.28 2.68 Favored 'General case' 0 N--CA 1.503 2.178 0 CA-C-N 118.605 0.639 . . . . 0.0 110.681 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.83 101.0 0.6 Allowed Glycine 0 N--CA 1.501 3.021 0 N-CA-C 107.921 -2.071 . . . . 0.0 107.921 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 30.3 ttp85 . . . . . 0 N--CA 1.495 1.797 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -176.961 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 . . . . . 0 N--CA 1.502 2.134 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -164.51 177.64 7.99 Favored 'General case' 0 N--CA 1.503 2.22 0 C-N-CA 119.861 -0.736 . . . . 0.0 112.744 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.3 pttt -167.42 163.6 14.99 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 177.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -99.79 119.34 38.01 Favored 'General case' 0 N--CA 1.511 2.618 0 O-C-N 121.884 -0.51 . . . . 0.0 111.698 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.1 mp -104.17 118.47 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -84.06 125.65 32.31 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.6 t -119.26 126.08 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 O-C-N 121.719 -0.613 . . . . 0.0 109.792 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 51.1 mt -116.4 157.97 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.5 2.053 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.394 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 37.6 t . . . . . 0 N--CA 1.501 2.123 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.467 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 1.6 mmm -108.43 111.54 23.49 Favored 'General case' 0 N--CA 1.508 2.468 0 C-N-CA 120.144 -0.622 . . . . 0.0 109.821 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -67.65 119.87 13.11 Favored 'General case' 0 N--CA 1.505 2.319 0 CA-C-O 120.786 0.327 . . . . 0.0 110.783 -178.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.56 160.29 36.99 Favored 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 121.553 0.692 . . . . 0.0 111.114 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 31.41 58.81 0.29 Allowed 'General case' 0 N--CA 1.519 2.994 0 C-N-CA 124.148 0.979 . . . . 0.0 113.561 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -121.37 79.14 36.43 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.697 -0.627 . . . . 0.0 110.74 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -65.75 114.12 2.82 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 N-CA-C 109.189 -1.12 . . . . 0.0 109.189 178.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.438 ' CB ' ' HD3' ' A' ' 10' ' ' PRO . 0.2 OUTLIER -67.75 -66.76 1.02 Allowed Pre-proline 0 N--CA 1.498 1.956 0 CA-C-O 117.059 -1.448 . . . . 0.0 111.208 -178.335 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.438 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.4 Cg_endo -72.17 89.22 0.8 Allowed 'Trans proline' 0 N--CA 1.498 1.763 0 CA-C-N 121.108 1.432 . . . . 0.0 111.199 178.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -100.36 171.75 7.57 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 120.715 -1.24 . . . . 0.0 110.088 178.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -154.4 127.44 8.31 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.816 -0.552 . . . . 0.0 111.646 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -125.73 -164.0 1.26 Allowed 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.36 142.63 51.13 Favored 'General case' 0 N--CA 1.513 2.694 0 CA-C-O 121.856 0.836 . . . . 0.0 111.455 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -56.26 141.86 39.73 Favored 'General case' 0 N--CA 1.51 2.536 0 O-C-N 121.831 -0.543 . . . . 0.0 111.082 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.15 12.73 72.38 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.414 ' O ' HG23 ' A' ' 63' ' ' ILE . 12.1 tp10 -104.87 156.09 18.33 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 119.116 1.458 . . . . 0.0 111.34 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -81.12 95.45 6.88 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 176.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.15 166.34 11.46 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.996 -0.682 . . . . 0.0 112.203 -176.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 94.3 t -140.04 140.05 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 178.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 47.9 mt -94.87 117.0 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 178.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.419 ' HA ' ' CE2' ' A' ' 57' ' ' TYR . 39.2 t -77.08 119.48 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 CA-C-O 121.431 0.634 . . . . 0.0 110.98 -176.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.4 t -161.34 92.03 0.88 Allowed 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.09 140.59 29.49 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.905 -0.718 . . . . 0.0 109.314 -179.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.7 t -146.79 128.19 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.467 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 45.9 t -89.42 74.09 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.0 m -78.44 161.79 26.86 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 178.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 t -41.96 -78.29 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.199 0 CA-C-N 118.191 0.451 . . . . 0.0 111.566 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -174.0 -62.54 0.0 OUTLIER Pre-proline 0 N--CA 1.515 2.809 0 CA-C-O 117.873 -1.06 . . . . 0.0 111.498 177.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.68 -53.44 3.31 Favored 'Trans proline' 0 CA--C 1.562 1.913 0 CA-C-N 119.845 0.981 . . . . 0.0 112.519 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -61.4 -165.28 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 120.535 0.823 . . . . 0.0 112.61 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -170.35 -170.13 0.92 Allowed 'General case' 0 N--CA 1.521 3.114 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.717 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 18.3 tt -100.92 140.22 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.1 mp -102.91 128.36 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.412 ' CE2' ' HB2' ' A' ' 58' ' ' LEU . 73.6 m95 -90.56 112.88 24.73 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.0 ttpt . . . . . 0 N--CA 1.504 2.251 0 O-C-N 121.783 -0.573 . . . . 0.0 111.059 -178.685 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.4 m . . . . . 0 N--CA 1.503 2.208 0 CA-C-O 121.111 0.481 . . . . 0.0 109.791 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 77.3 mt -60.24 -17.61 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.855 0 O-C-N 122.071 -0.393 . . . . 0.0 111.418 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.7 mp -90.16 -23.65 21.27 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.511 -0.743 . . . . 0.0 110.617 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 45.0 pttt -99.15 -36.91 9.52 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.719 -0.613 . . . . 0.0 109.572 178.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.7 mmmt 47.97 56.72 6.87 Favored 'General case' 0 N--CA 1.508 2.426 0 CA-C-O 121.503 0.668 . . . . 0.0 111.88 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.67 168.45 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.811 0 O-C-N 121.863 -0.523 . . . . 0.0 111.638 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.9 m -59.91 -20.04 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.68 0 O-C-N 121.923 -0.485 . . . . 0.0 112.268 -178.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.9 ptp85 -114.68 4.37 15.03 Favored 'General case' 0 N--CA 1.507 2.42 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -102.32 111.3 23.53 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.143 -0.973 . . . . 0.0 110.916 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 82.6 mt -132.87 105.96 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.2 t -73.39 136.73 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.4 mt -90.22 166.83 13.13 Favored 'General case' 0 N--CA 1.507 2.386 0 CA-C-O 121.319 0.58 . . . . 0.0 111.845 -178.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 92.9 p -60.87 -21.7 63.54 Favored 'General case' 0 N--CA 1.509 2.487 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.249 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 42.0 p-10 -90.32 17.92 6.67 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.629 -0.67 . . . . 0.0 111.475 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.5 m120 68.26 30.72 5.49 Favored 'General case' 0 N--CA 1.518 2.948 0 O-C-N 121.605 -0.685 . . . . 0.0 112.051 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.419 ' CE2' ' HA ' ' A' ' 22' ' ' VAL . 3.6 m-85 -101.71 165.2 11.34 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.412 ' HB2' ' CE2' ' A' ' 35' ' ' TRP . 17.1 tp -120.06 102.61 8.65 Favored 'General case' 0 N--CA 1.518 2.942 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.751 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -80.0 103.42 9.87 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.368 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.422 HG23 HD11 ' A' ' 60' ' ' ILE . 95.1 mt -95.89 104.7 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 177.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -68.01 113.22 5.51 Favored 'General case' 0 N--CA 1.505 2.289 0 CA-C-O 121.07 0.462 . . . . 0.0 110.756 -178.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 100.92 -40.17 2.51 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.445 ' O ' HG21 ' A' ' 63' ' ' ILE . 1.7 tp 42.91 72.14 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.961 0 CA-C-O 122.228 1.013 . . . . 0.0 112.446 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 59.9 mttt -62.33 158.62 16.95 Favored 'General case' 0 N--CA 1.51 2.527 0 O-C-N 121.63 -0.669 . . . . 0.0 112.154 -178.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.5 mtmt -62.84 -23.65 67.39 Favored 'General case' 0 N--CA 1.508 2.473 0 O-C-N 122.134 -0.354 . . . . 0.0 110.879 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.0 p -80.77 -17.28 51.44 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.741 -0.6 . . . . 0.0 110.774 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -94.23 10.02 35.7 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.701 -0.624 . . . . 0.0 111.725 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -98.18 144.57 27.49 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-N 119.209 0.913 . . . . 0.0 110.156 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 167.94 -102.93 0.19 Allowed Glycine 0 N--CA 1.499 2.878 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.7 m -145.98 102.87 3.69 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 122.123 -0.634 . . . . 0.0 111.122 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -83.97 133.73 34.68 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -95.41 120.68 36.07 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.405 -179.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 85' ' ' PHE . 7.3 m -85.21 122.57 29.6 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 177.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -125.06 88.39 2.88 Favored 'General case' 0 N--CA 1.505 2.293 0 CA-C-N 119.021 0.828 . . . . 0.0 111.061 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.39 110.52 3.46 Favored Glycine 0 N--CA 1.502 3.071 0 N-CA-C 107.911 -2.076 . . . . 0.0 107.911 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.7 ttp85 . . . . . 0 N--CA 1.499 2.004 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -177.096 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.6 m120 . . . . . 0 N--CA 1.501 2.083 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 30.7 p90 -157.24 -177.25 6.46 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 119.497 -0.881 . . . . 0.0 112.669 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 9.6 tptt -168.4 165.36 12.73 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -110.31 108.74 18.92 Favored 'General case' 0 N--CA 1.509 2.494 0 CA-C-O 120.974 0.416 . . . . 0.0 110.245 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.4 ' N ' ' CD1' ' A' ' 88' ' ' ILE . 2.2 mp -92.76 113.78 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -80.68 105.08 11.65 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.3 t -99.97 136.5 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.156 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 63.4 mt -126.92 156.95 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.498 1.948 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.594 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.9 t . . . . . 0 N--CA 1.501 2.117 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.471 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 6.3 mmt -116.46 113.37 22.74 Favored 'General case' 0 N--CA 1.507 2.413 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.416 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -70.31 116.5 10.73 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 122.103 -0.373 . . . . 0.0 111.1 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt -119.9 155.98 31.65 Favored 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 44.48 81.24 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.747 0 C-N-CA 122.718 0.407 . . . . 0.0 111.517 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -126.35 56.86 17.8 Favored Pre-proline 0 N--CA 1.497 1.907 0 O-C-N 121.64 -0.663 . . . . 0.0 112.425 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.02 90.67 0.16 Allowed 'Trans proline' 0 N--CA 1.496 1.62 0 N-CA-C 107.983 -1.583 . . . . 0.0 107.983 176.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.513 ' OG1' ' HD3' ' A' ' 10' ' ' PRO . 0.5 OUTLIER -52.93 -54.87 39.19 Favored Pre-proline 0 N--CA 1.503 2.194 0 CA-C-O 117.119 -1.419 . . . . 0.0 113.575 -176.268 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.513 ' HD3' ' OG1' ' A' ' 9' ' ' THR . 1.6 Cg_endo -80.27 92.84 1.07 Allowed 'Trans proline' 0 CA--C 1.549 1.242 0 CA-C-N 120.892 1.354 . . . . 0.0 111.584 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -100.99 171.04 7.88 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.088 -1.007 . . . . 0.0 110.197 178.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -156.76 118.1 3.77 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.635 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -114.47 -170.0 1.64 Allowed 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.901 -0.499 . . . . 0.0 110.024 179.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -101.79 139.71 37.07 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.517 0.675 . . . . 0.0 111.452 -178.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -59.87 119.03 6.93 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 121.015 0.436 . . . . 0.0 110.842 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.69 23.49 46.26 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.431 ' O ' HG23 ' A' ' 63' ' ' ILE . 14.4 tt0 -114.57 164.31 14.18 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 118.621 1.211 . . . . 0.0 110.907 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -79.72 98.88 7.17 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 177.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.78 170.64 8.41 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 120.218 -0.593 . . . . 0.0 111.731 -177.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 87.5 t -143.47 141.11 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 178.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 18.9 mt -96.11 115.25 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 178.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.401 ' HA ' ' CE2' ' A' ' 57' ' ' TYR . 46.0 t -74.94 122.0 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 CA-C-O 121.371 0.605 . . . . 0.0 111.205 -176.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -164.94 88.6 0.47 Allowed 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.79 145.01 26.3 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 119.785 -0.766 . . . . 0.0 108.995 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.9 t -151.64 137.17 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.471 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 62.2 t -99.49 78.45 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 108.174 -1.046 . . . . 0.0 108.174 178.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.2 m -80.1 163.13 24.38 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 178.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.8 t -42.11 -79.83 0.01 OUTLIER 'General case' 0 N--CA 1.524 3.237 0 O-C-N 121.87 -0.519 . . . . 0.0 111.595 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -171.13 -63.29 0.0 OUTLIER Pre-proline 0 N--CA 1.514 2.768 0 CA-C-O 117.715 -1.136 . . . . 0.0 111.593 177.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.26 -53.21 3.17 Favored 'Trans proline' 0 CA--C 1.562 1.914 0 CA-C-N 120.045 1.052 . . . . 0.0 112.812 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.04 -163.99 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 120.456 0.771 . . . . 0.0 112.716 -178.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -170.53 -168.12 0.67 Allowed 'General case' 0 N--CA 1.518 2.931 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.134 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 15.4 tt -100.24 155.28 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.7 mp -117.65 132.35 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.44 ' CE2' ' HB2' ' A' ' 58' ' ' LEU . 79.4 m95 -94.54 104.67 16.62 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.2 tttt . . . . . 0 N--CA 1.498 1.969 0 CA-C-O 121.192 0.52 . . . . 0.0 110.609 -178.848 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.5 m . . . . . 0 N--CA 1.508 2.461 0 CA-C-O 120.896 0.379 . . . . 0.0 110.605 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 57.7 mt -59.21 -17.51 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.796 0 O-C-N 121.551 -0.718 . . . . 0.0 111.546 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.8 mp -92.13 -21.82 20.21 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.491 -0.756 . . . . 0.0 111.122 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 39.9 pttt -97.25 -38.55 9.64 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.54 -0.725 . . . . 0.0 109.584 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.8 mmmt 46.31 55.05 7.77 Favored 'General case' 0 N--CA 1.51 2.54 0 CA-C-O 121.533 0.682 . . . . 0.0 112.116 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.05 169.86 0.09 Allowed 'General case' 0 N--CA 1.514 2.761 0 O-C-N 121.734 -0.604 . . . . 0.0 110.819 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.4 m -60.79 -19.57 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.621 0 O-C-N 121.965 -0.459 . . . . 0.0 111.664 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 8.9 ptp85 -119.32 46.82 1.81 Allowed 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.662 -0.649 . . . . 0.0 112.174 -178.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -145.62 99.21 3.25 Favored 'General case' 0 N--CA 1.508 2.431 0 O-C-N 121.556 -0.715 . . . . 0.0 110.081 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.3 mp -125.8 114.44 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.5 t -79.99 131.69 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.9 mt -82.1 163.97 21.66 Favored 'General case' 0 N--CA 1.507 2.409 0 CA-C-O 121.328 0.585 . . . . 0.0 111.774 -178.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 92.4 p -60.4 -20.2 58.81 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 122.171 -0.331 . . . . 0.0 111.221 179.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 48.7 p-10 -91.33 19.23 6.18 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.609 -0.682 . . . . 0.0 111.389 179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.9 m120 67.23 32.17 6.19 Favored 'General case' 0 N--CA 1.516 2.835 0 O-C-N 121.613 -0.68 . . . . 0.0 112.401 178.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.401 ' CE2' ' HA ' ' A' ' 22' ' ' VAL . 4.0 m-85 -103.39 166.61 10.32 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.44 ' HB2' ' CE2' ' A' ' 35' ' ' TRP . 19.7 tp -121.72 97.99 5.75 Favored 'General case' 0 N--CA 1.515 2.791 0 C-N-CA 119.407 -0.917 . . . . 0.0 111.748 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -74.91 105.44 5.94 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.861 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 97.0 mt -96.44 112.1 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 178.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -73.1 112.66 9.35 Favored 'General case' 0 N--CA 1.506 2.336 0 CA-C-O 121.384 0.611 . . . . 0.0 111.423 -177.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.65 -36.08 4.15 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 178.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.431 HG23 ' O ' ' A' ' 17' ' ' GLU . 1.7 tp 41.97 69.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.808 0 CA-C-O 122.185 0.993 . . . . 0.0 112.379 -178.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 55.3 mttt -57.55 158.9 5.42 Favored 'General case' 0 N--CA 1.51 2.56 0 O-C-N 121.615 -0.678 . . . . 0.0 112.209 -178.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 45.4 tttt -62.33 -23.63 66.88 Favored 'General case' 0 N--CA 1.508 2.452 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.895 178.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.7 t -83.15 -15.85 49.03 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.794 -0.566 . . . . 0.0 111.184 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -93.95 9.57 36.92 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.714 -0.616 . . . . 0.0 111.653 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -98.45 142.63 29.83 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.33 -0.856 . . . . 0.0 109.626 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 168.0 -103.81 0.2 Allowed Glycine 0 N--CA 1.498 2.815 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.4 m -145.93 102.78 3.69 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.974 -0.721 . . . . 0.0 111.21 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -83.91 135.28 34.55 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.8 ttt85 -97.51 117.64 32.22 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.103 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.2 m -80.47 133.11 35.81 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 177.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -134.59 91.33 2.77 Favored 'General case' 0 N--CA 1.505 2.297 0 CA-C-N 118.686 0.676 . . . . 0.0 110.396 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.47 118.83 8.78 Favored Glycine 0 N--CA 1.503 3.141 0 N-CA-C 107.746 -2.142 . . . . 0.0 107.746 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.1 ttm180 . . . . . 0 N--CA 1.501 2.104 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -177.238 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.9 m120 . . . . . 0 N--CA 1.505 2.322 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -162.42 -175.21 4.4 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 119.684 -0.806 . . . . 0.0 112.715 -179.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.4 tptt -171.1 167.5 7.12 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -115.37 108.09 16.07 Favored 'General case' 0 N--CA 1.513 2.723 0 O-C-N 121.844 -0.535 . . . . 0.0 110.222 178.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.406 ' N ' ' CD1' ' A' ' 88' ' ' ILE . 2.4 mp -96.16 115.71 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -84.63 111.02 19.17 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 42.5 t -105.48 138.05 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.917 -0.489 . . . . 0.0 110.291 -179.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 82.3 mt -128.23 157.31 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.916 0 CA-C-O 118.062 -0.971 . . . . 0.0 110.458 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.2 t . . . . . 0 N--CA 1.506 2.332 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.509 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 6.5 mmt -110.27 110.9 21.89 Favored 'General case' 0 N--CA 1.506 2.348 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.18 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -71.24 113.71 8.56 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 122.086 -0.384 . . . . 0.0 110.239 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.6 ptpt -129.03 163.7 24.83 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 122.013 0.911 . . . . 0.0 112.301 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 29.69 95.49 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.014 0 C-N-CA 124.654 1.182 . . . . 0.0 114.185 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -164.47 84.67 1.19 Allowed Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.8 -0.562 . . . . 0.0 111.263 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -66.17 104.38 0.72 Allowed 'Trans proline' 0 N--CA 1.49 1.309 0 N-CA-C 108.288 -1.466 . . . . 0.0 108.288 177.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.433 ' CB ' ' HD3' ' A' ' 10' ' ' PRO . 0.2 OUTLIER -50.61 -66.01 0.76 Allowed Pre-proline 0 N--CA 1.51 2.56 0 CA-C-O 116.932 -1.509 . . . . 0.0 112.54 -176.973 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.433 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.6 Cg_endo -73.99 94.5 0.88 Allowed 'Trans proline' 0 N--CA 1.494 1.542 0 CA-C-N 121.203 1.465 . . . . 0.0 110.937 178.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -99.66 173.47 6.7 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.047 -1.033 . . . . 0.0 110.091 178.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -155.23 121.25 5.15 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 120.373 -0.531 . . . . 0.0 112.01 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -120.2 -170.5 1.98 Allowed 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 178.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 30.7 ttpt -104.92 139.32 39.81 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.339 0.59 . . . . 0.0 111.489 -179.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -62.1 111.6 2.01 Favored 'General case' 0 N--CA 1.508 2.447 0 CA-C-O 121.062 0.458 . . . . 0.0 110.359 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.51 22.31 16.93 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.448 ' O ' HG23 ' A' ' 63' ' ' ILE . 30.2 tt0 -117.16 164.83 14.18 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 118.474 1.137 . . . . 0.0 110.668 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -82.62 100.1 9.96 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 178.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -102.42 167.42 9.96 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.955 -177.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 95.7 t -138.99 141.2 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 178.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 22.5 mt -95.76 112.39 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 178.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.41 ' HA ' ' CE2' ' A' ' 57' ' ' TYR . 57.8 t -74.12 122.35 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 CA-C-O 121.551 0.691 . . . . 0.0 110.682 -176.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.2 t -163.7 92.55 0.7 Allowed 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.02 137.87 32.01 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.373 -179.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.1 t -147.18 125.71 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.509 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 40.8 t -91.06 79.43 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.3 m -78.06 167.14 21.9 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 178.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 t -45.49 -80.23 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.165 0 O-C-N 121.761 -0.587 . . . . 0.0 111.09 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -166.98 -64.56 0.01 OUTLIER Pre-proline 0 N--CA 1.512 2.635 0 CA-C-O 117.566 -1.207 . . . . 0.0 111.697 177.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.36 -53.49 2.89 Favored 'Trans proline' 0 CA--C 1.562 1.916 0 CA-C-N 120.233 1.119 . . . . 0.0 112.847 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -61.15 -165.72 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 120.498 0.798 . . . . 0.0 113.223 -178.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -172.83 -161.36 0.15 Allowed 'General case' 0 N--CA 1.52 3.051 0 O-C-N 121.927 -0.483 . . . . 0.0 109.906 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -106.04 148.63 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.896 -0.503 . . . . 0.0 110.415 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.3 mp -109.53 125.19 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.431 ' CE2' ' HB2' ' A' ' 58' ' ' LEU . 77.1 m95 -85.21 120.53 26.8 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.6 mmmt . . . . . 0 N--CA 1.503 2.184 0 CA-C-O 121.439 0.637 . . . . 0.0 111.71 -177.75 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.509 2.511 0 CA-C-O 121.13 0.49 . . . . 0.0 109.99 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.437 HG22 HD11 ' A' ' 43' ' ' ILE . 47.9 mm -59.57 -18.25 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.702 0 O-C-N 121.92 -0.487 . . . . 0.0 111.76 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.7 mp -92.32 -21.4 20.3 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.509 -0.744 . . . . 0.0 111.195 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 35.1 pttt -98.55 -37.87 9.38 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.625 -0.672 . . . . 0.0 109.408 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.4 mmmt 47.61 54.25 10.03 Favored 'General case' 0 N--CA 1.51 2.551 0 CA-C-O 121.498 0.666 . . . . 0.0 111.859 179.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.99 161.43 2.32 Favored 'General case' 0 N--CA 1.512 2.661 0 O-C-N 121.754 -0.591 . . . . 0.0 110.404 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.4 m -58.42 -20.3 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.77 0 O-C-N 121.924 -0.485 . . . . 0.0 111.613 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -108.0 37.86 2.35 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.78 -0.575 . . . . 0.0 111.806 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -144.86 106.75 4.29 Favored 'General case' 0 N--CA 1.506 2.375 0 O-C-N 121.767 -0.583 . . . . 0.0 109.598 178.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 72.9 mt -126.21 102.14 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.2 t -74.33 132.08 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.4 mt -88.15 162.45 16.71 Favored 'General case' 0 N--CA 1.504 2.272 0 CA-C-O 121.272 0.558 . . . . 0.0 111.571 -178.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.6 p -60.24 -19.64 55.44 Favored 'General case' 0 N--CA 1.511 2.598 0 O-C-N 122.141 -0.35 . . . . 0.0 111.427 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 43.2 p-10 -91.74 19.5 6.4 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.565 -0.71 . . . . 0.0 111.374 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.7 m120 67.93 32.05 5.34 Favored 'General case' 0 N--CA 1.518 2.93 0 O-C-N 121.783 -0.573 . . . . 0.0 112.356 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.41 ' CE2' ' HA ' ' A' ' 22' ' ' VAL . 4.3 m-85 -103.59 163.37 12.35 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.431 ' HB2' ' CE2' ' A' ' 35' ' ' TRP . 16.8 tp -122.14 97.51 5.51 Favored 'General case' 0 N--CA 1.513 2.722 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.715 -179.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.53 98.48 3.97 Favored 'General case' 0 N--CA 1.501 2.082 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.825 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 98.0 mt -90.73 115.94 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.17 115.08 15.55 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 121.265 0.555 . . . . 0.0 110.991 -178.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.31 -37.5 3.46 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.448 HG23 ' O ' ' A' ' 17' ' ' GLU . 2.5 tp 41.7 70.57 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.517 2.897 0 CA-C-O 122.237 1.018 . . . . 0.0 112.246 -178.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 39.7 mtpt -67.04 149.89 49.97 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.589 -0.694 . . . . 0.0 111.472 -178.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.6 pttt -60.96 -24.29 65.97 Favored 'General case' 0 N--CA 1.511 2.582 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.493 178.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.4 t -71.17 -18.15 62.5 Favored 'General case' 0 N--CA 1.502 2.144 0 C-N-CA 120.261 -0.575 . . . . 0.0 110.134 177.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -102.67 -1.03 30.87 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.644 -0.66 . . . . 0.0 111.842 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -79.23 153.5 29.91 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.163 -0.961 . . . . 0.0 109.606 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 161.74 -102.66 0.21 Allowed Glycine 0 N--CA 1.497 2.733 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.5 m -152.97 104.18 2.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 122.084 -0.656 . . . . 0.0 110.305 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -82.82 135.37 34.97 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -96.77 119.8 35.93 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.762 -0.586 . . . . 0.0 110.99 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 85' ' ' PHE . 7.4 m -83.85 116.66 22.85 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 177.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -115.94 88.16 2.83 Favored 'General case' 0 N--CA 1.503 2.185 0 CA-C-N 118.637 0.653 . . . . 0.0 110.928 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.76 113.64 5.38 Favored Glycine 0 N--CA 1.504 3.184 0 N-CA-C 107.883 -2.087 . . . . 0.0 107.883 178.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.3 ttm-85 . . . . . 0 N--CA 1.499 1.998 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -177.411 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 N--CA 1.503 2.213 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 30.7 p90 -163.97 177.9 8.15 Favored 'General case' 0 N--CA 1.503 2.197 0 C-N-CA 119.765 -0.774 . . . . 0.0 112.833 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.4 pttt -166.85 165.59 16.08 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -101.42 119.09 38.23 Favored 'General case' 0 N--CA 1.511 2.606 0 O-C-N 121.857 -0.527 . . . . 0.0 111.956 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.6 mp -102.28 117.01 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 178.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -83.47 123.11 29.38 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -179.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 37.5 t -118.15 131.23 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 121.775 -0.578 . . . . 0.0 109.721 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 69.3 mt -127.34 152.94 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.502 2.15 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.042 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 36.0 t . . . . . 0 N--CA 1.505 2.32 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.506 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 73.1 mtp -119.09 112.59 19.73 Favored 'General case' 0 N--CA 1.511 2.579 0 O-C-N 121.752 -0.592 . . . . 0.0 111.19 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -72.48 107.11 4.86 Favored 'General case' 0 N--CA 1.508 2.432 0 CA-C-O 121.01 0.433 . . . . 0.0 110.454 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -118.75 170.98 8.53 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-O 121.221 0.534 . . . . 0.0 110.669 -179.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 25.43 63.23 0.06 Allowed 'General case' 0 N--CA 1.526 3.342 0 C-N-CA 124.291 1.037 . . . . 0.0 113.753 178.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -128.33 66.79 74.2 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 121.627 -0.671 . . . . 0.0 111.646 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.73 108.25 1.03 Allowed 'Trans proline' 0 N--CA 1.493 1.48 0 N-CA-C 108.218 -1.493 . . . . 0.0 108.218 177.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.487 ' OG1' ' HD3' ' A' ' 10' ' ' PRO . 11.4 p -62.24 -43.9 86.97 Favored Pre-proline 0 N--CA 1.503 2.208 0 CA-C-O 117.287 -1.339 . . . . 0.0 113.178 -176.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.487 ' HD3' ' OG1' ' A' ' 9' ' ' THR . 1.6 Cg_endo -84.11 84.79 1.49 Allowed 'Trans proline' 0 CA--C 1.551 1.329 0 CA-C-N 120.677 1.277 . . . . 0.0 111.513 -177.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -100.49 172.74 6.93 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 121.085 -1.009 . . . . 0.0 110.748 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -158.03 120.52 3.77 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.897 -0.502 . . . . 0.0 111.342 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -116.41 -169.73 1.67 Allowed 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.965 -0.459 . . . . 0.0 110.196 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 49.5 tttm -101.85 135.77 42.83 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.378 0.609 . . . . 0.0 111.256 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -60.74 116.86 4.73 Favored 'General case' 0 N--CA 1.509 2.498 0 CA-C-O 121.082 0.468 . . . . 0.0 110.582 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.88 22.81 29.58 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.457 ' O ' HG23 ' A' ' 63' ' ' ILE . 16.9 tt0 -117.26 164.58 14.6 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 118.471 1.135 . . . . 0.0 110.93 -179.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -81.08 98.41 7.99 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 177.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.11 167.22 10.6 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 120.291 -0.564 . . . . 0.0 111.911 -177.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 98.5 t -140.55 139.98 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 178.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 38.4 mt -95.2 116.73 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 178.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.411 ' HA ' ' CE2' ' A' ' 57' ' ' TYR . 44.6 t -78.87 117.02 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-O 121.321 0.581 . . . . 0.0 110.781 -176.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -154.47 95.01 1.76 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -90.05 137.79 32.05 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.9 t -147.81 122.26 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.506 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 14.8 t -85.15 81.53 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.9 m -87.38 155.2 20.14 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.6 t -44.94 -84.03 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.15 0 O-C-N 121.884 -0.51 . . . . 0.0 111.909 -178.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -166.94 -62.23 0.01 OUTLIER Pre-proline 0 N--CA 1.511 2.576 0 CA-C-O 117.76 -1.114 . . . . 0.0 112.094 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -59.37 -53.87 3.09 Favored 'Trans proline' 0 CA--C 1.559 1.741 0 CA-C-N 120.082 1.065 . . . . 0.0 112.336 -178.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.46 -168.97 0.11 Allowed 'Trans proline' 0 N--CA 1.496 1.663 0 CA-C-N 119.399 0.821 . . . . 0.0 110.984 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -172.04 -165.29 0.34 Allowed 'General case' 0 N--CA 1.521 3.086 0 O-C-N 121.723 -0.611 . . . . 0.0 109.844 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.3 tt -99.39 150.73 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 122.053 -0.405 . . . . 0.0 109.925 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.6 mt -115.56 115.42 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 72.7 m95 -81.18 104.96 12.02 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.7 tttt . . . . . 0 N--CA 1.502 2.142 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.885 -178.78 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.0 m . . . . . 0 N--CA 1.507 2.386 0 CA-C-O 121.312 0.577 . . . . 0.0 109.675 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 64.5 mt -60.66 -18.44 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.72 0 O-C-N 121.951 -0.468 . . . . 0.0 111.167 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.6 mp -90.95 -22.56 20.79 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.52 -0.737 . . . . 0.0 110.823 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 30.6 pttt -99.18 -36.83 9.53 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.577 -0.702 . . . . 0.0 109.716 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 17.2 mmmt 48.92 54.77 10.28 Favored 'General case' 0 N--CA 1.51 2.563 0 CA-C-O 121.507 0.67 . . . . 0.0 111.562 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.61 172.14 0.05 OUTLIER 'General case' 0 N--CA 1.514 2.741 0 O-C-N 121.836 -0.54 . . . . 0.0 111.067 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.6 m -61.22 -19.19 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.605 0 O-C-N 121.982 -0.449 . . . . 0.0 111.954 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 26.6 ptt-85 -121.78 47.46 1.88 Allowed 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.757 -0.59 . . . . 0.0 112.356 -178.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -145.04 108.52 4.63 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 121.521 -0.737 . . . . 0.0 110.094 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 71.3 mt -129.12 102.01 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.8 t -73.84 128.1 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.8 mt -82.56 165.43 20.11 Favored 'General case' 0 N--CA 1.508 2.445 0 CA-C-O 121.299 0.571 . . . . 0.0 111.828 -178.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 93.7 p -59.94 -20.84 59.71 Favored 'General case' 0 N--CA 1.51 2.534 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.39 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 36.2 p-10 -92.38 21.2 5.45 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.699 -0.626 . . . . 0.0 111.343 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.5 m120 65.18 33.53 9.27 Favored 'General case' 0 N--CA 1.514 2.727 0 O-C-N 121.756 -0.59 . . . . 0.0 112.496 178.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.411 ' CE2' ' HA ' ' A' ' 22' ' ' VAL . 3.9 m-85 -102.15 164.77 11.52 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 177.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 15.5 tp -120.61 97.07 5.39 Favored 'General case' 0 N--CA 1.517 2.887 0 C-N-CA 119.327 -0.949 . . . . 0.0 111.651 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.83 95.97 3.59 Favored 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.799 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 93.1 mt -86.95 117.0 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -78.3 111.72 14.56 Favored 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 121.393 0.616 . . . . 0.0 111.663 -178.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 100.13 -35.65 4.64 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.457 HG23 ' O ' ' A' ' 17' ' ' GLU . 1.6 tp 40.96 69.65 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.842 0 CA-C-O 122.201 1.0 . . . . 0.0 112.657 -179.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -57.75 157.75 7.03 Favored 'General case' 0 N--CA 1.513 2.684 0 O-C-N 121.638 -0.663 . . . . 0.0 112.417 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 35.7 tttm -61.47 -22.53 65.15 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 122.218 -0.301 . . . . 0.0 110.876 178.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.7 p -83.36 -19.96 35.16 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.772 -0.58 . . . . 0.0 110.74 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.76 7.7 35.53 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.61 -0.681 . . . . 0.0 111.678 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -96.79 141.12 30.38 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.35 -0.844 . . . . 0.0 109.365 179.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 169.98 -105.72 0.23 Allowed Glycine 0 N--CA 1.498 2.831 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.2 m -144.12 103.65 4.03 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 122.031 -0.688 . . . . 0.0 111.206 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -84.57 134.43 34.4 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.7 tpp85 -91.64 119.54 31.62 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.743 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 85' ' ' PHE . 1.8 m -87.83 90.26 8.31 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -91.57 88.64 6.84 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.276 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.55 91.31 0.56 Allowed Glycine 0 N--CA 1.499 2.873 0 N-CA-C 107.531 -2.227 . . . . 0.0 107.531 178.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.1 ttm180 . . . . . 0 N--CA 1.496 1.859 0 CA-C-O 121.923 0.868 . . . . 0.0 113.043 -177.257 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 . . . . . 0 N--CA 1.506 2.336 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.429 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 25.5 p90 -157.06 175.78 13.63 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.658 -0.817 . . . . 0.0 112.583 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 20.0 tttt -165.25 169.61 15.73 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -116.75 134.4 54.85 Favored 'General case' 0 N--CA 1.51 2.557 0 O-C-N 121.829 -0.544 . . . . 0.0 110.654 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 47.9 mm -117.47 109.24 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -77.09 100.41 5.7 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.6 t -96.27 136.99 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.915 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 65.9 mt -125.51 159.1 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.5 2.056 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.539 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 26.2 t . . . . . 0 N--CA 1.508 2.427 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.493 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 7.9 mmm -121.17 117.31 26.79 Favored 'General case' 0 N--CA 1.511 2.575 0 O-C-N 121.879 -0.513 . . . . 0.0 110.551 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -74.33 114.41 12.67 Favored 'General case' 0 N--CA 1.507 2.415 0 CA-C-O 120.98 0.419 . . . . 0.0 111.099 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.21 162.32 26.45 Favored 'General case' 0 N--CA 1.503 2.22 0 CA-C-O 121.758 0.79 . . . . 0.0 111.594 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 32.02 80.56 0.02 OUTLIER 'General case' 0 N--CA 1.52 3.057 0 C-N-CA 124.177 0.991 . . . . 0.0 113.274 179.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -138.41 79.97 28.8 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.954 -0.466 . . . . 0.0 110.727 -179.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -65.44 96.89 0.3 Allowed 'Trans proline' 0 N--CA 1.491 1.336 0 N-CA-C 108.503 -1.383 . . . . 0.0 108.503 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.438 ' CB ' ' HD3' ' A' ' 10' ' ' PRO . 0.6 OUTLIER -51.25 -72.29 0.17 Allowed Pre-proline 0 N--CA 1.506 2.331 0 CA-C-O 116.437 -1.744 . . . . 0.0 112.485 -177.172 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.438 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.5 Cg_endo -71.48 97.1 0.76 Allowed 'Trans proline' 0 N--CA 1.498 1.755 0 CA-C-N 121.921 1.722 . . . . 0.0 111.719 178.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -101.59 178.11 4.73 Favored 'General case' 0 N--CA 1.507 2.41 0 O-C-N 120.974 -1.079 . . . . 0.0 110.055 178.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -156.23 127.5 7.07 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.833 -0.542 . . . . 0.0 111.568 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -127.84 -169.2 2.01 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.847 -0.533 . . . . 0.0 109.802 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -115.49 145.42 42.62 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.838 0.827 . . . . 0.0 111.841 -178.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -61.82 121.24 12.39 Favored 'General case' 0 N--CA 1.508 2.442 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.45 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.74 22.83 48.66 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -112.98 159.84 18.71 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 118.478 1.139 . . . . 0.0 111.186 -179.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.36 97.65 8.44 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 177.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -103.4 164.2 11.79 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.528 0.68 . . . . 0.0 112.498 -177.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 95.3 t -139.31 141.82 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 178.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 55.3 mt -97.42 115.29 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 178.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.406 ' HA ' ' CE2' ' A' ' 57' ' ' TYR . 46.8 t -76.32 120.86 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 121.505 0.669 . . . . 0.0 111.055 -176.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.7 t -161.68 94.85 0.97 Allowed 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.88 141.44 28.42 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 120.121 -0.632 . . . . 0.0 109.684 -178.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 32.9 t -149.52 123.46 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.493 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 21.6 t -81.7 80.42 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.6 m -87.61 154.09 20.88 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.2 t -44.09 -83.11 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.216 0 O-C-N 121.956 -0.465 . . . . 0.0 111.953 -178.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -168.96 -61.29 0.01 OUTLIER Pre-proline 0 N--CA 1.51 2.566 0 CA-C-O 117.731 -1.128 . . . . 0.0 111.785 178.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.74 -54.13 2.21 Favored 'Trans proline' 0 CA--C 1.561 1.86 0 CA-C-N 120.028 1.046 . . . . 0.0 112.519 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -63.66 -166.83 0.07 OUTLIER 'Trans proline' 0 N--CA 1.498 1.765 0 CA-C-N 119.539 0.871 . . . . 0.0 111.678 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -170.97 -166.62 0.49 Allowed 'General case' 0 N--CA 1.523 3.188 0 O-C-N 121.813 -0.554 . . . . 0.0 110.36 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 18.7 tt -104.1 136.73 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.9 mp -101.17 124.37 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.405 ' CE2' ' HB2' ' A' ' 58' ' ' LEU . 75.1 m95 -84.64 109.69 18.18 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.2 tttt . . . . . 0 N--CA 1.501 2.095 0 CA-C-O 121.48 0.657 . . . . 0.0 111.625 -178.05 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.3 m . . . . . 0 N--CA 1.508 2.438 0 CA-C-O 120.804 0.335 . . . . 0.0 110.823 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.7 mm -59.26 -17.95 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.819 0 O-C-N 121.577 -0.702 . . . . 0.0 111.572 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.0 mp -91.38 -22.84 20.28 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.457 -0.777 . . . . 0.0 110.978 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -98.66 -40.44 8.19 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.764 -0.585 . . . . 0.0 109.478 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm 47.26 56.02 7.42 Favored 'General case' 0 N--CA 1.509 2.517 0 CA-C-O 121.473 0.654 . . . . 0.0 112.04 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.58 155.19 1.64 Allowed 'General case' 0 N--CA 1.515 2.796 0 O-C-N 121.649 -0.657 . . . . 0.0 111.013 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.7 m -54.32 -24.36 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.816 0 O-C-N 121.907 -0.496 . . . . 0.0 112.125 -178.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.95 -3.67 31.81 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -95.79 109.41 21.73 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.388 -0.82 . . . . 0.0 110.18 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 71.8 mt -129.44 104.27 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.2 t -73.76 128.59 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 39.5 mt -82.11 166.3 19.83 Favored 'General case' 0 N--CA 1.508 2.466 0 CA-C-O 121.308 0.575 . . . . 0.0 111.806 -178.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.4 p -61.19 -21.55 63.91 Favored 'General case' 0 N--CA 1.51 2.532 0 O-C-N 122.106 -0.371 . . . . 0.0 111.211 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -90.87 19.12 5.81 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.577 -0.702 . . . . 0.0 111.338 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.1 m120 67.42 33.21 5.36 Favored 'General case' 0 N--CA 1.516 2.862 0 O-C-N 121.57 -0.706 . . . . 0.0 112.524 178.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.406 ' CE2' ' HA ' ' A' ' 22' ' ' VAL . 3.9 m-85 -103.3 166.77 10.23 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 177.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.405 ' HB2' ' CE2' ' A' ' 35' ' ' TRP . 16.8 tp -120.69 98.24 5.93 Favored 'General case' 0 N--CA 1.519 2.995 0 C-N-CA 119.356 -0.938 . . . . 0.0 111.919 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.45 101.62 7.4 Favored 'General case' 0 N--CA 1.504 2.263 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.364 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.438 HD11 HG22 ' A' ' 60' ' ' ILE . 96.8 mt -93.82 103.4 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 177.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 19.3 tpp85 -70.3 116.6 10.84 Favored 'General case' 0 N--CA 1.504 2.233 0 CA-C-O 121.317 0.58 . . . . 0.0 110.865 -178.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.64 -35.1 4.83 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.8 tp 35.27 94.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.519 2.999 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 59.0 mmtt -73.4 148.71 43.09 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.613 -0.68 . . . . 0.0 110.656 -178.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -62.58 -18.89 63.04 Favored 'General case' 0 N--CA 1.51 2.559 0 O-C-N 122.072 -0.393 . . . . 0.0 110.978 178.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.8 t -87.83 -13.5 41.98 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.686 -0.634 . . . . 0.0 111.376 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -91.67 14.36 15.39 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.53 -0.731 . . . . 0.0 111.491 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.78 150.3 20.55 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.433 -0.792 . . . . 0.0 109.792 179.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 166.06 -101.25 0.18 Allowed Glycine 0 N--CA 1.499 2.887 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.6 m -149.02 101.13 3.13 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.953 -0.734 . . . . 0.0 111.239 179.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -81.47 133.56 35.42 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 177.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.8 ttm105 -97.29 120.3 37.4 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.11 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 85' ' ' PHE . 9.3 m -83.46 113.33 20.7 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 177.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -111.5 85.63 2.17 Favored 'General case' 0 N--CA 1.504 2.272 0 CA-C-N 118.537 0.608 . . . . 0.0 109.609 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.68 96.67 0.31 Allowed Glycine 0 N--CA 1.502 3.057 0 N-CA-C 108.475 -1.85 . . . . 0.0 108.475 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.1 ttp85 . . . . . 0 N--CA 1.494 1.736 0 O-C-N 122.059 -0.671 . . . . 0.0 112.212 -177.705 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 . . . . . 0 N--CA 1.505 2.29 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.411 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 39.1 p90 -166.73 175.8 7.61 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 121.352 -0.843 . . . . 0.0 113.158 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.2 ptpt -167.78 161.27 13.14 Favored 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -98.06 122.93 41.79 Favored 'General case' 0 N--CA 1.512 2.635 0 O-C-N 121.736 -0.602 . . . . 0.0 112.107 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.3 mp -106.72 122.55 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -87.25 134.82 33.5 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.2 t -127.52 129.08 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 O-C-N 121.673 -0.642 . . . . 0.0 110.22 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 74.6 mt -116.26 139.63 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.6 t . . . . . 0 N--CA 1.503 2.18 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.364 -179.23 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 36.6 t . . . . . 0 N--CA 1.504 2.228 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.477 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 7.1 mmt -122.73 115.92 22.88 Favored 'General case' 0 N--CA 1.51 2.565 0 O-C-N 121.783 -0.573 . . . . 0.0 110.482 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -74.38 113.1 11.22 Favored 'General case' 0 N--CA 1.506 2.374 0 O-C-N 122.005 -0.434 . . . . 0.0 110.538 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.0 ptpt -127.16 163.7 23.26 Favored 'General case' 0 N--CA 1.503 2.215 0 CA-C-O 121.712 0.768 . . . . 0.0 111.753 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 31.88 72.68 0.07 Allowed 'General case' 0 N--CA 1.52 3.048 0 C-N-CA 124.188 0.995 . . . . 0.0 113.342 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -136.81 81.01 35.31 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.802 -0.561 . . . . 0.0 110.721 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -65.58 102.09 0.48 Allowed 'Trans proline' 0 N--CA 1.49 1.294 0 N-CA-C 108.62 -1.339 . . . . 0.0 108.62 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.451 ' CB ' ' HD3' ' A' ' 10' ' ' PRO . 0.2 OUTLIER -55.86 -66.62 1.0 Allowed Pre-proline 0 N--CA 1.503 2.213 0 CA-C-O 116.93 -1.509 . . . . 0.0 112.216 -177.314 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.451 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.5 Cg_endo -74.18 91.4 0.94 Allowed 'Trans proline' 0 CA--C 1.556 1.609 0 CA-C-N 121.258 1.485 . . . . 0.0 111.148 178.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -100.0 176.49 5.4 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 120.871 -1.143 . . . . 0.0 110.006 178.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -160.62 122.76 3.17 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.741 -0.599 . . . . 0.0 111.374 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -119.26 -170.64 1.96 Allowed 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.963 -0.461 . . . . 0.0 110.205 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 15.8 tptm -104.71 138.8 40.46 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.567 0.699 . . . . 0.0 111.413 -178.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -59.19 118.61 6.1 Favored 'General case' 0 N--CA 1.509 2.522 0 O-C-N 121.933 -0.479 . . . . 0.0 110.88 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.33 23.47 40.24 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.425 ' O ' HG23 ' A' ' 63' ' ' ILE . 13.0 tt0 -114.98 164.6 13.92 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 118.411 1.105 . . . . 0.0 110.531 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -82.85 98.46 9.17 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 178.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.17 168.27 9.92 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 120.365 -0.534 . . . . 0.0 112.053 -177.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 99.6 t -142.75 141.09 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 43.5 mt -97.02 111.96 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 178.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.8 t -75.17 119.93 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 CA-C-O 121.47 0.652 . . . . 0.0 110.493 -176.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -160.83 92.68 0.95 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.16 140.75 29.52 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.529 -179.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.5 t -147.53 121.67 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.477 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 16.0 t -81.2 80.68 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.4 m -87.83 154.75 20.3 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.6 t -43.66 -84.0 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.18 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -166.32 -62.21 0.01 OUTLIER Pre-proline 0 N--CA 1.509 2.475 0 CA-C-O 117.675 -1.155 . . . . 0.0 111.584 178.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.2 -53.81 2.72 Favored 'Trans proline' 0 CA--C 1.561 1.844 0 CA-C-N 120.086 1.066 . . . . 0.0 112.552 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -63.02 -168.53 0.08 OUTLIER 'Trans proline' 0 N--CA 1.496 1.668 0 CA-C-N 119.425 0.83 . . . . 0.0 111.746 -179.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -171.58 -164.77 0.34 Allowed 'General case' 0 N--CA 1.52 3.067 0 O-C-N 121.92 -0.488 . . . . 0.0 109.78 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.1 tt -102.53 147.31 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.925 -0.484 . . . . 0.0 110.056 179.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.2 mp -114.5 121.07 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.404 ' CE2' ' HB2' ' A' ' 58' ' ' LEU . 83.6 m95 -82.77 104.4 12.99 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.1 tttm . . . . . 0 N--CA 1.506 2.359 0 CA-C-O 121.322 0.582 . . . . 0.0 111.494 -177.995 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.51 2.562 0 CA-C-O 121.019 0.438 . . . . 0.0 110.421 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.403 HD11 HG22 ' A' ' 43' ' ' ILE . 48.7 mm -58.42 -18.11 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.688 0 O-C-N 121.71 -0.618 . . . . 0.0 111.864 -179.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.3 mp -92.47 -22.18 19.74 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.492 -0.755 . . . . 0.0 111.106 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.1 pttt -97.88 -41.04 8.21 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.8 mmmt 46.91 56.91 6.14 Favored 'General case' 0 N--CA 1.509 2.505 0 CA-C-O 121.166 0.507 . . . . 0.0 112.308 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -49.69 161.17 0.24 Allowed 'General case' 0 N--CA 1.519 2.987 0 O-C-N 121.804 -0.56 . . . . 0.0 111.081 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 36.0 m -56.83 -21.92 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.779 0 O-C-N 121.911 -0.493 . . . . 0.0 112.172 -178.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 24.1 ptt-85 -104.22 -2.44 25.7 Favored 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -96.24 108.28 20.74 Favored 'General case' 0 N--CA 1.503 2.18 0 CA-C-N 119.145 0.884 . . . . 0.0 110.166 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 75.6 mt -129.36 104.84 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.8 t -74.78 127.89 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 42.7 mt -80.63 165.54 21.94 Favored 'General case' 0 N--CA 1.509 2.477 0 CA-C-O 121.34 0.591 . . . . 0.0 111.905 -178.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 89.9 p -60.19 -20.92 60.83 Favored 'General case' 0 N--CA 1.51 2.547 0 O-C-N 122.07 -0.394 . . . . 0.0 111.484 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 42.8 p-10 -91.74 19.83 6.11 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.658 -0.652 . . . . 0.0 111.392 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.3 m120 67.24 32.13 6.2 Favored 'General case' 0 N--CA 1.516 2.846 0 O-C-N 121.594 -0.691 . . . . 0.0 112.39 178.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -102.06 167.64 9.9 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.404 ' HB2' ' CE2' ' A' ' 35' ' ' TRP . 15.2 tp -121.99 98.8 6.11 Favored 'General case' 0 N--CA 1.519 2.978 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.954 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.72 101.15 7.39 Favored 'General case' 0 N--CA 1.503 2.202 0 C-N-CA 120.479 -0.489 . . . . 0.0 111.12 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.442 HG22 HD11 ' A' ' 60' ' ' ILE . 97.2 mt -94.68 104.31 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 177.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.85 115.65 8.42 Favored 'General case' 0 N--CA 1.505 2.301 0 CA-C-O 121.187 0.517 . . . . 0.0 110.721 -178.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 100.31 -39.26 2.8 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.425 HG23 ' O ' ' A' ' 17' ' ' GLU . 3.0 tp 42.52 83.58 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.517 2.901 0 CA-C-O 122.225 1.012 . . . . 0.0 112.117 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -72.11 158.42 35.97 Favored 'General case' 0 N--CA 1.508 2.454 0 O-C-N 121.751 -0.593 . . . . 0.0 111.984 -178.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt -61.27 -24.55 66.47 Favored 'General case' 0 N--CA 1.51 2.558 0 O-C-N 121.941 -0.474 . . . . 0.0 110.918 178.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.9 t -79.32 -15.0 58.63 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.893 -0.505 . . . . 0.0 111.691 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -87.37 -27.77 22.6 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.502 -0.749 . . . . 0.0 110.718 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -62.0 140.56 58.34 Favored 'General case' 0 N--CA 1.507 2.406 0 O-C-N 121.691 -0.631 . . . . 0.0 110.752 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 167.09 -104.88 0.23 Allowed Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.7 m -146.72 102.28 3.54 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 122.03 -0.688 . . . . 0.0 110.543 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -83.52 134.65 34.83 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 -94.0 115.65 28.01 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.85 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 85' ' ' PHE . 1.9 m -85.68 90.58 8.05 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -92.08 88.65 6.62 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.317 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.85 90.24 0.57 Allowed Glycine 0 N--CA 1.499 2.855 0 N-CA-C 107.44 -2.264 . . . . 0.0 107.44 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 30.1 ttm-85 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.805 0.812 . . . . 0.0 112.823 -177.181 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 . . . . . 0 N--CA 1.506 2.365 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.44 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 29.7 p90 -159.02 171.5 19.9 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 119.505 -0.878 . . . . 0.0 113.09 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 10.8 mttp -160.55 159.25 30.42 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -106.02 120.08 40.84 Favored 'General case' 0 N--CA 1.513 2.697 0 O-C-N 121.84 -0.538 . . . . 0.0 110.769 179.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.8 mp -104.74 121.6 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -85.32 115.61 23.17 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.5 t -110.33 131.93 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.171 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 67.0 mt -120.38 157.57 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.503 2.196 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.382 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 47.3 p90 . . . . . 0 N--CA 1.498 1.932 0 CA-C-O 120.752 0.31 . . . . 0.0 110.438 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.0 t -146.85 107.63 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.49 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 7.6 mmt -114.33 116.84 29.61 Favored 'General case' 0 N--CA 1.507 2.386 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.137 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -75.37 115.16 14.72 Favored 'General case' 0 N--CA 1.504 2.248 0 CA-C-O 120.9 0.381 . . . . 0.0 110.479 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.5 ptpt -127.22 163.71 23.28 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.649 0.738 . . . . 0.0 111.529 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 32.36 76.97 0.04 OUTLIER 'General case' 0 N--CA 1.517 2.901 0 C-N-CA 124.266 1.026 . . . . 0.0 113.49 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -145.03 78.45 12.48 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.812 -0.555 . . . . 0.0 110.916 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -64.37 104.39 0.51 Allowed 'Trans proline' 0 N--CA 1.492 1.412 0 N-CA-C 108.532 -1.372 . . . . 0.0 108.532 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.441 ' CB ' ' HD3' ' A' ' 10' ' ' PRO . 0.5 OUTLIER -50.92 -69.69 0.28 Allowed Pre-proline 0 N--CA 1.509 2.5 0 CA-C-O 116.625 -1.655 . . . . 0.0 112.802 -176.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.441 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.6 Cg_endo -72.62 96.72 0.84 Allowed 'Trans proline' 0 N--CA 1.498 1.741 0 CA-C-N 121.69 1.639 . . . . 0.0 111.518 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -101.3 177.5 4.91 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 120.951 -1.093 . . . . 0.0 110.319 178.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -158.57 125.16 4.72 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.897 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -123.17 -170.65 2.15 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.953 -0.467 . . . . 0.0 109.876 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -104.67 143.86 32.51 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.617 0.722 . . . . 0.0 111.519 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -60.27 125.0 22.0 Favored 'General case' 0 N--CA 1.508 2.431 0 O-C-N 121.965 -0.459 . . . . 0.0 111.049 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.29 22.24 68.32 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 110.889 -0.885 . . . . 0.0 110.889 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -110.21 164.44 12.65 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 118.714 1.257 . . . . 0.0 110.61 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.43 98.62 8.98 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 177.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.78 165.82 11.4 Favored 'General case' 0 N--CA 1.497 1.925 0 C-N-CA 120.121 -0.631 . . . . 0.0 111.991 -177.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 85.1 t -138.94 139.68 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 40.9 mt -95.47 115.62 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 178.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.406 ' HA ' ' CE2' ' A' ' 57' ' ' TYR . 47.4 t -76.9 118.19 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-O 121.544 0.687 . . . . 0.0 110.507 -177.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.1 t -160.08 87.11 0.78 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.03 142.11 28.17 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 119.946 -0.702 . . . . 0.0 109.269 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.3 t -147.7 129.28 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.49 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 60.1 t -92.71 78.28 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.2 m -79.45 164.62 23.82 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.9 t -42.13 -80.52 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.224 0 CA-C-N 118.283 0.492 . . . . 0.0 111.607 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -170.69 -63.43 0.0 OUTLIER Pre-proline 0 N--CA 1.515 2.786 0 CA-C-O 117.658 -1.163 . . . . 0.0 111.467 177.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.84 -53.29 2.77 Favored 'Trans proline' 0 CA--C 1.563 1.97 0 CA-C-N 120.1 1.071 . . . . 0.0 112.805 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.47 ' CB ' ' HA ' ' A' ' 77' ' ' ILE . 2.9 Cg_endo -61.71 -162.94 0.03 OUTLIER 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 120.516 0.811 . . . . 0.0 112.666 -178.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -170.16 -165.67 0.49 Allowed 'General case' 0 N--CA 1.518 2.936 0 O-C-N 121.849 -0.532 . . . . 0.0 110.403 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.5 tt -100.82 162.79 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.1 mt -125.23 126.77 71.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -90.44 110.65 21.75 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.0 tttt -112.78 -178.05 3.29 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.941 -0.475 . . . . 0.0 110.594 -179.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 24.8 t-80 63.76 150.58 0.03 OUTLIER 'General case' 0 N--CA 1.512 2.671 0 O-C-N 121.769 -0.582 . . . . 0.0 110.053 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.9 tppt? 54.33 43.73 30.04 Favored 'General case' 0 N--CA 1.515 2.796 0 O-C-N 121.538 -0.726 . . . . 0.0 110.415 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 150.37 -17.94 1.02 Allowed Glycine 0 N--CA 1.491 2.35 0 C-N-CA 120.337 -0.935 . . . . 0.0 111.099 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.75 88.35 0.05 Allowed 'General case' 0 N--CA 1.516 2.828 0 CA-C-N 118.797 1.299 . . . . 0.0 110.051 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 55.06 84.61 0.07 Allowed 'General case' 0 N--CA 1.514 2.773 0 O-C-N 121.727 -0.608 . . . . 0.0 110.217 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.4 m -69.19 -32.35 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.364 0 O-C-N 121.869 -0.519 . . . . 0.0 110.052 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.8 mm -58.27 -18.75 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.825 0 O-C-N 121.807 -0.558 . . . . 0.0 111.87 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.3 mp -93.2 -20.71 20.19 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.47 -0.769 . . . . 0.0 111.531 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 42.2 pttt -98.97 -37.89 9.21 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.531 -0.731 . . . . 0.0 109.802 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt 48.61 55.19 9.41 Favored 'General case' 0 N--CA 1.509 2.513 0 CA-C-O 121.581 0.705 . . . . 0.0 111.766 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -53.11 171.3 0.07 Allowed 'General case' 0 N--CA 1.513 2.682 0 O-C-N 121.755 -0.591 . . . . 0.0 110.876 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.6 t -66.9 -19.41 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.467 0 O-C-N 122.007 -0.433 . . . . 0.0 110.996 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 10.0 ptt-85 -115.64 45.7 1.64 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.504 -0.747 . . . . 0.0 112.1 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -145.28 105.33 4.04 Favored 'General case' 0 N--CA 1.506 2.346 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 177.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 45.2 mt -126.0 102.45 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.5 t -73.37 129.04 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 29.8 mt -82.71 167.6 18.05 Favored 'General case' 0 N--CA 1.509 2.498 0 CA-C-O 121.358 0.599 . . . . 0.0 112.143 -178.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.4 p -61.63 -22.02 64.89 Favored 'General case' 0 N--CA 1.509 2.496 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.985 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 52.4 p30 -91.49 18.85 6.76 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.749 -0.595 . . . . 0.0 111.337 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.8 m120 66.88 34.44 5.4 Favored 'General case' 0 N--CA 1.517 2.921 0 O-C-N 121.534 -0.728 . . . . 0.0 112.832 178.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.406 ' CE2' ' HA ' ' A' ' 22' ' ' VAL . 3.7 m-85 -103.06 166.03 10.67 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 177.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 15.2 tp -119.51 97.19 5.53 Favored 'General case' 0 N--CA 1.519 2.993 0 C-N-CA 119.371 -0.932 . . . . 0.0 111.505 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.67 95.39 3.97 Favored 'General case' 0 N--CA 1.502 2.166 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.857 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.441 HG22 HD11 ' A' ' 60' ' ' ILE . 99.4 mt -87.04 119.74 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 177.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 32.9 tpt85 -80.3 117.39 21.03 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-O 121.324 0.583 . . . . 0.0 110.638 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.26 -39.59 2.75 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.464 ' O ' HG21 ' A' ' 63' ' ' ILE . 2.8 tp 42.3 73.59 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.776 0 CA-C-O 122.16 0.981 . . . . 0.0 112.581 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 37.5 mmtt -59.8 150.61 27.71 Favored 'General case' 0 N--CA 1.51 2.573 0 O-C-N 121.377 -0.827 . . . . 0.0 111.661 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.7 ttmt -62.52 -17.59 60.11 Favored 'General case' 0 N--CA 1.506 2.374 0 O-C-N 122.087 -0.383 . . . . 0.0 111.213 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.8 t -89.32 -15.95 32.23 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.651 -0.656 . . . . 0.0 111.127 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -92.47 15.03 14.98 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.502 -0.748 . . . . 0.0 111.536 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -96.73 160.98 14.07 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.422 -0.798 . . . . 0.0 109.283 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 154.99 -99.4 0.19 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.371 -1.491 . . . . 0.0 109.371 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.8 m -151.05 101.35 2.87 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 122.016 -0.696 . . . . 0.0 111.988 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -82.17 131.74 35.24 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.1 tpp85 -98.11 117.02 31.53 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 120.087 -0.645 . . . . 0.0 111.212 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 14.4 m -79.43 129.84 34.85 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 177.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -128.03 88.63 2.79 Favored 'General case' 0 N--CA 1.502 2.15 0 CA-C-N 118.581 0.628 . . . . 0.0 110.265 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.47 111.11 3.84 Favored Glycine 0 N--CA 1.504 3.178 0 N-CA-C 107.915 -2.074 . . . . 0.0 107.915 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.2 ttm180 -125.28 141.08 52.3 Favored 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 121.959 0.885 . . . . 0.0 113.366 -177.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.47 ' HA ' ' CB ' ' A' ' 31' ' ' PRO . 87.6 mt -120.61 134.7 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.283 177.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.5 mt -93.4 -36.09 12.67 Favored 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.622 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.83 -54.85 28.61 Favored 'General case' 0 N--CA 1.514 2.731 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 68.9 mtt180 -107.98 63.59 0.62 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 177.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -13.71 80.77 0.0 OUTLIER Glycine 1 N--CA 1.527 4.714 0 C-N-CA 125.098 1.332 . . . . 0.0 114.879 -178.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -116.83 143.7 45.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 122.161 -0.611 . . . . 0.0 109.772 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.1 pt -136.23 81.11 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 CA-C-O 121.316 0.579 . . . . 0.0 111.459 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -97.3 154.04 17.67 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -167.76 176.19 6.49 Favored 'General case' 0 N--CA 1.508 2.475 0 O-C-N 121.455 -0.778 . . . . 0.0 112.692 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -168.13 155.95 8.45 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -93.16 120.53 33.55 Favored 'General case' 0 N--CA 1.51 2.55 0 O-C-N 121.713 -0.617 . . . . 0.0 111.796 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.6 mp -106.04 119.47 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -85.11 130.84 34.54 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.1 t -123.25 128.76 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 54.7 mt -121.07 142.29 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.7 p . . . . . 0 N--CA 1.5 2.056 0 CA-C-O 117.876 -1.059 . . . . 0.0 110.469 179.726 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 37.4 p90 . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 121.368 0.604 . . . . 0.0 111.268 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.4 t -142.39 96.99 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.479 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 7.3 mmm -96.56 113.92 25.53 Favored 'General case' 0 N--CA 1.506 2.354 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.907 -178.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -72.13 115.06 10.91 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.22 158.01 35.11 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 121.323 0.582 . . . . 0.0 110.354 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 38.88 70.92 0.18 Allowed 'General case' 0 N--CA 1.518 2.954 0 C-N-CA 123.374 0.67 . . . . 0.0 112.151 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.03 72.01 72.69 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.748 -0.595 . . . . 0.0 111.258 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -65.09 102.07 0.43 Allowed 'Trans proline' 0 N--CA 1.49 1.323 0 N-CA-C 108.886 -1.236 . . . . 0.0 108.886 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.446 ' CB ' ' HD3' ' A' ' 10' ' ' PRO . 0.4 OUTLIER -54.28 -68.3 0.51 Allowed Pre-proline 0 N--CA 1.508 2.461 0 CA-C-O 116.782 -1.58 . . . . 0.0 112.25 -177.636 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.446 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.4 Cg_endo -72.43 90.5 0.79 Allowed 'Trans proline' 0 N--CA 1.496 1.676 0 CA-C-N 121.52 1.579 . . . . 0.0 111.353 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -100.85 173.93 6.27 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 120.785 -1.197 . . . . 0.0 110.352 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -157.16 122.88 4.71 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.803 -0.561 . . . . 0.0 111.003 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -117.16 -170.09 1.78 Allowed 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.963 -0.46 . . . . 0.0 110.552 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -103.31 140.45 37.4 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.862 0.839 . . . . 0.0 111.907 -178.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -60.79 126.96 29.32 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.822 -0.548 . . . . 0.0 111.017 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.07 21.82 72.83 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.418 ' O ' HG23 ' A' ' 63' ' ' ILE . 18.2 tp10 -110.91 161.5 15.77 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 118.652 1.226 . . . . 0.0 111.018 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -79.79 95.8 6.11 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 177.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.66 169.68 9.86 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.851 -177.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 84.5 t -142.98 141.3 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.0 mt -96.36 114.4 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 178.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.41 ' HA ' ' CE2' ' A' ' 57' ' ' TYR . 38.8 t -75.51 118.33 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 CA-C-O 121.477 0.656 . . . . 0.0 110.735 -176.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.9 t -163.61 80.49 0.44 Allowed 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.06 146.21 32.06 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.4 t -148.88 133.84 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 60.6 t -94.88 88.49 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -88.29 140.2 29.72 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.0 t -97.97 30.57 3.0 Favored 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -177.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.442 ' HB3' ' HD2' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -161.79 170.41 8.12 Favored Pre-proline 0 N--CA 1.513 2.693 0 O-C-N 120.896 -1.127 . . . . 0.0 111.12 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.435 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 4.0 Cg_exo -49.81 -47.93 21.32 Favored 'Trans proline' 0 N--CA 1.502 1.973 0 C-N-CA 121.639 1.559 . . . . 0.0 114.491 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 29' ' ' LEU . 4.5 Cg_exo -52.66 -170.02 0.01 OUTLIER 'Trans proline' 0 N--CA 1.506 2.235 0 CA-C-N 120.044 1.051 . . . . 0.0 112.896 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -168.93 -156.21 0.16 Allowed 'General case' 0 N--CA 1.522 3.154 0 O-C-N 120.381 -1.45 . . . . 0.0 111.634 -176.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.5 tt -88.02 143.04 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 O-C-N 121.897 -0.502 . . . . 0.0 111.906 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.6 mp -109.47 130.44 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 177.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.436 ' CE2' ' HB2' ' A' ' 58' ' ' LEU . 79.3 m95 -90.28 110.61 21.66 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -110.37 -170.18 1.6 Allowed 'General case' 0 N--CA 1.501 2.1 0 CA-C-O 121.394 0.616 . . . . 0.0 111.199 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 64.06 163.79 0.13 Allowed 'General case' 0 N--CA 1.511 2.621 0 O-C-N 121.87 -0.519 . . . . 0.0 110.24 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.87 -51.71 0.57 Allowed 'General case' 0 N--CA 1.522 3.13 0 C-N-CA 123.873 0.869 . . . . 0.0 110.575 -178.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -144.94 30.37 1.8 Allowed Glycine 0 N--CA 1.498 2.818 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.61 89.06 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.791 0 O-C-N 121.496 -1.003 . . . . 0.0 111.625 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.36 105.89 0.01 OUTLIER 'General case' 0 N--CA 1.518 2.932 0 O-C-N 121.807 -0.558 . . . . 0.0 110.865 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.6 m -76.99 -31.38 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.394 0 O-C-N 121.715 -0.616 . . . . 0.0 110.646 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 79.6 mt -59.27 -17.33 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.87 0 O-C-N 121.754 -0.591 . . . . 0.0 111.803 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.8 mp -89.47 -25.22 21.59 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.599 -0.688 . . . . 0.0 110.55 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.0 pttt -98.6 -38.87 8.97 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.756 -0.59 . . . . 0.0 109.655 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.5 mmmt 47.06 55.64 7.79 Favored 'General case' 0 N--CA 1.51 2.55 0 CA-C-O 121.399 0.618 . . . . 0.0 111.959 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.8 169.46 0.07 Allowed 'General case' 0 N--CA 1.515 2.778 0 O-C-N 121.792 -0.567 . . . . 0.0 111.116 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 31.4 m -63.54 -21.59 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.591 0 O-C-N 121.985 -0.447 . . . . 0.0 111.649 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 16.4 ptt-85 -113.67 48.5 1.06 Allowed 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.648 -0.658 . . . . 0.0 111.747 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -144.73 102.97 3.87 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.553 -0.717 . . . . 0.0 109.895 178.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 48.0 mm -127.74 114.05 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 t -80.13 146.64 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 24.6 mt -102.71 162.99 12.48 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 121.244 0.545 . . . . 0.0 111.605 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 81.8 p -59.88 -20.58 57.96 Favored 'General case' 0 N--CA 1.51 2.552 0 O-C-N 122.098 -0.376 . . . . 0.0 111.689 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 38.5 p-10 -91.36 17.74 8.06 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.662 -0.649 . . . . 0.0 111.736 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.1 m120 70.21 29.54 3.67 Favored 'General case' 0 N--CA 1.52 3.046 0 O-C-N 121.635 -0.666 . . . . 0.0 111.931 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.41 ' CE2' ' HA ' ' A' ' 22' ' ' VAL . 4.3 m-85 -103.18 159.92 15.11 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.436 ' HB2' ' CE2' ' A' ' 35' ' ' TRP . 26.9 tp -120.85 100.81 7.3 Favored 'General case' 0 N--CA 1.514 2.743 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.814 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -75.48 103.47 5.62 Favored 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 120.759 -0.377 . . . . 0.0 111.244 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 99.8 mt -95.53 114.09 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 177.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -74.59 115.55 14.28 Favored 'General case' 0 N--CA 1.503 2.175 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.229 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.04 -39.02 2.89 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.45 ' O ' HG21 ' A' ' 63' ' ' ILE . 1.9 tp 42.92 71.79 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.843 0 CA-C-O 122.256 1.027 . . . . 0.0 112.241 -178.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.1 mtpp -63.32 158.01 21.46 Favored 'General case' 0 N--CA 1.506 2.374 0 O-C-N 121.59 -0.694 . . . . 0.0 112.333 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -62.02 -23.63 66.56 Favored 'General case' 0 N--CA 1.508 2.441 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.933 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.7 p -83.78 -16.56 44.24 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.74 -0.6 . . . . 0.0 111.015 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.91 -19.47 25.77 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.704 -0.623 . . . . 0.0 111.042 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -67.6 150.1 49.23 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.445 -0.785 . . . . 0.0 109.916 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 166.31 -111.69 0.46 Allowed Glycine 0 N--CA 1.498 2.822 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.4 m -144.57 101.59 3.7 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.941 -0.74 . . . . 0.0 110.034 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -82.16 133.52 35.27 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -94.64 117.94 30.92 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 120.002 -0.679 . . . . 0.0 111.143 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 85' ' ' PHE . 12.0 m -80.3 120.82 24.87 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 177.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.82 82.59 1.97 Allowed 'General case' 0 N--CA 1.509 2.512 0 CA-C-N 118.962 0.801 . . . . 0.0 110.556 -179.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.61 100.79 0.29 Allowed Glycine 0 N--CA 1.508 3.493 0 N-CA-C 108.779 -1.729 . . . . 0.0 108.779 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 25.1 ttp85 -116.62 128.75 55.68 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -177.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.6 mp -136.22 119.45 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 177.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.7 mt -91.38 52.54 2.11 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.42 0.629 . . . . 0.0 111.531 -178.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -152.2 -60.01 0.16 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 45.7 mtp85 -135.37 -43.33 0.7 Allowed 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -63.63 -18.45 61.49 Favored Glycine 0 N--CA 1.496 2.696 0 CA-C-O 119.538 -0.59 . . . . 0.0 111.956 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 45.79 -150.06 0.08 Allowed 'General case' 0 N--CA 1.515 2.813 0 CA-C-N 118.613 1.206 . . . . 0.0 112.842 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.1 pt -105.5 112.48 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.493 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -177.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -118.89 150.63 39.55 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 177.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.402 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 39.0 p90 -159.51 178.38 9.95 Favored 'General case' 0 N--CA 1.504 2.248 0 CA-C-N 119.773 1.17 . . . . 0.0 113.752 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -171.3 159.61 5.83 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -102.39 118.15 36.25 Favored 'General case' 0 N--CA 1.512 2.656 0 O-C-N 121.795 -0.566 . . . . 0.0 110.773 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.9 mp -101.99 119.73 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.06 112.83 21.63 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -179.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.9 t -106.74 133.26 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.13 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.9 mt -124.64 158.53 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.499 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 10.4 t80 . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 120.759 0.314 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 42.2 t -150.19 105.27 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 O-C-N 122.063 -0.398 . . . . 0.0 110.383 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.402 ' CG ' ' HB ' ' A' ' 26' ' ' VAL . 25.6 ptm -119.29 122.87 42.87 Favored 'General case' 0 N--CA 1.509 2.485 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 177.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -73.71 136.87 43.75 Favored 'General case' 0 N--CA 1.511 2.603 0 O-C-N 122.031 -0.418 . . . . 0.0 111.992 -176.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -136.47 158.15 45.11 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 121.424 0.631 . . . . 0.0 110.823 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 32.93 84.1 0.02 OUTLIER 'General case' 0 N--CA 1.521 3.103 0 C-N-CA 123.998 0.919 . . . . 0.0 113.347 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -145.19 80.86 10.81 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.7 -0.625 . . . . 0.0 111.23 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -67.07 105.3 0.96 Allowed 'Trans proline' 0 N--CA 1.49 1.32 0 N-CA-C 108.693 -1.31 . . . . 0.0 108.693 178.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.427 ' CB ' ' HD3' ' A' ' 10' ' ' PRO . 0.4 OUTLIER -57.88 -67.25 0.95 Allowed Pre-proline 0 N--CA 1.507 2.415 0 CA-C-O 116.905 -1.521 . . . . 0.0 111.828 -177.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.427 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.6 Cg_endo -71.46 92.02 0.68 Allowed 'Trans proline' 0 N--CA 1.493 1.445 0 CA-C-N 121.32 1.507 . . . . 0.0 111.604 178.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -101.27 166.31 10.83 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.068 -1.02 . . . . 0.0 110.141 178.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -152.37 120.62 6.3 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 120.196 -0.601 . . . . 0.0 111.844 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -116.12 -172.03 2.1 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 122.028 -0.42 . . . . 0.0 110.056 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 62.2 tttt -101.2 140.77 35.04 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.477 0.656 . . . . 0.0 111.468 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -59.52 122.17 13.37 Favored 'General case' 0 N--CA 1.51 2.541 0 O-C-N 121.99 -0.443 . . . . 0.0 111.041 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.26 21.97 59.71 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.415 ' O ' HG23 ' A' ' 63' ' ' ILE . 14.3 tt0 -111.76 164.43 13.06 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 118.738 1.269 . . . . 0.0 110.628 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -82.81 99.85 9.95 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -101.62 171.06 7.78 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.772 -177.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 84.5 t -141.96 141.26 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 19.0 mt -95.18 112.35 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.413 ' HA ' ' CE2' ' A' ' 57' ' ' TYR . 43.6 t -74.1 121.49 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.546 -176.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.6 t -164.85 93.56 0.64 Allowed 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.95 142.53 27.67 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.9 t -144.41 138.2 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 C-N-CA 120.311 -0.556 . . . . 0.0 109.541 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.402 ' HB ' ' CG ' ' A' ' 3' ' ' MET . 90.0 t -106.08 79.46 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.8 m -84.37 169.38 14.67 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.4 t -45.46 -76.31 0.02 OUTLIER 'General case' 0 N--CA 1.521 3.091 0 O-C-N 121.689 -0.632 . . . . 0.0 111.458 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -173.04 -62.52 0.0 OUTLIER Pre-proline 0 N--CA 1.518 2.953 0 CA-C-O 117.832 -1.08 . . . . 0.0 111.987 177.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.19 -53.31 3.13 Favored 'Trans proline' 0 CA--C 1.562 1.909 0 CA-C-N 119.939 1.014 . . . . 0.0 112.897 -179.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.472 ' CB ' ' HA ' ' A' ' 77' ' ' ILE . 2.8 Cg_endo -62.48 -163.63 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.745 0 CA-C-N 119.275 0.777 . . . . 0.0 112.676 -178.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -170.25 -166.37 0.53 Allowed 'General case' 0 N--CA 1.519 3.001 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.203 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.413 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 15.1 tt -97.61 161.11 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 122.065 -0.397 . . . . 0.0 110.056 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 90.4 mt -126.3 124.69 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.414 ' CE2' ' HB2' ' A' ' 58' ' ' LEU . 78.2 m95 -87.56 105.95 17.67 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 24.9 tttt -112.31 -172.9 2.13 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 122.052 -0.405 . . . . 0.0 110.617 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 30.5 t-80 63.78 147.2 0.03 OUTLIER 'General case' 0 N--CA 1.511 2.599 0 O-C-N 121.802 -0.561 . . . . 0.0 109.938 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.6 tptt 54.87 28.3 10.25 Favored 'General case' 0 N--CA 1.514 2.773 0 O-C-N 121.537 -0.727 . . . . 0.0 111.218 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 162.29 -29.15 0.27 Allowed Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? 56.14 104.77 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.788 0 O-C-N 121.607 -0.937 . . . . 0.0 111.179 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 54.97 70.35 0.63 Allowed 'General case' 0 N--CA 1.511 2.588 0 O-C-N 121.732 -0.605 . . . . 0.0 110.668 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.6 m -68.25 -35.06 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.325 0 O-C-N 121.677 -0.64 . . . . 0.0 109.375 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 50.6 mt -60.51 -18.62 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.68 0 O-C-N 121.877 -0.515 . . . . 0.0 111.173 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.0 mp -91.73 -20.94 21.02 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.608 -0.682 . . . . 0.0 110.975 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -98.88 -38.14 9.14 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt 48.35 56.69 7.1 Favored 'General case' 0 N--CA 1.508 2.463 0 CA-C-O 121.508 0.671 . . . . 0.0 111.649 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -50.57 173.71 0.02 OUTLIER 'General case' 0 N--CA 1.516 2.842 0 O-C-N 121.895 -0.503 . . . . 0.0 111.421 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.3 m -61.33 -18.47 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.636 0 O-C-N 121.882 -0.511 . . . . 0.0 111.804 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -126.05 48.33 2.12 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.6 -0.687 . . . . 0.0 112.337 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -144.47 106.47 4.32 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 121.56 -0.712 . . . . 0.0 109.689 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 65.8 mt -128.05 106.84 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.3 t -75.67 136.73 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.287 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.5 mt -91.16 165.26 13.58 Favored 'General case' 0 N--CA 1.506 2.338 0 CA-C-O 121.309 0.576 . . . . 0.0 111.724 -178.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.8 p -60.55 -21.22 62.29 Favored 'General case' 0 N--CA 1.511 2.576 0 O-C-N 122.114 -0.366 . . . . 0.0 111.453 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 40.4 p-10 -90.57 17.23 7.72 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.627 -0.671 . . . . 0.0 111.505 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.5 m120 69.38 31.58 3.79 Favored 'General case' 0 N--CA 1.516 2.856 0 O-C-N 121.594 -0.691 . . . . 0.0 111.846 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.413 ' CE2' ' HA ' ' A' ' 22' ' ' VAL . 4.3 m-85 -102.41 166.03 10.78 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 177.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.414 ' HB2' ' CE2' ' A' ' 35' ' ' TRP . 18.5 tp -123.62 99.92 6.54 Favored 'General case' 0 N--CA 1.515 2.818 0 C-N-CA 119.333 -0.947 . . . . 0.0 111.808 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.28 101.5 6.29 Favored 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 120.805 0.336 . . . . 0.0 111.107 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 97.6 mt -92.78 115.97 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.51 115.24 17.12 Favored 'General case' 0 N--CA 1.505 2.302 0 CA-C-O 121.299 0.571 . . . . 0.0 111.306 -178.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.31 -38.81 2.95 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 179.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.453 ' O ' HG21 ' A' ' 63' ' ' ILE . 1.7 tp 41.47 72.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.846 0 CA-C-O 121.995 0.903 . . . . 0.0 112.624 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -62.72 155.37 26.72 Favored 'General case' 0 N--CA 1.509 2.508 0 O-C-N 121.391 -0.818 . . . . 0.0 111.687 -178.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 33.9 tttt -62.82 -21.45 65.92 Favored 'General case' 0 N--CA 1.51 2.542 0 O-C-N 122.119 -0.363 . . . . 0.0 110.772 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 50.7 p -85.17 -13.97 48.39 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.79 -0.569 . . . . 0.0 111.106 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.88 -6.38 48.83 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.607 -0.683 . . . . 0.0 111.452 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.04 172.74 13.38 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-N 119.005 0.82 . . . . 0.0 110.067 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 145.33 -108.16 0.46 Allowed Glycine 0 N--CA 1.496 2.646 0 N-CA-C 108.991 -1.643 . . . . 0.0 108.991 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.7 m -143.17 100.99 3.74 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 122.041 -0.682 . . . . 0.0 111.418 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -83.72 129.46 34.95 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 29.4 ttp180 -94.84 119.21 33.03 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.324 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 5.5 m -81.88 124.12 29.44 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 177.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -125.12 89.94 3.15 Favored 'General case' 0 N--CA 1.503 2.201 0 CA-C-N 118.995 0.816 . . . . 0.0 111.021 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 33' ' ' ILE . . . -69.44 107.89 2.28 Favored Glycine 0 N--CA 1.502 3.045 0 N-CA-C 107.336 -2.306 . . . . 0.0 107.336 178.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -122.83 142.85 50.31 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -176.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.472 ' HA ' ' CB ' ' A' ' 31' ' ' PRO . 90.4 mt -115.74 137.63 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.104 177.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 14.2 mt -90.97 -47.35 7.63 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.119 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.19 -56.69 18.94 Favored 'General case' 0 N--CA 1.516 2.872 0 O-C-N 121.639 -0.663 . . . . 0.0 109.99 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 78.4 mtt180 -101.92 61.67 0.88 Allowed 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -14.62 81.72 0.0 OUTLIER Glycine 1 N--CA 1.525 4.599 0 C-N-CA 125.011 1.291 . . . . 0.0 114.867 -178.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -115.17 145.46 42.36 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 122.222 -0.575 . . . . 0.0 109.471 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.7 pt -135.41 70.68 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 CA-C-O 121.183 0.516 . . . . 0.0 111.534 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -85.79 150.37 24.61 Favored 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -163.01 -175.94 4.62 Favored 'General case' 0 N--CA 1.503 2.19 0 C-N-CA 119.551 -0.86 . . . . 0.0 112.979 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 9.1 tttt -167.6 162.27 14.12 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -106.71 110.5 22.7 Favored 'General case' 0 N--CA 1.51 2.531 0 O-C-N 121.764 -0.585 . . . . 0.0 111.0 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.6 mp -95.74 120.13 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 10.6 tm0? -91.63 113.53 25.82 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.046 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.7 t -104.75 143.33 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.931 -0.481 . . . . 0.0 109.967 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 68.4 mt -134.95 139.92 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.311 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 8.4 p . . . . . 0 N--CA 1.5 2.045 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.76 179.725 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 2.1 t80 . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 45.3 t -150.89 104.52 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 O-C-N 122.055 -0.403 . . . . 0.0 110.045 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.416 ' CG ' ' HB ' ' A' ' 26' ' ' VAL . 17.1 ptm -119.09 123.31 44.13 Favored 'General case' 0 N--CA 1.508 2.456 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -74.17 133.29 42.74 Favored 'General case' 0 N--CA 1.511 2.606 0 CA-C-O 120.974 0.416 . . . . 0.0 112.045 -176.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.37 163.38 30.15 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-O 121.367 0.603 . . . . 0.0 111.093 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.5 t30 27.78 70.24 0.06 Allowed 'General case' 0 N--CA 1.523 3.205 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -135.76 82.85 37.09 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.736 -0.603 . . . . 0.0 110.619 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -65.44 110.0 1.51 Allowed 'Trans proline' 0 N--CA 1.491 1.366 0 N-CA-C 109.02 -1.185 . . . . 0.0 109.02 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.476 ' OG1' ' HD3' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -60.64 -59.05 15.09 Favored Pre-proline 0 N--CA 1.502 2.151 0 CA-C-O 117.113 -1.422 . . . . 0.0 112.161 -177.777 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.476 ' HD3' ' OG1' ' A' ' 9' ' ' THR . 1.4 Cg_endo -80.11 91.44 1.17 Allowed 'Trans proline' 0 CA--C 1.554 1.488 0 CA-C-N 121.055 1.413 . . . . 0.0 111.557 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -101.38 173.5 6.41 Favored 'General case' 0 N--CA 1.509 2.504 0 O-C-N 120.973 -1.079 . . . . 0.0 110.521 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -158.37 121.13 3.76 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.783 -0.573 . . . . 0.0 111.478 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -116.68 -170.02 1.74 Allowed 'General case' 0 N--CA 1.503 2.203 0 O-C-N 122.06 -0.4 . . . . 0.0 109.943 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -103.48 137.52 41.46 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.527 0.68 . . . . 0.0 111.444 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -61.08 116.67 4.71 Favored 'General case' 0 N--CA 1.508 2.466 0 CA-C-O 121.051 0.453 . . . . 0.0 110.333 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.13 22.46 29.96 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -117.48 165.41 13.56 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 118.567 1.183 . . . . 0.0 111.085 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -80.62 99.85 8.34 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 177.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.29 165.85 11.49 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.968 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 99.2 t -141.68 139.47 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 177.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 42.6 mt -97.15 113.47 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 178.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.401 ' HA ' ' CE2' ' A' ' 57' ' ' TYR . 48.4 t -76.43 117.47 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 CA-C-O 121.558 0.694 . . . . 0.0 110.401 -177.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.3 t -157.94 91.26 1.11 Allowed 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.01 138.95 31.0 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -178.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.3 t -143.87 131.11 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 C-N-CA 120.283 -0.567 . . . . 0.0 109.476 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.416 ' HB ' ' CG ' ' A' ' 3' ' ' MET . 93.3 t -97.63 83.21 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.8 m -84.62 171.18 12.65 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 177.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.5 t -46.18 -81.49 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.091 0 O-C-N 121.594 -0.691 . . . . 0.0 111.261 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -165.93 -64.01 0.01 OUTLIER Pre-proline 0 N--CA 1.514 2.758 0 CA-C-O 117.706 -1.14 . . . . 0.0 111.752 177.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.13 -53.07 2.76 Favored 'Trans proline' 0 CA--C 1.563 1.939 0 CA-C-N 120.189 1.103 . . . . 0.0 113.013 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.465 ' CB ' ' HA ' ' A' ' 77' ' ' ILE . 3.2 Cg_exo -61.14 -163.83 0.03 OUTLIER 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 120.549 0.832 . . . . 0.0 113.108 -178.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -168.97 -162.81 0.39 Allowed 'General case' 0 N--CA 1.517 2.915 0 O-C-N 121.966 -0.459 . . . . 0.0 109.768 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.0 tt -101.23 167.35 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.879 -0.513 . . . . 0.0 110.195 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.7 mt -131.89 134.35 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.423 ' CE2' ' HB2' ' A' ' 58' ' ' LEU . 85.4 m95 -95.9 114.88 26.64 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.5 tttt -121.65 -162.68 0.99 Allowed 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.814 -0.554 . . . . 0.0 111.129 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.8 t60 69.35 -166.38 0.18 Allowed 'General case' 0 N--CA 1.509 2.524 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.27 19.51 6.34 Favored 'General case' 0 N--CA 1.516 2.863 0 O-C-N 121.493 -0.755 . . . . 0.0 111.14 -178.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 121.91 -46.9 1.06 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.29 -173.45 0.66 Allowed 'General case' 0 N--CA 1.51 2.547 0 O-C-N 121.895 -0.768 . . . . 0.0 109.773 -178.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -70.77 146.48 49.76 Favored 'General case' 0 N--CA 1.506 2.36 0 C-N-CA 120.708 -0.397 . . . . 0.0 109.973 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.3 m -95.1 -34.21 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 CA-C-O 121.192 0.52 . . . . 0.0 109.663 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.41 HG22 HD11 ' A' ' 43' ' ' ILE . 47.8 mm -58.35 -19.36 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.795 0 O-C-N 121.867 -0.52 . . . . 0.0 111.558 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.2 mp -93.03 -22.78 18.94 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.478 -0.764 . . . . 0.0 111.126 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 31.2 pttt -97.96 -38.57 9.34 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.4 mmmt 49.14 54.86 10.22 Favored 'General case' 0 N--CA 1.507 2.395 0 CA-C-O 121.487 0.66 . . . . 0.0 111.726 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.75 161.47 0.74 Allowed 'General case' 0 N--CA 1.514 2.764 0 O-C-N 121.731 -0.605 . . . . 0.0 110.916 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.9 m -58.42 -21.1 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.666 0 O-C-N 121.909 -0.494 . . . . 0.0 111.876 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.1 ptp85 -111.53 46.11 1.14 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.78 -0.575 . . . . 0.0 111.633 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -146.24 106.36 4.02 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.72 -0.613 . . . . 0.0 109.836 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 81.1 mt -129.03 107.5 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.1 t -74.94 139.32 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 43.1 mt -94.82 167.84 11.18 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 121.224 0.535 . . . . 0.0 111.963 -178.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.4 p -61.76 -23.22 66.03 Favored 'General case' 0 N--CA 1.509 2.484 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.072 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 35.6 p-10 -90.03 16.93 7.49 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.659 -0.651 . . . . 0.0 111.414 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.5 m120 69.43 32.18 3.55 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 121.558 -0.714 . . . . 0.0 112.283 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.401 ' CE2' ' HA ' ' A' ' 22' ' ' VAL . 4.0 m-85 -103.24 157.97 16.64 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.423 ' HB2' ' CE2' ' A' ' 35' ' ' TRP . 17.8 tp -114.13 98.92 7.26 Favored 'General case' 0 N--CA 1.517 2.897 0 C-N-CA 119.487 -0.885 . . . . 0.0 111.624 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -76.97 98.96 5.1 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 120.325 -0.55 . . . . 0.0 111.075 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 98.2 mt -89.58 119.56 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 177.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.2 tpt85 -81.45 114.12 19.98 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-O 121.443 0.639 . . . . 0.0 111.247 -178.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.17 -36.73 3.75 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.427 ' O ' HG21 ' A' ' 63' ' ' ILE . 3.1 tp 42.3 93.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.826 0 CA-C-N 118.14 0.97 . . . . 0.0 112.237 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -80.36 154.68 27.59 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.377 -0.827 . . . . 0.0 112.004 -177.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.7 tttm -62.04 -25.07 67.45 Favored 'General case' 0 N--CA 1.509 2.517 0 O-C-N 122.174 -0.329 . . . . 0.0 111.002 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 56.3 p -82.22 -16.62 48.98 Favored 'General case' 0 N--CA 1.505 2.325 0 O-C-N 121.848 -0.532 . . . . 0.0 110.978 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.88 -12.42 36.26 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.622 -0.674 . . . . 0.0 111.732 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -73.42 142.87 46.92 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.385 -0.822 . . . . 0.0 109.792 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 171.85 -104.27 0.2 Allowed Glycine 0 N--CA 1.498 2.792 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.4 m -147.77 102.13 3.39 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 122.055 -0.674 . . . . 0.0 110.45 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -81.97 139.61 34.46 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.8 ttt180 -102.46 116.79 33.34 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.02 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 7.0 m -79.04 133.43 36.81 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 177.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -133.71 91.58 2.86 Favored 'General case' 0 N--CA 1.504 2.243 0 CA-C-N 118.711 0.687 . . . . 0.0 110.452 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.36 109.6 2.96 Favored Glycine 0 N--CA 1.504 3.185 0 N-CA-C 107.631 -2.187 . . . . 0.0 107.631 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 5.9 ttm180 -120.54 140.2 51.83 Favored 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -176.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.465 ' HA ' ' CB ' ' A' ' 31' ' ' PRO . 85.1 mt -118.89 137.76 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-N 114.933 -1.03 . . . . 0.0 108.505 177.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.5 mt -92.18 -44.29 8.87 Favored 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 121.071 -0.252 . . . . 0.0 110.886 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.07 -57.36 12.89 Favored 'General case' 0 N--CA 1.515 2.806 0 O-C-N 121.645 -0.659 . . . . 0.0 109.797 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 60.1 mtt85 -102.14 61.99 0.87 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -14.31 82.1 0.0 OUTLIER Glycine 1 N--CA 1.526 4.685 0 C-N-CA 124.946 1.26 . . . . 0.0 114.733 -178.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -116.8 148.59 41.07 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 122.146 -0.62 . . . . 0.0 109.636 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.9 pt -138.26 65.93 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 CA-C-O 121.111 0.482 . . . . 0.0 111.169 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -79.42 155.36 28.38 Favored 'General case' 0 N--CA 1.505 2.292 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -164.83 -178.6 5.34 Favored 'General case' 0 N--CA 1.506 2.348 0 C-N-CA 119.723 -0.791 . . . . 0.0 112.937 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.9 mttm -168.72 159.52 9.9 Favored 'General case' 0 N--CA 1.505 2.294 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -103.66 112.75 25.82 Favored 'General case' 0 N--CA 1.512 2.642 0 O-C-N 121.847 -0.533 . . . . 0.0 110.644 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.8 mp -98.85 115.23 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -82.87 110.87 18.24 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 44.4 t -105.54 135.69 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.032 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.1 mp -124.71 159.76 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.503 2.205 0 CA-C-O 117.937 -1.03 . . . . 0.0 110.35 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 45.2 p90 . . . . . 0 N--CA 1.499 1.976 0 CA-C-O 120.704 0.287 . . . . 0.0 110.451 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 43.3 t -148.11 104.03 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.485 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 0.8 OUTLIER -108.31 112.89 25.58 Favored 'General case' 0 N--CA 1.507 2.42 0 C-N-CA 120.251 -0.579 . . . . 0.0 109.56 179.289 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -69.91 120.43 15.63 Favored 'General case' 0 N--CA 1.504 2.242 0 CA-C-O 120.926 0.393 . . . . 0.0 110.485 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.0 pttt -130.92 161.55 31.63 Favored 'General case' 0 N--CA 1.502 2.133 0 CA-C-O 121.624 0.726 . . . . 0.0 111.068 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 32.55 72.38 0.08 Allowed 'General case' 0 N--CA 1.518 2.942 0 C-N-CA 124.213 1.005 . . . . 0.0 113.31 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -136.5 80.79 37.87 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.739 -0.601 . . . . 0.0 110.972 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -66.08 102.32 0.54 Allowed 'Trans proline' 0 N--CA 1.491 1.378 0 N-CA-C 108.455 -1.402 . . . . 0.0 108.455 178.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.45 ' CB ' ' HD3' ' A' ' 10' ' ' PRO . 0.3 OUTLIER -53.15 -67.82 0.53 Allowed Pre-proline 0 N--CA 1.509 2.5 0 CA-C-O 116.732 -1.604 . . . . 0.0 112.401 -177.219 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.45 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.4 Cg_endo -74.88 95.14 0.96 Allowed 'Trans proline' 0 N--CA 1.498 1.749 0 CA-C-N 121.54 1.586 . . . . 0.0 111.123 178.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -100.49 179.51 4.42 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.96 -1.087 . . . . 0.0 110.389 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -159.61 124.68 4.06 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.852 -0.53 . . . . 0.0 111.921 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -124.18 -169.04 1.89 Allowed 'General case' 0 N--CA 1.505 2.315 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.0 tttt -106.04 137.18 44.41 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.598 0.713 . . . . 0.0 111.542 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -62.18 115.87 4.5 Favored 'General case' 0 N--CA 1.508 2.471 0 CA-C-O 121.105 0.478 . . . . 0.0 110.168 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.0 22.4 23.12 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -118.3 165.31 14.0 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 118.371 1.086 . . . . 0.0 110.851 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -83.3 99.34 9.94 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 177.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.26 169.07 9.38 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.315 0.579 . . . . 0.0 112.197 -177.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 88.5 t -142.01 141.05 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.2 mt -97.01 114.18 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 178.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.405 ' HA ' ' CE2' ' A' ' 57' ' ' TYR . 46.8 t -75.41 120.41 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.64 -176.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.0 t -162.4 89.91 0.71 Allowed 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.88 142.88 27.28 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.0 t -147.34 132.61 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.485 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 48.9 t -93.63 75.54 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.1 m -77.6 163.96 25.78 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.5 t -45.44 -83.58 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.145 0 O-C-N 121.895 -0.503 . . . . 0.0 111.189 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -167.06 -64.37 0.01 OUTLIER Pre-proline 0 N--CA 1.513 2.712 0 CA-C-O 117.61 -1.186 . . . . 0.0 111.686 177.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -59.6 -53.15 3.61 Favored 'Trans proline' 0 CA--C 1.563 1.969 0 CA-C-N 120.235 1.12 . . . . 0.0 112.682 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.439 ' CB ' ' HA ' ' A' ' 77' ' ' ILE . 3.0 Cg_endo -61.73 -163.73 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 120.601 0.867 . . . . 0.0 112.611 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -169.94 -168.76 0.79 Allowed 'General case' 0 N--CA 1.518 2.95 0 O-C-N 121.932 -0.48 . . . . 0.0 110.283 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 tt -97.52 164.24 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 86.6 mt -129.34 129.66 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.433 ' CE2' ' HB2' ' A' ' 58' ' ' LEU . 84.6 m95 -91.95 101.03 13.59 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -99.87 -170.14 1.84 Allowed 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.065 0.46 . . . . 0.0 110.493 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 61.78 161.71 0.07 Allowed 'General case' 0 N--CA 1.512 2.642 0 O-C-N 121.809 -0.557 . . . . 0.0 110.339 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.3 tppm? 56.55 40.45 29.45 Favored 'General case' 0 N--CA 1.517 2.919 0 O-C-N 121.492 -0.755 . . . . 0.0 110.682 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 133.83 8.13 2.22 Favored Glycine 0 N--CA 1.497 2.741 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.991 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? 52.59 90.58 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.786 0 CA-C-N 119.376 1.588 . . . . 0.0 111.18 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.2 t0 53.95 100.02 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.904 0 O-C-N 121.85 -0.531 . . . . 0.0 110.94 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.1 m -71.72 -26.25 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.494 0 O-C-N 121.794 -0.567 . . . . 0.0 110.618 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.3 mm -58.91 -17.76 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.757 0 O-C-N 121.578 -0.702 . . . . 0.0 111.679 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.9 mp -92.53 -22.47 19.53 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.48 -0.762 . . . . 0.0 110.986 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.6 pttt -98.03 -42.27 7.57 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.574 -0.704 . . . . 0.0 109.635 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 20.1 mmmt 46.37 56.49 6.28 Favored 'General case' 0 N--CA 1.51 2.55 0 CA-C-O 121.457 0.646 . . . . 0.0 112.038 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -52.19 169.58 0.07 Allowed 'General case' 0 N--CA 1.515 2.798 0 O-C-N 121.694 -0.628 . . . . 0.0 110.968 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.8 m -61.99 -19.25 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.638 0 O-C-N 121.975 -0.453 . . . . 0.0 111.893 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.1 ptt-85 -116.93 46.49 1.65 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.678 -0.639 . . . . 0.0 111.703 -179.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -143.8 102.99 4.0 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.609 -0.682 . . . . 0.0 109.501 178.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 71.3 mt -128.17 113.22 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.4 t -78.62 127.37 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 65.1 mt -78.82 165.51 23.47 Favored 'General case' 0 N--CA 1.508 2.473 0 CA-C-O 121.224 0.535 . . . . 0.0 112.169 -177.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.2 p -60.16 -21.59 61.84 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 122.196 -0.315 . . . . 0.0 111.505 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -91.39 19.04 6.42 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.676 -0.64 . . . . 0.0 111.526 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.0 m120 68.11 31.48 5.38 Favored 'General case' 0 N--CA 1.516 2.851 0 O-C-N 121.661 -0.649 . . . . 0.0 112.145 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.405 ' CE2' ' HA ' ' A' ' 22' ' ' VAL . 4.0 m-85 -102.12 165.21 11.28 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.433 ' HB2' ' CE2' ' A' ' 35' ' ' TRP . 21.9 tp -120.65 98.68 6.14 Favored 'General case' 0 N--CA 1.517 2.908 0 C-N-CA 119.341 -0.944 . . . . 0.0 112.008 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.18 104.97 6.96 Favored 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.991 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 98.9 mt -96.56 113.63 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 177.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -77.08 115.95 17.32 Favored 'General case' 0 N--CA 1.503 2.224 0 CA-C-O 121.394 0.616 . . . . 0.0 111.287 -178.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.53 -37.02 3.65 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.409 HG22 ' O ' ' A' ' 63' ' ' ILE . 3.6 tp 40.11 84.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.521 3.095 0 CA-C-O 122.133 0.968 . . . . 0.0 112.44 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 45.6 mttt -75.99 160.08 30.2 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 121.631 -0.668 . . . . 0.0 112.151 -178.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.8 tttm -60.86 -25.6 66.79 Favored 'General case' 0 N--CA 1.51 2.564 0 O-C-N 122.022 -0.424 . . . . 0.0 110.974 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 63.9 p -80.14 -16.9 53.92 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 121.859 -0.525 . . . . 0.0 111.56 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.25 -29.47 26.46 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.51 -0.743 . . . . 0.0 110.509 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -61.72 140.68 58.17 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.884 -0.51 . . . . 0.0 111.18 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 169.06 -101.39 0.17 Allowed Glycine 0 N--CA 1.497 2.765 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.3 m -151.23 100.6 2.77 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 122.079 -0.659 . . . . 0.0 110.382 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -81.64 140.05 34.63 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.2 ttm-85 -102.44 121.09 41.64 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 120.059 -0.656 . . . . 0.0 111.511 -179.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 9.8 m -86.1 130.1 34.64 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 177.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -131.38 90.47 2.87 Favored 'General case' 0 N--CA 1.506 2.331 0 CA-C-N 118.783 0.719 . . . . 0.0 110.526 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.2 106.27 1.74 Allowed Glycine 0 N--CA 1.504 3.208 0 N-CA-C 107.827 -2.109 . . . . 0.0 107.827 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 -118.85 138.74 52.51 Favored 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -177.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.439 ' HA ' ' CB ' ' A' ' 31' ' ' PRO . 74.2 mt -124.21 135.9 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.569 177.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 35.6 mt -94.95 -39.97 9.92 Favored 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 121.044 -0.263 . . . . 0.0 110.684 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.83 -58.96 5.96 Favored 'General case' 0 N--CA 1.515 2.812 0 O-C-N 121.788 -0.57 . . . . 0.0 109.509 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 81.4 mtt-85 -100.83 61.23 0.98 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 177.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -14.41 81.8 0.0 OUTLIER Glycine 1 N--CA 1.525 4.618 0 C-N-CA 125.012 1.291 . . . . 0.0 114.92 -178.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -120.29 142.98 48.59 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 122.271 -0.546 . . . . 0.0 109.978 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.1 pt -135.48 81.81 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 CA-C-O 121.275 0.559 . . . . 0.0 111.129 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -100.15 153.54 19.16 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -161.9 -179.25 7.02 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 120.009 -0.676 . . . . 0.0 112.221 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.0 mttt -165.76 160.39 17.11 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -104.17 113.36 26.86 Favored 'General case' 0 N--CA 1.511 2.612 0 O-C-N 121.896 -0.502 . . . . 0.0 110.213 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.0 mp -100.89 116.74 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -82.96 122.09 27.84 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 44.6 t -116.01 126.5 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.16 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 71.0 mt -115.68 155.75 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.499 1.975 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.71 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 39.6 p90 . . . . . 0 N--CA 1.5 2.052 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 48.4 t -147.44 114.02 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.3 mtp -114.81 106.56 14.33 Favored 'General case' 0 N--CA 1.513 2.698 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -66.38 119.16 11.11 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.959 -0.463 . . . . 0.0 110.747 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.87 156.2 45.44 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-O 121.578 0.704 . . . . 0.0 110.558 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.6 t30 39.13 87.75 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.051 0 C-N-CA 123.404 0.682 . . . . 0.0 112.193 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -143.04 61.36 10.32 Favored Pre-proline 0 N--CA 1.497 1.917 0 C-N-CA 119.91 -0.716 . . . . 0.0 112.332 -178.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -64.68 93.34 0.2 Allowed 'Trans proline' 0 N--CA 1.494 1.506 0 N-CA-C 107.972 -1.588 . . . . 0.0 107.972 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.493 ' OG1' ' HD3' ' A' ' 10' ' ' PRO . 18.3 p -53.04 -42.79 92.53 Favored Pre-proline 0 N--CA 1.508 2.472 0 CA-C-O 117.343 -1.313 . . . . 0.0 113.631 -176.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.493 ' HD3' ' OG1' ' A' ' 9' ' ' THR . 1.6 Cg_endo -82.83 86.55 1.46 Allowed 'Trans proline' 0 CA--C 1.548 1.203 0 CA-C-N 120.785 1.316 . . . . 0.0 111.051 -177.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -100.16 171.17 7.97 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 121.15 -0.969 . . . . 0.0 111.068 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -155.92 119.9 4.48 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 122.089 -0.382 . . . . 0.0 110.975 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -116.28 -171.09 1.93 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.871 -0.518 . . . . 0.0 110.196 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.0 tttm -103.68 139.58 38.76 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.492 0.663 . . . . 0.0 111.633 -178.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -59.83 125.83 25.2 Favored 'General case' 0 N--CA 1.508 2.442 0 O-C-N 121.767 -0.583 . . . . 0.0 110.815 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.24 22.04 66.16 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -113.59 160.9 18.06 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-N 118.829 1.314 . . . . 0.0 111.094 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -78.29 98.38 5.91 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.39 174.0 6.49 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.125 0.488 . . . . 0.0 111.875 -177.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 85.9 t -145.57 141.52 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 21.9 mt -95.95 116.77 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.411 ' HA ' ' CE2' ' A' ' 57' ' ' TYR . 55.6 t -75.98 121.02 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 CA-C-O 121.446 0.641 . . . . 0.0 111.42 -176.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.8 t -165.2 93.75 0.61 Allowed 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.4 139.11 31.03 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.044 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.8 t -147.08 131.95 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.2 t -94.09 74.06 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.1 m -76.18 165.93 24.2 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.1 t -47.65 -82.75 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.085 0 O-C-N 121.877 -0.515 . . . . 0.0 111.206 -179.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -166.59 -63.22 0.01 OUTLIER Pre-proline 0 N--CA 1.513 2.694 0 CA-C-O 117.661 -1.161 . . . . 0.0 111.696 178.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.22 -53.19 3.2 Favored 'Trans proline' 0 CA--C 1.561 1.852 0 CA-C-N 120.203 1.108 . . . . 0.0 112.503 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.486 ' CB ' ' HA ' ' A' ' 77' ' ' ILE . 2.8 Cg_endo -63.45 -164.58 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.715 0 CA-C-N 119.211 0.754 . . . . 0.0 112.51 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -171.79 -164.5 0.32 Allowed 'General case' 0 N--CA 1.52 3.037 0 O-C-N 121.925 -0.484 . . . . 0.0 110.206 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 18.8 tt -103.49 136.32 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 122.038 -0.414 . . . . 0.0 110.069 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.0 mp -100.79 130.03 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.434 ' CE2' ' HB2' ' A' ' 58' ' ' LEU . 74.7 m95 -89.73 107.34 19.04 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 48.2 mttt -108.88 -165.44 1.02 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 122.02 -0.425 . . . . 0.0 110.618 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 66.2 162.78 0.16 Allowed 'General case' 0 N--CA 1.511 2.609 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -178.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.7 tppm? 55.48 23.14 5.61 Favored 'General case' 0 N--CA 1.515 2.789 0 O-C-N 121.613 -0.679 . . . . 0.0 111.534 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 142.28 36.21 0.09 OUTLIER Glycine 0 N--CA 1.498 2.812 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.582 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 60.86 -75.39 0.03 OUTLIER 'General case' 0 N--CA 1.518 2.973 0 CA-C-N 118.42 1.11 . . . . 0.0 111.102 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -144.62 140.4 28.69 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.8 m -95.93 -36.68 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.332 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.28 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 77.9 mt -60.61 -16.87 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.829 0 O-C-N 121.943 -0.473 . . . . 0.0 111.658 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.3 mp -91.43 -22.29 20.52 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.469 -0.769 . . . . 0.0 110.731 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.5 pttt -98.55 -36.43 9.91 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.71 -0.619 . . . . 0.0 109.411 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.4 mmmt 47.92 55.0 9.19 Favored 'General case' 0 N--CA 1.507 2.379 0 CA-C-O 121.405 0.622 . . . . 0.0 112.035 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.52 169.39 0.13 Allowed 'General case' 0 N--CA 1.513 2.685 0 O-C-N 121.705 -0.622 . . . . 0.0 110.81 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.7 m -63.78 -16.02 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.612 0 O-C-N 121.891 -0.506 . . . . 0.0 111.872 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.5 ptt-85 -120.07 45.05 2.27 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.585 -0.697 . . . . 0.0 111.956 -178.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -145.49 101.59 3.6 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.56 -0.712 . . . . 0.0 110.418 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.401 HG22 HD11 ' A' ' 51' ' ' ILE . 49.9 mm -125.96 113.79 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.5 t -80.02 139.4 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 31.8 mt -92.92 165.51 12.85 Favored 'General case' 0 N--CA 1.506 2.327 0 CA-C-O 121.335 0.588 . . . . 0.0 112.0 -178.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.1 p -61.09 -21.25 63.51 Favored 'General case' 0 N--CA 1.509 2.493 0 O-C-N 122.097 -0.377 . . . . 0.0 111.212 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 46.5 p-10 -89.67 16.97 6.99 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.573 -0.704 . . . . 0.0 111.503 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.6 m120 68.14 31.49 5.33 Favored 'General case' 0 N--CA 1.517 2.896 0 O-C-N 121.559 -0.713 . . . . 0.0 112.278 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.411 ' CE2' ' HA ' ' A' ' 22' ' ' VAL . 4.2 m-85 -103.68 165.64 10.91 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 177.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.434 ' HB2' ' CE2' ' A' ' 35' ' ' TRP . 23.4 tp -121.48 99.42 6.46 Favored 'General case' 0 N--CA 1.516 2.833 0 C-N-CA 119.404 -0.918 . . . . 0.0 111.901 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -76.0 105.16 6.89 Favored 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.089 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.5 mt -95.26 115.08 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.45 113.32 12.72 Favored 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.642 -177.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.66 -35.12 4.69 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 178.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.454 ' O ' HG21 ' A' ' 63' ' ' ILE . 3.1 tp 41.07 76.65 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.519 2.98 0 CA-C-N 118.15 0.975 . . . . 0.0 112.116 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.6 mtpp -59.65 147.63 36.74 Favored 'General case' 0 N--CA 1.508 2.444 0 O-C-N 121.411 -0.805 . . . . 0.0 111.769 -178.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.2 tttt -62.22 -17.46 58.34 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 122.23 -0.294 . . . . 0.0 111.037 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.8 p -90.81 -16.72 27.82 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.6 -0.688 . . . . 0.0 111.116 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.2 12.44 20.13 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.573 -0.704 . . . . 0.0 112.039 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.78 160.93 14.73 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.33 -0.856 . . . . 0.0 109.368 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 157.12 -98.68 0.18 Allowed Glycine 0 N--CA 1.495 2.625 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.7 m -153.67 102.49 2.55 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 117.52 0.66 . . . . 0.0 111.292 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -82.38 139.38 34.09 Favored 'General case' 0 N--CA 1.506 2.33 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.9 ttp180 -101.25 119.61 39.01 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.282 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 37.8 m -79.56 127.85 32.66 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 177.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.71 85.11 2.35 Favored 'General case' 0 N--CA 1.505 2.321 0 CA-C-N 119.312 0.96 . . . . 0.0 110.549 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.88 105.12 1.31 Allowed Glycine 0 N--CA 1.504 3.231 0 N-CA-C 107.688 -2.165 . . . . 0.0 107.688 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 34.4 ttp85 -122.13 140.74 52.19 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -176.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.486 ' HA ' ' CB ' ' A' ' 31' ' ' PRO . 91.0 mt -118.62 133.68 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.137 177.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 17.3 mt -92.26 -33.86 14.48 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.005 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.97 -57.15 8.46 Favored 'General case' 0 N--CA 1.512 2.661 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 38.2 mtp85 -103.66 61.72 0.76 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 177.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -14.09 81.16 0.0 OUTLIER Glycine 1 N--CA 1.526 4.657 0 C-N-CA 124.999 1.285 . . . . 0.0 114.952 -178.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -121.64 141.79 50.77 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 122.229 -0.571 . . . . 0.0 109.803 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.1 pt -132.85 86.21 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.374 0 CA-C-O 121.391 0.615 . . . . 0.0 111.803 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -98.27 148.65 23.42 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -159.2 176.07 12.66 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 119.544 -0.862 . . . . 0.0 112.9 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.8 mttp -165.74 158.68 15.49 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -96.92 138.52 34.34 Favored 'General case' 0 N--CA 1.506 2.351 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.212 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 46.4 mm -121.04 104.73 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -71.17 113.32 8.09 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 43.5 t -110.72 132.48 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.621 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 71.7 mt -124.76 143.83 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.365 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.503 2.194 0 CA-C-O 118.043 -0.98 . . . . 0.0 110.863 -179.96 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 42.3 p90 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.26 0.552 . . . . 0.0 110.999 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 44.3 t -143.05 102.67 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.47 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 12.0 mmt -110.16 123.14 49.21 Favored 'General case' 0 N--CA 1.51 2.54 0 O-C-N 121.85 -0.531 . . . . 0.0 111.868 -178.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -77.26 122.11 24.62 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 120.927 0.394 . . . . 0.0 110.585 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.4 ' HG2' HG21 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -132.83 157.06 45.96 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 40.17 70.67 0.22 Allowed 'General case' 0 N--CA 1.517 2.913 0 C-N-CA 123.178 0.591 . . . . 0.0 111.956 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -130.16 71.47 82.22 Favored Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.599 -0.688 . . . . 0.0 111.017 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -64.52 108.36 1.01 Allowed 'Trans proline' 0 N--CA 1.492 1.406 0 N-CA-C 109.161 -1.13 . . . . 0.0 109.161 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.445 ' CB ' ' HD3' ' A' ' 10' ' ' PRO . 0.3 OUTLIER -63.2 -69.18 0.63 Allowed Pre-proline 0 N--CA 1.503 2.189 0 CA-C-O 116.767 -1.587 . . . . 0.0 111.5 -178.101 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.445 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.4 Cg_endo -71.52 88.34 0.75 Allowed 'Trans proline' 0 N--CA 1.492 1.432 0 CA-C-N 121.392 1.533 . . . . 0.0 111.706 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -100.66 169.45 9.02 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 120.99 -1.069 . . . . 0.0 109.192 177.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -157.01 122.35 4.64 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.708 -0.62 . . . . 0.0 111.277 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -115.21 -173.78 2.38 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.948 -0.47 . . . . 0.0 110.033 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -102.54 140.51 36.72 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.536 0.684 . . . . 0.0 111.404 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -60.16 117.78 5.55 Favored 'General case' 0 N--CA 1.51 2.535 0 O-C-N 121.985 -0.447 . . . . 0.0 110.855 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.27 22.05 36.25 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -113.81 159.69 19.52 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 118.465 1.132 . . . . 0.0 111.465 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -79.55 100.31 7.7 Favored 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 177.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -101.86 168.61 9.32 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.59 0.709 . . . . 0.0 112.386 -177.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 98.6 t -144.16 137.33 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 178.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 53.7 mt -93.89 115.85 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 178.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.416 ' HA ' ' CE2' ' A' ' 57' ' ' TYR . 43.0 t -76.41 115.49 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-O 121.492 0.663 . . . . 0.0 110.903 -176.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.1 t -161.16 81.38 0.62 Allowed 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.37 147.74 30.92 Favored 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.878 -178.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.7 t -147.64 137.73 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.47 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 25.8 t -97.7 88.95 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.52 138.58 31.66 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.7 t -94.86 14.76 20.46 Favored 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -177.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 17.3 mt -140.59 168.18 15.37 Favored Pre-proline 0 N--CA 1.503 2.22 0 O-C-N 121.164 -0.96 . . . . 0.0 111.677 -178.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -48.2 -47.37 19.82 Favored 'Trans proline' 0 N--CA 1.502 2.029 0 C-N-CA 121.616 1.544 . . . . 0.0 114.516 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -55.13 -165.43 0.01 OUTLIER 'Trans proline' 0 N--CA 1.504 2.116 0 CA-C-N 120.004 1.037 . . . . 0.0 112.794 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -169.65 -157.29 0.16 Allowed 'General case' 0 N--CA 1.518 2.935 0 O-C-N 120.556 -1.34 . . . . 0.0 111.02 -176.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.442 ' HA ' ' HA2' ' A' ' 75' ' ' GLY . 20.2 tt -78.98 166.75 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.876 -0.515 . . . . 0.0 110.796 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.44 HG22 HD11 ' A' ' 34' ' ' ILE . 38.2 mm -128.85 128.51 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.436 ' CE2' ' HB2' ' A' ' 58' ' ' LEU . 81.5 m95 -93.89 99.18 11.58 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 120.191 -0.604 . . . . 0.0 109.44 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.4 tttm -102.63 -167.07 1.35 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.922 -0.486 . . . . 0.0 110.285 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 66.77 165.36 0.21 Allowed 'General case' 0 N--CA 1.509 2.515 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 56.29 28.88 14.01 Favored 'General case' 0 N--CA 1.515 2.786 0 O-C-N 121.643 -0.661 . . . . 0.0 110.871 -178.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.07 40.99 0.49 Allowed Glycine 0 N--CA 1.497 2.746 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 17.1 mmt180 54.8 -161.39 0.15 Allowed 'General case' 0 N--CA 1.517 2.891 0 O-C-N 121.628 -0.925 . . . . 0.0 110.579 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -62.03 120.27 10.51 Favored 'General case' 0 N--CA 1.512 2.658 0 O-C-N 121.636 -0.665 . . . . 0.0 110.463 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.7 m -71.97 -28.42 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.527 0 O-C-N 122.011 -0.43 . . . . 0.0 110.342 -179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 50.6 mt -59.24 -17.24 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.812 0 O-C-N 121.746 -0.596 . . . . 0.0 111.651 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.7 mp -90.82 -23.27 20.64 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.504 -0.748 . . . . 0.0 110.882 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 53.9 pttt -97.89 -37.06 9.96 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.696 -0.627 . . . . 0.0 109.595 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm 46.49 55.26 7.72 Favored 'General case' 0 N--CA 1.51 2.529 0 CA-C-O 121.335 0.588 . . . . 0.0 112.229 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.3 163.71 0.55 Allowed 'General case' 0 N--CA 1.515 2.778 0 O-C-N 121.657 -0.652 . . . . 0.0 110.736 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.8 m -58.6 -20.77 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.779 0 O-C-N 121.868 -0.52 . . . . 0.0 111.823 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 16.8 ptt-85 -113.95 46.05 1.38 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.757 -0.59 . . . . 0.0 111.684 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -146.25 108.33 4.39 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.67 -0.644 . . . . 0.0 110.138 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 71.6 mt -130.85 107.8 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 t -74.76 134.17 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.0 mt -89.23 160.43 16.94 Favored 'General case' 0 N--CA 1.505 2.307 0 CA-C-O 121.223 0.535 . . . . 0.0 111.364 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 90.5 p -60.2 -19.74 55.56 Favored 'General case' 0 N--CA 1.508 2.459 0 O-C-N 122.091 -0.381 . . . . 0.0 111.194 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 49.8 p-10 -91.87 19.21 6.81 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.673 -0.642 . . . . 0.0 111.653 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.2 m120 70.51 29.68 3.36 Favored 'General case' 0 N--CA 1.524 3.23 0 O-C-N 121.615 -0.678 . . . . 0.0 112.681 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.416 ' CE2' ' HA ' ' A' ' 22' ' ' VAL . 4.6 m-85 -105.74 157.85 17.15 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.436 ' HB2' ' CE2' ' A' ' 35' ' ' TRP . 20.5 tp -115.61 98.94 6.99 Favored 'General case' 0 N--CA 1.517 2.912 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.164 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -75.96 100.18 4.78 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.099 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.429 HD11 HG22 ' A' ' 60' ' ' ILE . 88.3 mt -92.1 120.72 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 177.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -83.71 114.59 21.69 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 121.299 0.571 . . . . 0.0 111.308 -178.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 100.25 -37.32 3.62 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 178.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.1 tp 38.21 97.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.139 0 CA-C-O 121.862 0.839 . . . . 0.0 112.8 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.7 mmtp -90.7 150.02 21.82 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.26 -0.9 . . . . 0.0 111.172 -178.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.6 ptmt -59.48 -28.25 66.84 Favored 'General case' 0 N--CA 1.512 2.637 0 O-C-N 122.002 -0.436 . . . . 0.0 110.271 178.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.3 t -72.12 -14.97 61.98 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.897 -0.502 . . . . 0.0 110.603 178.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -99.12 -6.48 28.25 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.638 -0.664 . . . . 0.0 111.579 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -71.94 162.21 29.8 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.319 -0.863 . . . . 0.0 109.144 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 155.02 -111.97 0.51 Allowed Glycine 0 N--CA 1.496 2.691 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 16.9 m -143.62 99.16 3.37 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 122.108 -0.642 . . . . 0.0 110.867 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -79.3 133.47 36.63 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -95.4 119.41 33.85 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.671 -0.812 . . . . 0.0 111.5 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 9.1 m -81.97 129.15 34.69 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 177.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -132.36 85.99 2.29 Favored 'General case' 0 N--CA 1.507 2.409 0 CA-C-N 119.155 0.889 . . . . 0.0 110.791 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 33' ' ' ILE . . . -58.55 103.6 0.38 Allowed Glycine 0 N--CA 1.508 3.492 0 N-CA-C 108.507 -1.837 . . . . 0.0 108.507 178.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.8 ttm-85 -120.88 129.8 53.65 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 122.255 1.026 . . . . 0.0 113.752 -176.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.5 mp -131.27 140.2 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.5 mt -95.06 -46.27 6.88 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.842 -0.536 . . . . 0.0 111.898 -178.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.11 -55.13 30.63 Favored 'General case' 0 N--CA 1.523 3.219 0 O-C-N 121.442 -0.786 . . . . 0.0 109.896 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 28.4 mmm-85 -100.5 59.28 0.97 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -14.33 81.46 0.0 OUTLIER Glycine 1 N--CA 1.526 4.688 0 C-N-CA 125.042 1.306 . . . . 0.0 114.665 -178.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -125.26 141.85 51.84 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 122.183 -0.599 . . . . 0.0 109.449 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.0 pt -137.48 64.66 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 CA-C-O 121.188 0.518 . . . . 0.0 109.999 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -79.75 155.88 27.74 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -160.63 175.5 12.59 Favored 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 119.507 -0.877 . . . . 0.0 112.918 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 8.1 mttp -166.58 154.8 10.21 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -99.66 114.01 26.82 Favored 'General case' 0 N--CA 1.51 2.559 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.007 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.418 ' N ' ' CD1' ' A' ' 88' ' ' ILE . 2.1 mp -102.45 123.38 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -91.96 120.32 32.51 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 48.3 t -107.73 140.53 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 C-N-CA 120.658 -0.417 . . . . 0.0 109.907 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 32.2 mm -126.18 147.52 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.41 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 N--CA 1.502 2.174 0 CA-C-O 117.962 -1.018 . . . . 0.0 108.553 179.456 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 44.1 p90 . . . . . 0 N--CA 1.498 1.963 0 CA-C-O 120.78 0.324 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 48.0 t -148.03 106.78 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.481 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 3.1 mmt -112.54 110.65 20.96 Favored 'General case' 0 N--CA 1.509 2.494 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.242 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -69.35 115.41 8.58 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 122.114 -0.366 . . . . 0.0 110.901 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.34 160.33 32.52 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 121.723 0.773 . . . . 0.0 111.283 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 32.92 79.39 0.03 OUTLIER 'General case' 0 N--CA 1.52 3.049 0 C-N-CA 123.975 0.91 . . . . 0.0 113.35 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -142.1 78.68 16.89 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.726 -0.609 . . . . 0.0 111.103 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -66.62 104.48 0.79 Allowed 'Trans proline' 0 N--CA 1.489 1.263 0 N-CA-C 108.535 -1.371 . . . . 0.0 108.535 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.483 ' OG1' ' HD3' ' A' ' 10' ' ' PRO . 0.2 OUTLIER -55.46 -61.03 6.8 Favored Pre-proline 0 N--CA 1.505 2.304 0 CA-C-O 116.974 -1.489 . . . . 0.0 112.361 -177.586 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.483 ' HD3' ' OG1' ' A' ' 9' ' ' THR . 1.4 Cg_endo -78.66 93.75 1.09 Allowed 'Trans proline' 0 N--CA 1.493 1.443 0 CA-C-N 121.134 1.441 . . . . 0.0 111.552 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -101.2 172.17 7.16 Favored 'General case' 0 N--CA 1.508 2.445 0 O-C-N 120.911 -1.118 . . . . 0.0 109.864 178.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -148.47 125.72 11.51 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.822 -0.549 . . . . 0.0 111.587 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -127.14 -165.54 1.48 Allowed 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.07 147.59 52.64 Favored 'General case' 0 N--CA 1.517 2.897 0 CA-C-O 121.92 0.866 . . . . 0.0 111.906 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -57.96 130.47 46.68 Favored 'General case' 0 N--CA 1.507 2.411 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.209 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.3 17.8 77.34 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -109.38 155.11 21.64 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 119.182 1.491 . . . . 0.0 111.434 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -79.77 98.54 7.06 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -104.69 169.49 8.42 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.626 0.727 . . . . 0.0 112.586 -177.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 87.9 t -144.53 140.82 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 48.5 mt -96.84 114.95 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 178.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.4 t -75.5 119.35 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 CA-C-O 121.61 0.719 . . . . 0.0 110.842 -176.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.6 t -161.71 89.01 0.72 Allowed 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.41 138.77 31.14 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.193 -179.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.4 t -147.04 126.55 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.481 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 48.1 t -90.87 77.76 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.5 m -78.74 165.85 23.13 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 t -43.96 -85.51 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.177 0 O-C-N 121.753 -0.592 . . . . 0.0 111.443 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 mt -165.48 -63.06 0.01 OUTLIER Pre-proline 0 N--CA 1.512 2.657 0 CA-C-O 117.677 -1.154 . . . . 0.0 111.52 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.55 -53.37 2.88 Favored 'Trans proline' 0 CA--C 1.564 1.987 0 CA-C-N 120.102 1.072 . . . . 0.0 112.524 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.478 ' CB ' ' HA ' ' A' ' 77' ' ' ILE . 2.9 Cg_endo -62.68 -163.66 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 120.541 0.827 . . . . 0.0 112.418 -179.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -171.75 -166.15 0.42 Allowed 'General case' 0 N--CA 1.518 2.937 0 O-C-N 121.861 -0.525 . . . . 0.0 110.304 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.9 tt -99.54 147.98 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 78.0 mt -111.23 127.3 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.418 ' CE2' ' HB2' ' A' ' 58' ' ' LEU . 76.8 m95 -89.9 109.69 20.69 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.0 tttm -116.77 -165.54 1.07 Allowed 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.072 0.463 . . . . 0.0 110.572 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 58.6 60.65 2.47 Favored 'General case' 0 N--CA 1.51 2.542 0 CA-C-O 121.484 0.659 . . . . 0.0 111.129 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.9 ttpp -170.94 -42.3 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.398 0 O-C-N 121.718 -0.613 . . . . 0.0 109.995 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -169.51 39.74 0.2 Allowed Glycine 0 N--CA 1.497 2.746 0 N-CA-C 108.641 -1.784 . . . . 0.0 108.641 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 58.59 80.39 0.18 Allowed 'General case' 0 N--CA 1.512 2.663 0 O-C-N 122.005 -0.703 . . . . 0.0 110.463 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 58.48 107.98 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.823 0 O-C-N 121.912 -0.492 . . . . 0.0 110.845 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.7 m -72.99 -30.98 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.527 0 O-C-N 121.963 -0.461 . . . . 0.0 110.494 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 66.8 mt -60.56 -15.7 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.781 0 O-C-N 121.817 -0.552 . . . . 0.0 111.768 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.9 mp -90.68 -21.79 21.46 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.527 -0.733 . . . . 0.0 110.666 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.1 pttt -97.77 -35.48 10.53 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.598 -0.689 . . . . 0.0 109.733 178.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.1 mmmt 46.35 56.5 6.25 Favored 'General case' 0 N--CA 1.509 2.525 0 CA-C-O 121.382 0.61 . . . . 0.0 112.134 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -50.32 171.59 0.03 OUTLIER 'General case' 0 N--CA 1.516 2.84 0 O-C-N 121.732 -0.605 . . . . 0.0 111.491 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.5 t -65.57 -14.9 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.539 0 O-C-N 121.952 -0.468 . . . . 0.0 111.415 -179.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -115.85 -4.6 12.09 Favored 'General case' 0 N--CA 1.506 2.364 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -94.14 115.22 27.48 Favored 'General case' 0 N--CA 1.503 2.182 0 CA-C-N 119.075 0.852 . . . . 0.0 110.616 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.2 mp -137.19 106.25 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 t -73.74 128.18 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.6 mt -81.93 166.84 19.53 Favored 'General case' 0 N--CA 1.506 2.357 0 CA-C-O 121.377 0.608 . . . . 0.0 112.022 -178.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.6 p -60.66 -21.69 63.07 Favored 'General case' 0 N--CA 1.509 2.51 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.229 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 42.1 p-10 -91.55 19.03 6.61 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.665 -0.647 . . . . 0.0 111.403 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.5 m120 66.63 32.72 6.91 Favored 'General case' 0 N--CA 1.515 2.798 0 O-C-N 121.627 -0.67 . . . . 0.0 112.223 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -101.69 168.34 9.53 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.418 ' HB2' ' CE2' ' A' ' 35' ' ' TRP . 17.1 tp -121.43 96.99 5.3 Favored 'General case' 0 N--CA 1.517 2.912 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.621 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.4 104.2 6.8 Favored 'General case' 0 N--CA 1.502 2.174 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.919 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.435 HD11 HG22 ' A' ' 60' ' ' ILE . 96.5 mt -97.55 101.37 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 177.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.35 114.77 7.91 Favored 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 121.252 0.549 . . . . 0.0 110.97 -178.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.418 ' O ' HG21 ' A' ' 63' ' ' ILE . . . 101.39 -34.18 5.87 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 109.971 -1.251 . . . . 0.0 109.971 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.418 HG21 ' O ' ' A' ' 62' ' ' GLY . 1.8 tp 32.92 92.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.523 3.212 0 CA-C-N 117.925 0.863 . . . . 0.0 113.251 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm -74.23 148.25 41.72 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.697 -0.627 . . . . 0.0 110.834 -178.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -63.4 -19.13 64.42 Favored 'General case' 0 N--CA 1.508 2.455 0 C-N-CA 120.571 -0.451 . . . . 0.0 110.711 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.1 t -83.76 -12.85 55.15 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.441 -0.787 . . . . 0.0 111.105 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.43 11.03 36.36 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.49 -0.756 . . . . 0.0 111.571 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -88.0 152.73 21.83 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.286 -0.884 . . . . 0.0 109.533 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 163.95 -106.15 0.27 Allowed Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.2 m -146.51 103.85 3.71 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 122.156 -0.614 . . . . 0.0 110.654 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -83.61 128.72 34.74 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.4 tpp180 -91.77 118.37 30.62 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.179 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 85' ' ' PHE . 5.1 m -83.77 122.59 28.86 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 177.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -123.27 88.27 2.89 Favored 'General case' 0 N--CA 1.506 2.349 0 CA-C-N 118.738 0.699 . . . . 0.0 110.643 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.7 103.03 0.9 Allowed Glycine 0 N--CA 1.503 3.161 0 N-CA-C 107.653 -2.179 . . . . 0.0 107.653 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 -118.73 141.64 48.42 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -176.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.478 ' HA ' ' CB ' ' A' ' 31' ' ' PRO . 88.1 mt -121.63 137.02 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.553 177.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 30.6 mt -92.7 -39.87 11.03 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 121.074 -0.25 . . . . 0.0 110.652 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.82 -58.21 7.53 Favored 'General case' 0 N--CA 1.515 2.776 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.8 mtt180 -101.02 61.72 0.96 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 177.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -14.48 81.68 0.0 OUTLIER Glycine 1 N--CA 1.526 4.696 0 C-N-CA 125.079 1.323 . . . . 0.0 114.73 -178.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -117.69 144.51 45.18 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 122.162 -0.611 . . . . 0.0 110.25 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.1 pt -136.73 74.82 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 CA-C-O 121.132 0.491 . . . . 0.0 110.689 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -93.77 149.57 21.12 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.405 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 42.7 p90 -162.06 -179.21 6.93 Favored 'General case' 0 N--CA 1.503 2.191 0 C-N-CA 119.612 -0.835 . . . . 0.0 113.142 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.6 mttt -167.16 161.54 14.64 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -103.27 112.35 25.18 Favored 'General case' 0 N--CA 1.51 2.545 0 O-C-N 121.782 -0.574 . . . . 0.0 111.221 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.0 mp -97.06 115.62 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -85.22 117.27 24.06 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 42.7 t -111.05 135.27 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 CA-C-O 121.058 0.456 . . . . 0.0 110.045 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 47.7 mt -121.76 135.02 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.7 t . . . . . 0 N--CA 1.504 2.27 0 CA-C-O 118.308 -0.853 . . . . 0.0 109.782 -179.289 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 43.5 p90 . . . . . 0 N--CA 1.499 2.008 0 CA-C-O 120.668 0.27 . . . . 0.0 110.438 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.2 t -147.9 105.71 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.51 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 4.7 mmt -111.38 116.86 31.66 Favored 'General case' 0 N--CA 1.51 2.556 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.142 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -73.44 119.63 17.94 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 122.039 -0.413 . . . . 0.0 110.485 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -132.82 160.15 37.73 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 121.495 0.664 . . . . 0.0 111.076 -179.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 33.31 88.85 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.107 0 C-N-CA 124.013 0.925 . . . . 0.0 113.423 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -157.25 81.23 3.27 Favored Pre-proline 0 N--CA 1.495 1.806 0 C-N-CA 120.084 -0.646 . . . . 0.0 111.55 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -64.97 105.61 0.69 Allowed 'Trans proline' 0 N--CA 1.492 1.416 0 N-CA-C 108.588 -1.351 . . . . 0.0 108.588 177.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.438 ' CB ' ' HD3' ' A' ' 10' ' ' PRO . 0.2 OUTLIER -53.88 -66.91 0.71 Allowed Pre-proline 0 N--CA 1.508 2.468 0 CA-C-O 116.91 -1.519 . . . . 0.0 112.245 -177.593 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.438 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.4 Cg_endo -73.13 92.47 0.82 Allowed 'Trans proline' 0 N--CA 1.495 1.591 0 CA-C-N 121.242 1.479 . . . . 0.0 110.978 178.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -100.18 173.05 6.8 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 120.917 -1.114 . . . . 0.0 110.192 178.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -155.1 125.3 6.72 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.937 -0.477 . . . . 0.0 111.304 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -122.98 -169.73 1.98 Allowed 'General case' 0 N--CA 1.504 2.246 0 O-C-N 122.025 -0.422 . . . . 0.0 110.04 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -106.05 138.65 41.87 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.578 0.704 . . . . 0.0 111.507 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -60.13 126.6 28.13 Favored 'General case' 0 N--CA 1.509 2.498 0 O-C-N 121.717 -0.614 . . . . 0.0 110.739 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.36 21.14 62.96 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -112.85 161.63 16.72 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 118.811 1.306 . . . . 0.0 111.31 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.88 98.66 7.2 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 177.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -101.56 169.02 9.12 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 120.15 -0.62 . . . . 0.0 112.109 -177.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 84.1 t -142.23 140.68 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 178.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 43.9 mt -96.62 115.34 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.419 ' HA ' ' CE2' ' A' ' 57' ' ' TYR . 57.3 t -76.41 116.98 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 CA-C-O 121.355 0.598 . . . . 0.0 110.536 -177.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.2 t -160.67 89.82 0.83 Allowed 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.53 141.56 28.52 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.5 t -147.11 129.18 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.51 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 26.4 t -90.41 75.17 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.8 m -79.53 162.22 25.52 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 178.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 t -43.18 -85.04 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.25 0 O-C-N 121.844 -0.535 . . . . 0.0 111.433 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.3 mt -166.77 -63.56 0.01 OUTLIER Pre-proline 0 N--CA 1.512 2.658 0 CA-C-O 117.747 -1.121 . . . . 0.0 111.1 177.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -59.65 -53.37 3.39 Favored 'Trans proline' 0 CA--C 1.565 2.05 0 CA-C-N 120.113 1.076 . . . . 0.0 112.347 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.417 ' CB ' ' HA ' ' A' ' 77' ' ' ILE . 3.3 Cg_exo -61.02 -165.65 0.04 OUTLIER 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 120.685 0.923 . . . . 0.0 112.358 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -170.64 -161.3 0.23 Allowed 'General case' 0 N--CA 1.523 3.197 0 C-N-CA 120.134 -0.626 . . . . 0.0 111.045 -179.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.2 tt -111.3 137.39 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.978 -0.451 . . . . 0.0 110.249 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 70.6 mt -94.56 129.98 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -94.66 103.46 15.39 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.181 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.6 tptm -81.52 142.97 32.37 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 177.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -142.04 -146.37 0.19 Allowed 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 120.063 -0.655 . . . . 0.0 111.518 -178.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 5.1 mmpt? -78.55 -0.89 31.43 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.864 -0.523 . . . . 0.0 111.331 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -136.26 34.2 2.28 Favored Glycine 0 N--CA 1.499 2.886 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? 54.58 101.87 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.627 0 O-C-N 121.704 -0.88 . . . . 0.0 112.147 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.8 t0 61.05 133.89 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.712 0 CA-C-O 121.199 0.523 . . . . 0.0 111.744 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.8 m -101.95 -32.68 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.437 0 O-C-N 121.755 -0.59 . . . . 0.0 109.758 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.9 mm -57.7 -18.92 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.778 0 O-C-N 121.889 -0.507 . . . . 0.0 111.854 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.8 mp -89.05 -25.34 22.0 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.581 -0.699 . . . . 0.0 110.767 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.5 pttt -98.67 -39.82 8.49 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.775 -0.578 . . . . 0.0 109.957 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.5 mmmt 47.75 55.01 9.05 Favored 'General case' 0 N--CA 1.511 2.623 0 CA-C-O 121.593 0.711 . . . . 0.0 111.569 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.15 169.47 0.17 Allowed 'General case' 0 N--CA 1.511 2.61 0 O-C-N 121.724 -0.61 . . . . 0.0 110.81 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 29.4 m -62.55 -20.55 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.534 0 O-C-N 122.052 -0.405 . . . . 0.0 111.601 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.9 ptp85 -113.51 46.6 1.25 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.735 -0.603 . . . . 0.0 112.055 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -144.93 107.02 4.31 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.685 -0.634 . . . . 0.0 109.778 178.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 66.3 mt -128.93 104.82 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.1 t -73.95 132.16 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.9 mt -85.91 166.66 15.79 Favored 'General case' 0 N--CA 1.508 2.431 0 O-C-N 121.786 -0.571 . . . . 0.0 111.699 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.8 p -61.57 -21.43 64.3 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 122.204 -0.31 . . . . 0.0 111.137 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -90.93 18.15 6.99 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.614 -0.679 . . . . 0.0 111.46 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.0 m120 67.98 32.54 5.03 Favored 'General case' 0 N--CA 1.517 2.899 0 O-C-N 121.596 -0.69 . . . . 0.0 112.189 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.419 ' CE2' ' HA ' ' A' ' 22' ' ' VAL . 4.0 m-85 -102.75 162.79 12.64 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 177.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 17.4 tp -118.2 98.37 6.26 Favored 'General case' 0 N--CA 1.517 2.913 0 C-N-CA 119.276 -0.97 . . . . 0.0 111.591 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.01 97.98 4.82 Favored 'General case' 0 N--CA 1.501 2.12 0 C-N-CA 120.391 -0.523 . . . . 0.0 110.84 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.0 mt -89.09 119.64 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.0 tpp180 -80.14 115.43 19.69 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 121.369 0.604 . . . . 0.0 110.707 -178.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.04 -33.28 5.87 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.9 tp 37.85 72.02 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.521 3.108 0 CA-C-N 118.155 0.978 . . . . 0.0 112.861 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.6 mtpp -62.77 158.34 18.96 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 121.751 -0.593 . . . . 0.0 112.187 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 45.2 tttt -62.35 -24.14 67.18 Favored 'General case' 0 N--CA 1.509 2.521 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.908 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 48.0 p -82.86 -15.91 49.67 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.894 -0.504 . . . . 0.0 111.056 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -88.69 -21.67 23.78 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.672 -0.642 . . . . 0.0 110.998 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -66.74 151.14 48.03 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.519 -0.738 . . . . 0.0 110.312 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 164.24 -115.73 0.66 Allowed Glycine 0 N--CA 1.498 2.787 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.6 m -138.4 100.55 4.14 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.94 -0.741 . . . . 0.0 110.431 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -83.22 135.68 34.69 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.6 ttm105 -103.81 119.61 39.28 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.749 -0.78 . . . . 0.0 111.003 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 19.6 m -78.51 122.64 26.12 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 177.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -121.43 84.26 2.21 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 121.216 0.532 . . . . 0.0 110.695 -178.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.44 117.27 8.74 Favored Glycine 0 N--CA 1.504 3.178 0 N-CA-C 108.062 -2.015 . . . . 0.0 108.062 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.6 ttp180 -134.74 140.88 46.28 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -177.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.417 ' HA ' ' CB ' ' A' ' 31' ' ' PRO . 78.7 mt -122.52 137.57 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-N 114.545 -1.207 . . . . 0.0 108.015 177.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 15.1 mt -91.67 -45.85 8.24 Favored 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.107 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.09 -57.81 11.42 Favored 'General case' 0 N--CA 1.517 2.888 0 O-C-N 121.584 -0.697 . . . . 0.0 109.672 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 70.8 mtt-85 -98.62 59.27 1.25 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 177.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -15.18 81.97 0.0 OUTLIER Glycine 1 N--CA 1.524 4.561 0 C-N-CA 125.037 1.303 . . . . 0.0 114.931 -178.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -120.41 143.72 48.31 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 122.295 -0.532 . . . . 0.0 109.66 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.6 pt -138.01 80.17 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.275 0 CA-C-O 121.483 0.659 . . . . 0.0 111.279 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -96.77 151.17 19.91 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -167.26 174.96 7.68 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.538 -0.726 . . . . 0.0 112.556 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -166.71 155.1 10.2 Favored 'General case' 0 N--CA 1.503 2.221 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -91.78 120.38 32.45 Favored 'General case' 0 N--CA 1.512 2.669 0 O-C-N 121.839 -0.538 . . . . 0.0 111.933 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.1 mp -102.91 120.51 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -87.69 114.81 24.66 Favored 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 32.5 t -107.96 133.88 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.07 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 74.0 mt -125.62 156.72 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.498 1.937 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.578 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.767 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 62.3 t -151.48 80.13 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.297 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.414 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 11.5 mmm -107.52 114.72 28.9 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 122.032 -0.418 . . . . 0.0 109.953 -178.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -68.45 119.2 12.55 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.935 -0.478 . . . . 0.0 109.892 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.2 pttt -129.43 161.54 30.14 Favored 'General case' 0 N--CA 1.503 2.201 0 CA-C-O 121.693 0.758 . . . . 0.0 111.482 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 32.85 51.39 0.26 Allowed 'General case' 0 N--CA 1.517 2.917 0 C-N-CA 124.134 0.974 . . . . 0.0 113.243 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -116.64 81.89 12.02 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.725 -0.61 . . . . 0.0 110.645 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -65.54 107.33 1.01 Allowed 'Trans proline' 0 N--CA 1.491 1.373 0 N-CA-C 109.142 -1.138 . . . . 0.0 109.142 178.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.451 ' CB ' ' HD3' ' A' ' 10' ' ' PRO . 0.3 OUTLIER -60.19 -67.84 0.93 Allowed Pre-proline 0 N--CA 1.505 2.311 0 CA-C-O 116.802 -1.57 . . . . 0.0 110.985 -178.336 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.451 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.5 Cg_endo -73.8 89.63 0.99 Allowed 'Trans proline' 0 CA--C 1.559 1.739 0 CA-C-N 121.385 1.53 . . . . 0.0 110.67 177.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -98.44 178.65 4.96 Favored 'General case' 0 N--CA 1.508 2.45 0 O-C-N 120.675 -1.266 . . . . 0.0 110.193 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -159.38 124.53 4.13 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 120.294 -0.562 . . . . 0.0 112.03 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -122.54 -165.21 1.26 Allowed 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.49 137.43 53.2 Favored 'General case' 0 N--CA 1.514 2.765 0 CA-C-O 121.734 0.778 . . . . 0.0 110.941 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -55.32 140.2 40.23 Favored 'General case' 0 N--CA 1.511 2.604 0 O-C-N 121.707 -0.62 . . . . 0.0 111.352 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.13 12.27 81.59 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -106.93 157.47 17.76 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 119.332 1.566 . . . . 0.0 111.821 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -80.07 95.15 6.11 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 176.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.09 169.73 9.2 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.191 0.519 . . . . 0.0 112.204 -176.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 85.3 t -139.75 140.73 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 27.7 mt -93.17 115.64 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 105.969 -1.864 . . . . 0.0 105.969 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.423 ' HA ' ' CE2' ' A' ' 57' ' ' TYR . 48.1 t -77.54 119.68 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 CA-C-O 121.446 0.641 . . . . 0.0 110.618 -176.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.6 t -161.33 92.18 0.89 Allowed 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.04 145.43 25.09 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 -179.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.6 t -146.42 119.92 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.414 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 21.2 t -75.9 73.46 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 178.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.4 m -84.09 157.24 21.82 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.6 t -47.46 -79.4 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.078 0 O-C-N 121.762 -0.586 . . . . 0.0 111.385 -178.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -172.94 -61.02 0.0 OUTLIER Pre-proline 0 N--CA 1.514 2.758 0 CA-C-O 117.918 -1.039 . . . . 0.0 111.018 177.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.09 -53.97 3.13 Favored 'Trans proline' 0 CA--C 1.563 1.935 0 CA-C-N 119.7 0.928 . . . . 0.0 112.634 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.426 ' HB2' HG13 ' A' ' 77' ' ' ILE . 2.2 Cg_endo -61.99 -166.41 0.05 OUTLIER 'Trans proline' 0 N--CA 1.501 1.936 0 CA-C-N 119.322 0.794 . . . . 0.0 111.545 -179.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -170.7 -164.93 0.4 Allowed 'General case' 0 N--CA 1.518 2.966 0 O-C-N 121.7 -0.625 . . . . 0.0 110.078 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.9 tt -105.1 158.22 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.992 -0.443 . . . . 0.0 110.023 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 68.8 mt -125.58 118.89 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.45 ' CE2' ' HB2' ' A' ' 58' ' ' LEU . 83.0 m95 -81.6 102.15 10.46 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.2 tttt -102.18 -172.39 2.13 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 121.222 0.534 . . . . 0.0 110.906 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 63.76 157.86 0.08 Allowed 'General case' 0 N--CA 1.511 2.603 0 O-C-N 121.89 -0.506 . . . . 0.0 110.173 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.3 tptt 57.03 44.6 22.49 Favored 'General case' 0 N--CA 1.514 2.738 0 O-C-N 121.67 -0.644 . . . . 0.0 110.771 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 133.76 2.88 3.42 Favored Glycine 0 N--CA 1.497 2.757 0 C-N-CA 120.371 -0.919 . . . . 0.0 111.84 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 54.38 90.49 0.03 OUTLIER 'General case' 0 N--CA 1.516 2.847 0 CA-C-N 119.247 1.524 . . . . 0.0 110.739 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 t0 54.54 97.88 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.963 0 O-C-N 121.783 -0.573 . . . . 0.0 110.431 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.5 m -69.32 -28.97 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.519 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.769 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 73.5 mt -59.79 -16.6 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.83 0 O-C-N 121.624 -0.673 . . . . 0.0 111.656 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.6 mp -91.45 -23.39 20.02 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.433 -0.792 . . . . 0.0 110.732 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -97.86 -38.95 9.24 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.697 -0.627 . . . . 0.0 109.379 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 17.5 mmmt 46.35 55.55 7.27 Favored 'General case' 0 N--CA 1.51 2.559 0 CA-C-O 121.438 0.637 . . . . 0.0 112.228 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.33 165.76 0.33 Allowed 'General case' 0 N--CA 1.513 2.688 0 O-C-N 121.782 -0.574 . . . . 0.0 111.106 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.5 m -58.85 -20.88 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.699 0 O-C-N 122.018 -0.426 . . . . 0.0 111.856 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 5.0 ptt-85 -115.79 47.22 1.39 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.791 -0.568 . . . . 0.0 111.886 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -146.26 101.56 3.51 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.645 -0.659 . . . . 0.0 109.796 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 62.5 mt -125.92 113.42 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.4 t -79.49 128.05 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.5 mt -80.56 164.1 23.19 Favored 'General case' 0 N--CA 1.506 2.354 0 CA-C-O 121.195 0.521 . . . . 0.0 111.601 -178.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 96.6 p -60.0 -20.63 58.76 Favored 'General case' 0 N--CA 1.511 2.618 0 O-C-N 122.139 -0.351 . . . . 0.0 111.336 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.7 p-10 -91.19 19.44 5.87 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.721 -0.612 . . . . 0.0 111.43 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.8 m120 66.64 32.87 6.81 Favored 'General case' 0 N--CA 1.515 2.806 0 O-C-N 121.607 -0.683 . . . . 0.0 112.165 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.423 ' CE2' ' HA ' ' A' ' 22' ' ' VAL . 3.9 m-85 -103.4 168.82 8.92 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.45 ' HB2' ' CE2' ' A' ' 35' ' ' TRP . 18.0 tp -124.77 98.47 5.72 Favored 'General case' 0 N--CA 1.515 2.788 0 C-N-CA 119.29 -0.964 . . . . 0.0 112.241 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.79 100.16 3.96 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 120.77 0.319 . . . . 0.0 110.825 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 97.3 mt -92.7 110.9 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 178.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.27 113.89 9.8 Favored 'General case' 0 N--CA 1.504 2.261 0 CA-C-O 121.386 0.612 . . . . 0.0 111.343 -178.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.36 -38.3 3.15 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.404 ' O ' HG21 ' A' ' 63' ' ' ILE . 1.5 tp 41.84 67.24 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.927 0 CA-C-O 122.145 0.974 . . . . 0.0 112.544 -178.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.5 mttm -58.35 157.38 8.71 Favored 'General case' 0 N--CA 1.51 2.557 0 CA-C-O 121.398 0.618 . . . . 0.0 112.611 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.8 ttmm -62.06 -21.81 65.24 Favored 'General case' 0 N--CA 1.509 2.486 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.97 178.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.1 p -83.78 -18.86 36.31 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.802 -0.561 . . . . 0.0 110.96 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.75 -5.7 56.72 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.653 -0.655 . . . . 0.0 111.607 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -81.7 137.01 35.46 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 119.006 0.821 . . . . 0.0 109.619 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 176.97 -111.39 0.33 Allowed Glycine 0 N--CA 1.499 2.863 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.0 m -138.8 104.1 5.0 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 122.034 -0.686 . . . . 0.0 110.708 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -86.8 135.89 33.19 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -93.72 118.62 31.65 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.21 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 85' ' ' PHE . 3.4 m -86.48 91.33 8.51 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 178.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -91.53 88.45 6.78 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.842 -0.536 . . . . 0.0 109.929 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.47 96.3 0.82 Allowed Glycine 0 N--CA 1.5 2.95 0 N-CA-C 107.311 -2.315 . . . . 0.0 107.311 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.7 ttm180 -99.5 127.23 45.56 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 122.031 0.919 . . . . 0.0 113.198 -176.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.426 HG13 ' HB2' ' A' ' 31' ' ' PRO . 4.8 mp -143.09 89.55 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 CA-C-N 114.387 -1.279 . . . . 0.0 107.693 178.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 28.2 mt -95.39 20.05 9.97 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.954 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -113.3 -31.85 6.46 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.665 -0.647 . . . . 0.0 110.692 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -115.84 -63.56 1.43 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.919 -0.488 . . . . 0.0 110.784 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -98.55 -81.74 1.62 Allowed Glycine 0 N--CA 1.49 2.279 0 C-N-CA 121.056 -0.592 . . . . 0.0 111.808 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 179.33 -160.03 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.76 0 O-C-N 122.038 -0.683 . . . . 0.0 110.281 -178.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.1 pp -99.93 103.62 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.424 0 O-C-N 121.717 -0.615 . . . . 0.0 110.944 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -100.71 158.72 15.74 Favored 'General case' 0 N--CA 1.507 2.401 0 O-C-N 121.444 -0.785 . . . . 0.0 110.026 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.427 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 36.1 p90 -161.1 171.93 17.68 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.534 -0.729 . . . . 0.0 112.4 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.9 mttp -165.78 159.0 15.7 Favored 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -103.94 121.29 42.81 Favored 'General case' 0 N--CA 1.512 2.662 0 O-C-N 121.757 -0.589 . . . . 0.0 110.756 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.8 mp -105.46 121.49 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -85.26 111.46 19.87 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.7 t -104.73 127.75 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.097 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 72.2 mt -117.17 159.71 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.501 2.092 0 CA-C-O 117.922 -1.037 . . . . 0.0 110.496 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 45.9 p90 . . . . . 0 N--CA 1.498 1.941 0 CA-C-O 120.679 0.276 . . . . 0.0 110.494 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 49.0 t -146.95 106.06 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.469 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 17.8 mmm -112.53 111.22 21.89 Favored 'General case' 0 N--CA 1.506 2.371 0 C-N-CA 120.501 -0.479 . . . . 0.0 110.475 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -70.91 116.5 11.28 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 122.041 -0.412 . . . . 0.0 110.841 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -124.8 155.3 39.6 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 121.531 0.681 . . . . 0.0 110.133 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 41.85 86.04 0.02 OUTLIER 'General case' 0 N--CA 1.52 3.044 0 C-N-CA 123.073 0.549 . . . . 0.0 111.803 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -131.95 62.9 66.62 Favored Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 121.696 -0.627 . . . . 0.0 112.155 -178.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -66.28 89.83 0.26 Allowed 'Trans proline' 0 N--CA 1.494 1.543 0 N-CA-C 108.162 -1.514 . . . . 0.0 108.162 177.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.49 ' OG1' ' HD3' ' A' ' 10' ' ' PRO . 13.6 p -59.47 -43.34 95.89 Favored Pre-proline 0 N--CA 1.508 2.459 0 CA-C-O 117.382 -1.294 . . . . 0.0 113.156 -177.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.49 ' HD3' ' OG1' ' A' ' 9' ' ' THR . 1.7 Cg_endo -81.8 82.88 2.23 Favored 'Trans proline' 0 CA--C 1.549 1.251 0 CA-C-N 120.651 1.268 . . . . 0.0 111.332 -177.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -100.73 170.52 8.29 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.163 -0.96 . . . . 0.0 110.978 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -155.3 124.34 6.2 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 122.002 -0.436 . . . . 0.0 110.996 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -122.49 -169.59 1.93 Allowed 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.912 -0.493 . . . . 0.0 109.778 179.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -115.96 145.61 42.79 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.479 0.657 . . . . 0.0 111.67 -178.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -61.44 121.24 12.18 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 121.947 -0.471 . . . . 0.0 110.399 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.35 20.61 51.6 Favored Glycine 0 N--CA 1.497 2.714 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -179.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -112.37 158.1 20.22 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 118.619 1.21 . . . . 0.0 111.212 -179.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -80.45 98.09 7.38 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 177.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -102.9 165.5 11.0 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 120.169 -0.612 . . . . 0.0 112.398 -177.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.8 t -140.0 143.26 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 178.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 47.1 mt -99.96 113.24 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 178.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.4 t -73.22 120.15 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 CA-C-O 121.513 0.673 . . . . 0.0 111.057 -176.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.0 t -165.09 93.12 0.6 Allowed 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.15 140.79 29.11 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.314 -179.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.7 t -148.83 133.24 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.469 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 59.5 t -99.85 78.71 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.8 m -79.23 165.71 22.95 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.9 t -43.56 -82.31 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.19 0 O-C-N 121.899 -0.501 . . . . 0.0 111.509 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -167.73 -63.27 0.01 OUTLIER Pre-proline 0 N--CA 1.513 2.708 0 CA-C-O 117.778 -1.106 . . . . 0.0 111.661 177.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.1 -53.13 3.32 Favored 'Trans proline' 0 CA--C 1.563 1.939 0 CA-C-N 120.107 1.074 . . . . 0.0 112.676 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.505 ' CB ' ' HA ' ' A' ' 77' ' ' ILE . 2.8 Cg_endo -62.57 -163.98 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.794 0 CA-C-N 119.268 0.774 . . . . 0.0 112.634 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -169.95 -160.13 0.22 Allowed 'General case' 0 N--CA 1.519 3.017 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.21 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.7 tt -107.98 145.19 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.924 -0.485 . . . . 0.0 110.036 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.0 mt -104.59 130.43 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.436 ' HB2' ' CG2' ' A' ' 42' ' ' VAL . 55.8 m95 -96.02 119.37 34.38 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.217 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.6 tptt -100.4 103.6 14.99 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 32.3 p-80 -93.32 125.6 38.01 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.256 0.551 . . . . 0.0 111.569 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.6 mmtt 49.23 23.64 0.84 Allowed 'General case' 0 N--CA 1.514 2.74 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 178.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.96 -31.99 7.06 Favored Glycine 0 N--CA 1.5 2.909 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.2 -179.56 4.98 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-N 117.824 0.812 . . . . 0.0 110.307 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -109.02 147.35 32.46 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.962 -0.461 . . . . 0.0 110.196 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.436 ' CG2' ' HB2' ' A' ' 35' ' ' TRP . 8.4 m -93.26 -35.46 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.705 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.6 mm -57.95 -19.41 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.683 0 O-C-N 122.028 -0.42 . . . . 0.0 111.796 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.9 mp -90.59 -24.96 20.41 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.562 -0.711 . . . . 0.0 110.843 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 41.6 pttt -99.03 -39.97 8.26 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.665 -0.647 . . . . 0.0 109.802 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm 49.6 54.51 10.89 Favored 'General case' 0 N--CA 1.509 2.523 0 CA-C-O 121.464 0.649 . . . . 0.0 111.744 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -53.49 164.21 0.53 Allowed 'General case' 0 N--CA 1.514 2.771 0 O-C-N 121.698 -0.626 . . . . 0.0 110.715 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.8 m -60.83 -21.0 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.728 0 O-C-N 121.943 -0.473 . . . . 0.0 111.767 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.8 ptt-85 -100.87 -8.89 22.14 Favored 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -93.47 107.61 19.43 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-N 118.852 0.751 . . . . 0.0 110.272 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 71.7 mt -128.64 105.68 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.9 t -75.17 131.51 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 37.8 mt -84.15 168.1 16.11 Favored 'General case' 0 N--CA 1.508 2.452 0 CA-C-O 121.172 0.511 . . . . 0.0 111.717 -178.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 55.3 p -61.58 -22.87 65.58 Favored 'General case' 0 N--CA 1.509 2.522 0 O-C-N 122.182 -0.324 . . . . 0.0 111.074 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 50.9 p-10 -91.25 18.42 7.03 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.825 -0.547 . . . . 0.0 111.345 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.3 m120 66.82 34.63 5.38 Favored 'General case' 0 N--CA 1.515 2.795 0 O-C-N 121.542 -0.724 . . . . 0.0 112.406 178.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -102.67 159.21 15.66 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.412 ' HB2' ' CE2' ' A' ' 35' ' ' TRP . 17.8 tp -114.01 98.31 6.9 Favored 'General case' 0 N--CA 1.515 2.815 0 C-N-CA 119.353 -0.939 . . . . 0.0 112.026 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.76 101.42 7.57 Favored 'General case' 0 N--CA 1.503 2.205 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.088 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.429 HD11 HG22 ' A' ' 60' ' ' ILE . 91.1 mt -93.58 102.43 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 177.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -68.98 114.19 7.05 Favored 'General case' 0 N--CA 1.506 2.371 0 CA-C-O 121.24 0.543 . . . . 0.0 111.378 -178.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 100.4 -34.8 5.26 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 110.079 -1.209 . . . . 0.0 110.079 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.9 tp 35.98 95.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.13 0 CA-C-N 118.001 0.901 . . . . 0.0 113.205 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -72.88 146.78 45.93 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.626 -0.671 . . . . 0.0 111.116 -178.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -63.28 -18.71 63.87 Favored 'General case' 0 N--CA 1.51 2.545 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.676 178.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 58.5 p -86.14 -16.43 37.94 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.422 -0.798 . . . . 0.0 110.859 179.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -93.18 17.45 11.02 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.601 -0.687 . . . . 0.0 111.479 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -95.72 145.03 25.62 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.581 -0.699 . . . . 0.0 109.737 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 169.6 -105.36 0.22 Allowed Glycine 0 N--CA 1.497 2.757 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.0 m -142.89 101.38 3.83 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.99 -0.712 . . . . 0.0 111.277 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -83.11 127.55 33.69 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.0 ttt180 -95.71 122.21 38.23 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 120.087 -0.645 . . . . 0.0 111.407 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 65.1 m -79.85 127.34 32.11 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 177.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -126.16 84.63 2.29 Favored 'General case' 0 N--CA 1.506 2.344 0 CA-C-N 119.245 0.929 . . . . 0.0 110.36 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.09 102.35 0.71 Allowed Glycine 0 N--CA 1.506 3.307 0 N-CA-C 107.898 -2.081 . . . . 0.0 107.898 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -117.59 140.49 49.56 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -176.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.505 ' HA ' ' CB ' ' A' ' 31' ' ' PRO . 96.4 mt -114.86 138.28 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.19 177.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 52.2 mt -88.93 -58.01 2.7 Favored 'General case' 0 N--CA 1.503 2.188 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.357 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.08 -57.1 12.35 Favored 'General case' 0 N--CA 1.519 2.991 0 O-C-N 121.677 -0.639 . . . . 0.0 110.502 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -98.66 60.59 1.31 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -16.06 82.18 0.0 OUTLIER Glycine 1 N--CA 1.524 4.55 0 C-N-CA 125.06 1.314 . . . . 0.0 114.872 -178.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -114.0 147.49 38.54 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 122.109 -0.642 . . . . 0.0 109.844 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.1 pt -138.35 72.62 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 CA-C-O 121.225 0.536 . . . . 0.0 111.562 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -91.72 150.4 21.14 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -159.47 -178.2 6.96 Favored 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 119.419 -0.912 . . . . 0.0 113.429 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -168.24 163.18 13.07 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -104.22 144.86 31.03 Favored 'General case' 0 N--CA 1.511 2.58 0 O-C-N 121.771 -0.581 . . . . 0.0 111.442 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 50.8 mm -126.48 106.24 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -72.52 101.1 2.89 Favored 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 25.7 t -100.25 133.51 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.438 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 72.8 mt -119.68 144.72 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 43.5 t . . . . . 0 N--CA 1.505 2.281 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.625 -179.176 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.78 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 62.4 t -152.19 78.11 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.44 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 61.4 mmm -104.16 120.21 40.63 Favored 'General case' 0 N--CA 1.509 2.484 0 O-C-N 121.831 -0.543 . . . . 0.0 110.741 -178.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -78.1 113.59 16.18 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 122.053 -0.404 . . . . 0.0 110.192 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.6 ptpt -127.61 165.93 19.02 Favored 'General case' 0 N--CA 1.503 2.182 0 CA-C-O 121.748 0.785 . . . . 0.0 112.235 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 31.26 80.27 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.959 0 C-N-CA 124.442 1.097 . . . . 0.0 113.226 179.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -154.4 81.44 4.48 Favored Pre-proline 0 N--CA 1.489 1.505 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.864 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.6 105.49 0.63 Allowed 'Trans proline' 0 N--CA 1.491 1.339 0 N-CA-C 108.58 -1.354 . . . . 0.0 108.58 178.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.446 ' CB ' ' HD3' ' A' ' 10' ' ' PRO . 0.2 OUTLIER -51.41 -64.6 1.31 Allowed Pre-proline 0 N--CA 1.509 2.481 0 CA-C-O 117.139 -1.41 . . . . 0.0 111.909 -177.563 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.446 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.6 Cg_endo -74.6 90.56 1.03 Allowed 'Trans proline' 0 CA--C 1.557 1.67 0 CA-C-N 120.974 1.384 . . . . 0.0 110.545 177.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -99.03 177.04 5.36 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 120.805 -1.185 . . . . 0.0 110.2 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -159.81 121.29 3.22 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.855 -0.528 . . . . 0.0 111.856 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -116.2 -169.89 1.7 Allowed 'General case' 0 N--CA 1.504 2.259 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -103.43 137.12 41.95 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.553 0.692 . . . . 0.0 111.524 -178.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -61.06 113.97 2.85 Favored 'General case' 0 N--CA 1.509 2.484 0 O-C-N 121.897 -0.502 . . . . 0.0 110.539 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.16 23.33 22.61 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.526 -1.029 . . . . 0.0 110.526 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -117.88 164.83 14.46 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 118.335 1.068 . . . . 0.0 110.998 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -80.47 99.31 7.95 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 177.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.77 167.44 10.77 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.454 0.645 . . . . 0.0 112.119 -177.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 87.5 t -143.72 133.84 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 178.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 42.1 mt -90.35 115.18 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 178.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.407 ' HA ' ' CE2' ' A' ' 57' ' ' TYR . 54.4 t -74.83 120.99 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.852 -176.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -162.19 91.74 0.8 Allowed 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.59 140.6 29.6 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.5 t -146.35 124.0 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.44 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 45.3 t -82.45 77.51 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.1 m -87.47 154.64 20.48 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.6 t -43.88 -85.69 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.255 0 O-C-N 121.919 -0.488 . . . . 0.0 112.294 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.2 mt -165.4 -62.51 0.01 OUTLIER Pre-proline 0 N--CA 1.51 2.555 0 CA-C-O 117.711 -1.137 . . . . 0.0 111.24 178.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -59.4 -53.45 3.46 Favored 'Trans proline' 0 CA--C 1.561 1.864 0 CA-C-N 120.091 1.068 . . . . 0.0 112.307 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -62.91 -170.07 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.668 0 CA-C-N 119.286 0.781 . . . . 0.0 111.467 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -171.17 -165.41 0.41 Allowed 'General case' 0 N--CA 1.519 2.979 0 O-C-N 121.767 -0.583 . . . . 0.0 109.647 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.3 tt -99.11 161.03 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 66.2 mt -128.74 121.04 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.406 ' CE2' ' HB2' ' A' ' 58' ' ' LEU . 83.5 m95 -85.51 113.13 21.53 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 120.49 -0.484 . . . . 0.0 109.778 -179.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 50.9 mttt -128.07 -166.4 1.62 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.79 -0.569 . . . . 0.0 111.539 -178.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 66.14 49.77 1.49 Allowed 'General case' 0 N--CA 1.513 2.719 0 O-C-N 121.698 -0.626 . . . . 0.0 111.296 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -171.73 -43.09 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.591 -0.693 . . . . 0.0 109.488 178.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -153.94 34.82 0.73 Allowed Glycine 0 N--CA 1.495 2.633 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? 51.72 85.03 0.04 OUTLIER 'General case' 0 N--CA 1.514 2.76 0 O-C-N 121.575 -0.956 . . . . 0.0 110.997 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.4 t0 55.17 96.39 0.02 OUTLIER 'General case' 0 N--CA 1.516 2.826 0 O-C-N 121.634 -0.666 . . . . 0.0 110.276 -179.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.6 m -64.3 -30.35 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.491 0 O-C-N 121.919 -0.488 . . . . 0.0 110.695 -178.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 71.1 mt -59.43 -18.08 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.769 0 O-C-N 121.711 -0.618 . . . . 0.0 111.738 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.4 mp -92.57 -21.35 20.14 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.455 -0.778 . . . . 0.0 111.119 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 42.8 pttt -98.06 -37.43 9.75 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.633 -0.667 . . . . 0.0 109.233 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.4 mmmt 48.05 54.75 9.65 Favored 'General case' 0 N--CA 1.509 2.493 0 CA-C-O 121.421 0.629 . . . . 0.0 111.824 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -51.83 168.29 0.09 Allowed 'General case' 0 N--CA 1.515 2.789 0 O-C-N 121.867 -0.521 . . . . 0.0 110.943 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.8 m -61.16 -18.77 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.689 0 O-C-N 121.976 -0.452 . . . . 0.0 111.799 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 29.6 ptt-85 -121.26 46.82 1.96 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.728 -0.607 . . . . 0.0 111.973 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -145.36 106.97 4.23 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.574 -0.704 . . . . 0.0 110.156 178.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 82.7 mt -129.66 107.99 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.0 t -76.17 131.66 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.5 mt -85.02 164.43 18.25 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.909 -0.494 . . . . 0.0 111.49 -178.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.3 p -62.03 -20.68 64.19 Favored 'General case' 0 N--CA 1.509 2.48 0 O-C-N 122.102 -0.374 . . . . 0.0 110.812 178.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 50.3 p30 -88.17 13.58 11.06 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.721 -0.612 . . . . 0.0 111.528 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.3 m120 71.09 33.94 1.94 Allowed 'General case' 0 N--CA 1.518 2.968 0 O-C-N 121.547 -0.72 . . . . 0.0 112.493 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.407 ' CE2' ' HA ' ' A' ' 22' ' ' VAL . 5.3 m-85 -106.0 163.77 12.5 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 177.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.406 ' HB2' ' CE2' ' A' ' 35' ' ' TRP . 18.1 tp -118.07 97.54 5.86 Favored 'General case' 0 N--CA 1.519 3.005 0 C-N-CA 119.381 -0.928 . . . . 0.0 111.218 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.39 99.49 4.16 Favored 'General case' 0 N--CA 1.501 2.081 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.763 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 92.6 mt -90.75 118.95 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 177.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.8 tpt85 -81.2 113.06 19.09 Favored 'General case' 0 N--CA 1.501 2.092 0 CA-C-O 121.29 0.566 . . . . 0.0 111.012 -178.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.55 -37.28 3.6 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.418 ' O ' HG21 ' A' ' 63' ' ' ILE . 3.2 tp 41.6 94.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.521 3.08 0 CA-C-N 118.126 0.963 . . . . 0.0 112.253 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.2 mttm -86.87 157.45 19.53 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 121.233 -0.917 . . . . 0.0 112.693 -177.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.6 tttp -61.68 -27.38 68.65 Favored 'General case' 0 N--CA 1.508 2.453 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.12 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.5 t -81.11 -11.74 59.41 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 121.896 -0.503 . . . . 0.0 111.601 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.64 -17.54 20.31 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.534 -0.729 . . . . 0.0 111.482 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -68.75 148.28 50.58 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.36 -0.837 . . . . 0.0 109.933 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 167.01 -107.15 0.28 Allowed Glycine 0 N--CA 1.496 2.695 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.9 m -145.26 104.2 3.92 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 122.023 -0.692 . . . . 0.0 110.864 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -85.44 138.02 32.53 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -97.42 120.29 37.52 Favored 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.447 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 85' ' ' PHE . 2.9 m -87.31 105.73 17.45 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -104.63 85.97 2.41 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.298 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.29 87.96 0.25 Allowed Glycine 0 N--CA 1.499 2.899 0 N-CA-C 107.674 -2.17 . . . . 0.0 107.674 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 -92.91 125.69 37.64 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.706 0.765 . . . . 0.0 112.967 -176.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 5.2 mp -141.43 91.55 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 18.6 mt -96.94 19.11 13.24 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.009 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -112.59 -26.2 8.77 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.717 -0.614 . . . . 0.0 110.847 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 78.2 mmt-85 -121.22 -62.9 1.38 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.777 -0.577 . . . . 0.0 110.753 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.58 -81.71 1.62 Allowed Glycine 0 N--CA 1.491 2.305 0 C-N-CA 121.02 -0.61 . . . . 0.0 111.645 -178.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 178.09 -159.83 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.765 0 O-C-N 122.204 -0.586 . . . . 0.0 109.827 -178.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.7 pp -98.16 115.06 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 O-C-N 121.743 -0.598 . . . . 0.0 110.42 179.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -113.61 155.95 24.55 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.539 -0.725 . . . . 0.0 109.869 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.43 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 35.4 p90 -164.12 176.69 9.04 Favored 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.2 pttt -170.53 167.13 8.17 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -105.54 123.96 48.77 Favored 'General case' 0 N--CA 1.513 2.677 0 O-C-N 121.801 -0.562 . . . . 0.0 111.703 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.9 mp -104.85 119.24 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -83.54 114.83 21.79 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.5 t -108.52 132.92 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.235 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 50.2 mt -121.95 159.25 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.498 1.943 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.699 179.749 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 47.9 p90 . . . . . 0 N--CA 1.499 1.999 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 44.5 t -147.17 109.26 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.49 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 12.5 mmt -119.85 116.23 25.44 Favored 'General case' 0 N--CA 1.507 2.396 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.803 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -72.88 115.71 12.5 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 122.118 -0.364 . . . . 0.0 111.101 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -124.49 156.56 37.05 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.566 0.698 . . . . 0.0 110.357 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 41.07 81.82 0.03 OUTLIER 'General case' 0 N--CA 1.518 2.94 0 C-N-CA 123.479 0.712 . . . . 0.0 111.919 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -131.92 68.54 80.49 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.711 -0.618 . . . . 0.0 111.68 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -67.12 88.85 0.31 Allowed 'Trans proline' 0 N--CA 1.492 1.397 0 N-CA-C 107.966 -1.59 . . . . 0.0 107.966 177.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.42 ' CB ' ' HD3' ' A' ' 10' ' ' PRO . 0.6 OUTLIER -48.69 -68.27 0.34 Allowed Pre-proline 0 N--CA 1.509 2.496 0 CA-C-O 116.795 -1.574 . . . . 0.0 113.069 -176.702 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.42 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.5 Cg_endo -71.31 93.88 0.66 Allowed 'Trans proline' 0 N--CA 1.497 1.686 0 CA-C-N 121.516 1.577 . . . . 0.0 111.441 178.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -101.0 173.98 6.22 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.02 -1.05 . . . . 0.0 110.26 178.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -158.79 120.39 3.45 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.238 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -116.72 -169.76 1.69 Allowed 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.945 -0.472 . . . . 0.0 109.94 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -102.01 137.46 40.25 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.597 0.713 . . . . 0.0 111.705 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -60.79 118.78 7.07 Favored 'General case' 0 N--CA 1.508 2.444 0 O-C-N 121.964 -0.46 . . . . 0.0 110.494 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.3 23.54 37.01 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -118.26 165.17 14.14 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 118.412 1.106 . . . . 0.0 110.867 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.71 97.74 8.08 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 178.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.19 169.96 9.23 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.729 -177.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.2 t -142.88 140.76 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 178.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 20.8 mt -96.02 113.32 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 178.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.403 ' HA ' ' CE2' ' A' ' 57' ' ' TYR . 45.2 t -73.66 122.04 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.21 -176.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -164.92 89.81 0.5 Allowed 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.6 141.3 28.64 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.056 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.3 t -148.16 132.08 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.49 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 53.8 t -95.32 78.57 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.6 m -81.52 163.48 22.65 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 178.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 t -43.04 -85.06 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.329 0 O-C-N 121.825 -0.547 . . . . 0.0 111.582 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -167.29 -63.15 0.01 OUTLIER Pre-proline 0 N--CA 1.514 2.768 0 CA-C-O 117.707 -1.14 . . . . 0.0 111.663 177.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -59.76 -53.23 3.45 Favored 'Trans proline' 0 CA--C 1.564 1.999 0 CA-C-N 120.209 1.11 . . . . 0.0 112.446 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.438 ' CB ' ' HA ' ' A' ' 77' ' ' ILE . 3.0 Cg_endo -62.55 -164.4 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 120.55 0.833 . . . . 0.0 112.185 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -171.12 -166.69 0.49 Allowed 'General case' 0 N--CA 1.519 3.019 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.443 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 15.1 tt -97.96 165.45 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 81.1 mt -128.65 133.9 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.439 ' CE2' ' HB2' ' A' ' 58' ' ' LEU . 82.7 m95 -97.55 115.49 27.95 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -114.98 -172.72 2.18 Favored 'General case' 0 N--CA 1.505 2.3 0 CA-C-O 121.334 0.588 . . . . 0.0 111.295 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 9.0 t60 63.66 153.08 0.04 OUTLIER 'General case' 0 N--CA 1.51 2.563 0 CA-C-O 121.08 0.467 . . . . 0.0 110.468 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 26.1 tptt 55.28 53.63 9.76 Favored 'General case' 0 N--CA 1.515 2.796 0 O-C-N 121.732 -0.605 . . . . 0.0 110.783 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 133.34 -7.26 5.02 Favored Glycine 0 N--CA 1.496 2.651 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.229 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 56.4 89.61 0.04 OUTLIER 'General case' 0 N--CA 1.514 2.748 0 CA-C-N 118.902 1.351 . . . . 0.0 110.553 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 55.2 98.03 0.02 OUTLIER 'General case' 0 N--CA 1.514 2.77 0 O-C-N 121.766 -0.584 . . . . 0.0 110.775 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.7 m -73.05 -26.29 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.421 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.626 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.5 mm -58.44 -18.41 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.806 0 O-C-N 121.623 -0.673 . . . . 0.0 111.77 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.4 mp -91.66 -23.02 19.96 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.527 -0.733 . . . . 0.0 111.133 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -98.9 -42.28 7.23 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.753 -0.592 . . . . 0.0 110.034 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt 48.05 56.91 6.65 Favored 'General case' 0 N--CA 1.509 2.499 0 CA-C-O 121.492 0.663 . . . . 0.0 111.892 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -50.9 170.14 0.04 OUTLIER 'General case' 0 N--CA 1.517 2.893 0 O-C-N 121.689 -0.632 . . . . 0.0 111.506 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 36.0 m -63.21 -19.5 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.64 0 O-C-N 122.054 -0.404 . . . . 0.0 111.985 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.1 ptp85 -109.42 0.16 19.23 Favored 'General case' 0 N--CA 1.506 2.349 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -99.33 106.1 18.16 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.35 -0.844 . . . . 0.0 110.562 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 74.5 mt -129.64 110.49 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.5 t -77.62 137.88 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 45.0 mt -89.97 167.44 12.8 Favored 'General case' 0 N--CA 1.505 2.321 0 CA-C-O 121.387 0.613 . . . . 0.0 112.01 -178.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.7 p -60.92 -22.41 64.33 Favored 'General case' 0 N--CA 1.51 2.554 0 O-C-N 122.137 -0.352 . . . . 0.0 111.229 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 35.5 p-10 -91.29 18.54 6.92 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.735 -0.603 . . . . 0.0 111.48 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.6 m120 67.48 33.21 5.3 Favored 'General case' 0 N--CA 1.516 2.86 0 O-C-N 121.544 -0.722 . . . . 0.0 111.999 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.403 ' CE2' ' HA ' ' A' ' 22' ' ' VAL . 4.1 m-85 -103.06 163.84 11.97 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 177.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.439 ' HB2' ' CE2' ' A' ' 35' ' ' TRP . 20.8 tp -120.11 100.6 7.3 Favored 'General case' 0 N--CA 1.516 2.859 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.968 -179.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.69 105.32 9.9 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.328 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.4 mt -97.47 102.81 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 177.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -67.55 118.17 10.49 Favored 'General case' 0 N--CA 1.506 2.33 0 CA-C-O 121.155 0.503 . . . . 0.0 111.221 -178.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.57 -39.14 2.85 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.414 HG22 ' O ' ' A' ' 63' ' ' ILE . 2.8 tp 40.13 85.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.52 3.042 0 CA-C-O 122.023 0.916 . . . . 0.0 112.308 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.2 mtpt -68.95 151.28 46.74 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 121.548 -0.72 . . . . 0.0 111.347 -178.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.24 -17.99 63.06 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 122.15 -0.344 . . . . 0.0 110.956 179.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.0 t -90.98 -12.37 36.11 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.551 -0.718 . . . . 0.0 111.246 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.81 14.71 18.51 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.454 -0.779 . . . . 0.0 111.532 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.41 148.07 23.56 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.416 -0.802 . . . . 0.0 109.946 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 169.52 -102.1 0.18 Allowed Glycine 0 N--CA 1.498 2.769 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.6 m -148.38 100.76 3.18 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 122.025 -0.691 . . . . 0.0 110.994 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -80.76 133.41 35.64 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.8 tpt180 -96.32 116.56 29.22 Favored 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.651 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 7.1 m -79.29 132.89 36.6 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -134.82 91.13 2.72 Favored 'General case' 0 N--CA 1.503 2.178 0 CA-C-N 118.719 0.69 . . . . 0.0 110.724 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.76 121.21 10.56 Favored Glycine 0 N--CA 1.501 3.03 0 N-CA-C 107.598 -2.201 . . . . 0.0 107.598 178.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 -136.29 139.23 42.49 Favored 'General case' 0 N--CA 1.503 2.188 0 CA-C-N 118.308 1.054 . . . . 0.0 113.581 -177.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.438 ' HA ' ' CB ' ' A' ' 31' ' ' PRO . 81.0 mt -122.41 139.54 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.34 177.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 37.1 mt -92.7 -43.13 9.23 Favored 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 121.113 -0.235 . . . . 0.0 110.775 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.34 -57.81 10.79 Favored 'General case' 0 N--CA 1.514 2.774 0 O-C-N 121.63 -0.669 . . . . 0.0 109.583 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 23.2 mtm180 -100.58 61.34 1.01 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 177.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -15.33 82.21 0.0 OUTLIER Glycine 1 N--CA 1.524 4.535 0 C-N-CA 124.961 1.267 . . . . 0.0 114.845 -178.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -116.85 144.7 44.2 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.5 pt -137.82 68.26 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 CA-C-O 121.197 0.522 . . . . 0.0 111.033 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -85.19 154.83 21.73 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -161.37 -177.92 6.31 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.797 -0.761 . . . . 0.0 112.035 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.5 tptp -169.17 166.07 10.87 Favored 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -111.03 112.86 24.98 Favored 'General case' 0 N--CA 1.51 2.544 0 CA-C-O 121.071 0.462 . . . . 0.0 110.46 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.2 mp -101.07 118.99 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -83.52 127.32 33.63 Favored 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 40.7 t -121.11 132.7 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 O-C-N 121.808 -0.558 . . . . 0.0 109.905 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 72.1 mt -126.05 146.34 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 N--CA 1.501 2.103 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.714 -179.768 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 53.5 p90 . . . . . 0 N--CA 1.496 1.851 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.5 m -136.9 93.0 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 CA-C-O 121.335 0.588 . . . . 0.0 109.464 178.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.483 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 0.7 OUTLIER -87.8 106.81 18.33 Favored 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.907 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -67.13 119.9 12.83 Favored 'General case' 0 N--CA 1.506 2.346 0 CA-C-O 120.812 0.339 . . . . 0.0 110.738 -178.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.2 pttt -135.13 163.84 29.03 Favored 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 121.88 0.847 . . . . 0.0 112.26 -179.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 28.59 95.58 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.134 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 179.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -164.82 84.0 1.16 Allowed Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.953 -0.467 . . . . 0.0 111.154 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -65.2 106.04 0.77 Allowed 'Trans proline' 0 N--CA 1.492 1.392 0 N-CA-C 108.419 -1.416 . . . . 0.0 108.419 177.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.44 ' CB ' ' HD3' ' A' ' 10' ' ' PRO . 0.2 OUTLIER -51.04 -65.64 0.88 Allowed Pre-proline 0 N--CA 1.508 2.45 0 CA-C-O 116.91 -1.519 . . . . 0.0 112.594 -177.02 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.44 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.4 Cg_endo -75.1 94.55 0.96 Allowed 'Trans proline' 0 N--CA 1.495 1.59 0 CA-C-N 121.182 1.458 . . . . 0.0 111.019 178.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -99.96 179.35 4.53 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 120.949 -1.095 . . . . 0.0 110.276 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -160.6 121.75 2.99 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.825 -0.547 . . . . 0.0 111.82 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -118.95 -170.95 2.01 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.929 -0.482 . . . . 0.0 109.988 178.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.1 tttp -102.33 135.95 43.04 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.505 0.669 . . . . 0.0 111.339 -178.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -60.66 112.42 2.0 Allowed 'General case' 0 N--CA 1.508 2.47 0 O-C-N 121.929 -0.482 . . . . 0.0 110.533 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.02 23.89 16.42 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.423 ' O ' HG23 ' A' ' 63' ' ' ILE . 18.3 tt0 -118.4 165.79 13.44 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-N 118.397 1.099 . . . . 0.0 110.676 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -81.72 98.98 8.68 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 177.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.03 166.67 10.92 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 120.24 -0.584 . . . . 0.0 112.116 -177.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 89.6 t -141.19 139.7 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 178.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 42.7 mt -95.38 119.11 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 106.563 -1.644 . . . . 0.0 106.563 178.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.41 ' HA ' ' CE2' ' A' ' 57' ' ' TYR . 54.1 t -78.59 118.87 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 CA-C-O 121.415 0.626 . . . . 0.0 110.922 -176.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.6 t -159.91 91.56 0.97 Allowed 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.12 138.29 31.64 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.103 -179.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.6 t -147.51 124.17 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.483 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 29.0 t -85.51 75.01 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.4 m -75.48 158.22 32.9 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.5 t -40.45 -77.97 0.02 OUTLIER 'General case' 0 N--CA 1.525 3.323 0 CA-C-N 118.158 0.435 . . . . 0.0 111.597 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.2 mt -173.27 -63.47 0.0 OUTLIER Pre-proline 0 N--CA 1.515 2.789 0 CA-C-O 117.719 -1.134 . . . . 0.0 111.064 177.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.13 -53.35 3.13 Favored 'Trans proline' 0 CA--C 1.564 1.98 0 CA-C-N 120.105 1.073 . . . . 0.0 112.473 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.496 ' CB ' ' HA ' ' A' ' 77' ' ' ILE . 3.0 Cg_exo -62.11 -164.83 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 120.503 0.802 . . . . 0.0 112.558 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -170.34 -167.37 0.61 Allowed 'General case' 0 N--CA 1.519 3.003 0 O-C-N 121.921 -0.487 . . . . 0.0 110.434 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.8 tt -103.59 139.42 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.0 mp -102.13 130.57 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.426 ' CE2' ' HB2' ' A' ' 58' ' ' LEU . 72.3 m95 -92.68 114.78 27.43 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt -115.04 -175.17 2.63 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.903 -0.498 . . . . 0.0 111.035 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 60.99 150.22 0.02 OUTLIER 'General case' 0 N--CA 1.511 2.596 0 CA-C-O 121.264 0.554 . . . . 0.0 110.812 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? 54.96 33.97 21.29 Favored 'General case' 0 N--CA 1.517 2.903 0 O-C-N 121.483 -0.761 . . . . 0.0 110.536 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 159.93 -25.92 0.32 Allowed Glycine 0 N--CA 1.491 2.323 0 C-N-CA 120.266 -0.968 . . . . 0.0 110.906 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.47 97.22 0.02 OUTLIER 'General case' 0 N--CA 1.516 2.837 0 O-C-N 121.238 -1.154 . . . . 0.0 110.0 -179.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 54.3 75.76 0.27 Allowed 'General case' 0 N--CA 1.513 2.721 0 O-C-N 121.675 -0.641 . . . . 0.0 110.376 -179.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.7 m -67.53 -38.93 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 O-C-N 121.793 -0.567 . . . . 0.0 109.739 -178.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 58.5 mt -60.94 -17.48 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.718 0 O-C-N 121.964 -0.46 . . . . 0.0 111.423 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.1 mp -90.08 -23.64 21.35 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.473 -0.767 . . . . 0.0 110.451 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -99.06 -35.45 10.03 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.721 -0.612 . . . . 0.0 109.544 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.5 mmmt 49.27 54.85 10.25 Favored 'General case' 0 N--CA 1.506 2.351 0 CA-C-O 121.359 0.6 . . . . 0.0 111.978 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.0 167.24 0.12 Allowed 'General case' 0 N--CA 1.517 2.888 0 O-C-N 121.895 -0.503 . . . . 0.0 110.729 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.9 m -60.81 -19.38 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.741 0 O-C-N 121.874 -0.516 . . . . 0.0 111.843 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 25.6 ptt-85 -118.52 45.41 2.04 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.676 -0.64 . . . . 0.0 111.915 -179.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -146.51 104.84 3.8 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.604 -0.685 . . . . 0.0 109.752 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 76.1 mt -129.87 108.32 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.7 t -74.65 140.88 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.0 mt -95.49 169.59 9.95 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.821 -0.549 . . . . 0.0 111.899 -178.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.6 p -61.88 -23.11 66.09 Favored 'General case' 0 N--CA 1.509 2.521 0 O-C-N 122.183 -0.323 . . . . 0.0 111.007 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 44.6 p-10 -88.19 15.15 7.93 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.768 -0.582 . . . . 0.0 111.412 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.6 m120 68.13 33.47 4.43 Favored 'General case' 0 N--CA 1.516 2.834 0 O-C-N 121.577 -0.702 . . . . 0.0 112.023 179.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.41 ' CE2' ' HA ' ' A' ' 22' ' ' VAL . 3.8 m-85 -102.85 166.83 10.25 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.426 ' HB2' ' CE2' ' A' ' 35' ' ' TRP . 19.2 tp -120.83 98.03 5.81 Favored 'General case' 0 N--CA 1.519 2.991 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.666 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -75.65 101.11 4.85 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.917 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 95.5 mt -92.12 115.37 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 177.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -77.58 112.23 14.16 Favored 'General case' 0 N--CA 1.505 2.298 0 CA-C-O 121.521 0.677 . . . . 0.0 111.467 -178.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 100.16 -36.44 4.12 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 179.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.435 ' O ' HG21 ' A' ' 63' ' ' ILE . 2.6 tp 41.77 74.47 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.519 3.003 0 CA-C-O 122.249 1.024 . . . . 0.0 112.454 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.9 mmtp -62.8 158.6 18.39 Favored 'General case' 0 N--CA 1.509 2.483 0 O-C-N 121.488 -0.758 . . . . 0.0 112.336 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.3 tptt -61.97 -24.55 67.08 Favored 'General case' 0 N--CA 1.51 2.557 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.833 178.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.3 t -83.61 -15.1 50.31 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.773 -0.579 . . . . 0.0 111.109 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -94.12 11.09 31.22 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.635 -0.666 . . . . 0.0 111.595 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -98.74 137.3 37.55 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.275 -0.891 . . . . 0.0 109.593 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 174.7 -106.37 0.22 Allowed Glycine 0 N--CA 1.499 2.886 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.3 m -143.33 102.2 3.93 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.946 -0.737 . . . . 0.0 110.901 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -83.61 132.55 34.89 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.7 tpp85 -96.42 118.18 32.4 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.459 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 9.0 m -81.04 126.4 31.38 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 177.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -125.26 87.28 2.68 Favored 'General case' 0 N--CA 1.503 2.178 0 CA-C-N 118.605 0.639 . . . . 0.0 110.681 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.83 101.0 0.6 Allowed Glycine 0 N--CA 1.501 3.021 0 N-CA-C 107.921 -2.071 . . . . 0.0 107.921 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 30.3 ttp85 -112.72 135.4 53.51 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -176.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.496 ' HA ' ' CB ' ' A' ' 31' ' ' PRO . 95.8 mt -117.35 135.98 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 18.9 mt -90.71 -45.74 8.68 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.338 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.29 -58.89 6.49 Favored 'General case' 0 N--CA 1.516 2.87 0 O-C-N 121.574 -0.704 . . . . 0.0 109.652 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 20.9 mtt180 -96.87 58.26 1.6 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 177.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -15.02 82.3 0.0 OUTLIER Glycine 1 N--CA 1.524 4.541 0 C-N-CA 125.016 1.293 . . . . 0.0 114.66 -178.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -127.15 149.97 49.72 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 122.312 -0.522 . . . . 0.0 109.676 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.4 pt -137.25 74.17 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 CA-C-O 121.385 0.612 . . . . 0.0 110.834 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -82.31 151.04 26.91 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -164.51 177.64 7.99 Favored 'General case' 0 N--CA 1.503 2.22 0 C-N-CA 119.861 -0.736 . . . . 0.0 112.744 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.3 pttt -167.42 163.6 14.99 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 177.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -99.79 119.34 38.01 Favored 'General case' 0 N--CA 1.511 2.618 0 O-C-N 121.884 -0.51 . . . . 0.0 111.698 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.1 mp -104.17 118.47 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -84.06 125.65 32.31 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.6 t -119.26 126.08 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 O-C-N 121.719 -0.613 . . . . 0.0 109.792 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 51.1 mt -116.4 157.97 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.5 2.053 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.394 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 45.0 p90 . . . . . 0 N--CA 1.499 2.005 0 CA-C-O 120.779 0.323 . . . . 0.0 110.413 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 37.6 t -146.1 105.34 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.467 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 1.6 mmm -108.43 111.54 23.49 Favored 'General case' 0 N--CA 1.508 2.468 0 C-N-CA 120.144 -0.622 . . . . 0.0 109.821 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -67.65 119.87 13.11 Favored 'General case' 0 N--CA 1.505 2.319 0 CA-C-O 120.786 0.327 . . . . 0.0 110.783 -178.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.56 160.29 36.99 Favored 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 121.553 0.692 . . . . 0.0 111.114 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 31.41 58.81 0.29 Allowed 'General case' 0 N--CA 1.519 2.994 0 C-N-CA 124.148 0.979 . . . . 0.0 113.561 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -121.37 79.14 36.43 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.697 -0.627 . . . . 0.0 110.74 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -65.75 114.12 2.82 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 N-CA-C 109.189 -1.12 . . . . 0.0 109.189 178.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.438 ' CB ' ' HD3' ' A' ' 10' ' ' PRO . 0.2 OUTLIER -67.75 -66.76 1.02 Allowed Pre-proline 0 N--CA 1.498 1.956 0 CA-C-O 117.059 -1.448 . . . . 0.0 111.208 -178.335 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.438 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.4 Cg_endo -72.17 89.22 0.8 Allowed 'Trans proline' 0 N--CA 1.498 1.763 0 CA-C-N 121.108 1.432 . . . . 0.0 111.199 178.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -100.36 171.75 7.57 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 120.715 -1.24 . . . . 0.0 110.088 178.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -154.4 127.44 8.31 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.816 -0.552 . . . . 0.0 111.646 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -125.73 -164.0 1.26 Allowed 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.36 142.63 51.13 Favored 'General case' 0 N--CA 1.513 2.694 0 CA-C-O 121.856 0.836 . . . . 0.0 111.455 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -56.26 141.86 39.73 Favored 'General case' 0 N--CA 1.51 2.536 0 O-C-N 121.831 -0.543 . . . . 0.0 111.082 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.15 12.73 72.38 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.414 ' O ' HG23 ' A' ' 63' ' ' ILE . 12.1 tp10 -104.87 156.09 18.33 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 119.116 1.458 . . . . 0.0 111.34 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -81.12 95.45 6.88 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 176.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.15 166.34 11.46 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.996 -0.682 . . . . 0.0 112.203 -176.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 94.3 t -140.04 140.05 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 178.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 47.9 mt -94.87 117.0 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 178.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.419 ' HA ' ' CE2' ' A' ' 57' ' ' TYR . 39.2 t -77.08 119.48 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 CA-C-O 121.431 0.634 . . . . 0.0 110.98 -176.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.4 t -161.34 92.03 0.88 Allowed 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.09 140.59 29.49 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.905 -0.718 . . . . 0.0 109.314 -179.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.7 t -146.79 128.19 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.467 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 45.9 t -89.42 74.09 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.0 m -78.44 161.79 26.86 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 178.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 t -41.96 -78.29 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.199 0 CA-C-N 118.191 0.451 . . . . 0.0 111.566 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -174.0 -62.54 0.0 OUTLIER Pre-proline 0 N--CA 1.515 2.809 0 CA-C-O 117.873 -1.06 . . . . 0.0 111.498 177.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.68 -53.44 3.31 Favored 'Trans proline' 0 CA--C 1.562 1.913 0 CA-C-N 119.845 0.981 . . . . 0.0 112.519 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.435 ' CB ' ' HA ' ' A' ' 77' ' ' ILE . 3.3 Cg_exo -61.4 -165.28 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 120.535 0.823 . . . . 0.0 112.61 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -170.35 -170.13 0.92 Allowed 'General case' 0 N--CA 1.521 3.114 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.717 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 18.3 tt -100.92 140.22 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.1 mp -102.91 128.36 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.412 ' CE2' ' HB2' ' A' ' 58' ' ' LEU . 73.6 m95 -90.56 112.88 24.73 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.0 ttpt -114.25 -176.32 2.87 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.783 -0.573 . . . . 0.0 111.059 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 62.06 153.5 0.03 OUTLIER 'General case' 0 N--CA 1.512 2.641 0 O-C-N 121.915 -0.491 . . . . 0.0 110.788 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.5 tppt? 53.4 37.03 24.54 Favored 'General case' 0 N--CA 1.516 2.861 0 O-C-N 121.677 -0.64 . . . . 0.0 110.578 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 154.73 -23.77 0.63 Allowed Glycine 0 N--CA 1.488 2.112 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.34 98.45 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.689 0 O-C-N 121.374 -1.074 . . . . 0.0 110.458 -179.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 54.96 79.34 0.15 Allowed 'General case' 0 N--CA 1.513 2.711 0 O-C-N 121.721 -0.612 . . . . 0.0 110.298 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.4 m -70.97 -36.95 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 O-C-N 121.79 -0.569 . . . . 0.0 109.791 -178.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 77.3 mt -60.24 -17.61 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.855 0 O-C-N 122.071 -0.393 . . . . 0.0 111.418 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.7 mp -90.16 -23.65 21.27 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.511 -0.743 . . . . 0.0 110.617 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 45.0 pttt -99.15 -36.91 9.52 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.719 -0.613 . . . . 0.0 109.572 178.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.7 mmmt 47.97 56.72 6.87 Favored 'General case' 0 N--CA 1.508 2.426 0 CA-C-O 121.503 0.668 . . . . 0.0 111.88 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.67 168.45 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.811 0 O-C-N 121.863 -0.523 . . . . 0.0 111.638 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.9 m -59.91 -20.04 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.68 0 O-C-N 121.923 -0.485 . . . . 0.0 112.268 -178.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.9 ptp85 -114.68 4.37 15.03 Favored 'General case' 0 N--CA 1.507 2.42 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -102.32 111.3 23.53 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.143 -0.973 . . . . 0.0 110.916 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 82.6 mt -132.87 105.96 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.2 t -73.39 136.73 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.4 mt -90.22 166.83 13.13 Favored 'General case' 0 N--CA 1.507 2.386 0 CA-C-O 121.319 0.58 . . . . 0.0 111.845 -178.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 92.9 p -60.87 -21.7 63.54 Favored 'General case' 0 N--CA 1.509 2.487 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.249 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 42.0 p-10 -90.32 17.92 6.67 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.629 -0.67 . . . . 0.0 111.475 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.5 m120 68.26 30.72 5.49 Favored 'General case' 0 N--CA 1.518 2.948 0 O-C-N 121.605 -0.685 . . . . 0.0 112.051 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.419 ' CE2' ' HA ' ' A' ' 22' ' ' VAL . 3.6 m-85 -101.71 165.2 11.34 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.412 ' HB2' ' CE2' ' A' ' 35' ' ' TRP . 17.1 tp -120.06 102.61 8.65 Favored 'General case' 0 N--CA 1.518 2.942 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.751 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -80.0 103.42 9.87 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.368 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.422 HG23 HD11 ' A' ' 60' ' ' ILE . 95.1 mt -95.89 104.7 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 177.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -68.01 113.22 5.51 Favored 'General case' 0 N--CA 1.505 2.289 0 CA-C-O 121.07 0.462 . . . . 0.0 110.756 -178.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 100.92 -40.17 2.51 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.445 ' O ' HG21 ' A' ' 63' ' ' ILE . 1.7 tp 42.91 72.14 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.961 0 CA-C-O 122.228 1.013 . . . . 0.0 112.446 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 59.9 mttt -62.33 158.62 16.95 Favored 'General case' 0 N--CA 1.51 2.527 0 O-C-N 121.63 -0.669 . . . . 0.0 112.154 -178.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.5 mtmt -62.84 -23.65 67.39 Favored 'General case' 0 N--CA 1.508 2.473 0 O-C-N 122.134 -0.354 . . . . 0.0 110.879 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.0 p -80.77 -17.28 51.44 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.741 -0.6 . . . . 0.0 110.774 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -94.23 10.02 35.7 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.701 -0.624 . . . . 0.0 111.725 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -98.18 144.57 27.49 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-N 119.209 0.913 . . . . 0.0 110.156 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 167.94 -102.93 0.19 Allowed Glycine 0 N--CA 1.499 2.878 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.7 m -145.98 102.87 3.69 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 122.123 -0.634 . . . . 0.0 111.122 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -83.97 133.73 34.68 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -95.41 120.68 36.07 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.405 -179.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 85' ' ' PHE . 7.3 m -85.21 122.57 29.6 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 177.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -125.06 88.39 2.88 Favored 'General case' 0 N--CA 1.505 2.293 0 CA-C-N 119.021 0.828 . . . . 0.0 111.061 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.39 110.52 3.46 Favored Glycine 0 N--CA 1.502 3.071 0 N-CA-C 107.911 -2.076 . . . . 0.0 107.911 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.7 ttp85 -124.92 138.9 54.23 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -177.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.435 ' HA ' ' CB ' ' A' ' 31' ' ' PRO . 84.2 mt -119.6 137.84 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.273 177.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 46.9 mt -92.84 -45.67 7.89 Favored 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.865 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.48 -56.95 15.47 Favored 'General case' 0 N--CA 1.515 2.813 0 O-C-N 121.538 -0.726 . . . . 0.0 109.819 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 23.1 mtp85 -102.06 61.01 0.86 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 177.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -14.81 81.56 0.0 OUTLIER Glycine 1 N--CA 1.526 4.673 0 C-N-CA 125.07 1.319 . . . . 0.0 114.9 -178.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -117.81 143.93 45.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 122.273 -0.545 . . . . 0.0 109.718 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.1 pt -137.08 73.24 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.345 0 CA-C-O 121.319 0.58 . . . . 0.0 111.153 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -90.13 147.61 23.5 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 30.7 p90 -157.24 -177.25 6.46 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 119.497 -0.881 . . . . 0.0 112.669 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 9.6 tptt -168.4 165.36 12.73 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -110.31 108.74 18.92 Favored 'General case' 0 N--CA 1.509 2.494 0 CA-C-O 120.974 0.416 . . . . 0.0 110.245 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.4 ' N ' ' CD1' ' A' ' 88' ' ' ILE . 2.2 mp -92.76 113.78 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -80.68 105.08 11.65 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.3 t -99.97 136.5 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.156 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 63.4 mt -126.92 156.95 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.498 1.948 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.594 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 48.4 p90 . . . . . 0 N--CA 1.497 1.921 0 CA-C-O 120.636 0.255 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.9 t -146.72 108.46 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.471 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 6.3 mmt -116.46 113.37 22.74 Favored 'General case' 0 N--CA 1.507 2.413 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.416 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -70.31 116.5 10.73 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 122.103 -0.373 . . . . 0.0 111.1 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt -119.9 155.98 31.65 Favored 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 44.48 81.24 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.747 0 C-N-CA 122.718 0.407 . . . . 0.0 111.517 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -126.35 56.86 17.8 Favored Pre-proline 0 N--CA 1.497 1.907 0 O-C-N 121.64 -0.663 . . . . 0.0 112.425 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.02 90.67 0.16 Allowed 'Trans proline' 0 N--CA 1.496 1.62 0 N-CA-C 107.983 -1.583 . . . . 0.0 107.983 176.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.513 ' OG1' ' HD3' ' A' ' 10' ' ' PRO . 0.5 OUTLIER -52.93 -54.87 39.19 Favored Pre-proline 0 N--CA 1.503 2.194 0 CA-C-O 117.119 -1.419 . . . . 0.0 113.575 -176.268 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.513 ' HD3' ' OG1' ' A' ' 9' ' ' THR . 1.6 Cg_endo -80.27 92.84 1.07 Allowed 'Trans proline' 0 CA--C 1.549 1.242 0 CA-C-N 120.892 1.354 . . . . 0.0 111.584 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -100.99 171.04 7.88 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.088 -1.007 . . . . 0.0 110.197 178.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -156.76 118.1 3.77 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.635 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -114.47 -170.0 1.64 Allowed 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.901 -0.499 . . . . 0.0 110.024 179.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -101.79 139.71 37.07 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.517 0.675 . . . . 0.0 111.452 -178.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -59.87 119.03 6.93 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 121.015 0.436 . . . . 0.0 110.842 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.69 23.49 46.26 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.431 ' O ' HG23 ' A' ' 63' ' ' ILE . 14.4 tt0 -114.57 164.31 14.18 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 118.621 1.211 . . . . 0.0 110.907 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -79.72 98.88 7.17 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 177.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.78 170.64 8.41 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 120.218 -0.593 . . . . 0.0 111.731 -177.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 87.5 t -143.47 141.11 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 178.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 18.9 mt -96.11 115.25 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 178.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.401 ' HA ' ' CE2' ' A' ' 57' ' ' TYR . 46.0 t -74.94 122.0 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 CA-C-O 121.371 0.605 . . . . 0.0 111.205 -176.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -164.94 88.6 0.47 Allowed 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.79 145.01 26.3 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 119.785 -0.766 . . . . 0.0 108.995 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.9 t -151.64 137.17 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.471 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 62.2 t -99.49 78.45 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 108.174 -1.046 . . . . 0.0 108.174 178.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.2 m -80.1 163.13 24.38 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 178.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.8 t -42.11 -79.83 0.01 OUTLIER 'General case' 0 N--CA 1.524 3.237 0 O-C-N 121.87 -0.519 . . . . 0.0 111.595 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -171.13 -63.29 0.0 OUTLIER Pre-proline 0 N--CA 1.514 2.768 0 CA-C-O 117.715 -1.136 . . . . 0.0 111.593 177.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.26 -53.21 3.17 Favored 'Trans proline' 0 CA--C 1.562 1.914 0 CA-C-N 120.045 1.052 . . . . 0.0 112.812 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.467 ' CB ' ' HA ' ' A' ' 77' ' ' ILE . 3.0 Cg_endo -62.04 -163.99 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 120.456 0.771 . . . . 0.0 112.716 -178.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -170.53 -168.12 0.67 Allowed 'General case' 0 N--CA 1.518 2.931 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.134 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 15.4 tt -100.24 155.28 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.7 mp -117.65 132.35 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.44 ' CE2' ' HB2' ' A' ' 58' ' ' LEU . 79.4 m95 -94.54 104.67 16.62 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.2 tttt -105.1 -171.99 2.02 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.192 0.52 . . . . 0.0 110.609 -178.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 65.64 167.19 0.19 Allowed 'General case' 0 N--CA 1.511 2.593 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.53 26.63 11.2 Favored 'General case' 0 N--CA 1.515 2.82 0 O-C-N 121.68 -0.637 . . . . 0.0 111.154 -178.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.34 40.58 0.43 Allowed Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 51.84 -161.55 0.09 Allowed 'General case' 0 N--CA 1.516 2.875 0 O-C-N 121.576 -0.955 . . . . 0.0 110.871 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -60.33 111.94 1.75 Allowed 'General case' 0 N--CA 1.513 2.711 0 O-C-N 121.644 -0.66 . . . . 0.0 110.109 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.5 m -67.64 -27.69 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.461 0 O-C-N 122.057 -0.402 . . . . 0.0 110.605 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 57.7 mt -59.21 -17.51 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.796 0 O-C-N 121.551 -0.718 . . . . 0.0 111.546 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.8 mp -92.13 -21.82 20.21 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.491 -0.756 . . . . 0.0 111.122 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 39.9 pttt -97.25 -38.55 9.64 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.54 -0.725 . . . . 0.0 109.584 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.8 mmmt 46.31 55.05 7.77 Favored 'General case' 0 N--CA 1.51 2.54 0 CA-C-O 121.533 0.682 . . . . 0.0 112.116 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.05 169.86 0.09 Allowed 'General case' 0 N--CA 1.514 2.761 0 O-C-N 121.734 -0.604 . . . . 0.0 110.819 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.4 m -60.79 -19.57 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.621 0 O-C-N 121.965 -0.459 . . . . 0.0 111.664 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 8.9 ptp85 -119.32 46.82 1.81 Allowed 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.662 -0.649 . . . . 0.0 112.174 -178.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -145.62 99.21 3.25 Favored 'General case' 0 N--CA 1.508 2.431 0 O-C-N 121.556 -0.715 . . . . 0.0 110.081 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.3 mp -125.8 114.44 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.5 t -79.99 131.69 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.9 mt -82.1 163.97 21.66 Favored 'General case' 0 N--CA 1.507 2.409 0 CA-C-O 121.328 0.585 . . . . 0.0 111.774 -178.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 92.4 p -60.4 -20.2 58.81 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 122.171 -0.331 . . . . 0.0 111.221 179.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 48.7 p-10 -91.33 19.23 6.18 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.609 -0.682 . . . . 0.0 111.389 179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.9 m120 67.23 32.17 6.19 Favored 'General case' 0 N--CA 1.516 2.835 0 O-C-N 121.613 -0.68 . . . . 0.0 112.401 178.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.401 ' CE2' ' HA ' ' A' ' 22' ' ' VAL . 4.0 m-85 -103.39 166.61 10.32 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.44 ' HB2' ' CE2' ' A' ' 35' ' ' TRP . 19.7 tp -121.72 97.99 5.75 Favored 'General case' 0 N--CA 1.515 2.791 0 C-N-CA 119.407 -0.917 . . . . 0.0 111.748 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -74.91 105.44 5.94 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.861 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 97.0 mt -96.44 112.1 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 178.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -73.1 112.66 9.35 Favored 'General case' 0 N--CA 1.506 2.336 0 CA-C-O 121.384 0.611 . . . . 0.0 111.423 -177.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.65 -36.08 4.15 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 178.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.431 HG23 ' O ' ' A' ' 17' ' ' GLU . 1.7 tp 41.97 69.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.808 0 CA-C-O 122.185 0.993 . . . . 0.0 112.379 -178.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 55.3 mttt -57.55 158.9 5.42 Favored 'General case' 0 N--CA 1.51 2.56 0 O-C-N 121.615 -0.678 . . . . 0.0 112.209 -178.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 45.4 tttt -62.33 -23.63 66.88 Favored 'General case' 0 N--CA 1.508 2.452 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.895 178.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.7 t -83.15 -15.85 49.03 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.794 -0.566 . . . . 0.0 111.184 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -93.95 9.57 36.92 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.714 -0.616 . . . . 0.0 111.653 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -98.45 142.63 29.83 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.33 -0.856 . . . . 0.0 109.626 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 168.0 -103.81 0.2 Allowed Glycine 0 N--CA 1.498 2.815 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.4 m -145.93 102.78 3.69 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.974 -0.721 . . . . 0.0 111.21 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -83.91 135.28 34.55 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.8 ttt85 -97.51 117.64 32.22 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.103 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.2 m -80.47 133.11 35.81 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 177.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -134.59 91.33 2.77 Favored 'General case' 0 N--CA 1.505 2.297 0 CA-C-N 118.686 0.676 . . . . 0.0 110.396 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.47 118.83 8.78 Favored Glycine 0 N--CA 1.503 3.141 0 N-CA-C 107.746 -2.142 . . . . 0.0 107.746 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.1 ttm180 -132.14 138.79 48.19 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -177.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.467 ' HA ' ' CB ' ' A' ' 31' ' ' PRO . 87.4 mt -118.78 138.12 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-N 114.968 -1.015 . . . . 0.0 108.33 177.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.3 mt -92.88 -39.4 11.2 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.889 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.1 -56.23 14.22 Favored 'General case' 0 N--CA 1.512 2.673 0 O-C-N 121.7 -0.625 . . . . 0.0 109.383 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 57.9 mtt180 -103.7 63.39 0.78 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 177.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -14.07 80.95 0.0 OUTLIER Glycine 1 N--CA 1.526 4.659 0 C-N-CA 125.14 1.353 . . . . 0.0 114.714 -178.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -112.6 146.62 38.26 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.9 pt -140.75 63.2 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.151 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -79.17 157.89 27.79 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 178.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -162.42 -175.21 4.4 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 119.684 -0.806 . . . . 0.0 112.715 -179.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.4 tptt -171.1 167.5 7.12 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -115.37 108.09 16.07 Favored 'General case' 0 N--CA 1.513 2.723 0 O-C-N 121.844 -0.535 . . . . 0.0 110.222 178.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.406 ' N ' ' CD1' ' A' ' 88' ' ' ILE . 2.4 mp -96.16 115.71 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -84.63 111.02 19.17 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 42.5 t -105.48 138.05 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.917 -0.489 . . . . 0.0 110.291 -179.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 82.3 mt -128.23 157.31 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.916 0 CA-C-O 118.062 -0.971 . . . . 0.0 110.458 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 38.4 p90 . . . . . 0 N--CA 1.5 2.06 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.2 t -148.8 105.35 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.332 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.509 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 6.5 mmt -110.27 110.9 21.89 Favored 'General case' 0 N--CA 1.506 2.348 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.18 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -71.24 113.71 8.56 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 122.086 -0.384 . . . . 0.0 110.239 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.6 ptpt -129.03 163.7 24.83 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 122.013 0.911 . . . . 0.0 112.301 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 29.69 95.49 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.014 0 C-N-CA 124.654 1.182 . . . . 0.0 114.185 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -164.47 84.67 1.19 Allowed Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.8 -0.562 . . . . 0.0 111.263 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -66.17 104.38 0.72 Allowed 'Trans proline' 0 N--CA 1.49 1.309 0 N-CA-C 108.288 -1.466 . . . . 0.0 108.288 177.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.433 ' CB ' ' HD3' ' A' ' 10' ' ' PRO . 0.2 OUTLIER -50.61 -66.01 0.76 Allowed Pre-proline 0 N--CA 1.51 2.56 0 CA-C-O 116.932 -1.509 . . . . 0.0 112.54 -176.973 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.433 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.6 Cg_endo -73.99 94.5 0.88 Allowed 'Trans proline' 0 N--CA 1.494 1.542 0 CA-C-N 121.203 1.465 . . . . 0.0 110.937 178.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -99.66 173.47 6.7 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.047 -1.033 . . . . 0.0 110.091 178.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -155.23 121.25 5.15 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 120.373 -0.531 . . . . 0.0 112.01 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -120.2 -170.5 1.98 Allowed 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 178.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 30.7 ttpt -104.92 139.32 39.81 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.339 0.59 . . . . 0.0 111.489 -179.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -62.1 111.6 2.01 Favored 'General case' 0 N--CA 1.508 2.447 0 CA-C-O 121.062 0.458 . . . . 0.0 110.359 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.51 22.31 16.93 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.448 ' O ' HG23 ' A' ' 63' ' ' ILE . 30.2 tt0 -117.16 164.83 14.18 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 118.474 1.137 . . . . 0.0 110.668 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -82.62 100.1 9.96 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 178.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -102.42 167.42 9.96 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.955 -177.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 95.7 t -138.99 141.2 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 178.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 22.5 mt -95.76 112.39 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 178.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.41 ' HA ' ' CE2' ' A' ' 57' ' ' TYR . 57.8 t -74.12 122.35 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 CA-C-O 121.551 0.691 . . . . 0.0 110.682 -176.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.2 t -163.7 92.55 0.7 Allowed 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.02 137.87 32.01 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.373 -179.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.1 t -147.18 125.71 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.509 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 40.8 t -91.06 79.43 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.3 m -78.06 167.14 21.9 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 178.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 t -45.49 -80.23 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.165 0 O-C-N 121.761 -0.587 . . . . 0.0 111.09 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -166.98 -64.56 0.01 OUTLIER Pre-proline 0 N--CA 1.512 2.635 0 CA-C-O 117.566 -1.207 . . . . 0.0 111.697 177.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.36 -53.49 2.89 Favored 'Trans proline' 0 CA--C 1.562 1.916 0 CA-C-N 120.233 1.119 . . . . 0.0 112.847 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.456 ' CB ' ' HA ' ' A' ' 77' ' ' ILE . 3.2 Cg_exo -61.15 -165.72 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 120.498 0.798 . . . . 0.0 113.223 -178.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -172.83 -161.36 0.15 Allowed 'General case' 0 N--CA 1.52 3.051 0 O-C-N 121.927 -0.483 . . . . 0.0 109.906 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -106.04 148.63 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.896 -0.503 . . . . 0.0 110.415 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.3 mp -109.53 125.19 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.431 ' CE2' ' HB2' ' A' ' 58' ' ' LEU . 77.1 m95 -85.21 120.53 26.8 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.6 mmmt -131.25 -166.99 1.78 Allowed 'General case' 0 N--CA 1.503 2.184 0 CA-C-O 121.439 0.637 . . . . 0.0 111.71 -177.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 67.24 52.0 0.87 Allowed 'General case' 0 N--CA 1.511 2.603 0 CA-C-O 121.608 0.718 . . . . 0.0 111.525 179.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -162.64 29.75 0.1 Allowed 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.841 -0.537 . . . . 0.0 109.912 178.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 116.13 -53.71 0.61 Allowed Glycine 0 N--CA 1.486 2.02 0 N-CA-C 108.176 -1.97 . . . . 0.0 108.176 -178.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.97 -164.91 0.66 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 122.223 -0.575 . . . . 0.0 109.487 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -74.61 119.3 18.61 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.3 m -66.15 -34.12 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.511 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.99 -178.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.437 HG22 HD11 ' A' ' 43' ' ' ILE . 47.9 mm -59.57 -18.25 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.702 0 O-C-N 121.92 -0.487 . . . . 0.0 111.76 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.7 mp -92.32 -21.4 20.3 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.509 -0.744 . . . . 0.0 111.195 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 35.1 pttt -98.55 -37.87 9.38 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.625 -0.672 . . . . 0.0 109.408 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.4 mmmt 47.61 54.25 10.03 Favored 'General case' 0 N--CA 1.51 2.551 0 CA-C-O 121.498 0.666 . . . . 0.0 111.859 179.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.99 161.43 2.32 Favored 'General case' 0 N--CA 1.512 2.661 0 O-C-N 121.754 -0.591 . . . . 0.0 110.404 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.4 m -58.42 -20.3 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.77 0 O-C-N 121.924 -0.485 . . . . 0.0 111.613 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -108.0 37.86 2.35 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.78 -0.575 . . . . 0.0 111.806 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -144.86 106.75 4.29 Favored 'General case' 0 N--CA 1.506 2.375 0 O-C-N 121.767 -0.583 . . . . 0.0 109.598 178.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 72.9 mt -126.21 102.14 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.2 t -74.33 132.08 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.4 mt -88.15 162.45 16.71 Favored 'General case' 0 N--CA 1.504 2.272 0 CA-C-O 121.272 0.558 . . . . 0.0 111.571 -178.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.6 p -60.24 -19.64 55.44 Favored 'General case' 0 N--CA 1.511 2.598 0 O-C-N 122.141 -0.35 . . . . 0.0 111.427 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 43.2 p-10 -91.74 19.5 6.4 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.565 -0.71 . . . . 0.0 111.374 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.7 m120 67.93 32.05 5.34 Favored 'General case' 0 N--CA 1.518 2.93 0 O-C-N 121.783 -0.573 . . . . 0.0 112.356 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.41 ' CE2' ' HA ' ' A' ' 22' ' ' VAL . 4.3 m-85 -103.59 163.37 12.35 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.431 ' HB2' ' CE2' ' A' ' 35' ' ' TRP . 16.8 tp -122.14 97.51 5.51 Favored 'General case' 0 N--CA 1.513 2.722 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.715 -179.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.53 98.48 3.97 Favored 'General case' 0 N--CA 1.501 2.082 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.825 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 98.0 mt -90.73 115.94 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.17 115.08 15.55 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 121.265 0.555 . . . . 0.0 110.991 -178.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.31 -37.5 3.46 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.448 HG23 ' O ' ' A' ' 17' ' ' GLU . 2.5 tp 41.7 70.57 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.517 2.897 0 CA-C-O 122.237 1.018 . . . . 0.0 112.246 -178.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 39.7 mtpt -67.04 149.89 49.97 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.589 -0.694 . . . . 0.0 111.472 -178.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.6 pttt -60.96 -24.29 65.97 Favored 'General case' 0 N--CA 1.511 2.582 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.493 178.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.4 t -71.17 -18.15 62.5 Favored 'General case' 0 N--CA 1.502 2.144 0 C-N-CA 120.261 -0.575 . . . . 0.0 110.134 177.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -102.67 -1.03 30.87 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.644 -0.66 . . . . 0.0 111.842 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -79.23 153.5 29.91 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.163 -0.961 . . . . 0.0 109.606 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 161.74 -102.66 0.21 Allowed Glycine 0 N--CA 1.497 2.733 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.5 m -152.97 104.18 2.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 122.084 -0.656 . . . . 0.0 110.305 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -82.82 135.37 34.97 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -96.77 119.8 35.93 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.762 -0.586 . . . . 0.0 110.99 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 85' ' ' PHE . 7.4 m -83.85 116.66 22.85 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 177.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -115.94 88.16 2.83 Favored 'General case' 0 N--CA 1.503 2.185 0 CA-C-N 118.637 0.653 . . . . 0.0 110.928 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.76 113.64 5.38 Favored Glycine 0 N--CA 1.504 3.184 0 N-CA-C 107.883 -2.087 . . . . 0.0 107.883 178.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.3 ttm-85 -130.51 143.71 50.93 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -177.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.456 ' HA ' ' CB ' ' A' ' 31' ' ' PRO . 85.1 mt -120.58 137.88 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.37 177.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 56.8 mt -93.17 -38.2 11.7 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.762 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.53 -58.26 6.89 Favored 'General case' 0 N--CA 1.512 2.663 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 26.3 mtt85 -100.07 60.39 1.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 177.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -14.2 81.24 0.0 OUTLIER Glycine 1 N--CA 1.526 4.682 0 C-N-CA 125.046 1.308 . . . . 0.0 114.805 -178.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -117.89 144.18 45.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 122.218 -0.577 . . . . 0.0 110.075 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.1 pt -134.8 75.41 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 CA-C-O 121.191 0.519 . . . . 0.0 110.839 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -92.8 148.96 21.6 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 30.7 p90 -163.97 177.9 8.15 Favored 'General case' 0 N--CA 1.503 2.197 0 C-N-CA 119.765 -0.774 . . . . 0.0 112.833 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.4 pttt -166.85 165.59 16.08 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -101.42 119.09 38.23 Favored 'General case' 0 N--CA 1.511 2.606 0 O-C-N 121.857 -0.527 . . . . 0.0 111.956 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.6 mp -102.28 117.01 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 178.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -83.47 123.11 29.38 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -179.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 37.5 t -118.15 131.23 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 121.775 -0.578 . . . . 0.0 109.721 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 69.3 mt -127.34 152.94 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.502 2.15 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.042 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 42.4 p90 . . . . . 0 N--CA 1.499 1.992 0 CA-C-O 120.634 0.255 . . . . 0.0 110.357 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 36.0 t -143.0 107.13 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.32 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.506 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 73.1 mtp -119.09 112.59 19.73 Favored 'General case' 0 N--CA 1.511 2.579 0 O-C-N 121.752 -0.592 . . . . 0.0 111.19 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -72.48 107.11 4.86 Favored 'General case' 0 N--CA 1.508 2.432 0 CA-C-O 121.01 0.433 . . . . 0.0 110.454 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -118.75 170.98 8.53 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-O 121.221 0.534 . . . . 0.0 110.669 -179.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 25.43 63.23 0.06 Allowed 'General case' 0 N--CA 1.526 3.342 0 C-N-CA 124.291 1.037 . . . . 0.0 113.753 178.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -128.33 66.79 74.2 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 121.627 -0.671 . . . . 0.0 111.646 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.73 108.25 1.03 Allowed 'Trans proline' 0 N--CA 1.493 1.48 0 N-CA-C 108.218 -1.493 . . . . 0.0 108.218 177.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.487 ' OG1' ' HD3' ' A' ' 10' ' ' PRO . 11.4 p -62.24 -43.9 86.97 Favored Pre-proline 0 N--CA 1.503 2.208 0 CA-C-O 117.287 -1.339 . . . . 0.0 113.178 -176.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.487 ' HD3' ' OG1' ' A' ' 9' ' ' THR . 1.6 Cg_endo -84.11 84.79 1.49 Allowed 'Trans proline' 0 CA--C 1.551 1.329 0 CA-C-N 120.677 1.277 . . . . 0.0 111.513 -177.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -100.49 172.74 6.93 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 121.085 -1.009 . . . . 0.0 110.748 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -158.03 120.52 3.77 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.897 -0.502 . . . . 0.0 111.342 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -116.41 -169.73 1.67 Allowed 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.965 -0.459 . . . . 0.0 110.196 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 49.5 tttm -101.85 135.77 42.83 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.378 0.609 . . . . 0.0 111.256 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -60.74 116.86 4.73 Favored 'General case' 0 N--CA 1.509 2.498 0 CA-C-O 121.082 0.468 . . . . 0.0 110.582 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.88 22.81 29.58 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.457 ' O ' HG23 ' A' ' 63' ' ' ILE . 16.9 tt0 -117.26 164.58 14.6 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 118.471 1.135 . . . . 0.0 110.93 -179.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -81.08 98.41 7.99 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 177.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.11 167.22 10.6 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 120.291 -0.564 . . . . 0.0 111.911 -177.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 98.5 t -140.55 139.98 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 178.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 38.4 mt -95.2 116.73 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 178.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.411 ' HA ' ' CE2' ' A' ' 57' ' ' TYR . 44.6 t -78.87 117.02 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-O 121.321 0.581 . . . . 0.0 110.781 -176.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -154.47 95.01 1.76 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -90.05 137.79 32.05 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.9 t -147.81 122.26 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.506 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 14.8 t -85.15 81.53 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.9 m -87.38 155.2 20.14 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.6 t -44.94 -84.03 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.15 0 O-C-N 121.884 -0.51 . . . . 0.0 111.909 -178.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -166.94 -62.23 0.01 OUTLIER Pre-proline 0 N--CA 1.511 2.576 0 CA-C-O 117.76 -1.114 . . . . 0.0 112.094 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -59.37 -53.87 3.09 Favored 'Trans proline' 0 CA--C 1.559 1.741 0 CA-C-N 120.082 1.065 . . . . 0.0 112.336 -178.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.408 ' HB2' HG13 ' A' ' 77' ' ' ILE . 2.4 Cg_endo -64.46 -168.97 0.11 Allowed 'Trans proline' 0 N--CA 1.496 1.663 0 CA-C-N 119.399 0.821 . . . . 0.0 110.984 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -172.04 -165.29 0.34 Allowed 'General case' 0 N--CA 1.521 3.086 0 O-C-N 121.723 -0.611 . . . . 0.0 109.844 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.3 tt -99.39 150.73 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 122.053 -0.405 . . . . 0.0 109.925 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.6 mt -115.56 115.42 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 72.7 m95 -81.18 104.96 12.02 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -109.21 -175.31 2.73 Favored 'General case' 0 N--CA 1.502 2.142 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.885 -178.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 2.4 t60 62.7 153.24 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.669 0 O-C-N 121.876 -0.515 . . . . 0.0 110.146 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.6 tppm? 52.35 29.86 7.36 Favored 'General case' 0 N--CA 1.519 2.979 0 O-C-N 121.566 -0.709 . . . . 0.0 110.869 -179.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 160.84 -28.31 0.31 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 56.9 101.15 0.02 OUTLIER 'General case' 0 N--CA 1.517 2.888 0 O-C-N 121.528 -0.984 . . . . 0.0 110.472 -179.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 55.14 70.93 0.58 Allowed 'General case' 0 N--CA 1.511 2.623 0 O-C-N 121.646 -0.659 . . . . 0.0 109.934 -178.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.0 m -65.77 -37.24 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.386 0 CA-C-O 121.312 0.577 . . . . 0.0 109.675 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 64.5 mt -60.66 -18.44 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.72 0 O-C-N 121.951 -0.468 . . . . 0.0 111.167 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.6 mp -90.95 -22.56 20.79 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.52 -0.737 . . . . 0.0 110.823 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 30.6 pttt -99.18 -36.83 9.53 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.577 -0.702 . . . . 0.0 109.716 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 17.2 mmmt 48.92 54.77 10.28 Favored 'General case' 0 N--CA 1.51 2.563 0 CA-C-O 121.507 0.67 . . . . 0.0 111.562 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.61 172.14 0.05 OUTLIER 'General case' 0 N--CA 1.514 2.741 0 O-C-N 121.836 -0.54 . . . . 0.0 111.067 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.6 m -61.22 -19.19 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.605 0 O-C-N 121.982 -0.449 . . . . 0.0 111.954 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 26.6 ptt-85 -121.78 47.46 1.88 Allowed 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.757 -0.59 . . . . 0.0 112.356 -178.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -145.04 108.52 4.63 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 121.521 -0.737 . . . . 0.0 110.094 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 71.3 mt -129.12 102.01 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.8 t -73.84 128.1 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.8 mt -82.56 165.43 20.11 Favored 'General case' 0 N--CA 1.508 2.445 0 CA-C-O 121.299 0.571 . . . . 0.0 111.828 -178.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 93.7 p -59.94 -20.84 59.71 Favored 'General case' 0 N--CA 1.51 2.534 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.39 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 36.2 p-10 -92.38 21.2 5.45 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.699 -0.626 . . . . 0.0 111.343 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.5 m120 65.18 33.53 9.27 Favored 'General case' 0 N--CA 1.514 2.727 0 O-C-N 121.756 -0.59 . . . . 0.0 112.496 178.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.411 ' CE2' ' HA ' ' A' ' 22' ' ' VAL . 3.9 m-85 -102.15 164.77 11.52 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 177.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 15.5 tp -120.61 97.07 5.39 Favored 'General case' 0 N--CA 1.517 2.887 0 C-N-CA 119.327 -0.949 . . . . 0.0 111.651 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.83 95.97 3.59 Favored 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.799 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 93.1 mt -86.95 117.0 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -78.3 111.72 14.56 Favored 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 121.393 0.616 . . . . 0.0 111.663 -178.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 100.13 -35.65 4.64 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.457 HG23 ' O ' ' A' ' 17' ' ' GLU . 1.6 tp 40.96 69.65 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.842 0 CA-C-O 122.201 1.0 . . . . 0.0 112.657 -179.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -57.75 157.75 7.03 Favored 'General case' 0 N--CA 1.513 2.684 0 O-C-N 121.638 -0.663 . . . . 0.0 112.417 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 35.7 tttm -61.47 -22.53 65.15 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 122.218 -0.301 . . . . 0.0 110.876 178.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.7 p -83.36 -19.96 35.16 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.772 -0.58 . . . . 0.0 110.74 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.76 7.7 35.53 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.61 -0.681 . . . . 0.0 111.678 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -96.79 141.12 30.38 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.35 -0.844 . . . . 0.0 109.365 179.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 169.98 -105.72 0.23 Allowed Glycine 0 N--CA 1.498 2.831 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.2 m -144.12 103.65 4.03 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 122.031 -0.688 . . . . 0.0 111.206 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -84.57 134.43 34.4 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.7 tpp85 -91.64 119.54 31.62 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.743 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 85' ' ' PHE . 1.8 m -87.83 90.26 8.31 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -91.57 88.64 6.84 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.276 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.55 91.31 0.56 Allowed Glycine 0 N--CA 1.499 2.873 0 N-CA-C 107.531 -2.227 . . . . 0.0 107.531 178.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.1 ttm180 -98.05 125.24 42.94 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.923 0.868 . . . . 0.0 113.043 -177.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.408 HG13 ' HB2' ' A' ' 31' ' ' PRO . 5.1 mp -142.03 90.16 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-N 114.506 -1.224 . . . . 0.0 107.899 178.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.8 mt -97.38 20.42 11.64 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.671 178.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -110.71 -22.53 11.54 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.777 -0.577 . . . . 0.0 110.601 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -127.05 -62.39 1.11 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.781 -0.574 . . . . 0.0 110.649 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.24 -81.35 1.59 Allowed Glycine 0 N--CA 1.49 2.29 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.864 -178.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 179.72 -161.99 0.04 OUTLIER 'General case' 0 N--CA 1.516 2.832 0 O-C-N 122.09 -0.653 . . . . 0.0 110.408 -177.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.5 pp -99.98 116.59 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.321 0 O-C-N 121.776 -0.577 . . . . 0.0 110.333 178.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -117.53 159.68 22.46 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.65 -0.656 . . . . 0.0 109.663 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.429 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 25.5 p90 -157.06 175.78 13.63 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.658 -0.817 . . . . 0.0 112.583 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 20.0 tttt -165.25 169.61 15.73 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -116.75 134.4 54.85 Favored 'General case' 0 N--CA 1.51 2.557 0 O-C-N 121.829 -0.544 . . . . 0.0 110.654 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 47.9 mm -117.47 109.24 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -77.09 100.41 5.7 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.6 t -96.27 136.99 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.915 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 65.9 mt -125.51 159.1 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.5 2.056 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.539 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 28.6 p90 . . . . . 0 N--CA 1.499 2.021 0 N-CA-C 110.372 -0.233 . . . . 0.0 110.372 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 26.2 t -141.51 106.55 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.427 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.493 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 7.9 mmm -121.17 117.31 26.79 Favored 'General case' 0 N--CA 1.511 2.575 0 O-C-N 121.879 -0.513 . . . . 0.0 110.551 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -74.33 114.41 12.67 Favored 'General case' 0 N--CA 1.507 2.415 0 CA-C-O 120.98 0.419 . . . . 0.0 111.099 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.21 162.32 26.45 Favored 'General case' 0 N--CA 1.503 2.22 0 CA-C-O 121.758 0.79 . . . . 0.0 111.594 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 32.02 80.56 0.02 OUTLIER 'General case' 0 N--CA 1.52 3.057 0 C-N-CA 124.177 0.991 . . . . 0.0 113.274 179.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -138.41 79.97 28.8 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.954 -0.466 . . . . 0.0 110.727 -179.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -65.44 96.89 0.3 Allowed 'Trans proline' 0 N--CA 1.491 1.336 0 N-CA-C 108.503 -1.383 . . . . 0.0 108.503 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.438 ' CB ' ' HD3' ' A' ' 10' ' ' PRO . 0.6 OUTLIER -51.25 -72.29 0.17 Allowed Pre-proline 0 N--CA 1.506 2.331 0 CA-C-O 116.437 -1.744 . . . . 0.0 112.485 -177.172 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.438 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.5 Cg_endo -71.48 97.1 0.76 Allowed 'Trans proline' 0 N--CA 1.498 1.755 0 CA-C-N 121.921 1.722 . . . . 0.0 111.719 178.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -101.59 178.11 4.73 Favored 'General case' 0 N--CA 1.507 2.41 0 O-C-N 120.974 -1.079 . . . . 0.0 110.055 178.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -156.23 127.5 7.07 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.833 -0.542 . . . . 0.0 111.568 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -127.84 -169.2 2.01 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.847 -0.533 . . . . 0.0 109.802 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -115.49 145.42 42.62 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.838 0.827 . . . . 0.0 111.841 -178.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -61.82 121.24 12.39 Favored 'General case' 0 N--CA 1.508 2.442 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.45 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.74 22.83 48.66 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -112.98 159.84 18.71 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 118.478 1.139 . . . . 0.0 111.186 -179.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.36 97.65 8.44 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 177.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -103.4 164.2 11.79 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.528 0.68 . . . . 0.0 112.498 -177.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 95.3 t -139.31 141.82 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 178.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 55.3 mt -97.42 115.29 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 178.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.406 ' HA ' ' CE2' ' A' ' 57' ' ' TYR . 46.8 t -76.32 120.86 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 121.505 0.669 . . . . 0.0 111.055 -176.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.7 t -161.68 94.85 0.97 Allowed 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.88 141.44 28.42 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 120.121 -0.632 . . . . 0.0 109.684 -178.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 32.9 t -149.52 123.46 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.493 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 21.6 t -81.7 80.42 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.6 m -87.61 154.09 20.88 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.2 t -44.09 -83.11 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.216 0 O-C-N 121.956 -0.465 . . . . 0.0 111.953 -178.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -168.96 -61.29 0.01 OUTLIER Pre-proline 0 N--CA 1.51 2.566 0 CA-C-O 117.731 -1.128 . . . . 0.0 111.785 178.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.74 -54.13 2.21 Favored 'Trans proline' 0 CA--C 1.561 1.86 0 CA-C-N 120.028 1.046 . . . . 0.0 112.519 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -63.66 -166.83 0.07 OUTLIER 'Trans proline' 0 N--CA 1.498 1.765 0 CA-C-N 119.539 0.871 . . . . 0.0 111.678 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -170.97 -166.62 0.49 Allowed 'General case' 0 N--CA 1.523 3.188 0 O-C-N 121.813 -0.554 . . . . 0.0 110.36 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 18.7 tt -104.1 136.73 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.9 mp -101.17 124.37 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.405 ' CE2' ' HB2' ' A' ' 58' ' ' LEU . 75.1 m95 -84.64 109.69 18.18 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.2 tttt -108.81 -174.84 2.61 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 121.48 0.657 . . . . 0.0 111.625 -178.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 27.8 t-80 66.36 153.04 0.07 Allowed 'General case' 0 N--CA 1.511 2.584 0 CA-C-O 121.023 0.44 . . . . 0.0 110.111 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 19.9 tptt 57.97 50.7 9.87 Favored 'General case' 0 N--CA 1.513 2.723 0 O-C-N 121.838 -0.539 . . . . 0.0 110.727 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 131.5 -0.85 5.17 Favored Glycine 0 N--CA 1.498 2.774 0 C-N-CA 120.545 -0.836 . . . . 0.0 111.582 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 54.77 89.81 0.03 OUTLIER 'General case' 0 N--CA 1.513 2.715 0 CA-C-N 119.184 1.492 . . . . 0.0 110.768 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.5 t0 55.66 97.96 0.02 OUTLIER 'General case' 0 N--CA 1.516 2.827 0 O-C-N 121.713 -0.617 . . . . 0.0 110.587 -179.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.3 m -67.95 -24.55 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.438 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.823 -179.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.7 mm -59.26 -17.95 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.819 0 O-C-N 121.577 -0.702 . . . . 0.0 111.572 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.0 mp -91.38 -22.84 20.28 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.457 -0.777 . . . . 0.0 110.978 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -98.66 -40.44 8.19 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.764 -0.585 . . . . 0.0 109.478 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm 47.26 56.02 7.42 Favored 'General case' 0 N--CA 1.509 2.517 0 CA-C-O 121.473 0.654 . . . . 0.0 112.04 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.58 155.19 1.64 Allowed 'General case' 0 N--CA 1.515 2.796 0 O-C-N 121.649 -0.657 . . . . 0.0 111.013 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.7 m -54.32 -24.36 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.816 0 O-C-N 121.907 -0.496 . . . . 0.0 112.125 -178.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.95 -3.67 31.81 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -95.79 109.41 21.73 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.388 -0.82 . . . . 0.0 110.18 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 71.8 mt -129.44 104.27 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.2 t -73.76 128.59 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 39.5 mt -82.11 166.3 19.83 Favored 'General case' 0 N--CA 1.508 2.466 0 CA-C-O 121.308 0.575 . . . . 0.0 111.806 -178.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.4 p -61.19 -21.55 63.91 Favored 'General case' 0 N--CA 1.51 2.532 0 O-C-N 122.106 -0.371 . . . . 0.0 111.211 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -90.87 19.12 5.81 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.577 -0.702 . . . . 0.0 111.338 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.1 m120 67.42 33.21 5.36 Favored 'General case' 0 N--CA 1.516 2.862 0 O-C-N 121.57 -0.706 . . . . 0.0 112.524 178.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.406 ' CE2' ' HA ' ' A' ' 22' ' ' VAL . 3.9 m-85 -103.3 166.77 10.23 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 177.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.405 ' HB2' ' CE2' ' A' ' 35' ' ' TRP . 16.8 tp -120.69 98.24 5.93 Favored 'General case' 0 N--CA 1.519 2.995 0 C-N-CA 119.356 -0.938 . . . . 0.0 111.919 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.45 101.62 7.4 Favored 'General case' 0 N--CA 1.504 2.263 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.364 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.438 HD11 HG22 ' A' ' 60' ' ' ILE . 96.8 mt -93.82 103.4 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 177.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 19.3 tpp85 -70.3 116.6 10.84 Favored 'General case' 0 N--CA 1.504 2.233 0 CA-C-O 121.317 0.58 . . . . 0.0 110.865 -178.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.64 -35.1 4.83 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.8 tp 35.27 94.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.519 2.999 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 59.0 mmtt -73.4 148.71 43.09 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.613 -0.68 . . . . 0.0 110.656 -178.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -62.58 -18.89 63.04 Favored 'General case' 0 N--CA 1.51 2.559 0 O-C-N 122.072 -0.393 . . . . 0.0 110.978 178.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.8 t -87.83 -13.5 41.98 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.686 -0.634 . . . . 0.0 111.376 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -91.67 14.36 15.39 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.53 -0.731 . . . . 0.0 111.491 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.78 150.3 20.55 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.433 -0.792 . . . . 0.0 109.792 179.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 166.06 -101.25 0.18 Allowed Glycine 0 N--CA 1.499 2.887 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.6 m -149.02 101.13 3.13 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.953 -0.734 . . . . 0.0 111.239 179.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -81.47 133.56 35.42 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 177.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.8 ttm105 -97.29 120.3 37.4 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.11 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 85' ' ' PHE . 9.3 m -83.46 113.33 20.7 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 177.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -111.5 85.63 2.17 Favored 'General case' 0 N--CA 1.504 2.272 0 CA-C-N 118.537 0.608 . . . . 0.0 109.609 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.68 96.67 0.31 Allowed Glycine 0 N--CA 1.502 3.057 0 N-CA-C 108.475 -1.85 . . . . 0.0 108.475 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.1 ttp85 -102.4 117.83 35.57 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 122.059 -0.671 . . . . 0.0 112.212 -177.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 5.3 mp -141.3 90.77 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.539 179.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 21.8 mt -99.87 26.75 6.01 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.286 178.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -111.61 -34.29 6.11 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.875 -0.515 . . . . 0.0 110.003 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -118.06 -62.56 1.53 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 122.036 -0.415 . . . . 0.0 110.811 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.414 ' O ' ' HB3' ' A' ' 82' ' ' GLU . . . -98.54 -82.78 1.68 Allowed Glycine 0 N--CA 1.489 2.183 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.956 -178.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.414 ' HB3' ' O ' ' A' ' 81' ' ' GLY . 9.9 pt-20 176.53 -155.29 0.02 OUTLIER 'General case' 0 N--CA 1.517 2.89 0 O-C-N 122.182 -0.599 . . . . 0.0 109.719 -177.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 8.4 pt -104.13 153.84 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 121.436 -0.79 . . . . 0.0 110.868 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -155.24 162.13 40.99 Favored 'General case' 0 N--CA 1.505 2.29 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.411 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 39.1 p90 -166.73 175.8 7.61 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 121.352 -0.843 . . . . 0.0 113.158 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.2 ptpt -167.78 161.27 13.14 Favored 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -98.06 122.93 41.79 Favored 'General case' 0 N--CA 1.512 2.635 0 O-C-N 121.736 -0.602 . . . . 0.0 112.107 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.3 mp -106.72 122.55 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -87.25 134.82 33.5 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.2 t -127.52 129.08 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 O-C-N 121.673 -0.642 . . . . 0.0 110.22 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 74.6 mt -116.26 139.63 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.6 t . . . . . 0 N--CA 1.503 2.18 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.364 -179.23 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 41.0 p90 . . . . . 0 N--CA 1.497 1.896 0 CA-C-O 120.624 0.249 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 36.6 t -143.07 108.97 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.477 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 7.1 mmt -122.73 115.92 22.88 Favored 'General case' 0 N--CA 1.51 2.565 0 O-C-N 121.783 -0.573 . . . . 0.0 110.482 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -74.38 113.1 11.22 Favored 'General case' 0 N--CA 1.506 2.374 0 O-C-N 122.005 -0.434 . . . . 0.0 110.538 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.0 ptpt -127.16 163.7 23.26 Favored 'General case' 0 N--CA 1.503 2.215 0 CA-C-O 121.712 0.768 . . . . 0.0 111.753 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 31.88 72.68 0.07 Allowed 'General case' 0 N--CA 1.52 3.048 0 C-N-CA 124.188 0.995 . . . . 0.0 113.342 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -136.81 81.01 35.31 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.802 -0.561 . . . . 0.0 110.721 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -65.58 102.09 0.48 Allowed 'Trans proline' 0 N--CA 1.49 1.294 0 N-CA-C 108.62 -1.339 . . . . 0.0 108.62 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.451 ' CB ' ' HD3' ' A' ' 10' ' ' PRO . 0.2 OUTLIER -55.86 -66.62 1.0 Allowed Pre-proline 0 N--CA 1.503 2.213 0 CA-C-O 116.93 -1.509 . . . . 0.0 112.216 -177.314 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.451 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.5 Cg_endo -74.18 91.4 0.94 Allowed 'Trans proline' 0 CA--C 1.556 1.609 0 CA-C-N 121.258 1.485 . . . . 0.0 111.148 178.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -100.0 176.49 5.4 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 120.871 -1.143 . . . . 0.0 110.006 178.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -160.62 122.76 3.17 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.741 -0.599 . . . . 0.0 111.374 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -119.26 -170.64 1.96 Allowed 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.963 -0.461 . . . . 0.0 110.205 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 15.8 tptm -104.71 138.8 40.46 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.567 0.699 . . . . 0.0 111.413 -178.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -59.19 118.61 6.1 Favored 'General case' 0 N--CA 1.509 2.522 0 O-C-N 121.933 -0.479 . . . . 0.0 110.88 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.33 23.47 40.24 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.425 ' O ' HG23 ' A' ' 63' ' ' ILE . 13.0 tt0 -114.98 164.6 13.92 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 118.411 1.105 . . . . 0.0 110.531 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -82.85 98.46 9.17 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 178.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.17 168.27 9.92 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 120.365 -0.534 . . . . 0.0 112.053 -177.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 99.6 t -142.75 141.09 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 43.5 mt -97.02 111.96 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 178.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.8 t -75.17 119.93 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 CA-C-O 121.47 0.652 . . . . 0.0 110.493 -176.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -160.83 92.68 0.95 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.16 140.75 29.52 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.529 -179.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.5 t -147.53 121.67 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.477 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 16.0 t -81.2 80.68 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.4 m -87.83 154.75 20.3 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.6 t -43.66 -84.0 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.18 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -166.32 -62.21 0.01 OUTLIER Pre-proline 0 N--CA 1.509 2.475 0 CA-C-O 117.675 -1.155 . . . . 0.0 111.584 178.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.2 -53.81 2.72 Favored 'Trans proline' 0 CA--C 1.561 1.844 0 CA-C-N 120.086 1.066 . . . . 0.0 112.552 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -63.02 -168.53 0.08 OUTLIER 'Trans proline' 0 N--CA 1.496 1.668 0 CA-C-N 119.425 0.83 . . . . 0.0 111.746 -179.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -171.58 -164.77 0.34 Allowed 'General case' 0 N--CA 1.52 3.067 0 O-C-N 121.92 -0.488 . . . . 0.0 109.78 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.1 tt -102.53 147.31 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.925 -0.484 . . . . 0.0 110.056 179.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.2 mp -114.5 121.07 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.404 ' CE2' ' HB2' ' A' ' 58' ' ' LEU . 83.6 m95 -82.77 104.4 12.99 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -118.04 -165.7 1.13 Allowed 'General case' 0 N--CA 1.506 2.359 0 CA-C-O 121.322 0.582 . . . . 0.0 111.494 -177.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 56.32 58.83 3.99 Favored 'General case' 0 N--CA 1.511 2.58 0 CA-C-O 121.598 0.713 . . . . 0.0 111.461 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.12 -48.06 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.733 -0.604 . . . . 0.0 109.403 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -158.58 44.62 0.47 Allowed Glycine 0 N--CA 1.494 2.538 0 N-CA-C 108.522 -1.831 . . . . 0.0 108.522 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? 55.88 75.81 0.31 Allowed 'General case' 0 N--CA 1.511 2.587 0 O-C-N 121.903 -0.763 . . . . 0.0 110.725 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.0 t0 57.59 105.53 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.815 0 O-C-N 121.678 -0.639 . . . . 0.0 111.007 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.4 m -68.1 -28.53 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.562 0 O-C-N 121.876 -0.515 . . . . 0.0 110.421 -179.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.403 HD11 HG22 ' A' ' 43' ' ' ILE . 48.7 mm -58.42 -18.11 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.688 0 O-C-N 121.71 -0.618 . . . . 0.0 111.864 -179.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.3 mp -92.47 -22.18 19.74 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.492 -0.755 . . . . 0.0 111.106 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.1 pttt -97.88 -41.04 8.21 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.8 mmmt 46.91 56.91 6.14 Favored 'General case' 0 N--CA 1.509 2.505 0 CA-C-O 121.166 0.507 . . . . 0.0 112.308 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -49.69 161.17 0.24 Allowed 'General case' 0 N--CA 1.519 2.987 0 O-C-N 121.804 -0.56 . . . . 0.0 111.081 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 36.0 m -56.83 -21.92 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.779 0 O-C-N 121.911 -0.493 . . . . 0.0 112.172 -178.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 24.1 ptt-85 -104.22 -2.44 25.7 Favored 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -96.24 108.28 20.74 Favored 'General case' 0 N--CA 1.503 2.18 0 CA-C-N 119.145 0.884 . . . . 0.0 110.166 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 75.6 mt -129.36 104.84 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.8 t -74.78 127.89 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 42.7 mt -80.63 165.54 21.94 Favored 'General case' 0 N--CA 1.509 2.477 0 CA-C-O 121.34 0.591 . . . . 0.0 111.905 -178.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 89.9 p -60.19 -20.92 60.83 Favored 'General case' 0 N--CA 1.51 2.547 0 O-C-N 122.07 -0.394 . . . . 0.0 111.484 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 42.8 p-10 -91.74 19.83 6.11 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.658 -0.652 . . . . 0.0 111.392 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.3 m120 67.24 32.13 6.2 Favored 'General case' 0 N--CA 1.516 2.846 0 O-C-N 121.594 -0.691 . . . . 0.0 112.39 178.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -102.06 167.64 9.9 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.404 ' HB2' ' CE2' ' A' ' 35' ' ' TRP . 15.2 tp -121.99 98.8 6.11 Favored 'General case' 0 N--CA 1.519 2.978 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.954 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.72 101.15 7.39 Favored 'General case' 0 N--CA 1.503 2.202 0 C-N-CA 120.479 -0.489 . . . . 0.0 111.12 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.442 HG22 HD11 ' A' ' 60' ' ' ILE . 97.2 mt -94.68 104.31 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 177.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.85 115.65 8.42 Favored 'General case' 0 N--CA 1.505 2.301 0 CA-C-O 121.187 0.517 . . . . 0.0 110.721 -178.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 100.31 -39.26 2.8 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.425 HG23 ' O ' ' A' ' 17' ' ' GLU . 3.0 tp 42.52 83.58 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.517 2.901 0 CA-C-O 122.225 1.012 . . . . 0.0 112.117 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -72.11 158.42 35.97 Favored 'General case' 0 N--CA 1.508 2.454 0 O-C-N 121.751 -0.593 . . . . 0.0 111.984 -178.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt -61.27 -24.55 66.47 Favored 'General case' 0 N--CA 1.51 2.558 0 O-C-N 121.941 -0.474 . . . . 0.0 110.918 178.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.9 t -79.32 -15.0 58.63 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.893 -0.505 . . . . 0.0 111.691 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -87.37 -27.77 22.6 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.502 -0.749 . . . . 0.0 110.718 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -62.0 140.56 58.34 Favored 'General case' 0 N--CA 1.507 2.406 0 O-C-N 121.691 -0.631 . . . . 0.0 110.752 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 167.09 -104.88 0.23 Allowed Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.7 m -146.72 102.28 3.54 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 122.03 -0.688 . . . . 0.0 110.543 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -83.52 134.65 34.83 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 -94.0 115.65 28.01 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.85 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 85' ' ' PHE . 1.9 m -85.68 90.58 8.05 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -92.08 88.65 6.62 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.317 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.85 90.24 0.57 Allowed Glycine 0 N--CA 1.499 2.855 0 N-CA-C 107.44 -2.264 . . . . 0.0 107.44 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 30.1 ttm-85 -96.49 125.63 41.11 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.805 0.812 . . . . 0.0 112.823 -177.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 5.2 mp -142.05 91.01 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.183 178.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 14.1 mt -99.09 24.12 8.23 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.591 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -111.15 -28.87 8.09 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.866 -0.521 . . . . 0.0 110.592 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 11.1 mmt85 -123.2 -61.53 1.41 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.909 -0.494 . . . . 0.0 110.733 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -98.54 -81.85 1.62 Allowed Glycine 0 N--CA 1.489 2.203 0 C-N-CA 120.995 -0.621 . . . . 0.0 111.708 -178.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 178.14 -164.04 0.04 OUTLIER 'General case' 0 N--CA 1.518 2.967 0 O-C-N 122.059 -0.671 . . . . 0.0 110.57 -178.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.5 pp -96.03 129.25 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.449 0 O-C-N 121.784 -0.572 . . . . 0.0 110.392 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -130.29 159.44 36.93 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 121.702 -0.624 . . . . 0.0 109.617 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.44 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 29.7 p90 -159.02 171.5 19.9 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 119.505 -0.878 . . . . 0.0 113.09 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 10.8 mttp -160.55 159.25 30.42 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -106.02 120.08 40.84 Favored 'General case' 0 N--CA 1.513 2.697 0 O-C-N 121.84 -0.538 . . . . 0.0 110.769 179.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.8 mp -104.74 121.6 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -85.32 115.61 23.17 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.5 t -110.33 131.93 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.171 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 67.0 mt -120.38 157.57 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.503 2.196 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.382 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.0 t . . . . . 0 N--CA 1.502 2.146 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.524 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 7.6 mmt -114.33 116.84 29.61 Favored 'General case' 0 N--CA 1.507 2.386 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.137 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -75.37 115.16 14.72 Favored 'General case' 0 N--CA 1.504 2.248 0 CA-C-O 120.9 0.381 . . . . 0.0 110.479 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.5 ptpt -127.22 163.71 23.28 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.649 0.738 . . . . 0.0 111.529 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 32.36 76.97 0.04 OUTLIER 'General case' 0 N--CA 1.517 2.901 0 C-N-CA 124.266 1.026 . . . . 0.0 113.49 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -145.03 78.45 12.48 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.812 -0.555 . . . . 0.0 110.916 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -64.37 104.39 0.51 Allowed 'Trans proline' 0 N--CA 1.492 1.412 0 N-CA-C 108.532 -1.372 . . . . 0.0 108.532 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.61 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.5 OUTLIER -50.92 -69.69 0.28 Allowed Pre-proline 0 N--CA 1.509 2.5 0 CA-C-O 116.625 -1.655 . . . . 0.0 112.802 -176.968 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.487 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.6 Cg_endo -72.62 96.72 0.84 Allowed 'Trans proline' 0 N--CA 1.498 1.741 0 CA-C-N 121.69 1.639 . . . . 0.0 111.518 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.441 HE21 HG13 ' A' ' 90' ' ' VAL . 16.1 pt20 -101.3 177.5 4.91 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 120.951 -1.093 . . . . 0.0 110.319 178.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -158.57 125.16 4.72 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.897 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -123.17 -170.65 2.15 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.953 -0.467 . . . . 0.0 109.876 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -104.67 143.86 32.51 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.617 0.722 . . . . 0.0 111.519 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -60.27 125.0 22.0 Favored 'General case' 0 N--CA 1.508 2.431 0 O-C-N 121.965 -0.459 . . . . 0.0 111.049 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.29 22.24 68.32 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 110.889 -0.885 . . . . 0.0 110.889 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -110.21 164.44 12.65 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 118.714 1.257 . . . . 0.0 110.61 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.43 98.62 8.98 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 177.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.78 165.82 11.4 Favored 'General case' 0 N--CA 1.497 1.925 0 C-N-CA 120.121 -0.631 . . . . 0.0 111.991 -177.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.671 HG22 ' HG2' ' A' ' 59' ' ' GLN . 85.1 t -138.94 139.68 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.737 HD12 HD23 ' A' ' 58' ' ' LEU . 40.9 mt -95.47 115.62 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 178.157 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.495 HG13 ' CE2' ' A' ' 57' ' ' TYR . 47.4 t -76.9 118.19 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-O 121.544 0.687 . . . . 0.0 110.507 -177.129 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.1 t -160.08 87.11 0.78 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.03 142.11 28.17 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 119.946 -0.702 . . . . 0.0 109.269 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.666 HG21 HD12 ' A' ' 33' ' ' ILE . 39.3 t -147.7 129.28 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.524 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 60.1 t -92.71 78.28 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.2 m -79.45 164.62 23.82 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.9 t -42.13 -80.52 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.224 0 CA-C-N 118.283 0.492 . . . . 0.0 111.607 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.416 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 0.4 OUTLIER -170.69 -63.43 0.0 OUTLIER Pre-proline 0 N--CA 1.515 2.786 0 CA-C-O 117.658 -1.163 . . . . 0.0 111.467 177.5 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.416 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 2.9 Cg_endo -60.84 -53.29 2.77 Favored 'Trans proline' 0 CA--C 1.563 1.97 0 CA-C-N 120.1 1.071 . . . . 0.0 112.805 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.71 -162.94 0.03 OUTLIER 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 120.516 0.811 . . . . 0.0 112.666 -178.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -170.16 -165.67 0.49 Allowed 'General case' 0 N--CA 1.518 2.936 0 O-C-N 121.849 -0.532 . . . . 0.0 110.403 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.677 HD11 ' HB3' ' A' ' 73' ' ' CYS . 17.5 tt -100.82 162.79 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.1 mt -125.23 126.77 71.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.567 ' HB2' HG22 ' A' ' 42' ' ' VAL . 78.5 m95 -90.44 110.65 21.75 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.0 tttt . . . . . 0 N--CA 1.502 2.131 0 O-C-N 121.941 -0.475 . . . . 0.0 110.594 -179.001 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.567 HG22 ' HB2' ' A' ' 35' ' ' TRP . 4.4 m . . . . . 0 N--CA 1.506 2.364 0 CA-C-O 120.993 0.425 . . . . 0.0 110.052 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.652 HD11 HG21 ' A' ' 52' ' ' VAL . 47.8 mm -58.27 -18.75 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.825 0 O-C-N 121.807 -0.558 . . . . 0.0 111.87 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.435 ' N ' HD12 ' A' ' 44' ' ' LEU . 10.3 mp -93.2 -20.71 20.19 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.47 -0.769 . . . . 0.0 111.531 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 42.2 pttt -98.97 -37.89 9.21 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.531 -0.731 . . . . 0.0 109.802 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt 48.61 55.19 9.41 Favored 'General case' 0 N--CA 1.509 2.513 0 CA-C-O 121.581 0.705 . . . . 0.0 111.766 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -53.11 171.3 0.07 Allowed 'General case' 0 N--CA 1.513 2.682 0 O-C-N 121.755 -0.591 . . . . 0.0 110.876 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.6 t -66.9 -19.41 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.467 0 O-C-N 122.007 -0.433 . . . . 0.0 110.996 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 10.0 ptt-85 -115.64 45.7 1.64 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.504 -0.747 . . . . 0.0 112.1 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -145.28 105.33 4.04 Favored 'General case' 0 N--CA 1.506 2.346 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 177.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 45.2 mt -126.0 102.45 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.652 HG21 HD11 ' A' ' 43' ' ' ILE . 3.5 t -73.37 129.04 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.55 HD11 ' CG ' ' A' ' 59' ' ' GLN . 29.8 mt -82.71 167.6 18.05 Favored 'General case' 0 N--CA 1.509 2.498 0 CA-C-O 121.358 0.599 . . . . 0.0 112.143 -178.143 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.4 p -61.63 -22.02 64.89 Favored 'General case' 0 N--CA 1.509 2.496 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.985 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 52.4 p30 -91.49 18.85 6.76 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.749 -0.595 . . . . 0.0 111.337 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.8 m120 66.88 34.44 5.4 Favored 'General case' 0 N--CA 1.517 2.921 0 O-C-N 121.534 -0.728 . . . . 0.0 112.832 178.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.495 ' CE2' HG13 ' A' ' 22' ' ' VAL . 3.7 m-85 -103.06 166.03 10.67 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 177.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.737 HD23 HD12 ' A' ' 21' ' ' ILE . 15.2 tp -119.51 97.19 5.53 Favored 'General case' 0 N--CA 1.519 2.993 0 C-N-CA 119.371 -0.932 . . . . 0.0 111.505 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.671 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -76.67 95.39 3.97 Favored 'General case' 0 N--CA 1.502 2.166 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.857 179.609 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.584 HD11 HD11 ' A' ' 21' ' ' ILE . 99.4 mt -87.04 119.74 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 177.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 32.9 tpt85 -80.3 117.39 21.03 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-O 121.324 0.583 . . . . 0.0 110.638 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.26 -39.59 2.75 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.628 HG23 HG21 ' A' ' 92' ' ' VAL . 2.8 tp 42.3 73.59 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.776 0 CA-C-O 122.16 0.981 . . . . 0.0 112.581 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.406 ' HB3' HG22 ' A' ' 66' ' ' THR . 37.5 mmtt -59.8 150.61 27.71 Favored 'General case' 0 N--CA 1.51 2.573 0 O-C-N 121.377 -0.827 . . . . 0.0 111.661 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.619 ' HA ' HG13 ' A' ' 92' ' ' VAL . 20.7 ttmt -62.52 -17.59 60.11 Favored 'General case' 0 N--CA 1.506 2.374 0 O-C-N 122.087 -0.383 . . . . 0.0 111.213 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.406 HG22 ' HB3' ' A' ' 64' ' ' LYS . 8.8 t -89.32 -15.95 32.23 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.651 -0.656 . . . . 0.0 111.127 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -92.47 15.03 14.98 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.502 -0.748 . . . . 0.0 111.536 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.74 ' HB3' HG12 ' A' ' 92' ' ' VAL . 0.5 OUTLIER -96.73 160.98 14.07 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.422 -0.798 . . . . 0.0 109.283 179.294 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 154.99 -99.4 0.19 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.371 -1.491 . . . . 0.0 109.371 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.8 m -151.05 101.35 2.87 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 122.016 -0.696 . . . . 0.0 111.988 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -82.17 131.74 35.24 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.1 tpp85 -98.11 117.02 31.53 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 120.087 -0.645 . . . . 0.0 111.212 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.677 ' HB3' HD11 ' A' ' 33' ' ' ILE . 14.4 m -79.43 129.84 34.85 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 177.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -128.03 88.63 2.79 Favored 'General case' 0 N--CA 1.502 2.15 0 CA-C-N 118.581 0.628 . . . . 0.0 110.265 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.47 111.11 3.84 Favored Glycine 0 N--CA 1.504 3.178 0 N-CA-C 107.915 -2.074 . . . . 0.0 107.915 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.2 ttm180 . . . . . 0 N--CA 1.502 2.165 0 CA-C-O 121.959 0.885 . . . . 0.0 113.366 -177.109 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.651 HD21 ' N ' ' A' ' 84' ' ' ASN . 0.8 OUTLIER . . . . . 0 N--CA 1.501 2.122 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -167.76 176.19 6.49 Favored 'General case' 0 N--CA 1.508 2.475 0 O-C-N 121.455 -0.778 . . . . 0.0 112.692 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.547 ' CD ' HD11 ' A' ' 88' ' ' ILE . 3.3 ptpt -168.13 155.95 8.45 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.61 ' O ' HG22 ' A' ' 9' ' ' THR . 4.5 p30 -93.16 120.53 33.55 Favored 'General case' 0 N--CA 1.51 2.55 0 O-C-N 121.713 -0.617 . . . . 0.0 111.796 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.57 HD12 ' N ' ' A' ' 88' ' ' ILE . 3.6 mp -106.04 119.47 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.199 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -85.11 130.84 34.54 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.441 HG13 HE21 ' A' ' 11' ' ' GLN . 46.1 t -123.25 128.76 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 54.7 mt -121.07 142.29 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.74 HG12 ' HB3' ' A' ' 68' ' ' GLU . 6.7 p . . . . . 0 N--CA 1.5 2.056 0 CA-C-O 117.876 -1.059 . . . . 0.0 110.469 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.4 t . . . . . 0 N--CA 1.5 2.059 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.502 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 7.3 mmm -96.56 113.92 25.53 Favored 'General case' 0 N--CA 1.506 2.354 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.907 -178.219 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -72.13 115.06 10.91 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.421 ' HG2' HG23 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -125.22 158.01 35.11 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 121.323 0.582 . . . . 0.0 110.354 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.439 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.1 OUTLIER 38.88 70.92 0.18 Allowed 'General case' 0 N--CA 1.518 2.954 0 C-N-CA 123.374 0.67 . . . . 0.0 112.151 -179.654 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.03 72.01 72.69 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.748 -0.595 . . . . 0.0 111.258 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -65.09 102.07 0.43 Allowed 'Trans proline' 0 N--CA 1.49 1.323 0 N-CA-C 108.886 -1.236 . . . . 0.0 108.886 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.576 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.4 OUTLIER -54.28 -68.3 0.51 Allowed Pre-proline 0 N--CA 1.508 2.461 0 CA-C-O 116.782 -1.58 . . . . 0.0 112.25 -177.636 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.491 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.4 Cg_endo -72.43 90.5 0.79 Allowed 'Trans proline' 0 N--CA 1.496 1.676 0 CA-C-N 121.52 1.579 . . . . 0.0 111.353 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -100.85 173.93 6.27 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 120.785 -1.197 . . . . 0.0 110.352 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -157.16 122.88 4.71 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.803 -0.561 . . . . 0.0 111.003 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -117.16 -170.09 1.78 Allowed 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.963 -0.46 . . . . 0.0 110.552 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -103.31 140.45 37.4 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.862 0.839 . . . . 0.0 111.907 -178.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -60.79 126.96 29.32 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.822 -0.548 . . . . 0.0 111.017 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.07 21.82 72.83 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -110.91 161.5 15.77 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 118.652 1.226 . . . . 0.0 111.018 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -79.79 95.8 6.11 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 177.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.66 169.68 9.86 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.851 -177.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.651 HG22 ' HG2' ' A' ' 59' ' ' GLN . 84.5 t -142.98 141.3 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.771 HD12 HD23 ' A' ' 58' ' ' LEU . 26.0 mt -96.36 114.4 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 178.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.63 HG13 ' CZ ' ' A' ' 57' ' ' TYR . 38.8 t -75.51 118.33 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 CA-C-O 121.477 0.656 . . . . 0.0 110.735 -176.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.9 t -163.61 80.49 0.44 Allowed 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.439 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.4 OUTLIER -80.06 146.21 32.06 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.149 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.488 HG21 HD12 ' A' ' 33' ' ' ILE . 60.4 t -148.88 133.84 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.502 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 60.6 t -94.88 88.49 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -88.29 140.2 29.72 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.0 t -97.97 30.57 3.0 Favored 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -177.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.632 HD23 ' HD2' ' A' ' 30' ' ' PRO . 0.2 OUTLIER -161.79 170.41 8.12 Favored Pre-proline 0 N--CA 1.513 2.693 0 O-C-N 120.896 -1.127 . . . . 0.0 111.12 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.632 ' HD2' HD23 ' A' ' 29' ' ' LEU . 4.0 Cg_exo -49.81 -47.93 21.32 Favored 'Trans proline' 0 N--CA 1.502 1.973 0 C-N-CA 121.639 1.559 . . . . 0.0 114.491 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 29' ' ' LEU . 4.5 Cg_exo -52.66 -170.02 0.01 OUTLIER 'Trans proline' 0 N--CA 1.506 2.235 0 CA-C-N 120.044 1.051 . . . . 0.0 112.896 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.549 HG22 ' ND2' ' A' ' 56' ' ' ASN . 0.2 OUTLIER -168.93 -156.21 0.16 Allowed 'General case' 0 N--CA 1.522 3.154 0 O-C-N 120.381 -1.45 . . . . 0.0 111.634 -176.915 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.563 HD11 ' HB3' ' A' ' 73' ' ' CYS . 19.5 tt -88.02 143.04 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 O-C-N 121.897 -0.502 . . . . 0.0 111.906 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.546 ' N ' HD12 ' A' ' 34' ' ' ILE . 3.6 mp -109.47 130.44 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 177.027 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.529 ' CG ' HD22 ' A' ' 58' ' ' LEU . 79.3 m95 -90.28 110.61 21.66 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.0 mttt . . . . . 0 N--CA 1.501 2.1 0 CA-C-O 121.394 0.616 . . . . 0.0 111.199 -178.76 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.527 HG22 ' HB2' ' A' ' 35' ' ' TRP . 5.6 m . . . . . 0 N--CA 1.507 2.394 0 CA-C-O 120.757 0.313 . . . . 0.0 110.646 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 79.6 mt -59.27 -17.33 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.87 0 O-C-N 121.754 -0.591 . . . . 0.0 111.803 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.495 ' N ' HD12 ' A' ' 44' ' ' LEU . 9.8 mp -89.47 -25.22 21.59 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.599 -0.688 . . . . 0.0 110.55 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.0 pttt -98.6 -38.87 8.97 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.756 -0.59 . . . . 0.0 109.655 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.5 mmmt 47.06 55.64 7.79 Favored 'General case' 0 N--CA 1.51 2.55 0 CA-C-O 121.399 0.618 . . . . 0.0 111.959 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.8 169.46 0.07 Allowed 'General case' 0 N--CA 1.515 2.778 0 O-C-N 121.792 -0.567 . . . . 0.0 111.116 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 31.4 m -63.54 -21.59 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.591 0 O-C-N 121.985 -0.447 . . . . 0.0 111.649 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 16.4 ptt-85 -113.67 48.5 1.06 Allowed 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.648 -0.658 . . . . 0.0 111.747 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.411 ' O ' HD13 ' A' ' 51' ' ' ILE . 7.6 m-85 -144.73 102.97 3.87 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.553 -0.717 . . . . 0.0 109.895 178.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.411 HD13 ' O ' ' A' ' 50' ' ' PHE . 48.0 mm -127.74 114.05 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.474 HG22 ' CD1' ' A' ' 58' ' ' LEU . 2.6 t -80.13 146.64 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 24.6 mt -102.71 162.99 12.48 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 121.244 0.545 . . . . 0.0 111.605 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 81.8 p -59.88 -20.58 57.96 Favored 'General case' 0 N--CA 1.51 2.552 0 O-C-N 122.098 -0.376 . . . . 0.0 111.689 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 38.5 p-10 -91.36 17.74 8.06 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.662 -0.649 . . . . 0.0 111.736 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.549 ' ND2' HG22 ' A' ' 32' ' ' THR . 8.1 m120 70.21 29.54 3.67 Favored 'General case' 0 N--CA 1.52 3.046 0 O-C-N 121.635 -0.666 . . . . 0.0 111.931 179.026 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.63 ' CZ ' HG13 ' A' ' 22' ' ' VAL . 4.3 m-85 -103.18 159.92 15.11 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.771 HD23 HD12 ' A' ' 21' ' ' ILE . 26.9 tp -120.85 100.81 7.3 Favored 'General case' 0 N--CA 1.514 2.743 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.814 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.651 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.7 OUTLIER -75.48 103.47 5.62 Favored 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 120.759 -0.377 . . . . 0.0 111.244 179.717 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.739 HD11 HD11 ' A' ' 21' ' ' ILE . 99.8 mt -95.53 114.09 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 177.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -74.59 115.55 14.28 Favored 'General case' 0 N--CA 1.503 2.175 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.229 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.401 ' O ' HG22 ' A' ' 63' ' ' ILE . . . 97.04 -39.02 2.89 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 178.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.5 ' CG1' HG21 ' A' ' 92' ' ' VAL . 1.9 tp 42.92 71.79 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.843 0 CA-C-O 122.256 1.027 . . . . 0.0 112.241 -178.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.1 mtpp -63.32 158.01 21.46 Favored 'General case' 0 N--CA 1.506 2.374 0 O-C-N 121.59 -0.694 . . . . 0.0 112.333 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -62.02 -23.63 66.56 Favored 'General case' 0 N--CA 1.508 2.441 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.933 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.7 p -83.78 -16.56 44.24 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.74 -0.6 . . . . 0.0 111.015 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.91 -19.47 25.77 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.704 -0.623 . . . . 0.0 111.042 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.497 ' HB3' HG12 ' A' ' 92' ' ' VAL . 7.6 pt-20 -67.6 150.1 49.23 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.445 -0.785 . . . . 0.0 109.916 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 166.31 -111.69 0.46 Allowed Glycine 0 N--CA 1.498 2.822 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.4 m -144.57 101.59 3.7 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.941 -0.74 . . . . 0.0 110.034 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -82.16 133.52 35.27 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -94.64 117.94 30.92 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 120.002 -0.679 . . . . 0.0 111.143 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.563 ' HB3' HD11 ' A' ' 33' ' ' ILE . 12.0 m -80.3 120.82 24.87 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 177.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.82 82.59 1.97 Allowed 'General case' 0 N--CA 1.509 2.512 0 CA-C-N 118.962 0.801 . . . . 0.0 110.556 -179.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.61 100.79 0.29 Allowed Glycine 0 N--CA 1.508 3.493 0 N-CA-C 108.779 -1.729 . . . . 0.0 108.779 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.4 ' O ' ' HB2' ' A' ' 31' ' ' PRO . 25.1 ttp85 . . . . . 0 N--CA 1.497 1.917 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -177.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.566 HD21 ' N ' ' A' ' 84' ' ' ASN . 0.9 OUTLIER . . . . . 0 N--CA 1.499 2.016 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.417 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 39.0 p90 -159.51 178.38 9.95 Favored 'General case' 0 N--CA 1.504 2.248 0 CA-C-N 119.773 1.17 . . . . 0.0 113.752 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -171.3 159.61 5.83 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.576 ' O ' HG22 ' A' ' 9' ' ' THR . 7.1 p-10 -102.39 118.15 36.25 Favored 'General case' 0 N--CA 1.512 2.656 0 O-C-N 121.795 -0.566 . . . . 0.0 110.773 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.552 HD12 ' N ' ' A' ' 88' ' ' ILE . 1.9 mp -101.99 119.73 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 179.2 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.06 112.83 21.63 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -179.122 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.9 t -106.74 133.26 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.13 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.9 mt -124.64 158.53 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.5 HG21 ' CG1' ' A' ' 63' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.499 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 42.2 t . . . . . 0 N--CA 1.505 2.281 0 N-CA-C 110.383 -0.229 . . . . 0.0 110.383 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.417 ' CG ' ' HB ' ' A' ' 26' ' ' VAL . 25.6 ptm -119.29 122.87 42.87 Favored 'General case' 0 N--CA 1.509 2.485 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 177.119 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -73.71 136.87 43.75 Favored 'General case' 0 N--CA 1.511 2.603 0 O-C-N 122.031 -0.418 . . . . 0.0 111.992 -176.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.606 ' HG2' HG23 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -136.47 158.15 45.11 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 121.424 0.631 . . . . 0.0 110.823 179.287 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.414 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.6 OUTLIER 32.93 84.1 0.02 OUTLIER 'General case' 0 N--CA 1.521 3.103 0 C-N-CA 123.998 0.919 . . . . 0.0 113.347 179.635 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -145.19 80.86 10.81 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.7 -0.625 . . . . 0.0 111.23 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -67.07 105.3 0.96 Allowed 'Trans proline' 0 N--CA 1.49 1.32 0 N-CA-C 108.693 -1.31 . . . . 0.0 108.693 178.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.563 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.4 OUTLIER -57.88 -67.25 0.95 Allowed Pre-proline 0 N--CA 1.507 2.415 0 CA-C-O 116.905 -1.521 . . . . 0.0 111.828 -177.967 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.486 ' HD3' ' OG1' ' A' ' 9' ' ' THR . 1.6 Cg_endo -71.46 92.02 0.68 Allowed 'Trans proline' 0 N--CA 1.493 1.445 0 CA-C-N 121.32 1.507 . . . . 0.0 111.604 178.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.52 HE21 HG13 ' A' ' 90' ' ' VAL . 14.7 pt20 -101.27 166.31 10.83 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.068 -1.02 . . . . 0.0 110.141 178.233 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -152.37 120.62 6.3 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 120.196 -0.601 . . . . 0.0 111.844 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -116.12 -172.03 2.1 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 122.028 -0.42 . . . . 0.0 110.056 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 62.2 tttt -101.2 140.77 35.04 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.477 0.656 . . . . 0.0 111.468 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -59.52 122.17 13.37 Favored 'General case' 0 N--CA 1.51 2.541 0 O-C-N 121.99 -0.443 . . . . 0.0 111.041 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.26 21.97 59.71 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.418 ' O ' HG22 ' A' ' 63' ' ' ILE . 14.3 tt0 -111.76 164.43 13.06 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 118.738 1.269 . . . . 0.0 110.628 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -82.81 99.85 9.95 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -101.62 171.06 7.78 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.772 -177.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.669 HG22 ' HG2' ' A' ' 59' ' ' GLN . 84.5 t -141.96 141.26 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 178.039 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.788 HD12 HD23 ' A' ' 58' ' ' LEU . 19.0 mt -95.18 112.35 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 178.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.504 HG13 ' CE2' ' A' ' 57' ' ' TYR . 43.6 t -74.1 121.49 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.546 -176.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.6 t -164.85 93.56 0.64 Allowed 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.414 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -90.95 142.53 27.67 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -179.569 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.888 HG21 HD12 ' A' ' 33' ' ' ILE . 44.9 t -144.41 138.2 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 C-N-CA 120.311 -0.556 . . . . 0.0 109.541 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.606 HG23 ' HG2' ' A' ' 5' ' ' LYS . 90.0 t -106.08 79.46 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.8 m -84.37 169.38 14.67 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.4 t -45.46 -76.31 0.02 OUTLIER 'General case' 0 N--CA 1.521 3.091 0 O-C-N 121.689 -0.632 . . . . 0.0 111.458 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.411 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 0.3 OUTLIER -173.04 -62.52 0.0 OUTLIER Pre-proline 0 N--CA 1.518 2.953 0 CA-C-O 117.832 -1.08 . . . . 0.0 111.987 177.608 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.411 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 2.9 Cg_endo -60.19 -53.31 3.13 Favored 'Trans proline' 0 CA--C 1.562 1.909 0 CA-C-N 119.939 1.014 . . . . 0.0 112.897 -179.077 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.428 ' C ' ' HG1' ' A' ' 32' ' ' THR . 2.8 Cg_endo -62.48 -163.63 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.745 0 CA-C-N 119.275 0.777 . . . . 0.0 112.676 -178.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.428 ' HG1' ' C ' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -170.25 -166.37 0.53 Allowed 'General case' 0 N--CA 1.519 3.001 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.203 -179.534 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.888 HD12 HG21 ' A' ' 25' ' ' VAL . 15.1 tt -97.61 161.11 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 122.065 -0.397 . . . . 0.0 110.056 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 90.4 mt -126.3 124.69 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.597 ' HB2' HG22 ' A' ' 42' ' ' VAL . 78.2 m95 -87.56 105.95 17.67 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 24.9 tttt . . . . . 0 N--CA 1.497 1.896 0 O-C-N 122.052 -0.405 . . . . 0.0 110.617 -178.654 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.597 HG22 ' HB2' ' A' ' 35' ' ' TRP . 9.6 m . . . . . 0 N--CA 1.506 2.325 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.694 HG12 HG21 ' A' ' 52' ' ' VAL . 50.6 mt -60.51 -18.62 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.68 0 O-C-N 121.877 -0.515 . . . . 0.0 111.173 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.496 ' N ' HD12 ' A' ' 44' ' ' LEU . 9.0 mp -91.73 -20.94 21.02 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.608 -0.682 . . . . 0.0 110.975 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.416 ' HG2' ' HA ' ' A' ' 42' ' ' VAL . 51.5 pttt -98.88 -38.14 9.14 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt 48.35 56.69 7.1 Favored 'General case' 0 N--CA 1.508 2.463 0 CA-C-O 121.508 0.671 . . . . 0.0 111.649 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -50.57 173.71 0.02 OUTLIER 'General case' 0 N--CA 1.516 2.842 0 O-C-N 121.895 -0.503 . . . . 0.0 111.421 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.3 m -61.33 -18.47 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.636 0 O-C-N 121.882 -0.511 . . . . 0.0 111.804 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -126.05 48.33 2.12 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.6 -0.687 . . . . 0.0 112.337 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -144.47 106.47 4.32 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 121.56 -0.712 . . . . 0.0 109.689 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 65.8 mt -128.05 106.84 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.694 HG21 HG12 ' A' ' 43' ' ' ILE . 3.3 t -75.67 136.73 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.287 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.446 HD11 ' OE1' ' A' ' 59' ' ' GLN . 14.5 mt -91.16 165.26 13.58 Favored 'General case' 0 N--CA 1.506 2.338 0 CA-C-O 121.309 0.576 . . . . 0.0 111.724 -178.295 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.8 p -60.55 -21.22 62.29 Favored 'General case' 0 N--CA 1.511 2.576 0 O-C-N 122.114 -0.366 . . . . 0.0 111.453 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 40.4 p-10 -90.57 17.23 7.72 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.627 -0.671 . . . . 0.0 111.505 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.5 m120 69.38 31.58 3.79 Favored 'General case' 0 N--CA 1.516 2.856 0 O-C-N 121.594 -0.691 . . . . 0.0 111.846 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.504 ' CE2' HG13 ' A' ' 22' ' ' VAL . 4.3 m-85 -102.41 166.03 10.78 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 177.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.788 HD23 HD12 ' A' ' 21' ' ' ILE . 18.5 tp -123.62 99.92 6.54 Favored 'General case' 0 N--CA 1.515 2.818 0 C-N-CA 119.333 -0.947 . . . . 0.0 111.808 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.669 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -77.28 101.5 6.29 Favored 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 120.805 0.336 . . . . 0.0 111.107 179.647 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.776 HD11 HD11 ' A' ' 21' ' ' ILE . 97.6 mt -92.78 115.97 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.51 115.24 17.12 Favored 'General case' 0 N--CA 1.505 2.302 0 CA-C-O 121.299 0.571 . . . . 0.0 111.306 -178.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.31 -38.81 2.95 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 179.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.727 HG23 HG21 ' A' ' 92' ' ' VAL . 1.7 tp 41.47 72.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.846 0 CA-C-O 121.995 0.903 . . . . 0.0 112.624 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -62.72 155.37 26.72 Favored 'General case' 0 N--CA 1.509 2.508 0 O-C-N 121.391 -0.818 . . . . 0.0 111.687 -178.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.413 ' HA ' HG13 ' A' ' 92' ' ' VAL . 33.9 tttt -62.82 -21.45 65.92 Favored 'General case' 0 N--CA 1.51 2.542 0 O-C-N 122.119 -0.363 . . . . 0.0 110.772 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 50.7 p -85.17 -13.97 48.39 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.79 -0.569 . . . . 0.0 111.106 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.88 -6.38 48.83 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.607 -0.683 . . . . 0.0 111.452 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.794 ' HB3' HG12 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -80.04 172.74 13.38 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-N 119.005 0.82 . . . . 0.0 110.067 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 145.33 -108.16 0.46 Allowed Glycine 0 N--CA 1.496 2.646 0 N-CA-C 108.991 -1.643 . . . . 0.0 108.991 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.7 m -143.17 100.99 3.74 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 122.041 -0.682 . . . . 0.0 111.418 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -83.72 129.46 34.95 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 29.4 ttp180 -94.84 119.21 33.03 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.324 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.506 ' HB3' HD11 ' A' ' 33' ' ' ILE . 5.5 m -81.88 124.12 29.44 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 177.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -125.12 89.94 3.15 Favored 'General case' 0 N--CA 1.503 2.201 0 CA-C-N 118.995 0.816 . . . . 0.0 111.021 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.44 107.89 2.28 Favored Glycine 0 N--CA 1.502 3.045 0 N-CA-C 107.336 -2.306 . . . . 0.0 107.336 178.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 . . . . . 0 N--CA 1.502 2.159 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -176.603 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.505 HD21 ' N ' ' A' ' 84' ' ' ASN . 1.6 m-80 . . . . . 0 N--CA 1.504 2.239 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -163.01 -175.94 4.62 Favored 'General case' 0 N--CA 1.503 2.19 0 C-N-CA 119.551 -0.86 . . . . 0.0 112.979 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 9.1 tttt -167.6 162.27 14.12 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.563 ' O ' HG22 ' A' ' 9' ' ' THR . 4.5 p-10 -106.71 110.5 22.7 Favored 'General case' 0 N--CA 1.51 2.531 0 O-C-N 121.764 -0.585 . . . . 0.0 111.0 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.589 HD12 ' N ' ' A' ' 88' ' ' ILE . 2.6 mp -95.74 120.13 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 10.6 tm0? -91.63 113.53 25.82 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.046 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.52 HG13 HE21 ' A' ' 11' ' ' GLN . 39.7 t -104.75 143.33 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.931 -0.481 . . . . 0.0 109.967 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 68.4 mt -134.95 139.92 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.311 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.794 HG12 ' HB3' ' A' ' 68' ' ' GLU . 8.4 p . . . . . 0 N--CA 1.5 2.045 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.76 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 45.3 t . . . . . 0 N--CA 1.504 2.256 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.437 ' CG ' ' HB ' ' A' ' 26' ' ' VAL . 17.1 ptm -119.09 123.31 44.13 Favored 'General case' 0 N--CA 1.508 2.456 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -74.17 133.29 42.74 Favored 'General case' 0 N--CA 1.511 2.606 0 CA-C-O 120.974 0.416 . . . . 0.0 112.045 -176.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.517 ' HG2' HG23 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -135.37 163.38 30.15 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-O 121.367 0.603 . . . . 0.0 111.093 179.34 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.5 t30 27.78 70.24 0.06 Allowed 'General case' 0 N--CA 1.523 3.205 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -135.76 82.85 37.09 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.736 -0.603 . . . . 0.0 110.619 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -65.44 110.0 1.51 Allowed 'Trans proline' 0 N--CA 1.491 1.366 0 N-CA-C 109.02 -1.185 . . . . 0.0 109.02 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.586 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.1 OUTLIER -60.64 -59.05 15.09 Favored Pre-proline 0 N--CA 1.502 2.151 0 CA-C-O 117.113 -1.422 . . . . 0.0 112.161 -177.777 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.528 ' HD3' ' OG1' ' A' ' 9' ' ' THR . 1.4 Cg_endo -80.11 91.44 1.17 Allowed 'Trans proline' 0 CA--C 1.554 1.488 0 CA-C-N 121.055 1.413 . . . . 0.0 111.557 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.533 HE21 HG13 ' A' ' 90' ' ' VAL . 15.7 pt20 -101.38 173.5 6.41 Favored 'General case' 0 N--CA 1.509 2.504 0 O-C-N 120.973 -1.079 . . . . 0.0 110.521 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -158.37 121.13 3.76 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.783 -0.573 . . . . 0.0 111.478 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -116.68 -170.02 1.74 Allowed 'General case' 0 N--CA 1.503 2.203 0 O-C-N 122.06 -0.4 . . . . 0.0 109.943 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -103.48 137.52 41.46 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.527 0.68 . . . . 0.0 111.444 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -61.08 116.67 4.71 Favored 'General case' 0 N--CA 1.508 2.466 0 CA-C-O 121.051 0.453 . . . . 0.0 110.333 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.13 22.46 29.96 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -117.48 165.41 13.56 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 118.567 1.183 . . . . 0.0 111.085 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -80.62 99.85 8.34 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 177.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.29 165.85 11.49 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.968 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.677 HG22 ' HG2' ' A' ' 59' ' ' GLN . 99.2 t -141.68 139.47 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 177.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.746 HD12 HD23 ' A' ' 58' ' ' LEU . 42.6 mt -97.15 113.47 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 178.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.557 HG13 ' CE2' ' A' ' 57' ' ' TYR . 48.4 t -76.43 117.47 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 CA-C-O 121.558 0.694 . . . . 0.0 110.401 -177.164 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.3 t -157.94 91.26 1.11 Allowed 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.01 138.95 31.0 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -178.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.804 HG21 HD12 ' A' ' 33' ' ' ILE . 44.3 t -143.87 131.11 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 C-N-CA 120.283 -0.567 . . . . 0.0 109.476 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.517 HG23 ' HG2' ' A' ' 5' ' ' LYS . 93.3 t -97.63 83.21 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.8 m -84.62 171.18 12.65 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 177.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.5 t -46.18 -81.49 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.091 0 O-C-N 121.594 -0.691 . . . . 0.0 111.261 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.431 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 0.9 OUTLIER -165.93 -64.01 0.01 OUTLIER Pre-proline 0 N--CA 1.514 2.758 0 CA-C-O 117.706 -1.14 . . . . 0.0 111.752 177.687 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.431 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 3.0 Cg_endo -61.13 -53.07 2.76 Favored 'Trans proline' 0 CA--C 1.563 1.939 0 CA-C-N 120.189 1.103 . . . . 0.0 113.013 -179.167 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.404 ' C ' ' HG1' ' A' ' 32' ' ' THR . 3.2 Cg_exo -61.14 -163.83 0.03 OUTLIER 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 120.549 0.832 . . . . 0.0 113.108 -178.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.404 ' HG1' ' C ' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -168.97 -162.81 0.39 Allowed 'General case' 0 N--CA 1.517 2.915 0 O-C-N 121.966 -0.459 . . . . 0.0 109.768 -179.293 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.804 HD12 HG21 ' A' ' 25' ' ' VAL . 14.0 tt -101.23 167.35 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.879 -0.513 . . . . 0.0 110.195 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.435 HD12 ' NE ' ' A' ' 76' ' ' ARG . 96.7 mt -131.89 134.35 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.196 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.539 ' HB2' HG22 ' A' ' 42' ' ' VAL . 85.4 m95 -95.9 114.88 26.64 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.5 tttt . . . . . 0 N--CA 1.503 2.213 0 O-C-N 121.814 -0.554 . . . . 0.0 111.129 -178.72 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.539 HG22 ' HB2' ' A' ' 35' ' ' TRP . 3.3 m . . . . . 0 N--CA 1.505 2.323 0 CA-C-O 121.192 0.52 . . . . 0.0 109.663 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.48 HD11 HG21 ' A' ' 52' ' ' VAL . 47.8 mm -58.35 -19.36 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.795 0 O-C-N 121.867 -0.52 . . . . 0.0 111.558 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.525 ' N ' HD12 ' A' ' 44' ' ' LEU . 8.2 mp -93.03 -22.78 18.94 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.478 -0.764 . . . . 0.0 111.126 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.421 ' HG2' ' HA ' ' A' ' 42' ' ' VAL . 31.2 pttt -97.96 -38.57 9.34 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.4 mmmt 49.14 54.86 10.22 Favored 'General case' 0 N--CA 1.507 2.395 0 CA-C-O 121.487 0.66 . . . . 0.0 111.726 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.75 161.47 0.74 Allowed 'General case' 0 N--CA 1.514 2.764 0 O-C-N 121.731 -0.605 . . . . 0.0 110.916 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.9 m -58.42 -21.1 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.666 0 O-C-N 121.909 -0.494 . . . . 0.0 111.876 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.1 ptp85 -111.53 46.11 1.14 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.78 -0.575 . . . . 0.0 111.633 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -146.24 106.36 4.02 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.72 -0.613 . . . . 0.0 109.836 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 81.1 mt -129.03 107.5 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.523 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.1 t -74.94 139.32 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.466 HD11 ' CG ' ' A' ' 59' ' ' GLN . 43.1 mt -94.82 167.84 11.18 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 121.224 0.535 . . . . 0.0 111.963 -178.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.4 p -61.76 -23.22 66.03 Favored 'General case' 0 N--CA 1.509 2.484 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.072 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 35.6 p-10 -90.03 16.93 7.49 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.659 -0.651 . . . . 0.0 111.414 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.5 m120 69.43 32.18 3.55 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 121.558 -0.714 . . . . 0.0 112.283 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.557 ' CE2' HG13 ' A' ' 22' ' ' VAL . 4.0 m-85 -103.24 157.97 16.64 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.746 HD23 HD12 ' A' ' 21' ' ' ILE . 17.8 tp -114.13 98.92 7.26 Favored 'General case' 0 N--CA 1.517 2.897 0 C-N-CA 119.487 -0.885 . . . . 0.0 111.624 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.677 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -76.97 98.96 5.1 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 120.325 -0.55 . . . . 0.0 111.075 179.609 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.58 HD11 HD11 ' A' ' 21' ' ' ILE . 98.2 mt -89.58 119.56 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 177.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.2 tpt85 -81.45 114.12 19.98 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-O 121.443 0.639 . . . . 0.0 111.247 -178.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.17 -36.73 3.75 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.507 ' CG1' HG21 ' A' ' 92' ' ' VAL . 3.1 tp 42.3 93.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.826 0 CA-C-N 118.14 0.97 . . . . 0.0 112.237 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -80.36 154.68 27.59 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.377 -0.827 . . . . 0.0 112.004 -177.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.7 tttm -62.04 -25.07 67.45 Favored 'General case' 0 N--CA 1.509 2.517 0 O-C-N 122.174 -0.329 . . . . 0.0 111.002 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 56.3 p -82.22 -16.62 48.98 Favored 'General case' 0 N--CA 1.505 2.325 0 O-C-N 121.848 -0.532 . . . . 0.0 110.978 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.88 -12.42 36.26 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.622 -0.674 . . . . 0.0 111.732 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.551 ' HB3' HG12 ' A' ' 92' ' ' VAL . 8.2 pt-20 -73.42 142.87 46.92 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.385 -0.822 . . . . 0.0 109.792 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 171.85 -104.27 0.2 Allowed Glycine 0 N--CA 1.498 2.792 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.4 m -147.77 102.13 3.39 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 122.055 -0.674 . . . . 0.0 110.45 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -81.97 139.61 34.46 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.8 ttt180 -102.46 116.79 33.34 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.02 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.482 ' HB3' HD11 ' A' ' 33' ' ' ILE . 7.0 m -79.04 133.43 36.81 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 177.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -133.71 91.58 2.86 Favored 'General case' 0 N--CA 1.504 2.243 0 CA-C-N 118.711 0.687 . . . . 0.0 110.452 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.36 109.6 2.96 Favored Glycine 0 N--CA 1.504 3.185 0 N-CA-C 107.631 -2.187 . . . . 0.0 107.631 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.435 ' NE ' HD12 ' A' ' 34' ' ' ILE . 5.9 ttm180 . . . . . 0 N--CA 1.505 2.284 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -176.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.61 HD21 ' N ' ' A' ' 84' ' ' ASN . 1.1 m-80 . . . . . 0 N--CA 1.505 2.292 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -164.83 -178.6 5.34 Favored 'General case' 0 N--CA 1.506 2.348 0 C-N-CA 119.723 -0.791 . . . . 0.0 112.937 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.9 mttm -168.72 159.52 9.9 Favored 'General case' 0 N--CA 1.505 2.294 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.586 ' O ' HG22 ' A' ' 9' ' ' THR . 4.0 p-10 -103.66 112.75 25.82 Favored 'General case' 0 N--CA 1.512 2.642 0 O-C-N 121.847 -0.533 . . . . 0.0 110.644 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.572 HD12 ' N ' ' A' ' 88' ' ' ILE . 2.8 mp -98.85 115.23 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -82.87 110.87 18.24 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.533 HG13 HE21 ' A' ' 11' ' ' GLN . 44.4 t -105.54 135.69 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.032 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.41 ' N ' HD12 ' A' ' 91' ' ' ILE . 5.1 mp -124.71 159.76 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.551 HG12 ' HB3' ' A' ' 68' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.503 2.205 0 CA-C-O 117.937 -1.03 . . . . 0.0 110.35 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 43.3 t . . . . . 0 N--CA 1.502 2.129 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.512 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 0.8 OUTLIER -108.31 112.89 25.58 Favored 'General case' 0 N--CA 1.507 2.42 0 C-N-CA 120.251 -0.579 . . . . 0.0 109.56 179.289 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -69.91 120.43 15.63 Favored 'General case' 0 N--CA 1.504 2.242 0 CA-C-O 120.926 0.393 . . . . 0.0 110.485 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.438 ' HG2' HG23 ' A' ' 26' ' ' VAL . 3.0 pttt -130.92 161.55 31.63 Favored 'General case' 0 N--CA 1.502 2.133 0 CA-C-O 121.624 0.726 . . . . 0.0 111.068 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.405 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.4 OUTLIER 32.55 72.38 0.08 Allowed 'General case' 0 N--CA 1.518 2.942 0 C-N-CA 124.213 1.005 . . . . 0.0 113.31 179.602 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -136.5 80.79 37.87 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.739 -0.601 . . . . 0.0 110.972 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -66.08 102.32 0.54 Allowed 'Trans proline' 0 N--CA 1.491 1.378 0 N-CA-C 108.455 -1.402 . . . . 0.0 108.455 178.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.589 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.3 OUTLIER -53.15 -67.82 0.53 Allowed Pre-proline 0 N--CA 1.509 2.5 0 CA-C-O 116.732 -1.604 . . . . 0.0 112.401 -177.219 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.497 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.4 Cg_endo -74.88 95.14 0.96 Allowed 'Trans proline' 0 N--CA 1.498 1.749 0 CA-C-N 121.54 1.586 . . . . 0.0 111.123 178.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.436 HE21 HG13 ' A' ' 90' ' ' VAL . 16.3 pt20 -100.49 179.51 4.42 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.96 -1.087 . . . . 0.0 110.389 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -159.61 124.68 4.06 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.852 -0.53 . . . . 0.0 111.921 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -124.18 -169.04 1.89 Allowed 'General case' 0 N--CA 1.505 2.315 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.0 tttt -106.04 137.18 44.41 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.598 0.713 . . . . 0.0 111.542 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -62.18 115.87 4.5 Favored 'General case' 0 N--CA 1.508 2.471 0 CA-C-O 121.105 0.478 . . . . 0.0 110.168 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.0 22.4 23.12 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.436 ' O ' HG22 ' A' ' 63' ' ' ILE . 15.8 tt0 -118.3 165.31 14.0 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 118.371 1.086 . . . . 0.0 110.851 -179.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -83.3 99.34 9.94 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 177.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.26 169.07 9.38 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.315 0.579 . . . . 0.0 112.197 -177.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.683 HG22 ' HG2' ' A' ' 59' ' ' GLN . 88.5 t -142.01 141.05 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 177.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.801 HD12 HD23 ' A' ' 58' ' ' LEU . 29.2 mt -97.01 114.18 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 178.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.503 HG13 ' CE2' ' A' ' 57' ' ' TYR . 46.8 t -75.41 120.41 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.64 -176.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.0 t -162.4 89.91 0.71 Allowed 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.405 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -88.88 142.88 27.28 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.313 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.781 HG21 HD12 ' A' ' 33' ' ' ILE . 48.0 t -147.34 132.61 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.512 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 48.9 t -93.63 75.54 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.1 m -77.6 163.96 25.78 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.5 t -45.44 -83.58 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.145 0 O-C-N 121.895 -0.503 . . . . 0.0 111.189 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.405 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 0.3 OUTLIER -167.06 -64.37 0.01 OUTLIER Pre-proline 0 N--CA 1.513 2.712 0 CA-C-O 117.61 -1.186 . . . . 0.0 111.686 177.592 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.405 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 2.9 Cg_endo -59.6 -53.15 3.61 Favored 'Trans proline' 0 CA--C 1.563 1.969 0 CA-C-N 120.235 1.12 . . . . 0.0 112.682 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.73 -163.73 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 120.601 0.867 . . . . 0.0 112.611 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.411 HG22 ' H ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -169.94 -168.76 0.79 Allowed 'General case' 0 N--CA 1.518 2.95 0 O-C-N 121.932 -0.48 . . . . 0.0 110.283 -179.576 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.781 HD12 HG21 ' A' ' 25' ' ' VAL . 14.8 tt -97.52 164.24 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 86.6 mt -129.34 129.66 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.563 ' HB2' HG22 ' A' ' 42' ' ' VAL . 84.6 m95 -91.95 101.03 13.59 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.8 tttt . . . . . 0 N--CA 1.5 2.068 0 CA-C-O 121.065 0.46 . . . . 0.0 110.493 -179.134 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.563 HG22 ' HB2' ' A' ' 35' ' ' TRP . 4.1 m . . . . . 0 N--CA 1.509 2.494 0 CA-C-O 120.77 0.319 . . . . 0.0 110.618 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.3 mm -58.91 -17.76 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.757 0 O-C-N 121.578 -0.702 . . . . 0.0 111.679 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.505 ' N ' HD12 ' A' ' 44' ' ' LEU . 8.9 mp -92.53 -22.47 19.53 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.48 -0.762 . . . . 0.0 110.986 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.6 pttt -98.03 -42.27 7.57 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.574 -0.704 . . . . 0.0 109.635 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 20.1 mmmt 46.37 56.49 6.28 Favored 'General case' 0 N--CA 1.51 2.55 0 CA-C-O 121.457 0.646 . . . . 0.0 112.038 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -52.19 169.58 0.07 Allowed 'General case' 0 N--CA 1.515 2.798 0 O-C-N 121.694 -0.628 . . . . 0.0 110.968 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.8 m -61.99 -19.25 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.638 0 O-C-N 121.975 -0.453 . . . . 0.0 111.893 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.1 ptt-85 -116.93 46.49 1.65 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.678 -0.639 . . . . 0.0 111.703 -179.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -143.8 102.99 4.0 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.609 -0.682 . . . . 0.0 109.501 178.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 71.3 mt -128.17 113.22 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.47 HG22 ' CD1' ' A' ' 58' ' ' LEU . 2.4 t -78.62 127.37 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.524 HD11 ' CG ' ' A' ' 59' ' ' GLN . 65.1 mt -78.82 165.51 23.47 Favored 'General case' 0 N--CA 1.508 2.473 0 CA-C-O 121.224 0.535 . . . . 0.0 112.169 -177.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.2 p -60.16 -21.59 61.84 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 122.196 -0.315 . . . . 0.0 111.505 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -91.39 19.04 6.42 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.676 -0.64 . . . . 0.0 111.526 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.0 m120 68.11 31.48 5.38 Favored 'General case' 0 N--CA 1.516 2.851 0 O-C-N 121.661 -0.649 . . . . 0.0 112.145 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.503 ' CE2' HG13 ' A' ' 22' ' ' VAL . 4.0 m-85 -102.12 165.21 11.28 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.801 HD23 HD12 ' A' ' 21' ' ' ILE . 21.9 tp -120.65 98.68 6.14 Favored 'General case' 0 N--CA 1.517 2.908 0 C-N-CA 119.341 -0.944 . . . . 0.0 112.008 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.683 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -76.18 104.97 6.96 Favored 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.991 179.486 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.716 HD11 HD11 ' A' ' 21' ' ' ILE . 98.9 mt -96.56 113.63 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 177.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -77.08 115.95 17.32 Favored 'General case' 0 N--CA 1.503 2.224 0 CA-C-O 121.394 0.616 . . . . 0.0 111.287 -178.085 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.53 -37.02 3.65 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.588 ' CG1' HG21 ' A' ' 92' ' ' VAL . 3.6 tp 40.11 84.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.521 3.095 0 CA-C-O 122.133 0.968 . . . . 0.0 112.44 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 45.6 mttt -75.99 160.08 30.2 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 121.631 -0.668 . . . . 0.0 112.151 -178.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.8 tttm -60.86 -25.6 66.79 Favored 'General case' 0 N--CA 1.51 2.564 0 O-C-N 122.022 -0.424 . . . . 0.0 110.974 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 63.9 p -80.14 -16.9 53.92 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 121.859 -0.525 . . . . 0.0 111.56 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.25 -29.47 26.46 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.51 -0.743 . . . . 0.0 110.509 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.438 ' HB3' HG12 ' A' ' 92' ' ' VAL . 5.7 pt-20 -61.72 140.68 58.17 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.884 -0.51 . . . . 0.0 111.18 -178.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 169.06 -101.39 0.17 Allowed Glycine 0 N--CA 1.497 2.765 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.3 m -151.23 100.6 2.77 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 122.079 -0.659 . . . . 0.0 110.382 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -81.64 140.05 34.63 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.2 ttm-85 -102.44 121.09 41.64 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 120.059 -0.656 . . . . 0.0 111.511 -179.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.501 ' HB3' HD11 ' A' ' 33' ' ' ILE . 9.8 m -86.1 130.1 34.64 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 177.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -131.38 90.47 2.87 Favored 'General case' 0 N--CA 1.506 2.331 0 CA-C-N 118.783 0.719 . . . . 0.0 110.526 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.2 106.27 1.74 Allowed Glycine 0 N--CA 1.504 3.208 0 N-CA-C 107.827 -2.109 . . . . 0.0 107.827 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 . . . . . 0 N--CA 1.504 2.24 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -177.12 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.606 HD21 ' N ' ' A' ' 84' ' ' ASN . 1.0 OUTLIER . . . . . 0 N--CA 1.498 1.952 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -161.9 -179.25 7.02 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 120.009 -0.676 . . . . 0.0 112.221 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.0 mttt -165.76 160.39 17.11 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.589 ' O ' HG22 ' A' ' 9' ' ' THR . 6.9 p-10 -104.17 113.36 26.86 Favored 'General case' 0 N--CA 1.511 2.612 0 O-C-N 121.896 -0.502 . . . . 0.0 110.213 178.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.582 HD12 ' N ' ' A' ' 88' ' ' ILE . 3.0 mp -100.89 116.74 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -82.96 122.09 27.84 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.436 HG13 HE21 ' A' ' 11' ' ' GLN . 44.6 t -116.01 126.5 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.16 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 71.0 mt -115.68 155.75 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.588 HG21 ' CG1' ' A' ' 63' ' ' ILE . 0.9 OUTLIER . . . . . 0 N--CA 1.499 1.975 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.71 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 48.4 t . . . . . 0 N--CA 1.504 2.243 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.427 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 16.3 mtp -114.81 106.56 14.33 Favored 'General case' 0 N--CA 1.513 2.698 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -66.38 119.16 11.11 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.959 -0.463 . . . . 0.0 110.747 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.401 ' HG2' HG23 ' A' ' 26' ' ' VAL . 0.4 OUTLIER -130.87 156.2 45.44 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-O 121.578 0.704 . . . . 0.0 110.558 179.768 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.422 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 1.6 t30 39.13 87.75 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.051 0 C-N-CA 123.404 0.682 . . . . 0.0 112.193 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -143.04 61.36 10.32 Favored Pre-proline 0 N--CA 1.497 1.917 0 C-N-CA 119.91 -0.716 . . . . 0.0 112.332 -178.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -64.68 93.34 0.2 Allowed 'Trans proline' 0 N--CA 1.494 1.506 0 N-CA-C 107.972 -1.588 . . . . 0.0 107.972 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.502 HG22 HD13 ' A' ' 88' ' ' ILE . 18.3 p -53.04 -42.79 92.53 Favored Pre-proline 0 N--CA 1.508 2.472 0 CA-C-O 117.343 -1.313 . . . . 0.0 113.631 -176.574 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.494 ' HD3' ' OG1' ' A' ' 9' ' ' THR . 1.6 Cg_endo -82.83 86.55 1.46 Allowed 'Trans proline' 0 CA--C 1.548 1.203 0 CA-C-N 120.785 1.316 . . . . 0.0 111.051 -177.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.491 HE21 HG13 ' A' ' 90' ' ' VAL . 17.8 pt20 -100.16 171.17 7.97 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 121.15 -0.969 . . . . 0.0 111.068 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -155.92 119.9 4.48 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 122.089 -0.382 . . . . 0.0 110.975 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -116.28 -171.09 1.93 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.871 -0.518 . . . . 0.0 110.196 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.0 tttm -103.68 139.58 38.76 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.492 0.663 . . . . 0.0 111.633 -178.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -59.83 125.83 25.2 Favored 'General case' 0 N--CA 1.508 2.442 0 O-C-N 121.767 -0.583 . . . . 0.0 110.815 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.24 22.04 66.16 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -113.59 160.9 18.06 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-N 118.829 1.314 . . . . 0.0 111.094 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -78.29 98.38 5.91 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.39 174.0 6.49 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.125 0.488 . . . . 0.0 111.875 -177.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.702 HG22 ' HG2' ' A' ' 59' ' ' GLN . 85.9 t -145.57 141.52 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.889 HD12 HD23 ' A' ' 58' ' ' LEU . 21.9 mt -95.95 116.77 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 178.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.417 ' HA ' ' CE2' ' A' ' 57' ' ' TYR . 55.6 t -75.98 121.02 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 CA-C-O 121.446 0.641 . . . . 0.0 111.42 -176.377 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.8 t -165.2 93.75 0.61 Allowed 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.422 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -91.4 139.11 31.03 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.044 -179.582 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.694 HG21 HD12 ' A' ' 33' ' ' ILE . 47.8 t -147.08 131.95 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.427 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 48.2 t -94.09 74.06 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.1 m -76.18 165.93 24.2 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.1 t -47.65 -82.75 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.085 0 O-C-N 121.877 -0.515 . . . . 0.0 111.206 -179.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.414 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 0.7 OUTLIER -166.59 -63.22 0.01 OUTLIER Pre-proline 0 N--CA 1.513 2.694 0 CA-C-O 117.661 -1.161 . . . . 0.0 111.696 178.173 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.414 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 2.9 Cg_endo -60.22 -53.19 3.2 Favored 'Trans proline' 0 CA--C 1.561 1.852 0 CA-C-N 120.203 1.108 . . . . 0.0 112.503 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.44 ' C ' ' HG1' ' A' ' 32' ' ' THR . 2.8 Cg_endo -63.45 -164.58 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.715 0 CA-C-N 119.211 0.754 . . . . 0.0 112.51 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.44 ' HG1' ' C ' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -171.79 -164.5 0.32 Allowed 'General case' 0 N--CA 1.52 3.037 0 O-C-N 121.925 -0.484 . . . . 0.0 110.206 -179.842 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.716 HD11 ' HB3' ' A' ' 73' ' ' CYS . 18.8 tt -103.49 136.32 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 122.038 -0.414 . . . . 0.0 110.069 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.507 ' N ' HD12 ' A' ' 34' ' ' ILE . 5.0 mp -100.79 130.03 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.579 ' CG ' HD22 ' A' ' 58' ' ' LEU . 74.7 m95 -89.73 107.34 19.04 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 48.2 mttt . . . . . 0 N--CA 1.496 1.841 0 O-C-N 122.02 -0.425 . . . . 0.0 110.618 -178.732 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.493 HG22 ' HB2' ' A' ' 35' ' ' TRP . 4.8 m . . . . . 0 N--CA 1.506 2.332 0 CA-C-O 120.877 0.37 . . . . 0.0 110.28 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 77.9 mt -60.61 -16.87 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.829 0 O-C-N 121.943 -0.473 . . . . 0.0 111.658 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.449 ' N ' HD12 ' A' ' 44' ' ' LEU . 10.3 mp -91.43 -22.29 20.52 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.469 -0.769 . . . . 0.0 110.731 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.5 pttt -98.55 -36.43 9.91 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.71 -0.619 . . . . 0.0 109.411 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.4 mmmt 47.92 55.0 9.19 Favored 'General case' 0 N--CA 1.507 2.379 0 CA-C-O 121.405 0.622 . . . . 0.0 112.035 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.52 169.39 0.13 Allowed 'General case' 0 N--CA 1.513 2.685 0 O-C-N 121.705 -0.622 . . . . 0.0 110.81 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.7 m -63.78 -16.02 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.612 0 O-C-N 121.891 -0.506 . . . . 0.0 111.872 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.5 ptt-85 -120.07 45.05 2.27 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.585 -0.697 . . . . 0.0 111.956 -178.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -145.49 101.59 3.6 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.56 -0.712 . . . . 0.0 110.418 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.9 mm -125.96 113.79 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.439 HG22 ' CD1' ' A' ' 58' ' ' LEU . 2.5 t -80.02 139.4 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.411 HD11 ' CG ' ' A' ' 59' ' ' GLN . 31.8 mt -92.92 165.51 12.85 Favored 'General case' 0 N--CA 1.506 2.327 0 CA-C-O 121.335 0.588 . . . . 0.0 112.0 -178.085 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.1 p -61.09 -21.25 63.51 Favored 'General case' 0 N--CA 1.509 2.493 0 O-C-N 122.097 -0.377 . . . . 0.0 111.212 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 46.5 p-10 -89.67 16.97 6.99 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.573 -0.704 . . . . 0.0 111.503 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.6 m120 68.14 31.49 5.33 Favored 'General case' 0 N--CA 1.517 2.896 0 O-C-N 121.559 -0.713 . . . . 0.0 112.278 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.417 ' CE2' ' HA ' ' A' ' 22' ' ' VAL . 4.2 m-85 -103.68 165.64 10.91 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 177.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.889 HD23 HD12 ' A' ' 21' ' ' ILE . 23.4 tp -121.48 99.42 6.46 Favored 'General case' 0 N--CA 1.516 2.833 0 C-N-CA 119.404 -0.918 . . . . 0.0 111.901 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.702 ' HG2' HG22 ' A' ' 20' ' ' VAL . 1.3 mt-30 -76.0 105.16 6.89 Favored 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.089 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.843 HD11 HD11 ' A' ' 21' ' ' ILE . 96.5 mt -95.26 115.08 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.45 113.32 12.72 Favored 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.642 -177.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.66 -35.12 4.69 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 178.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.652 HG23 HG21 ' A' ' 92' ' ' VAL . 3.1 tp 41.07 76.65 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.519 2.98 0 CA-C-N 118.15 0.975 . . . . 0.0 112.116 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.6 mtpp -59.65 147.63 36.74 Favored 'General case' 0 N--CA 1.508 2.444 0 O-C-N 121.411 -0.805 . . . . 0.0 111.769 -178.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.551 ' HA ' HG13 ' A' ' 92' ' ' VAL . 38.2 tttt -62.22 -17.46 58.34 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 122.23 -0.294 . . . . 0.0 111.037 178.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.8 p -90.81 -16.72 27.82 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.6 -0.688 . . . . 0.0 111.116 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.2 12.44 20.13 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.573 -0.704 . . . . 0.0 112.039 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.795 ' HB3' HG12 ' A' ' 92' ' ' VAL . 0.4 OUTLIER -92.78 160.93 14.73 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.33 -0.856 . . . . 0.0 109.368 179.342 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 157.12 -98.68 0.18 Allowed Glycine 0 N--CA 1.495 2.625 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.7 m -153.67 102.49 2.55 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 117.52 0.66 . . . . 0.0 111.292 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -82.38 139.38 34.09 Favored 'General case' 0 N--CA 1.506 2.33 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.9 ttp180 -101.25 119.61 39.01 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.282 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.716 ' HB3' HD11 ' A' ' 33' ' ' ILE . 37.8 m -79.56 127.85 32.66 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 177.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.71 85.11 2.35 Favored 'General case' 0 N--CA 1.505 2.321 0 CA-C-N 119.312 0.96 . . . . 0.0 110.549 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.88 105.12 1.31 Allowed Glycine 0 N--CA 1.504 3.231 0 N-CA-C 107.688 -2.165 . . . . 0.0 107.688 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 34.4 ttp85 . . . . . 0 N--CA 1.497 1.905 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -176.823 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.661 HD21 ' N ' ' A' ' 84' ' ' ASN . 0.9 OUTLIER . . . . . 0 N--CA 1.499 1.994 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -159.2 176.07 12.66 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 119.544 -0.862 . . . . 0.0 112.9 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.8 mttp -165.74 158.68 15.49 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -96.92 138.52 34.34 Favored 'General case' 0 N--CA 1.506 2.351 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.212 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.502 HD13 HG22 ' A' ' 9' ' ' THR . 46.4 mm -121.04 104.73 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -71.17 113.32 8.09 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.491 HG13 HE21 ' A' ' 11' ' ' GLN . 43.5 t -110.72 132.48 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.621 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 71.7 mt -124.76 143.83 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.365 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.795 HG12 ' HB3' ' A' ' 68' ' ' GLU . 9.9 p . . . . . 0 N--CA 1.503 2.194 0 CA-C-O 118.043 -0.98 . . . . 0.0 110.863 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 44.3 t . . . . . 0 N--CA 1.5 2.06 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.503 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 12.0 mmt -110.16 123.14 49.21 Favored 'General case' 0 N--CA 1.51 2.54 0 O-C-N 121.85 -0.531 . . . . 0.0 111.868 -178.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -77.26 122.11 24.62 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 120.927 0.394 . . . . 0.0 110.585 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.44 ' HG2' HG23 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -132.83 157.06 45.96 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.427 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.1 OUTLIER 40.17 70.67 0.22 Allowed 'General case' 0 N--CA 1.517 2.913 0 C-N-CA 123.178 0.591 . . . . 0.0 111.956 -179.493 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -130.16 71.47 82.22 Favored Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.599 -0.688 . . . . 0.0 111.017 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -64.52 108.36 1.01 Allowed 'Trans proline' 0 N--CA 1.492 1.406 0 N-CA-C 109.161 -1.13 . . . . 0.0 109.161 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.636 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.3 OUTLIER -63.2 -69.18 0.63 Allowed Pre-proline 0 N--CA 1.503 2.189 0 CA-C-O 116.767 -1.587 . . . . 0.0 111.5 -178.101 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.496 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.4 Cg_endo -71.52 88.34 0.75 Allowed 'Trans proline' 0 N--CA 1.492 1.432 0 CA-C-N 121.392 1.533 . . . . 0.0 111.706 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.507 HE21 HG13 ' A' ' 90' ' ' VAL . 12.0 pt20 -100.66 169.45 9.02 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 120.99 -1.069 . . . . 0.0 109.192 177.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -157.01 122.35 4.64 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.708 -0.62 . . . . 0.0 111.277 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -115.21 -173.78 2.38 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.948 -0.47 . . . . 0.0 110.033 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -102.54 140.51 36.72 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.536 0.684 . . . . 0.0 111.404 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -60.16 117.78 5.55 Favored 'General case' 0 N--CA 1.51 2.535 0 O-C-N 121.985 -0.447 . . . . 0.0 110.855 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.27 22.05 36.25 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.407 ' O ' HG22 ' A' ' 63' ' ' ILE . 15.4 tt0 -113.81 159.69 19.52 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 118.465 1.132 . . . . 0.0 111.465 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -79.55 100.31 7.7 Favored 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 177.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -101.86 168.61 9.32 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.59 0.709 . . . . 0.0 112.386 -177.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.656 HG22 ' HG2' ' A' ' 59' ' ' GLN . 98.6 t -144.16 137.33 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 178.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.759 HD12 HD23 ' A' ' 58' ' ' LEU . 53.7 mt -93.89 115.85 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 178.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.518 HG13 ' CZ ' ' A' ' 57' ' ' TYR . 43.0 t -76.41 115.49 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-O 121.492 0.663 . . . . 0.0 110.903 -176.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.1 t -161.16 81.38 0.62 Allowed 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.427 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.4 OUTLIER -80.37 147.74 30.92 Favored 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.878 -178.936 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.4 HG21 HD12 ' A' ' 33' ' ' ILE . 44.7 t -147.64 137.73 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.503 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 25.8 t -97.7 88.95 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.52 138.58 31.66 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.7 t -94.86 14.76 20.46 Favored 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -177.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.445 ' HB3' ' HD2' ' A' ' 31' ' ' PRO . 17.3 mt -140.59 168.18 15.37 Favored Pre-proline 0 N--CA 1.503 2.22 0 O-C-N 121.164 -0.96 . . . . 0.0 111.677 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.435 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 3.9 Cg_exo -48.2 -47.37 19.82 Favored 'Trans proline' 0 N--CA 1.502 2.029 0 C-N-CA 121.616 1.544 . . . . 0.0 114.516 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 29' ' ' LEU . 4.6 Cg_exo -55.13 -165.43 0.01 OUTLIER 'Trans proline' 0 N--CA 1.504 2.116 0 CA-C-N 120.004 1.037 . . . . 0.0 112.794 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.648 HG22 ' ND2' ' A' ' 56' ' ' ASN . 0.2 OUTLIER -169.65 -157.29 0.16 Allowed 'General case' 0 N--CA 1.518 2.935 0 O-C-N 120.556 -1.34 . . . . 0.0 111.02 -176.937 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.488 HD11 ' HB3' ' A' ' 73' ' ' CYS . 20.2 tt -78.98 166.75 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.876 -0.515 . . . . 0.0 110.796 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.452 HD13 ' O ' ' A' ' 33' ' ' ILE . 38.2 mm -128.85 128.51 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.592 ' HB2' HG22 ' A' ' 42' ' ' VAL . 81.5 m95 -93.89 99.18 11.58 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 120.191 -0.604 . . . . 0.0 109.44 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.4 tttm . . . . . 0 N--CA 1.497 1.892 0 O-C-N 121.922 -0.486 . . . . 0.0 110.285 -179.217 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.592 HG22 ' HB2' ' A' ' 35' ' ' TRP . 7.7 m . . . . . 0 N--CA 1.51 2.527 0 CA-C-O 120.897 0.38 . . . . 0.0 110.342 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 50.6 mt -59.24 -17.24 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.812 0 O-C-N 121.746 -0.596 . . . . 0.0 111.651 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.484 ' N ' HD12 ' A' ' 44' ' ' LEU . 9.7 mp -90.82 -23.27 20.64 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.504 -0.748 . . . . 0.0 110.882 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 53.9 pttt -97.89 -37.06 9.96 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.696 -0.627 . . . . 0.0 109.595 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm 46.49 55.26 7.72 Favored 'General case' 0 N--CA 1.51 2.529 0 CA-C-O 121.335 0.588 . . . . 0.0 112.229 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.3 163.71 0.55 Allowed 'General case' 0 N--CA 1.515 2.778 0 O-C-N 121.657 -0.652 . . . . 0.0 110.736 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.8 m -58.6 -20.77 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.779 0 O-C-N 121.868 -0.52 . . . . 0.0 111.823 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 16.8 ptt-85 -113.95 46.05 1.38 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.757 -0.59 . . . . 0.0 111.684 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -146.25 108.33 4.39 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.67 -0.644 . . . . 0.0 110.138 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 71.6 mt -130.85 107.8 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.422 HG22 ' CD1' ' A' ' 58' ' ' LEU . 2.6 t -74.76 134.17 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.0 mt -89.23 160.43 16.94 Favored 'General case' 0 N--CA 1.505 2.307 0 CA-C-O 121.223 0.535 . . . . 0.0 111.364 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 90.5 p -60.2 -19.74 55.56 Favored 'General case' 0 N--CA 1.508 2.459 0 O-C-N 122.091 -0.381 . . . . 0.0 111.194 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 49.8 p-10 -91.87 19.21 6.81 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.673 -0.642 . . . . 0.0 111.653 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.648 ' ND2' HG22 ' A' ' 32' ' ' THR . 6.2 m120 70.51 29.68 3.36 Favored 'General case' 0 N--CA 1.524 3.23 0 O-C-N 121.615 -0.678 . . . . 0.0 112.681 178.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.518 ' CZ ' HG13 ' A' ' 22' ' ' VAL . 4.6 m-85 -105.74 157.85 17.15 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.759 HD23 HD12 ' A' ' 21' ' ' ILE . 20.5 tp -115.61 98.94 6.99 Favored 'General case' 0 N--CA 1.517 2.912 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.164 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.656 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -75.96 100.18 4.78 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.099 179.719 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.58 HD11 HD11 ' A' ' 21' ' ' ILE . 88.3 mt -92.1 120.72 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 177.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -83.71 114.59 21.69 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 121.299 0.571 . . . . 0.0 111.308 -178.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 100.25 -37.32 3.62 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 178.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.751 ' CG1' HG21 ' A' ' 92' ' ' VAL . 4.1 tp 38.21 97.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.139 0 CA-C-O 121.862 0.839 . . . . 0.0 112.8 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.538 ' HB3' HG22 ' A' ' 66' ' ' THR . 20.7 mmtp -90.7 150.02 21.82 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.26 -0.9 . . . . 0.0 111.172 -178.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.6 ptmt -59.48 -28.25 66.84 Favored 'General case' 0 N--CA 1.512 2.637 0 O-C-N 122.002 -0.436 . . . . 0.0 110.271 178.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.538 HG22 ' HB3' ' A' ' 64' ' ' LYS . 7.3 t -72.12 -14.97 61.98 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.897 -0.502 . . . . 0.0 110.603 178.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -99.12 -6.48 28.25 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.638 -0.664 . . . . 0.0 111.579 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -71.94 162.21 29.8 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.319 -0.863 . . . . 0.0 109.144 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 155.02 -111.97 0.51 Allowed Glycine 0 N--CA 1.496 2.691 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 16.9 m -143.62 99.16 3.37 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 122.108 -0.642 . . . . 0.0 110.867 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -79.3 133.47 36.63 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -95.4 119.41 33.85 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.671 -0.812 . . . . 0.0 111.5 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.488 ' HB3' HD11 ' A' ' 33' ' ' ILE . 9.1 m -81.97 129.15 34.69 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 177.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -132.36 85.99 2.29 Favored 'General case' 0 N--CA 1.507 2.409 0 CA-C-N 119.155 0.889 . . . . 0.0 110.791 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' A' ' 33' ' ' ILE . . . -58.55 103.6 0.38 Allowed Glycine 0 N--CA 1.508 3.492 0 N-CA-C 108.507 -1.837 . . . . 0.0 108.507 178.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.8 ttm-85 . . . . . 0 N--CA 1.499 1.984 0 CA-C-O 122.255 1.026 . . . . 0.0 113.752 -176.744 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.51 HD21 ' N ' ' A' ' 84' ' ' ASN . 1.7 m-80 . . . . . 0 N--CA 1.505 2.3 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 43.8 p90 -160.63 175.5 12.59 Favored 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 119.507 -0.877 . . . . 0.0 112.918 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 8.1 mttp -166.58 154.8 10.21 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.636 ' O ' HG22 ' A' ' 9' ' ' THR . 4.9 p-10 -99.66 114.01 26.82 Favored 'General case' 0 N--CA 1.51 2.559 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.007 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.583 HD12 ' N ' ' A' ' 88' ' ' ILE . 2.1 mp -102.45 123.38 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -91.96 120.32 32.51 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.507 HG13 HE21 ' A' ' 11' ' ' GLN . 48.3 t -107.73 140.53 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 C-N-CA 120.658 -0.417 . . . . 0.0 109.907 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.618 ' O ' HG23 ' A' ' 92' ' ' VAL . 32.2 mm -126.18 147.52 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.41 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.751 HG21 ' CG1' ' A' ' 63' ' ' ILE . 2.1 t . . . . . 0 N--CA 1.502 2.174 0 CA-C-O 117.962 -1.018 . . . . 0.0 108.553 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 48.0 t . . . . . 0 N--CA 1.502 2.139 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.508 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 3.1 mmt -112.54 110.65 20.96 Favored 'General case' 0 N--CA 1.509 2.494 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.242 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -69.35 115.41 8.58 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 122.114 -0.366 . . . . 0.0 110.901 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.34 160.33 32.52 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 121.723 0.773 . . . . 0.0 111.283 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.406 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.3 OUTLIER 32.92 79.39 0.03 OUTLIER 'General case' 0 N--CA 1.52 3.049 0 C-N-CA 123.975 0.91 . . . . 0.0 113.35 179.398 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -142.1 78.68 16.89 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.726 -0.609 . . . . 0.0 111.103 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -66.62 104.48 0.79 Allowed 'Trans proline' 0 N--CA 1.489 1.263 0 N-CA-C 108.535 -1.371 . . . . 0.0 108.535 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.579 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.2 OUTLIER -55.46 -61.03 6.8 Favored Pre-proline 0 N--CA 1.505 2.304 0 CA-C-O 116.974 -1.489 . . . . 0.0 112.361 -177.586 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.547 ' HD3' ' OG1' ' A' ' 9' ' ' THR . 1.4 Cg_endo -78.66 93.75 1.09 Allowed 'Trans proline' 0 N--CA 1.493 1.443 0 CA-C-N 121.134 1.441 . . . . 0.0 111.552 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.496 HE21 HG13 ' A' ' 90' ' ' VAL . 16.6 pt20 -101.2 172.17 7.16 Favored 'General case' 0 N--CA 1.508 2.445 0 O-C-N 120.911 -1.118 . . . . 0.0 109.864 178.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -148.47 125.72 11.51 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.822 -0.549 . . . . 0.0 111.587 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -127.14 -165.54 1.48 Allowed 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.07 147.59 52.64 Favored 'General case' 0 N--CA 1.517 2.897 0 CA-C-O 121.92 0.866 . . . . 0.0 111.906 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -57.96 130.47 46.68 Favored 'General case' 0 N--CA 1.507 2.411 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.209 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.3 17.8 77.34 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.662 ' O ' HG22 ' A' ' 63' ' ' ILE . 7.7 tp10 -109.38 155.11 21.64 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 119.182 1.491 . . . . 0.0 111.434 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -79.77 98.54 7.06 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -104.69 169.49 8.42 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.626 0.727 . . . . 0.0 112.586 -177.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.675 HG22 ' HG2' ' A' ' 59' ' ' GLN . 87.9 t -144.53 140.82 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.867 HD12 HD23 ' A' ' 58' ' ' LEU . 48.5 mt -96.84 114.95 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 178.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.513 HG13 ' CZ ' ' A' ' 57' ' ' TYR . 47.4 t -75.5 119.35 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 CA-C-O 121.61 0.719 . . . . 0.0 110.842 -176.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.6 t -161.71 89.01 0.72 Allowed 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.406 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -88.41 138.77 31.14 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.193 -179.016 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.718 HG21 HD12 ' A' ' 33' ' ' ILE . 43.4 t -147.04 126.55 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.508 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 48.1 t -90.87 77.76 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.5 m -78.74 165.85 23.13 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 t -43.96 -85.51 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.177 0 O-C-N 121.753 -0.592 . . . . 0.0 111.443 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.417 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 1.1 mt -165.48 -63.06 0.01 OUTLIER Pre-proline 0 N--CA 1.512 2.657 0 CA-C-O 117.677 -1.154 . . . . 0.0 111.52 177.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.417 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 2.9 Cg_endo -60.55 -53.37 2.88 Favored 'Trans proline' 0 CA--C 1.564 1.987 0 CA-C-N 120.102 1.072 . . . . 0.0 112.524 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.409 ' HD3' ' CG ' ' A' ' 30' ' ' PRO . 2.9 Cg_endo -62.68 -163.66 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 120.541 0.827 . . . . 0.0 112.418 -179.161 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -171.75 -166.15 0.42 Allowed 'General case' 0 N--CA 1.518 2.937 0 O-C-N 121.861 -0.525 . . . . 0.0 110.304 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.718 HD12 HG21 ' A' ' 25' ' ' VAL . 16.9 tt -99.54 147.98 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 78.0 mt -111.23 127.3 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.573 ' HB2' HG22 ' A' ' 42' ' ' VAL . 76.8 m95 -89.9 109.69 20.69 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.0 tttm . . . . . 0 N--CA 1.502 2.146 0 CA-C-O 121.072 0.463 . . . . 0.0 110.572 -178.561 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.573 HG22 ' HB2' ' A' ' 35' ' ' TRP . 9.7 m . . . . . 0 N--CA 1.51 2.527 0 CA-C-O 121.054 0.454 . . . . 0.0 110.494 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 66.8 mt -60.56 -15.7 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.781 0 O-C-N 121.817 -0.552 . . . . 0.0 111.768 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.442 ' N ' HD12 ' A' ' 44' ' ' LEU . 10.9 mp -90.68 -21.79 21.46 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.527 -0.733 . . . . 0.0 110.666 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.1 pttt -97.77 -35.48 10.53 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.598 -0.689 . . . . 0.0 109.733 178.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.1 mmmt 46.35 56.5 6.25 Favored 'General case' 0 N--CA 1.509 2.525 0 CA-C-O 121.382 0.61 . . . . 0.0 112.134 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -50.32 171.59 0.03 OUTLIER 'General case' 0 N--CA 1.516 2.84 0 O-C-N 121.732 -0.605 . . . . 0.0 111.491 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.5 t -65.57 -14.9 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.539 0 O-C-N 121.952 -0.468 . . . . 0.0 111.415 -179.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -115.85 -4.6 12.09 Favored 'General case' 0 N--CA 1.506 2.364 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.438 ' C ' HD12 ' A' ' 51' ' ' ILE . 12.1 m-85 -94.14 115.22 27.48 Favored 'General case' 0 N--CA 1.503 2.182 0 CA-C-N 119.075 0.852 . . . . 0.0 110.616 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.438 HD12 ' C ' ' A' ' 50' ' ' PHE . 5.2 mp -137.19 106.25 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.154 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.442 HG22 ' CD1' ' A' ' 58' ' ' LEU . 2.8 t -73.74 128.18 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.502 HD11 ' CG ' ' A' ' 59' ' ' GLN . 52.6 mt -81.93 166.84 19.53 Favored 'General case' 0 N--CA 1.506 2.357 0 CA-C-O 121.377 0.608 . . . . 0.0 112.022 -178.066 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.6 p -60.66 -21.69 63.07 Favored 'General case' 0 N--CA 1.509 2.51 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.229 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 42.1 p-10 -91.55 19.03 6.61 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.665 -0.647 . . . . 0.0 111.403 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.5 m120 66.63 32.72 6.91 Favored 'General case' 0 N--CA 1.515 2.798 0 O-C-N 121.627 -0.67 . . . . 0.0 112.223 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.513 ' CZ ' HG13 ' A' ' 22' ' ' VAL . 3.5 m-85 -101.69 168.34 9.53 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.867 HD23 HD12 ' A' ' 21' ' ' ILE . 17.1 tp -121.43 96.99 5.3 Favored 'General case' 0 N--CA 1.517 2.912 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.621 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.675 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -76.4 104.2 6.8 Favored 'General case' 0 N--CA 1.502 2.174 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.919 179.49 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.549 HD11 HD11 ' A' ' 21' ' ' ILE . 96.5 mt -97.55 101.37 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 177.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.35 114.77 7.91 Favored 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 121.252 0.549 . . . . 0.0 110.97 -178.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 101.39 -34.18 5.87 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 109.971 -1.251 . . . . 0.0 109.971 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.662 HG22 ' O ' ' A' ' 17' ' ' GLU . 1.8 tp 32.92 92.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.523 3.212 0 CA-C-N 117.925 0.863 . . . . 0.0 113.251 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.549 ' HB3' HG22 ' A' ' 66' ' ' THR . 3.2 mmmm -74.23 148.25 41.72 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.697 -0.627 . . . . 0.0 110.834 -178.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -63.4 -19.13 64.42 Favored 'General case' 0 N--CA 1.508 2.455 0 C-N-CA 120.571 -0.451 . . . . 0.0 110.711 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.549 HG22 ' HB3' ' A' ' 64' ' ' LYS . 10.1 t -83.76 -12.85 55.15 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.441 -0.787 . . . . 0.0 111.105 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.43 11.03 36.36 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.49 -0.756 . . . . 0.0 111.571 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -88.0 152.73 21.83 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.286 -0.884 . . . . 0.0 109.533 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 163.95 -106.15 0.27 Allowed Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.2 m -146.51 103.85 3.71 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 122.156 -0.614 . . . . 0.0 110.654 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -83.61 128.72 34.74 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.4 tpp180 -91.77 118.37 30.62 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.179 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.567 ' HB3' HD11 ' A' ' 33' ' ' ILE . 5.1 m -83.77 122.59 28.86 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 177.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -123.27 88.27 2.89 Favored 'General case' 0 N--CA 1.506 2.349 0 CA-C-N 118.738 0.699 . . . . 0.0 110.643 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.7 103.03 0.9 Allowed Glycine 0 N--CA 1.503 3.161 0 N-CA-C 107.653 -2.179 . . . . 0.0 107.653 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 . . . . . 0 N--CA 1.5 2.054 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -176.808 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.561 HD21 ' N ' ' A' ' 84' ' ' ASN . 1.2 m-80 . . . . . 0 N--CA 1.503 2.208 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.403 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 42.7 p90 -162.06 -179.21 6.93 Favored 'General case' 0 N--CA 1.503 2.191 0 C-N-CA 119.612 -0.835 . . . . 0.0 113.142 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.6 mttt -167.16 161.54 14.64 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.579 ' O ' HG22 ' A' ' 9' ' ' THR . 4.7 p-10 -103.27 112.35 25.18 Favored 'General case' 0 N--CA 1.51 2.545 0 O-C-N 121.782 -0.574 . . . . 0.0 111.221 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.582 HD12 ' N ' ' A' ' 88' ' ' ILE . 3.0 mp -97.06 115.62 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -85.22 117.27 24.06 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.496 HG13 HE21 ' A' ' 11' ' ' GLN . 42.7 t -111.05 135.27 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 CA-C-O 121.058 0.456 . . . . 0.0 110.045 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 47.7 mt -121.76 135.02 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.44 HG21 ' CG1' ' A' ' 63' ' ' ILE . 54.7 t . . . . . 0 N--CA 1.504 2.27 0 CA-C-O 118.308 -0.853 . . . . 0.0 109.782 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.2 t . . . . . 0 N--CA 1.503 2.204 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.544 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 4.7 mmt -111.38 116.86 31.66 Favored 'General case' 0 N--CA 1.51 2.556 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.142 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -73.44 119.63 17.94 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 122.039 -0.413 . . . . 0.0 110.485 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.401 ' HG2' HG23 ' A' ' 26' ' ' VAL . 0.8 OUTLIER -132.82 160.15 37.73 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 121.495 0.664 . . . . 0.0 111.076 -179.388 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.407 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.4 OUTLIER 33.31 88.85 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.107 0 C-N-CA 124.013 0.925 . . . . 0.0 113.423 179.474 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -157.25 81.23 3.27 Favored Pre-proline 0 N--CA 1.495 1.806 0 C-N-CA 120.084 -0.646 . . . . 0.0 111.55 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -64.97 105.61 0.69 Allowed 'Trans proline' 0 N--CA 1.492 1.416 0 N-CA-C 108.588 -1.351 . . . . 0.0 108.588 177.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.544 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.2 OUTLIER -53.88 -66.91 0.71 Allowed Pre-proline 0 N--CA 1.508 2.468 0 CA-C-O 116.91 -1.519 . . . . 0.0 112.245 -177.593 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.486 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.4 Cg_endo -73.13 92.47 0.82 Allowed 'Trans proline' 0 N--CA 1.495 1.591 0 CA-C-N 121.242 1.479 . . . . 0.0 110.978 178.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.458 HE21 HG13 ' A' ' 90' ' ' VAL . 13.1 pt20 -100.18 173.05 6.8 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 120.917 -1.114 . . . . 0.0 110.192 178.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -155.1 125.3 6.72 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.937 -0.477 . . . . 0.0 111.304 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -122.98 -169.73 1.98 Allowed 'General case' 0 N--CA 1.504 2.246 0 O-C-N 122.025 -0.422 . . . . 0.0 110.04 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -106.05 138.65 41.87 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.578 0.704 . . . . 0.0 111.507 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -60.13 126.6 28.13 Favored 'General case' 0 N--CA 1.509 2.498 0 O-C-N 121.717 -0.614 . . . . 0.0 110.739 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.36 21.14 62.96 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.434 ' O ' HG22 ' A' ' 63' ' ' ILE . 7.5 tp10 -112.85 161.63 16.72 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 118.811 1.306 . . . . 0.0 111.31 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.88 98.66 7.2 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 177.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -101.56 169.02 9.12 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 120.15 -0.62 . . . . 0.0 112.109 -177.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.656 HG22 ' HG2' ' A' ' 59' ' ' GLN . 84.1 t -142.23 140.68 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 178.172 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.718 HD12 HD23 ' A' ' 58' ' ' LEU . 43.9 mt -96.62 115.34 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 178.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.426 ' HA ' ' CE2' ' A' ' 57' ' ' TYR . 57.3 t -76.41 116.98 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 CA-C-O 121.355 0.598 . . . . 0.0 110.536 -177.051 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.2 t -160.67 89.82 0.83 Allowed 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.407 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -87.53 141.56 28.52 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.212 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.689 HG21 HD12 ' A' ' 33' ' ' ILE . 44.5 t -147.11 129.18 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.544 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 26.4 t -90.41 75.17 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.8 m -79.53 162.22 25.52 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 178.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 t -43.18 -85.04 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.25 0 O-C-N 121.844 -0.535 . . . . 0.0 111.433 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.4 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 1.3 mt -166.77 -63.56 0.01 OUTLIER Pre-proline 0 N--CA 1.512 2.658 0 CA-C-O 117.747 -1.121 . . . . 0.0 111.1 177.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.4 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 3.0 Cg_endo -59.65 -53.37 3.39 Favored 'Trans proline' 0 CA--C 1.565 2.05 0 CA-C-N 120.113 1.076 . . . . 0.0 112.347 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -61.02 -165.65 0.04 OUTLIER 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 120.685 0.923 . . . . 0.0 112.358 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -170.64 -161.3 0.23 Allowed 'General case' 0 N--CA 1.523 3.197 0 C-N-CA 120.134 -0.626 . . . . 0.0 111.045 -179.141 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.835 HD11 ' HB3' ' A' ' 73' ' ' CYS . 21.2 tt -111.3 137.39 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.978 -0.451 . . . . 0.0 110.249 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.45 HD11 ' NE ' ' A' ' 76' ' ' ARG . 70.6 mt -94.56 129.98 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.506 ' HB2' HG22 ' A' ' 42' ' ' VAL . 48.1 m95 -94.66 103.46 15.39 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.181 -178.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.6 tptm . . . . . 0 N--CA 1.497 1.888 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 177.54 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.506 HG22 ' HB2' ' A' ' 35' ' ' TRP . 12.8 m . . . . . 0 N--CA 1.508 2.437 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.746 HD11 HG21 ' A' ' 52' ' ' VAL . 46.9 mm -57.7 -18.92 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.778 0 O-C-N 121.889 -0.507 . . . . 0.0 111.854 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.467 ' N ' HD12 ' A' ' 44' ' ' LEU . 10.8 mp -89.05 -25.34 22.0 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.581 -0.699 . . . . 0.0 110.767 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.5 pttt -98.67 -39.82 8.49 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.775 -0.578 . . . . 0.0 109.957 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.5 mmmt 47.75 55.01 9.05 Favored 'General case' 0 N--CA 1.511 2.623 0 CA-C-O 121.593 0.711 . . . . 0.0 111.569 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.15 169.47 0.17 Allowed 'General case' 0 N--CA 1.511 2.61 0 O-C-N 121.724 -0.61 . . . . 0.0 110.81 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 29.4 m -62.55 -20.55 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.534 0 O-C-N 122.052 -0.405 . . . . 0.0 111.601 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.9 ptp85 -113.51 46.6 1.25 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.735 -0.603 . . . . 0.0 112.055 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.405 ' HE2' HD21 ' A' ' 58' ' ' LEU . 7.8 m-85 -144.93 107.02 4.31 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.685 -0.634 . . . . 0.0 109.778 178.253 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 66.3 mt -128.93 104.82 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.746 HG21 HD11 ' A' ' 43' ' ' ILE . 3.1 t -73.95 132.16 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.9 mt -85.91 166.66 15.79 Favored 'General case' 0 N--CA 1.508 2.431 0 O-C-N 121.786 -0.571 . . . . 0.0 111.699 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.8 p -61.57 -21.43 64.3 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 122.204 -0.31 . . . . 0.0 111.137 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -90.93 18.15 6.99 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.614 -0.679 . . . . 0.0 111.46 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.443 ' HB3' HG21 ' A' ' 33' ' ' ILE . 4.0 m120 67.98 32.54 5.03 Favored 'General case' 0 N--CA 1.517 2.899 0 O-C-N 121.596 -0.69 . . . . 0.0 112.189 178.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.426 ' CE2' ' HA ' ' A' ' 22' ' ' VAL . 4.0 m-85 -102.75 162.79 12.64 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 177.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.718 HD23 HD12 ' A' ' 21' ' ' ILE . 17.4 tp -118.2 98.37 6.26 Favored 'General case' 0 N--CA 1.517 2.913 0 C-N-CA 119.276 -0.97 . . . . 0.0 111.591 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.656 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -77.01 97.98 4.82 Favored 'General case' 0 N--CA 1.501 2.12 0 C-N-CA 120.391 -0.523 . . . . 0.0 110.84 179.439 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.548 HD11 HD11 ' A' ' 21' ' ' ILE . 96.0 mt -89.09 119.64 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 177.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.0 tpp180 -80.14 115.43 19.69 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 121.369 0.604 . . . . 0.0 110.707 -178.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.04 -33.28 5.87 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.501 HG23 HG21 ' A' ' 92' ' ' VAL . 1.9 tp 37.85 72.02 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.521 3.108 0 CA-C-N 118.155 0.978 . . . . 0.0 112.861 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.6 mtpp -62.77 158.34 18.96 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 121.751 -0.593 . . . . 0.0 112.187 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 45.2 tttt -62.35 -24.14 67.18 Favored 'General case' 0 N--CA 1.509 2.521 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.908 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 48.0 p -82.86 -15.91 49.67 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.894 -0.504 . . . . 0.0 111.056 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -88.69 -21.67 23.78 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.672 -0.642 . . . . 0.0 110.998 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.464 ' HB3' HG12 ' A' ' 92' ' ' VAL . 7.2 pt-20 -66.74 151.14 48.03 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.519 -0.738 . . . . 0.0 110.312 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 164.24 -115.73 0.66 Allowed Glycine 0 N--CA 1.498 2.787 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.6 m -138.4 100.55 4.14 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.94 -0.741 . . . . 0.0 110.431 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -83.22 135.68 34.69 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.6 ttm105 -103.81 119.61 39.28 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.749 -0.78 . . . . 0.0 111.003 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.835 ' HB3' HD11 ' A' ' 33' ' ' ILE . 19.6 m -78.51 122.64 26.12 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 177.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -121.43 84.26 2.21 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 121.216 0.532 . . . . 0.0 110.695 -178.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.44 117.27 8.74 Favored Glycine 0 N--CA 1.504 3.178 0 N-CA-C 108.062 -2.015 . . . . 0.0 108.062 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.45 ' NE ' HD11 ' A' ' 34' ' ' ILE . 11.6 ttp180 . . . . . 0 N--CA 1.498 1.938 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -177.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.664 HD21 ' N ' ' A' ' 84' ' ' ASN . 0.9 OUTLIER . . . . . 0 N--CA 1.499 2.016 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -167.26 174.96 7.68 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.538 -0.726 . . . . 0.0 112.556 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.508 ' HD2' HD11 ' A' ' 88' ' ' ILE . 1.0 OUTLIER -166.71 155.1 10.2 Favored 'General case' 0 N--CA 1.503 2.221 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.461 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.544 ' O ' HG22 ' A' ' 9' ' ' THR . 5.3 p-10 -91.78 120.38 32.45 Favored 'General case' 0 N--CA 1.512 2.669 0 O-C-N 121.839 -0.538 . . . . 0.0 111.933 -178.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.574 HD12 ' N ' ' A' ' 88' ' ' ILE . 3.1 mp -102.91 120.51 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 178.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -87.69 114.81 24.66 Favored 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.458 HG13 HE21 ' A' ' 11' ' ' GLN . 32.5 t -107.96 133.88 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.07 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 74.0 mt -125.62 156.72 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.501 HG21 HG23 ' A' ' 63' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.498 1.937 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.578 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 62.3 t . . . . . 0 N--CA 1.505 2.297 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.449 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 11.5 mmm -107.52 114.72 28.9 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 122.032 -0.418 . . . . 0.0 109.953 -178.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -68.45 119.2 12.55 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.935 -0.478 . . . . 0.0 109.892 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.691 ' HG2' HG23 ' A' ' 26' ' ' VAL . 3.2 pttt -129.43 161.54 30.14 Favored 'General case' 0 N--CA 1.503 2.201 0 CA-C-O 121.693 0.758 . . . . 0.0 111.482 -178.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.418 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.4 OUTLIER 32.85 51.39 0.26 Allowed 'General case' 0 N--CA 1.517 2.917 0 C-N-CA 124.134 0.974 . . . . 0.0 113.243 179.423 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -116.64 81.89 12.02 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.725 -0.61 . . . . 0.0 110.645 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -65.54 107.33 1.01 Allowed 'Trans proline' 0 N--CA 1.491 1.373 0 N-CA-C 109.142 -1.138 . . . . 0.0 109.142 178.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.58 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.3 OUTLIER -60.19 -67.84 0.93 Allowed Pre-proline 0 N--CA 1.505 2.311 0 CA-C-O 116.802 -1.57 . . . . 0.0 110.985 -178.336 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.496 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.5 Cg_endo -73.8 89.63 0.99 Allowed 'Trans proline' 0 CA--C 1.559 1.739 0 CA-C-N 121.385 1.53 . . . . 0.0 110.67 177.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -98.44 178.65 4.96 Favored 'General case' 0 N--CA 1.508 2.45 0 O-C-N 120.675 -1.266 . . . . 0.0 110.193 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -159.38 124.53 4.13 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 120.294 -0.562 . . . . 0.0 112.03 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -122.54 -165.21 1.26 Allowed 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.49 137.43 53.2 Favored 'General case' 0 N--CA 1.514 2.765 0 CA-C-O 121.734 0.778 . . . . 0.0 110.941 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -55.32 140.2 40.23 Favored 'General case' 0 N--CA 1.511 2.604 0 O-C-N 121.707 -0.62 . . . . 0.0 111.352 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.13 12.27 81.59 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -106.93 157.47 17.76 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 119.332 1.566 . . . . 0.0 111.821 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -80.07 95.15 6.11 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 176.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.09 169.73 9.2 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.191 0.519 . . . . 0.0 112.204 -176.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.631 HG22 ' HG2' ' A' ' 59' ' ' GLN . 85.3 t -139.75 140.73 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.936 HD12 HD23 ' A' ' 58' ' ' LEU . 27.7 mt -93.17 115.64 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 105.969 -1.864 . . . . 0.0 105.969 177.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.46 HG13 ' CE2' ' A' ' 57' ' ' TYR . 48.1 t -77.54 119.68 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 CA-C-O 121.446 0.641 . . . . 0.0 110.618 -176.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.6 t -161.33 92.18 0.89 Allowed 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.418 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -90.04 145.43 25.09 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 -179.501 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.606 HG21 HD12 ' A' ' 33' ' ' ILE . 23.6 t -146.42 119.92 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.691 HG23 ' HG2' ' A' ' 5' ' ' LYS . 21.2 t -75.9 73.46 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 178.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.4 m -84.09 157.24 21.82 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.6 t -47.46 -79.4 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.078 0 O-C-N 121.762 -0.586 . . . . 0.0 111.385 -178.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -172.94 -61.02 0.0 OUTLIER Pre-proline 0 N--CA 1.514 2.758 0 CA-C-O 117.918 -1.039 . . . . 0.0 111.018 177.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.09 -53.97 3.13 Favored 'Trans proline' 0 CA--C 1.563 1.935 0 CA-C-N 119.7 0.928 . . . . 0.0 112.634 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -61.99 -166.41 0.05 OUTLIER 'Trans proline' 0 N--CA 1.501 1.936 0 CA-C-N 119.322 0.794 . . . . 0.0 111.545 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -170.7 -164.93 0.4 Allowed 'General case' 0 N--CA 1.518 2.966 0 O-C-N 121.7 -0.625 . . . . 0.0 110.078 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.606 HD12 HG21 ' A' ' 25' ' ' VAL . 17.9 tt -105.1 158.22 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.992 -0.443 . . . . 0.0 110.023 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 68.8 mt -125.58 118.89 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.558 ' HB2' HG22 ' A' ' 42' ' ' VAL . 83.0 m95 -81.6 102.15 10.46 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.2 tttt . . . . . 0 N--CA 1.499 1.978 0 CA-C-O 121.222 0.534 . . . . 0.0 110.906 -178.785 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.558 HG22 ' HB2' ' A' ' 35' ' ' TRP . 4.5 m . . . . . 0 N--CA 1.509 2.519 0 CA-C-O 120.792 0.33 . . . . 0.0 110.769 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 73.5 mt -59.79 -16.6 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.83 0 O-C-N 121.624 -0.673 . . . . 0.0 111.656 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.495 ' N ' HD12 ' A' ' 44' ' ' LEU . 10.6 mp -91.45 -23.39 20.02 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.433 -0.792 . . . . 0.0 110.732 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -97.86 -38.95 9.24 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.697 -0.627 . . . . 0.0 109.379 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 17.5 mmmt 46.35 55.55 7.27 Favored 'General case' 0 N--CA 1.51 2.559 0 CA-C-O 121.438 0.637 . . . . 0.0 112.228 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.33 165.76 0.33 Allowed 'General case' 0 N--CA 1.513 2.688 0 O-C-N 121.782 -0.574 . . . . 0.0 111.106 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.5 m -58.85 -20.88 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.699 0 O-C-N 122.018 -0.426 . . . . 0.0 111.856 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 5.0 ptt-85 -115.79 47.22 1.39 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.791 -0.568 . . . . 0.0 111.886 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -146.26 101.56 3.51 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.645 -0.659 . . . . 0.0 109.796 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 62.5 mt -125.92 113.42 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.439 HG22 ' CD1' ' A' ' 58' ' ' LEU . 2.4 t -79.49 128.05 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.411 HD11 ' CG ' ' A' ' 59' ' ' GLN . 15.5 mt -80.56 164.1 23.19 Favored 'General case' 0 N--CA 1.506 2.354 0 CA-C-O 121.195 0.521 . . . . 0.0 111.601 -178.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 96.6 p -60.0 -20.63 58.76 Favored 'General case' 0 N--CA 1.511 2.618 0 O-C-N 122.139 -0.351 . . . . 0.0 111.336 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.7 p-10 -91.19 19.44 5.87 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.721 -0.612 . . . . 0.0 111.43 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.8 m120 66.64 32.87 6.81 Favored 'General case' 0 N--CA 1.515 2.806 0 O-C-N 121.607 -0.683 . . . . 0.0 112.165 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.46 ' CE2' HG13 ' A' ' 22' ' ' VAL . 3.9 m-85 -103.4 168.82 8.92 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.936 HD23 HD12 ' A' ' 21' ' ' ILE . 18.0 tp -124.77 98.47 5.72 Favored 'General case' 0 N--CA 1.515 2.788 0 C-N-CA 119.29 -0.964 . . . . 0.0 112.241 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.631 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -74.79 100.16 3.96 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 120.77 0.319 . . . . 0.0 110.825 179.338 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.849 HD11 HD11 ' A' ' 21' ' ' ILE . 97.3 mt -92.7 110.9 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 178.148 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.27 113.89 9.8 Favored 'General case' 0 N--CA 1.504 2.261 0 CA-C-O 121.386 0.612 . . . . 0.0 111.343 -178.063 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.36 -38.3 3.15 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.506 HG12 HG21 ' A' ' 92' ' ' VAL . 1.5 tp 41.84 67.24 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.927 0 CA-C-O 122.145 0.974 . . . . 0.0 112.544 -178.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.5 mttm -58.35 157.38 8.71 Favored 'General case' 0 N--CA 1.51 2.557 0 CA-C-O 121.398 0.618 . . . . 0.0 112.611 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.8 ttmm -62.06 -21.81 65.24 Favored 'General case' 0 N--CA 1.509 2.486 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.97 178.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.1 p -83.78 -18.86 36.31 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.802 -0.561 . . . . 0.0 110.96 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.75 -5.7 56.72 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.653 -0.655 . . . . 0.0 111.607 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.529 ' HB3' HG12 ' A' ' 92' ' ' VAL . 8.2 pt-20 -81.7 137.01 35.46 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 119.006 0.821 . . . . 0.0 109.619 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 176.97 -111.39 0.33 Allowed Glycine 0 N--CA 1.499 2.863 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.0 m -138.8 104.1 5.0 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 122.034 -0.686 . . . . 0.0 110.708 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -86.8 135.89 33.19 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -93.72 118.62 31.65 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.21 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 85' ' ' PHE . 3.4 m -86.48 91.33 8.51 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 178.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -91.53 88.45 6.78 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.842 -0.536 . . . . 0.0 109.929 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.47 96.3 0.82 Allowed Glycine 0 N--CA 1.5 2.95 0 N-CA-C 107.311 -2.315 . . . . 0.0 107.311 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.7 ttm180 . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 122.031 0.919 . . . . 0.0 113.198 -176.921 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.566 HD21 ' N ' ' A' ' 84' ' ' ASN . 1.3 m-80 . . . . . 0 N--CA 1.507 2.401 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.474 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 36.1 p90 -161.1 171.93 17.68 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.534 -0.729 . . . . 0.0 112.4 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.9 mttp -165.78 159.0 15.7 Favored 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.58 ' O ' HG22 ' A' ' 9' ' ' THR . 6.9 p-10 -103.94 121.29 42.81 Favored 'General case' 0 N--CA 1.512 2.662 0 O-C-N 121.757 -0.589 . . . . 0.0 110.756 179.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.521 HD12 ' N ' ' A' ' 88' ' ' ILE . 1.8 mp -105.46 121.49 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -85.26 111.46 19.87 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.7 t -104.73 127.75 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.097 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 72.2 mt -117.17 159.71 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.529 HG12 ' HB3' ' A' ' 68' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.501 2.092 0 CA-C-O 117.922 -1.037 . . . . 0.0 110.496 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 49.0 t . . . . . 0 N--CA 1.501 2.105 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.493 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 17.8 mmm -112.53 111.22 21.89 Favored 'General case' 0 N--CA 1.506 2.371 0 C-N-CA 120.501 -0.479 . . . . 0.0 110.475 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -70.91 116.5 11.28 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 122.041 -0.412 . . . . 0.0 110.841 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -124.8 155.3 39.6 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 121.531 0.681 . . . . 0.0 110.133 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 41.85 86.04 0.02 OUTLIER 'General case' 0 N--CA 1.52 3.044 0 C-N-CA 123.073 0.549 . . . . 0.0 111.803 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -131.95 62.9 66.62 Favored Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 121.696 -0.627 . . . . 0.0 112.155 -178.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.408 ' HD2' HG12 ' A' ' 22' ' ' VAL . 2.5 Cg_endo -66.28 89.83 0.26 Allowed 'Trans proline' 0 N--CA 1.494 1.543 0 N-CA-C 108.162 -1.514 . . . . 0.0 108.162 177.412 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.489 ' OG1' ' HD3' ' A' ' 10' ' ' PRO . 13.6 p -59.47 -43.34 95.89 Favored Pre-proline 0 N--CA 1.508 2.459 0 CA-C-O 117.382 -1.294 . . . . 0.0 113.156 -177.179 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.489 ' HD3' ' OG1' ' A' ' 9' ' ' THR . 1.7 Cg_endo -81.8 82.88 2.23 Favored 'Trans proline' 0 CA--C 1.549 1.251 0 CA-C-N 120.651 1.268 . . . . 0.0 111.332 -177.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.477 HE21 HG13 ' A' ' 90' ' ' VAL . 15.7 pt20 -100.73 170.52 8.29 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.163 -0.96 . . . . 0.0 110.978 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -155.3 124.34 6.2 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 122.002 -0.436 . . . . 0.0 110.996 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -122.49 -169.59 1.93 Allowed 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.912 -0.493 . . . . 0.0 109.778 179.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -115.96 145.61 42.79 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.479 0.657 . . . . 0.0 111.67 -178.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -61.44 121.24 12.18 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 121.947 -0.471 . . . . 0.0 110.399 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.35 20.61 51.6 Favored Glycine 0 N--CA 1.497 2.714 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -179.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.506 ' O ' HG22 ' A' ' 63' ' ' ILE . 7.7 tp10 -112.37 158.1 20.22 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 118.619 1.21 . . . . 0.0 111.212 -179.161 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -80.45 98.09 7.38 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 177.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -102.9 165.5 11.0 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 120.169 -0.612 . . . . 0.0 112.398 -177.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.699 HG22 ' HG2' ' A' ' 59' ' ' GLN . 93.8 t -140.0 143.26 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 178.138 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.895 HD12 HD23 ' A' ' 58' ' ' LEU . 47.1 mt -99.96 113.24 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 178.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.411 HG13 ' CE2' ' A' ' 57' ' ' TYR . 58.4 t -73.22 120.15 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 CA-C-O 121.513 0.673 . . . . 0.0 111.057 -176.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.0 t -165.09 93.12 0.6 Allowed 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.15 140.79 29.11 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.314 -179.206 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.627 HG21 HD12 ' A' ' 33' ' ' ILE . 43.7 t -148.83 133.24 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.493 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 59.5 t -99.85 78.71 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.8 m -79.23 165.71 22.95 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.9 t -43.56 -82.31 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.19 0 O-C-N 121.899 -0.501 . . . . 0.0 111.509 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.416 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 1.0 OUTLIER -167.73 -63.27 0.01 OUTLIER Pre-proline 0 N--CA 1.513 2.708 0 CA-C-O 117.778 -1.106 . . . . 0.0 111.661 177.642 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.416 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 2.9 Cg_endo -60.1 -53.13 3.32 Favored 'Trans proline' 0 CA--C 1.563 1.939 0 CA-C-N 120.107 1.074 . . . . 0.0 112.676 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.403 ' HD3' ' CG ' ' A' ' 30' ' ' PRO . 2.8 Cg_endo -62.57 -163.98 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.794 0 CA-C-N 119.268 0.774 . . . . 0.0 112.634 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -169.95 -160.13 0.22 Allowed 'General case' 0 N--CA 1.519 3.017 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.21 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.847 HD11 ' HB3' ' A' ' 73' ' ' CYS . 20.7 tt -107.98 145.19 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.924 -0.485 . . . . 0.0 110.036 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.0 mt -104.59 130.43 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.533 ' HB2' HG22 ' A' ' 42' ' ' VAL . 55.8 m95 -96.02 119.37 34.38 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.217 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.6 tptt . . . . . 0 N--CA 1.498 1.935 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.274 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.533 HG22 ' HB2' ' A' ' 35' ' ' TRP . 8.4 m . . . . . 0 N--CA 1.505 2.307 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.6 mm -57.95 -19.41 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.683 0 O-C-N 122.028 -0.42 . . . . 0.0 111.796 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.472 ' N ' HD12 ' A' ' 44' ' ' LEU . 9.9 mp -90.59 -24.96 20.41 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.562 -0.711 . . . . 0.0 110.843 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 41.6 pttt -99.03 -39.97 8.26 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.665 -0.647 . . . . 0.0 109.802 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm 49.6 54.51 10.89 Favored 'General case' 0 N--CA 1.509 2.523 0 CA-C-O 121.464 0.649 . . . . 0.0 111.744 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -53.49 164.21 0.53 Allowed 'General case' 0 N--CA 1.514 2.771 0 O-C-N 121.698 -0.626 . . . . 0.0 110.715 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.8 m -60.83 -21.0 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.728 0 O-C-N 121.943 -0.473 . . . . 0.0 111.767 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.8 ptt-85 -100.87 -8.89 22.14 Favored 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -93.47 107.61 19.43 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-N 118.852 0.751 . . . . 0.0 110.272 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 71.7 mt -128.64 105.68 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.478 HG22 ' CD1' ' A' ' 58' ' ' LEU . 2.9 t -75.17 131.51 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.51 HD11 ' CG ' ' A' ' 59' ' ' GLN . 37.8 mt -84.15 168.1 16.11 Favored 'General case' 0 N--CA 1.508 2.452 0 CA-C-O 121.172 0.511 . . . . 0.0 111.717 -178.343 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 55.3 p -61.58 -22.87 65.58 Favored 'General case' 0 N--CA 1.509 2.522 0 O-C-N 122.182 -0.324 . . . . 0.0 111.074 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 50.9 p-10 -91.25 18.42 7.03 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.825 -0.547 . . . . 0.0 111.345 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.441 ' HB3' HG21 ' A' ' 33' ' ' ILE . 4.3 m120 66.82 34.63 5.38 Favored 'General case' 0 N--CA 1.515 2.795 0 O-C-N 121.542 -0.724 . . . . 0.0 112.406 178.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.411 ' CE2' HG13 ' A' ' 22' ' ' VAL . 4.0 m-85 -102.67 159.21 15.66 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.895 HD23 HD12 ' A' ' 21' ' ' ILE . 17.8 tp -114.01 98.31 6.9 Favored 'General case' 0 N--CA 1.515 2.815 0 C-N-CA 119.353 -0.939 . . . . 0.0 112.026 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.699 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -78.76 101.42 7.57 Favored 'General case' 0 N--CA 1.503 2.205 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.088 179.439 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.581 HD11 HD11 ' A' ' 21' ' ' ILE . 91.1 mt -93.58 102.43 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 177.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -68.98 114.19 7.05 Favored 'General case' 0 N--CA 1.506 2.371 0 CA-C-O 121.24 0.543 . . . . 0.0 111.378 -178.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 100.4 -34.8 5.26 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 110.079 -1.209 . . . . 0.0 110.079 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.506 HG22 ' O ' ' A' ' 17' ' ' GLU . 1.9 tp 35.98 95.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.13 0 CA-C-N 118.001 0.901 . . . . 0.0 113.205 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -72.88 146.78 45.93 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.626 -0.671 . . . . 0.0 111.116 -178.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -63.28 -18.71 63.87 Favored 'General case' 0 N--CA 1.51 2.545 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.676 178.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 58.5 p -86.14 -16.43 37.94 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.422 -0.798 . . . . 0.0 110.859 179.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -93.18 17.45 11.02 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.601 -0.687 . . . . 0.0 111.479 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -95.72 145.03 25.62 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.581 -0.699 . . . . 0.0 109.737 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 169.6 -105.36 0.22 Allowed Glycine 0 N--CA 1.497 2.757 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.0 m -142.89 101.38 3.83 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.99 -0.712 . . . . 0.0 111.277 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -83.11 127.55 33.69 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.0 ttt180 -95.71 122.21 38.23 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 120.087 -0.645 . . . . 0.0 111.407 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.847 ' HB3' HD11 ' A' ' 33' ' ' ILE . 65.1 m -79.85 127.34 32.11 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 177.485 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -126.16 84.63 2.29 Favored 'General case' 0 N--CA 1.506 2.344 0 CA-C-N 119.245 0.929 . . . . 0.0 110.36 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.09 102.35 0.71 Allowed Glycine 0 N--CA 1.506 3.307 0 N-CA-C 107.898 -2.081 . . . . 0.0 107.898 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 . . . . . 0 N--CA 1.497 1.919 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -176.814 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.573 HD21 ' N ' ' A' ' 84' ' ' ASN . 0.9 OUTLIER . . . . . 0 N--CA 1.503 2.186 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -159.47 -178.2 6.96 Favored 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 119.419 -0.912 . . . . 0.0 113.429 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -168.24 163.18 13.07 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -104.22 144.86 31.03 Favored 'General case' 0 N--CA 1.511 2.58 0 O-C-N 121.771 -0.581 . . . . 0.0 111.442 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.519 HG21 ' CG2' ' A' ' 21' ' ' ILE . 50.8 mm -126.48 106.24 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.267 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -72.52 101.1 2.89 Favored 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.477 HG13 HE21 ' A' ' 11' ' ' GLN . 25.7 t -100.25 133.51 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.438 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 72.8 mt -119.68 144.72 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 43.5 t . . . . . 0 N--CA 1.505 2.281 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.625 -179.176 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 62.4 t . . . . . 0 N--CA 1.504 2.266 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.462 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 61.4 mmm -104.16 120.21 40.63 Favored 'General case' 0 N--CA 1.509 2.484 0 O-C-N 121.831 -0.543 . . . . 0.0 110.741 -178.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -78.1 113.59 16.18 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 122.053 -0.404 . . . . 0.0 110.192 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.6 ptpt -127.61 165.93 19.02 Favored 'General case' 0 N--CA 1.503 2.182 0 CA-C-O 121.748 0.785 . . . . 0.0 112.235 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.432 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.3 OUTLIER 31.26 80.27 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.959 0 C-N-CA 124.442 1.097 . . . . 0.0 113.226 179.077 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.418 ' HB2' ' HA ' ' A' ' 23' ' ' CYS . . . -154.4 81.44 4.48 Favored Pre-proline 0 N--CA 1.489 1.505 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.864 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.6 105.49 0.63 Allowed 'Trans proline' 0 N--CA 1.491 1.339 0 N-CA-C 108.58 -1.354 . . . . 0.0 108.58 178.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.583 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.2 OUTLIER -51.41 -64.6 1.31 Allowed Pre-proline 0 N--CA 1.509 2.481 0 CA-C-O 117.139 -1.41 . . . . 0.0 111.909 -177.563 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.491 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.6 Cg_endo -74.6 90.56 1.03 Allowed 'Trans proline' 0 CA--C 1.557 1.67 0 CA-C-N 120.974 1.384 . . . . 0.0 110.545 177.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.409 HE21 HG13 ' A' ' 90' ' ' VAL . 13.3 pt20 -99.03 177.04 5.36 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 120.805 -1.185 . . . . 0.0 110.2 179.046 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -159.81 121.29 3.22 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.855 -0.528 . . . . 0.0 111.856 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -116.2 -169.89 1.7 Allowed 'General case' 0 N--CA 1.504 2.259 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -103.43 137.12 41.95 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.553 0.692 . . . . 0.0 111.524 -178.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -61.06 113.97 2.85 Favored 'General case' 0 N--CA 1.509 2.484 0 O-C-N 121.897 -0.502 . . . . 0.0 110.539 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.16 23.33 22.61 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.526 -1.029 . . . . 0.0 110.526 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -117.88 164.83 14.46 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 118.335 1.068 . . . . 0.0 110.998 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -80.47 99.31 7.95 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 177.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.77 167.44 10.77 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.454 0.645 . . . . 0.0 112.119 -177.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.631 HG22 ' HG2' ' A' ' 59' ' ' GLN . 87.5 t -143.72 133.84 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 178.057 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.736 HD12 HD23 ' A' ' 58' ' ' LEU . 42.1 mt -90.35 115.18 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 178.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.426 ' HA ' ' CE2' ' A' ' 57' ' ' TYR . 54.4 t -74.83 120.99 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.852 -176.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.418 ' HA ' ' HB2' ' A' ' 7' ' ' ALA . 0.7 OUTLIER -162.19 91.74 0.8 Allowed 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.406 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.432 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -90.59 140.6 29.6 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.651 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.605 HG21 HD12 ' A' ' 33' ' ' ILE . 14.5 t -146.35 124.0 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.462 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 45.3 t -82.45 77.51 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.1 m -87.47 154.64 20.48 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.6 t -43.88 -85.69 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.255 0 O-C-N 121.919 -0.488 . . . . 0.0 112.294 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.402 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 1.2 mt -165.4 -62.51 0.01 OUTLIER Pre-proline 0 N--CA 1.51 2.555 0 CA-C-O 117.711 -1.137 . . . . 0.0 111.24 178.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.402 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 2.9 Cg_endo -59.4 -53.45 3.46 Favored 'Trans proline' 0 CA--C 1.561 1.864 0 CA-C-N 120.091 1.068 . . . . 0.0 112.307 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.412 ' C ' ' HG1' ' A' ' 32' ' ' THR . 2.7 Cg_endo -62.91 -170.07 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.668 0 CA-C-N 119.286 0.781 . . . . 0.0 111.467 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.412 ' HG1' ' C ' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -171.17 -165.41 0.41 Allowed 'General case' 0 N--CA 1.519 2.979 0 O-C-N 121.767 -0.583 . . . . 0.0 109.647 179.808 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.605 HD12 HG21 ' A' ' 25' ' ' VAL . 16.3 tt -99.11 161.03 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.246 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 66.2 mt -128.74 121.04 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.597 ' HB2' HG22 ' A' ' 42' ' ' VAL . 83.5 m95 -85.51 113.13 21.53 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 120.49 -0.484 . . . . 0.0 109.778 -179.156 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 50.9 mttt . . . . . 0 N--CA 1.502 2.16 0 O-C-N 121.79 -0.569 . . . . 0.0 111.539 -178.929 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.597 HG22 ' HB2' ' A' ' 35' ' ' TRP . 13.6 m . . . . . 0 N--CA 1.509 2.491 0 CA-C-O 121.022 0.439 . . . . 0.0 110.695 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 71.1 mt -59.43 -18.08 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.769 0 O-C-N 121.711 -0.618 . . . . 0.0 111.738 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.476 ' N ' HD12 ' A' ' 44' ' ' LEU . 10.4 mp -92.57 -21.35 20.14 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.455 -0.778 . . . . 0.0 111.119 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.41 ' HG2' ' HA ' ' A' ' 42' ' ' VAL . 42.8 pttt -98.06 -37.43 9.75 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.633 -0.667 . . . . 0.0 109.233 178.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.4 mmmt 48.05 54.75 9.65 Favored 'General case' 0 N--CA 1.509 2.493 0 CA-C-O 121.421 0.629 . . . . 0.0 111.824 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -51.83 168.29 0.09 Allowed 'General case' 0 N--CA 1.515 2.789 0 O-C-N 121.867 -0.521 . . . . 0.0 110.943 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.8 m -61.16 -18.77 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.689 0 O-C-N 121.976 -0.452 . . . . 0.0 111.799 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 29.6 ptt-85 -121.26 46.82 1.96 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.728 -0.607 . . . . 0.0 111.973 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.426 ' HE2' HD21 ' A' ' 58' ' ' LEU . 6.8 m-85 -145.36 106.97 4.23 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.574 -0.704 . . . . 0.0 110.156 178.493 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 82.7 mt -129.66 107.99 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.556 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.0 t -76.17 131.66 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.5 mt -85.02 164.43 18.25 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.909 -0.494 . . . . 0.0 111.49 -178.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.3 p -62.03 -20.68 64.19 Favored 'General case' 0 N--CA 1.509 2.48 0 O-C-N 122.102 -0.374 . . . . 0.0 110.812 178.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 50.3 p30 -88.17 13.58 11.06 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.721 -0.612 . . . . 0.0 111.528 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.3 m120 71.09 33.94 1.94 Allowed 'General case' 0 N--CA 1.518 2.968 0 O-C-N 121.547 -0.72 . . . . 0.0 112.493 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.426 ' CE2' ' HA ' ' A' ' 22' ' ' VAL . 5.3 m-85 -106.0 163.77 12.5 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 177.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.736 HD23 HD12 ' A' ' 21' ' ' ILE . 18.1 tp -118.07 97.54 5.86 Favored 'General case' 0 N--CA 1.519 3.005 0 C-N-CA 119.381 -0.928 . . . . 0.0 111.218 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.631 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -75.39 99.49 4.16 Favored 'General case' 0 N--CA 1.501 2.081 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.763 179.651 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.597 HD11 HD11 ' A' ' 21' ' ' ILE . 92.6 mt -90.75 118.95 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 177.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.8 tpt85 -81.2 113.06 19.09 Favored 'General case' 0 N--CA 1.501 2.092 0 CA-C-O 121.29 0.566 . . . . 0.0 111.012 -178.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.55 -37.28 3.6 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.585 ' CG1' HG21 ' A' ' 92' ' ' VAL . 3.2 tp 41.6 94.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.521 3.08 0 CA-C-N 118.126 0.963 . . . . 0.0 112.253 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.2 mttm -86.87 157.45 19.53 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 121.233 -0.917 . . . . 0.0 112.693 -177.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.6 tttp -61.68 -27.38 68.65 Favored 'General case' 0 N--CA 1.508 2.453 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.12 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.5 t -81.11 -11.74 59.41 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 121.896 -0.503 . . . . 0.0 111.601 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.64 -17.54 20.31 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.534 -0.729 . . . . 0.0 111.482 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.475 ' HB3' HG12 ' A' ' 92' ' ' VAL . 8.4 pt-20 -68.75 148.28 50.58 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.36 -0.837 . . . . 0.0 109.933 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 167.01 -107.15 0.28 Allowed Glycine 0 N--CA 1.496 2.695 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.9 m -145.26 104.2 3.92 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 122.023 -0.692 . . . . 0.0 110.864 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -85.44 138.02 32.53 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -97.42 120.29 37.52 Favored 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.447 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 85' ' ' PHE . 2.9 m -87.31 105.73 17.45 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.277 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -104.63 85.97 2.41 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.298 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.29 87.96 0.25 Allowed Glycine 0 N--CA 1.499 2.899 0 N-CA-C 107.674 -2.17 . . . . 0.0 107.674 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.706 0.765 . . . . 0.0 112.967 -176.961 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.651 HD21 ' N ' ' A' ' 84' ' ' ASN . 0.8 OUTLIER . . . . . 0 N--CA 1.504 2.266 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.451 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 35.4 p90 -164.12 176.69 9.04 Favored 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.2 pttt -170.53 167.13 8.17 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.583 ' O ' HG22 ' A' ' 9' ' ' THR . 5.8 p-10 -105.54 123.96 48.77 Favored 'General case' 0 N--CA 1.513 2.677 0 O-C-N 121.801 -0.562 . . . . 0.0 111.703 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.537 HD12 ' N ' ' A' ' 88' ' ' ILE . 1.9 mp -104.85 119.24 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -83.54 114.83 21.79 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.409 HG13 HE21 ' A' ' 11' ' ' GLN . 46.5 t -108.52 132.92 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.235 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 50.2 mt -121.95 159.25 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.585 HG21 ' CG1' ' A' ' 63' ' ' ILE . 1.4 p . . . . . 0 N--CA 1.498 1.943 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.699 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 44.5 t . . . . . 0 N--CA 1.505 2.276 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.527 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 12.5 mmt -119.85 116.23 25.44 Favored 'General case' 0 N--CA 1.507 2.396 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.803 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -72.88 115.71 12.5 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 122.118 -0.364 . . . . 0.0 111.101 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -124.49 156.56 37.05 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.566 0.698 . . . . 0.0 110.357 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.426 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.2 OUTLIER 41.07 81.82 0.03 OUTLIER 'General case' 0 N--CA 1.518 2.94 0 C-N-CA 123.479 0.712 . . . . 0.0 111.919 -179.47 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -131.92 68.54 80.49 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.711 -0.618 . . . . 0.0 111.68 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -67.12 88.85 0.31 Allowed 'Trans proline' 0 N--CA 1.492 1.397 0 N-CA-C 107.966 -1.59 . . . . 0.0 107.966 177.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.544 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.6 OUTLIER -48.69 -68.27 0.34 Allowed Pre-proline 0 N--CA 1.509 2.496 0 CA-C-O 116.795 -1.574 . . . . 0.0 113.069 -176.702 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.487 ' HD3' ' OG1' ' A' ' 9' ' ' THR . 1.5 Cg_endo -71.31 93.88 0.66 Allowed 'Trans proline' 0 N--CA 1.497 1.686 0 CA-C-N 121.516 1.577 . . . . 0.0 111.441 178.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.498 HE21 HG13 ' A' ' 90' ' ' VAL . 16.1 pt20 -101.0 173.98 6.22 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.02 -1.05 . . . . 0.0 110.26 178.408 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 15.5 tt0 -158.79 120.39 3.45 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.238 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -116.72 -169.76 1.69 Allowed 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.945 -0.472 . . . . 0.0 109.94 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -102.01 137.46 40.25 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.597 0.713 . . . . 0.0 111.705 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -60.79 118.78 7.07 Favored 'General case' 0 N--CA 1.508 2.444 0 O-C-N 121.964 -0.46 . . . . 0.0 110.494 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.3 23.54 37.01 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.422 ' O ' HG22 ' A' ' 63' ' ' ILE . 15.4 tt0 -118.26 165.17 14.14 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 118.412 1.106 . . . . 0.0 110.867 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.71 97.74 8.08 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 178.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.19 169.96 9.23 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.729 -177.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.681 HG22 ' HG2' ' A' ' 59' ' ' GLN . 93.2 t -142.88 140.76 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 178.247 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.873 HD12 HD23 ' A' ' 58' ' ' LEU . 20.8 mt -96.02 113.32 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 178.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.437 HG13 ' CE2' ' A' ' 57' ' ' TYR . 45.2 t -73.66 122.04 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.21 -176.323 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -164.92 89.81 0.5 Allowed 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.426 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -88.6 141.3 28.64 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.056 -179.374 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.675 HG21 HD12 ' A' ' 33' ' ' ILE . 38.3 t -148.16 132.08 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.527 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 53.8 t -95.32 78.57 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.6 m -81.52 163.48 22.65 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 178.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 t -43.04 -85.06 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.329 0 O-C-N 121.825 -0.547 . . . . 0.0 111.582 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.401 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 0.5 OUTLIER -167.29 -63.15 0.01 OUTLIER Pre-proline 0 N--CA 1.514 2.768 0 CA-C-O 117.707 -1.14 . . . . 0.0 111.663 177.783 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.401 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 2.9 Cg_endo -59.76 -53.23 3.45 Favored 'Trans proline' 0 CA--C 1.564 1.999 0 CA-C-N 120.209 1.11 . . . . 0.0 112.446 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.55 -164.4 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 120.55 0.833 . . . . 0.0 112.185 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -171.12 -166.69 0.49 Allowed 'General case' 0 N--CA 1.519 3.019 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.443 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.675 HD12 HG21 ' A' ' 25' ' ' VAL . 15.1 tt -97.96 165.45 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 81.1 mt -128.65 133.9 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.55 ' HB2' HG22 ' A' ' 42' ' ' VAL . 82.7 m95 -97.55 115.49 27.95 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.7 tttt . . . . . 0 N--CA 1.505 2.3 0 CA-C-O 121.334 0.588 . . . . 0.0 111.295 -178.623 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.55 HG22 ' HB2' ' A' ' 35' ' ' TRP . 5.7 m . . . . . 0 N--CA 1.507 2.421 0 CA-C-O 120.831 0.348 . . . . 0.0 110.626 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.5 mm -58.44 -18.41 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.806 0 O-C-N 121.623 -0.673 . . . . 0.0 111.77 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.47 ' N ' HD12 ' A' ' 44' ' ' LEU . 10.4 mp -91.66 -23.02 19.96 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.527 -0.733 . . . . 0.0 111.133 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -98.9 -42.28 7.23 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.753 -0.592 . . . . 0.0 110.034 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt 48.05 56.91 6.65 Favored 'General case' 0 N--CA 1.509 2.499 0 CA-C-O 121.492 0.663 . . . . 0.0 111.892 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -50.9 170.14 0.04 OUTLIER 'General case' 0 N--CA 1.517 2.893 0 O-C-N 121.689 -0.632 . . . . 0.0 111.506 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 36.0 m -63.21 -19.5 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.64 0 O-C-N 122.054 -0.404 . . . . 0.0 111.985 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.1 ptp85 -109.42 0.16 19.23 Favored 'General case' 0 N--CA 1.506 2.349 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -99.33 106.1 18.16 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.35 -0.844 . . . . 0.0 110.562 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 74.5 mt -129.64 110.49 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.478 HG22 ' CD1' ' A' ' 58' ' ' LEU . 2.5 t -77.62 137.88 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.51 HD11 ' CG ' ' A' ' 59' ' ' GLN . 45.0 mt -89.97 167.44 12.8 Favored 'General case' 0 N--CA 1.505 2.321 0 CA-C-O 121.387 0.613 . . . . 0.0 112.01 -178.121 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.7 p -60.92 -22.41 64.33 Favored 'General case' 0 N--CA 1.51 2.554 0 O-C-N 122.137 -0.352 . . . . 0.0 111.229 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 35.5 p-10 -91.29 18.54 6.92 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.735 -0.603 . . . . 0.0 111.48 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.6 m120 67.48 33.21 5.3 Favored 'General case' 0 N--CA 1.516 2.86 0 O-C-N 121.544 -0.722 . . . . 0.0 111.999 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.437 ' CE2' HG13 ' A' ' 22' ' ' VAL . 4.1 m-85 -103.06 163.84 11.97 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 177.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.873 HD23 HD12 ' A' ' 21' ' ' ILE . 20.8 tp -120.11 100.6 7.3 Favored 'General case' 0 N--CA 1.516 2.859 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.968 -179.452 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.681 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -78.69 105.32 9.9 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.328 179.672 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.755 HD11 HD11 ' A' ' 21' ' ' ILE . 96.4 mt -97.47 102.81 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 177.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -67.55 118.17 10.49 Favored 'General case' 0 N--CA 1.506 2.33 0 CA-C-O 121.155 0.503 . . . . 0.0 111.221 -178.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.57 -39.14 2.85 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.582 HG23 HG21 ' A' ' 92' ' ' VAL . 2.8 tp 40.13 85.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.52 3.042 0 CA-C-O 122.023 0.916 . . . . 0.0 112.308 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.452 ' HB3' HG22 ' A' ' 66' ' ' THR . 28.2 mtpt -68.95 151.28 46.74 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 121.548 -0.72 . . . . 0.0 111.347 -178.223 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.619 ' HA ' HG13 ' A' ' 92' ' ' VAL . 0.1 OUTLIER -63.24 -17.99 63.06 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 122.15 -0.344 . . . . 0.0 110.956 179.023 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.452 HG22 ' HB3' ' A' ' 64' ' ' LYS . 10.0 t -90.98 -12.37 36.11 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.551 -0.718 . . . . 0.0 111.246 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.81 14.71 18.51 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.454 -0.779 . . . . 0.0 111.532 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.813 ' HB3' HG12 ' A' ' 92' ' ' VAL . 0.7 OUTLIER -97.41 148.07 23.56 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.416 -0.802 . . . . 0.0 109.946 179.674 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 169.52 -102.1 0.18 Allowed Glycine 0 N--CA 1.498 2.769 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.6 m -148.38 100.76 3.18 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 122.025 -0.691 . . . . 0.0 110.994 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -80.76 133.41 35.64 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.211 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.8 tpt180 -96.32 116.56 29.22 Favored 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.651 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 7.1 m -79.29 132.89 36.6 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -134.82 91.13 2.72 Favored 'General case' 0 N--CA 1.503 2.178 0 CA-C-N 118.719 0.69 . . . . 0.0 110.724 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.76 121.21 10.56 Favored Glycine 0 N--CA 1.501 3.03 0 N-CA-C 107.598 -2.201 . . . . 0.0 107.598 178.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 . . . . . 0 N--CA 1.503 2.188 0 CA-C-N 118.308 1.054 . . . . 0.0 113.581 -177.251 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.614 HD21 ' N ' ' A' ' 84' ' ' ASN . 1.2 m-80 . . . . . 0 N--CA 1.501 2.124 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -161.37 -177.92 6.31 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.797 -0.761 . . . . 0.0 112.035 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.5 tptp -169.17 166.07 10.87 Favored 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.544 ' O ' HG22 ' A' ' 9' ' ' THR . 4.4 p-10 -111.03 112.86 24.98 Favored 'General case' 0 N--CA 1.51 2.544 0 CA-C-O 121.071 0.462 . . . . 0.0 110.46 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.57 HD12 ' N ' ' A' ' 88' ' ' ILE . 2.2 mp -101.07 118.99 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -83.52 127.32 33.63 Favored 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.498 HG13 HE21 ' A' ' 11' ' ' GLN . 40.7 t -121.11 132.7 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 O-C-N 121.808 -0.558 . . . . 0.0 109.905 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 72.1 mt -126.05 146.34 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.813 HG12 ' HB3' ' A' ' 68' ' ' GLU . 9.8 p . . . . . 0 N--CA 1.501 2.103 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.714 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.603 HG12 ' HA ' ' A' ' 27' ' ' SER . 14.5 m . . . . . 0 N--CA 1.504 2.272 0 CA-C-O 121.335 0.588 . . . . 0.0 109.464 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.514 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 0.7 OUTLIER -87.8 106.81 18.33 Favored 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.907 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -67.13 119.9 12.83 Favored 'General case' 0 N--CA 1.506 2.346 0 CA-C-O 120.812 0.339 . . . . 0.0 110.738 -178.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.408 ' HG2' HG23 ' A' ' 26' ' ' VAL . 3.2 pttt -135.13 163.84 29.03 Favored 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 121.88 0.847 . . . . 0.0 112.26 -179.054 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.4 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.3 OUTLIER 28.59 95.58 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.134 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 179.133 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.429 ' HB2' ' HA ' ' A' ' 23' ' ' CYS . . . -164.82 84.0 1.16 Allowed Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.953 -0.467 . . . . 0.0 111.154 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -65.2 106.04 0.77 Allowed 'Trans proline' 0 N--CA 1.492 1.392 0 N-CA-C 108.419 -1.416 . . . . 0.0 108.419 177.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.558 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.2 OUTLIER -51.04 -65.64 0.88 Allowed Pre-proline 0 N--CA 1.508 2.45 0 CA-C-O 116.91 -1.519 . . . . 0.0 112.594 -177.02 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.488 ' HD3' ' OG1' ' A' ' 9' ' ' THR . 1.4 Cg_endo -75.1 94.55 0.96 Allowed 'Trans proline' 0 N--CA 1.495 1.59 0 CA-C-N 121.182 1.458 . . . . 0.0 111.019 178.475 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.434 HE21 HG13 ' A' ' 90' ' ' VAL . 16.1 pt20 -99.96 179.35 4.53 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 120.949 -1.095 . . . . 0.0 110.276 178.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -160.6 121.75 2.99 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.825 -0.547 . . . . 0.0 111.82 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -118.95 -170.95 2.01 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.929 -0.482 . . . . 0.0 109.988 178.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.1 tttp -102.33 135.95 43.04 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.505 0.669 . . . . 0.0 111.339 -178.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -60.66 112.42 2.0 Allowed 'General case' 0 N--CA 1.508 2.47 0 O-C-N 121.929 -0.482 . . . . 0.0 110.533 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.02 23.89 16.42 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.417 ' O ' HG22 ' A' ' 63' ' ' ILE . 18.3 tt0 -118.4 165.79 13.44 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-N 118.397 1.099 . . . . 0.0 110.676 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -81.72 98.98 8.68 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 177.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.03 166.67 10.92 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 120.24 -0.584 . . . . 0.0 112.116 -177.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.679 HG22 ' HG2' ' A' ' 59' ' ' GLN . 89.6 t -141.19 139.7 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 178.11 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.772 HD12 HD23 ' A' ' 58' ' ' LEU . 42.7 mt -95.38 119.11 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 106.563 -1.644 . . . . 0.0 106.563 178.406 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.412 ' HA ' ' CE2' ' A' ' 57' ' ' TYR . 54.1 t -78.59 118.87 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 CA-C-O 121.415 0.626 . . . . 0.0 110.922 -176.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.429 ' HA ' ' HB2' ' A' ' 7' ' ' ALA . 1.6 t -159.91 91.56 0.97 Allowed 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.4 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -90.12 138.29 31.64 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.103 -179.051 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.708 HG21 HD12 ' A' ' 33' ' ' ILE . 43.6 t -147.51 124.17 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.514 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 29.0 t -85.51 75.01 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.603 ' HA ' HG12 ' A' ' 2' ' ' VAL . 3.4 m -75.48 158.22 32.9 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.468 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.5 t -40.45 -77.97 0.02 OUTLIER 'General case' 0 N--CA 1.525 3.323 0 CA-C-N 118.158 0.435 . . . . 0.0 111.597 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.404 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 1.2 mt -173.27 -63.47 0.0 OUTLIER Pre-proline 0 N--CA 1.515 2.789 0 CA-C-O 117.719 -1.134 . . . . 0.0 111.064 177.154 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.404 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 2.9 Cg_endo -60.13 -53.35 3.13 Favored 'Trans proline' 0 CA--C 1.564 1.98 0 CA-C-N 120.105 1.073 . . . . 0.0 112.473 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -62.11 -164.83 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 120.503 0.802 . . . . 0.0 112.558 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -170.34 -167.37 0.61 Allowed 'General case' 0 N--CA 1.519 3.003 0 O-C-N 121.921 -0.487 . . . . 0.0 110.434 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.708 HD12 HG21 ' A' ' 25' ' ' VAL . 17.8 tt -103.59 139.42 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.539 ' N ' HD12 ' A' ' 34' ' ' ILE . 4.0 mp -102.13 130.57 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.528 ' HB2' HG22 ' A' ' 42' ' ' VAL . 72.3 m95 -92.68 114.78 27.43 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt . . . . . 0 N--CA 1.501 2.115 0 O-C-N 121.903 -0.498 . . . . 0.0 111.035 -178.981 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.528 HG22 ' HB2' ' A' ' 35' ' ' TRP . 8.7 m . . . . . 0 N--CA 1.507 2.387 0 CA-C-O 121.282 0.563 . . . . 0.0 109.739 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.579 HG12 HG21 ' A' ' 52' ' ' VAL . 58.5 mt -60.94 -17.48 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.718 0 O-C-N 121.964 -0.46 . . . . 0.0 111.423 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.476 ' N ' HD12 ' A' ' 44' ' ' LEU . 10.1 mp -90.08 -23.64 21.35 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.473 -0.767 . . . . 0.0 110.451 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -99.06 -35.45 10.03 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.721 -0.612 . . . . 0.0 109.544 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.5 mmmt 49.27 54.85 10.25 Favored 'General case' 0 N--CA 1.506 2.351 0 CA-C-O 121.359 0.6 . . . . 0.0 111.978 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.0 167.24 0.12 Allowed 'General case' 0 N--CA 1.517 2.888 0 O-C-N 121.895 -0.503 . . . . 0.0 110.729 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.9 m -60.81 -19.38 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.741 0 O-C-N 121.874 -0.516 . . . . 0.0 111.843 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 25.6 ptt-85 -118.52 45.41 2.04 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.676 -0.64 . . . . 0.0 111.915 -179.275 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -146.51 104.84 3.8 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.604 -0.685 . . . . 0.0 109.752 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 76.1 mt -129.87 108.32 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.579 HG21 HG12 ' A' ' 43' ' ' ILE . 2.7 t -74.65 140.88 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.422 HD11 ' OE1' ' A' ' 59' ' ' GLN . 17.0 mt -95.49 169.59 9.95 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.821 -0.549 . . . . 0.0 111.899 -178.213 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.6 p -61.88 -23.11 66.09 Favored 'General case' 0 N--CA 1.509 2.521 0 O-C-N 122.183 -0.323 . . . . 0.0 111.007 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 44.6 p-10 -88.19 15.15 7.93 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.768 -0.582 . . . . 0.0 111.412 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.424 ' HB3' HG21 ' A' ' 33' ' ' ILE . 7.6 m120 68.13 33.47 4.43 Favored 'General case' 0 N--CA 1.516 2.834 0 O-C-N 121.577 -0.702 . . . . 0.0 112.023 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.412 ' CE2' ' HA ' ' A' ' 22' ' ' VAL . 3.8 m-85 -102.85 166.83 10.25 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.165 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.772 HD23 HD12 ' A' ' 21' ' ' ILE . 19.2 tp -120.83 98.03 5.81 Favored 'General case' 0 N--CA 1.519 2.991 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.666 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.679 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.7 OUTLIER -75.65 101.11 4.85 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.917 179.464 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.599 HD11 HD11 ' A' ' 21' ' ' ILE . 95.5 mt -92.12 115.37 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 177.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -77.58 112.23 14.16 Favored 'General case' 0 N--CA 1.505 2.298 0 CA-C-O 121.521 0.677 . . . . 0.0 111.467 -178.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 100.16 -36.44 4.12 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 179.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.587 ' CG1' HG21 ' A' ' 92' ' ' VAL . 2.6 tp 41.77 74.47 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.519 3.003 0 CA-C-O 122.249 1.024 . . . . 0.0 112.454 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.9 mmtp -62.8 158.6 18.39 Favored 'General case' 0 N--CA 1.509 2.483 0 O-C-N 121.488 -0.758 . . . . 0.0 112.336 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.3 tptt -61.97 -24.55 67.08 Favored 'General case' 0 N--CA 1.51 2.557 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.833 178.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.3 t -83.61 -15.1 50.31 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.773 -0.579 . . . . 0.0 111.109 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -94.12 11.09 31.22 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.635 -0.666 . . . . 0.0 111.595 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.512 ' HB3' HG12 ' A' ' 92' ' ' VAL . 9.1 pt-20 -98.74 137.3 37.55 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.275 -0.891 . . . . 0.0 109.593 179.136 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 174.7 -106.37 0.22 Allowed Glycine 0 N--CA 1.499 2.886 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.3 m -143.33 102.2 3.93 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.946 -0.737 . . . . 0.0 110.901 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -83.61 132.55 34.89 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.7 tpp85 -96.42 118.18 32.4 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.459 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.692 ' HB3' HD11 ' A' ' 33' ' ' ILE . 9.0 m -81.04 126.4 31.38 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 177.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -125.26 87.28 2.68 Favored 'General case' 0 N--CA 1.503 2.178 0 CA-C-N 118.605 0.639 . . . . 0.0 110.681 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.83 101.0 0.6 Allowed Glycine 0 N--CA 1.501 3.021 0 N-CA-C 107.921 -2.071 . . . . 0.0 107.921 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 30.3 ttp85 . . . . . 0 N--CA 1.495 1.797 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -176.961 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.414 ' N ' HD21 ' A' ' 84' ' ' ASN . 1.2 m-80 . . . . . 0 N--CA 1.502 2.134 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -164.51 177.64 7.99 Favored 'General case' 0 N--CA 1.503 2.22 0 C-N-CA 119.861 -0.736 . . . . 0.0 112.744 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.48 ' HG3' HD11 ' A' ' 88' ' ' ILE . 1.3 pttt -167.42 163.6 14.99 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 177.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.558 ' O ' HG22 ' A' ' 9' ' ' THR . 10.2 p-10 -99.79 119.34 38.01 Favored 'General case' 0 N--CA 1.511 2.618 0 O-C-N 121.884 -0.51 . . . . 0.0 111.698 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.579 HD12 ' N ' ' A' ' 88' ' ' ILE . 3.1 mp -104.17 118.47 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.013 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -84.06 125.65 32.31 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.434 HG13 HE21 ' A' ' 11' ' ' GLN . 47.6 t -119.26 126.08 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 O-C-N 121.719 -0.613 . . . . 0.0 109.792 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 51.1 mt -116.4 157.97 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.587 HG21 ' CG1' ' A' ' 63' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.5 2.053 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.394 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 37.6 t . . . . . 0 N--CA 1.501 2.123 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.49 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 1.6 mmm -108.43 111.54 23.49 Favored 'General case' 0 N--CA 1.508 2.468 0 C-N-CA 120.144 -0.622 . . . . 0.0 109.821 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -67.65 119.87 13.11 Favored 'General case' 0 N--CA 1.505 2.319 0 CA-C-O 120.786 0.327 . . . . 0.0 110.783 -178.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.462 ' HG2' HG23 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -132.56 160.29 36.99 Favored 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 121.553 0.692 . . . . 0.0 111.114 -179.821 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.415 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.4 OUTLIER 31.41 58.81 0.29 Allowed 'General case' 0 N--CA 1.519 2.994 0 C-N-CA 124.148 0.979 . . . . 0.0 113.561 179.411 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -121.37 79.14 36.43 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.697 -0.627 . . . . 0.0 110.74 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -65.75 114.12 2.82 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 N-CA-C 109.189 -1.12 . . . . 0.0 109.189 178.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.581 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.2 OUTLIER -67.75 -66.76 1.02 Allowed Pre-proline 0 N--CA 1.498 1.956 0 CA-C-O 117.059 -1.448 . . . . 0.0 111.208 -178.335 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.485 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.4 Cg_endo -72.17 89.22 0.8 Allowed 'Trans proline' 0 N--CA 1.498 1.763 0 CA-C-N 121.108 1.432 . . . . 0.0 111.199 178.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.421 HE21 HG13 ' A' ' 90' ' ' VAL . 10.5 pt20 -100.36 171.75 7.57 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 120.715 -1.24 . . . . 0.0 110.088 178.521 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -154.4 127.44 8.31 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.816 -0.552 . . . . 0.0 111.646 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -125.73 -164.0 1.26 Allowed 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.36 142.63 51.13 Favored 'General case' 0 N--CA 1.513 2.694 0 CA-C-O 121.856 0.836 . . . . 0.0 111.455 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -56.26 141.86 39.73 Favored 'General case' 0 N--CA 1.51 2.536 0 O-C-N 121.831 -0.543 . . . . 0.0 111.082 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.15 12.73 72.38 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -104.87 156.09 18.33 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 119.116 1.458 . . . . 0.0 111.34 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -81.12 95.45 6.88 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 176.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.15 166.34 11.46 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.996 -0.682 . . . . 0.0 112.203 -176.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.713 HG22 ' HG2' ' A' ' 59' ' ' GLN . 94.3 t -140.04 140.05 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 178.355 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.816 HD12 HD23 ' A' ' 58' ' ' LEU . 47.9 mt -94.87 117.0 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 178.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.497 HG13 ' CE2' ' A' ' 57' ' ' TYR . 39.2 t -77.08 119.48 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 CA-C-O 121.431 0.634 . . . . 0.0 110.98 -176.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.4 t -161.34 92.03 0.88 Allowed 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.415 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.2 OUTLIER -92.09 140.59 29.49 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.905 -0.718 . . . . 0.0 109.314 -179.131 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.687 HG21 HD12 ' A' ' 33' ' ' ILE . 43.7 t -146.79 128.19 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.49 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 45.9 t -89.42 74.09 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.0 m -78.44 161.79 26.86 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 178.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 t -41.96 -78.29 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.199 0 CA-C-N 118.191 0.451 . . . . 0.0 111.566 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -174.0 -62.54 0.0 OUTLIER Pre-proline 0 N--CA 1.515 2.809 0 CA-C-O 117.873 -1.06 . . . . 0.0 111.498 177.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.68 -53.44 3.31 Favored 'Trans proline' 0 CA--C 1.562 1.913 0 CA-C-N 119.845 0.981 . . . . 0.0 112.519 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -61.4 -165.28 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 120.535 0.823 . . . . 0.0 112.61 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -170.35 -170.13 0.92 Allowed 'General case' 0 N--CA 1.521 3.114 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.717 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.687 HD12 HG21 ' A' ' 25' ' ' VAL . 18.3 tt -100.92 140.22 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.226 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.535 ' N ' HD12 ' A' ' 34' ' ' ILE . 5.1 mp -102.91 128.36 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.009 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.527 ' HB2' HG22 ' A' ' 42' ' ' VAL . 73.6 m95 -90.56 112.88 24.73 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.0 ttpt . . . . . 0 N--CA 1.504 2.251 0 O-C-N 121.783 -0.573 . . . . 0.0 111.059 -178.685 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.527 HG22 ' HB2' ' A' ' 35' ' ' TRP . 6.4 m . . . . . 0 N--CA 1.503 2.208 0 CA-C-O 121.111 0.481 . . . . 0.0 109.791 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 77.3 mt -60.24 -17.61 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.855 0 O-C-N 122.071 -0.393 . . . . 0.0 111.418 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.463 ' N ' HD12 ' A' ' 44' ' ' LEU . 10.7 mp -90.16 -23.65 21.27 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.511 -0.743 . . . . 0.0 110.617 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.403 ' HG2' ' HA ' ' A' ' 42' ' ' VAL . 45.0 pttt -99.15 -36.91 9.52 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.719 -0.613 . . . . 0.0 109.572 178.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.7 mmmt 47.97 56.72 6.87 Favored 'General case' 0 N--CA 1.508 2.426 0 CA-C-O 121.503 0.668 . . . . 0.0 111.88 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.67 168.45 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.811 0 O-C-N 121.863 -0.523 . . . . 0.0 111.638 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.9 m -59.91 -20.04 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.68 0 O-C-N 121.923 -0.485 . . . . 0.0 112.268 -178.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.9 ptp85 -114.68 4.37 15.03 Favored 'General case' 0 N--CA 1.507 2.42 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -102.32 111.3 23.53 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.143 -0.973 . . . . 0.0 110.916 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 82.6 mt -132.87 105.96 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.531 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.2 t -73.39 136.73 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.417 HD11 ' CG ' ' A' ' 59' ' ' GLN . 14.4 mt -90.22 166.83 13.13 Favored 'General case' 0 N--CA 1.507 2.386 0 CA-C-O 121.319 0.58 . . . . 0.0 111.845 -178.237 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 92.9 p -60.87 -21.7 63.54 Favored 'General case' 0 N--CA 1.509 2.487 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.249 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 42.0 p-10 -90.32 17.92 6.67 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.629 -0.67 . . . . 0.0 111.475 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.416 ' HB3' HG21 ' A' ' 33' ' ' ILE . 4.5 m120 68.26 30.72 5.49 Favored 'General case' 0 N--CA 1.518 2.948 0 O-C-N 121.605 -0.685 . . . . 0.0 112.051 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.497 ' CE2' HG13 ' A' ' 22' ' ' VAL . 3.6 m-85 -101.71 165.2 11.34 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.347 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.816 HD23 HD12 ' A' ' 21' ' ' ILE . 17.1 tp -120.06 102.61 8.65 Favored 'General case' 0 N--CA 1.518 2.942 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.751 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.713 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.7 OUTLIER -80.0 103.42 9.87 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.368 179.653 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.522 HD11 HD11 ' A' ' 21' ' ' ILE . 95.1 mt -95.89 104.7 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 177.343 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -68.01 113.22 5.51 Favored 'General case' 0 N--CA 1.505 2.289 0 CA-C-O 121.07 0.462 . . . . 0.0 110.756 -178.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.402 ' O ' HG22 ' A' ' 63' ' ' ILE . . . 100.92 -40.17 2.51 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 179.226 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.55 ' CG1' HG21 ' A' ' 92' ' ' VAL . 1.7 tp 42.91 72.14 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.961 0 CA-C-O 122.228 1.013 . . . . 0.0 112.446 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 59.9 mttt -62.33 158.62 16.95 Favored 'General case' 0 N--CA 1.51 2.527 0 O-C-N 121.63 -0.669 . . . . 0.0 112.154 -178.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.5 mtmt -62.84 -23.65 67.39 Favored 'General case' 0 N--CA 1.508 2.473 0 O-C-N 122.134 -0.354 . . . . 0.0 110.879 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.0 p -80.77 -17.28 51.44 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.741 -0.6 . . . . 0.0 110.774 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -94.23 10.02 35.7 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.701 -0.624 . . . . 0.0 111.725 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.542 ' HB3' HG12 ' A' ' 92' ' ' VAL . 8.2 pt-20 -98.18 144.57 27.49 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-N 119.209 0.913 . . . . 0.0 110.156 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 167.94 -102.93 0.19 Allowed Glycine 0 N--CA 1.499 2.878 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.7 m -145.98 102.87 3.69 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 122.123 -0.634 . . . . 0.0 111.122 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -83.97 133.73 34.68 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -95.41 120.68 36.07 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.405 -179.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.681 ' HB3' HD11 ' A' ' 33' ' ' ILE . 7.3 m -85.21 122.57 29.6 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 177.403 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -125.06 88.39 2.88 Favored 'General case' 0 N--CA 1.505 2.293 0 CA-C-N 119.021 0.828 . . . . 0.0 111.061 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.39 110.52 3.46 Favored Glycine 0 N--CA 1.502 3.071 0 N-CA-C 107.911 -2.076 . . . . 0.0 107.911 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.7 ttp85 . . . . . 0 N--CA 1.499 2.004 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -177.096 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.653 HD21 ' N ' ' A' ' 84' ' ' ASN . 0.9 OUTLIER . . . . . 0 N--CA 1.501 2.083 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.422 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 30.7 p90 -157.24 -177.25 6.46 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 119.497 -0.881 . . . . 0.0 112.669 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 9.6 tptt -168.4 165.36 12.73 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.581 ' O ' HG22 ' A' ' 9' ' ' THR . 7.5 p-10 -110.31 108.74 18.92 Favored 'General case' 0 N--CA 1.509 2.494 0 CA-C-O 120.974 0.416 . . . . 0.0 110.245 178.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.588 HD12 ' N ' ' A' ' 88' ' ' ILE . 2.2 mp -92.76 113.78 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -80.68 105.08 11.65 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.421 HG13 HE21 ' A' ' 11' ' ' GLN . 39.3 t -99.97 136.5 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.156 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 63.4 mt -126.92 156.95 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.55 HG21 ' CG1' ' A' ' 63' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.498 1.948 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.594 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.9 t . . . . . 0 N--CA 1.501 2.117 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.499 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 6.3 mmt -116.46 113.37 22.74 Favored 'General case' 0 N--CA 1.507 2.413 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.416 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -70.31 116.5 10.73 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 122.103 -0.373 . . . . 0.0 111.1 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt -119.9 155.98 31.65 Favored 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.423 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.1 OUTLIER 44.48 81.24 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.747 0 C-N-CA 122.718 0.407 . . . . 0.0 111.517 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -126.35 56.86 17.8 Favored Pre-proline 0 N--CA 1.497 1.907 0 O-C-N 121.64 -0.663 . . . . 0.0 112.425 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.02 90.67 0.16 Allowed 'Trans proline' 0 N--CA 1.496 1.62 0 N-CA-C 107.983 -1.583 . . . . 0.0 107.983 176.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.551 ' OG1' ' HD3' ' A' ' 10' ' ' PRO . 0.5 OUTLIER -52.93 -54.87 39.19 Favored Pre-proline 0 N--CA 1.503 2.194 0 CA-C-O 117.119 -1.419 . . . . 0.0 113.575 -176.268 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.551 ' HD3' ' OG1' ' A' ' 9' ' ' THR . 1.6 Cg_endo -80.27 92.84 1.07 Allowed 'Trans proline' 0 CA--C 1.549 1.242 0 CA-C-N 120.892 1.354 . . . . 0.0 111.584 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.544 HE21 HG13 ' A' ' 90' ' ' VAL . 16.7 pt20 -100.99 171.04 7.88 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.088 -1.007 . . . . 0.0 110.197 178.645 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -156.76 118.1 3.77 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.635 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -114.47 -170.0 1.64 Allowed 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.901 -0.499 . . . . 0.0 110.024 179.202 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -101.79 139.71 37.07 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.517 0.675 . . . . 0.0 111.452 -178.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -59.87 119.03 6.93 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 121.015 0.436 . . . . 0.0 110.842 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.69 23.49 46.26 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -114.57 164.31 14.18 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 118.621 1.211 . . . . 0.0 110.907 -179.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -79.72 98.88 7.17 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 177.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.78 170.64 8.41 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 120.218 -0.593 . . . . 0.0 111.731 -177.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.692 HG22 ' HG2' ' A' ' 59' ' ' GLN . 87.5 t -143.47 141.11 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 178.341 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.923 HD11 HD11 ' A' ' 60' ' ' ILE . 18.9 mt -96.11 115.25 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 178.506 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.414 HG13 ' CE2' ' A' ' 57' ' ' TYR . 46.0 t -74.94 122.0 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 CA-C-O 121.371 0.605 . . . . 0.0 111.205 -176.441 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -164.94 88.6 0.47 Allowed 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.423 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -87.79 145.01 26.3 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 119.785 -0.766 . . . . 0.0 108.995 -179.612 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.649 HG21 HD12 ' A' ' 33' ' ' ILE . 39.9 t -151.64 137.17 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.119 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.499 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 62.2 t -99.49 78.45 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 108.174 -1.046 . . . . 0.0 108.174 178.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.2 m -80.1 163.13 24.38 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 178.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.8 t -42.11 -79.83 0.01 OUTLIER 'General case' 0 N--CA 1.524 3.237 0 O-C-N 121.87 -0.519 . . . . 0.0 111.595 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.418 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 0.2 OUTLIER -171.13 -63.29 0.0 OUTLIER Pre-proline 0 N--CA 1.514 2.768 0 CA-C-O 117.715 -1.136 . . . . 0.0 111.593 177.675 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.418 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 2.8 Cg_endo -60.26 -53.21 3.17 Favored 'Trans proline' 0 CA--C 1.562 1.914 0 CA-C-N 120.045 1.052 . . . . 0.0 112.812 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.4 ' HD3' ' CG ' ' A' ' 30' ' ' PRO . 3.0 Cg_endo -62.04 -163.99 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 120.456 0.771 . . . . 0.0 112.716 -178.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -170.53 -168.12 0.67 Allowed 'General case' 0 N--CA 1.518 2.931 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.134 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.649 HD12 HG21 ' A' ' 25' ' ' VAL . 15.4 tt -100.24 155.28 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.294 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.529 ' N ' HD12 ' A' ' 34' ' ' ILE . 4.7 mp -117.65 132.35 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.577 ' CG ' HD22 ' A' ' 58' ' ' LEU . 79.4 m95 -94.54 104.67 16.62 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.2 tttt . . . . . 0 N--CA 1.498 1.969 0 CA-C-O 121.192 0.52 . . . . 0.0 110.609 -178.848 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.563 HG22 ' HB2' ' A' ' 35' ' ' TRP . 8.5 m . . . . . 0 N--CA 1.508 2.461 0 CA-C-O 120.896 0.379 . . . . 0.0 110.605 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 57.7 mt -59.21 -17.51 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.796 0 O-C-N 121.551 -0.718 . . . . 0.0 111.546 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.499 ' N ' HD12 ' A' ' 44' ' ' LEU . 8.8 mp -92.13 -21.82 20.21 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.491 -0.756 . . . . 0.0 111.122 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 39.9 pttt -97.25 -38.55 9.64 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.54 -0.725 . . . . 0.0 109.584 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.8 mmmt 46.31 55.05 7.77 Favored 'General case' 0 N--CA 1.51 2.54 0 CA-C-O 121.533 0.682 . . . . 0.0 112.116 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.05 169.86 0.09 Allowed 'General case' 0 N--CA 1.514 2.761 0 O-C-N 121.734 -0.604 . . . . 0.0 110.819 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.4 m -60.79 -19.57 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.621 0 O-C-N 121.965 -0.459 . . . . 0.0 111.664 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 8.9 ptp85 -119.32 46.82 1.81 Allowed 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.662 -0.649 . . . . 0.0 112.174 -178.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -145.62 99.21 3.25 Favored 'General case' 0 N--CA 1.508 2.431 0 O-C-N 121.556 -0.715 . . . . 0.0 110.081 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.485 ' N ' HD12 ' A' ' 51' ' ' ILE . 5.3 mp -125.8 114.44 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.251 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.509 HG22 ' CD1' ' A' ' 58' ' ' LEU . 2.5 t -79.99 131.69 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.9 mt -82.1 163.97 21.66 Favored 'General case' 0 N--CA 1.507 2.409 0 CA-C-O 121.328 0.585 . . . . 0.0 111.774 -178.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 92.4 p -60.4 -20.2 58.81 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 122.171 -0.331 . . . . 0.0 111.221 179.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 48.7 p-10 -91.33 19.23 6.18 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.609 -0.682 . . . . 0.0 111.389 179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.9 m120 67.23 32.17 6.19 Favored 'General case' 0 N--CA 1.516 2.835 0 O-C-N 121.613 -0.68 . . . . 0.0 112.401 178.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.414 ' CE2' HG13 ' A' ' 22' ' ' VAL . 4.0 m-85 -103.39 166.61 10.32 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.914 HD23 HD12 ' A' ' 21' ' ' ILE . 19.7 tp -121.72 97.99 5.75 Favored 'General case' 0 N--CA 1.515 2.791 0 C-N-CA 119.407 -0.917 . . . . 0.0 111.748 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.692 ' HG2' HG22 ' A' ' 20' ' ' VAL . 1.3 mt-30 -74.91 105.44 5.94 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.861 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.923 HD11 HD11 ' A' ' 21' ' ' ILE . 97.0 mt -96.44 112.1 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 178.136 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -73.1 112.66 9.35 Favored 'General case' 0 N--CA 1.506 2.336 0 CA-C-O 121.384 0.611 . . . . 0.0 111.423 -177.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.65 -36.08 4.15 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 178.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.506 HG23 HG21 ' A' ' 92' ' ' VAL . 1.7 tp 41.97 69.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.808 0 CA-C-O 122.185 0.993 . . . . 0.0 112.379 -178.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 55.3 mttt -57.55 158.9 5.42 Favored 'General case' 0 N--CA 1.51 2.56 0 O-C-N 121.615 -0.678 . . . . 0.0 112.209 -178.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 45.4 tttt -62.33 -23.63 66.88 Favored 'General case' 0 N--CA 1.508 2.452 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.895 178.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.7 t -83.15 -15.85 49.03 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.794 -0.566 . . . . 0.0 111.184 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -93.95 9.57 36.92 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.714 -0.616 . . . . 0.0 111.653 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -98.45 142.63 29.83 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.33 -0.856 . . . . 0.0 109.626 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 168.0 -103.81 0.2 Allowed Glycine 0 N--CA 1.498 2.815 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.4 m -145.93 102.78 3.69 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.974 -0.721 . . . . 0.0 111.21 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.4 ' CG ' HD13 ' A' ' 21' ' ' ILE . 24.9 m-85 -83.91 135.28 34.55 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.212 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.8 ttt85 -97.51 117.64 32.22 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.103 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.2 m -80.47 133.11 35.81 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 177.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -134.59 91.33 2.77 Favored 'General case' 0 N--CA 1.505 2.297 0 CA-C-N 118.686 0.676 . . . . 0.0 110.396 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.47 118.83 8.78 Favored Glycine 0 N--CA 1.503 3.141 0 N-CA-C 107.746 -2.142 . . . . 0.0 107.746 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.1 ttm180 . . . . . 0 N--CA 1.501 2.104 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -177.238 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.9 m120 . . . . . 0 N--CA 1.505 2.322 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -162.42 -175.21 4.4 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 119.684 -0.806 . . . . 0.0 112.715 -179.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.4 tptt -171.1 167.5 7.12 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.519 ' O ' HG22 ' A' ' 9' ' ' THR . 2.7 p-10 -115.37 108.09 16.07 Favored 'General case' 0 N--CA 1.513 2.723 0 O-C-N 121.844 -0.535 . . . . 0.0 110.222 178.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.606 HD12 ' N ' ' A' ' 88' ' ' ILE . 2.4 mp -96.16 115.71 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -84.63 111.02 19.17 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.544 HG13 HE21 ' A' ' 11' ' ' GLN . 42.5 t -105.48 138.05 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.917 -0.489 . . . . 0.0 110.291 -179.031 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 82.3 mt -128.23 157.31 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.506 HG21 HG23 ' A' ' 63' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.916 0 CA-C-O 118.062 -0.971 . . . . 0.0 110.458 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.2 t . . . . . 0 N--CA 1.506 2.332 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.542 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 6.5 mmt -110.27 110.9 21.89 Favored 'General case' 0 N--CA 1.506 2.348 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.18 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -71.24 113.71 8.56 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 122.086 -0.384 . . . . 0.0 110.239 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.6 ptpt -129.03 163.7 24.83 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 122.013 0.911 . . . . 0.0 112.301 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 29.69 95.49 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.014 0 C-N-CA 124.654 1.182 . . . . 0.0 114.185 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.403 ' HB2' ' HA ' ' A' ' 23' ' ' CYS . . . -164.47 84.67 1.19 Allowed Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.8 -0.562 . . . . 0.0 111.263 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -66.17 104.38 0.72 Allowed 'Trans proline' 0 N--CA 1.49 1.309 0 N-CA-C 108.288 -1.466 . . . . 0.0 108.288 177.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.548 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.2 OUTLIER -50.61 -66.01 0.76 Allowed Pre-proline 0 N--CA 1.51 2.56 0 CA-C-O 116.932 -1.509 . . . . 0.0 112.54 -176.973 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.485 ' HD3' ' OG1' ' A' ' 9' ' ' THR . 1.6 Cg_endo -73.99 94.5 0.88 Allowed 'Trans proline' 0 N--CA 1.494 1.542 0 CA-C-N 121.203 1.465 . . . . 0.0 110.937 178.266 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.441 HE21 HG13 ' A' ' 90' ' ' VAL . 17.1 pt20 -99.66 173.47 6.7 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.047 -1.033 . . . . 0.0 110.091 178.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -155.23 121.25 5.15 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 120.373 -0.531 . . . . 0.0 112.01 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -120.2 -170.5 1.98 Allowed 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 178.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 30.7 ttpt -104.92 139.32 39.81 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.339 0.59 . . . . 0.0 111.489 -179.023 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -62.1 111.6 2.01 Favored 'General case' 0 N--CA 1.508 2.447 0 CA-C-O 121.062 0.458 . . . . 0.0 110.359 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.51 22.31 16.93 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -117.16 164.83 14.18 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 118.474 1.137 . . . . 0.0 110.668 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -82.62 100.1 9.96 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 178.221 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -102.42 167.42 9.96 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.955 -177.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.666 HG22 ' HG2' ' A' ' 59' ' ' GLN . 95.7 t -138.99 141.2 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 178.049 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.894 HD12 HD23 ' A' ' 58' ' ' LEU . 22.5 mt -95.76 112.39 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 178.208 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.477 HG13 ' CE2' ' A' ' 57' ' ' TYR . 57.8 t -74.12 122.35 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 CA-C-O 121.551 0.691 . . . . 0.0 110.682 -176.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.403 ' HA ' ' HB2' ' A' ' 7' ' ' ALA . 1.2 t -163.7 92.55 0.7 Allowed 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.02 137.87 32.01 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.373 -179.094 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.432 HG21 HD13 ' A' ' 33' ' ' ILE . 41.1 t -147.18 125.71 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.542 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 40.8 t -91.06 79.43 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.3 m -78.06 167.14 21.9 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 178.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 t -45.49 -80.23 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.165 0 O-C-N 121.761 -0.587 . . . . 0.0 111.09 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.428 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 0.6 OUTLIER -166.98 -64.56 0.01 OUTLIER Pre-proline 0 N--CA 1.512 2.635 0 CA-C-O 117.566 -1.207 . . . . 0.0 111.697 177.529 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.428 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 2.8 Cg_endo -60.36 -53.49 2.89 Favored 'Trans proline' 0 CA--C 1.562 1.916 0 CA-C-N 120.233 1.119 . . . . 0.0 112.847 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.4 ' HD3' ' CG ' ' A' ' 30' ' ' PRO . 3.2 Cg_exo -61.15 -165.72 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 120.498 0.798 . . . . 0.0 113.223 -178.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -172.83 -161.36 0.15 Allowed 'General case' 0 N--CA 1.52 3.051 0 O-C-N 121.927 -0.483 . . . . 0.0 109.906 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.574 HD12 ' N ' ' A' ' 75' ' ' GLY . 0.6 OUTLIER -106.04 148.63 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.896 -0.503 . . . . 0.0 110.415 179.502 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.538 ' N ' HD12 ' A' ' 34' ' ' ILE . 5.3 mp -109.53 125.19 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.619 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.546 ' CG ' HD22 ' A' ' 58' ' ' LEU . 77.1 m95 -85.21 120.53 26.8 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.6 mmmt . . . . . 0 N--CA 1.503 2.184 0 CA-C-O 121.439 0.637 . . . . 0.0 111.71 -177.75 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.518 HG22 ' HB2' ' A' ' 35' ' ' TRP . 4.3 m . . . . . 0 N--CA 1.509 2.511 0 CA-C-O 121.13 0.49 . . . . 0.0 109.99 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.821 ' CD1' HG21 ' A' ' 52' ' ' VAL . 47.9 mm -59.57 -18.25 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.702 0 O-C-N 121.92 -0.487 . . . . 0.0 111.76 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.435 ' N ' HD12 ' A' ' 44' ' ' LEU . 10.7 mp -92.32 -21.4 20.3 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.509 -0.744 . . . . 0.0 111.195 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 35.1 pttt -98.55 -37.87 9.38 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.625 -0.672 . . . . 0.0 109.408 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.4 mmmt 47.61 54.25 10.03 Favored 'General case' 0 N--CA 1.51 2.551 0 CA-C-O 121.498 0.666 . . . . 0.0 111.859 179.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.99 161.43 2.32 Favored 'General case' 0 N--CA 1.512 2.661 0 O-C-N 121.754 -0.591 . . . . 0.0 110.404 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.4 m -58.42 -20.3 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.77 0 O-C-N 121.924 -0.485 . . . . 0.0 111.613 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -108.0 37.86 2.35 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.78 -0.575 . . . . 0.0 111.806 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -144.86 106.75 4.29 Favored 'General case' 0 N--CA 1.506 2.375 0 O-C-N 121.767 -0.583 . . . . 0.0 109.598 178.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 72.9 mt -126.21 102.14 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.821 HG21 ' CD1' ' A' ' 43' ' ' ILE . 4.2 t -74.33 132.08 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.4 mt -88.15 162.45 16.71 Favored 'General case' 0 N--CA 1.504 2.272 0 CA-C-O 121.272 0.558 . . . . 0.0 111.571 -178.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.6 p -60.24 -19.64 55.44 Favored 'General case' 0 N--CA 1.511 2.598 0 O-C-N 122.141 -0.35 . . . . 0.0 111.427 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 43.2 p-10 -91.74 19.5 6.4 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.565 -0.71 . . . . 0.0 111.374 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.43 ' HB3' HG21 ' A' ' 33' ' ' ILE . 4.7 m120 67.93 32.05 5.34 Favored 'General case' 0 N--CA 1.518 2.93 0 O-C-N 121.783 -0.573 . . . . 0.0 112.356 178.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.477 ' CE2' HG13 ' A' ' 22' ' ' VAL . 4.3 m-85 -103.59 163.37 12.35 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.608 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.894 HD23 HD12 ' A' ' 21' ' ' ILE . 16.8 tp -122.14 97.51 5.51 Favored 'General case' 0 N--CA 1.513 2.722 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.715 -179.421 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.666 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -75.53 98.48 3.97 Favored 'General case' 0 N--CA 1.501 2.082 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.825 179.512 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.801 HD11 HD11 ' A' ' 21' ' ' ILE . 98.0 mt -90.73 115.94 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.369 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.17 115.08 15.55 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 121.265 0.555 . . . . 0.0 110.991 -178.529 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.31 -37.5 3.46 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.447 ' CG1' HG21 ' A' ' 92' ' ' VAL . 2.5 tp 41.7 70.57 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.517 2.897 0 CA-C-O 122.237 1.018 . . . . 0.0 112.246 -178.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.533 ' HB3' HG22 ' A' ' 66' ' ' THR . 39.7 mtpt -67.04 149.89 49.97 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.589 -0.694 . . . . 0.0 111.472 -178.533 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.618 ' HA ' HG12 ' A' ' 92' ' ' VAL . 22.6 pttt -60.96 -24.29 65.97 Favored 'General case' 0 N--CA 1.511 2.582 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.493 178.214 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.533 HG22 ' HB3' ' A' ' 64' ' ' LYS . 9.4 t -71.17 -18.15 62.5 Favored 'General case' 0 N--CA 1.502 2.144 0 C-N-CA 120.261 -0.575 . . . . 0.0 110.134 177.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -102.67 -1.03 30.87 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.644 -0.66 . . . . 0.0 111.842 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -79.23 153.5 29.91 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.163 -0.961 . . . . 0.0 109.606 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 161.74 -102.66 0.21 Allowed Glycine 0 N--CA 1.497 2.733 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.5 m -152.97 104.18 2.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 122.084 -0.656 . . . . 0.0 110.305 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -82.82 135.37 34.97 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -96.77 119.8 35.93 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.762 -0.586 . . . . 0.0 110.99 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.481 ' HB3' HD11 ' A' ' 33' ' ' ILE . 7.4 m -83.85 116.66 22.85 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 177.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.449 ' O ' HD12 ' A' ' 34' ' ' ILE . 26.2 mt-10 -115.94 88.16 2.83 Favored 'General case' 0 N--CA 1.503 2.185 0 CA-C-N 118.637 0.653 . . . . 0.0 110.928 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.574 ' N ' HD12 ' A' ' 33' ' ' ILE . . . -68.76 113.64 5.38 Favored Glycine 0 N--CA 1.504 3.184 0 N-CA-C 107.883 -2.087 . . . . 0.0 107.883 178.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.3 ttm-85 . . . . . 0 N--CA 1.499 1.998 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -177.411 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.649 HD21 ' N ' ' A' ' 84' ' ' ASN . 0.9 OUTLIER . . . . . 0 N--CA 1.503 2.213 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.415 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 30.7 p90 -163.97 177.9 8.15 Favored 'General case' 0 N--CA 1.503 2.197 0 C-N-CA 119.765 -0.774 . . . . 0.0 112.833 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.4 pttt -166.85 165.59 16.08 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.548 ' O ' HG22 ' A' ' 9' ' ' THR . 8.8 p-10 -101.42 119.09 38.23 Favored 'General case' 0 N--CA 1.511 2.606 0 O-C-N 121.857 -0.527 . . . . 0.0 111.956 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.565 HD12 ' N ' ' A' ' 88' ' ' ILE . 2.6 mp -102.28 117.01 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 178.401 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -83.47 123.11 29.38 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -179.311 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.441 HG13 HE21 ' A' ' 11' ' ' GLN . 37.5 t -118.15 131.23 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 121.775 -0.578 . . . . 0.0 109.721 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 69.3 mt -127.34 152.94 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.618 HG12 ' HA ' ' A' ' 65' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.502 2.15 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.042 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 36.0 t . . . . . 0 N--CA 1.505 2.32 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.565 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 73.1 mtp -119.09 112.59 19.73 Favored 'General case' 0 N--CA 1.511 2.579 0 O-C-N 121.752 -0.592 . . . . 0.0 111.19 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -72.48 107.11 4.86 Favored 'General case' 0 N--CA 1.508 2.432 0 CA-C-O 121.01 0.433 . . . . 0.0 110.454 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -118.75 170.98 8.53 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-O 121.221 0.534 . . . . 0.0 110.669 -179.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.412 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.9 OUTLIER 25.43 63.23 0.06 Allowed 'General case' 0 N--CA 1.526 3.342 0 C-N-CA 124.291 1.037 . . . . 0.0 113.753 178.424 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -128.33 66.79 74.2 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 121.627 -0.671 . . . . 0.0 111.646 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.73 108.25 1.03 Allowed 'Trans proline' 0 N--CA 1.493 1.48 0 N-CA-C 108.218 -1.493 . . . . 0.0 108.218 177.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.516 HG22 HD13 ' A' ' 88' ' ' ILE . 11.4 p -62.24 -43.9 86.97 Favored Pre-proline 0 N--CA 1.503 2.208 0 CA-C-O 117.287 -1.339 . . . . 0.0 113.178 -176.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.487 ' HD3' ' OG1' ' A' ' 9' ' ' THR . 1.6 Cg_endo -84.11 84.79 1.49 Allowed 'Trans proline' 0 CA--C 1.551 1.329 0 CA-C-N 120.677 1.277 . . . . 0.0 111.513 -177.326 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.449 HE21 HG13 ' A' ' 90' ' ' VAL . 15.8 pt20 -100.49 172.74 6.93 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 121.085 -1.009 . . . . 0.0 110.748 179.193 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -158.03 120.52 3.77 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.897 -0.502 . . . . 0.0 111.342 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -116.41 -169.73 1.67 Allowed 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.965 -0.459 . . . . 0.0 110.196 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 49.5 tttm -101.85 135.77 42.83 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.378 0.609 . . . . 0.0 111.256 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -60.74 116.86 4.73 Favored 'General case' 0 N--CA 1.509 2.498 0 CA-C-O 121.082 0.468 . . . . 0.0 110.582 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.88 22.81 29.58 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.419 ' O ' HG22 ' A' ' 63' ' ' ILE . 16.9 tt0 -117.26 164.58 14.6 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 118.471 1.135 . . . . 0.0 110.93 -179.338 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -81.08 98.41 7.99 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 177.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.11 167.22 10.6 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 120.291 -0.564 . . . . 0.0 111.911 -177.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.662 HG22 ' HG2' ' A' ' 59' ' ' GLN . 98.5 t -140.55 139.98 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 178.054 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.703 HD12 HD23 ' A' ' 58' ' ' LEU . 38.4 mt -95.2 116.73 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 178.109 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.498 HG13 ' CE2' ' A' ' 57' ' ' TYR . 44.6 t -78.87 117.02 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-O 121.321 0.581 . . . . 0.0 110.781 -176.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -154.47 95.01 1.76 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.412 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 1.7 m-20 -90.05 137.79 32.05 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.48 HG21 HD12 ' A' ' 33' ' ' ILE . 13.9 t -147.81 122.26 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.565 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 14.8 t -85.15 81.53 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.9 m -87.38 155.2 20.14 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.6 t -44.94 -84.03 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.15 0 O-C-N 121.884 -0.51 . . . . 0.0 111.909 -178.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.404 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 0.8 OUTLIER -166.94 -62.23 0.01 OUTLIER Pre-proline 0 N--CA 1.511 2.576 0 CA-C-O 117.76 -1.114 . . . . 0.0 112.094 178.568 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.404 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 2.7 Cg_endo -59.37 -53.87 3.09 Favored 'Trans proline' 0 CA--C 1.559 1.741 0 CA-C-N 120.082 1.065 . . . . 0.0 112.336 -178.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.414 ' C ' ' HG1' ' A' ' 32' ' ' THR . 2.4 Cg_endo -64.46 -168.97 0.11 Allowed 'Trans proline' 0 N--CA 1.496 1.663 0 CA-C-N 119.399 0.821 . . . . 0.0 110.984 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.414 ' HG1' ' C ' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -172.04 -165.29 0.34 Allowed 'General case' 0 N--CA 1.521 3.086 0 O-C-N 121.723 -0.611 . . . . 0.0 109.844 179.838 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.48 HD12 HG21 ' A' ' 25' ' ' VAL . 20.3 tt -99.39 150.73 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 122.053 -0.405 . . . . 0.0 109.925 179.043 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.6 mt -115.56 115.42 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.553 ' HB2' HG22 ' A' ' 42' ' ' VAL . 72.7 m95 -81.18 104.96 12.02 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.7 tttt . . . . . 0 N--CA 1.502 2.142 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.885 -178.78 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.553 HG22 ' HB2' ' A' ' 35' ' ' TRP . 7.0 m . . . . . 0 N--CA 1.507 2.386 0 CA-C-O 121.312 0.577 . . . . 0.0 109.675 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.571 HG12 HG21 ' A' ' 52' ' ' VAL . 64.5 mt -60.66 -18.44 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.72 0 O-C-N 121.951 -0.468 . . . . 0.0 111.167 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.493 ' N ' HD12 ' A' ' 44' ' ' LEU . 9.6 mp -90.95 -22.56 20.79 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.52 -0.737 . . . . 0.0 110.823 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.414 ' HG2' ' HA ' ' A' ' 42' ' ' VAL . 30.6 pttt -99.18 -36.83 9.53 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.577 -0.702 . . . . 0.0 109.716 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 17.2 mmmt 48.92 54.77 10.28 Favored 'General case' 0 N--CA 1.51 2.563 0 CA-C-O 121.507 0.67 . . . . 0.0 111.562 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.61 172.14 0.05 OUTLIER 'General case' 0 N--CA 1.514 2.741 0 O-C-N 121.836 -0.54 . . . . 0.0 111.067 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.6 m -61.22 -19.19 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.605 0 O-C-N 121.982 -0.449 . . . . 0.0 111.954 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.402 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 26.6 ptt-85 -121.78 47.46 1.88 Allowed 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.757 -0.59 . . . . 0.0 112.356 -178.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -145.04 108.52 4.63 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 121.521 -0.737 . . . . 0.0 110.094 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 71.3 mt -129.12 102.01 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.645 HG22 ' CD1' ' A' ' 58' ' ' LEU . 4.8 t -73.84 128.1 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.42 HD11 ' OE1' ' A' ' 59' ' ' GLN . 18.8 mt -82.56 165.43 20.11 Favored 'General case' 0 N--CA 1.508 2.445 0 CA-C-O 121.299 0.571 . . . . 0.0 111.828 -178.463 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 93.7 p -59.94 -20.84 59.71 Favored 'General case' 0 N--CA 1.51 2.534 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.39 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 36.2 p-10 -92.38 21.2 5.45 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.699 -0.626 . . . . 0.0 111.343 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.412 ' HB3' HG21 ' A' ' 33' ' ' ILE . 5.5 m120 65.18 33.53 9.27 Favored 'General case' 0 N--CA 1.514 2.727 0 O-C-N 121.756 -0.59 . . . . 0.0 112.496 178.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.498 ' CE2' HG13 ' A' ' 22' ' ' VAL . 3.9 m-85 -102.15 164.77 11.52 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 177.269 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.703 HD23 HD12 ' A' ' 21' ' ' ILE . 15.5 tp -120.61 97.07 5.39 Favored 'General case' 0 N--CA 1.517 2.887 0 C-N-CA 119.327 -0.949 . . . . 0.0 111.651 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.662 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -75.83 95.97 3.59 Favored 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.799 179.499 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.551 HD11 HD11 ' A' ' 21' ' ' ILE . 93.1 mt -86.95 117.0 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -78.3 111.72 14.56 Favored 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 121.393 0.616 . . . . 0.0 111.663 -178.021 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 100.13 -35.65 4.64 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.499 HG23 HG21 ' A' ' 92' ' ' VAL . 1.6 tp 40.96 69.65 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.842 0 CA-C-O 122.201 1.0 . . . . 0.0 112.657 -179.173 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -57.75 157.75 7.03 Favored 'General case' 0 N--CA 1.513 2.684 0 O-C-N 121.638 -0.663 . . . . 0.0 112.417 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 35.7 tttm -61.47 -22.53 65.15 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 122.218 -0.301 . . . . 0.0 110.876 178.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.7 p -83.36 -19.96 35.16 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.772 -0.58 . . . . 0.0 110.74 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.76 7.7 35.53 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.61 -0.681 . . . . 0.0 111.678 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.438 ' HB3' HG12 ' A' ' 92' ' ' VAL . 8.4 pt-20 -96.79 141.12 30.38 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.35 -0.844 . . . . 0.0 109.365 179.237 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 169.98 -105.72 0.23 Allowed Glycine 0 N--CA 1.498 2.831 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.2 m -144.12 103.65 4.03 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 122.031 -0.688 . . . . 0.0 111.206 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -84.57 134.43 34.4 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.7 tpp85 -91.64 119.54 31.62 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.743 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 85' ' ' PHE . 1.8 m -87.83 90.26 8.31 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.464 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -91.57 88.64 6.84 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.276 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.55 91.31 0.56 Allowed Glycine 0 N--CA 1.499 2.873 0 N-CA-C 107.531 -2.227 . . . . 0.0 107.531 178.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.1 ttm180 . . . . . 0 N--CA 1.496 1.859 0 CA-C-O 121.923 0.868 . . . . 0.0 113.043 -177.257 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 . . . . . 0 N--CA 1.506 2.336 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.484 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 25.5 p90 -157.06 175.78 13.63 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.658 -0.817 . . . . 0.0 112.583 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 20.0 tttt -165.25 169.61 15.73 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -116.75 134.4 54.85 Favored 'General case' 0 N--CA 1.51 2.557 0 O-C-N 121.829 -0.544 . . . . 0.0 110.654 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.516 HD13 HG22 ' A' ' 9' ' ' THR . 47.9 mm -117.47 109.24 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -77.09 100.41 5.7 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.449 HG13 HE21 ' A' ' 11' ' ' GLN . 46.6 t -96.27 136.99 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.915 -179.166 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 65.9 mt -125.51 159.1 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.499 HG21 HG23 ' A' ' 63' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.5 2.056 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.539 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 26.2 t . . . . . 0 N--CA 1.508 2.427 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.535 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 7.9 mmm -121.17 117.31 26.79 Favored 'General case' 0 N--CA 1.511 2.575 0 O-C-N 121.879 -0.513 . . . . 0.0 110.551 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -74.33 114.41 12.67 Favored 'General case' 0 N--CA 1.507 2.415 0 CA-C-O 120.98 0.419 . . . . 0.0 111.099 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.21 162.32 26.45 Favored 'General case' 0 N--CA 1.503 2.22 0 CA-C-O 121.758 0.79 . . . . 0.0 111.594 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.416 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.3 OUTLIER 32.02 80.56 0.02 OUTLIER 'General case' 0 N--CA 1.52 3.057 0 C-N-CA 124.177 0.991 . . . . 0.0 113.274 179.266 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -138.41 79.97 28.8 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.954 -0.466 . . . . 0.0 110.727 -179.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -65.44 96.89 0.3 Allowed 'Trans proline' 0 N--CA 1.491 1.336 0 N-CA-C 108.503 -1.383 . . . . 0.0 108.503 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.582 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.6 OUTLIER -51.25 -72.29 0.17 Allowed Pre-proline 0 N--CA 1.506 2.331 0 CA-C-O 116.437 -1.744 . . . . 0.0 112.485 -177.172 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.492 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.5 Cg_endo -71.48 97.1 0.76 Allowed 'Trans proline' 0 N--CA 1.498 1.755 0 CA-C-N 121.921 1.722 . . . . 0.0 111.719 178.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -101.59 178.11 4.73 Favored 'General case' 0 N--CA 1.507 2.41 0 O-C-N 120.974 -1.079 . . . . 0.0 110.055 178.108 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -156.23 127.5 7.07 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.833 -0.542 . . . . 0.0 111.568 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -127.84 -169.2 2.01 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.847 -0.533 . . . . 0.0 109.802 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -115.49 145.42 42.62 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.838 0.827 . . . . 0.0 111.841 -178.214 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -61.82 121.24 12.39 Favored 'General case' 0 N--CA 1.508 2.442 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.45 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.74 22.83 48.66 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.513 ' O ' HG22 ' A' ' 63' ' ' ILE . 18.4 tt0 -112.98 159.84 18.71 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 118.478 1.139 . . . . 0.0 111.186 -179.221 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.36 97.65 8.44 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 177.823 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -103.4 164.2 11.79 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.528 0.68 . . . . 0.0 112.498 -177.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.695 HG22 ' HG2' ' A' ' 59' ' ' GLN . 95.3 t -139.31 141.82 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 178.084 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.903 HD12 HD23 ' A' ' 58' ' ' LEU . 55.3 mt -97.42 115.29 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 178.166 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.483 HG13 ' CE2' ' A' ' 57' ' ' TYR . 46.8 t -76.32 120.86 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 121.505 0.669 . . . . 0.0 111.055 -176.547 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.7 t -161.68 94.85 0.97 Allowed 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.416 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -92.88 141.44 28.42 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 120.121 -0.632 . . . . 0.0 109.684 -178.767 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.643 HG21 HD12 ' A' ' 33' ' ' ILE . 32.9 t -149.52 123.46 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.535 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 21.6 t -81.7 80.42 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.6 m -87.61 154.09 20.88 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.2 t -44.09 -83.11 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.216 0 O-C-N 121.956 -0.465 . . . . 0.0 111.953 -178.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.417 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 0.3 OUTLIER -168.96 -61.29 0.01 OUTLIER Pre-proline 0 N--CA 1.51 2.566 0 CA-C-O 117.731 -1.128 . . . . 0.0 111.785 178.532 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.417 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 2.7 Cg_endo -60.74 -54.13 2.21 Favored 'Trans proline' 0 CA--C 1.561 1.86 0 CA-C-N 120.028 1.046 . . . . 0.0 112.519 -179.133 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.409 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 2.7 Cg_endo -63.66 -166.83 0.07 OUTLIER 'Trans proline' 0 N--CA 1.498 1.765 0 CA-C-N 119.539 0.871 . . . . 0.0 111.678 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -170.97 -166.62 0.49 Allowed 'General case' 0 N--CA 1.523 3.188 0 O-C-N 121.813 -0.554 . . . . 0.0 110.36 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.643 HD12 HG21 ' A' ' 25' ' ' VAL . 18.7 tt -104.1 136.73 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.546 ' N ' HD12 ' A' ' 34' ' ' ILE . 4.9 mp -101.17 124.37 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.568 ' HB2' HG22 ' A' ' 42' ' ' VAL . 75.1 m95 -84.64 109.69 18.18 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.2 tttt . . . . . 0 N--CA 1.501 2.095 0 CA-C-O 121.48 0.657 . . . . 0.0 111.625 -178.05 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.568 HG22 ' HB2' ' A' ' 35' ' ' TRP . 6.3 m . . . . . 0 N--CA 1.508 2.438 0 CA-C-O 120.804 0.335 . . . . 0.0 110.823 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.7 mm -59.26 -17.95 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.819 0 O-C-N 121.577 -0.702 . . . . 0.0 111.572 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.489 ' N ' HD12 ' A' ' 44' ' ' LEU . 10.0 mp -91.38 -22.84 20.28 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.457 -0.777 . . . . 0.0 110.978 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -98.66 -40.44 8.19 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.764 -0.585 . . . . 0.0 109.478 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm 47.26 56.02 7.42 Favored 'General case' 0 N--CA 1.509 2.517 0 CA-C-O 121.473 0.654 . . . . 0.0 112.04 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.58 155.19 1.64 Allowed 'General case' 0 N--CA 1.515 2.796 0 O-C-N 121.649 -0.657 . . . . 0.0 111.013 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.7 m -54.32 -24.36 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.816 0 O-C-N 121.907 -0.496 . . . . 0.0 112.125 -178.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.95 -3.67 31.81 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.484 ' HE2' HD21 ' A' ' 58' ' ' LEU . 7.5 m-85 -95.79 109.41 21.73 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.388 -0.82 . . . . 0.0 110.18 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 71.8 mt -129.44 104.27 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.524 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.2 t -73.76 128.59 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.494 HD11 ' CG ' ' A' ' 59' ' ' GLN . 39.5 mt -82.11 166.3 19.83 Favored 'General case' 0 N--CA 1.508 2.466 0 CA-C-O 121.308 0.575 . . . . 0.0 111.806 -178.217 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.4 p -61.19 -21.55 63.91 Favored 'General case' 0 N--CA 1.51 2.532 0 O-C-N 122.106 -0.371 . . . . 0.0 111.211 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -90.87 19.12 5.81 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.577 -0.702 . . . . 0.0 111.338 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.408 ' HB3' HG21 ' A' ' 33' ' ' ILE . 6.1 m120 67.42 33.21 5.36 Favored 'General case' 0 N--CA 1.516 2.862 0 O-C-N 121.57 -0.706 . . . . 0.0 112.524 178.589 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.483 ' CE2' HG13 ' A' ' 22' ' ' VAL . 3.9 m-85 -103.3 166.77 10.23 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 177.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.903 HD23 HD12 ' A' ' 21' ' ' ILE . 16.8 tp -120.69 98.24 5.93 Favored 'General case' 0 N--CA 1.519 2.995 0 C-N-CA 119.356 -0.938 . . . . 0.0 111.919 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.695 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -78.45 101.62 7.4 Favored 'General case' 0 N--CA 1.504 2.263 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.364 179.66 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.509 HD11 HD11 ' A' ' 21' ' ' ILE . 96.8 mt -93.82 103.4 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 177.38 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 19.3 tpp85 -70.3 116.6 10.84 Favored 'General case' 0 N--CA 1.504 2.233 0 CA-C-O 121.317 0.58 . . . . 0.0 110.865 -178.076 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.64 -35.1 4.83 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.513 HG22 ' O ' ' A' ' 17' ' ' GLU . 1.8 tp 35.27 94.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.519 2.999 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 59.0 mmtt -73.4 148.71 43.09 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.613 -0.68 . . . . 0.0 110.656 -178.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -62.58 -18.89 63.04 Favored 'General case' 0 N--CA 1.51 2.559 0 O-C-N 122.072 -0.393 . . . . 0.0 110.978 178.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.8 t -87.83 -13.5 41.98 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.686 -0.634 . . . . 0.0 111.376 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -91.67 14.36 15.39 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.53 -0.731 . . . . 0.0 111.491 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.78 150.3 20.55 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.433 -0.792 . . . . 0.0 109.792 179.431 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 166.06 -101.25 0.18 Allowed Glycine 0 N--CA 1.499 2.887 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.6 m -149.02 101.13 3.13 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.953 -0.734 . . . . 0.0 111.239 179.243 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -81.47 133.56 35.42 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 177.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.8 ttm105 -97.29 120.3 37.4 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.11 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.624 ' HB3' HD11 ' A' ' 33' ' ' ILE . 9.3 m -83.46 113.33 20.7 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 177.583 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -111.5 85.63 2.17 Favored 'General case' 0 N--CA 1.504 2.272 0 CA-C-N 118.537 0.608 . . . . 0.0 109.609 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.68 96.67 0.31 Allowed Glycine 0 N--CA 1.502 3.057 0 N-CA-C 108.475 -1.85 . . . . 0.0 108.475 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.409 ' O ' ' HB2' ' A' ' 31' ' ' PRO . 2.1 ttp85 . . . . . 0 N--CA 1.494 1.736 0 O-C-N 122.059 -0.671 . . . . 0.0 112.212 -177.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 . . . . . 0 N--CA 1.505 2.29 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.418 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 39.1 p90 -166.73 175.8 7.61 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 121.352 -0.843 . . . . 0.0 113.158 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.538 ' HD2' HD11 ' A' ' 88' ' ' ILE . 3.2 ptpt -167.78 161.27 13.14 Favored 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.582 ' O ' HG22 ' A' ' 9' ' ' THR . 7.7 p-10 -98.06 122.93 41.79 Favored 'General case' 0 N--CA 1.512 2.635 0 O-C-N 121.736 -0.602 . . . . 0.0 112.107 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.55 HD12 ' N ' ' A' ' 88' ' ' ILE . 2.3 mp -106.72 122.55 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 178.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -87.25 134.82 33.5 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.2 t -127.52 129.08 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 O-C-N 121.673 -0.642 . . . . 0.0 110.22 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 74.6 mt -116.26 139.63 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.426 HG21 ' CG1' ' A' ' 63' ' ' ILE . 44.6 t . . . . . 0 N--CA 1.503 2.18 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.364 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 36.6 t . . . . . 0 N--CA 1.504 2.228 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.52 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 7.1 mmt -122.73 115.92 22.88 Favored 'General case' 0 N--CA 1.51 2.565 0 O-C-N 121.783 -0.573 . . . . 0.0 110.482 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -74.38 113.1 11.22 Favored 'General case' 0 N--CA 1.506 2.374 0 O-C-N 122.005 -0.434 . . . . 0.0 110.538 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.435 ' HG2' HG23 ' A' ' 26' ' ' VAL . 5.0 ptpt -127.16 163.7 23.26 Favored 'General case' 0 N--CA 1.503 2.215 0 CA-C-O 121.712 0.768 . . . . 0.0 111.753 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.419 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.3 OUTLIER 31.88 72.68 0.07 Allowed 'General case' 0 N--CA 1.52 3.048 0 C-N-CA 124.188 0.995 . . . . 0.0 113.342 179.317 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -136.81 81.01 35.31 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.802 -0.561 . . . . 0.0 110.721 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -65.58 102.09 0.48 Allowed 'Trans proline' 0 N--CA 1.49 1.294 0 N-CA-C 108.62 -1.339 . . . . 0.0 108.62 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.581 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.2 OUTLIER -55.86 -66.62 1.0 Allowed Pre-proline 0 N--CA 1.503 2.213 0 CA-C-O 116.93 -1.509 . . . . 0.0 112.216 -177.314 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.499 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.5 Cg_endo -74.18 91.4 0.94 Allowed 'Trans proline' 0 CA--C 1.556 1.609 0 CA-C-N 121.258 1.485 . . . . 0.0 111.148 178.715 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.525 HE21 HG13 ' A' ' 90' ' ' VAL . 15.9 pt20 -100.0 176.49 5.4 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 120.871 -1.143 . . . . 0.0 110.006 178.539 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -160.62 122.76 3.17 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.741 -0.599 . . . . 0.0 111.374 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -119.26 -170.64 1.96 Allowed 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.963 -0.461 . . . . 0.0 110.205 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 15.8 tptm -104.71 138.8 40.46 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.567 0.699 . . . . 0.0 111.413 -178.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -59.19 118.61 6.1 Favored 'General case' 0 N--CA 1.509 2.522 0 O-C-N 121.933 -0.479 . . . . 0.0 110.88 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.33 23.47 40.24 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.43 ' O ' HG22 ' A' ' 63' ' ' ILE . 13.0 tt0 -114.98 164.6 13.92 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 118.411 1.105 . . . . 0.0 110.531 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -82.85 98.46 9.17 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 178.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.17 168.27 9.92 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 120.365 -0.534 . . . . 0.0 112.053 -177.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.658 HG22 ' HG2' ' A' ' 59' ' ' GLN . 99.6 t -142.75 141.09 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.82 HD12 HD23 ' A' ' 58' ' ' LEU . 43.5 mt -97.02 111.96 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 178.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.442 HG13 ' CE2' ' A' ' 57' ' ' TYR . 57.8 t -75.17 119.93 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 CA-C-O 121.47 0.652 . . . . 0.0 110.493 -176.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -160.83 92.68 0.95 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.419 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.2 OUTLIER -91.16 140.75 29.52 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.529 -179.198 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.596 HG21 HD12 ' A' ' 33' ' ' ILE . 13.5 t -147.53 121.67 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.52 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 16.0 t -81.2 80.68 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.4 m -87.83 154.75 20.3 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.6 t -43.66 -84.0 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.18 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.407 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 0.9 OUTLIER -166.32 -62.21 0.01 OUTLIER Pre-proline 0 N--CA 1.509 2.475 0 CA-C-O 117.675 -1.155 . . . . 0.0 111.584 178.639 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.407 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 2.8 Cg_endo -60.2 -53.81 2.72 Favored 'Trans proline' 0 CA--C 1.561 1.844 0 CA-C-N 120.086 1.066 . . . . 0.0 112.552 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.414 ' C ' ' HG1' ' A' ' 32' ' ' THR . 2.6 Cg_endo -63.02 -168.53 0.08 OUTLIER 'Trans proline' 0 N--CA 1.496 1.668 0 CA-C-N 119.425 0.83 . . . . 0.0 111.746 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.414 ' HG1' ' C ' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -171.58 -164.77 0.34 Allowed 'General case' 0 N--CA 1.52 3.067 0 O-C-N 121.92 -0.488 . . . . 0.0 109.78 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.596 HD12 HG21 ' A' ' 25' ' ' VAL . 17.1 tt -102.53 147.31 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.925 -0.484 . . . . 0.0 110.056 179.208 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.553 ' N ' HD12 ' A' ' 34' ' ' ILE . 5.2 mp -114.5 121.07 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.56 ' HB2' HG22 ' A' ' 42' ' ' VAL . 83.6 m95 -82.77 104.4 12.99 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.1 tttm . . . . . 0 N--CA 1.506 2.359 0 CA-C-O 121.322 0.582 . . . . 0.0 111.494 -177.995 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.56 HG22 ' HB2' ' A' ' 35' ' ' TRP . 4.4 m . . . . . 0 N--CA 1.51 2.562 0 CA-C-O 121.019 0.438 . . . . 0.0 110.421 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.7 mm -58.42 -18.11 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.688 0 O-C-N 121.71 -0.618 . . . . 0.0 111.864 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.475 ' N ' HD12 ' A' ' 44' ' ' LEU . 9.3 mp -92.47 -22.18 19.74 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.492 -0.755 . . . . 0.0 111.106 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.1 pttt -97.88 -41.04 8.21 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.8 mmmt 46.91 56.91 6.14 Favored 'General case' 0 N--CA 1.509 2.505 0 CA-C-O 121.166 0.507 . . . . 0.0 112.308 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -49.69 161.17 0.24 Allowed 'General case' 0 N--CA 1.519 2.987 0 O-C-N 121.804 -0.56 . . . . 0.0 111.081 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 36.0 m -56.83 -21.92 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.779 0 O-C-N 121.911 -0.493 . . . . 0.0 112.172 -178.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 24.1 ptt-85 -104.22 -2.44 25.7 Favored 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.404 ' HE2' HD21 ' A' ' 58' ' ' LEU . 7.6 m-85 -96.24 108.28 20.74 Favored 'General case' 0 N--CA 1.503 2.18 0 CA-C-N 119.145 0.884 . . . . 0.0 110.166 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 75.6 mt -129.36 104.84 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.677 HG22 ' CD1' ' A' ' 58' ' ' LEU . 4.8 t -74.78 127.89 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.513 HD11 ' CG ' ' A' ' 59' ' ' GLN . 42.7 mt -80.63 165.54 21.94 Favored 'General case' 0 N--CA 1.509 2.477 0 CA-C-O 121.34 0.591 . . . . 0.0 111.905 -178.083 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 89.9 p -60.19 -20.92 60.83 Favored 'General case' 0 N--CA 1.51 2.547 0 O-C-N 122.07 -0.394 . . . . 0.0 111.484 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 42.8 p-10 -91.74 19.83 6.11 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.658 -0.652 . . . . 0.0 111.392 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.3 m120 67.24 32.13 6.2 Favored 'General case' 0 N--CA 1.516 2.846 0 O-C-N 121.594 -0.691 . . . . 0.0 112.39 178.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.442 ' CE2' HG13 ' A' ' 22' ' ' VAL . 3.7 m-85 -102.06 167.64 9.9 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.004 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.82 HD23 HD12 ' A' ' 21' ' ' ILE . 15.2 tp -121.99 98.8 6.11 Favored 'General case' 0 N--CA 1.519 2.978 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.954 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.658 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -78.72 101.15 7.39 Favored 'General case' 0 N--CA 1.503 2.202 0 C-N-CA 120.479 -0.489 . . . . 0.0 111.12 179.413 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.557 HD11 HD11 ' A' ' 21' ' ' ILE . 97.2 mt -94.68 104.31 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 177.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.85 115.65 8.42 Favored 'General case' 0 N--CA 1.505 2.301 0 CA-C-O 121.187 0.517 . . . . 0.0 110.721 -178.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 100.31 -39.26 2.8 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.577 ' CG1' HG21 ' A' ' 92' ' ' VAL . 3.0 tp 42.52 83.58 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.517 2.901 0 CA-C-O 122.225 1.012 . . . . 0.0 112.117 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -72.11 158.42 35.97 Favored 'General case' 0 N--CA 1.508 2.454 0 O-C-N 121.751 -0.593 . . . . 0.0 111.984 -178.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt -61.27 -24.55 66.47 Favored 'General case' 0 N--CA 1.51 2.558 0 O-C-N 121.941 -0.474 . . . . 0.0 110.918 178.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.9 t -79.32 -15.0 58.63 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.893 -0.505 . . . . 0.0 111.691 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -87.37 -27.77 22.6 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.502 -0.749 . . . . 0.0 110.718 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.402 ' HB3' HG12 ' A' ' 92' ' ' VAL . 5.1 pt-20 -62.0 140.56 58.34 Favored 'General case' 0 N--CA 1.507 2.406 0 O-C-N 121.691 -0.631 . . . . 0.0 110.752 -179.231 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 167.09 -104.88 0.23 Allowed Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.7 m -146.72 102.28 3.54 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 122.03 -0.688 . . . . 0.0 110.543 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -83.52 134.65 34.83 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 -94.0 115.65 28.01 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.85 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 85' ' ' PHE . 1.9 m -85.68 90.58 8.05 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.505 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -92.08 88.65 6.62 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.317 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.85 90.24 0.57 Allowed Glycine 0 N--CA 1.499 2.855 0 N-CA-C 107.44 -2.264 . . . . 0.0 107.44 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.406 ' HB2' HD13 ' A' ' 34' ' ' ILE . 30.1 ttm-85 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.805 0.812 . . . . 0.0 112.823 -177.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 . . . . . 0 N--CA 1.506 2.365 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.494 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 29.7 p90 -159.02 171.5 19.9 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 119.505 -0.878 . . . . 0.0 113.09 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 10.8 mttp -160.55 159.25 30.42 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.581 ' O ' HG22 ' A' ' 9' ' ' THR . 3.6 p30 -106.02 120.08 40.84 Favored 'General case' 0 N--CA 1.513 2.697 0 O-C-N 121.84 -0.538 . . . . 0.0 110.769 179.381 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.523 HD12 ' N ' ' A' ' 88' ' ' ILE . 1.8 mp -104.74 121.6 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -85.32 115.61 23.17 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.525 HG13 HE21 ' A' ' 11' ' ' GLN . 46.5 t -110.33 131.93 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.171 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 67.0 mt -120.38 157.57 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.577 HG21 ' CG1' ' A' ' 63' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.503 2.196 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.382 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 47.3 p90 . . . . . 0 N--CA 1.498 1.932 0 CA-C-O 120.752 0.31 . . . . 0.0 110.438 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.674 ' CG2' HD11 ' A' ' 77' ' ' ILE . 47.0 t -146.85 107.63 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.524 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 7.6 mmt -114.33 116.84 29.61 Favored 'General case' 0 N--CA 1.507 2.386 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.137 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -75.37 115.16 14.72 Favored 'General case' 0 N--CA 1.504 2.248 0 CA-C-O 120.9 0.381 . . . . 0.0 110.479 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.5 ptpt -127.22 163.71 23.28 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.649 0.738 . . . . 0.0 111.529 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 32.36 76.97 0.04 OUTLIER 'General case' 0 N--CA 1.517 2.901 0 C-N-CA 124.266 1.026 . . . . 0.0 113.49 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -145.03 78.45 12.48 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.812 -0.555 . . . . 0.0 110.916 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -64.37 104.39 0.51 Allowed 'Trans proline' 0 N--CA 1.492 1.412 0 N-CA-C 108.532 -1.372 . . . . 0.0 108.532 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.61 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.5 OUTLIER -50.92 -69.69 0.28 Allowed Pre-proline 0 N--CA 1.509 2.5 0 CA-C-O 116.625 -1.655 . . . . 0.0 112.802 -176.968 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.487 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.6 Cg_endo -72.62 96.72 0.84 Allowed 'Trans proline' 0 N--CA 1.498 1.741 0 CA-C-N 121.69 1.639 . . . . 0.0 111.518 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.441 HE21 HG13 ' A' ' 90' ' ' VAL . 16.1 pt20 -101.3 177.5 4.91 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 120.951 -1.093 . . . . 0.0 110.319 178.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -158.57 125.16 4.72 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.897 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -123.17 -170.65 2.15 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.953 -0.467 . . . . 0.0 109.876 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -104.67 143.86 32.51 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.617 0.722 . . . . 0.0 111.519 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -60.27 125.0 22.0 Favored 'General case' 0 N--CA 1.508 2.431 0 O-C-N 121.965 -0.459 . . . . 0.0 111.049 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.29 22.24 68.32 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 110.889 -0.885 . . . . 0.0 110.889 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -110.21 164.44 12.65 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 118.714 1.257 . . . . 0.0 110.61 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.43 98.62 8.98 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 177.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.78 165.82 11.4 Favored 'General case' 0 N--CA 1.497 1.925 0 C-N-CA 120.121 -0.631 . . . . 0.0 111.991 -177.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.671 HG22 ' HG2' ' A' ' 59' ' ' GLN . 85.1 t -138.94 139.68 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.737 HD12 HD23 ' A' ' 58' ' ' LEU . 40.9 mt -95.47 115.62 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 178.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.495 HG13 ' CE2' ' A' ' 57' ' ' TYR . 47.4 t -76.9 118.19 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-O 121.544 0.687 . . . . 0.0 110.507 -177.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.1 t -160.08 87.11 0.78 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.03 142.11 28.17 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 119.946 -0.702 . . . . 0.0 109.269 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.666 HG21 HD12 ' A' ' 33' ' ' ILE . 39.3 t -147.7 129.28 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.524 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 60.1 t -92.71 78.28 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.2 m -79.45 164.62 23.82 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.9 t -42.13 -80.52 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.224 0 CA-C-N 118.283 0.492 . . . . 0.0 111.607 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.416 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 0.4 OUTLIER -170.69 -63.43 0.0 OUTLIER Pre-proline 0 N--CA 1.515 2.786 0 CA-C-O 117.658 -1.163 . . . . 0.0 111.467 177.5 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.416 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 2.9 Cg_endo -60.84 -53.29 2.77 Favored 'Trans proline' 0 CA--C 1.563 1.97 0 CA-C-N 120.1 1.071 . . . . 0.0 112.805 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.515 ' HG3' HG23 ' A' ' 77' ' ' ILE . 2.9 Cg_endo -61.71 -162.94 0.03 OUTLIER 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 120.516 0.811 . . . . 0.0 112.666 -178.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -170.16 -165.67 0.49 Allowed 'General case' 0 N--CA 1.518 2.936 0 O-C-N 121.849 -0.532 . . . . 0.0 110.403 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.677 HD11 ' HB3' ' A' ' 73' ' ' CYS . 17.5 tt -100.82 162.79 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.1 mt -125.23 126.77 71.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.567 ' HB2' HG22 ' A' ' 42' ' ' VAL . 78.5 m95 -90.44 110.65 21.75 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.0 tttt -112.78 -178.05 3.29 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.941 -0.475 . . . . 0.0 110.594 -179.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 24.8 t-80 63.76 150.58 0.03 OUTLIER 'General case' 0 N--CA 1.512 2.671 0 O-C-N 121.769 -0.582 . . . . 0.0 110.053 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.9 tppt? 54.33 43.73 30.04 Favored 'General case' 0 N--CA 1.515 2.796 0 O-C-N 121.538 -0.726 . . . . 0.0 110.415 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 150.37 -17.94 1.02 Allowed Glycine 0 N--CA 1.491 2.35 0 C-N-CA 120.337 -0.935 . . . . 0.0 111.099 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.75 88.35 0.05 Allowed 'General case' 0 N--CA 1.516 2.828 0 CA-C-N 118.797 1.299 . . . . 0.0 110.051 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 55.06 84.61 0.07 Allowed 'General case' 0 N--CA 1.514 2.773 0 O-C-N 121.727 -0.608 . . . . 0.0 110.217 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.567 HG22 ' HB2' ' A' ' 35' ' ' TRP . 4.4 m -69.19 -32.35 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.364 0 O-C-N 121.869 -0.519 . . . . 0.0 110.052 -178.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.652 HD11 HG21 ' A' ' 52' ' ' VAL . 47.8 mm -58.27 -18.75 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.825 0 O-C-N 121.807 -0.558 . . . . 0.0 111.87 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.435 ' N ' HD12 ' A' ' 44' ' ' LEU . 10.3 mp -93.2 -20.71 20.19 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.47 -0.769 . . . . 0.0 111.531 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 42.2 pttt -98.97 -37.89 9.21 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.531 -0.731 . . . . 0.0 109.802 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt 48.61 55.19 9.41 Favored 'General case' 0 N--CA 1.509 2.513 0 CA-C-O 121.581 0.705 . . . . 0.0 111.766 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -53.11 171.3 0.07 Allowed 'General case' 0 N--CA 1.513 2.682 0 O-C-N 121.755 -0.591 . . . . 0.0 110.876 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.6 t -66.9 -19.41 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.467 0 O-C-N 122.007 -0.433 . . . . 0.0 110.996 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 10.0 ptt-85 -115.64 45.7 1.64 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.504 -0.747 . . . . 0.0 112.1 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -145.28 105.33 4.04 Favored 'General case' 0 N--CA 1.506 2.346 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 177.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 45.2 mt -126.0 102.45 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.652 HG21 HD11 ' A' ' 43' ' ' ILE . 3.5 t -73.37 129.04 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.55 HD11 ' CG ' ' A' ' 59' ' ' GLN . 29.8 mt -82.71 167.6 18.05 Favored 'General case' 0 N--CA 1.509 2.498 0 CA-C-O 121.358 0.599 . . . . 0.0 112.143 -178.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.4 p -61.63 -22.02 64.89 Favored 'General case' 0 N--CA 1.509 2.496 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.985 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 52.4 p30 -91.49 18.85 6.76 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.749 -0.595 . . . . 0.0 111.337 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.8 m120 66.88 34.44 5.4 Favored 'General case' 0 N--CA 1.517 2.921 0 O-C-N 121.534 -0.728 . . . . 0.0 112.832 178.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.495 ' CE2' HG13 ' A' ' 22' ' ' VAL . 3.7 m-85 -103.06 166.03 10.67 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 177.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.737 HD23 HD12 ' A' ' 21' ' ' ILE . 15.2 tp -119.51 97.19 5.53 Favored 'General case' 0 N--CA 1.519 2.993 0 C-N-CA 119.371 -0.932 . . . . 0.0 111.505 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.671 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -76.67 95.39 3.97 Favored 'General case' 0 N--CA 1.502 2.166 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.857 179.609 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.584 HD11 HD11 ' A' ' 21' ' ' ILE . 99.4 mt -87.04 119.74 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 177.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 32.9 tpt85 -80.3 117.39 21.03 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-O 121.324 0.583 . . . . 0.0 110.638 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.26 -39.59 2.75 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.628 HG23 HG21 ' A' ' 92' ' ' VAL . 2.8 tp 42.3 73.59 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.776 0 CA-C-O 122.16 0.981 . . . . 0.0 112.581 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.406 ' HB3' HG22 ' A' ' 66' ' ' THR . 37.5 mmtt -59.8 150.61 27.71 Favored 'General case' 0 N--CA 1.51 2.573 0 O-C-N 121.377 -0.827 . . . . 0.0 111.661 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.619 ' HA ' HG13 ' A' ' 92' ' ' VAL . 20.7 ttmt -62.52 -17.59 60.11 Favored 'General case' 0 N--CA 1.506 2.374 0 O-C-N 122.087 -0.383 . . . . 0.0 111.213 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.406 HG22 ' HB3' ' A' ' 64' ' ' LYS . 8.8 t -89.32 -15.95 32.23 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.651 -0.656 . . . . 0.0 111.127 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -92.47 15.03 14.98 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.502 -0.748 . . . . 0.0 111.536 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.74 ' HB3' HG12 ' A' ' 92' ' ' VAL . 0.5 OUTLIER -96.73 160.98 14.07 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.422 -0.798 . . . . 0.0 109.283 179.294 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 154.99 -99.4 0.19 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.371 -1.491 . . . . 0.0 109.371 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.8 m -151.05 101.35 2.87 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 122.016 -0.696 . . . . 0.0 111.988 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -82.17 131.74 35.24 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.1 tpp85 -98.11 117.02 31.53 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 120.087 -0.645 . . . . 0.0 111.212 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.677 ' HB3' HD11 ' A' ' 33' ' ' ILE . 14.4 m -79.43 129.84 34.85 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 177.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -128.03 88.63 2.79 Favored 'General case' 0 N--CA 1.502 2.15 0 CA-C-N 118.581 0.628 . . . . 0.0 110.265 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.47 111.11 3.84 Favored Glycine 0 N--CA 1.504 3.178 0 N-CA-C 107.915 -2.074 . . . . 0.0 107.915 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.2 ttm180 -125.28 141.08 52.3 Favored 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 121.959 0.885 . . . . 0.0 113.366 -177.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.674 HD11 ' CG2' ' A' ' 2' ' ' VAL . 87.6 mt -120.61 134.7 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.283 177.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.5 mt -93.4 -36.09 12.67 Favored 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.622 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.83 -54.85 28.61 Favored 'General case' 0 N--CA 1.514 2.731 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.442 ' H ' HG22 ' A' ' 77' ' ' ILE . 68.9 mtt180 -107.98 63.59 0.62 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 177.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -13.71 80.77 0.0 OUTLIER Glycine 1 N--CA 1.527 4.714 0 C-N-CA 125.098 1.332 . . . . 0.0 114.879 -178.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -116.83 143.7 45.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 122.161 -0.611 . . . . 0.0 109.772 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.1 pt -136.23 81.11 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 CA-C-O 121.316 0.579 . . . . 0.0 111.459 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -97.3 154.04 17.67 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -167.76 176.19 6.49 Favored 'General case' 0 N--CA 1.508 2.475 0 O-C-N 121.455 -0.778 . . . . 0.0 112.692 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.547 ' CD ' HD11 ' A' ' 88' ' ' ILE . 3.3 ptpt -168.13 155.95 8.45 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.61 ' O ' HG22 ' A' ' 9' ' ' THR . 4.5 p30 -93.16 120.53 33.55 Favored 'General case' 0 N--CA 1.51 2.55 0 O-C-N 121.713 -0.617 . . . . 0.0 111.796 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.57 HD12 ' N ' ' A' ' 88' ' ' ILE . 3.6 mp -106.04 119.47 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -85.11 130.84 34.54 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.441 HG13 HE21 ' A' ' 11' ' ' GLN . 46.1 t -123.25 128.76 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 54.7 mt -121.07 142.29 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.74 HG12 ' HB3' ' A' ' 68' ' ' GLU . 6.7 p . . . . . 0 N--CA 1.5 2.056 0 CA-C-O 117.876 -1.059 . . . . 0.0 110.469 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 37.4 p90 . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 121.368 0.604 . . . . 0.0 111.268 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.662 ' CG2' HD13 ' A' ' 77' ' ' ILE . 11.4 t -142.39 96.99 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.502 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 7.3 mmm -96.56 113.92 25.53 Favored 'General case' 0 N--CA 1.506 2.354 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.907 -178.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -72.13 115.06 10.91 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.421 ' HG2' HG23 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -125.22 158.01 35.11 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 121.323 0.582 . . . . 0.0 110.354 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.439 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.1 OUTLIER 38.88 70.92 0.18 Allowed 'General case' 0 N--CA 1.518 2.954 0 C-N-CA 123.374 0.67 . . . . 0.0 112.151 -179.654 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.03 72.01 72.69 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.748 -0.595 . . . . 0.0 111.258 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -65.09 102.07 0.43 Allowed 'Trans proline' 0 N--CA 1.49 1.323 0 N-CA-C 108.886 -1.236 . . . . 0.0 108.886 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.576 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.4 OUTLIER -54.28 -68.3 0.51 Allowed Pre-proline 0 N--CA 1.508 2.461 0 CA-C-O 116.782 -1.58 . . . . 0.0 112.25 -177.636 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.491 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.4 Cg_endo -72.43 90.5 0.79 Allowed 'Trans proline' 0 N--CA 1.496 1.676 0 CA-C-N 121.52 1.579 . . . . 0.0 111.353 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -100.85 173.93 6.27 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 120.785 -1.197 . . . . 0.0 110.352 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -157.16 122.88 4.71 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.803 -0.561 . . . . 0.0 111.003 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -117.16 -170.09 1.78 Allowed 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.963 -0.46 . . . . 0.0 110.552 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -103.31 140.45 37.4 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.862 0.839 . . . . 0.0 111.907 -178.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -60.79 126.96 29.32 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.822 -0.548 . . . . 0.0 111.017 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.07 21.82 72.83 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -110.91 161.5 15.77 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 118.652 1.226 . . . . 0.0 111.018 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -79.79 95.8 6.11 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 177.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.66 169.68 9.86 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.851 -177.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.651 HG22 ' HG2' ' A' ' 59' ' ' GLN . 84.5 t -142.98 141.3 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.771 HD12 HD23 ' A' ' 58' ' ' LEU . 26.0 mt -96.36 114.4 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 178.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.63 HG13 ' CZ ' ' A' ' 57' ' ' TYR . 38.8 t -75.51 118.33 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 CA-C-O 121.477 0.656 . . . . 0.0 110.735 -176.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.9 t -163.61 80.49 0.44 Allowed 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.439 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.4 OUTLIER -80.06 146.21 32.06 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.149 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.488 HG21 HD12 ' A' ' 33' ' ' ILE . 60.4 t -148.88 133.84 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.502 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 60.6 t -94.88 88.49 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -88.29 140.2 29.72 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.0 t -97.97 30.57 3.0 Favored 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -177.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.664 HD22 ' CB ' ' A' ' 79' ' ' ALA . 0.2 OUTLIER -161.79 170.41 8.12 Favored Pre-proline 0 N--CA 1.513 2.693 0 O-C-N 120.896 -1.127 . . . . 0.0 111.12 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.632 ' HD2' HD23 ' A' ' 29' ' ' LEU . 4.0 Cg_exo -49.81 -47.93 21.32 Favored 'Trans proline' 0 N--CA 1.502 1.973 0 C-N-CA 121.639 1.559 . . . . 0.0 114.491 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 29' ' ' LEU . 4.5 Cg_exo -52.66 -170.02 0.01 OUTLIER 'Trans proline' 0 N--CA 1.506 2.235 0 CA-C-N 120.044 1.051 . . . . 0.0 112.896 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.549 HG22 ' ND2' ' A' ' 56' ' ' ASN . 0.2 OUTLIER -168.93 -156.21 0.16 Allowed 'General case' 0 N--CA 1.522 3.154 0 O-C-N 120.381 -1.45 . . . . 0.0 111.634 -176.915 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.563 HD11 ' HB3' ' A' ' 73' ' ' CYS . 19.5 tt -88.02 143.04 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 O-C-N 121.897 -0.502 . . . . 0.0 111.906 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.546 ' N ' HD12 ' A' ' 34' ' ' ILE . 3.6 mp -109.47 130.44 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 177.027 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.529 ' CG ' HD22 ' A' ' 58' ' ' LEU . 79.3 m95 -90.28 110.61 21.66 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -110.37 -170.18 1.6 Allowed 'General case' 0 N--CA 1.501 2.1 0 CA-C-O 121.394 0.616 . . . . 0.0 111.199 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 64.06 163.79 0.13 Allowed 'General case' 0 N--CA 1.511 2.621 0 O-C-N 121.87 -0.519 . . . . 0.0 110.24 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.404 ' HG3' ' CE1' ' A' ' 71' ' ' TYR . 0.0 OUTLIER 76.87 -51.71 0.57 Allowed 'General case' 0 N--CA 1.522 3.13 0 C-N-CA 123.873 0.869 . . . . 0.0 110.575 -178.754 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -144.94 30.37 1.8 Allowed Glycine 0 N--CA 1.498 2.818 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.61 89.06 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.791 0 O-C-N 121.496 -1.003 . . . . 0.0 111.625 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.36 105.89 0.01 OUTLIER 'General case' 0 N--CA 1.518 2.932 0 O-C-N 121.807 -0.558 . . . . 0.0 110.865 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.527 HG22 ' HB2' ' A' ' 35' ' ' TRP . 5.6 m -76.99 -31.38 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.394 0 O-C-N 121.715 -0.616 . . . . 0.0 110.646 -179.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 79.6 mt -59.27 -17.33 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.87 0 O-C-N 121.754 -0.591 . . . . 0.0 111.803 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.495 ' N ' HD12 ' A' ' 44' ' ' LEU . 9.8 mp -89.47 -25.22 21.59 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.599 -0.688 . . . . 0.0 110.55 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.0 pttt -98.6 -38.87 8.97 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.756 -0.59 . . . . 0.0 109.655 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.5 mmmt 47.06 55.64 7.79 Favored 'General case' 0 N--CA 1.51 2.55 0 CA-C-O 121.399 0.618 . . . . 0.0 111.959 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.8 169.46 0.07 Allowed 'General case' 0 N--CA 1.515 2.778 0 O-C-N 121.792 -0.567 . . . . 0.0 111.116 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 31.4 m -63.54 -21.59 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.591 0 O-C-N 121.985 -0.447 . . . . 0.0 111.649 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 16.4 ptt-85 -113.67 48.5 1.06 Allowed 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.648 -0.658 . . . . 0.0 111.747 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.411 ' O ' HD13 ' A' ' 51' ' ' ILE . 7.6 m-85 -144.73 102.97 3.87 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.553 -0.717 . . . . 0.0 109.895 178.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.411 HD13 ' O ' ' A' ' 50' ' ' PHE . 48.0 mm -127.74 114.05 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.474 HG22 ' CD1' ' A' ' 58' ' ' LEU . 2.6 t -80.13 146.64 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 24.6 mt -102.71 162.99 12.48 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 121.244 0.545 . . . . 0.0 111.605 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 81.8 p -59.88 -20.58 57.96 Favored 'General case' 0 N--CA 1.51 2.552 0 O-C-N 122.098 -0.376 . . . . 0.0 111.689 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 38.5 p-10 -91.36 17.74 8.06 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.662 -0.649 . . . . 0.0 111.736 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.549 ' ND2' HG22 ' A' ' 32' ' ' THR . 8.1 m120 70.21 29.54 3.67 Favored 'General case' 0 N--CA 1.52 3.046 0 O-C-N 121.635 -0.666 . . . . 0.0 111.931 179.026 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.63 ' CZ ' HG13 ' A' ' 22' ' ' VAL . 4.3 m-85 -103.18 159.92 15.11 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.771 HD23 HD12 ' A' ' 21' ' ' ILE . 26.9 tp -120.85 100.81 7.3 Favored 'General case' 0 N--CA 1.514 2.743 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.814 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.651 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.7 OUTLIER -75.48 103.47 5.62 Favored 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 120.759 -0.377 . . . . 0.0 111.244 179.717 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.739 HD11 HD11 ' A' ' 21' ' ' ILE . 99.8 mt -95.53 114.09 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 177.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -74.59 115.55 14.28 Favored 'General case' 0 N--CA 1.503 2.175 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.229 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.401 ' O ' HG22 ' A' ' 63' ' ' ILE . . . 97.04 -39.02 2.89 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 178.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.5 ' CG1' HG21 ' A' ' 92' ' ' VAL . 1.9 tp 42.92 71.79 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.843 0 CA-C-O 122.256 1.027 . . . . 0.0 112.241 -178.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.1 mtpp -63.32 158.01 21.46 Favored 'General case' 0 N--CA 1.506 2.374 0 O-C-N 121.59 -0.694 . . . . 0.0 112.333 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -62.02 -23.63 66.56 Favored 'General case' 0 N--CA 1.508 2.441 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.933 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.7 p -83.78 -16.56 44.24 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.74 -0.6 . . . . 0.0 111.015 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.91 -19.47 25.77 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.704 -0.623 . . . . 0.0 111.042 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.497 ' HB3' HG12 ' A' ' 92' ' ' VAL . 7.6 pt-20 -67.6 150.1 49.23 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.445 -0.785 . . . . 0.0 109.916 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 166.31 -111.69 0.46 Allowed Glycine 0 N--CA 1.498 2.822 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.4 m -144.57 101.59 3.7 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.941 -0.74 . . . . 0.0 110.034 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.404 ' CE1' ' HG3' ' A' ' 38' ' ' LYS . 24.3 m-85 -82.16 133.52 35.27 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -94.64 117.94 30.92 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 120.002 -0.679 . . . . 0.0 111.143 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.563 ' HB3' HD11 ' A' ' 33' ' ' ILE . 12.0 m -80.3 120.82 24.87 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 177.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.82 82.59 1.97 Allowed 'General case' 0 N--CA 1.509 2.512 0 CA-C-N 118.962 0.801 . . . . 0.0 110.556 -179.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.61 100.79 0.29 Allowed Glycine 0 N--CA 1.508 3.493 0 N-CA-C 108.779 -1.729 . . . . 0.0 108.779 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.604 ' C ' HD12 ' A' ' 77' ' ' ILE . 25.1 ttp85 -116.62 128.75 55.68 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -177.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.662 HD13 ' CG2' ' A' ' 2' ' ' VAL . 4.6 mp -136.22 119.45 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 177.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.7 mt -91.38 52.54 2.11 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.42 0.629 . . . . 0.0 111.531 -178.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.664 ' CB ' HD22 ' A' ' 29' ' ' LEU . . . -152.2 -60.01 0.16 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 178.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 45.7 mtp85 -135.37 -43.33 0.7 Allowed 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -63.63 -18.45 61.49 Favored Glycine 0 N--CA 1.496 2.696 0 CA-C-O 119.538 -0.59 . . . . 0.0 111.956 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 45.79 -150.06 0.08 Allowed 'General case' 0 N--CA 1.515 2.813 0 CA-C-N 118.613 1.206 . . . . 0.0 112.842 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.589 HG22 ' HG3' ' A' ' 76' ' ' ARG . 1.1 pt -105.5 112.48 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.493 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -177.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -118.89 150.63 39.55 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 177.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.417 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 39.0 p90 -159.51 178.38 9.95 Favored 'General case' 0 N--CA 1.504 2.248 0 CA-C-N 119.773 1.17 . . . . 0.0 113.752 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -171.3 159.61 5.83 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.576 ' O ' HG22 ' A' ' 9' ' ' THR . 7.1 p-10 -102.39 118.15 36.25 Favored 'General case' 0 N--CA 1.512 2.656 0 O-C-N 121.795 -0.566 . . . . 0.0 110.773 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.552 HD12 ' N ' ' A' ' 88' ' ' ILE . 1.9 mp -101.99 119.73 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 179.2 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.06 112.83 21.63 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -179.122 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.9 t -106.74 133.26 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.13 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.9 mt -124.64 158.53 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.5 HG21 ' CG1' ' A' ' 63' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.499 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 10.4 t80 . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 120.759 0.314 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.721 ' CG2' HD11 ' A' ' 77' ' ' ILE . 42.2 t -150.19 105.27 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 O-C-N 122.063 -0.398 . . . . 0.0 110.383 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.417 ' CG ' ' HB ' ' A' ' 26' ' ' VAL . 25.6 ptm -119.29 122.87 42.87 Favored 'General case' 0 N--CA 1.509 2.485 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 177.119 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -73.71 136.87 43.75 Favored 'General case' 0 N--CA 1.511 2.603 0 O-C-N 122.031 -0.418 . . . . 0.0 111.992 -176.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.606 ' HG2' HG23 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -136.47 158.15 45.11 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 121.424 0.631 . . . . 0.0 110.823 179.287 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.414 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.6 OUTLIER 32.93 84.1 0.02 OUTLIER 'General case' 0 N--CA 1.521 3.103 0 C-N-CA 123.998 0.919 . . . . 0.0 113.347 179.635 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -145.19 80.86 10.81 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.7 -0.625 . . . . 0.0 111.23 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -67.07 105.3 0.96 Allowed 'Trans proline' 0 N--CA 1.49 1.32 0 N-CA-C 108.693 -1.31 . . . . 0.0 108.693 178.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.563 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.4 OUTLIER -57.88 -67.25 0.95 Allowed Pre-proline 0 N--CA 1.507 2.415 0 CA-C-O 116.905 -1.521 . . . . 0.0 111.828 -177.967 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.486 ' HD3' ' OG1' ' A' ' 9' ' ' THR . 1.6 Cg_endo -71.46 92.02 0.68 Allowed 'Trans proline' 0 N--CA 1.493 1.445 0 CA-C-N 121.32 1.507 . . . . 0.0 111.604 178.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.52 HE21 HG13 ' A' ' 90' ' ' VAL . 14.7 pt20 -101.27 166.31 10.83 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.068 -1.02 . . . . 0.0 110.141 178.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -152.37 120.62 6.3 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 120.196 -0.601 . . . . 0.0 111.844 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -116.12 -172.03 2.1 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 122.028 -0.42 . . . . 0.0 110.056 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 62.2 tttt -101.2 140.77 35.04 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.477 0.656 . . . . 0.0 111.468 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -59.52 122.17 13.37 Favored 'General case' 0 N--CA 1.51 2.541 0 O-C-N 121.99 -0.443 . . . . 0.0 111.041 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.26 21.97 59.71 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.418 ' O ' HG22 ' A' ' 63' ' ' ILE . 14.3 tt0 -111.76 164.43 13.06 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 118.738 1.269 . . . . 0.0 110.628 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -82.81 99.85 9.95 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -101.62 171.06 7.78 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.772 -177.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.669 HG22 ' HG2' ' A' ' 59' ' ' GLN . 84.5 t -141.96 141.26 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 178.039 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.788 HD12 HD23 ' A' ' 58' ' ' LEU . 19.0 mt -95.18 112.35 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 178.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.504 HG13 ' CE2' ' A' ' 57' ' ' TYR . 43.6 t -74.1 121.49 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.546 -176.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.6 t -164.85 93.56 0.64 Allowed 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.414 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -90.95 142.53 27.67 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -179.569 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.888 HG21 HD12 ' A' ' 33' ' ' ILE . 44.9 t -144.41 138.2 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 C-N-CA 120.311 -0.556 . . . . 0.0 109.541 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.606 HG23 ' HG2' ' A' ' 5' ' ' LYS . 90.0 t -106.08 79.46 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.8 m -84.37 169.38 14.67 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.4 t -45.46 -76.31 0.02 OUTLIER 'General case' 0 N--CA 1.521 3.091 0 O-C-N 121.689 -0.632 . . . . 0.0 111.458 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.411 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 0.3 OUTLIER -173.04 -62.52 0.0 OUTLIER Pre-proline 0 N--CA 1.518 2.953 0 CA-C-O 117.832 -1.08 . . . . 0.0 111.987 177.608 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.411 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 2.9 Cg_endo -60.19 -53.31 3.13 Favored 'Trans proline' 0 CA--C 1.562 1.909 0 CA-C-N 119.939 1.014 . . . . 0.0 112.897 -179.077 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.514 ' HG3' HG23 ' A' ' 77' ' ' ILE . 2.8 Cg_endo -62.48 -163.63 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.745 0 CA-C-N 119.275 0.777 . . . . 0.0 112.676 -178.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.428 ' HG1' ' C ' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -170.25 -166.37 0.53 Allowed 'General case' 0 N--CA 1.519 3.001 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.203 -179.534 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.888 HD12 HG21 ' A' ' 25' ' ' VAL . 15.1 tt -97.61 161.11 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 122.065 -0.397 . . . . 0.0 110.056 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 90.4 mt -126.3 124.69 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.597 ' HB2' HG22 ' A' ' 42' ' ' VAL . 78.2 m95 -87.56 105.95 17.67 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 24.9 tttt -112.31 -172.9 2.13 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 122.052 -0.405 . . . . 0.0 110.617 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 30.5 t-80 63.78 147.2 0.03 OUTLIER 'General case' 0 N--CA 1.511 2.599 0 O-C-N 121.802 -0.561 . . . . 0.0 109.938 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.6 tptt 54.87 28.3 10.25 Favored 'General case' 0 N--CA 1.514 2.773 0 O-C-N 121.537 -0.727 . . . . 0.0 111.218 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 162.29 -29.15 0.27 Allowed Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? 56.14 104.77 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.788 0 O-C-N 121.607 -0.937 . . . . 0.0 111.179 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 54.97 70.35 0.63 Allowed 'General case' 0 N--CA 1.511 2.588 0 O-C-N 121.732 -0.605 . . . . 0.0 110.668 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.597 HG22 ' HB2' ' A' ' 35' ' ' TRP . 9.6 m -68.25 -35.06 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.325 0 O-C-N 121.677 -0.64 . . . . 0.0 109.375 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.694 HG12 HG21 ' A' ' 52' ' ' VAL . 50.6 mt -60.51 -18.62 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.68 0 O-C-N 121.877 -0.515 . . . . 0.0 111.173 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.496 ' N ' HD12 ' A' ' 44' ' ' LEU . 9.0 mp -91.73 -20.94 21.02 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.608 -0.682 . . . . 0.0 110.975 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.416 ' HG2' ' HA ' ' A' ' 42' ' ' VAL . 51.5 pttt -98.88 -38.14 9.14 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt 48.35 56.69 7.1 Favored 'General case' 0 N--CA 1.508 2.463 0 CA-C-O 121.508 0.671 . . . . 0.0 111.649 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -50.57 173.71 0.02 OUTLIER 'General case' 0 N--CA 1.516 2.842 0 O-C-N 121.895 -0.503 . . . . 0.0 111.421 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.3 m -61.33 -18.47 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.636 0 O-C-N 121.882 -0.511 . . . . 0.0 111.804 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -126.05 48.33 2.12 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.6 -0.687 . . . . 0.0 112.337 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -144.47 106.47 4.32 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 121.56 -0.712 . . . . 0.0 109.689 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 65.8 mt -128.05 106.84 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.694 HG21 HG12 ' A' ' 43' ' ' ILE . 3.3 t -75.67 136.73 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.287 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.446 HD11 ' OE1' ' A' ' 59' ' ' GLN . 14.5 mt -91.16 165.26 13.58 Favored 'General case' 0 N--CA 1.506 2.338 0 CA-C-O 121.309 0.576 . . . . 0.0 111.724 -178.295 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.8 p -60.55 -21.22 62.29 Favored 'General case' 0 N--CA 1.511 2.576 0 O-C-N 122.114 -0.366 . . . . 0.0 111.453 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 40.4 p-10 -90.57 17.23 7.72 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.627 -0.671 . . . . 0.0 111.505 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.5 m120 69.38 31.58 3.79 Favored 'General case' 0 N--CA 1.516 2.856 0 O-C-N 121.594 -0.691 . . . . 0.0 111.846 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.504 ' CE2' HG13 ' A' ' 22' ' ' VAL . 4.3 m-85 -102.41 166.03 10.78 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 177.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.788 HD23 HD12 ' A' ' 21' ' ' ILE . 18.5 tp -123.62 99.92 6.54 Favored 'General case' 0 N--CA 1.515 2.818 0 C-N-CA 119.333 -0.947 . . . . 0.0 111.808 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.669 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -77.28 101.5 6.29 Favored 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 120.805 0.336 . . . . 0.0 111.107 179.647 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.776 HD11 HD11 ' A' ' 21' ' ' ILE . 97.6 mt -92.78 115.97 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.51 115.24 17.12 Favored 'General case' 0 N--CA 1.505 2.302 0 CA-C-O 121.299 0.571 . . . . 0.0 111.306 -178.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.31 -38.81 2.95 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 179.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.727 HG23 HG21 ' A' ' 92' ' ' VAL . 1.7 tp 41.47 72.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.846 0 CA-C-O 121.995 0.903 . . . . 0.0 112.624 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -62.72 155.37 26.72 Favored 'General case' 0 N--CA 1.509 2.508 0 O-C-N 121.391 -0.818 . . . . 0.0 111.687 -178.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.413 ' HA ' HG13 ' A' ' 92' ' ' VAL . 33.9 tttt -62.82 -21.45 65.92 Favored 'General case' 0 N--CA 1.51 2.542 0 O-C-N 122.119 -0.363 . . . . 0.0 110.772 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 50.7 p -85.17 -13.97 48.39 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.79 -0.569 . . . . 0.0 111.106 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.88 -6.38 48.83 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.607 -0.683 . . . . 0.0 111.452 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.794 ' HB3' HG12 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -80.04 172.74 13.38 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-N 119.005 0.82 . . . . 0.0 110.067 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 145.33 -108.16 0.46 Allowed Glycine 0 N--CA 1.496 2.646 0 N-CA-C 108.991 -1.643 . . . . 0.0 108.991 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.7 m -143.17 100.99 3.74 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 122.041 -0.682 . . . . 0.0 111.418 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -83.72 129.46 34.95 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 29.4 ttp180 -94.84 119.21 33.03 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.324 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.506 ' HB3' HD11 ' A' ' 33' ' ' ILE . 5.5 m -81.88 124.12 29.44 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 177.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -125.12 89.94 3.15 Favored 'General case' 0 N--CA 1.503 2.201 0 CA-C-N 118.995 0.816 . . . . 0.0 111.021 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.44 107.89 2.28 Favored Glycine 0 N--CA 1.502 3.045 0 N-CA-C 107.336 -2.306 . . . . 0.0 107.336 178.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -122.83 142.85 50.31 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -176.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.721 HD11 ' CG2' ' A' ' 2' ' ' VAL . 90.4 mt -115.74 137.63 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.104 177.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 14.2 mt -90.97 -47.35 7.63 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.119 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.19 -56.69 18.94 Favored 'General case' 0 N--CA 1.516 2.872 0 O-C-N 121.639 -0.663 . . . . 0.0 109.99 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 78.4 mtt180 -101.92 61.67 0.88 Allowed 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -14.62 81.72 0.0 OUTLIER Glycine 1 N--CA 1.525 4.599 0 C-N-CA 125.011 1.291 . . . . 0.0 114.867 -178.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -115.17 145.46 42.36 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 122.222 -0.575 . . . . 0.0 109.471 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.7 pt -135.41 70.68 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 CA-C-O 121.183 0.516 . . . . 0.0 111.534 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -85.79 150.37 24.61 Favored 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -163.01 -175.94 4.62 Favored 'General case' 0 N--CA 1.503 2.19 0 C-N-CA 119.551 -0.86 . . . . 0.0 112.979 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 9.1 tttt -167.6 162.27 14.12 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.563 ' O ' HG22 ' A' ' 9' ' ' THR . 4.5 p-10 -106.71 110.5 22.7 Favored 'General case' 0 N--CA 1.51 2.531 0 O-C-N 121.764 -0.585 . . . . 0.0 111.0 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.589 HD12 ' N ' ' A' ' 88' ' ' ILE . 2.6 mp -95.74 120.13 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 10.6 tm0? -91.63 113.53 25.82 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.046 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.52 HG13 HE21 ' A' ' 11' ' ' GLN . 39.7 t -104.75 143.33 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.931 -0.481 . . . . 0.0 109.967 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 68.4 mt -134.95 139.92 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.311 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.794 HG12 ' HB3' ' A' ' 68' ' ' GLU . 8.4 p . . . . . 0 N--CA 1.5 2.045 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.76 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 2.1 t80 . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.701 ' CG2' HD11 ' A' ' 77' ' ' ILE . 45.3 t -150.89 104.52 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 O-C-N 122.055 -0.403 . . . . 0.0 110.045 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.437 ' CG ' ' HB ' ' A' ' 26' ' ' VAL . 17.1 ptm -119.09 123.31 44.13 Favored 'General case' 0 N--CA 1.508 2.456 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -74.17 133.29 42.74 Favored 'General case' 0 N--CA 1.511 2.606 0 CA-C-O 120.974 0.416 . . . . 0.0 112.045 -176.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.517 ' HG2' HG23 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -135.37 163.38 30.15 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-O 121.367 0.603 . . . . 0.0 111.093 179.34 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.5 t30 27.78 70.24 0.06 Allowed 'General case' 0 N--CA 1.523 3.205 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -135.76 82.85 37.09 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.736 -0.603 . . . . 0.0 110.619 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -65.44 110.0 1.51 Allowed 'Trans proline' 0 N--CA 1.491 1.366 0 N-CA-C 109.02 -1.185 . . . . 0.0 109.02 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.586 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.1 OUTLIER -60.64 -59.05 15.09 Favored Pre-proline 0 N--CA 1.502 2.151 0 CA-C-O 117.113 -1.422 . . . . 0.0 112.161 -177.777 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.528 ' HD3' ' OG1' ' A' ' 9' ' ' THR . 1.4 Cg_endo -80.11 91.44 1.17 Allowed 'Trans proline' 0 CA--C 1.554 1.488 0 CA-C-N 121.055 1.413 . . . . 0.0 111.557 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.533 HE21 HG13 ' A' ' 90' ' ' VAL . 15.7 pt20 -101.38 173.5 6.41 Favored 'General case' 0 N--CA 1.509 2.504 0 O-C-N 120.973 -1.079 . . . . 0.0 110.521 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -158.37 121.13 3.76 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.783 -0.573 . . . . 0.0 111.478 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -116.68 -170.02 1.74 Allowed 'General case' 0 N--CA 1.503 2.203 0 O-C-N 122.06 -0.4 . . . . 0.0 109.943 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -103.48 137.52 41.46 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.527 0.68 . . . . 0.0 111.444 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -61.08 116.67 4.71 Favored 'General case' 0 N--CA 1.508 2.466 0 CA-C-O 121.051 0.453 . . . . 0.0 110.333 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.13 22.46 29.96 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -117.48 165.41 13.56 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 118.567 1.183 . . . . 0.0 111.085 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -80.62 99.85 8.34 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 177.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.29 165.85 11.49 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.968 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.677 HG22 ' HG2' ' A' ' 59' ' ' GLN . 99.2 t -141.68 139.47 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 177.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.746 HD12 HD23 ' A' ' 58' ' ' LEU . 42.6 mt -97.15 113.47 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 178.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.557 HG13 ' CE2' ' A' ' 57' ' ' TYR . 48.4 t -76.43 117.47 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 CA-C-O 121.558 0.694 . . . . 0.0 110.401 -177.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.3 t -157.94 91.26 1.11 Allowed 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.01 138.95 31.0 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -178.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.804 HG21 HD12 ' A' ' 33' ' ' ILE . 44.3 t -143.87 131.11 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 C-N-CA 120.283 -0.567 . . . . 0.0 109.476 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.517 HG23 ' HG2' ' A' ' 5' ' ' LYS . 93.3 t -97.63 83.21 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.8 m -84.62 171.18 12.65 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 177.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.5 t -46.18 -81.49 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.091 0 O-C-N 121.594 -0.691 . . . . 0.0 111.261 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.431 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 0.9 OUTLIER -165.93 -64.01 0.01 OUTLIER Pre-proline 0 N--CA 1.514 2.758 0 CA-C-O 117.706 -1.14 . . . . 0.0 111.752 177.687 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.431 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 3.0 Cg_endo -61.13 -53.07 2.76 Favored 'Trans proline' 0 CA--C 1.563 1.939 0 CA-C-N 120.189 1.103 . . . . 0.0 113.013 -179.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.498 ' HG3' HG23 ' A' ' 77' ' ' ILE . 3.2 Cg_exo -61.14 -163.83 0.03 OUTLIER 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 120.549 0.832 . . . . 0.0 113.108 -178.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.404 ' HG1' ' C ' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -168.97 -162.81 0.39 Allowed 'General case' 0 N--CA 1.517 2.915 0 O-C-N 121.966 -0.459 . . . . 0.0 109.768 -179.293 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.804 HD12 HG21 ' A' ' 25' ' ' VAL . 14.0 tt -101.23 167.35 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.879 -0.513 . . . . 0.0 110.195 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.435 HD12 ' NE ' ' A' ' 76' ' ' ARG . 96.7 mt -131.89 134.35 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.539 ' HB2' HG22 ' A' ' 42' ' ' VAL . 85.4 m95 -95.9 114.88 26.64 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.5 tttt -121.65 -162.68 0.99 Allowed 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.814 -0.554 . . . . 0.0 111.129 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 69.35 -166.38 0.18 Allowed 'General case' 0 N--CA 1.509 2.524 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.27 19.51 6.34 Favored 'General case' 0 N--CA 1.516 2.863 0 O-C-N 121.493 -0.755 . . . . 0.0 111.14 -178.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 121.91 -46.9 1.06 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.29 -173.45 0.66 Allowed 'General case' 0 N--CA 1.51 2.547 0 O-C-N 121.895 -0.768 . . . . 0.0 109.773 -178.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -70.77 146.48 49.76 Favored 'General case' 0 N--CA 1.506 2.36 0 C-N-CA 120.708 -0.397 . . . . 0.0 109.973 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.539 HG22 ' HB2' ' A' ' 35' ' ' TRP . 3.3 m -95.1 -34.21 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 CA-C-O 121.192 0.52 . . . . 0.0 109.663 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.48 HD11 HG21 ' A' ' 52' ' ' VAL . 47.8 mm -58.35 -19.36 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.795 0 O-C-N 121.867 -0.52 . . . . 0.0 111.558 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.525 ' N ' HD12 ' A' ' 44' ' ' LEU . 8.2 mp -93.03 -22.78 18.94 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.478 -0.764 . . . . 0.0 111.126 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.421 ' HG2' ' HA ' ' A' ' 42' ' ' VAL . 31.2 pttt -97.96 -38.57 9.34 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.4 mmmt 49.14 54.86 10.22 Favored 'General case' 0 N--CA 1.507 2.395 0 CA-C-O 121.487 0.66 . . . . 0.0 111.726 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.75 161.47 0.74 Allowed 'General case' 0 N--CA 1.514 2.764 0 O-C-N 121.731 -0.605 . . . . 0.0 110.916 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.9 m -58.42 -21.1 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.666 0 O-C-N 121.909 -0.494 . . . . 0.0 111.876 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.1 ptp85 -111.53 46.11 1.14 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.78 -0.575 . . . . 0.0 111.633 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -146.24 106.36 4.02 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.72 -0.613 . . . . 0.0 109.836 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 81.1 mt -129.03 107.5 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.523 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.1 t -74.94 139.32 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.466 HD11 ' CG ' ' A' ' 59' ' ' GLN . 43.1 mt -94.82 167.84 11.18 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 121.224 0.535 . . . . 0.0 111.963 -178.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.4 p -61.76 -23.22 66.03 Favored 'General case' 0 N--CA 1.509 2.484 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.072 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 35.6 p-10 -90.03 16.93 7.49 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.659 -0.651 . . . . 0.0 111.414 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.5 m120 69.43 32.18 3.55 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 121.558 -0.714 . . . . 0.0 112.283 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.557 ' CE2' HG13 ' A' ' 22' ' ' VAL . 4.0 m-85 -103.24 157.97 16.64 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.746 HD23 HD12 ' A' ' 21' ' ' ILE . 17.8 tp -114.13 98.92 7.26 Favored 'General case' 0 N--CA 1.517 2.897 0 C-N-CA 119.487 -0.885 . . . . 0.0 111.624 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.677 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -76.97 98.96 5.1 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 120.325 -0.55 . . . . 0.0 111.075 179.609 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.58 HD11 HD11 ' A' ' 21' ' ' ILE . 98.2 mt -89.58 119.56 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 177.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.2 tpt85 -81.45 114.12 19.98 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-O 121.443 0.639 . . . . 0.0 111.247 -178.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.17 -36.73 3.75 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.507 ' CG1' HG21 ' A' ' 92' ' ' VAL . 3.1 tp 42.3 93.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.826 0 CA-C-N 118.14 0.97 . . . . 0.0 112.237 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -80.36 154.68 27.59 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.377 -0.827 . . . . 0.0 112.004 -177.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.7 tttm -62.04 -25.07 67.45 Favored 'General case' 0 N--CA 1.509 2.517 0 O-C-N 122.174 -0.329 . . . . 0.0 111.002 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 56.3 p -82.22 -16.62 48.98 Favored 'General case' 0 N--CA 1.505 2.325 0 O-C-N 121.848 -0.532 . . . . 0.0 110.978 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.88 -12.42 36.26 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.622 -0.674 . . . . 0.0 111.732 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.551 ' HB3' HG12 ' A' ' 92' ' ' VAL . 8.2 pt-20 -73.42 142.87 46.92 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.385 -0.822 . . . . 0.0 109.792 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 171.85 -104.27 0.2 Allowed Glycine 0 N--CA 1.498 2.792 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.4 m -147.77 102.13 3.39 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 122.055 -0.674 . . . . 0.0 110.45 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -81.97 139.61 34.46 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.8 ttt180 -102.46 116.79 33.34 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.02 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.482 ' HB3' HD11 ' A' ' 33' ' ' ILE . 7.0 m -79.04 133.43 36.81 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 177.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -133.71 91.58 2.86 Favored 'General case' 0 N--CA 1.504 2.243 0 CA-C-N 118.711 0.687 . . . . 0.0 110.452 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.36 109.6 2.96 Favored Glycine 0 N--CA 1.504 3.185 0 N-CA-C 107.631 -2.187 . . . . 0.0 107.631 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.435 ' NE ' HD12 ' A' ' 34' ' ' ILE . 5.9 ttm180 -120.54 140.2 51.83 Favored 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -176.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.701 HD11 ' CG2' ' A' ' 2' ' ' VAL . 85.1 mt -118.89 137.76 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-N 114.933 -1.03 . . . . 0.0 108.505 177.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.5 mt -92.18 -44.29 8.87 Favored 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 121.071 -0.252 . . . . 0.0 110.886 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.07 -57.36 12.89 Favored 'General case' 0 N--CA 1.515 2.806 0 O-C-N 121.645 -0.659 . . . . 0.0 109.797 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 60.1 mtt85 -102.14 61.99 0.87 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -14.31 82.1 0.0 OUTLIER Glycine 1 N--CA 1.526 4.685 0 C-N-CA 124.946 1.26 . . . . 0.0 114.733 -178.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.464 ' OE1' HD12 ' A' ' 77' ' ' ILE . 2.1 tt0 -116.8 148.59 41.07 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 122.146 -0.62 . . . . 0.0 109.636 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.9 pt -138.26 65.93 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 CA-C-O 121.111 0.482 . . . . 0.0 111.169 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -79.42 155.36 28.38 Favored 'General case' 0 N--CA 1.505 2.292 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -164.83 -178.6 5.34 Favored 'General case' 0 N--CA 1.506 2.348 0 C-N-CA 119.723 -0.791 . . . . 0.0 112.937 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.9 mttm -168.72 159.52 9.9 Favored 'General case' 0 N--CA 1.505 2.294 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.586 ' O ' HG22 ' A' ' 9' ' ' THR . 4.0 p-10 -103.66 112.75 25.82 Favored 'General case' 0 N--CA 1.512 2.642 0 O-C-N 121.847 -0.533 . . . . 0.0 110.644 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.572 HD12 ' N ' ' A' ' 88' ' ' ILE . 2.8 mp -98.85 115.23 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -82.87 110.87 18.24 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.533 HG13 HE21 ' A' ' 11' ' ' GLN . 44.4 t -105.54 135.69 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.032 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.41 ' N ' HD12 ' A' ' 91' ' ' ILE . 5.1 mp -124.71 159.76 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.551 HG12 ' HB3' ' A' ' 68' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.503 2.205 0 CA-C-O 117.937 -1.03 . . . . 0.0 110.35 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 45.2 p90 . . . . . 0 N--CA 1.499 1.976 0 CA-C-O 120.704 0.287 . . . . 0.0 110.451 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.642 ' CG2' HD11 ' A' ' 77' ' ' ILE . 43.3 t -148.11 104.03 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.512 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 0.8 OUTLIER -108.31 112.89 25.58 Favored 'General case' 0 N--CA 1.507 2.42 0 C-N-CA 120.251 -0.579 . . . . 0.0 109.56 179.289 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -69.91 120.43 15.63 Favored 'General case' 0 N--CA 1.504 2.242 0 CA-C-O 120.926 0.393 . . . . 0.0 110.485 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.438 ' HG2' HG23 ' A' ' 26' ' ' VAL . 3.0 pttt -130.92 161.55 31.63 Favored 'General case' 0 N--CA 1.502 2.133 0 CA-C-O 121.624 0.726 . . . . 0.0 111.068 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.405 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.4 OUTLIER 32.55 72.38 0.08 Allowed 'General case' 0 N--CA 1.518 2.942 0 C-N-CA 124.213 1.005 . . . . 0.0 113.31 179.602 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -136.5 80.79 37.87 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.739 -0.601 . . . . 0.0 110.972 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -66.08 102.32 0.54 Allowed 'Trans proline' 0 N--CA 1.491 1.378 0 N-CA-C 108.455 -1.402 . . . . 0.0 108.455 178.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.589 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.3 OUTLIER -53.15 -67.82 0.53 Allowed Pre-proline 0 N--CA 1.509 2.5 0 CA-C-O 116.732 -1.604 . . . . 0.0 112.401 -177.219 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.497 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.4 Cg_endo -74.88 95.14 0.96 Allowed 'Trans proline' 0 N--CA 1.498 1.749 0 CA-C-N 121.54 1.586 . . . . 0.0 111.123 178.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.436 HE21 HG13 ' A' ' 90' ' ' VAL . 16.3 pt20 -100.49 179.51 4.42 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.96 -1.087 . . . . 0.0 110.389 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -159.61 124.68 4.06 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.852 -0.53 . . . . 0.0 111.921 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -124.18 -169.04 1.89 Allowed 'General case' 0 N--CA 1.505 2.315 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.0 tttt -106.04 137.18 44.41 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.598 0.713 . . . . 0.0 111.542 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -62.18 115.87 4.5 Favored 'General case' 0 N--CA 1.508 2.471 0 CA-C-O 121.105 0.478 . . . . 0.0 110.168 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.0 22.4 23.12 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.436 ' O ' HG22 ' A' ' 63' ' ' ILE . 15.8 tt0 -118.3 165.31 14.0 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 118.371 1.086 . . . . 0.0 110.851 -179.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -83.3 99.34 9.94 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 177.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.26 169.07 9.38 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.315 0.579 . . . . 0.0 112.197 -177.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.683 HG22 ' HG2' ' A' ' 59' ' ' GLN . 88.5 t -142.01 141.05 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 177.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.801 HD12 HD23 ' A' ' 58' ' ' LEU . 29.2 mt -97.01 114.18 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 178.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.503 HG13 ' CE2' ' A' ' 57' ' ' TYR . 46.8 t -75.41 120.41 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.64 -176.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.0 t -162.4 89.91 0.71 Allowed 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.405 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -88.88 142.88 27.28 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.313 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.781 HG21 HD12 ' A' ' 33' ' ' ILE . 48.0 t -147.34 132.61 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.512 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 48.9 t -93.63 75.54 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.1 m -77.6 163.96 25.78 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.5 t -45.44 -83.58 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.145 0 O-C-N 121.895 -0.503 . . . . 0.0 111.189 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.405 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 0.3 OUTLIER -167.06 -64.37 0.01 OUTLIER Pre-proline 0 N--CA 1.513 2.712 0 CA-C-O 117.61 -1.186 . . . . 0.0 111.686 177.592 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.405 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 2.9 Cg_endo -59.6 -53.15 3.61 Favored 'Trans proline' 0 CA--C 1.563 1.969 0 CA-C-N 120.235 1.12 . . . . 0.0 112.682 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.599 ' HG3' HG23 ' A' ' 77' ' ' ILE . 3.0 Cg_endo -61.73 -163.73 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 120.601 0.867 . . . . 0.0 112.611 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.411 HG22 ' H ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -169.94 -168.76 0.79 Allowed 'General case' 0 N--CA 1.518 2.95 0 O-C-N 121.932 -0.48 . . . . 0.0 110.283 -179.576 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.781 HD12 HG21 ' A' ' 25' ' ' VAL . 14.8 tt -97.52 164.24 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 86.6 mt -129.34 129.66 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.563 ' HB2' HG22 ' A' ' 42' ' ' VAL . 84.6 m95 -91.95 101.03 13.59 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -99.87 -170.14 1.84 Allowed 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.065 0.46 . . . . 0.0 110.493 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 61.78 161.71 0.07 Allowed 'General case' 0 N--CA 1.512 2.642 0 O-C-N 121.809 -0.557 . . . . 0.0 110.339 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.3 tppm? 56.55 40.45 29.45 Favored 'General case' 0 N--CA 1.517 2.919 0 O-C-N 121.492 -0.755 . . . . 0.0 110.682 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 133.83 8.13 2.22 Favored Glycine 0 N--CA 1.497 2.741 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.991 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? 52.59 90.58 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.786 0 CA-C-N 119.376 1.588 . . . . 0.0 111.18 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.2 t0 53.95 100.02 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.904 0 O-C-N 121.85 -0.531 . . . . 0.0 110.94 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.563 HG22 ' HB2' ' A' ' 35' ' ' TRP . 4.1 m -71.72 -26.25 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.494 0 O-C-N 121.794 -0.567 . . . . 0.0 110.618 -179.148 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.3 mm -58.91 -17.76 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.757 0 O-C-N 121.578 -0.702 . . . . 0.0 111.679 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.505 ' N ' HD12 ' A' ' 44' ' ' LEU . 8.9 mp -92.53 -22.47 19.53 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.48 -0.762 . . . . 0.0 110.986 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.6 pttt -98.03 -42.27 7.57 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.574 -0.704 . . . . 0.0 109.635 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 20.1 mmmt 46.37 56.49 6.28 Favored 'General case' 0 N--CA 1.51 2.55 0 CA-C-O 121.457 0.646 . . . . 0.0 112.038 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -52.19 169.58 0.07 Allowed 'General case' 0 N--CA 1.515 2.798 0 O-C-N 121.694 -0.628 . . . . 0.0 110.968 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.8 m -61.99 -19.25 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.638 0 O-C-N 121.975 -0.453 . . . . 0.0 111.893 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.1 ptt-85 -116.93 46.49 1.65 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.678 -0.639 . . . . 0.0 111.703 -179.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -143.8 102.99 4.0 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.609 -0.682 . . . . 0.0 109.501 178.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 71.3 mt -128.17 113.22 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.47 HG22 ' CD1' ' A' ' 58' ' ' LEU . 2.4 t -78.62 127.37 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.524 HD11 ' CG ' ' A' ' 59' ' ' GLN . 65.1 mt -78.82 165.51 23.47 Favored 'General case' 0 N--CA 1.508 2.473 0 CA-C-O 121.224 0.535 . . . . 0.0 112.169 -177.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.2 p -60.16 -21.59 61.84 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 122.196 -0.315 . . . . 0.0 111.505 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -91.39 19.04 6.42 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.676 -0.64 . . . . 0.0 111.526 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.0 m120 68.11 31.48 5.38 Favored 'General case' 0 N--CA 1.516 2.851 0 O-C-N 121.661 -0.649 . . . . 0.0 112.145 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.503 ' CE2' HG13 ' A' ' 22' ' ' VAL . 4.0 m-85 -102.12 165.21 11.28 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.801 HD23 HD12 ' A' ' 21' ' ' ILE . 21.9 tp -120.65 98.68 6.14 Favored 'General case' 0 N--CA 1.517 2.908 0 C-N-CA 119.341 -0.944 . . . . 0.0 112.008 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.683 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -76.18 104.97 6.96 Favored 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.991 179.486 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.716 HD11 HD11 ' A' ' 21' ' ' ILE . 98.9 mt -96.56 113.63 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 177.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -77.08 115.95 17.32 Favored 'General case' 0 N--CA 1.503 2.224 0 CA-C-O 121.394 0.616 . . . . 0.0 111.287 -178.085 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.53 -37.02 3.65 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.588 ' CG1' HG21 ' A' ' 92' ' ' VAL . 3.6 tp 40.11 84.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.521 3.095 0 CA-C-O 122.133 0.968 . . . . 0.0 112.44 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 45.6 mttt -75.99 160.08 30.2 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 121.631 -0.668 . . . . 0.0 112.151 -178.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.8 tttm -60.86 -25.6 66.79 Favored 'General case' 0 N--CA 1.51 2.564 0 O-C-N 122.022 -0.424 . . . . 0.0 110.974 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 63.9 p -80.14 -16.9 53.92 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 121.859 -0.525 . . . . 0.0 111.56 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.25 -29.47 26.46 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.51 -0.743 . . . . 0.0 110.509 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.438 ' HB3' HG12 ' A' ' 92' ' ' VAL . 5.7 pt-20 -61.72 140.68 58.17 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.884 -0.51 . . . . 0.0 111.18 -178.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 169.06 -101.39 0.17 Allowed Glycine 0 N--CA 1.497 2.765 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.3 m -151.23 100.6 2.77 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 122.079 -0.659 . . . . 0.0 110.382 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -81.64 140.05 34.63 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.2 ttm-85 -102.44 121.09 41.64 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 120.059 -0.656 . . . . 0.0 111.511 -179.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.501 ' HB3' HD11 ' A' ' 33' ' ' ILE . 9.8 m -86.1 130.1 34.64 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 177.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -131.38 90.47 2.87 Favored 'General case' 0 N--CA 1.506 2.331 0 CA-C-N 118.783 0.719 . . . . 0.0 110.526 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.2 106.27 1.74 Allowed Glycine 0 N--CA 1.504 3.208 0 N-CA-C 107.827 -2.109 . . . . 0.0 107.827 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 -118.85 138.74 52.51 Favored 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -177.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.642 HD11 ' CG2' ' A' ' 2' ' ' VAL . 74.2 mt -124.21 135.9 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.569 177.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 35.6 mt -94.95 -39.97 9.92 Favored 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 121.044 -0.263 . . . . 0.0 110.684 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.83 -58.96 5.96 Favored 'General case' 0 N--CA 1.515 2.812 0 O-C-N 121.788 -0.57 . . . . 0.0 109.509 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 81.4 mtt-85 -100.83 61.23 0.98 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 177.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -14.41 81.8 0.0 OUTLIER Glycine 1 N--CA 1.525 4.618 0 C-N-CA 125.012 1.291 . . . . 0.0 114.92 -178.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -120.29 142.98 48.59 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 122.271 -0.546 . . . . 0.0 109.978 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.1 pt -135.48 81.81 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 CA-C-O 121.275 0.559 . . . . 0.0 111.129 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -100.15 153.54 19.16 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -161.9 -179.25 7.02 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 120.009 -0.676 . . . . 0.0 112.221 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.0 mttt -165.76 160.39 17.11 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.589 ' O ' HG22 ' A' ' 9' ' ' THR . 6.9 p-10 -104.17 113.36 26.86 Favored 'General case' 0 N--CA 1.511 2.612 0 O-C-N 121.896 -0.502 . . . . 0.0 110.213 178.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.582 HD12 ' N ' ' A' ' 88' ' ' ILE . 3.0 mp -100.89 116.74 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -82.96 122.09 27.84 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.436 HG13 HE21 ' A' ' 11' ' ' GLN . 44.6 t -116.01 126.5 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.16 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 71.0 mt -115.68 155.75 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.588 HG21 ' CG1' ' A' ' 63' ' ' ILE . 0.9 OUTLIER . . . . . 0 N--CA 1.499 1.975 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.71 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 39.6 p90 . . . . . 0 N--CA 1.5 2.052 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.637 ' CG2' HD11 ' A' ' 77' ' ' ILE . 48.4 t -147.44 114.02 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.427 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 16.3 mtp -114.81 106.56 14.33 Favored 'General case' 0 N--CA 1.513 2.698 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -66.38 119.16 11.11 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.959 -0.463 . . . . 0.0 110.747 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.401 ' HG2' HG23 ' A' ' 26' ' ' VAL . 0.4 OUTLIER -130.87 156.2 45.44 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-O 121.578 0.704 . . . . 0.0 110.558 179.768 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.422 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 1.6 t30 39.13 87.75 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.051 0 C-N-CA 123.404 0.682 . . . . 0.0 112.193 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -143.04 61.36 10.32 Favored Pre-proline 0 N--CA 1.497 1.917 0 C-N-CA 119.91 -0.716 . . . . 0.0 112.332 -178.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -64.68 93.34 0.2 Allowed 'Trans proline' 0 N--CA 1.494 1.506 0 N-CA-C 107.972 -1.588 . . . . 0.0 107.972 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.502 HG22 HD13 ' A' ' 88' ' ' ILE . 18.3 p -53.04 -42.79 92.53 Favored Pre-proline 0 N--CA 1.508 2.472 0 CA-C-O 117.343 -1.313 . . . . 0.0 113.631 -176.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.494 ' HD3' ' OG1' ' A' ' 9' ' ' THR . 1.6 Cg_endo -82.83 86.55 1.46 Allowed 'Trans proline' 0 CA--C 1.548 1.203 0 CA-C-N 120.785 1.316 . . . . 0.0 111.051 -177.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.491 HE21 HG13 ' A' ' 90' ' ' VAL . 17.8 pt20 -100.16 171.17 7.97 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 121.15 -0.969 . . . . 0.0 111.068 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -155.92 119.9 4.48 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 122.089 -0.382 . . . . 0.0 110.975 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -116.28 -171.09 1.93 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.871 -0.518 . . . . 0.0 110.196 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.0 tttm -103.68 139.58 38.76 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.492 0.663 . . . . 0.0 111.633 -178.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -59.83 125.83 25.2 Favored 'General case' 0 N--CA 1.508 2.442 0 O-C-N 121.767 -0.583 . . . . 0.0 110.815 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.24 22.04 66.16 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -113.59 160.9 18.06 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-N 118.829 1.314 . . . . 0.0 111.094 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -78.29 98.38 5.91 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.39 174.0 6.49 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.125 0.488 . . . . 0.0 111.875 -177.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.702 HG22 ' HG2' ' A' ' 59' ' ' GLN . 85.9 t -145.57 141.52 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.889 HD12 HD23 ' A' ' 58' ' ' LEU . 21.9 mt -95.95 116.77 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 178.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.417 ' HA ' ' CE2' ' A' ' 57' ' ' TYR . 55.6 t -75.98 121.02 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 CA-C-O 121.446 0.641 . . . . 0.0 111.42 -176.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.8 t -165.2 93.75 0.61 Allowed 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.422 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -91.4 139.11 31.03 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.044 -179.582 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.694 HG21 HD12 ' A' ' 33' ' ' ILE . 47.8 t -147.08 131.95 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.427 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 48.2 t -94.09 74.06 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.1 m -76.18 165.93 24.2 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.1 t -47.65 -82.75 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.085 0 O-C-N 121.877 -0.515 . . . . 0.0 111.206 -179.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.414 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 0.7 OUTLIER -166.59 -63.22 0.01 OUTLIER Pre-proline 0 N--CA 1.513 2.694 0 CA-C-O 117.661 -1.161 . . . . 0.0 111.696 178.173 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.414 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 2.9 Cg_endo -60.22 -53.19 3.2 Favored 'Trans proline' 0 CA--C 1.561 1.852 0 CA-C-N 120.203 1.108 . . . . 0.0 112.503 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.511 ' CB ' ' HA ' ' A' ' 77' ' ' ILE . 2.8 Cg_endo -63.45 -164.58 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.715 0 CA-C-N 119.211 0.754 . . . . 0.0 112.51 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.44 ' HG1' ' C ' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -171.79 -164.5 0.32 Allowed 'General case' 0 N--CA 1.52 3.037 0 O-C-N 121.925 -0.484 . . . . 0.0 110.206 -179.842 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.716 HD11 ' HB3' ' A' ' 73' ' ' CYS . 18.8 tt -103.49 136.32 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 122.038 -0.414 . . . . 0.0 110.069 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.507 ' N ' HD12 ' A' ' 34' ' ' ILE . 5.0 mp -100.79 130.03 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.579 ' CG ' HD22 ' A' ' 58' ' ' LEU . 74.7 m95 -89.73 107.34 19.04 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 48.2 mttt -108.88 -165.44 1.02 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 122.02 -0.425 . . . . 0.0 110.618 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 66.2 162.78 0.16 Allowed 'General case' 0 N--CA 1.511 2.609 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -178.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.7 tppm? 55.48 23.14 5.61 Favored 'General case' 0 N--CA 1.515 2.789 0 O-C-N 121.613 -0.679 . . . . 0.0 111.534 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 142.28 36.21 0.09 OUTLIER Glycine 0 N--CA 1.498 2.812 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.582 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 60.86 -75.39 0.03 OUTLIER 'General case' 0 N--CA 1.518 2.973 0 CA-C-N 118.42 1.11 . . . . 0.0 111.102 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -144.62 140.4 28.69 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.493 HG22 ' HB2' ' A' ' 35' ' ' TRP . 4.8 m -95.93 -36.68 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.332 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.28 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 77.9 mt -60.61 -16.87 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.829 0 O-C-N 121.943 -0.473 . . . . 0.0 111.658 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.449 ' N ' HD12 ' A' ' 44' ' ' LEU . 10.3 mp -91.43 -22.29 20.52 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.469 -0.769 . . . . 0.0 110.731 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.5 pttt -98.55 -36.43 9.91 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.71 -0.619 . . . . 0.0 109.411 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.4 mmmt 47.92 55.0 9.19 Favored 'General case' 0 N--CA 1.507 2.379 0 CA-C-O 121.405 0.622 . . . . 0.0 112.035 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.52 169.39 0.13 Allowed 'General case' 0 N--CA 1.513 2.685 0 O-C-N 121.705 -0.622 . . . . 0.0 110.81 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.7 m -63.78 -16.02 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.612 0 O-C-N 121.891 -0.506 . . . . 0.0 111.872 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.5 ptt-85 -120.07 45.05 2.27 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.585 -0.697 . . . . 0.0 111.956 -178.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -145.49 101.59 3.6 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.56 -0.712 . . . . 0.0 110.418 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.9 mm -125.96 113.79 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.439 HG22 ' CD1' ' A' ' 58' ' ' LEU . 2.5 t -80.02 139.4 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.411 HD11 ' CG ' ' A' ' 59' ' ' GLN . 31.8 mt -92.92 165.51 12.85 Favored 'General case' 0 N--CA 1.506 2.327 0 CA-C-O 121.335 0.588 . . . . 0.0 112.0 -178.085 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.1 p -61.09 -21.25 63.51 Favored 'General case' 0 N--CA 1.509 2.493 0 O-C-N 122.097 -0.377 . . . . 0.0 111.212 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 46.5 p-10 -89.67 16.97 6.99 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.573 -0.704 . . . . 0.0 111.503 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.6 m120 68.14 31.49 5.33 Favored 'General case' 0 N--CA 1.517 2.896 0 O-C-N 121.559 -0.713 . . . . 0.0 112.278 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.417 ' CE2' ' HA ' ' A' ' 22' ' ' VAL . 4.2 m-85 -103.68 165.64 10.91 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 177.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.889 HD23 HD12 ' A' ' 21' ' ' ILE . 23.4 tp -121.48 99.42 6.46 Favored 'General case' 0 N--CA 1.516 2.833 0 C-N-CA 119.404 -0.918 . . . . 0.0 111.901 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.702 ' HG2' HG22 ' A' ' 20' ' ' VAL . 1.3 mt-30 -76.0 105.16 6.89 Favored 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.089 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.843 HD11 HD11 ' A' ' 21' ' ' ILE . 96.5 mt -95.26 115.08 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.45 113.32 12.72 Favored 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.642 -177.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.66 -35.12 4.69 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 178.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.652 HG23 HG21 ' A' ' 92' ' ' VAL . 3.1 tp 41.07 76.65 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.519 2.98 0 CA-C-N 118.15 0.975 . . . . 0.0 112.116 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.6 mtpp -59.65 147.63 36.74 Favored 'General case' 0 N--CA 1.508 2.444 0 O-C-N 121.411 -0.805 . . . . 0.0 111.769 -178.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.551 ' HA ' HG13 ' A' ' 92' ' ' VAL . 38.2 tttt -62.22 -17.46 58.34 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 122.23 -0.294 . . . . 0.0 111.037 178.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.8 p -90.81 -16.72 27.82 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.6 -0.688 . . . . 0.0 111.116 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.2 12.44 20.13 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.573 -0.704 . . . . 0.0 112.039 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.795 ' HB3' HG12 ' A' ' 92' ' ' VAL . 0.4 OUTLIER -92.78 160.93 14.73 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.33 -0.856 . . . . 0.0 109.368 179.342 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 157.12 -98.68 0.18 Allowed Glycine 0 N--CA 1.495 2.625 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.7 m -153.67 102.49 2.55 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 117.52 0.66 . . . . 0.0 111.292 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -82.38 139.38 34.09 Favored 'General case' 0 N--CA 1.506 2.33 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.9 ttp180 -101.25 119.61 39.01 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.282 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.716 ' HB3' HD11 ' A' ' 33' ' ' ILE . 37.8 m -79.56 127.85 32.66 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 177.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.71 85.11 2.35 Favored 'General case' 0 N--CA 1.505 2.321 0 CA-C-N 119.312 0.96 . . . . 0.0 110.549 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.88 105.12 1.31 Allowed Glycine 0 N--CA 1.504 3.231 0 N-CA-C 107.688 -2.165 . . . . 0.0 107.688 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 34.4 ttp85 -122.13 140.74 52.19 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -176.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.637 HD11 ' CG2' ' A' ' 2' ' ' VAL . 91.0 mt -118.62 133.68 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.137 177.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 17.3 mt -92.26 -33.86 14.48 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.005 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.97 -57.15 8.46 Favored 'General case' 0 N--CA 1.512 2.661 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 38.2 mtp85 -103.66 61.72 0.76 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 177.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -14.09 81.16 0.0 OUTLIER Glycine 1 N--CA 1.526 4.657 0 C-N-CA 124.999 1.285 . . . . 0.0 114.952 -178.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -121.64 141.79 50.77 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 122.229 -0.571 . . . . 0.0 109.803 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.1 pt -132.85 86.21 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.374 0 CA-C-O 121.391 0.615 . . . . 0.0 111.803 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -98.27 148.65 23.42 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -159.2 176.07 12.66 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 119.544 -0.862 . . . . 0.0 112.9 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.8 mttp -165.74 158.68 15.49 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -96.92 138.52 34.34 Favored 'General case' 0 N--CA 1.506 2.351 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.212 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.502 HD13 HG22 ' A' ' 9' ' ' THR . 46.4 mm -121.04 104.73 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -71.17 113.32 8.09 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.491 HG13 HE21 ' A' ' 11' ' ' GLN . 43.5 t -110.72 132.48 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.621 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 71.7 mt -124.76 143.83 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.365 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.795 HG12 ' HB3' ' A' ' 68' ' ' GLU . 9.9 p . . . . . 0 N--CA 1.503 2.194 0 CA-C-O 118.043 -0.98 . . . . 0.0 110.863 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 42.3 p90 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.26 0.552 . . . . 0.0 110.999 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.662 HG21 HD13 ' A' ' 77' ' ' ILE . 44.3 t -143.05 102.67 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.503 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 12.0 mmt -110.16 123.14 49.21 Favored 'General case' 0 N--CA 1.51 2.54 0 O-C-N 121.85 -0.531 . . . . 0.0 111.868 -178.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -77.26 122.11 24.62 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 120.927 0.394 . . . . 0.0 110.585 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.44 ' HG2' HG23 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -132.83 157.06 45.96 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.427 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.1 OUTLIER 40.17 70.67 0.22 Allowed 'General case' 0 N--CA 1.517 2.913 0 C-N-CA 123.178 0.591 . . . . 0.0 111.956 -179.493 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -130.16 71.47 82.22 Favored Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.599 -0.688 . . . . 0.0 111.017 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -64.52 108.36 1.01 Allowed 'Trans proline' 0 N--CA 1.492 1.406 0 N-CA-C 109.161 -1.13 . . . . 0.0 109.161 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.636 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.3 OUTLIER -63.2 -69.18 0.63 Allowed Pre-proline 0 N--CA 1.503 2.189 0 CA-C-O 116.767 -1.587 . . . . 0.0 111.5 -178.101 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.496 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.4 Cg_endo -71.52 88.34 0.75 Allowed 'Trans proline' 0 N--CA 1.492 1.432 0 CA-C-N 121.392 1.533 . . . . 0.0 111.706 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.507 HE21 HG13 ' A' ' 90' ' ' VAL . 12.0 pt20 -100.66 169.45 9.02 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 120.99 -1.069 . . . . 0.0 109.192 177.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -157.01 122.35 4.64 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.708 -0.62 . . . . 0.0 111.277 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -115.21 -173.78 2.38 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.948 -0.47 . . . . 0.0 110.033 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -102.54 140.51 36.72 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.536 0.684 . . . . 0.0 111.404 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -60.16 117.78 5.55 Favored 'General case' 0 N--CA 1.51 2.535 0 O-C-N 121.985 -0.447 . . . . 0.0 110.855 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.27 22.05 36.25 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.407 ' O ' HG22 ' A' ' 63' ' ' ILE . 15.4 tt0 -113.81 159.69 19.52 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 118.465 1.132 . . . . 0.0 111.465 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -79.55 100.31 7.7 Favored 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 177.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -101.86 168.61 9.32 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.59 0.709 . . . . 0.0 112.386 -177.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.656 HG22 ' HG2' ' A' ' 59' ' ' GLN . 98.6 t -144.16 137.33 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 178.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.759 HD12 HD23 ' A' ' 58' ' ' LEU . 53.7 mt -93.89 115.85 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 178.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.518 HG13 ' CZ ' ' A' ' 57' ' ' TYR . 43.0 t -76.41 115.49 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-O 121.492 0.663 . . . . 0.0 110.903 -176.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.1 t -161.16 81.38 0.62 Allowed 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.427 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.4 OUTLIER -80.37 147.74 30.92 Favored 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.878 -178.936 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.4 HG21 HD12 ' A' ' 33' ' ' ILE . 44.7 t -147.64 137.73 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.503 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 25.8 t -97.7 88.95 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.52 138.58 31.66 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.7 t -94.86 14.76 20.46 Favored 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -177.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.026 HD13 ' HB3' ' A' ' 79' ' ' ALA . 17.3 mt -140.59 168.18 15.37 Favored Pre-proline 0 N--CA 1.503 2.22 0 O-C-N 121.164 -0.96 . . . . 0.0 111.677 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.435 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 3.9 Cg_exo -48.2 -47.37 19.82 Favored 'Trans proline' 0 N--CA 1.502 2.029 0 C-N-CA 121.616 1.544 . . . . 0.0 114.516 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 29' ' ' LEU . 4.6 Cg_exo -55.13 -165.43 0.01 OUTLIER 'Trans proline' 0 N--CA 1.504 2.116 0 CA-C-N 120.004 1.037 . . . . 0.0 112.794 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.648 HG22 ' ND2' ' A' ' 56' ' ' ASN . 0.2 OUTLIER -169.65 -157.29 0.16 Allowed 'General case' 0 N--CA 1.518 2.935 0 O-C-N 120.556 -1.34 . . . . 0.0 111.02 -176.937 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.488 HD11 ' HB3' ' A' ' 73' ' ' CYS . 20.2 tt -78.98 166.75 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.876 -0.515 . . . . 0.0 110.796 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.452 HD13 ' O ' ' A' ' 33' ' ' ILE . 38.2 mm -128.85 128.51 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.592 ' HB2' HG22 ' A' ' 42' ' ' VAL . 81.5 m95 -93.89 99.18 11.58 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 120.191 -0.604 . . . . 0.0 109.44 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.4 tttm -102.63 -167.07 1.35 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.922 -0.486 . . . . 0.0 110.285 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 66.77 165.36 0.21 Allowed 'General case' 0 N--CA 1.509 2.515 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 56.29 28.88 14.01 Favored 'General case' 0 N--CA 1.515 2.786 0 O-C-N 121.643 -0.661 . . . . 0.0 110.871 -178.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.07 40.99 0.49 Allowed Glycine 0 N--CA 1.497 2.746 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 17.1 mmt180 54.8 -161.39 0.15 Allowed 'General case' 0 N--CA 1.517 2.891 0 O-C-N 121.628 -0.925 . . . . 0.0 110.579 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -62.03 120.27 10.51 Favored 'General case' 0 N--CA 1.512 2.658 0 O-C-N 121.636 -0.665 . . . . 0.0 110.463 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.592 HG22 ' HB2' ' A' ' 35' ' ' TRP . 7.7 m -71.97 -28.42 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.527 0 O-C-N 122.011 -0.43 . . . . 0.0 110.342 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 50.6 mt -59.24 -17.24 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.812 0 O-C-N 121.746 -0.596 . . . . 0.0 111.651 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.484 ' N ' HD12 ' A' ' 44' ' ' LEU . 9.7 mp -90.82 -23.27 20.64 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.504 -0.748 . . . . 0.0 110.882 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 53.9 pttt -97.89 -37.06 9.96 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.696 -0.627 . . . . 0.0 109.595 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm 46.49 55.26 7.72 Favored 'General case' 0 N--CA 1.51 2.529 0 CA-C-O 121.335 0.588 . . . . 0.0 112.229 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.3 163.71 0.55 Allowed 'General case' 0 N--CA 1.515 2.778 0 O-C-N 121.657 -0.652 . . . . 0.0 110.736 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.8 m -58.6 -20.77 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.779 0 O-C-N 121.868 -0.52 . . . . 0.0 111.823 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 16.8 ptt-85 -113.95 46.05 1.38 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.757 -0.59 . . . . 0.0 111.684 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -146.25 108.33 4.39 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.67 -0.644 . . . . 0.0 110.138 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 71.6 mt -130.85 107.8 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.422 HG22 ' CD1' ' A' ' 58' ' ' LEU . 2.6 t -74.76 134.17 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.0 mt -89.23 160.43 16.94 Favored 'General case' 0 N--CA 1.505 2.307 0 CA-C-O 121.223 0.535 . . . . 0.0 111.364 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 90.5 p -60.2 -19.74 55.56 Favored 'General case' 0 N--CA 1.508 2.459 0 O-C-N 122.091 -0.381 . . . . 0.0 111.194 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 49.8 p-10 -91.87 19.21 6.81 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.673 -0.642 . . . . 0.0 111.653 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.648 ' ND2' HG22 ' A' ' 32' ' ' THR . 6.2 m120 70.51 29.68 3.36 Favored 'General case' 0 N--CA 1.524 3.23 0 O-C-N 121.615 -0.678 . . . . 0.0 112.681 178.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.518 ' CZ ' HG13 ' A' ' 22' ' ' VAL . 4.6 m-85 -105.74 157.85 17.15 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.759 HD23 HD12 ' A' ' 21' ' ' ILE . 20.5 tp -115.61 98.94 6.99 Favored 'General case' 0 N--CA 1.517 2.912 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.164 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.656 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -75.96 100.18 4.78 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.099 179.719 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.58 HD11 HD11 ' A' ' 21' ' ' ILE . 88.3 mt -92.1 120.72 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 177.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -83.71 114.59 21.69 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 121.299 0.571 . . . . 0.0 111.308 -178.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 100.25 -37.32 3.62 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 178.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.751 ' CG1' HG21 ' A' ' 92' ' ' VAL . 4.1 tp 38.21 97.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.139 0 CA-C-O 121.862 0.839 . . . . 0.0 112.8 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.538 ' HB3' HG22 ' A' ' 66' ' ' THR . 20.7 mmtp -90.7 150.02 21.82 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.26 -0.9 . . . . 0.0 111.172 -178.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.6 ptmt -59.48 -28.25 66.84 Favored 'General case' 0 N--CA 1.512 2.637 0 O-C-N 122.002 -0.436 . . . . 0.0 110.271 178.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.538 HG22 ' HB3' ' A' ' 64' ' ' LYS . 7.3 t -72.12 -14.97 61.98 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.897 -0.502 . . . . 0.0 110.603 178.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -99.12 -6.48 28.25 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.638 -0.664 . . . . 0.0 111.579 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -71.94 162.21 29.8 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.319 -0.863 . . . . 0.0 109.144 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 155.02 -111.97 0.51 Allowed Glycine 0 N--CA 1.496 2.691 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 16.9 m -143.62 99.16 3.37 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 122.108 -0.642 . . . . 0.0 110.867 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -79.3 133.47 36.63 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -95.4 119.41 33.85 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.671 -0.812 . . . . 0.0 111.5 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.488 ' HB3' HD11 ' A' ' 33' ' ' ILE . 9.1 m -81.97 129.15 34.69 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 177.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -132.36 85.99 2.29 Favored 'General case' 0 N--CA 1.507 2.409 0 CA-C-N 119.155 0.889 . . . . 0.0 110.791 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' A' ' 33' ' ' ILE . . . -58.55 103.6 0.38 Allowed Glycine 0 N--CA 1.508 3.492 0 N-CA-C 108.507 -1.837 . . . . 0.0 108.507 178.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.624 ' C ' HD12 ' A' ' 77' ' ' ILE . 6.8 ttm-85 -120.88 129.8 53.65 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 122.255 1.026 . . . . 0.0 113.752 -176.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.662 HD13 HG21 ' A' ' 2' ' ' VAL . 3.5 mp -131.27 140.2 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.5 mt -95.06 -46.27 6.88 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.842 -0.536 . . . . 0.0 111.898 -178.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 1.026 ' HB3' HD13 ' A' ' 29' ' ' LEU . . . -54.11 -55.13 30.63 Favored 'General case' 0 N--CA 1.523 3.219 0 O-C-N 121.442 -0.786 . . . . 0.0 109.896 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.419 ' CG ' HD11 ' A' ' 29' ' ' LEU . 28.4 mmm-85 -100.5 59.28 0.97 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 177.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -14.33 81.46 0.0 OUTLIER Glycine 1 N--CA 1.526 4.688 0 C-N-CA 125.042 1.306 . . . . 0.0 114.665 -178.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -125.26 141.85 51.84 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 122.183 -0.599 . . . . 0.0 109.449 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.0 pt -137.48 64.66 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 CA-C-O 121.188 0.518 . . . . 0.0 109.999 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -79.75 155.88 27.74 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 43.8 p90 -160.63 175.5 12.59 Favored 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 119.507 -0.877 . . . . 0.0 112.918 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 8.1 mttp -166.58 154.8 10.21 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.636 ' O ' HG22 ' A' ' 9' ' ' THR . 4.9 p-10 -99.66 114.01 26.82 Favored 'General case' 0 N--CA 1.51 2.559 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.007 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.583 HD12 ' N ' ' A' ' 88' ' ' ILE . 2.1 mp -102.45 123.38 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -91.96 120.32 32.51 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.507 HG13 HE21 ' A' ' 11' ' ' GLN . 48.3 t -107.73 140.53 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 C-N-CA 120.658 -0.417 . . . . 0.0 109.907 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.618 ' O ' HG23 ' A' ' 92' ' ' VAL . 32.2 mm -126.18 147.52 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.41 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.751 HG21 ' CG1' ' A' ' 63' ' ' ILE . 2.1 t . . . . . 0 N--CA 1.502 2.174 0 CA-C-O 117.962 -1.018 . . . . 0.0 108.553 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 44.1 p90 . . . . . 0 N--CA 1.498 1.963 0 CA-C-O 120.78 0.324 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.65 ' CG2' HD11 ' A' ' 77' ' ' ILE . 48.0 t -148.03 106.78 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.508 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 3.1 mmt -112.54 110.65 20.96 Favored 'General case' 0 N--CA 1.509 2.494 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.242 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -69.35 115.41 8.58 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 122.114 -0.366 . . . . 0.0 110.901 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.34 160.33 32.52 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 121.723 0.773 . . . . 0.0 111.283 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.406 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.3 OUTLIER 32.92 79.39 0.03 OUTLIER 'General case' 0 N--CA 1.52 3.049 0 C-N-CA 123.975 0.91 . . . . 0.0 113.35 179.398 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -142.1 78.68 16.89 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.726 -0.609 . . . . 0.0 111.103 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -66.62 104.48 0.79 Allowed 'Trans proline' 0 N--CA 1.489 1.263 0 N-CA-C 108.535 -1.371 . . . . 0.0 108.535 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.579 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.2 OUTLIER -55.46 -61.03 6.8 Favored Pre-proline 0 N--CA 1.505 2.304 0 CA-C-O 116.974 -1.489 . . . . 0.0 112.361 -177.586 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.547 ' HD3' ' OG1' ' A' ' 9' ' ' THR . 1.4 Cg_endo -78.66 93.75 1.09 Allowed 'Trans proline' 0 N--CA 1.493 1.443 0 CA-C-N 121.134 1.441 . . . . 0.0 111.552 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.496 HE21 HG13 ' A' ' 90' ' ' VAL . 16.6 pt20 -101.2 172.17 7.16 Favored 'General case' 0 N--CA 1.508 2.445 0 O-C-N 120.911 -1.118 . . . . 0.0 109.864 178.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -148.47 125.72 11.51 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.822 -0.549 . . . . 0.0 111.587 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -127.14 -165.54 1.48 Allowed 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.07 147.59 52.64 Favored 'General case' 0 N--CA 1.517 2.897 0 CA-C-O 121.92 0.866 . . . . 0.0 111.906 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -57.96 130.47 46.68 Favored 'General case' 0 N--CA 1.507 2.411 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.209 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.3 17.8 77.34 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.662 ' O ' HG22 ' A' ' 63' ' ' ILE . 7.7 tp10 -109.38 155.11 21.64 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 119.182 1.491 . . . . 0.0 111.434 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -79.77 98.54 7.06 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -104.69 169.49 8.42 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.626 0.727 . . . . 0.0 112.586 -177.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.675 HG22 ' HG2' ' A' ' 59' ' ' GLN . 87.9 t -144.53 140.82 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.867 HD12 HD23 ' A' ' 58' ' ' LEU . 48.5 mt -96.84 114.95 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 178.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.513 HG13 ' CZ ' ' A' ' 57' ' ' TYR . 47.4 t -75.5 119.35 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 CA-C-O 121.61 0.719 . . . . 0.0 110.842 -176.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.6 t -161.71 89.01 0.72 Allowed 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.406 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -88.41 138.77 31.14 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.193 -179.016 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.718 HG21 HD12 ' A' ' 33' ' ' ILE . 43.4 t -147.04 126.55 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.508 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 48.1 t -90.87 77.76 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.5 m -78.74 165.85 23.13 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 t -43.96 -85.51 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.177 0 O-C-N 121.753 -0.592 . . . . 0.0 111.443 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.417 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 1.1 mt -165.48 -63.06 0.01 OUTLIER Pre-proline 0 N--CA 1.512 2.657 0 CA-C-O 117.677 -1.154 . . . . 0.0 111.52 177.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.417 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 2.9 Cg_endo -60.55 -53.37 2.88 Favored 'Trans proline' 0 CA--C 1.564 1.987 0 CA-C-N 120.102 1.072 . . . . 0.0 112.524 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.502 ' CB ' ' HA ' ' A' ' 77' ' ' ILE . 2.9 Cg_endo -62.68 -163.66 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 120.541 0.827 . . . . 0.0 112.418 -179.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -171.75 -166.15 0.42 Allowed 'General case' 0 N--CA 1.518 2.937 0 O-C-N 121.861 -0.525 . . . . 0.0 110.304 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.718 HD12 HG21 ' A' ' 25' ' ' VAL . 16.9 tt -99.54 147.98 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 78.0 mt -111.23 127.3 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.573 ' HB2' HG22 ' A' ' 42' ' ' VAL . 76.8 m95 -89.9 109.69 20.69 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.0 tttm -116.77 -165.54 1.07 Allowed 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.072 0.463 . . . . 0.0 110.572 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 58.6 60.65 2.47 Favored 'General case' 0 N--CA 1.51 2.542 0 CA-C-O 121.484 0.659 . . . . 0.0 111.129 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.9 ttpp -170.94 -42.3 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.398 0 O-C-N 121.718 -0.613 . . . . 0.0 109.995 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -169.51 39.74 0.2 Allowed Glycine 0 N--CA 1.497 2.746 0 N-CA-C 108.641 -1.784 . . . . 0.0 108.641 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 58.59 80.39 0.18 Allowed 'General case' 0 N--CA 1.512 2.663 0 O-C-N 122.005 -0.703 . . . . 0.0 110.463 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.423 ' HB3' HD13 ' A' ' 44' ' ' LEU . 2.7 m-20 58.48 107.98 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.823 0 O-C-N 121.912 -0.492 . . . . 0.0 110.845 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.573 HG22 ' HB2' ' A' ' 35' ' ' TRP . 9.7 m -72.99 -30.98 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.527 0 O-C-N 121.963 -0.461 . . . . 0.0 110.494 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 66.8 mt -60.56 -15.7 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.781 0 O-C-N 121.817 -0.552 . . . . 0.0 111.768 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.442 ' N ' HD12 ' A' ' 44' ' ' LEU . 10.9 mp -90.68 -21.79 21.46 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.527 -0.733 . . . . 0.0 110.666 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.1 pttt -97.77 -35.48 10.53 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.598 -0.689 . . . . 0.0 109.733 178.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.1 mmmt 46.35 56.5 6.25 Favored 'General case' 0 N--CA 1.509 2.525 0 CA-C-O 121.382 0.61 . . . . 0.0 112.134 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -50.32 171.59 0.03 OUTLIER 'General case' 0 N--CA 1.516 2.84 0 O-C-N 121.732 -0.605 . . . . 0.0 111.491 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.5 t -65.57 -14.9 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.539 0 O-C-N 121.952 -0.468 . . . . 0.0 111.415 -179.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -115.85 -4.6 12.09 Favored 'General case' 0 N--CA 1.506 2.364 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.438 ' C ' HD12 ' A' ' 51' ' ' ILE . 12.1 m-85 -94.14 115.22 27.48 Favored 'General case' 0 N--CA 1.503 2.182 0 CA-C-N 119.075 0.852 . . . . 0.0 110.616 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.438 HD12 ' C ' ' A' ' 50' ' ' PHE . 5.2 mp -137.19 106.25 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.154 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.442 HG22 ' CD1' ' A' ' 58' ' ' LEU . 2.8 t -73.74 128.18 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.502 HD11 ' CG ' ' A' ' 59' ' ' GLN . 52.6 mt -81.93 166.84 19.53 Favored 'General case' 0 N--CA 1.506 2.357 0 CA-C-O 121.377 0.608 . . . . 0.0 112.022 -178.066 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.6 p -60.66 -21.69 63.07 Favored 'General case' 0 N--CA 1.509 2.51 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.229 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 42.1 p-10 -91.55 19.03 6.61 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.665 -0.647 . . . . 0.0 111.403 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.5 m120 66.63 32.72 6.91 Favored 'General case' 0 N--CA 1.515 2.798 0 O-C-N 121.627 -0.67 . . . . 0.0 112.223 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.513 ' CZ ' HG13 ' A' ' 22' ' ' VAL . 3.5 m-85 -101.69 168.34 9.53 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.867 HD23 HD12 ' A' ' 21' ' ' ILE . 17.1 tp -121.43 96.99 5.3 Favored 'General case' 0 N--CA 1.517 2.912 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.621 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.675 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -76.4 104.2 6.8 Favored 'General case' 0 N--CA 1.502 2.174 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.919 179.49 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.549 HD11 HD11 ' A' ' 21' ' ' ILE . 96.5 mt -97.55 101.37 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 177.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.35 114.77 7.91 Favored 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 121.252 0.549 . . . . 0.0 110.97 -178.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 101.39 -34.18 5.87 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 109.971 -1.251 . . . . 0.0 109.971 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.662 HG22 ' O ' ' A' ' 17' ' ' GLU . 1.8 tp 32.92 92.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.523 3.212 0 CA-C-N 117.925 0.863 . . . . 0.0 113.251 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.549 ' HB3' HG22 ' A' ' 66' ' ' THR . 3.2 mmmm -74.23 148.25 41.72 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.697 -0.627 . . . . 0.0 110.834 -178.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -63.4 -19.13 64.42 Favored 'General case' 0 N--CA 1.508 2.455 0 C-N-CA 120.571 -0.451 . . . . 0.0 110.711 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.549 HG22 ' HB3' ' A' ' 64' ' ' LYS . 10.1 t -83.76 -12.85 55.15 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.441 -0.787 . . . . 0.0 111.105 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.43 11.03 36.36 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.49 -0.756 . . . . 0.0 111.571 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -88.0 152.73 21.83 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.286 -0.884 . . . . 0.0 109.533 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 163.95 -106.15 0.27 Allowed Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.2 m -146.51 103.85 3.71 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 122.156 -0.614 . . . . 0.0 110.654 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -83.61 128.72 34.74 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.4 tpp180 -91.77 118.37 30.62 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.179 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.567 ' HB3' HD11 ' A' ' 33' ' ' ILE . 5.1 m -83.77 122.59 28.86 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 177.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -123.27 88.27 2.89 Favored 'General case' 0 N--CA 1.506 2.349 0 CA-C-N 118.738 0.699 . . . . 0.0 110.643 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.7 103.03 0.9 Allowed Glycine 0 N--CA 1.503 3.161 0 N-CA-C 107.653 -2.179 . . . . 0.0 107.653 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 -118.73 141.64 48.42 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -176.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.65 HD11 ' CG2' ' A' ' 2' ' ' VAL . 88.1 mt -121.63 137.02 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.553 177.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 30.6 mt -92.7 -39.87 11.03 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 121.074 -0.25 . . . . 0.0 110.652 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.82 -58.21 7.53 Favored 'General case' 0 N--CA 1.515 2.776 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.8 mtt180 -101.02 61.72 0.96 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 177.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -14.48 81.68 0.0 OUTLIER Glycine 1 N--CA 1.526 4.696 0 C-N-CA 125.079 1.323 . . . . 0.0 114.73 -178.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -117.69 144.51 45.18 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 122.162 -0.611 . . . . 0.0 110.25 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.1 pt -136.73 74.82 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 CA-C-O 121.132 0.491 . . . . 0.0 110.689 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -93.77 149.57 21.12 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.403 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 42.7 p90 -162.06 -179.21 6.93 Favored 'General case' 0 N--CA 1.503 2.191 0 C-N-CA 119.612 -0.835 . . . . 0.0 113.142 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.6 mttt -167.16 161.54 14.64 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.579 ' O ' HG22 ' A' ' 9' ' ' THR . 4.7 p-10 -103.27 112.35 25.18 Favored 'General case' 0 N--CA 1.51 2.545 0 O-C-N 121.782 -0.574 . . . . 0.0 111.221 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.582 HD12 ' N ' ' A' ' 88' ' ' ILE . 3.0 mp -97.06 115.62 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -85.22 117.27 24.06 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.496 HG13 HE21 ' A' ' 11' ' ' GLN . 42.7 t -111.05 135.27 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 CA-C-O 121.058 0.456 . . . . 0.0 110.045 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 47.7 mt -121.76 135.02 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.44 HG21 ' CG1' ' A' ' 63' ' ' ILE . 54.7 t . . . . . 0 N--CA 1.504 2.27 0 CA-C-O 118.308 -0.853 . . . . 0.0 109.782 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 43.5 p90 . . . . . 0 N--CA 1.499 2.008 0 CA-C-O 120.668 0.27 . . . . 0.0 110.438 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.505 ' CG2' HD11 ' A' ' 77' ' ' ILE . 47.2 t -147.9 105.71 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.544 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 4.7 mmt -111.38 116.86 31.66 Favored 'General case' 0 N--CA 1.51 2.556 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.142 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -73.44 119.63 17.94 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 122.039 -0.413 . . . . 0.0 110.485 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.401 ' HG2' HG23 ' A' ' 26' ' ' VAL . 0.8 OUTLIER -132.82 160.15 37.73 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 121.495 0.664 . . . . 0.0 111.076 -179.388 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.407 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.4 OUTLIER 33.31 88.85 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.107 0 C-N-CA 124.013 0.925 . . . . 0.0 113.423 179.474 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -157.25 81.23 3.27 Favored Pre-proline 0 N--CA 1.495 1.806 0 C-N-CA 120.084 -0.646 . . . . 0.0 111.55 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -64.97 105.61 0.69 Allowed 'Trans proline' 0 N--CA 1.492 1.416 0 N-CA-C 108.588 -1.351 . . . . 0.0 108.588 177.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.544 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.2 OUTLIER -53.88 -66.91 0.71 Allowed Pre-proline 0 N--CA 1.508 2.468 0 CA-C-O 116.91 -1.519 . . . . 0.0 112.245 -177.593 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.486 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.4 Cg_endo -73.13 92.47 0.82 Allowed 'Trans proline' 0 N--CA 1.495 1.591 0 CA-C-N 121.242 1.479 . . . . 0.0 110.978 178.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.458 HE21 HG13 ' A' ' 90' ' ' VAL . 13.1 pt20 -100.18 173.05 6.8 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 120.917 -1.114 . . . . 0.0 110.192 178.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -155.1 125.3 6.72 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.937 -0.477 . . . . 0.0 111.304 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -122.98 -169.73 1.98 Allowed 'General case' 0 N--CA 1.504 2.246 0 O-C-N 122.025 -0.422 . . . . 0.0 110.04 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -106.05 138.65 41.87 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.578 0.704 . . . . 0.0 111.507 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -60.13 126.6 28.13 Favored 'General case' 0 N--CA 1.509 2.498 0 O-C-N 121.717 -0.614 . . . . 0.0 110.739 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.36 21.14 62.96 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.434 ' O ' HG22 ' A' ' 63' ' ' ILE . 7.5 tp10 -112.85 161.63 16.72 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 118.811 1.306 . . . . 0.0 111.31 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.88 98.66 7.2 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 177.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -101.56 169.02 9.12 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 120.15 -0.62 . . . . 0.0 112.109 -177.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.656 HG22 ' HG2' ' A' ' 59' ' ' GLN . 84.1 t -142.23 140.68 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 178.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.718 HD12 HD23 ' A' ' 58' ' ' LEU . 43.9 mt -96.62 115.34 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 178.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.426 ' HA ' ' CE2' ' A' ' 57' ' ' TYR . 57.3 t -76.41 116.98 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 CA-C-O 121.355 0.598 . . . . 0.0 110.536 -177.051 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.2 t -160.67 89.82 0.83 Allowed 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.407 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -87.53 141.56 28.52 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.212 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.689 HG21 HD12 ' A' ' 33' ' ' ILE . 44.5 t -147.11 129.18 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.544 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 26.4 t -90.41 75.17 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.8 m -79.53 162.22 25.52 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 178.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 t -43.18 -85.04 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.25 0 O-C-N 121.844 -0.535 . . . . 0.0 111.433 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.4 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 1.3 mt -166.77 -63.56 0.01 OUTLIER Pre-proline 0 N--CA 1.512 2.658 0 CA-C-O 117.747 -1.121 . . . . 0.0 111.1 177.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.4 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 3.0 Cg_endo -59.65 -53.37 3.39 Favored 'Trans proline' 0 CA--C 1.565 2.05 0 CA-C-N 120.113 1.076 . . . . 0.0 112.347 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.459 ' HG3' HG23 ' A' ' 77' ' ' ILE . 3.3 Cg_exo -61.02 -165.65 0.04 OUTLIER 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 120.685 0.923 . . . . 0.0 112.358 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -170.64 -161.3 0.23 Allowed 'General case' 0 N--CA 1.523 3.197 0 C-N-CA 120.134 -0.626 . . . . 0.0 111.045 -179.141 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.835 HD11 ' HB3' ' A' ' 73' ' ' CYS . 21.2 tt -111.3 137.39 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.978 -0.451 . . . . 0.0 110.249 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.45 HD11 ' NE ' ' A' ' 76' ' ' ARG . 70.6 mt -94.56 129.98 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.506 ' HB2' HG22 ' A' ' 42' ' ' VAL . 48.1 m95 -94.66 103.46 15.39 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.181 -178.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.6 tptm -81.52 142.97 32.37 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 177.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.617 ' CG ' HG12 ' A' ' 42' ' ' VAL . 15.4 p-80 -142.04 -146.37 0.19 Allowed 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 120.063 -0.655 . . . . 0.0 111.518 -178.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 5.1 mmpt? -78.55 -0.89 31.43 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.864 -0.523 . . . . 0.0 111.331 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -136.26 34.2 2.28 Favored Glycine 0 N--CA 1.499 2.886 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? 54.58 101.87 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.627 0 O-C-N 121.704 -0.88 . . . . 0.0 112.147 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.8 t0 61.05 133.89 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.712 0 CA-C-O 121.199 0.523 . . . . 0.0 111.744 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.617 HG12 ' CG ' ' A' ' 37' ' ' HIS . 12.8 m -101.95 -32.68 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.437 0 O-C-N 121.755 -0.59 . . . . 0.0 109.758 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.746 HD11 HG21 ' A' ' 52' ' ' VAL . 46.9 mm -57.7 -18.92 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.778 0 O-C-N 121.889 -0.507 . . . . 0.0 111.854 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.467 ' N ' HD12 ' A' ' 44' ' ' LEU . 10.8 mp -89.05 -25.34 22.0 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.581 -0.699 . . . . 0.0 110.767 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.5 pttt -98.67 -39.82 8.49 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.775 -0.578 . . . . 0.0 109.957 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.5 mmmt 47.75 55.01 9.05 Favored 'General case' 0 N--CA 1.511 2.623 0 CA-C-O 121.593 0.711 . . . . 0.0 111.569 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.15 169.47 0.17 Allowed 'General case' 0 N--CA 1.511 2.61 0 O-C-N 121.724 -0.61 . . . . 0.0 110.81 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 29.4 m -62.55 -20.55 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.534 0 O-C-N 122.052 -0.405 . . . . 0.0 111.601 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.9 ptp85 -113.51 46.6 1.25 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.735 -0.603 . . . . 0.0 112.055 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.405 ' HE2' HD21 ' A' ' 58' ' ' LEU . 7.8 m-85 -144.93 107.02 4.31 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.685 -0.634 . . . . 0.0 109.778 178.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 66.3 mt -128.93 104.82 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.746 HG21 HD11 ' A' ' 43' ' ' ILE . 3.1 t -73.95 132.16 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.9 mt -85.91 166.66 15.79 Favored 'General case' 0 N--CA 1.508 2.431 0 O-C-N 121.786 -0.571 . . . . 0.0 111.699 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.8 p -61.57 -21.43 64.3 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 122.204 -0.31 . . . . 0.0 111.137 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -90.93 18.15 6.99 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.614 -0.679 . . . . 0.0 111.46 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.443 ' HB3' HG21 ' A' ' 33' ' ' ILE . 4.0 m120 67.98 32.54 5.03 Favored 'General case' 0 N--CA 1.517 2.899 0 O-C-N 121.596 -0.69 . . . . 0.0 112.189 178.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.426 ' CE2' ' HA ' ' A' ' 22' ' ' VAL . 4.0 m-85 -102.75 162.79 12.64 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 177.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.718 HD23 HD12 ' A' ' 21' ' ' ILE . 17.4 tp -118.2 98.37 6.26 Favored 'General case' 0 N--CA 1.517 2.913 0 C-N-CA 119.276 -0.97 . . . . 0.0 111.591 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.656 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -77.01 97.98 4.82 Favored 'General case' 0 N--CA 1.501 2.12 0 C-N-CA 120.391 -0.523 . . . . 0.0 110.84 179.439 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.548 HD11 HD11 ' A' ' 21' ' ' ILE . 96.0 mt -89.09 119.64 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 177.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.0 tpp180 -80.14 115.43 19.69 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 121.369 0.604 . . . . 0.0 110.707 -178.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.04 -33.28 5.87 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.501 HG23 HG21 ' A' ' 92' ' ' VAL . 1.9 tp 37.85 72.02 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.521 3.108 0 CA-C-N 118.155 0.978 . . . . 0.0 112.861 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.6 mtpp -62.77 158.34 18.96 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 121.751 -0.593 . . . . 0.0 112.187 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 45.2 tttt -62.35 -24.14 67.18 Favored 'General case' 0 N--CA 1.509 2.521 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.908 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 48.0 p -82.86 -15.91 49.67 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.894 -0.504 . . . . 0.0 111.056 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -88.69 -21.67 23.78 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.672 -0.642 . . . . 0.0 110.998 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.464 ' HB3' HG12 ' A' ' 92' ' ' VAL . 7.2 pt-20 -66.74 151.14 48.03 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.519 -0.738 . . . . 0.0 110.312 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 164.24 -115.73 0.66 Allowed Glycine 0 N--CA 1.498 2.787 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.6 m -138.4 100.55 4.14 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.94 -0.741 . . . . 0.0 110.431 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -83.22 135.68 34.69 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.6 ttm105 -103.81 119.61 39.28 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.749 -0.78 . . . . 0.0 111.003 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.835 ' HB3' HD11 ' A' ' 33' ' ' ILE . 19.6 m -78.51 122.64 26.12 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 177.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -121.43 84.26 2.21 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 121.216 0.532 . . . . 0.0 110.695 -178.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.44 117.27 8.74 Favored Glycine 0 N--CA 1.504 3.178 0 N-CA-C 108.062 -2.015 . . . . 0.0 108.062 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.45 ' NE ' HD11 ' A' ' 34' ' ' ILE . 11.6 ttp180 -134.74 140.88 46.28 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -177.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.505 HD11 ' CG2' ' A' ' 2' ' ' VAL . 78.7 mt -122.52 137.57 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-N 114.545 -1.207 . . . . 0.0 108.015 177.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 15.1 mt -91.67 -45.85 8.24 Favored 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.107 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.09 -57.81 11.42 Favored 'General case' 0 N--CA 1.517 2.888 0 O-C-N 121.584 -0.697 . . . . 0.0 109.672 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 70.8 mtt-85 -98.62 59.27 1.25 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 177.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -15.18 81.97 0.0 OUTLIER Glycine 1 N--CA 1.524 4.561 0 C-N-CA 125.037 1.303 . . . . 0.0 114.931 -178.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -120.41 143.72 48.31 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 122.295 -0.532 . . . . 0.0 109.66 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.6 pt -138.01 80.17 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.275 0 CA-C-O 121.483 0.659 . . . . 0.0 111.279 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -96.77 151.17 19.91 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -167.26 174.96 7.68 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.538 -0.726 . . . . 0.0 112.556 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.508 ' HD2' HD11 ' A' ' 88' ' ' ILE . 1.0 OUTLIER -166.71 155.1 10.2 Favored 'General case' 0 N--CA 1.503 2.221 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.461 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.544 ' O ' HG22 ' A' ' 9' ' ' THR . 5.3 p-10 -91.78 120.38 32.45 Favored 'General case' 0 N--CA 1.512 2.669 0 O-C-N 121.839 -0.538 . . . . 0.0 111.933 -178.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.574 HD12 ' N ' ' A' ' 88' ' ' ILE . 3.1 mp -102.91 120.51 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 178.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -87.69 114.81 24.66 Favored 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.458 HG13 HE21 ' A' ' 11' ' ' GLN . 32.5 t -107.96 133.88 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.07 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 74.0 mt -125.62 156.72 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.501 HG21 HG23 ' A' ' 63' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.498 1.937 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.578 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.767 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.634 ' CG2' HD13 ' A' ' 77' ' ' ILE . 62.3 t -151.48 80.13 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.297 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.449 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 11.5 mmm -107.52 114.72 28.9 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 122.032 -0.418 . . . . 0.0 109.953 -178.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -68.45 119.2 12.55 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.935 -0.478 . . . . 0.0 109.892 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.691 ' HG2' HG23 ' A' ' 26' ' ' VAL . 3.2 pttt -129.43 161.54 30.14 Favored 'General case' 0 N--CA 1.503 2.201 0 CA-C-O 121.693 0.758 . . . . 0.0 111.482 -178.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.418 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.4 OUTLIER 32.85 51.39 0.26 Allowed 'General case' 0 N--CA 1.517 2.917 0 C-N-CA 124.134 0.974 . . . . 0.0 113.243 179.423 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -116.64 81.89 12.02 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.725 -0.61 . . . . 0.0 110.645 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -65.54 107.33 1.01 Allowed 'Trans proline' 0 N--CA 1.491 1.373 0 N-CA-C 109.142 -1.138 . . . . 0.0 109.142 178.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.58 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.3 OUTLIER -60.19 -67.84 0.93 Allowed Pre-proline 0 N--CA 1.505 2.311 0 CA-C-O 116.802 -1.57 . . . . 0.0 110.985 -178.336 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.496 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.5 Cg_endo -73.8 89.63 0.99 Allowed 'Trans proline' 0 CA--C 1.559 1.739 0 CA-C-N 121.385 1.53 . . . . 0.0 110.67 177.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -98.44 178.65 4.96 Favored 'General case' 0 N--CA 1.508 2.45 0 O-C-N 120.675 -1.266 . . . . 0.0 110.193 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -159.38 124.53 4.13 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 120.294 -0.562 . . . . 0.0 112.03 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -122.54 -165.21 1.26 Allowed 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.49 137.43 53.2 Favored 'General case' 0 N--CA 1.514 2.765 0 CA-C-O 121.734 0.778 . . . . 0.0 110.941 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -55.32 140.2 40.23 Favored 'General case' 0 N--CA 1.511 2.604 0 O-C-N 121.707 -0.62 . . . . 0.0 111.352 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.13 12.27 81.59 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -106.93 157.47 17.76 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 119.332 1.566 . . . . 0.0 111.821 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -80.07 95.15 6.11 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 176.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.09 169.73 9.2 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.191 0.519 . . . . 0.0 112.204 -176.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.631 HG22 ' HG2' ' A' ' 59' ' ' GLN . 85.3 t -139.75 140.73 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.936 HD12 HD23 ' A' ' 58' ' ' LEU . 27.7 mt -93.17 115.64 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 105.969 -1.864 . . . . 0.0 105.969 177.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.46 HG13 ' CE2' ' A' ' 57' ' ' TYR . 48.1 t -77.54 119.68 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 CA-C-O 121.446 0.641 . . . . 0.0 110.618 -176.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.6 t -161.33 92.18 0.89 Allowed 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.418 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -90.04 145.43 25.09 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 -179.501 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.606 HG21 HD12 ' A' ' 33' ' ' ILE . 23.6 t -146.42 119.92 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.691 HG23 ' HG2' ' A' ' 5' ' ' LYS . 21.2 t -75.9 73.46 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 178.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.4 m -84.09 157.24 21.82 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.6 t -47.46 -79.4 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.078 0 O-C-N 121.762 -0.586 . . . . 0.0 111.385 -178.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -172.94 -61.02 0.0 OUTLIER Pre-proline 0 N--CA 1.514 2.758 0 CA-C-O 117.918 -1.039 . . . . 0.0 111.018 177.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.09 -53.97 3.13 Favored 'Trans proline' 0 CA--C 1.563 1.935 0 CA-C-N 119.7 0.928 . . . . 0.0 112.634 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.451 ' HB2' HG13 ' A' ' 77' ' ' ILE . 2.2 Cg_endo -61.99 -166.41 0.05 OUTLIER 'Trans proline' 0 N--CA 1.501 1.936 0 CA-C-N 119.322 0.794 . . . . 0.0 111.545 -179.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -170.7 -164.93 0.4 Allowed 'General case' 0 N--CA 1.518 2.966 0 O-C-N 121.7 -0.625 . . . . 0.0 110.078 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.606 HD12 HG21 ' A' ' 25' ' ' VAL . 17.9 tt -105.1 158.22 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.992 -0.443 . . . . 0.0 110.023 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 68.8 mt -125.58 118.89 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.558 ' HB2' HG22 ' A' ' 42' ' ' VAL . 83.0 m95 -81.6 102.15 10.46 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.2 tttt -102.18 -172.39 2.13 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 121.222 0.534 . . . . 0.0 110.906 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 63.76 157.86 0.08 Allowed 'General case' 0 N--CA 1.511 2.603 0 O-C-N 121.89 -0.506 . . . . 0.0 110.173 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.3 tptt 57.03 44.6 22.49 Favored 'General case' 0 N--CA 1.514 2.738 0 O-C-N 121.67 -0.644 . . . . 0.0 110.771 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 133.76 2.88 3.42 Favored Glycine 0 N--CA 1.497 2.757 0 C-N-CA 120.371 -0.919 . . . . 0.0 111.84 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 54.38 90.49 0.03 OUTLIER 'General case' 0 N--CA 1.516 2.847 0 CA-C-N 119.247 1.524 . . . . 0.0 110.739 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 t0 54.54 97.88 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.963 0 O-C-N 121.783 -0.573 . . . . 0.0 110.431 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.558 HG22 ' HB2' ' A' ' 35' ' ' TRP . 4.5 m -69.32 -28.97 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.519 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.769 -178.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 73.5 mt -59.79 -16.6 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.83 0 O-C-N 121.624 -0.673 . . . . 0.0 111.656 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.495 ' N ' HD12 ' A' ' 44' ' ' LEU . 10.6 mp -91.45 -23.39 20.02 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.433 -0.792 . . . . 0.0 110.732 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -97.86 -38.95 9.24 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.697 -0.627 . . . . 0.0 109.379 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 17.5 mmmt 46.35 55.55 7.27 Favored 'General case' 0 N--CA 1.51 2.559 0 CA-C-O 121.438 0.637 . . . . 0.0 112.228 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.33 165.76 0.33 Allowed 'General case' 0 N--CA 1.513 2.688 0 O-C-N 121.782 -0.574 . . . . 0.0 111.106 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.5 m -58.85 -20.88 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.699 0 O-C-N 122.018 -0.426 . . . . 0.0 111.856 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 5.0 ptt-85 -115.79 47.22 1.39 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.791 -0.568 . . . . 0.0 111.886 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -146.26 101.56 3.51 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.645 -0.659 . . . . 0.0 109.796 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 62.5 mt -125.92 113.42 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.439 HG22 ' CD1' ' A' ' 58' ' ' LEU . 2.4 t -79.49 128.05 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.411 HD11 ' CG ' ' A' ' 59' ' ' GLN . 15.5 mt -80.56 164.1 23.19 Favored 'General case' 0 N--CA 1.506 2.354 0 CA-C-O 121.195 0.521 . . . . 0.0 111.601 -178.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 96.6 p -60.0 -20.63 58.76 Favored 'General case' 0 N--CA 1.511 2.618 0 O-C-N 122.139 -0.351 . . . . 0.0 111.336 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.7 p-10 -91.19 19.44 5.87 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.721 -0.612 . . . . 0.0 111.43 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.8 m120 66.64 32.87 6.81 Favored 'General case' 0 N--CA 1.515 2.806 0 O-C-N 121.607 -0.683 . . . . 0.0 112.165 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.46 ' CE2' HG13 ' A' ' 22' ' ' VAL . 3.9 m-85 -103.4 168.82 8.92 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.936 HD23 HD12 ' A' ' 21' ' ' ILE . 18.0 tp -124.77 98.47 5.72 Favored 'General case' 0 N--CA 1.515 2.788 0 C-N-CA 119.29 -0.964 . . . . 0.0 112.241 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.631 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -74.79 100.16 3.96 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 120.77 0.319 . . . . 0.0 110.825 179.338 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.849 HD11 HD11 ' A' ' 21' ' ' ILE . 97.3 mt -92.7 110.9 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 178.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.27 113.89 9.8 Favored 'General case' 0 N--CA 1.504 2.261 0 CA-C-O 121.386 0.612 . . . . 0.0 111.343 -178.063 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.36 -38.3 3.15 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.506 HG12 HG21 ' A' ' 92' ' ' VAL . 1.5 tp 41.84 67.24 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.927 0 CA-C-O 122.145 0.974 . . . . 0.0 112.544 -178.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.5 mttm -58.35 157.38 8.71 Favored 'General case' 0 N--CA 1.51 2.557 0 CA-C-O 121.398 0.618 . . . . 0.0 112.611 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.8 ttmm -62.06 -21.81 65.24 Favored 'General case' 0 N--CA 1.509 2.486 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.97 178.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.1 p -83.78 -18.86 36.31 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.802 -0.561 . . . . 0.0 110.96 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.75 -5.7 56.72 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.653 -0.655 . . . . 0.0 111.607 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.529 ' HB3' HG12 ' A' ' 92' ' ' VAL . 8.2 pt-20 -81.7 137.01 35.46 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 119.006 0.821 . . . . 0.0 109.619 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 176.97 -111.39 0.33 Allowed Glycine 0 N--CA 1.499 2.863 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.0 m -138.8 104.1 5.0 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 122.034 -0.686 . . . . 0.0 110.708 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -86.8 135.89 33.19 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -93.72 118.62 31.65 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.21 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 85' ' ' PHE . 3.4 m -86.48 91.33 8.51 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 178.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -91.53 88.45 6.78 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.842 -0.536 . . . . 0.0 109.929 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.47 96.3 0.82 Allowed Glycine 0 N--CA 1.5 2.95 0 N-CA-C 107.311 -2.315 . . . . 0.0 107.311 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.593 ' HG3' HG22 ' A' ' 83' ' ' ILE . 3.7 ttm180 -99.5 127.23 45.56 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 122.031 0.919 . . . . 0.0 113.198 -176.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.634 HD13 ' CG2' ' A' ' 2' ' ' VAL . 4.8 mp -143.09 89.55 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 CA-C-N 114.387 -1.279 . . . . 0.0 107.693 178.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 28.2 mt -95.39 20.05 9.97 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.954 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -113.3 -31.85 6.46 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.665 -0.647 . . . . 0.0 110.692 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -115.84 -63.56 1.43 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.919 -0.488 . . . . 0.0 110.784 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -98.55 -81.74 1.62 Allowed Glycine 0 N--CA 1.49 2.279 0 C-N-CA 121.056 -0.592 . . . . 0.0 111.808 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 179.33 -160.03 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.76 0 O-C-N 122.038 -0.683 . . . . 0.0 110.281 -178.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.593 HG22 ' HG3' ' A' ' 76' ' ' ARG . 1.1 pp -99.93 103.62 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.424 0 O-C-N 121.717 -0.615 . . . . 0.0 110.944 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -100.71 158.72 15.74 Favored 'General case' 0 N--CA 1.507 2.401 0 O-C-N 121.444 -0.785 . . . . 0.0 110.026 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.474 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 36.1 p90 -161.1 171.93 17.68 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.534 -0.729 . . . . 0.0 112.4 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.9 mttp -165.78 159.0 15.7 Favored 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.58 ' O ' HG22 ' A' ' 9' ' ' THR . 6.9 p-10 -103.94 121.29 42.81 Favored 'General case' 0 N--CA 1.512 2.662 0 O-C-N 121.757 -0.589 . . . . 0.0 110.756 179.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.521 HD12 ' N ' ' A' ' 88' ' ' ILE . 1.8 mp -105.46 121.49 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -85.26 111.46 19.87 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.7 t -104.73 127.75 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.097 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 72.2 mt -117.17 159.71 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.529 HG12 ' HB3' ' A' ' 68' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.501 2.092 0 CA-C-O 117.922 -1.037 . . . . 0.0 110.496 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 45.9 p90 . . . . . 0 N--CA 1.498 1.941 0 CA-C-O 120.679 0.276 . . . . 0.0 110.494 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.683 ' CG2' HD11 ' A' ' 77' ' ' ILE . 49.0 t -146.95 106.06 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.493 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 17.8 mmm -112.53 111.22 21.89 Favored 'General case' 0 N--CA 1.506 2.371 0 C-N-CA 120.501 -0.479 . . . . 0.0 110.475 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -70.91 116.5 11.28 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 122.041 -0.412 . . . . 0.0 110.841 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -124.8 155.3 39.6 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 121.531 0.681 . . . . 0.0 110.133 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 41.85 86.04 0.02 OUTLIER 'General case' 0 N--CA 1.52 3.044 0 C-N-CA 123.073 0.549 . . . . 0.0 111.803 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -131.95 62.9 66.62 Favored Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 121.696 -0.627 . . . . 0.0 112.155 -178.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.408 ' HD2' HG12 ' A' ' 22' ' ' VAL . 2.5 Cg_endo -66.28 89.83 0.26 Allowed 'Trans proline' 0 N--CA 1.494 1.543 0 N-CA-C 108.162 -1.514 . . . . 0.0 108.162 177.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.489 ' OG1' ' HD3' ' A' ' 10' ' ' PRO . 13.6 p -59.47 -43.34 95.89 Favored Pre-proline 0 N--CA 1.508 2.459 0 CA-C-O 117.382 -1.294 . . . . 0.0 113.156 -177.179 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.489 ' HD3' ' OG1' ' A' ' 9' ' ' THR . 1.7 Cg_endo -81.8 82.88 2.23 Favored 'Trans proline' 0 CA--C 1.549 1.251 0 CA-C-N 120.651 1.268 . . . . 0.0 111.332 -177.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.477 HE21 HG13 ' A' ' 90' ' ' VAL . 15.7 pt20 -100.73 170.52 8.29 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.163 -0.96 . . . . 0.0 110.978 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -155.3 124.34 6.2 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 122.002 -0.436 . . . . 0.0 110.996 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -122.49 -169.59 1.93 Allowed 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.912 -0.493 . . . . 0.0 109.778 179.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -115.96 145.61 42.79 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.479 0.657 . . . . 0.0 111.67 -178.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -61.44 121.24 12.18 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 121.947 -0.471 . . . . 0.0 110.399 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.35 20.61 51.6 Favored Glycine 0 N--CA 1.497 2.714 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -179.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.506 ' O ' HG22 ' A' ' 63' ' ' ILE . 7.7 tp10 -112.37 158.1 20.22 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 118.619 1.21 . . . . 0.0 111.212 -179.161 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -80.45 98.09 7.38 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 177.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -102.9 165.5 11.0 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 120.169 -0.612 . . . . 0.0 112.398 -177.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.699 HG22 ' HG2' ' A' ' 59' ' ' GLN . 93.8 t -140.0 143.26 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 178.138 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.895 HD12 HD23 ' A' ' 58' ' ' LEU . 47.1 mt -99.96 113.24 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 178.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.411 HG13 ' CE2' ' A' ' 57' ' ' TYR . 58.4 t -73.22 120.15 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 CA-C-O 121.513 0.673 . . . . 0.0 111.057 -176.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.0 t -165.09 93.12 0.6 Allowed 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.15 140.79 29.11 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.314 -179.206 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.627 HG21 HD12 ' A' ' 33' ' ' ILE . 43.7 t -148.83 133.24 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.493 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 59.5 t -99.85 78.71 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.8 m -79.23 165.71 22.95 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.9 t -43.56 -82.31 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.19 0 O-C-N 121.899 -0.501 . . . . 0.0 111.509 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.416 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 1.0 OUTLIER -167.73 -63.27 0.01 OUTLIER Pre-proline 0 N--CA 1.513 2.708 0 CA-C-O 117.778 -1.106 . . . . 0.0 111.661 177.642 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.416 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 2.9 Cg_endo -60.1 -53.13 3.32 Favored 'Trans proline' 0 CA--C 1.563 1.939 0 CA-C-N 120.107 1.074 . . . . 0.0 112.676 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.532 ' CB ' ' HA ' ' A' ' 77' ' ' ILE . 2.8 Cg_endo -62.57 -163.98 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.794 0 CA-C-N 119.268 0.774 . . . . 0.0 112.634 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -169.95 -160.13 0.22 Allowed 'General case' 0 N--CA 1.519 3.017 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.21 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.847 HD11 ' HB3' ' A' ' 73' ' ' CYS . 20.7 tt -107.98 145.19 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.924 -0.485 . . . . 0.0 110.036 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.0 mt -104.59 130.43 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.533 ' HB2' HG22 ' A' ' 42' ' ' VAL . 55.8 m95 -96.02 119.37 34.38 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.217 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.6 tptt -100.4 103.6 14.99 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 32.3 p-80 -93.32 125.6 38.01 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.256 0.551 . . . . 0.0 111.569 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.6 mmtt 49.23 23.64 0.84 Allowed 'General case' 0 N--CA 1.514 2.74 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 178.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.96 -31.99 7.06 Favored Glycine 0 N--CA 1.5 2.909 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.2 -179.56 4.98 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-N 117.824 0.812 . . . . 0.0 110.307 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -109.02 147.35 32.46 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.962 -0.461 . . . . 0.0 110.196 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.533 HG22 ' HB2' ' A' ' 35' ' ' TRP . 8.4 m -93.26 -35.46 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.705 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.6 mm -57.95 -19.41 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.683 0 O-C-N 122.028 -0.42 . . . . 0.0 111.796 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.472 ' N ' HD12 ' A' ' 44' ' ' LEU . 9.9 mp -90.59 -24.96 20.41 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.562 -0.711 . . . . 0.0 110.843 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 41.6 pttt -99.03 -39.97 8.26 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.665 -0.647 . . . . 0.0 109.802 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm 49.6 54.51 10.89 Favored 'General case' 0 N--CA 1.509 2.523 0 CA-C-O 121.464 0.649 . . . . 0.0 111.744 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -53.49 164.21 0.53 Allowed 'General case' 0 N--CA 1.514 2.771 0 O-C-N 121.698 -0.626 . . . . 0.0 110.715 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.8 m -60.83 -21.0 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.728 0 O-C-N 121.943 -0.473 . . . . 0.0 111.767 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.8 ptt-85 -100.87 -8.89 22.14 Favored 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -93.47 107.61 19.43 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-N 118.852 0.751 . . . . 0.0 110.272 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 71.7 mt -128.64 105.68 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.478 HG22 ' CD1' ' A' ' 58' ' ' LEU . 2.9 t -75.17 131.51 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.51 HD11 ' CG ' ' A' ' 59' ' ' GLN . 37.8 mt -84.15 168.1 16.11 Favored 'General case' 0 N--CA 1.508 2.452 0 CA-C-O 121.172 0.511 . . . . 0.0 111.717 -178.343 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 55.3 p -61.58 -22.87 65.58 Favored 'General case' 0 N--CA 1.509 2.522 0 O-C-N 122.182 -0.324 . . . . 0.0 111.074 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 50.9 p-10 -91.25 18.42 7.03 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.825 -0.547 . . . . 0.0 111.345 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.441 ' HB3' HG21 ' A' ' 33' ' ' ILE . 4.3 m120 66.82 34.63 5.38 Favored 'General case' 0 N--CA 1.515 2.795 0 O-C-N 121.542 -0.724 . . . . 0.0 112.406 178.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.411 ' CE2' HG13 ' A' ' 22' ' ' VAL . 4.0 m-85 -102.67 159.21 15.66 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.895 HD23 HD12 ' A' ' 21' ' ' ILE . 17.8 tp -114.01 98.31 6.9 Favored 'General case' 0 N--CA 1.515 2.815 0 C-N-CA 119.353 -0.939 . . . . 0.0 112.026 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.699 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -78.76 101.42 7.57 Favored 'General case' 0 N--CA 1.503 2.205 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.088 179.439 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.581 HD11 HD11 ' A' ' 21' ' ' ILE . 91.1 mt -93.58 102.43 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 177.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -68.98 114.19 7.05 Favored 'General case' 0 N--CA 1.506 2.371 0 CA-C-O 121.24 0.543 . . . . 0.0 111.378 -178.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 100.4 -34.8 5.26 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 110.079 -1.209 . . . . 0.0 110.079 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.506 HG22 ' O ' ' A' ' 17' ' ' GLU . 1.9 tp 35.98 95.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.13 0 CA-C-N 118.001 0.901 . . . . 0.0 113.205 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -72.88 146.78 45.93 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.626 -0.671 . . . . 0.0 111.116 -178.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -63.28 -18.71 63.87 Favored 'General case' 0 N--CA 1.51 2.545 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.676 178.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 58.5 p -86.14 -16.43 37.94 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.422 -0.798 . . . . 0.0 110.859 179.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -93.18 17.45 11.02 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.601 -0.687 . . . . 0.0 111.479 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -95.72 145.03 25.62 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.581 -0.699 . . . . 0.0 109.737 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 169.6 -105.36 0.22 Allowed Glycine 0 N--CA 1.497 2.757 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.0 m -142.89 101.38 3.83 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.99 -0.712 . . . . 0.0 111.277 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -83.11 127.55 33.69 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.0 ttt180 -95.71 122.21 38.23 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 120.087 -0.645 . . . . 0.0 111.407 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.847 ' HB3' HD11 ' A' ' 33' ' ' ILE . 65.1 m -79.85 127.34 32.11 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 177.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -126.16 84.63 2.29 Favored 'General case' 0 N--CA 1.506 2.344 0 CA-C-N 119.245 0.929 . . . . 0.0 110.36 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.09 102.35 0.71 Allowed Glycine 0 N--CA 1.506 3.307 0 N-CA-C 107.898 -2.081 . . . . 0.0 107.898 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -117.59 140.49 49.56 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -176.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.683 HD11 ' CG2' ' A' ' 2' ' ' VAL . 96.4 mt -114.86 138.28 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.19 177.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 52.2 mt -88.93 -58.01 2.7 Favored 'General case' 0 N--CA 1.503 2.188 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.357 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.08 -57.1 12.35 Favored 'General case' 0 N--CA 1.519 2.991 0 O-C-N 121.677 -0.639 . . . . 0.0 110.502 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -98.66 60.59 1.31 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -16.06 82.18 0.0 OUTLIER Glycine 1 N--CA 1.524 4.55 0 C-N-CA 125.06 1.314 . . . . 0.0 114.872 -178.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -114.0 147.49 38.54 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 122.109 -0.642 . . . . 0.0 109.844 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.1 pt -138.35 72.62 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 CA-C-O 121.225 0.536 . . . . 0.0 111.562 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -91.72 150.4 21.14 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -159.47 -178.2 6.96 Favored 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 119.419 -0.912 . . . . 0.0 113.429 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -168.24 163.18 13.07 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -104.22 144.86 31.03 Favored 'General case' 0 N--CA 1.511 2.58 0 O-C-N 121.771 -0.581 . . . . 0.0 111.442 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.519 HG21 ' CG2' ' A' ' 21' ' ' ILE . 50.8 mm -126.48 106.24 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.267 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -72.52 101.1 2.89 Favored 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.477 HG13 HE21 ' A' ' 11' ' ' GLN . 25.7 t -100.25 133.51 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.438 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 72.8 mt -119.68 144.72 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 43.5 t . . . . . 0 N--CA 1.505 2.281 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.625 -179.176 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.78 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.665 ' CG2' HD13 ' A' ' 77' ' ' ILE . 62.4 t -152.19 78.11 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.462 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 61.4 mmm -104.16 120.21 40.63 Favored 'General case' 0 N--CA 1.509 2.484 0 O-C-N 121.831 -0.543 . . . . 0.0 110.741 -178.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -78.1 113.59 16.18 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 122.053 -0.404 . . . . 0.0 110.192 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.6 ptpt -127.61 165.93 19.02 Favored 'General case' 0 N--CA 1.503 2.182 0 CA-C-O 121.748 0.785 . . . . 0.0 112.235 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.432 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.3 OUTLIER 31.26 80.27 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.959 0 C-N-CA 124.442 1.097 . . . . 0.0 113.226 179.077 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.418 ' HB2' ' HA ' ' A' ' 23' ' ' CYS . . . -154.4 81.44 4.48 Favored Pre-proline 0 N--CA 1.489 1.505 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.864 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.6 105.49 0.63 Allowed 'Trans proline' 0 N--CA 1.491 1.339 0 N-CA-C 108.58 -1.354 . . . . 0.0 108.58 178.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.583 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.2 OUTLIER -51.41 -64.6 1.31 Allowed Pre-proline 0 N--CA 1.509 2.481 0 CA-C-O 117.139 -1.41 . . . . 0.0 111.909 -177.563 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.491 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.6 Cg_endo -74.6 90.56 1.03 Allowed 'Trans proline' 0 CA--C 1.557 1.67 0 CA-C-N 120.974 1.384 . . . . 0.0 110.545 177.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.409 HE21 HG13 ' A' ' 90' ' ' VAL . 13.3 pt20 -99.03 177.04 5.36 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 120.805 -1.185 . . . . 0.0 110.2 179.046 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -159.81 121.29 3.22 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.855 -0.528 . . . . 0.0 111.856 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -116.2 -169.89 1.7 Allowed 'General case' 0 N--CA 1.504 2.259 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -103.43 137.12 41.95 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.553 0.692 . . . . 0.0 111.524 -178.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -61.06 113.97 2.85 Favored 'General case' 0 N--CA 1.509 2.484 0 O-C-N 121.897 -0.502 . . . . 0.0 110.539 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.16 23.33 22.61 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.526 -1.029 . . . . 0.0 110.526 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -117.88 164.83 14.46 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 118.335 1.068 . . . . 0.0 110.998 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -80.47 99.31 7.95 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 177.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.77 167.44 10.77 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.454 0.645 . . . . 0.0 112.119 -177.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.631 HG22 ' HG2' ' A' ' 59' ' ' GLN . 87.5 t -143.72 133.84 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 178.057 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.736 HD12 HD23 ' A' ' 58' ' ' LEU . 42.1 mt -90.35 115.18 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 178.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.426 ' HA ' ' CE2' ' A' ' 57' ' ' TYR . 54.4 t -74.83 120.99 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.852 -176.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.418 ' HA ' ' HB2' ' A' ' 7' ' ' ALA . 0.7 OUTLIER -162.19 91.74 0.8 Allowed 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.406 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.432 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -90.59 140.6 29.6 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.651 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.605 HG21 HD12 ' A' ' 33' ' ' ILE . 14.5 t -146.35 124.0 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.462 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 45.3 t -82.45 77.51 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.1 m -87.47 154.64 20.48 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.6 t -43.88 -85.69 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.255 0 O-C-N 121.919 -0.488 . . . . 0.0 112.294 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.402 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 1.2 mt -165.4 -62.51 0.01 OUTLIER Pre-proline 0 N--CA 1.51 2.555 0 CA-C-O 117.711 -1.137 . . . . 0.0 111.24 178.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.402 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 2.9 Cg_endo -59.4 -53.45 3.46 Favored 'Trans proline' 0 CA--C 1.561 1.864 0 CA-C-N 120.091 1.068 . . . . 0.0 112.307 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.556 ' HG2' HG23 ' A' ' 77' ' ' ILE . 2.7 Cg_endo -62.91 -170.07 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.668 0 CA-C-N 119.286 0.781 . . . . 0.0 111.467 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.412 ' HG1' ' C ' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -171.17 -165.41 0.41 Allowed 'General case' 0 N--CA 1.519 2.979 0 O-C-N 121.767 -0.583 . . . . 0.0 109.647 179.808 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.605 HD12 HG21 ' A' ' 25' ' ' VAL . 16.3 tt -99.11 161.03 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.246 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 66.2 mt -128.74 121.04 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.597 ' HB2' HG22 ' A' ' 42' ' ' VAL . 83.5 m95 -85.51 113.13 21.53 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 120.49 -0.484 . . . . 0.0 109.778 -179.156 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 50.9 mttt -128.07 -166.4 1.62 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.79 -0.569 . . . . 0.0 111.539 -178.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 66.14 49.77 1.49 Allowed 'General case' 0 N--CA 1.513 2.719 0 O-C-N 121.698 -0.626 . . . . 0.0 111.296 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -171.73 -43.09 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.591 -0.693 . . . . 0.0 109.488 178.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -153.94 34.82 0.73 Allowed Glycine 0 N--CA 1.495 2.633 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? 51.72 85.03 0.04 OUTLIER 'General case' 0 N--CA 1.514 2.76 0 O-C-N 121.575 -0.956 . . . . 0.0 110.997 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.424 ' CG ' HD13 ' A' ' 44' ' ' LEU . 3.4 t0 55.17 96.39 0.02 OUTLIER 'General case' 0 N--CA 1.516 2.826 0 O-C-N 121.634 -0.666 . . . . 0.0 110.276 -179.005 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.597 HG22 ' HB2' ' A' ' 35' ' ' TRP . 13.6 m -64.3 -30.35 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.491 0 O-C-N 121.919 -0.488 . . . . 0.0 110.695 -178.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 71.1 mt -59.43 -18.08 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.769 0 O-C-N 121.711 -0.618 . . . . 0.0 111.738 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.476 ' N ' HD12 ' A' ' 44' ' ' LEU . 10.4 mp -92.57 -21.35 20.14 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.455 -0.778 . . . . 0.0 111.119 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.41 ' HG2' ' HA ' ' A' ' 42' ' ' VAL . 42.8 pttt -98.06 -37.43 9.75 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.633 -0.667 . . . . 0.0 109.233 178.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.4 mmmt 48.05 54.75 9.65 Favored 'General case' 0 N--CA 1.509 2.493 0 CA-C-O 121.421 0.629 . . . . 0.0 111.824 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -51.83 168.29 0.09 Allowed 'General case' 0 N--CA 1.515 2.789 0 O-C-N 121.867 -0.521 . . . . 0.0 110.943 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.8 m -61.16 -18.77 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.689 0 O-C-N 121.976 -0.452 . . . . 0.0 111.799 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 29.6 ptt-85 -121.26 46.82 1.96 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.728 -0.607 . . . . 0.0 111.973 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.426 ' HE2' HD21 ' A' ' 58' ' ' LEU . 6.8 m-85 -145.36 106.97 4.23 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.574 -0.704 . . . . 0.0 110.156 178.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 82.7 mt -129.66 107.99 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.556 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.0 t -76.17 131.66 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.5 mt -85.02 164.43 18.25 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.909 -0.494 . . . . 0.0 111.49 -178.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.3 p -62.03 -20.68 64.19 Favored 'General case' 0 N--CA 1.509 2.48 0 O-C-N 122.102 -0.374 . . . . 0.0 110.812 178.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 50.3 p30 -88.17 13.58 11.06 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.721 -0.612 . . . . 0.0 111.528 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.3 m120 71.09 33.94 1.94 Allowed 'General case' 0 N--CA 1.518 2.968 0 O-C-N 121.547 -0.72 . . . . 0.0 112.493 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.426 ' CE2' ' HA ' ' A' ' 22' ' ' VAL . 5.3 m-85 -106.0 163.77 12.5 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 177.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.736 HD23 HD12 ' A' ' 21' ' ' ILE . 18.1 tp -118.07 97.54 5.86 Favored 'General case' 0 N--CA 1.519 3.005 0 C-N-CA 119.381 -0.928 . . . . 0.0 111.218 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.631 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -75.39 99.49 4.16 Favored 'General case' 0 N--CA 1.501 2.081 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.763 179.651 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.597 HD11 HD11 ' A' ' 21' ' ' ILE . 92.6 mt -90.75 118.95 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 177.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.8 tpt85 -81.2 113.06 19.09 Favored 'General case' 0 N--CA 1.501 2.092 0 CA-C-O 121.29 0.566 . . . . 0.0 111.012 -178.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.55 -37.28 3.6 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.585 ' CG1' HG21 ' A' ' 92' ' ' VAL . 3.2 tp 41.6 94.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.521 3.08 0 CA-C-N 118.126 0.963 . . . . 0.0 112.253 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.2 mttm -86.87 157.45 19.53 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 121.233 -0.917 . . . . 0.0 112.693 -177.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.6 tttp -61.68 -27.38 68.65 Favored 'General case' 0 N--CA 1.508 2.453 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.12 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.5 t -81.11 -11.74 59.41 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 121.896 -0.503 . . . . 0.0 111.601 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.64 -17.54 20.31 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.534 -0.729 . . . . 0.0 111.482 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.475 ' HB3' HG12 ' A' ' 92' ' ' VAL . 8.4 pt-20 -68.75 148.28 50.58 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.36 -0.837 . . . . 0.0 109.933 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 167.01 -107.15 0.28 Allowed Glycine 0 N--CA 1.496 2.695 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.9 m -145.26 104.2 3.92 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 122.023 -0.692 . . . . 0.0 110.864 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -85.44 138.02 32.53 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -97.42 120.29 37.52 Favored 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.447 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 85' ' ' PHE . 2.9 m -87.31 105.73 17.45 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -104.63 85.97 2.41 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.298 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.29 87.96 0.25 Allowed Glycine 0 N--CA 1.499 2.899 0 N-CA-C 107.674 -2.17 . . . . 0.0 107.674 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.592 ' HG3' HG22 ' A' ' 83' ' ' ILE . 2.6 ttm180 -92.91 125.69 37.64 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.706 0.765 . . . . 0.0 112.967 -176.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.665 HD13 ' CG2' ' A' ' 2' ' ' VAL . 5.2 mp -141.43 91.55 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.469 HD21 HG23 ' A' ' 83' ' ' ILE . 18.6 mt -96.94 19.11 13.24 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.009 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -112.59 -26.2 8.77 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.717 -0.614 . . . . 0.0 110.847 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 78.2 mmt-85 -121.22 -62.9 1.38 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.777 -0.577 . . . . 0.0 110.753 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.58 -81.71 1.62 Allowed Glycine 0 N--CA 1.491 2.305 0 C-N-CA 121.02 -0.61 . . . . 0.0 111.645 -178.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 178.09 -159.83 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.765 0 O-C-N 122.204 -0.586 . . . . 0.0 109.827 -178.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.592 HG22 ' HG3' ' A' ' 76' ' ' ARG . 1.7 pp -98.16 115.06 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 O-C-N 121.743 -0.598 . . . . 0.0 110.42 179.249 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -113.61 155.95 24.55 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.539 -0.725 . . . . 0.0 109.869 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.451 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 35.4 p90 -164.12 176.69 9.04 Favored 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.2 pttt -170.53 167.13 8.17 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.583 ' O ' HG22 ' A' ' 9' ' ' THR . 5.8 p-10 -105.54 123.96 48.77 Favored 'General case' 0 N--CA 1.513 2.677 0 O-C-N 121.801 -0.562 . . . . 0.0 111.703 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.537 HD12 ' N ' ' A' ' 88' ' ' ILE . 1.9 mp -104.85 119.24 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -83.54 114.83 21.79 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.409 HG13 HE21 ' A' ' 11' ' ' GLN . 46.5 t -108.52 132.92 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.235 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 50.2 mt -121.95 159.25 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.585 HG21 ' CG1' ' A' ' 63' ' ' ILE . 1.4 p . . . . . 0 N--CA 1.498 1.943 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.699 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 47.9 p90 . . . . . 0 N--CA 1.499 1.999 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.532 ' CG2' HD11 ' A' ' 77' ' ' ILE . 44.5 t -147.17 109.26 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.527 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 12.5 mmt -119.85 116.23 25.44 Favored 'General case' 0 N--CA 1.507 2.396 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.803 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -72.88 115.71 12.5 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 122.118 -0.364 . . . . 0.0 111.101 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -124.49 156.56 37.05 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.566 0.698 . . . . 0.0 110.357 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.426 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.2 OUTLIER 41.07 81.82 0.03 OUTLIER 'General case' 0 N--CA 1.518 2.94 0 C-N-CA 123.479 0.712 . . . . 0.0 111.919 -179.47 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -131.92 68.54 80.49 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.711 -0.618 . . . . 0.0 111.68 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -67.12 88.85 0.31 Allowed 'Trans proline' 0 N--CA 1.492 1.397 0 N-CA-C 107.966 -1.59 . . . . 0.0 107.966 177.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.544 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.6 OUTLIER -48.69 -68.27 0.34 Allowed Pre-proline 0 N--CA 1.509 2.496 0 CA-C-O 116.795 -1.574 . . . . 0.0 113.069 -176.702 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.487 ' HD3' ' OG1' ' A' ' 9' ' ' THR . 1.5 Cg_endo -71.31 93.88 0.66 Allowed 'Trans proline' 0 N--CA 1.497 1.686 0 CA-C-N 121.516 1.577 . . . . 0.0 111.441 178.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.498 HE21 HG13 ' A' ' 90' ' ' VAL . 16.1 pt20 -101.0 173.98 6.22 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.02 -1.05 . . . . 0.0 110.26 178.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 15.5 tt0 -158.79 120.39 3.45 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.238 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -116.72 -169.76 1.69 Allowed 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.945 -0.472 . . . . 0.0 109.94 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -102.01 137.46 40.25 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.597 0.713 . . . . 0.0 111.705 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -60.79 118.78 7.07 Favored 'General case' 0 N--CA 1.508 2.444 0 O-C-N 121.964 -0.46 . . . . 0.0 110.494 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.3 23.54 37.01 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.422 ' O ' HG22 ' A' ' 63' ' ' ILE . 15.4 tt0 -118.26 165.17 14.14 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 118.412 1.106 . . . . 0.0 110.867 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.71 97.74 8.08 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 178.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.19 169.96 9.23 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.729 -177.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.681 HG22 ' HG2' ' A' ' 59' ' ' GLN . 93.2 t -142.88 140.76 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 178.247 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.873 HD12 HD23 ' A' ' 58' ' ' LEU . 20.8 mt -96.02 113.32 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 178.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.437 HG13 ' CE2' ' A' ' 57' ' ' TYR . 45.2 t -73.66 122.04 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.21 -176.323 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -164.92 89.81 0.5 Allowed 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.426 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -88.6 141.3 28.64 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.056 -179.374 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.675 HG21 HD12 ' A' ' 33' ' ' ILE . 38.3 t -148.16 132.08 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.527 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 53.8 t -95.32 78.57 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.6 m -81.52 163.48 22.65 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 178.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 t -43.04 -85.06 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.329 0 O-C-N 121.825 -0.547 . . . . 0.0 111.582 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.401 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 0.5 OUTLIER -167.29 -63.15 0.01 OUTLIER Pre-proline 0 N--CA 1.514 2.768 0 CA-C-O 117.707 -1.14 . . . . 0.0 111.663 177.783 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.401 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 2.9 Cg_endo -59.76 -53.23 3.45 Favored 'Trans proline' 0 CA--C 1.564 1.999 0 CA-C-N 120.209 1.11 . . . . 0.0 112.446 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.468 ' HG3' HG23 ' A' ' 77' ' ' ILE . 3.0 Cg_endo -62.55 -164.4 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 120.55 0.833 . . . . 0.0 112.185 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -171.12 -166.69 0.49 Allowed 'General case' 0 N--CA 1.519 3.019 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.443 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.675 HD12 HG21 ' A' ' 25' ' ' VAL . 15.1 tt -97.96 165.45 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 81.1 mt -128.65 133.9 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.55 ' HB2' HG22 ' A' ' 42' ' ' VAL . 82.7 m95 -97.55 115.49 27.95 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -114.98 -172.72 2.18 Favored 'General case' 0 N--CA 1.505 2.3 0 CA-C-O 121.334 0.588 . . . . 0.0 111.295 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 9.0 t60 63.66 153.08 0.04 OUTLIER 'General case' 0 N--CA 1.51 2.563 0 CA-C-O 121.08 0.467 . . . . 0.0 110.468 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 26.1 tptt 55.28 53.63 9.76 Favored 'General case' 0 N--CA 1.515 2.796 0 O-C-N 121.732 -0.605 . . . . 0.0 110.783 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 133.34 -7.26 5.02 Favored Glycine 0 N--CA 1.496 2.651 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.229 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 56.4 89.61 0.04 OUTLIER 'General case' 0 N--CA 1.514 2.748 0 CA-C-N 118.902 1.351 . . . . 0.0 110.553 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 55.2 98.03 0.02 OUTLIER 'General case' 0 N--CA 1.514 2.77 0 O-C-N 121.766 -0.584 . . . . 0.0 110.775 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.55 HG22 ' HB2' ' A' ' 35' ' ' TRP . 5.7 m -73.05 -26.29 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.421 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.626 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.5 mm -58.44 -18.41 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.806 0 O-C-N 121.623 -0.673 . . . . 0.0 111.77 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.47 ' N ' HD12 ' A' ' 44' ' ' LEU . 10.4 mp -91.66 -23.02 19.96 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.527 -0.733 . . . . 0.0 111.133 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -98.9 -42.28 7.23 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.753 -0.592 . . . . 0.0 110.034 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt 48.05 56.91 6.65 Favored 'General case' 0 N--CA 1.509 2.499 0 CA-C-O 121.492 0.663 . . . . 0.0 111.892 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -50.9 170.14 0.04 OUTLIER 'General case' 0 N--CA 1.517 2.893 0 O-C-N 121.689 -0.632 . . . . 0.0 111.506 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 36.0 m -63.21 -19.5 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.64 0 O-C-N 122.054 -0.404 . . . . 0.0 111.985 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.1 ptp85 -109.42 0.16 19.23 Favored 'General case' 0 N--CA 1.506 2.349 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -99.33 106.1 18.16 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.35 -0.844 . . . . 0.0 110.562 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 74.5 mt -129.64 110.49 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.478 HG22 ' CD1' ' A' ' 58' ' ' LEU . 2.5 t -77.62 137.88 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.51 HD11 ' CG ' ' A' ' 59' ' ' GLN . 45.0 mt -89.97 167.44 12.8 Favored 'General case' 0 N--CA 1.505 2.321 0 CA-C-O 121.387 0.613 . . . . 0.0 112.01 -178.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.7 p -60.92 -22.41 64.33 Favored 'General case' 0 N--CA 1.51 2.554 0 O-C-N 122.137 -0.352 . . . . 0.0 111.229 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 35.5 p-10 -91.29 18.54 6.92 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.735 -0.603 . . . . 0.0 111.48 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.6 m120 67.48 33.21 5.3 Favored 'General case' 0 N--CA 1.516 2.86 0 O-C-N 121.544 -0.722 . . . . 0.0 111.999 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.437 ' CE2' HG13 ' A' ' 22' ' ' VAL . 4.1 m-85 -103.06 163.84 11.97 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 177.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.873 HD23 HD12 ' A' ' 21' ' ' ILE . 20.8 tp -120.11 100.6 7.3 Favored 'General case' 0 N--CA 1.516 2.859 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.968 -179.452 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.681 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -78.69 105.32 9.9 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.328 179.672 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.755 HD11 HD11 ' A' ' 21' ' ' ILE . 96.4 mt -97.47 102.81 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 177.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -67.55 118.17 10.49 Favored 'General case' 0 N--CA 1.506 2.33 0 CA-C-O 121.155 0.503 . . . . 0.0 111.221 -178.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.57 -39.14 2.85 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.582 HG23 HG21 ' A' ' 92' ' ' VAL . 2.8 tp 40.13 85.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.52 3.042 0 CA-C-O 122.023 0.916 . . . . 0.0 112.308 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.452 ' HB3' HG22 ' A' ' 66' ' ' THR . 28.2 mtpt -68.95 151.28 46.74 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 121.548 -0.72 . . . . 0.0 111.347 -178.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.619 ' HA ' HG13 ' A' ' 92' ' ' VAL . 0.1 OUTLIER -63.24 -17.99 63.06 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 122.15 -0.344 . . . . 0.0 110.956 179.023 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.452 HG22 ' HB3' ' A' ' 64' ' ' LYS . 10.0 t -90.98 -12.37 36.11 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.551 -0.718 . . . . 0.0 111.246 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.81 14.71 18.51 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.454 -0.779 . . . . 0.0 111.532 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.813 ' HB3' HG12 ' A' ' 92' ' ' VAL . 0.7 OUTLIER -97.41 148.07 23.56 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.416 -0.802 . . . . 0.0 109.946 179.674 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 169.52 -102.1 0.18 Allowed Glycine 0 N--CA 1.498 2.769 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.6 m -148.38 100.76 3.18 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 122.025 -0.691 . . . . 0.0 110.994 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -80.76 133.41 35.64 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.8 tpt180 -96.32 116.56 29.22 Favored 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.651 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 7.1 m -79.29 132.89 36.6 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -134.82 91.13 2.72 Favored 'General case' 0 N--CA 1.503 2.178 0 CA-C-N 118.719 0.69 . . . . 0.0 110.724 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.76 121.21 10.56 Favored Glycine 0 N--CA 1.501 3.03 0 N-CA-C 107.598 -2.201 . . . . 0.0 107.598 178.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 -136.29 139.23 42.49 Favored 'General case' 0 N--CA 1.503 2.188 0 CA-C-N 118.308 1.054 . . . . 0.0 113.581 -177.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.532 HD11 ' CG2' ' A' ' 2' ' ' VAL . 81.0 mt -122.41 139.54 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.34 177.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 37.1 mt -92.7 -43.13 9.23 Favored 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 121.113 -0.235 . . . . 0.0 110.775 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.34 -57.81 10.79 Favored 'General case' 0 N--CA 1.514 2.774 0 O-C-N 121.63 -0.669 . . . . 0.0 109.583 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 23.2 mtm180 -100.58 61.34 1.01 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 177.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -15.33 82.21 0.0 OUTLIER Glycine 1 N--CA 1.524 4.535 0 C-N-CA 124.961 1.267 . . . . 0.0 114.845 -178.206 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -116.85 144.7 44.2 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.5 pt -137.82 68.26 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 CA-C-O 121.197 0.522 . . . . 0.0 111.033 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -85.19 154.83 21.73 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -161.37 -177.92 6.31 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.797 -0.761 . . . . 0.0 112.035 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.5 tptp -169.17 166.07 10.87 Favored 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.544 ' O ' HG22 ' A' ' 9' ' ' THR . 4.4 p-10 -111.03 112.86 24.98 Favored 'General case' 0 N--CA 1.51 2.544 0 CA-C-O 121.071 0.462 . . . . 0.0 110.46 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.57 HD12 ' N ' ' A' ' 88' ' ' ILE . 2.2 mp -101.07 118.99 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -83.52 127.32 33.63 Favored 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.498 HG13 HE21 ' A' ' 11' ' ' GLN . 40.7 t -121.11 132.7 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 O-C-N 121.808 -0.558 . . . . 0.0 109.905 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 72.1 mt -126.05 146.34 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.813 HG12 ' HB3' ' A' ' 68' ' ' GLU . 9.8 p . . . . . 0 N--CA 1.501 2.103 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.714 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 53.5 p90 . . . . . 0 N--CA 1.496 1.851 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 1.097 HG13 HD11 ' A' ' 77' ' ' ILE . 14.5 m -136.9 93.0 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 CA-C-O 121.335 0.588 . . . . 0.0 109.464 178.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.514 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 0.7 OUTLIER -87.8 106.81 18.33 Favored 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.907 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -67.13 119.9 12.83 Favored 'General case' 0 N--CA 1.506 2.346 0 CA-C-O 120.812 0.339 . . . . 0.0 110.738 -178.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.408 ' HG2' HG23 ' A' ' 26' ' ' VAL . 3.2 pttt -135.13 163.84 29.03 Favored 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 121.88 0.847 . . . . 0.0 112.26 -179.054 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.4 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.3 OUTLIER 28.59 95.58 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.134 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 179.133 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.429 ' HB2' ' HA ' ' A' ' 23' ' ' CYS . . . -164.82 84.0 1.16 Allowed Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.953 -0.467 . . . . 0.0 111.154 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -65.2 106.04 0.77 Allowed 'Trans proline' 0 N--CA 1.492 1.392 0 N-CA-C 108.419 -1.416 . . . . 0.0 108.419 177.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.558 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.2 OUTLIER -51.04 -65.64 0.88 Allowed Pre-proline 0 N--CA 1.508 2.45 0 CA-C-O 116.91 -1.519 . . . . 0.0 112.594 -177.02 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.488 ' HD3' ' OG1' ' A' ' 9' ' ' THR . 1.4 Cg_endo -75.1 94.55 0.96 Allowed 'Trans proline' 0 N--CA 1.495 1.59 0 CA-C-N 121.182 1.458 . . . . 0.0 111.019 178.475 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.434 HE21 HG13 ' A' ' 90' ' ' VAL . 16.1 pt20 -99.96 179.35 4.53 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 120.949 -1.095 . . . . 0.0 110.276 178.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -160.6 121.75 2.99 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.825 -0.547 . . . . 0.0 111.82 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -118.95 -170.95 2.01 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.929 -0.482 . . . . 0.0 109.988 178.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.1 tttp -102.33 135.95 43.04 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.505 0.669 . . . . 0.0 111.339 -178.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -60.66 112.42 2.0 Allowed 'General case' 0 N--CA 1.508 2.47 0 O-C-N 121.929 -0.482 . . . . 0.0 110.533 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.02 23.89 16.42 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.417 ' O ' HG22 ' A' ' 63' ' ' ILE . 18.3 tt0 -118.4 165.79 13.44 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-N 118.397 1.099 . . . . 0.0 110.676 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -81.72 98.98 8.68 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 177.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.03 166.67 10.92 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 120.24 -0.584 . . . . 0.0 112.116 -177.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.679 HG22 ' HG2' ' A' ' 59' ' ' GLN . 89.6 t -141.19 139.7 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 178.11 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.772 HD12 HD23 ' A' ' 58' ' ' LEU . 42.7 mt -95.38 119.11 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 106.563 -1.644 . . . . 0.0 106.563 178.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.412 ' HA ' ' CE2' ' A' ' 57' ' ' TYR . 54.1 t -78.59 118.87 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 CA-C-O 121.415 0.626 . . . . 0.0 110.922 -176.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.429 ' HA ' ' HB2' ' A' ' 7' ' ' ALA . 1.6 t -159.91 91.56 0.97 Allowed 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.4 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -90.12 138.29 31.64 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.103 -179.051 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.708 HG21 HD12 ' A' ' 33' ' ' ILE . 43.6 t -147.51 124.17 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.514 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 29.0 t -85.51 75.01 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.603 ' HA ' HG12 ' A' ' 2' ' ' VAL . 3.4 m -75.48 158.22 32.9 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.5 t -40.45 -77.97 0.02 OUTLIER 'General case' 0 N--CA 1.525 3.323 0 CA-C-N 118.158 0.435 . . . . 0.0 111.597 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.404 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 1.2 mt -173.27 -63.47 0.0 OUTLIER Pre-proline 0 N--CA 1.515 2.789 0 CA-C-O 117.719 -1.134 . . . . 0.0 111.064 177.154 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.404 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 2.9 Cg_endo -60.13 -53.35 3.13 Favored 'Trans proline' 0 CA--C 1.564 1.98 0 CA-C-N 120.105 1.073 . . . . 0.0 112.473 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.52 ' CB ' ' HA ' ' A' ' 77' ' ' ILE . 3.0 Cg_exo -62.11 -164.83 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 120.503 0.802 . . . . 0.0 112.558 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -170.34 -167.37 0.61 Allowed 'General case' 0 N--CA 1.519 3.003 0 O-C-N 121.921 -0.487 . . . . 0.0 110.434 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.708 HD12 HG21 ' A' ' 25' ' ' VAL . 17.8 tt -103.59 139.42 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.539 ' N ' HD12 ' A' ' 34' ' ' ILE . 4.0 mp -102.13 130.57 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.528 ' HB2' HG22 ' A' ' 42' ' ' VAL . 72.3 m95 -92.68 114.78 27.43 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt -115.04 -175.17 2.63 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.903 -0.498 . . . . 0.0 111.035 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 60.99 150.22 0.02 OUTLIER 'General case' 0 N--CA 1.511 2.596 0 CA-C-O 121.264 0.554 . . . . 0.0 110.812 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? 54.96 33.97 21.29 Favored 'General case' 0 N--CA 1.517 2.903 0 O-C-N 121.483 -0.761 . . . . 0.0 110.536 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 159.93 -25.92 0.32 Allowed Glycine 0 N--CA 1.491 2.323 0 C-N-CA 120.266 -0.968 . . . . 0.0 110.906 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.47 97.22 0.02 OUTLIER 'General case' 0 N--CA 1.516 2.837 0 O-C-N 121.238 -1.154 . . . . 0.0 110.0 -179.11 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 54.3 75.76 0.27 Allowed 'General case' 0 N--CA 1.513 2.721 0 O-C-N 121.675 -0.641 . . . . 0.0 110.376 -179.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.528 HG22 ' HB2' ' A' ' 35' ' ' TRP . 8.7 m -67.53 -38.93 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 O-C-N 121.793 -0.567 . . . . 0.0 109.739 -178.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.579 HG12 HG21 ' A' ' 52' ' ' VAL . 58.5 mt -60.94 -17.48 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.718 0 O-C-N 121.964 -0.46 . . . . 0.0 111.423 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.476 ' N ' HD12 ' A' ' 44' ' ' LEU . 10.1 mp -90.08 -23.64 21.35 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.473 -0.767 . . . . 0.0 110.451 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -99.06 -35.45 10.03 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.721 -0.612 . . . . 0.0 109.544 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.5 mmmt 49.27 54.85 10.25 Favored 'General case' 0 N--CA 1.506 2.351 0 CA-C-O 121.359 0.6 . . . . 0.0 111.978 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.0 167.24 0.12 Allowed 'General case' 0 N--CA 1.517 2.888 0 O-C-N 121.895 -0.503 . . . . 0.0 110.729 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.9 m -60.81 -19.38 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.741 0 O-C-N 121.874 -0.516 . . . . 0.0 111.843 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 25.6 ptt-85 -118.52 45.41 2.04 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.676 -0.64 . . . . 0.0 111.915 -179.275 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -146.51 104.84 3.8 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.604 -0.685 . . . . 0.0 109.752 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 76.1 mt -129.87 108.32 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.579 HG21 HG12 ' A' ' 43' ' ' ILE . 2.7 t -74.65 140.88 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.422 HD11 ' OE1' ' A' ' 59' ' ' GLN . 17.0 mt -95.49 169.59 9.95 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.821 -0.549 . . . . 0.0 111.899 -178.213 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.6 p -61.88 -23.11 66.09 Favored 'General case' 0 N--CA 1.509 2.521 0 O-C-N 122.183 -0.323 . . . . 0.0 111.007 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 44.6 p-10 -88.19 15.15 7.93 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.768 -0.582 . . . . 0.0 111.412 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.424 ' HB3' HG21 ' A' ' 33' ' ' ILE . 7.6 m120 68.13 33.47 4.43 Favored 'General case' 0 N--CA 1.516 2.834 0 O-C-N 121.577 -0.702 . . . . 0.0 112.023 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.412 ' CE2' ' HA ' ' A' ' 22' ' ' VAL . 3.8 m-85 -102.85 166.83 10.25 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.165 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.772 HD23 HD12 ' A' ' 21' ' ' ILE . 19.2 tp -120.83 98.03 5.81 Favored 'General case' 0 N--CA 1.519 2.991 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.666 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.679 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.7 OUTLIER -75.65 101.11 4.85 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.917 179.464 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.599 HD11 HD11 ' A' ' 21' ' ' ILE . 95.5 mt -92.12 115.37 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 177.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -77.58 112.23 14.16 Favored 'General case' 0 N--CA 1.505 2.298 0 CA-C-O 121.521 0.677 . . . . 0.0 111.467 -178.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 100.16 -36.44 4.12 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 179.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.587 ' CG1' HG21 ' A' ' 92' ' ' VAL . 2.6 tp 41.77 74.47 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.519 3.003 0 CA-C-O 122.249 1.024 . . . . 0.0 112.454 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.9 mmtp -62.8 158.6 18.39 Favored 'General case' 0 N--CA 1.509 2.483 0 O-C-N 121.488 -0.758 . . . . 0.0 112.336 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.3 tptt -61.97 -24.55 67.08 Favored 'General case' 0 N--CA 1.51 2.557 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.833 178.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.3 t -83.61 -15.1 50.31 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.773 -0.579 . . . . 0.0 111.109 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -94.12 11.09 31.22 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.635 -0.666 . . . . 0.0 111.595 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.512 ' HB3' HG12 ' A' ' 92' ' ' VAL . 9.1 pt-20 -98.74 137.3 37.55 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.275 -0.891 . . . . 0.0 109.593 179.136 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 174.7 -106.37 0.22 Allowed Glycine 0 N--CA 1.499 2.886 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.3 m -143.33 102.2 3.93 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.946 -0.737 . . . . 0.0 110.901 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -83.61 132.55 34.89 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.7 tpp85 -96.42 118.18 32.4 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.459 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.692 ' HB3' HD11 ' A' ' 33' ' ' ILE . 9.0 m -81.04 126.4 31.38 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 177.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -125.26 87.28 2.68 Favored 'General case' 0 N--CA 1.503 2.178 0 CA-C-N 118.605 0.639 . . . . 0.0 110.681 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.83 101.0 0.6 Allowed Glycine 0 N--CA 1.501 3.021 0 N-CA-C 107.921 -2.071 . . . . 0.0 107.921 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 30.3 ttp85 -112.72 135.4 53.51 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -176.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 1.097 HD11 HG13 ' A' ' 2' ' ' VAL . 95.8 mt -117.35 135.98 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 18.9 mt -90.71 -45.74 8.68 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.338 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.29 -58.89 6.49 Favored 'General case' 0 N--CA 1.516 2.87 0 O-C-N 121.574 -0.704 . . . . 0.0 109.652 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 20.9 mtt180 -96.87 58.26 1.6 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 177.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -15.02 82.3 0.0 OUTLIER Glycine 1 N--CA 1.524 4.541 0 C-N-CA 125.016 1.293 . . . . 0.0 114.66 -178.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -127.15 149.97 49.72 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 122.312 -0.522 . . . . 0.0 109.676 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.4 pt -137.25 74.17 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 CA-C-O 121.385 0.612 . . . . 0.0 110.834 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -82.31 151.04 26.91 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -164.51 177.64 7.99 Favored 'General case' 0 N--CA 1.503 2.22 0 C-N-CA 119.861 -0.736 . . . . 0.0 112.744 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.48 ' HG3' HD11 ' A' ' 88' ' ' ILE . 1.3 pttt -167.42 163.6 14.99 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 177.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.558 ' O ' HG22 ' A' ' 9' ' ' THR . 10.2 p-10 -99.79 119.34 38.01 Favored 'General case' 0 N--CA 1.511 2.618 0 O-C-N 121.884 -0.51 . . . . 0.0 111.698 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.579 HD12 ' N ' ' A' ' 88' ' ' ILE . 3.1 mp -104.17 118.47 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.013 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -84.06 125.65 32.31 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.434 HG13 HE21 ' A' ' 11' ' ' GLN . 47.6 t -119.26 126.08 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 O-C-N 121.719 -0.613 . . . . 0.0 109.792 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 51.1 mt -116.4 157.97 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.587 HG21 ' CG1' ' A' ' 63' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.5 2.053 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.394 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 45.0 p90 . . . . . 0 N--CA 1.499 2.005 0 CA-C-O 120.779 0.323 . . . . 0.0 110.413 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.694 ' CG2' HD11 ' A' ' 77' ' ' ILE . 37.6 t -146.1 105.34 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.49 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 1.6 mmm -108.43 111.54 23.49 Favored 'General case' 0 N--CA 1.508 2.468 0 C-N-CA 120.144 -0.622 . . . . 0.0 109.821 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -67.65 119.87 13.11 Favored 'General case' 0 N--CA 1.505 2.319 0 CA-C-O 120.786 0.327 . . . . 0.0 110.783 -178.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.462 ' HG2' HG23 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -132.56 160.29 36.99 Favored 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 121.553 0.692 . . . . 0.0 111.114 -179.821 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.415 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.4 OUTLIER 31.41 58.81 0.29 Allowed 'General case' 0 N--CA 1.519 2.994 0 C-N-CA 124.148 0.979 . . . . 0.0 113.561 179.411 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -121.37 79.14 36.43 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.697 -0.627 . . . . 0.0 110.74 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -65.75 114.12 2.82 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 N-CA-C 109.189 -1.12 . . . . 0.0 109.189 178.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.581 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.2 OUTLIER -67.75 -66.76 1.02 Allowed Pre-proline 0 N--CA 1.498 1.956 0 CA-C-O 117.059 -1.448 . . . . 0.0 111.208 -178.335 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.485 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.4 Cg_endo -72.17 89.22 0.8 Allowed 'Trans proline' 0 N--CA 1.498 1.763 0 CA-C-N 121.108 1.432 . . . . 0.0 111.199 178.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.421 HE21 HG13 ' A' ' 90' ' ' VAL . 10.5 pt20 -100.36 171.75 7.57 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 120.715 -1.24 . . . . 0.0 110.088 178.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -154.4 127.44 8.31 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.816 -0.552 . . . . 0.0 111.646 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -125.73 -164.0 1.26 Allowed 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.36 142.63 51.13 Favored 'General case' 0 N--CA 1.513 2.694 0 CA-C-O 121.856 0.836 . . . . 0.0 111.455 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -56.26 141.86 39.73 Favored 'General case' 0 N--CA 1.51 2.536 0 O-C-N 121.831 -0.543 . . . . 0.0 111.082 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.15 12.73 72.38 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -104.87 156.09 18.33 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 119.116 1.458 . . . . 0.0 111.34 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -81.12 95.45 6.88 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 176.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.15 166.34 11.46 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.996 -0.682 . . . . 0.0 112.203 -176.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.713 HG22 ' HG2' ' A' ' 59' ' ' GLN . 94.3 t -140.04 140.05 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 178.355 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.816 HD12 HD23 ' A' ' 58' ' ' LEU . 47.9 mt -94.87 117.0 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 178.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.497 HG13 ' CE2' ' A' ' 57' ' ' TYR . 39.2 t -77.08 119.48 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 CA-C-O 121.431 0.634 . . . . 0.0 110.98 -176.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.4 t -161.34 92.03 0.88 Allowed 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.415 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.2 OUTLIER -92.09 140.59 29.49 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.905 -0.718 . . . . 0.0 109.314 -179.131 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.687 HG21 HD12 ' A' ' 33' ' ' ILE . 43.7 t -146.79 128.19 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.49 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 45.9 t -89.42 74.09 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.0 m -78.44 161.79 26.86 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 178.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 t -41.96 -78.29 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.199 0 CA-C-N 118.191 0.451 . . . . 0.0 111.566 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -174.0 -62.54 0.0 OUTLIER Pre-proline 0 N--CA 1.515 2.809 0 CA-C-O 117.873 -1.06 . . . . 0.0 111.498 177.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.68 -53.44 3.31 Favored 'Trans proline' 0 CA--C 1.562 1.913 0 CA-C-N 119.845 0.981 . . . . 0.0 112.519 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.498 ' HG3' HG23 ' A' ' 77' ' ' ILE . 3.3 Cg_exo -61.4 -165.28 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 120.535 0.823 . . . . 0.0 112.61 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -170.35 -170.13 0.92 Allowed 'General case' 0 N--CA 1.521 3.114 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.717 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.687 HD12 HG21 ' A' ' 25' ' ' VAL . 18.3 tt -100.92 140.22 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.226 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.535 ' N ' HD12 ' A' ' 34' ' ' ILE . 5.1 mp -102.91 128.36 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.009 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.527 ' HB2' HG22 ' A' ' 42' ' ' VAL . 73.6 m95 -90.56 112.88 24.73 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.0 ttpt -114.25 -176.32 2.87 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.783 -0.573 . . . . 0.0 111.059 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 62.06 153.5 0.03 OUTLIER 'General case' 0 N--CA 1.512 2.641 0 O-C-N 121.915 -0.491 . . . . 0.0 110.788 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.5 tppt? 53.4 37.03 24.54 Favored 'General case' 0 N--CA 1.516 2.861 0 O-C-N 121.677 -0.64 . . . . 0.0 110.578 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 154.73 -23.77 0.63 Allowed Glycine 0 N--CA 1.488 2.112 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.34 98.45 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.689 0 O-C-N 121.374 -1.074 . . . . 0.0 110.458 -179.391 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 54.96 79.34 0.15 Allowed 'General case' 0 N--CA 1.513 2.711 0 O-C-N 121.721 -0.612 . . . . 0.0 110.298 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.527 HG22 ' HB2' ' A' ' 35' ' ' TRP . 6.4 m -70.97 -36.95 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 O-C-N 121.79 -0.569 . . . . 0.0 109.791 -178.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 77.3 mt -60.24 -17.61 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.855 0 O-C-N 122.071 -0.393 . . . . 0.0 111.418 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.463 ' N ' HD12 ' A' ' 44' ' ' LEU . 10.7 mp -90.16 -23.65 21.27 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.511 -0.743 . . . . 0.0 110.617 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.403 ' HG2' ' HA ' ' A' ' 42' ' ' VAL . 45.0 pttt -99.15 -36.91 9.52 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.719 -0.613 . . . . 0.0 109.572 178.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.7 mmmt 47.97 56.72 6.87 Favored 'General case' 0 N--CA 1.508 2.426 0 CA-C-O 121.503 0.668 . . . . 0.0 111.88 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.67 168.45 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.811 0 O-C-N 121.863 -0.523 . . . . 0.0 111.638 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.9 m -59.91 -20.04 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.68 0 O-C-N 121.923 -0.485 . . . . 0.0 112.268 -178.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.9 ptp85 -114.68 4.37 15.03 Favored 'General case' 0 N--CA 1.507 2.42 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -102.32 111.3 23.53 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.143 -0.973 . . . . 0.0 110.916 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 82.6 mt -132.87 105.96 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.531 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.2 t -73.39 136.73 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.417 HD11 ' CG ' ' A' ' 59' ' ' GLN . 14.4 mt -90.22 166.83 13.13 Favored 'General case' 0 N--CA 1.507 2.386 0 CA-C-O 121.319 0.58 . . . . 0.0 111.845 -178.237 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 92.9 p -60.87 -21.7 63.54 Favored 'General case' 0 N--CA 1.509 2.487 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.249 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 42.0 p-10 -90.32 17.92 6.67 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.629 -0.67 . . . . 0.0 111.475 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.416 ' HB3' HG21 ' A' ' 33' ' ' ILE . 4.5 m120 68.26 30.72 5.49 Favored 'General case' 0 N--CA 1.518 2.948 0 O-C-N 121.605 -0.685 . . . . 0.0 112.051 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.497 ' CE2' HG13 ' A' ' 22' ' ' VAL . 3.6 m-85 -101.71 165.2 11.34 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.347 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.816 HD23 HD12 ' A' ' 21' ' ' ILE . 17.1 tp -120.06 102.61 8.65 Favored 'General case' 0 N--CA 1.518 2.942 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.751 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.713 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.7 OUTLIER -80.0 103.42 9.87 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.368 179.653 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.522 HD11 HD11 ' A' ' 21' ' ' ILE . 95.1 mt -95.89 104.7 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 177.343 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -68.01 113.22 5.51 Favored 'General case' 0 N--CA 1.505 2.289 0 CA-C-O 121.07 0.462 . . . . 0.0 110.756 -178.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.402 ' O ' HG22 ' A' ' 63' ' ' ILE . . . 100.92 -40.17 2.51 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 179.226 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.55 ' CG1' HG21 ' A' ' 92' ' ' VAL . 1.7 tp 42.91 72.14 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.961 0 CA-C-O 122.228 1.013 . . . . 0.0 112.446 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 59.9 mttt -62.33 158.62 16.95 Favored 'General case' 0 N--CA 1.51 2.527 0 O-C-N 121.63 -0.669 . . . . 0.0 112.154 -178.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.5 mtmt -62.84 -23.65 67.39 Favored 'General case' 0 N--CA 1.508 2.473 0 O-C-N 122.134 -0.354 . . . . 0.0 110.879 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.0 p -80.77 -17.28 51.44 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.741 -0.6 . . . . 0.0 110.774 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -94.23 10.02 35.7 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.701 -0.624 . . . . 0.0 111.725 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.542 ' HB3' HG12 ' A' ' 92' ' ' VAL . 8.2 pt-20 -98.18 144.57 27.49 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-N 119.209 0.913 . . . . 0.0 110.156 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 167.94 -102.93 0.19 Allowed Glycine 0 N--CA 1.499 2.878 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.7 m -145.98 102.87 3.69 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 122.123 -0.634 . . . . 0.0 111.122 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -83.97 133.73 34.68 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -95.41 120.68 36.07 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.405 -179.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.681 ' HB3' HD11 ' A' ' 33' ' ' ILE . 7.3 m -85.21 122.57 29.6 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 177.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -125.06 88.39 2.88 Favored 'General case' 0 N--CA 1.505 2.293 0 CA-C-N 119.021 0.828 . . . . 0.0 111.061 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.39 110.52 3.46 Favored Glycine 0 N--CA 1.502 3.071 0 N-CA-C 107.911 -2.076 . . . . 0.0 107.911 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.7 ttp85 -124.92 138.9 54.23 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -177.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.694 HD11 ' CG2' ' A' ' 2' ' ' VAL . 84.2 mt -119.6 137.84 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.273 177.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 46.9 mt -92.84 -45.67 7.89 Favored 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.865 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.48 -56.95 15.47 Favored 'General case' 0 N--CA 1.515 2.813 0 O-C-N 121.538 -0.726 . . . . 0.0 109.819 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 23.1 mtp85 -102.06 61.01 0.86 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 177.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -14.81 81.56 0.0 OUTLIER Glycine 1 N--CA 1.526 4.673 0 C-N-CA 125.07 1.319 . . . . 0.0 114.9 -178.209 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -117.81 143.93 45.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 122.273 -0.545 . . . . 0.0 109.718 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.1 pt -137.08 73.24 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.345 0 CA-C-O 121.319 0.58 . . . . 0.0 111.153 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -90.13 147.61 23.5 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.422 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 30.7 p90 -157.24 -177.25 6.46 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 119.497 -0.881 . . . . 0.0 112.669 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 9.6 tptt -168.4 165.36 12.73 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.581 ' O ' HG22 ' A' ' 9' ' ' THR . 7.5 p-10 -110.31 108.74 18.92 Favored 'General case' 0 N--CA 1.509 2.494 0 CA-C-O 120.974 0.416 . . . . 0.0 110.245 178.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.588 HD12 ' N ' ' A' ' 88' ' ' ILE . 2.2 mp -92.76 113.78 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -80.68 105.08 11.65 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.421 HG13 HE21 ' A' ' 11' ' ' GLN . 39.3 t -99.97 136.5 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.156 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 63.4 mt -126.92 156.95 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.55 HG21 ' CG1' ' A' ' 63' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.498 1.948 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.594 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 48.4 p90 . . . . . 0 N--CA 1.497 1.921 0 CA-C-O 120.636 0.255 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.692 ' CG2' HD11 ' A' ' 77' ' ' ILE . 47.9 t -146.72 108.46 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.499 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 6.3 mmt -116.46 113.37 22.74 Favored 'General case' 0 N--CA 1.507 2.413 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.416 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -70.31 116.5 10.73 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 122.103 -0.373 . . . . 0.0 111.1 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt -119.9 155.98 31.65 Favored 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.423 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.1 OUTLIER 44.48 81.24 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.747 0 C-N-CA 122.718 0.407 . . . . 0.0 111.517 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -126.35 56.86 17.8 Favored Pre-proline 0 N--CA 1.497 1.907 0 O-C-N 121.64 -0.663 . . . . 0.0 112.425 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.02 90.67 0.16 Allowed 'Trans proline' 0 N--CA 1.496 1.62 0 N-CA-C 107.983 -1.583 . . . . 0.0 107.983 176.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.551 ' OG1' ' HD3' ' A' ' 10' ' ' PRO . 0.5 OUTLIER -52.93 -54.87 39.19 Favored Pre-proline 0 N--CA 1.503 2.194 0 CA-C-O 117.119 -1.419 . . . . 0.0 113.575 -176.268 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.551 ' HD3' ' OG1' ' A' ' 9' ' ' THR . 1.6 Cg_endo -80.27 92.84 1.07 Allowed 'Trans proline' 0 CA--C 1.549 1.242 0 CA-C-N 120.892 1.354 . . . . 0.0 111.584 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.544 HE21 HG13 ' A' ' 90' ' ' VAL . 16.7 pt20 -100.99 171.04 7.88 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.088 -1.007 . . . . 0.0 110.197 178.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -156.76 118.1 3.77 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.635 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -114.47 -170.0 1.64 Allowed 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.901 -0.499 . . . . 0.0 110.024 179.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -101.79 139.71 37.07 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.517 0.675 . . . . 0.0 111.452 -178.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -59.87 119.03 6.93 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 121.015 0.436 . . . . 0.0 110.842 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.69 23.49 46.26 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -114.57 164.31 14.18 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 118.621 1.211 . . . . 0.0 110.907 -179.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -79.72 98.88 7.17 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 177.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.78 170.64 8.41 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 120.218 -0.593 . . . . 0.0 111.731 -177.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.692 HG22 ' HG2' ' A' ' 59' ' ' GLN . 87.5 t -143.47 141.11 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 178.341 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.923 HD11 HD11 ' A' ' 60' ' ' ILE . 18.9 mt -96.11 115.25 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 178.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.414 HG13 ' CE2' ' A' ' 57' ' ' TYR . 46.0 t -74.94 122.0 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 CA-C-O 121.371 0.605 . . . . 0.0 111.205 -176.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -164.94 88.6 0.47 Allowed 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.423 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -87.79 145.01 26.3 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 119.785 -0.766 . . . . 0.0 108.995 -179.612 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.649 HG21 HD12 ' A' ' 33' ' ' ILE . 39.9 t -151.64 137.17 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.119 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.499 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 62.2 t -99.49 78.45 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 108.174 -1.046 . . . . 0.0 108.174 178.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.2 m -80.1 163.13 24.38 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 178.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.8 t -42.11 -79.83 0.01 OUTLIER 'General case' 0 N--CA 1.524 3.237 0 O-C-N 121.87 -0.519 . . . . 0.0 111.595 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.418 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 0.2 OUTLIER -171.13 -63.29 0.0 OUTLIER Pre-proline 0 N--CA 1.514 2.768 0 CA-C-O 117.715 -1.136 . . . . 0.0 111.593 177.675 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.418 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 2.8 Cg_endo -60.26 -53.21 3.17 Favored 'Trans proline' 0 CA--C 1.562 1.914 0 CA-C-N 120.045 1.052 . . . . 0.0 112.812 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.502 ' HG3' HG23 ' A' ' 77' ' ' ILE . 3.0 Cg_endo -62.04 -163.99 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 120.456 0.771 . . . . 0.0 112.716 -178.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -170.53 -168.12 0.67 Allowed 'General case' 0 N--CA 1.518 2.931 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.134 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.649 HD12 HG21 ' A' ' 25' ' ' VAL . 15.4 tt -100.24 155.28 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.294 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.529 ' N ' HD12 ' A' ' 34' ' ' ILE . 4.7 mp -117.65 132.35 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.577 ' CG ' HD22 ' A' ' 58' ' ' LEU . 79.4 m95 -94.54 104.67 16.62 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.2 tttt -105.1 -171.99 2.02 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.192 0.52 . . . . 0.0 110.609 -178.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 65.64 167.19 0.19 Allowed 'General case' 0 N--CA 1.511 2.593 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.032 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.53 26.63 11.2 Favored 'General case' 0 N--CA 1.515 2.82 0 O-C-N 121.68 -0.637 . . . . 0.0 111.154 -178.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.34 40.58 0.43 Allowed Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 51.84 -161.55 0.09 Allowed 'General case' 0 N--CA 1.516 2.875 0 O-C-N 121.576 -0.955 . . . . 0.0 110.871 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -60.33 111.94 1.75 Allowed 'General case' 0 N--CA 1.513 2.711 0 O-C-N 121.644 -0.66 . . . . 0.0 110.109 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.563 HG22 ' HB2' ' A' ' 35' ' ' TRP . 8.5 m -67.64 -27.69 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.461 0 O-C-N 122.057 -0.402 . . . . 0.0 110.605 -178.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 57.7 mt -59.21 -17.51 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.796 0 O-C-N 121.551 -0.718 . . . . 0.0 111.546 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.499 ' N ' HD12 ' A' ' 44' ' ' LEU . 8.8 mp -92.13 -21.82 20.21 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.491 -0.756 . . . . 0.0 111.122 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 39.9 pttt -97.25 -38.55 9.64 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.54 -0.725 . . . . 0.0 109.584 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.8 mmmt 46.31 55.05 7.77 Favored 'General case' 0 N--CA 1.51 2.54 0 CA-C-O 121.533 0.682 . . . . 0.0 112.116 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.05 169.86 0.09 Allowed 'General case' 0 N--CA 1.514 2.761 0 O-C-N 121.734 -0.604 . . . . 0.0 110.819 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.4 m -60.79 -19.57 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.621 0 O-C-N 121.965 -0.459 . . . . 0.0 111.664 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 8.9 ptp85 -119.32 46.82 1.81 Allowed 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.662 -0.649 . . . . 0.0 112.174 -178.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -145.62 99.21 3.25 Favored 'General case' 0 N--CA 1.508 2.431 0 O-C-N 121.556 -0.715 . . . . 0.0 110.081 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.485 ' N ' HD12 ' A' ' 51' ' ' ILE . 5.3 mp -125.8 114.44 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.251 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.509 HG22 ' CD1' ' A' ' 58' ' ' LEU . 2.5 t -79.99 131.69 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.9 mt -82.1 163.97 21.66 Favored 'General case' 0 N--CA 1.507 2.409 0 CA-C-O 121.328 0.585 . . . . 0.0 111.774 -178.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 92.4 p -60.4 -20.2 58.81 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 122.171 -0.331 . . . . 0.0 111.221 179.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 48.7 p-10 -91.33 19.23 6.18 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.609 -0.682 . . . . 0.0 111.389 179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.9 m120 67.23 32.17 6.19 Favored 'General case' 0 N--CA 1.516 2.835 0 O-C-N 121.613 -0.68 . . . . 0.0 112.401 178.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.414 ' CE2' HG13 ' A' ' 22' ' ' VAL . 4.0 m-85 -103.39 166.61 10.32 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.914 HD23 HD12 ' A' ' 21' ' ' ILE . 19.7 tp -121.72 97.99 5.75 Favored 'General case' 0 N--CA 1.515 2.791 0 C-N-CA 119.407 -0.917 . . . . 0.0 111.748 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.692 ' HG2' HG22 ' A' ' 20' ' ' VAL . 1.3 mt-30 -74.91 105.44 5.94 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.861 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.923 HD11 HD11 ' A' ' 21' ' ' ILE . 97.0 mt -96.44 112.1 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 178.136 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -73.1 112.66 9.35 Favored 'General case' 0 N--CA 1.506 2.336 0 CA-C-O 121.384 0.611 . . . . 0.0 111.423 -177.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.65 -36.08 4.15 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 178.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.506 HG23 HG21 ' A' ' 92' ' ' VAL . 1.7 tp 41.97 69.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.808 0 CA-C-O 122.185 0.993 . . . . 0.0 112.379 -178.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 55.3 mttt -57.55 158.9 5.42 Favored 'General case' 0 N--CA 1.51 2.56 0 O-C-N 121.615 -0.678 . . . . 0.0 112.209 -178.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 45.4 tttt -62.33 -23.63 66.88 Favored 'General case' 0 N--CA 1.508 2.452 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.895 178.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.7 t -83.15 -15.85 49.03 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.794 -0.566 . . . . 0.0 111.184 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -93.95 9.57 36.92 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.714 -0.616 . . . . 0.0 111.653 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -98.45 142.63 29.83 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.33 -0.856 . . . . 0.0 109.626 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 168.0 -103.81 0.2 Allowed Glycine 0 N--CA 1.498 2.815 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.4 m -145.93 102.78 3.69 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.974 -0.721 . . . . 0.0 111.21 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.4 ' CG ' HD13 ' A' ' 21' ' ' ILE . 24.9 m-85 -83.91 135.28 34.55 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.212 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.8 ttt85 -97.51 117.64 32.22 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.103 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.2 m -80.47 133.11 35.81 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 177.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -134.59 91.33 2.77 Favored 'General case' 0 N--CA 1.505 2.297 0 CA-C-N 118.686 0.676 . . . . 0.0 110.396 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.47 118.83 8.78 Favored Glycine 0 N--CA 1.503 3.141 0 N-CA-C 107.746 -2.142 . . . . 0.0 107.746 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.1 ttm180 -132.14 138.79 48.19 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -177.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.692 HD11 ' CG2' ' A' ' 2' ' ' VAL . 87.4 mt -118.78 138.12 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-N 114.968 -1.015 . . . . 0.0 108.33 177.22 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.3 mt -92.88 -39.4 11.2 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.889 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.1 -56.23 14.22 Favored 'General case' 0 N--CA 1.512 2.673 0 O-C-N 121.7 -0.625 . . . . 0.0 109.383 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 57.9 mtt180 -103.7 63.39 0.78 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 177.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -14.07 80.95 0.0 OUTLIER Glycine 1 N--CA 1.526 4.659 0 C-N-CA 125.14 1.353 . . . . 0.0 114.714 -178.2 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -112.6 146.62 38.26 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.9 pt -140.75 63.2 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.151 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -79.17 157.89 27.79 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 178.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -162.42 -175.21 4.4 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 119.684 -0.806 . . . . 0.0 112.715 -179.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.4 tptt -171.1 167.5 7.12 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.519 ' O ' HG22 ' A' ' 9' ' ' THR . 2.7 p-10 -115.37 108.09 16.07 Favored 'General case' 0 N--CA 1.513 2.723 0 O-C-N 121.844 -0.535 . . . . 0.0 110.222 178.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.606 HD12 ' N ' ' A' ' 88' ' ' ILE . 2.4 mp -96.16 115.71 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -84.63 111.02 19.17 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.544 HG13 HE21 ' A' ' 11' ' ' GLN . 42.5 t -105.48 138.05 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.917 -0.489 . . . . 0.0 110.291 -179.031 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 82.3 mt -128.23 157.31 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.506 HG21 HG23 ' A' ' 63' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.916 0 CA-C-O 118.062 -0.971 . . . . 0.0 110.458 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 38.4 p90 . . . . . 0 N--CA 1.5 2.06 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.705 ' CG2' HD11 ' A' ' 77' ' ' ILE . 47.2 t -148.8 105.35 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.332 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.542 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 6.5 mmt -110.27 110.9 21.89 Favored 'General case' 0 N--CA 1.506 2.348 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.18 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -71.24 113.71 8.56 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 122.086 -0.384 . . . . 0.0 110.239 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.6 ptpt -129.03 163.7 24.83 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 122.013 0.911 . . . . 0.0 112.301 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 29.69 95.49 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.014 0 C-N-CA 124.654 1.182 . . . . 0.0 114.185 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.403 ' HB2' ' HA ' ' A' ' 23' ' ' CYS . . . -164.47 84.67 1.19 Allowed Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.8 -0.562 . . . . 0.0 111.263 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -66.17 104.38 0.72 Allowed 'Trans proline' 0 N--CA 1.49 1.309 0 N-CA-C 108.288 -1.466 . . . . 0.0 108.288 177.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.548 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.2 OUTLIER -50.61 -66.01 0.76 Allowed Pre-proline 0 N--CA 1.51 2.56 0 CA-C-O 116.932 -1.509 . . . . 0.0 112.54 -176.973 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.485 ' HD3' ' OG1' ' A' ' 9' ' ' THR . 1.6 Cg_endo -73.99 94.5 0.88 Allowed 'Trans proline' 0 N--CA 1.494 1.542 0 CA-C-N 121.203 1.465 . . . . 0.0 110.937 178.266 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.441 HE21 HG13 ' A' ' 90' ' ' VAL . 17.1 pt20 -99.66 173.47 6.7 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.047 -1.033 . . . . 0.0 110.091 178.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -155.23 121.25 5.15 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 120.373 -0.531 . . . . 0.0 112.01 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -120.2 -170.5 1.98 Allowed 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 178.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 30.7 ttpt -104.92 139.32 39.81 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.339 0.59 . . . . 0.0 111.489 -179.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -62.1 111.6 2.01 Favored 'General case' 0 N--CA 1.508 2.447 0 CA-C-O 121.062 0.458 . . . . 0.0 110.359 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.51 22.31 16.93 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -117.16 164.83 14.18 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 118.474 1.137 . . . . 0.0 110.668 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -82.62 100.1 9.96 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 178.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -102.42 167.42 9.96 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.955 -177.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.666 HG22 ' HG2' ' A' ' 59' ' ' GLN . 95.7 t -138.99 141.2 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 178.049 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.894 HD12 HD23 ' A' ' 58' ' ' LEU . 22.5 mt -95.76 112.39 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 178.208 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.477 HG13 ' CE2' ' A' ' 57' ' ' TYR . 57.8 t -74.12 122.35 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 CA-C-O 121.551 0.691 . . . . 0.0 110.682 -176.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.403 ' HA ' ' HB2' ' A' ' 7' ' ' ALA . 1.2 t -163.7 92.55 0.7 Allowed 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.02 137.87 32.01 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.373 -179.094 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.432 HG21 HD13 ' A' ' 33' ' ' ILE . 41.1 t -147.18 125.71 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.542 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 40.8 t -91.06 79.43 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.3 m -78.06 167.14 21.9 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 178.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 t -45.49 -80.23 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.165 0 O-C-N 121.761 -0.587 . . . . 0.0 111.09 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.428 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 0.6 OUTLIER -166.98 -64.56 0.01 OUTLIER Pre-proline 0 N--CA 1.512 2.635 0 CA-C-O 117.566 -1.207 . . . . 0.0 111.697 177.529 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.428 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 2.8 Cg_endo -60.36 -53.49 2.89 Favored 'Trans proline' 0 CA--C 1.562 1.916 0 CA-C-N 120.233 1.119 . . . . 0.0 112.847 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.483 ' HG3' HG23 ' A' ' 77' ' ' ILE . 3.2 Cg_exo -61.15 -165.72 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 120.498 0.798 . . . . 0.0 113.223 -178.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -172.83 -161.36 0.15 Allowed 'General case' 0 N--CA 1.52 3.051 0 O-C-N 121.927 -0.483 . . . . 0.0 109.906 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.574 HD12 ' N ' ' A' ' 75' ' ' GLY . 0.6 OUTLIER -106.04 148.63 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.896 -0.503 . . . . 0.0 110.415 179.502 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.538 ' N ' HD12 ' A' ' 34' ' ' ILE . 5.3 mp -109.53 125.19 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.546 ' CG ' HD22 ' A' ' 58' ' ' LEU . 77.1 m95 -85.21 120.53 26.8 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.6 mmmt -131.25 -166.99 1.78 Allowed 'General case' 0 N--CA 1.503 2.184 0 CA-C-O 121.439 0.637 . . . . 0.0 111.71 -177.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 67.24 52.0 0.87 Allowed 'General case' 0 N--CA 1.511 2.603 0 CA-C-O 121.608 0.718 . . . . 0.0 111.525 179.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -162.64 29.75 0.1 Allowed 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.841 -0.537 . . . . 0.0 109.912 178.328 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 116.13 -53.71 0.61 Allowed Glycine 0 N--CA 1.486 2.02 0 N-CA-C 108.176 -1.97 . . . . 0.0 108.176 -178.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.97 -164.91 0.66 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 122.223 -0.575 . . . . 0.0 109.487 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -74.61 119.3 18.61 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.518 HG22 ' HB2' ' A' ' 35' ' ' TRP . 4.3 m -66.15 -34.12 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.511 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.99 -178.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.821 ' CD1' HG21 ' A' ' 52' ' ' VAL . 47.9 mm -59.57 -18.25 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.702 0 O-C-N 121.92 -0.487 . . . . 0.0 111.76 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.435 ' N ' HD12 ' A' ' 44' ' ' LEU . 10.7 mp -92.32 -21.4 20.3 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.509 -0.744 . . . . 0.0 111.195 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 35.1 pttt -98.55 -37.87 9.38 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.625 -0.672 . . . . 0.0 109.408 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.4 mmmt 47.61 54.25 10.03 Favored 'General case' 0 N--CA 1.51 2.551 0 CA-C-O 121.498 0.666 . . . . 0.0 111.859 179.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.99 161.43 2.32 Favored 'General case' 0 N--CA 1.512 2.661 0 O-C-N 121.754 -0.591 . . . . 0.0 110.404 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.4 m -58.42 -20.3 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.77 0 O-C-N 121.924 -0.485 . . . . 0.0 111.613 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -108.0 37.86 2.35 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.78 -0.575 . . . . 0.0 111.806 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -144.86 106.75 4.29 Favored 'General case' 0 N--CA 1.506 2.375 0 O-C-N 121.767 -0.583 . . . . 0.0 109.598 178.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 72.9 mt -126.21 102.14 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.821 HG21 ' CD1' ' A' ' 43' ' ' ILE . 4.2 t -74.33 132.08 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.4 mt -88.15 162.45 16.71 Favored 'General case' 0 N--CA 1.504 2.272 0 CA-C-O 121.272 0.558 . . . . 0.0 111.571 -178.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.6 p -60.24 -19.64 55.44 Favored 'General case' 0 N--CA 1.511 2.598 0 O-C-N 122.141 -0.35 . . . . 0.0 111.427 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 43.2 p-10 -91.74 19.5 6.4 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.565 -0.71 . . . . 0.0 111.374 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.43 ' HB3' HG21 ' A' ' 33' ' ' ILE . 4.7 m120 67.93 32.05 5.34 Favored 'General case' 0 N--CA 1.518 2.93 0 O-C-N 121.783 -0.573 . . . . 0.0 112.356 178.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.477 ' CE2' HG13 ' A' ' 22' ' ' VAL . 4.3 m-85 -103.59 163.37 12.35 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.894 HD23 HD12 ' A' ' 21' ' ' ILE . 16.8 tp -122.14 97.51 5.51 Favored 'General case' 0 N--CA 1.513 2.722 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.715 -179.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.666 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -75.53 98.48 3.97 Favored 'General case' 0 N--CA 1.501 2.082 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.825 179.512 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.801 HD11 HD11 ' A' ' 21' ' ' ILE . 98.0 mt -90.73 115.94 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.369 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.17 115.08 15.55 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 121.265 0.555 . . . . 0.0 110.991 -178.529 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.31 -37.5 3.46 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.447 ' CG1' HG21 ' A' ' 92' ' ' VAL . 2.5 tp 41.7 70.57 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.517 2.897 0 CA-C-O 122.237 1.018 . . . . 0.0 112.246 -178.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.533 ' HB3' HG22 ' A' ' 66' ' ' THR . 39.7 mtpt -67.04 149.89 49.97 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.589 -0.694 . . . . 0.0 111.472 -178.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.618 ' HA ' HG12 ' A' ' 92' ' ' VAL . 22.6 pttt -60.96 -24.29 65.97 Favored 'General case' 0 N--CA 1.511 2.582 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.493 178.214 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.533 HG22 ' HB3' ' A' ' 64' ' ' LYS . 9.4 t -71.17 -18.15 62.5 Favored 'General case' 0 N--CA 1.502 2.144 0 C-N-CA 120.261 -0.575 . . . . 0.0 110.134 177.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -102.67 -1.03 30.87 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.644 -0.66 . . . . 0.0 111.842 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -79.23 153.5 29.91 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.163 -0.961 . . . . 0.0 109.606 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 161.74 -102.66 0.21 Allowed Glycine 0 N--CA 1.497 2.733 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.5 m -152.97 104.18 2.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 122.084 -0.656 . . . . 0.0 110.305 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -82.82 135.37 34.97 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -96.77 119.8 35.93 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.762 -0.586 . . . . 0.0 110.99 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.481 ' HB3' HD11 ' A' ' 33' ' ' ILE . 7.4 m -83.85 116.66 22.85 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 177.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.449 ' O ' HD12 ' A' ' 34' ' ' ILE . 26.2 mt-10 -115.94 88.16 2.83 Favored 'General case' 0 N--CA 1.503 2.185 0 CA-C-N 118.637 0.653 . . . . 0.0 110.928 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.574 ' N ' HD12 ' A' ' 33' ' ' ILE . . . -68.76 113.64 5.38 Favored Glycine 0 N--CA 1.504 3.184 0 N-CA-C 107.883 -2.087 . . . . 0.0 107.883 178.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.3 ttm-85 -130.51 143.71 50.93 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -177.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.705 HD11 ' CG2' ' A' ' 2' ' ' VAL . 85.1 mt -120.58 137.88 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.37 177.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 56.8 mt -93.17 -38.2 11.7 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.762 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.53 -58.26 6.89 Favored 'General case' 0 N--CA 1.512 2.663 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 26.3 mtt85 -100.07 60.39 1.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 177.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -14.2 81.24 0.0 OUTLIER Glycine 1 N--CA 1.526 4.682 0 C-N-CA 125.046 1.308 . . . . 0.0 114.805 -178.134 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -117.89 144.18 45.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 122.218 -0.577 . . . . 0.0 110.075 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.1 pt -134.8 75.41 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 CA-C-O 121.191 0.519 . . . . 0.0 110.839 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -92.8 148.96 21.6 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.415 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 30.7 p90 -163.97 177.9 8.15 Favored 'General case' 0 N--CA 1.503 2.197 0 C-N-CA 119.765 -0.774 . . . . 0.0 112.833 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.4 pttt -166.85 165.59 16.08 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.548 ' O ' HG22 ' A' ' 9' ' ' THR . 8.8 p-10 -101.42 119.09 38.23 Favored 'General case' 0 N--CA 1.511 2.606 0 O-C-N 121.857 -0.527 . . . . 0.0 111.956 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.565 HD12 ' N ' ' A' ' 88' ' ' ILE . 2.6 mp -102.28 117.01 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 178.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -83.47 123.11 29.38 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -179.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.441 HG13 HE21 ' A' ' 11' ' ' GLN . 37.5 t -118.15 131.23 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 121.775 -0.578 . . . . 0.0 109.721 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 69.3 mt -127.34 152.94 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.618 HG12 ' HA ' ' A' ' 65' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.502 2.15 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.042 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 42.4 p90 . . . . . 0 N--CA 1.499 1.992 0 CA-C-O 120.634 0.255 . . . . 0.0 110.357 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.709 ' CG2' HD13 ' A' ' 77' ' ' ILE . 36.0 t -143.0 107.13 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.32 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.108 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.565 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 73.1 mtp -119.09 112.59 19.73 Favored 'General case' 0 N--CA 1.511 2.579 0 O-C-N 121.752 -0.592 . . . . 0.0 111.19 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -72.48 107.11 4.86 Favored 'General case' 0 N--CA 1.508 2.432 0 CA-C-O 121.01 0.433 . . . . 0.0 110.454 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -118.75 170.98 8.53 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-O 121.221 0.534 . . . . 0.0 110.669 -179.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.412 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.9 OUTLIER 25.43 63.23 0.06 Allowed 'General case' 0 N--CA 1.526 3.342 0 C-N-CA 124.291 1.037 . . . . 0.0 113.753 178.424 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -128.33 66.79 74.2 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 121.627 -0.671 . . . . 0.0 111.646 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.73 108.25 1.03 Allowed 'Trans proline' 0 N--CA 1.493 1.48 0 N-CA-C 108.218 -1.493 . . . . 0.0 108.218 177.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.516 HG22 HD13 ' A' ' 88' ' ' ILE . 11.4 p -62.24 -43.9 86.97 Favored Pre-proline 0 N--CA 1.503 2.208 0 CA-C-O 117.287 -1.339 . . . . 0.0 113.178 -176.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.487 ' HD3' ' OG1' ' A' ' 9' ' ' THR . 1.6 Cg_endo -84.11 84.79 1.49 Allowed 'Trans proline' 0 CA--C 1.551 1.329 0 CA-C-N 120.677 1.277 . . . . 0.0 111.513 -177.326 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.449 HE21 HG13 ' A' ' 90' ' ' VAL . 15.8 pt20 -100.49 172.74 6.93 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 121.085 -1.009 . . . . 0.0 110.748 179.193 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -158.03 120.52 3.77 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.897 -0.502 . . . . 0.0 111.342 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -116.41 -169.73 1.67 Allowed 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.965 -0.459 . . . . 0.0 110.196 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 49.5 tttm -101.85 135.77 42.83 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.378 0.609 . . . . 0.0 111.256 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -60.74 116.86 4.73 Favored 'General case' 0 N--CA 1.509 2.498 0 CA-C-O 121.082 0.468 . . . . 0.0 110.582 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.88 22.81 29.58 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.419 ' O ' HG22 ' A' ' 63' ' ' ILE . 16.9 tt0 -117.26 164.58 14.6 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 118.471 1.135 . . . . 0.0 110.93 -179.338 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -81.08 98.41 7.99 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 177.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.11 167.22 10.6 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 120.291 -0.564 . . . . 0.0 111.911 -177.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.662 HG22 ' HG2' ' A' ' 59' ' ' GLN . 98.5 t -140.55 139.98 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 178.054 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.703 HD12 HD23 ' A' ' 58' ' ' LEU . 38.4 mt -95.2 116.73 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 178.109 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.498 HG13 ' CE2' ' A' ' 57' ' ' TYR . 44.6 t -78.87 117.02 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-O 121.321 0.581 . . . . 0.0 110.781 -176.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -154.47 95.01 1.76 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.412 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 1.7 m-20 -90.05 137.79 32.05 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.48 HG21 HD12 ' A' ' 33' ' ' ILE . 13.9 t -147.81 122.26 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.565 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 14.8 t -85.15 81.53 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.9 m -87.38 155.2 20.14 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.6 t -44.94 -84.03 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.15 0 O-C-N 121.884 -0.51 . . . . 0.0 111.909 -178.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.404 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 0.8 OUTLIER -166.94 -62.23 0.01 OUTLIER Pre-proline 0 N--CA 1.511 2.576 0 CA-C-O 117.76 -1.114 . . . . 0.0 112.094 178.568 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.404 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 2.7 Cg_endo -59.37 -53.87 3.09 Favored 'Trans proline' 0 CA--C 1.559 1.741 0 CA-C-N 120.082 1.065 . . . . 0.0 112.336 -178.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.653 ' HG2' HG23 ' A' ' 77' ' ' ILE . 2.4 Cg_endo -64.46 -168.97 0.11 Allowed 'Trans proline' 0 N--CA 1.496 1.663 0 CA-C-N 119.399 0.821 . . . . 0.0 110.984 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.414 ' HG1' ' C ' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -172.04 -165.29 0.34 Allowed 'General case' 0 N--CA 1.521 3.086 0 O-C-N 121.723 -0.611 . . . . 0.0 109.844 179.838 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.48 HD12 HG21 ' A' ' 25' ' ' VAL . 20.3 tt -99.39 150.73 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 122.053 -0.405 . . . . 0.0 109.925 179.043 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.6 mt -115.56 115.42 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.553 ' HB2' HG22 ' A' ' 42' ' ' VAL . 72.7 m95 -81.18 104.96 12.02 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -109.21 -175.31 2.73 Favored 'General case' 0 N--CA 1.502 2.142 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.885 -178.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 2.4 t60 62.7 153.24 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.669 0 O-C-N 121.876 -0.515 . . . . 0.0 110.146 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.6 tppm? 52.35 29.86 7.36 Favored 'General case' 0 N--CA 1.519 2.979 0 O-C-N 121.566 -0.709 . . . . 0.0 110.869 -179.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 160.84 -28.31 0.31 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 56.9 101.15 0.02 OUTLIER 'General case' 0 N--CA 1.517 2.888 0 O-C-N 121.528 -0.984 . . . . 0.0 110.472 -179.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 55.14 70.93 0.58 Allowed 'General case' 0 N--CA 1.511 2.623 0 O-C-N 121.646 -0.659 . . . . 0.0 109.934 -178.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.553 HG22 ' HB2' ' A' ' 35' ' ' TRP . 7.0 m -65.77 -37.24 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.386 0 CA-C-O 121.312 0.577 . . . . 0.0 109.675 -178.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.571 HG12 HG21 ' A' ' 52' ' ' VAL . 64.5 mt -60.66 -18.44 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.72 0 O-C-N 121.951 -0.468 . . . . 0.0 111.167 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.493 ' N ' HD12 ' A' ' 44' ' ' LEU . 9.6 mp -90.95 -22.56 20.79 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.52 -0.737 . . . . 0.0 110.823 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.414 ' HG2' ' HA ' ' A' ' 42' ' ' VAL . 30.6 pttt -99.18 -36.83 9.53 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.577 -0.702 . . . . 0.0 109.716 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 17.2 mmmt 48.92 54.77 10.28 Favored 'General case' 0 N--CA 1.51 2.563 0 CA-C-O 121.507 0.67 . . . . 0.0 111.562 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.61 172.14 0.05 OUTLIER 'General case' 0 N--CA 1.514 2.741 0 O-C-N 121.836 -0.54 . . . . 0.0 111.067 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.6 m -61.22 -19.19 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.605 0 O-C-N 121.982 -0.449 . . . . 0.0 111.954 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.402 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 26.6 ptt-85 -121.78 47.46 1.88 Allowed 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.757 -0.59 . . . . 0.0 112.356 -178.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -145.04 108.52 4.63 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 121.521 -0.737 . . . . 0.0 110.094 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 71.3 mt -129.12 102.01 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.645 HG22 ' CD1' ' A' ' 58' ' ' LEU . 4.8 t -73.84 128.1 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.42 HD11 ' OE1' ' A' ' 59' ' ' GLN . 18.8 mt -82.56 165.43 20.11 Favored 'General case' 0 N--CA 1.508 2.445 0 CA-C-O 121.299 0.571 . . . . 0.0 111.828 -178.463 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 93.7 p -59.94 -20.84 59.71 Favored 'General case' 0 N--CA 1.51 2.534 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.39 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 36.2 p-10 -92.38 21.2 5.45 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.699 -0.626 . . . . 0.0 111.343 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.412 ' HB3' HG21 ' A' ' 33' ' ' ILE . 5.5 m120 65.18 33.53 9.27 Favored 'General case' 0 N--CA 1.514 2.727 0 O-C-N 121.756 -0.59 . . . . 0.0 112.496 178.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.498 ' CE2' HG13 ' A' ' 22' ' ' VAL . 3.9 m-85 -102.15 164.77 11.52 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 177.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.703 HD23 HD12 ' A' ' 21' ' ' ILE . 15.5 tp -120.61 97.07 5.39 Favored 'General case' 0 N--CA 1.517 2.887 0 C-N-CA 119.327 -0.949 . . . . 0.0 111.651 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.662 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -75.83 95.97 3.59 Favored 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.799 179.499 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.551 HD11 HD11 ' A' ' 21' ' ' ILE . 93.1 mt -86.95 117.0 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -78.3 111.72 14.56 Favored 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 121.393 0.616 . . . . 0.0 111.663 -178.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 100.13 -35.65 4.64 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.499 HG23 HG21 ' A' ' 92' ' ' VAL . 1.6 tp 40.96 69.65 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.842 0 CA-C-O 122.201 1.0 . . . . 0.0 112.657 -179.173 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -57.75 157.75 7.03 Favored 'General case' 0 N--CA 1.513 2.684 0 O-C-N 121.638 -0.663 . . . . 0.0 112.417 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 35.7 tttm -61.47 -22.53 65.15 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 122.218 -0.301 . . . . 0.0 110.876 178.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.7 p -83.36 -19.96 35.16 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.772 -0.58 . . . . 0.0 110.74 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.76 7.7 35.53 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.61 -0.681 . . . . 0.0 111.678 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.438 ' HB3' HG12 ' A' ' 92' ' ' VAL . 8.4 pt-20 -96.79 141.12 30.38 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.35 -0.844 . . . . 0.0 109.365 179.237 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 169.98 -105.72 0.23 Allowed Glycine 0 N--CA 1.498 2.831 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.2 m -144.12 103.65 4.03 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 122.031 -0.688 . . . . 0.0 111.206 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -84.57 134.43 34.4 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.7 tpp85 -91.64 119.54 31.62 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.743 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 85' ' ' PHE . 1.8 m -87.83 90.26 8.31 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -91.57 88.64 6.84 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.276 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.55 91.31 0.56 Allowed Glycine 0 N--CA 1.499 2.873 0 N-CA-C 107.531 -2.227 . . . . 0.0 107.531 178.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.594 ' CG ' HG22 ' A' ' 83' ' ' ILE . 4.1 ttm180 -98.05 125.24 42.94 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.923 0.868 . . . . 0.0 113.043 -177.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.709 HD13 ' CG2' ' A' ' 2' ' ' VAL . 5.1 mp -142.03 90.16 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-N 114.506 -1.224 . . . . 0.0 107.899 178.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.414 ' HG ' HG23 ' A' ' 83' ' ' ILE . 8.8 mt -97.38 20.42 11.64 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.671 178.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -110.71 -22.53 11.54 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.777 -0.577 . . . . 0.0 110.601 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -127.05 -62.39 1.11 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.781 -0.574 . . . . 0.0 110.649 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.24 -81.35 1.59 Allowed Glycine 0 N--CA 1.49 2.29 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.864 -178.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 179.72 -161.99 0.04 OUTLIER 'General case' 0 N--CA 1.516 2.832 0 O-C-N 122.09 -0.653 . . . . 0.0 110.408 -177.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.594 HG22 ' CG ' ' A' ' 76' ' ' ARG . 1.5 pp -99.98 116.59 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.321 0 O-C-N 121.776 -0.577 . . . . 0.0 110.333 178.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -117.53 159.68 22.46 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.65 -0.656 . . . . 0.0 109.663 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.484 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 25.5 p90 -157.06 175.78 13.63 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.658 -0.817 . . . . 0.0 112.583 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 20.0 tttt -165.25 169.61 15.73 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -116.75 134.4 54.85 Favored 'General case' 0 N--CA 1.51 2.557 0 O-C-N 121.829 -0.544 . . . . 0.0 110.654 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.516 HD13 HG22 ' A' ' 9' ' ' THR . 47.9 mm -117.47 109.24 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -77.09 100.41 5.7 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.449 HG13 HE21 ' A' ' 11' ' ' GLN . 46.6 t -96.27 136.99 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.915 -179.166 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 65.9 mt -125.51 159.1 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.499 HG21 HG23 ' A' ' 63' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.5 2.056 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.539 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 28.6 p90 . . . . . 0 N--CA 1.499 2.021 0 N-CA-C 110.372 -0.233 . . . . 0.0 110.372 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.719 ' CG2' HD13 ' A' ' 77' ' ' ILE . 26.2 t -141.51 106.55 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.427 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.001 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.535 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 7.9 mmm -121.17 117.31 26.79 Favored 'General case' 0 N--CA 1.511 2.575 0 O-C-N 121.879 -0.513 . . . . 0.0 110.551 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -74.33 114.41 12.67 Favored 'General case' 0 N--CA 1.507 2.415 0 CA-C-O 120.98 0.419 . . . . 0.0 111.099 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.21 162.32 26.45 Favored 'General case' 0 N--CA 1.503 2.22 0 CA-C-O 121.758 0.79 . . . . 0.0 111.594 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.416 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.3 OUTLIER 32.02 80.56 0.02 OUTLIER 'General case' 0 N--CA 1.52 3.057 0 C-N-CA 124.177 0.991 . . . . 0.0 113.274 179.266 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -138.41 79.97 28.8 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.954 -0.466 . . . . 0.0 110.727 -179.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -65.44 96.89 0.3 Allowed 'Trans proline' 0 N--CA 1.491 1.336 0 N-CA-C 108.503 -1.383 . . . . 0.0 108.503 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.582 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.6 OUTLIER -51.25 -72.29 0.17 Allowed Pre-proline 0 N--CA 1.506 2.331 0 CA-C-O 116.437 -1.744 . . . . 0.0 112.485 -177.172 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.492 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.5 Cg_endo -71.48 97.1 0.76 Allowed 'Trans proline' 0 N--CA 1.498 1.755 0 CA-C-N 121.921 1.722 . . . . 0.0 111.719 178.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -101.59 178.11 4.73 Favored 'General case' 0 N--CA 1.507 2.41 0 O-C-N 120.974 -1.079 . . . . 0.0 110.055 178.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -156.23 127.5 7.07 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.833 -0.542 . . . . 0.0 111.568 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -127.84 -169.2 2.01 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.847 -0.533 . . . . 0.0 109.802 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -115.49 145.42 42.62 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.838 0.827 . . . . 0.0 111.841 -178.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -61.82 121.24 12.39 Favored 'General case' 0 N--CA 1.508 2.442 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.45 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.74 22.83 48.66 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.513 ' O ' HG22 ' A' ' 63' ' ' ILE . 18.4 tt0 -112.98 159.84 18.71 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 118.478 1.139 . . . . 0.0 111.186 -179.221 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.36 97.65 8.44 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 177.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -103.4 164.2 11.79 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.528 0.68 . . . . 0.0 112.498 -177.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.695 HG22 ' HG2' ' A' ' 59' ' ' GLN . 95.3 t -139.31 141.82 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 178.084 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.903 HD12 HD23 ' A' ' 58' ' ' LEU . 55.3 mt -97.42 115.29 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 178.166 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.483 HG13 ' CE2' ' A' ' 57' ' ' TYR . 46.8 t -76.32 120.86 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 121.505 0.669 . . . . 0.0 111.055 -176.547 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.7 t -161.68 94.85 0.97 Allowed 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.416 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -92.88 141.44 28.42 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 120.121 -0.632 . . . . 0.0 109.684 -178.767 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.643 HG21 HD12 ' A' ' 33' ' ' ILE . 32.9 t -149.52 123.46 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.535 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 21.6 t -81.7 80.42 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.6 m -87.61 154.09 20.88 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.2 t -44.09 -83.11 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.216 0 O-C-N 121.956 -0.465 . . . . 0.0 111.953 -178.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.417 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 0.3 OUTLIER -168.96 -61.29 0.01 OUTLIER Pre-proline 0 N--CA 1.51 2.566 0 CA-C-O 117.731 -1.128 . . . . 0.0 111.785 178.532 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.417 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 2.7 Cg_endo -60.74 -54.13 2.21 Favored 'Trans proline' 0 CA--C 1.561 1.86 0 CA-C-N 120.028 1.046 . . . . 0.0 112.519 -179.133 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.696 ' HG2' HG23 ' A' ' 77' ' ' ILE . 2.7 Cg_endo -63.66 -166.83 0.07 OUTLIER 'Trans proline' 0 N--CA 1.498 1.765 0 CA-C-N 119.539 0.871 . . . . 0.0 111.678 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -170.97 -166.62 0.49 Allowed 'General case' 0 N--CA 1.523 3.188 0 O-C-N 121.813 -0.554 . . . . 0.0 110.36 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.643 HD12 HG21 ' A' ' 25' ' ' VAL . 18.7 tt -104.1 136.73 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.546 ' N ' HD12 ' A' ' 34' ' ' ILE . 4.9 mp -101.17 124.37 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.568 ' HB2' HG22 ' A' ' 42' ' ' VAL . 75.1 m95 -84.64 109.69 18.18 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.2 tttt -108.81 -174.84 2.61 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 121.48 0.657 . . . . 0.0 111.625 -178.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 27.8 t-80 66.36 153.04 0.07 Allowed 'General case' 0 N--CA 1.511 2.584 0 CA-C-O 121.023 0.44 . . . . 0.0 110.111 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 19.9 tptt 57.97 50.7 9.87 Favored 'General case' 0 N--CA 1.513 2.723 0 O-C-N 121.838 -0.539 . . . . 0.0 110.727 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 131.5 -0.85 5.17 Favored Glycine 0 N--CA 1.498 2.774 0 C-N-CA 120.545 -0.836 . . . . 0.0 111.582 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 54.77 89.81 0.03 OUTLIER 'General case' 0 N--CA 1.513 2.715 0 CA-C-N 119.184 1.492 . . . . 0.0 110.768 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.5 t0 55.66 97.96 0.02 OUTLIER 'General case' 0 N--CA 1.516 2.827 0 O-C-N 121.713 -0.617 . . . . 0.0 110.587 -179.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.568 HG22 ' HB2' ' A' ' 35' ' ' TRP . 6.3 m -67.95 -24.55 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.438 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.823 -179.07 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.7 mm -59.26 -17.95 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.819 0 O-C-N 121.577 -0.702 . . . . 0.0 111.572 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.489 ' N ' HD12 ' A' ' 44' ' ' LEU . 10.0 mp -91.38 -22.84 20.28 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.457 -0.777 . . . . 0.0 110.978 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -98.66 -40.44 8.19 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.764 -0.585 . . . . 0.0 109.478 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm 47.26 56.02 7.42 Favored 'General case' 0 N--CA 1.509 2.517 0 CA-C-O 121.473 0.654 . . . . 0.0 112.04 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.58 155.19 1.64 Allowed 'General case' 0 N--CA 1.515 2.796 0 O-C-N 121.649 -0.657 . . . . 0.0 111.013 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.7 m -54.32 -24.36 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.816 0 O-C-N 121.907 -0.496 . . . . 0.0 112.125 -178.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.95 -3.67 31.81 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.484 ' HE2' HD21 ' A' ' 58' ' ' LEU . 7.5 m-85 -95.79 109.41 21.73 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.388 -0.82 . . . . 0.0 110.18 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 71.8 mt -129.44 104.27 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.524 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.2 t -73.76 128.59 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.494 HD11 ' CG ' ' A' ' 59' ' ' GLN . 39.5 mt -82.11 166.3 19.83 Favored 'General case' 0 N--CA 1.508 2.466 0 CA-C-O 121.308 0.575 . . . . 0.0 111.806 -178.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.4 p -61.19 -21.55 63.91 Favored 'General case' 0 N--CA 1.51 2.532 0 O-C-N 122.106 -0.371 . . . . 0.0 111.211 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -90.87 19.12 5.81 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.577 -0.702 . . . . 0.0 111.338 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.408 ' HB3' HG21 ' A' ' 33' ' ' ILE . 6.1 m120 67.42 33.21 5.36 Favored 'General case' 0 N--CA 1.516 2.862 0 O-C-N 121.57 -0.706 . . . . 0.0 112.524 178.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.483 ' CE2' HG13 ' A' ' 22' ' ' VAL . 3.9 m-85 -103.3 166.77 10.23 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 177.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.903 HD23 HD12 ' A' ' 21' ' ' ILE . 16.8 tp -120.69 98.24 5.93 Favored 'General case' 0 N--CA 1.519 2.995 0 C-N-CA 119.356 -0.938 . . . . 0.0 111.919 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.695 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -78.45 101.62 7.4 Favored 'General case' 0 N--CA 1.504 2.263 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.364 179.66 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.509 HD11 HD11 ' A' ' 21' ' ' ILE . 96.8 mt -93.82 103.4 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 177.38 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 19.3 tpp85 -70.3 116.6 10.84 Favored 'General case' 0 N--CA 1.504 2.233 0 CA-C-O 121.317 0.58 . . . . 0.0 110.865 -178.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.64 -35.1 4.83 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.513 HG22 ' O ' ' A' ' 17' ' ' GLU . 1.8 tp 35.27 94.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.519 2.999 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 59.0 mmtt -73.4 148.71 43.09 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.613 -0.68 . . . . 0.0 110.656 -178.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -62.58 -18.89 63.04 Favored 'General case' 0 N--CA 1.51 2.559 0 O-C-N 122.072 -0.393 . . . . 0.0 110.978 178.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.8 t -87.83 -13.5 41.98 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.686 -0.634 . . . . 0.0 111.376 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -91.67 14.36 15.39 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.53 -0.731 . . . . 0.0 111.491 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.78 150.3 20.55 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.433 -0.792 . . . . 0.0 109.792 179.431 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 166.06 -101.25 0.18 Allowed Glycine 0 N--CA 1.499 2.887 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.6 m -149.02 101.13 3.13 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.953 -0.734 . . . . 0.0 111.239 179.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -81.47 133.56 35.42 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 177.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.8 ttm105 -97.29 120.3 37.4 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.11 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.624 ' HB3' HD11 ' A' ' 33' ' ' ILE . 9.3 m -83.46 113.33 20.7 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 177.583 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -111.5 85.63 2.17 Favored 'General case' 0 N--CA 1.504 2.272 0 CA-C-N 118.537 0.608 . . . . 0.0 109.609 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.68 96.67 0.31 Allowed Glycine 0 N--CA 1.502 3.057 0 N-CA-C 108.475 -1.85 . . . . 0.0 108.475 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.64 ' HG3' HG22 ' A' ' 83' ' ' ILE . 2.1 ttp85 -102.4 117.83 35.57 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 122.059 -0.671 . . . . 0.0 112.212 -177.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.719 HD13 ' CG2' ' A' ' 2' ' ' VAL . 5.3 mp -141.3 90.77 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.539 179.034 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 21.8 mt -99.87 26.75 6.01 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.286 178.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -111.61 -34.29 6.11 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.875 -0.515 . . . . 0.0 110.003 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -118.06 -62.56 1.53 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 122.036 -0.415 . . . . 0.0 110.811 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.405 ' O ' ' HB3' ' A' ' 82' ' ' GLU . . . -98.54 -82.78 1.68 Allowed Glycine 0 N--CA 1.489 2.183 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.956 -178.016 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.405 ' HB3' ' O ' ' A' ' 81' ' ' GLY . 9.9 pt-20 176.53 -155.29 0.02 OUTLIER 'General case' 0 N--CA 1.517 2.89 0 O-C-N 122.182 -0.599 . . . . 0.0 109.719 -177.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.64 HG22 ' HG3' ' A' ' 76' ' ' ARG . 8.4 pt -104.13 153.84 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 121.436 -0.79 . . . . 0.0 110.868 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -155.24 162.13 40.99 Favored 'General case' 0 N--CA 1.505 2.29 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.418 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 39.1 p90 -166.73 175.8 7.61 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 121.352 -0.843 . . . . 0.0 113.158 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.538 ' HD2' HD11 ' A' ' 88' ' ' ILE . 3.2 ptpt -167.78 161.27 13.14 Favored 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.582 ' O ' HG22 ' A' ' 9' ' ' THR . 7.7 p-10 -98.06 122.93 41.79 Favored 'General case' 0 N--CA 1.512 2.635 0 O-C-N 121.736 -0.602 . . . . 0.0 112.107 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.55 HD12 ' N ' ' A' ' 88' ' ' ILE . 2.3 mp -106.72 122.55 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 178.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -87.25 134.82 33.5 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.2 t -127.52 129.08 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 O-C-N 121.673 -0.642 . . . . 0.0 110.22 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 74.6 mt -116.26 139.63 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.426 HG21 ' CG1' ' A' ' 63' ' ' ILE . 44.6 t . . . . . 0 N--CA 1.503 2.18 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.364 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 41.0 p90 . . . . . 0 N--CA 1.497 1.896 0 CA-C-O 120.624 0.249 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.722 ' CG2' HD13 ' A' ' 77' ' ' ILE . 36.6 t -143.07 108.97 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.025 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.52 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 7.1 mmt -122.73 115.92 22.88 Favored 'General case' 0 N--CA 1.51 2.565 0 O-C-N 121.783 -0.573 . . . . 0.0 110.482 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -74.38 113.1 11.22 Favored 'General case' 0 N--CA 1.506 2.374 0 O-C-N 122.005 -0.434 . . . . 0.0 110.538 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.435 ' HG2' HG23 ' A' ' 26' ' ' VAL . 5.0 ptpt -127.16 163.7 23.26 Favored 'General case' 0 N--CA 1.503 2.215 0 CA-C-O 121.712 0.768 . . . . 0.0 111.753 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.419 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.3 OUTLIER 31.88 72.68 0.07 Allowed 'General case' 0 N--CA 1.52 3.048 0 C-N-CA 124.188 0.995 . . . . 0.0 113.342 179.317 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -136.81 81.01 35.31 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.802 -0.561 . . . . 0.0 110.721 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -65.58 102.09 0.48 Allowed 'Trans proline' 0 N--CA 1.49 1.294 0 N-CA-C 108.62 -1.339 . . . . 0.0 108.62 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.581 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.2 OUTLIER -55.86 -66.62 1.0 Allowed Pre-proline 0 N--CA 1.503 2.213 0 CA-C-O 116.93 -1.509 . . . . 0.0 112.216 -177.314 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.499 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.5 Cg_endo -74.18 91.4 0.94 Allowed 'Trans proline' 0 CA--C 1.556 1.609 0 CA-C-N 121.258 1.485 . . . . 0.0 111.148 178.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.525 HE21 HG13 ' A' ' 90' ' ' VAL . 15.9 pt20 -100.0 176.49 5.4 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 120.871 -1.143 . . . . 0.0 110.006 178.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -160.62 122.76 3.17 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.741 -0.599 . . . . 0.0 111.374 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -119.26 -170.64 1.96 Allowed 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.963 -0.461 . . . . 0.0 110.205 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 15.8 tptm -104.71 138.8 40.46 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.567 0.699 . . . . 0.0 111.413 -178.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -59.19 118.61 6.1 Favored 'General case' 0 N--CA 1.509 2.522 0 O-C-N 121.933 -0.479 . . . . 0.0 110.88 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.33 23.47 40.24 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.43 ' O ' HG22 ' A' ' 63' ' ' ILE . 13.0 tt0 -114.98 164.6 13.92 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 118.411 1.105 . . . . 0.0 110.531 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -82.85 98.46 9.17 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 178.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.17 168.27 9.92 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 120.365 -0.534 . . . . 0.0 112.053 -177.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.658 HG22 ' HG2' ' A' ' 59' ' ' GLN . 99.6 t -142.75 141.09 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.82 HD12 HD23 ' A' ' 58' ' ' LEU . 43.5 mt -97.02 111.96 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 178.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.442 HG13 ' CE2' ' A' ' 57' ' ' TYR . 57.8 t -75.17 119.93 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 CA-C-O 121.47 0.652 . . . . 0.0 110.493 -176.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -160.83 92.68 0.95 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.419 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.2 OUTLIER -91.16 140.75 29.52 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.529 -179.198 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.596 HG21 HD12 ' A' ' 33' ' ' ILE . 13.5 t -147.53 121.67 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.52 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 16.0 t -81.2 80.68 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.4 m -87.83 154.75 20.3 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.6 t -43.66 -84.0 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.18 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.407 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 0.9 OUTLIER -166.32 -62.21 0.01 OUTLIER Pre-proline 0 N--CA 1.509 2.475 0 CA-C-O 117.675 -1.155 . . . . 0.0 111.584 178.639 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.407 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 2.8 Cg_endo -60.2 -53.81 2.72 Favored 'Trans proline' 0 CA--C 1.561 1.844 0 CA-C-N 120.086 1.066 . . . . 0.0 112.552 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.68 ' HG2' HG23 ' A' ' 77' ' ' ILE . 2.6 Cg_endo -63.02 -168.53 0.08 OUTLIER 'Trans proline' 0 N--CA 1.496 1.668 0 CA-C-N 119.425 0.83 . . . . 0.0 111.746 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.414 ' HG1' ' C ' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -171.58 -164.77 0.34 Allowed 'General case' 0 N--CA 1.52 3.067 0 O-C-N 121.92 -0.488 . . . . 0.0 109.78 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.596 HD12 HG21 ' A' ' 25' ' ' VAL . 17.1 tt -102.53 147.31 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.925 -0.484 . . . . 0.0 110.056 179.208 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.553 ' N ' HD12 ' A' ' 34' ' ' ILE . 5.2 mp -114.5 121.07 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.56 ' HB2' HG22 ' A' ' 42' ' ' VAL . 83.6 m95 -82.77 104.4 12.99 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -118.04 -165.7 1.13 Allowed 'General case' 0 N--CA 1.506 2.359 0 CA-C-O 121.322 0.582 . . . . 0.0 111.494 -177.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 56.32 58.83 3.99 Favored 'General case' 0 N--CA 1.511 2.58 0 CA-C-O 121.598 0.713 . . . . 0.0 111.461 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.407 ' HD3' ' CE1' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -166.12 -48.06 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.733 -0.604 . . . . 0.0 109.403 179.363 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -158.58 44.62 0.47 Allowed Glycine 0 N--CA 1.494 2.538 0 N-CA-C 108.522 -1.831 . . . . 0.0 108.522 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? 55.88 75.81 0.31 Allowed 'General case' 0 N--CA 1.511 2.587 0 O-C-N 121.903 -0.763 . . . . 0.0 110.725 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.0 t0 57.59 105.53 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.815 0 O-C-N 121.678 -0.639 . . . . 0.0 111.007 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.56 HG22 ' HB2' ' A' ' 35' ' ' TRP . 4.4 m -68.1 -28.53 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.562 0 O-C-N 121.876 -0.515 . . . . 0.0 110.421 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.7 mm -58.42 -18.11 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.688 0 O-C-N 121.71 -0.618 . . . . 0.0 111.864 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.475 ' N ' HD12 ' A' ' 44' ' ' LEU . 9.3 mp -92.47 -22.18 19.74 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.492 -0.755 . . . . 0.0 111.106 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.1 pttt -97.88 -41.04 8.21 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.8 mmmt 46.91 56.91 6.14 Favored 'General case' 0 N--CA 1.509 2.505 0 CA-C-O 121.166 0.507 . . . . 0.0 112.308 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -49.69 161.17 0.24 Allowed 'General case' 0 N--CA 1.519 2.987 0 O-C-N 121.804 -0.56 . . . . 0.0 111.081 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 36.0 m -56.83 -21.92 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.779 0 O-C-N 121.911 -0.493 . . . . 0.0 112.172 -178.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 24.1 ptt-85 -104.22 -2.44 25.7 Favored 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.404 ' HE2' HD21 ' A' ' 58' ' ' LEU . 7.6 m-85 -96.24 108.28 20.74 Favored 'General case' 0 N--CA 1.503 2.18 0 CA-C-N 119.145 0.884 . . . . 0.0 110.166 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 75.6 mt -129.36 104.84 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.677 HG22 ' CD1' ' A' ' 58' ' ' LEU . 4.8 t -74.78 127.89 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.513 HD11 ' CG ' ' A' ' 59' ' ' GLN . 42.7 mt -80.63 165.54 21.94 Favored 'General case' 0 N--CA 1.509 2.477 0 CA-C-O 121.34 0.591 . . . . 0.0 111.905 -178.083 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 89.9 p -60.19 -20.92 60.83 Favored 'General case' 0 N--CA 1.51 2.547 0 O-C-N 122.07 -0.394 . . . . 0.0 111.484 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 42.8 p-10 -91.74 19.83 6.11 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.658 -0.652 . . . . 0.0 111.392 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.3 m120 67.24 32.13 6.2 Favored 'General case' 0 N--CA 1.516 2.846 0 O-C-N 121.594 -0.691 . . . . 0.0 112.39 178.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.442 ' CE2' HG13 ' A' ' 22' ' ' VAL . 3.7 m-85 -102.06 167.64 9.9 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.004 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.82 HD23 HD12 ' A' ' 21' ' ' ILE . 15.2 tp -121.99 98.8 6.11 Favored 'General case' 0 N--CA 1.519 2.978 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.954 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.658 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -78.72 101.15 7.39 Favored 'General case' 0 N--CA 1.503 2.202 0 C-N-CA 120.479 -0.489 . . . . 0.0 111.12 179.413 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.557 HD11 HD11 ' A' ' 21' ' ' ILE . 97.2 mt -94.68 104.31 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 177.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.85 115.65 8.42 Favored 'General case' 0 N--CA 1.505 2.301 0 CA-C-O 121.187 0.517 . . . . 0.0 110.721 -178.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 100.31 -39.26 2.8 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.577 ' CG1' HG21 ' A' ' 92' ' ' VAL . 3.0 tp 42.52 83.58 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.517 2.901 0 CA-C-O 122.225 1.012 . . . . 0.0 112.117 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -72.11 158.42 35.97 Favored 'General case' 0 N--CA 1.508 2.454 0 O-C-N 121.751 -0.593 . . . . 0.0 111.984 -178.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt -61.27 -24.55 66.47 Favored 'General case' 0 N--CA 1.51 2.558 0 O-C-N 121.941 -0.474 . . . . 0.0 110.918 178.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.9 t -79.32 -15.0 58.63 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.893 -0.505 . . . . 0.0 111.691 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -87.37 -27.77 22.6 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.502 -0.749 . . . . 0.0 110.718 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.402 ' HB3' HG12 ' A' ' 92' ' ' VAL . 5.1 pt-20 -62.0 140.56 58.34 Favored 'General case' 0 N--CA 1.507 2.406 0 O-C-N 121.691 -0.631 . . . . 0.0 110.752 -179.231 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 167.09 -104.88 0.23 Allowed Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.7 m -146.72 102.28 3.54 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 122.03 -0.688 . . . . 0.0 110.543 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.407 ' CE1' ' HD3' ' A' ' 38' ' ' LYS . 26.1 m-85 -83.52 134.65 34.83 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 -94.0 115.65 28.01 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.85 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 85' ' ' PHE . 1.9 m -85.68 90.58 8.05 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.505 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -92.08 88.65 6.62 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.317 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.85 90.24 0.57 Allowed Glycine 0 N--CA 1.499 2.855 0 N-CA-C 107.44 -2.264 . . . . 0.0 107.44 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.633 ' CG ' HG22 ' A' ' 83' ' ' ILE . 30.1 ttm-85 -96.49 125.63 41.11 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.805 0.812 . . . . 0.0 112.823 -177.181 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.722 HD13 ' CG2' ' A' ' 2' ' ' VAL . 5.2 mp -142.05 91.01 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.183 178.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 14.1 mt -99.09 24.12 8.23 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.591 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -111.15 -28.87 8.09 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.866 -0.521 . . . . 0.0 110.592 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 11.1 mmt85 -123.2 -61.53 1.41 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.909 -0.494 . . . . 0.0 110.733 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -98.54 -81.85 1.62 Allowed Glycine 0 N--CA 1.489 2.203 0 C-N-CA 120.995 -0.621 . . . . 0.0 111.708 -178.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 178.14 -164.04 0.04 OUTLIER 'General case' 0 N--CA 1.518 2.967 0 O-C-N 122.059 -0.671 . . . . 0.0 110.57 -178.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.633 HG22 ' CG ' ' A' ' 76' ' ' ARG . 1.5 pp -96.03 129.25 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.449 0 O-C-N 121.784 -0.572 . . . . 0.0 110.392 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -130.29 159.44 36.93 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 121.702 -0.624 . . . . 0.0 109.617 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.494 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 29.7 p90 -159.02 171.5 19.9 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 119.505 -0.878 . . . . 0.0 113.09 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 10.8 mttp -160.55 159.25 30.42 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.581 ' O ' HG22 ' A' ' 9' ' ' THR . 3.6 p30 -106.02 120.08 40.84 Favored 'General case' 0 N--CA 1.513 2.697 0 O-C-N 121.84 -0.538 . . . . 0.0 110.769 179.381 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.523 HD12 ' N ' ' A' ' 88' ' ' ILE . 1.8 mp -104.74 121.6 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -85.32 115.61 23.17 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.525 HG13 HE21 ' A' ' 11' ' ' GLN . 46.5 t -110.33 131.93 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.171 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 67.0 mt -120.38 157.57 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.577 HG21 ' CG1' ' A' ' 63' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.503 2.196 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.382 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.0 t . . . . . 0 N--CA 1.502 2.146 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.524 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 7.6 mmt -114.33 116.84 29.61 Favored 'General case' 0 N--CA 1.507 2.386 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.137 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -75.37 115.16 14.72 Favored 'General case' 0 N--CA 1.504 2.248 0 CA-C-O 120.9 0.381 . . . . 0.0 110.479 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.5 ptpt -127.22 163.71 23.28 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.649 0.738 . . . . 0.0 111.529 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 32.36 76.97 0.04 OUTLIER 'General case' 0 N--CA 1.517 2.901 0 C-N-CA 124.266 1.026 . . . . 0.0 113.49 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -145.03 78.45 12.48 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.812 -0.555 . . . . 0.0 110.916 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -64.37 104.39 0.51 Allowed 'Trans proline' 0 N--CA 1.492 1.412 0 N-CA-C 108.532 -1.372 . . . . 0.0 108.532 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.61 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.5 OUTLIER -50.92 -69.69 0.28 Allowed Pre-proline 0 N--CA 1.509 2.5 0 CA-C-O 116.625 -1.655 . . . . 0.0 112.802 -176.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.487 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.6 Cg_endo -72.62 96.72 0.84 Allowed 'Trans proline' 0 N--CA 1.498 1.741 0 CA-C-N 121.69 1.639 . . . . 0.0 111.518 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.441 HE21 HG13 ' A' ' 90' ' ' VAL . 16.1 pt20 -101.3 177.5 4.91 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 120.951 -1.093 . . . . 0.0 110.319 178.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -158.57 125.16 4.72 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.897 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -123.17 -170.65 2.15 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.953 -0.467 . . . . 0.0 109.876 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -104.67 143.86 32.51 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.617 0.722 . . . . 0.0 111.519 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -60.27 125.0 22.0 Favored 'General case' 0 N--CA 1.508 2.431 0 O-C-N 121.965 -0.459 . . . . 0.0 111.049 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.29 22.24 68.32 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 110.889 -0.885 . . . . 0.0 110.889 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -110.21 164.44 12.65 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 118.714 1.257 . . . . 0.0 110.61 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.43 98.62 8.98 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 177.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.78 165.82 11.4 Favored 'General case' 0 N--CA 1.497 1.925 0 C-N-CA 120.121 -0.631 . . . . 0.0 111.991 -177.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.671 HG22 ' HG2' ' A' ' 59' ' ' GLN . 85.1 t -138.94 139.68 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.737 HD12 HD23 ' A' ' 58' ' ' LEU . 40.9 mt -95.47 115.62 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 178.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.495 HG13 ' CE2' ' A' ' 57' ' ' TYR . 47.4 t -76.9 118.19 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-O 121.544 0.687 . . . . 0.0 110.507 -177.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.1 t -160.08 87.11 0.78 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.03 142.11 28.17 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 119.946 -0.702 . . . . 0.0 109.269 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.666 HG21 HD12 ' A' ' 33' ' ' ILE . 39.3 t -147.7 129.28 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.524 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 60.1 t -92.71 78.28 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.2 m -79.45 164.62 23.82 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.9 t -42.13 -80.52 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.224 0 CA-C-N 118.283 0.492 . . . . 0.0 111.607 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.416 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 0.4 OUTLIER -170.69 -63.43 0.0 OUTLIER Pre-proline 0 N--CA 1.515 2.786 0 CA-C-O 117.658 -1.163 . . . . 0.0 111.467 177.5 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.416 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 2.9 Cg_endo -60.84 -53.29 2.77 Favored 'Trans proline' 0 CA--C 1.563 1.97 0 CA-C-N 120.1 1.071 . . . . 0.0 112.805 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.71 -162.94 0.03 OUTLIER 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 120.516 0.811 . . . . 0.0 112.666 -178.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -170.16 -165.67 0.49 Allowed 'General case' 0 N--CA 1.518 2.936 0 O-C-N 121.849 -0.532 . . . . 0.0 110.403 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.677 HD11 ' HB3' ' A' ' 73' ' ' CYS . 17.5 tt -100.82 162.79 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.1 mt -125.23 126.77 71.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.567 ' HB2' HG22 ' A' ' 42' ' ' VAL . 78.5 m95 -90.44 110.65 21.75 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.0 tttt . . . . . 0 N--CA 1.502 2.131 0 O-C-N 121.941 -0.475 . . . . 0.0 110.594 -179.001 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.567 HG22 ' HB2' ' A' ' 35' ' ' TRP . 4.4 m . . . . . 0 N--CA 1.506 2.364 0 CA-C-O 120.993 0.425 . . . . 0.0 110.052 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.652 HD11 HG21 ' A' ' 52' ' ' VAL . 47.8 mm -58.27 -18.75 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.825 0 O-C-N 121.807 -0.558 . . . . 0.0 111.87 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.435 ' N ' HD12 ' A' ' 44' ' ' LEU . 10.3 mp -93.2 -20.71 20.19 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.47 -0.769 . . . . 0.0 111.531 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 42.2 pttt -98.97 -37.89 9.21 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.531 -0.731 . . . . 0.0 109.802 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt 48.61 55.19 9.41 Favored 'General case' 0 N--CA 1.509 2.513 0 CA-C-O 121.581 0.705 . . . . 0.0 111.766 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -53.11 171.3 0.07 Allowed 'General case' 0 N--CA 1.513 2.682 0 O-C-N 121.755 -0.591 . . . . 0.0 110.876 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.6 t -66.9 -19.41 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.467 0 O-C-N 122.007 -0.433 . . . . 0.0 110.996 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 10.0 ptt-85 -115.64 45.7 1.64 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.504 -0.747 . . . . 0.0 112.1 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -145.28 105.33 4.04 Favored 'General case' 0 N--CA 1.506 2.346 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 177.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 45.2 mt -126.0 102.45 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.652 HG21 HD11 ' A' ' 43' ' ' ILE . 3.5 t -73.37 129.04 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.55 HD11 ' CG ' ' A' ' 59' ' ' GLN . 29.8 mt -82.71 167.6 18.05 Favored 'General case' 0 N--CA 1.509 2.498 0 CA-C-O 121.358 0.599 . . . . 0.0 112.143 -178.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.4 p -61.63 -22.02 64.89 Favored 'General case' 0 N--CA 1.509 2.496 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.985 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 52.4 p30 -91.49 18.85 6.76 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.749 -0.595 . . . . 0.0 111.337 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.8 m120 66.88 34.44 5.4 Favored 'General case' 0 N--CA 1.517 2.921 0 O-C-N 121.534 -0.728 . . . . 0.0 112.832 178.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.495 ' CE2' HG13 ' A' ' 22' ' ' VAL . 3.7 m-85 -103.06 166.03 10.67 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 177.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.737 HD23 HD12 ' A' ' 21' ' ' ILE . 15.2 tp -119.51 97.19 5.53 Favored 'General case' 0 N--CA 1.519 2.993 0 C-N-CA 119.371 -0.932 . . . . 0.0 111.505 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.671 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -76.67 95.39 3.97 Favored 'General case' 0 N--CA 1.502 2.166 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.857 179.609 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.584 HD11 HD11 ' A' ' 21' ' ' ILE . 99.4 mt -87.04 119.74 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 177.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 32.9 tpt85 -80.3 117.39 21.03 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-O 121.324 0.583 . . . . 0.0 110.638 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.26 -39.59 2.75 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.628 HG23 HG21 ' A' ' 92' ' ' VAL . 2.8 tp 42.3 73.59 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.776 0 CA-C-O 122.16 0.981 . . . . 0.0 112.581 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.406 ' HB3' HG22 ' A' ' 66' ' ' THR . 37.5 mmtt -59.8 150.61 27.71 Favored 'General case' 0 N--CA 1.51 2.573 0 O-C-N 121.377 -0.827 . . . . 0.0 111.661 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.619 ' HA ' HG13 ' A' ' 92' ' ' VAL . 20.7 ttmt -62.52 -17.59 60.11 Favored 'General case' 0 N--CA 1.506 2.374 0 O-C-N 122.087 -0.383 . . . . 0.0 111.213 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.406 HG22 ' HB3' ' A' ' 64' ' ' LYS . 8.8 t -89.32 -15.95 32.23 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.651 -0.656 . . . . 0.0 111.127 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -92.47 15.03 14.98 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.502 -0.748 . . . . 0.0 111.536 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.74 ' HB3' HG12 ' A' ' 92' ' ' VAL . 0.5 OUTLIER -96.73 160.98 14.07 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.422 -0.798 . . . . 0.0 109.283 179.294 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 154.99 -99.4 0.19 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.371 -1.491 . . . . 0.0 109.371 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.8 m -151.05 101.35 2.87 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 122.016 -0.696 . . . . 0.0 111.988 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -82.17 131.74 35.24 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.1 tpp85 -98.11 117.02 31.53 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 120.087 -0.645 . . . . 0.0 111.212 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.677 ' HB3' HD11 ' A' ' 33' ' ' ILE . 14.4 m -79.43 129.84 34.85 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 177.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -128.03 88.63 2.79 Favored 'General case' 0 N--CA 1.502 2.15 0 CA-C-N 118.581 0.628 . . . . 0.0 110.265 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.47 111.11 3.84 Favored Glycine 0 N--CA 1.504 3.178 0 N-CA-C 107.915 -2.074 . . . . 0.0 107.915 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.2 ttm180 . . . . . 0 N--CA 1.502 2.165 0 CA-C-O 121.959 0.885 . . . . 0.0 113.366 -177.109 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 N--CA 1.501 2.122 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -167.76 176.19 6.49 Favored 'General case' 0 N--CA 1.508 2.475 0 O-C-N 121.455 -0.778 . . . . 0.0 112.692 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.547 ' CD ' HD11 ' A' ' 88' ' ' ILE . 3.3 ptpt -168.13 155.95 8.45 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.61 ' O ' HG22 ' A' ' 9' ' ' THR . 4.5 p30 -93.16 120.53 33.55 Favored 'General case' 0 N--CA 1.51 2.55 0 O-C-N 121.713 -0.617 . . . . 0.0 111.796 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.57 ' N ' HD12 ' A' ' 88' ' ' ILE . 3.6 mp -106.04 119.47 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -85.11 130.84 34.54 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.441 HG13 HE21 ' A' ' 11' ' ' GLN . 46.1 t -123.25 128.76 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 54.7 mt -121.07 142.29 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.74 HG12 ' HB3' ' A' ' 68' ' ' GLU . 6.7 p . . . . . 0 N--CA 1.5 2.056 0 CA-C-O 117.876 -1.059 . . . . 0.0 110.469 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.4 t . . . . . 0 N--CA 1.5 2.059 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.502 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 7.3 mmm -96.56 113.92 25.53 Favored 'General case' 0 N--CA 1.506 2.354 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.907 -178.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -72.13 115.06 10.91 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.421 ' HG2' HG23 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -125.22 158.01 35.11 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 121.323 0.582 . . . . 0.0 110.354 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.439 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.1 OUTLIER 38.88 70.92 0.18 Allowed 'General case' 0 N--CA 1.518 2.954 0 C-N-CA 123.374 0.67 . . . . 0.0 112.151 -179.654 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.03 72.01 72.69 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.748 -0.595 . . . . 0.0 111.258 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -65.09 102.07 0.43 Allowed 'Trans proline' 0 N--CA 1.49 1.323 0 N-CA-C 108.886 -1.236 . . . . 0.0 108.886 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.576 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.4 OUTLIER -54.28 -68.3 0.51 Allowed Pre-proline 0 N--CA 1.508 2.461 0 CA-C-O 116.782 -1.58 . . . . 0.0 112.25 -177.636 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.491 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.4 Cg_endo -72.43 90.5 0.79 Allowed 'Trans proline' 0 N--CA 1.496 1.676 0 CA-C-N 121.52 1.579 . . . . 0.0 111.353 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -100.85 173.93 6.27 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 120.785 -1.197 . . . . 0.0 110.352 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -157.16 122.88 4.71 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.803 -0.561 . . . . 0.0 111.003 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -117.16 -170.09 1.78 Allowed 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.963 -0.46 . . . . 0.0 110.552 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -103.31 140.45 37.4 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.862 0.839 . . . . 0.0 111.907 -178.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -60.79 126.96 29.32 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.822 -0.548 . . . . 0.0 111.017 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.07 21.82 72.83 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -110.91 161.5 15.77 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 118.652 1.226 . . . . 0.0 111.018 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -79.79 95.8 6.11 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 177.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.66 169.68 9.86 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.851 -177.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.651 HG22 ' HG2' ' A' ' 59' ' ' GLN . 84.5 t -142.98 141.3 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.771 HD12 HD23 ' A' ' 58' ' ' LEU . 26.0 mt -96.36 114.4 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 178.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.63 HG13 ' CZ ' ' A' ' 57' ' ' TYR . 38.8 t -75.51 118.33 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 CA-C-O 121.477 0.656 . . . . 0.0 110.735 -176.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.9 t -163.61 80.49 0.44 Allowed 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.439 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.4 OUTLIER -80.06 146.21 32.06 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.149 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.488 HG21 HD12 ' A' ' 33' ' ' ILE . 60.4 t -148.88 133.84 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.502 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 60.6 t -94.88 88.49 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -88.29 140.2 29.72 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.0 t -97.97 30.57 3.0 Favored 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -177.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.632 HD23 ' HD2' ' A' ' 30' ' ' PRO . 0.2 OUTLIER -161.79 170.41 8.12 Favored Pre-proline 0 N--CA 1.513 2.693 0 O-C-N 120.896 -1.127 . . . . 0.0 111.12 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.632 ' HD2' HD23 ' A' ' 29' ' ' LEU . 4.0 Cg_exo -49.81 -47.93 21.32 Favored 'Trans proline' 0 N--CA 1.502 1.973 0 C-N-CA 121.639 1.559 . . . . 0.0 114.491 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 29' ' ' LEU . 4.5 Cg_exo -52.66 -170.02 0.01 OUTLIER 'Trans proline' 0 N--CA 1.506 2.235 0 CA-C-N 120.044 1.051 . . . . 0.0 112.896 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.549 HG22 ' ND2' ' A' ' 56' ' ' ASN . 0.2 OUTLIER -168.93 -156.21 0.16 Allowed 'General case' 0 N--CA 1.522 3.154 0 O-C-N 120.381 -1.45 . . . . 0.0 111.634 -176.915 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.563 HD11 ' HB3' ' A' ' 73' ' ' CYS . 19.5 tt -88.02 143.04 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 O-C-N 121.897 -0.502 . . . . 0.0 111.906 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.546 ' N ' HD12 ' A' ' 34' ' ' ILE . 3.6 mp -109.47 130.44 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 177.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.529 ' CG ' HD22 ' A' ' 58' ' ' LEU . 79.3 m95 -90.28 110.61 21.66 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.0 mttt . . . . . 0 N--CA 1.501 2.1 0 CA-C-O 121.394 0.616 . . . . 0.0 111.199 -178.76 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.527 HG22 ' HB2' ' A' ' 35' ' ' TRP . 5.6 m . . . . . 0 N--CA 1.507 2.394 0 CA-C-O 120.757 0.313 . . . . 0.0 110.646 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 79.6 mt -59.27 -17.33 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.87 0 O-C-N 121.754 -0.591 . . . . 0.0 111.803 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.495 ' N ' HD12 ' A' ' 44' ' ' LEU . 9.8 mp -89.47 -25.22 21.59 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.599 -0.688 . . . . 0.0 110.55 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.0 pttt -98.6 -38.87 8.97 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.756 -0.59 . . . . 0.0 109.655 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.5 mmmt 47.06 55.64 7.79 Favored 'General case' 0 N--CA 1.51 2.55 0 CA-C-O 121.399 0.618 . . . . 0.0 111.959 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.8 169.46 0.07 Allowed 'General case' 0 N--CA 1.515 2.778 0 O-C-N 121.792 -0.567 . . . . 0.0 111.116 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 31.4 m -63.54 -21.59 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.591 0 O-C-N 121.985 -0.447 . . . . 0.0 111.649 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 16.4 ptt-85 -113.67 48.5 1.06 Allowed 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.648 -0.658 . . . . 0.0 111.747 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.411 ' O ' HD13 ' A' ' 51' ' ' ILE . 7.6 m-85 -144.73 102.97 3.87 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.553 -0.717 . . . . 0.0 109.895 178.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.411 HD13 ' O ' ' A' ' 50' ' ' PHE . 48.0 mm -127.74 114.05 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.474 HG22 ' CD1' ' A' ' 58' ' ' LEU . 2.6 t -80.13 146.64 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 24.6 mt -102.71 162.99 12.48 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 121.244 0.545 . . . . 0.0 111.605 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 81.8 p -59.88 -20.58 57.96 Favored 'General case' 0 N--CA 1.51 2.552 0 O-C-N 122.098 -0.376 . . . . 0.0 111.689 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 38.5 p-10 -91.36 17.74 8.06 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.662 -0.649 . . . . 0.0 111.736 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.549 ' ND2' HG22 ' A' ' 32' ' ' THR . 8.1 m120 70.21 29.54 3.67 Favored 'General case' 0 N--CA 1.52 3.046 0 O-C-N 121.635 -0.666 . . . . 0.0 111.931 179.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.63 ' CZ ' HG13 ' A' ' 22' ' ' VAL . 4.3 m-85 -103.18 159.92 15.11 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.771 HD23 HD12 ' A' ' 21' ' ' ILE . 26.9 tp -120.85 100.81 7.3 Favored 'General case' 0 N--CA 1.514 2.743 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.814 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.651 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.7 OUTLIER -75.48 103.47 5.62 Favored 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 120.759 -0.377 . . . . 0.0 111.244 179.717 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.739 HD11 HD11 ' A' ' 21' ' ' ILE . 99.8 mt -95.53 114.09 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 177.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -74.59 115.55 14.28 Favored 'General case' 0 N--CA 1.503 2.175 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.229 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.401 ' O ' HG22 ' A' ' 63' ' ' ILE . . . 97.04 -39.02 2.89 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 178.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.5 ' CG1' HG21 ' A' ' 92' ' ' VAL . 1.9 tp 42.92 71.79 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.843 0 CA-C-O 122.256 1.027 . . . . 0.0 112.241 -178.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.1 mtpp -63.32 158.01 21.46 Favored 'General case' 0 N--CA 1.506 2.374 0 O-C-N 121.59 -0.694 . . . . 0.0 112.333 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -62.02 -23.63 66.56 Favored 'General case' 0 N--CA 1.508 2.441 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.933 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.7 p -83.78 -16.56 44.24 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.74 -0.6 . . . . 0.0 111.015 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.91 -19.47 25.77 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.704 -0.623 . . . . 0.0 111.042 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.497 ' HB3' HG12 ' A' ' 92' ' ' VAL . 7.6 pt-20 -67.6 150.1 49.23 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.445 -0.785 . . . . 0.0 109.916 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 166.31 -111.69 0.46 Allowed Glycine 0 N--CA 1.498 2.822 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.4 m -144.57 101.59 3.7 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.941 -0.74 . . . . 0.0 110.034 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -82.16 133.52 35.27 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -94.64 117.94 30.92 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 120.002 -0.679 . . . . 0.0 111.143 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.563 ' HB3' HD11 ' A' ' 33' ' ' ILE . 12.0 m -80.3 120.82 24.87 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 177.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.82 82.59 1.97 Allowed 'General case' 0 N--CA 1.509 2.512 0 CA-C-N 118.962 0.801 . . . . 0.0 110.556 -179.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.61 100.79 0.29 Allowed Glycine 0 N--CA 1.508 3.493 0 N-CA-C 108.779 -1.729 . . . . 0.0 108.779 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.4 ' O ' ' HB2' ' A' ' 31' ' ' PRO . 25.1 ttp85 . . . . . 0 N--CA 1.497 1.917 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -177.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 . . . . . 0 N--CA 1.499 2.016 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.417 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 39.0 p90 -159.51 178.38 9.95 Favored 'General case' 0 N--CA 1.504 2.248 0 CA-C-N 119.773 1.17 . . . . 0.0 113.752 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -171.3 159.61 5.83 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.576 ' O ' HG22 ' A' ' 9' ' ' THR . 7.1 p-10 -102.39 118.15 36.25 Favored 'General case' 0 N--CA 1.512 2.656 0 O-C-N 121.795 -0.566 . . . . 0.0 110.773 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.552 ' N ' HD12 ' A' ' 88' ' ' ILE . 1.9 mp -101.99 119.73 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 179.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.06 112.83 21.63 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -179.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.9 t -106.74 133.26 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.13 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.9 mt -124.64 158.53 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.5 HG21 ' CG1' ' A' ' 63' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.499 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 42.2 t . . . . . 0 N--CA 1.505 2.281 0 N-CA-C 110.383 -0.229 . . . . 0.0 110.383 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.417 ' CG ' ' HB ' ' A' ' 26' ' ' VAL . 25.6 ptm -119.29 122.87 42.87 Favored 'General case' 0 N--CA 1.509 2.485 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 177.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -73.71 136.87 43.75 Favored 'General case' 0 N--CA 1.511 2.603 0 O-C-N 122.031 -0.418 . . . . 0.0 111.992 -176.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.606 ' HG2' HG23 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -136.47 158.15 45.11 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 121.424 0.631 . . . . 0.0 110.823 179.287 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.414 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.6 OUTLIER 32.93 84.1 0.02 OUTLIER 'General case' 0 N--CA 1.521 3.103 0 C-N-CA 123.998 0.919 . . . . 0.0 113.347 179.635 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -145.19 80.86 10.81 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.7 -0.625 . . . . 0.0 111.23 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -67.07 105.3 0.96 Allowed 'Trans proline' 0 N--CA 1.49 1.32 0 N-CA-C 108.693 -1.31 . . . . 0.0 108.693 178.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.563 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.4 OUTLIER -57.88 -67.25 0.95 Allowed Pre-proline 0 N--CA 1.507 2.415 0 CA-C-O 116.905 -1.521 . . . . 0.0 111.828 -177.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.486 ' HD3' ' OG1' ' A' ' 9' ' ' THR . 1.6 Cg_endo -71.46 92.02 0.68 Allowed 'Trans proline' 0 N--CA 1.493 1.445 0 CA-C-N 121.32 1.507 . . . . 0.0 111.604 178.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.52 HE21 HG13 ' A' ' 90' ' ' VAL . 14.7 pt20 -101.27 166.31 10.83 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.068 -1.02 . . . . 0.0 110.141 178.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -152.37 120.62 6.3 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 120.196 -0.601 . . . . 0.0 111.844 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -116.12 -172.03 2.1 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 122.028 -0.42 . . . . 0.0 110.056 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 62.2 tttt -101.2 140.77 35.04 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.477 0.656 . . . . 0.0 111.468 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -59.52 122.17 13.37 Favored 'General case' 0 N--CA 1.51 2.541 0 O-C-N 121.99 -0.443 . . . . 0.0 111.041 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.26 21.97 59.71 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.418 ' O ' HG22 ' A' ' 63' ' ' ILE . 14.3 tt0 -111.76 164.43 13.06 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 118.738 1.269 . . . . 0.0 110.628 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -82.81 99.85 9.95 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -101.62 171.06 7.78 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.772 -177.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.669 HG22 ' HG2' ' A' ' 59' ' ' GLN . 84.5 t -141.96 141.26 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 178.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.788 HD12 HD23 ' A' ' 58' ' ' LEU . 19.0 mt -95.18 112.35 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 178.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.504 HG13 ' CE2' ' A' ' 57' ' ' TYR . 43.6 t -74.1 121.49 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.546 -176.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.6 t -164.85 93.56 0.64 Allowed 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.414 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -90.95 142.53 27.67 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -179.569 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.888 HG21 HD12 ' A' ' 33' ' ' ILE . 44.9 t -144.41 138.2 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 C-N-CA 120.311 -0.556 . . . . 0.0 109.541 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.606 HG23 ' HG2' ' A' ' 5' ' ' LYS . 90.0 t -106.08 79.46 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.8 m -84.37 169.38 14.67 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.4 t -45.46 -76.31 0.02 OUTLIER 'General case' 0 N--CA 1.521 3.091 0 O-C-N 121.689 -0.632 . . . . 0.0 111.458 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.411 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 0.3 OUTLIER -173.04 -62.52 0.0 OUTLIER Pre-proline 0 N--CA 1.518 2.953 0 CA-C-O 117.832 -1.08 . . . . 0.0 111.987 177.608 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.411 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 2.9 Cg_endo -60.19 -53.31 3.13 Favored 'Trans proline' 0 CA--C 1.562 1.909 0 CA-C-N 119.939 1.014 . . . . 0.0 112.897 -179.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.428 ' C ' ' HG1' ' A' ' 32' ' ' THR . 2.8 Cg_endo -62.48 -163.63 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.745 0 CA-C-N 119.275 0.777 . . . . 0.0 112.676 -178.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.428 ' HG1' ' C ' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -170.25 -166.37 0.53 Allowed 'General case' 0 N--CA 1.519 3.001 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.203 -179.534 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.888 HD12 HG21 ' A' ' 25' ' ' VAL . 15.1 tt -97.61 161.11 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 122.065 -0.397 . . . . 0.0 110.056 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 90.4 mt -126.3 124.69 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.597 ' HB2' HG22 ' A' ' 42' ' ' VAL . 78.2 m95 -87.56 105.95 17.67 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 24.9 tttt . . . . . 0 N--CA 1.497 1.896 0 O-C-N 122.052 -0.405 . . . . 0.0 110.617 -178.654 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.597 HG22 ' HB2' ' A' ' 35' ' ' TRP . 9.6 m . . . . . 0 N--CA 1.506 2.325 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.694 HG12 HG21 ' A' ' 52' ' ' VAL . 50.6 mt -60.51 -18.62 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.68 0 O-C-N 121.877 -0.515 . . . . 0.0 111.173 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.496 ' N ' HD12 ' A' ' 44' ' ' LEU . 9.0 mp -91.73 -20.94 21.02 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.608 -0.682 . . . . 0.0 110.975 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.416 ' HG2' ' HA ' ' A' ' 42' ' ' VAL . 51.5 pttt -98.88 -38.14 9.14 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt 48.35 56.69 7.1 Favored 'General case' 0 N--CA 1.508 2.463 0 CA-C-O 121.508 0.671 . . . . 0.0 111.649 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -50.57 173.71 0.02 OUTLIER 'General case' 0 N--CA 1.516 2.842 0 O-C-N 121.895 -0.503 . . . . 0.0 111.421 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.3 m -61.33 -18.47 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.636 0 O-C-N 121.882 -0.511 . . . . 0.0 111.804 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -126.05 48.33 2.12 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.6 -0.687 . . . . 0.0 112.337 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -144.47 106.47 4.32 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 121.56 -0.712 . . . . 0.0 109.689 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 65.8 mt -128.05 106.84 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.694 HG21 HG12 ' A' ' 43' ' ' ILE . 3.3 t -75.67 136.73 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.287 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.446 HD11 ' OE1' ' A' ' 59' ' ' GLN . 14.5 mt -91.16 165.26 13.58 Favored 'General case' 0 N--CA 1.506 2.338 0 CA-C-O 121.309 0.576 . . . . 0.0 111.724 -178.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.8 p -60.55 -21.22 62.29 Favored 'General case' 0 N--CA 1.511 2.576 0 O-C-N 122.114 -0.366 . . . . 0.0 111.453 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 40.4 p-10 -90.57 17.23 7.72 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.627 -0.671 . . . . 0.0 111.505 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.5 m120 69.38 31.58 3.79 Favored 'General case' 0 N--CA 1.516 2.856 0 O-C-N 121.594 -0.691 . . . . 0.0 111.846 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.504 ' CE2' HG13 ' A' ' 22' ' ' VAL . 4.3 m-85 -102.41 166.03 10.78 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 177.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.788 HD23 HD12 ' A' ' 21' ' ' ILE . 18.5 tp -123.62 99.92 6.54 Favored 'General case' 0 N--CA 1.515 2.818 0 C-N-CA 119.333 -0.947 . . . . 0.0 111.808 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.669 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -77.28 101.5 6.29 Favored 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 120.805 0.336 . . . . 0.0 111.107 179.647 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.776 HD11 HD11 ' A' ' 21' ' ' ILE . 97.6 mt -92.78 115.97 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.51 115.24 17.12 Favored 'General case' 0 N--CA 1.505 2.302 0 CA-C-O 121.299 0.571 . . . . 0.0 111.306 -178.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.31 -38.81 2.95 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 179.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.727 HG23 HG21 ' A' ' 92' ' ' VAL . 1.7 tp 41.47 72.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.846 0 CA-C-O 121.995 0.903 . . . . 0.0 112.624 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -62.72 155.37 26.72 Favored 'General case' 0 N--CA 1.509 2.508 0 O-C-N 121.391 -0.818 . . . . 0.0 111.687 -178.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.413 ' HA ' HG13 ' A' ' 92' ' ' VAL . 33.9 tttt -62.82 -21.45 65.92 Favored 'General case' 0 N--CA 1.51 2.542 0 O-C-N 122.119 -0.363 . . . . 0.0 110.772 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 50.7 p -85.17 -13.97 48.39 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.79 -0.569 . . . . 0.0 111.106 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.88 -6.38 48.83 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.607 -0.683 . . . . 0.0 111.452 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.794 ' HB3' HG12 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -80.04 172.74 13.38 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-N 119.005 0.82 . . . . 0.0 110.067 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 145.33 -108.16 0.46 Allowed Glycine 0 N--CA 1.496 2.646 0 N-CA-C 108.991 -1.643 . . . . 0.0 108.991 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.7 m -143.17 100.99 3.74 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 122.041 -0.682 . . . . 0.0 111.418 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -83.72 129.46 34.95 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 29.4 ttp180 -94.84 119.21 33.03 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.324 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.506 ' HB3' HD11 ' A' ' 33' ' ' ILE . 5.5 m -81.88 124.12 29.44 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 177.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -125.12 89.94 3.15 Favored 'General case' 0 N--CA 1.503 2.201 0 CA-C-N 118.995 0.816 . . . . 0.0 111.021 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.44 107.89 2.28 Favored Glycine 0 N--CA 1.502 3.045 0 N-CA-C 107.336 -2.306 . . . . 0.0 107.336 178.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 . . . . . 0 N--CA 1.502 2.159 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -176.603 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.2 m120 . . . . . 0 N--CA 1.504 2.239 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -163.01 -175.94 4.62 Favored 'General case' 0 N--CA 1.503 2.19 0 C-N-CA 119.551 -0.86 . . . . 0.0 112.979 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 9.1 tttt -167.6 162.27 14.12 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.563 ' O ' HG22 ' A' ' 9' ' ' THR . 4.5 p-10 -106.71 110.5 22.7 Favored 'General case' 0 N--CA 1.51 2.531 0 O-C-N 121.764 -0.585 . . . . 0.0 111.0 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.589 ' N ' HD12 ' A' ' 88' ' ' ILE . 2.6 mp -95.74 120.13 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 10.6 tm0? -91.63 113.53 25.82 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.046 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.52 HG13 HE21 ' A' ' 11' ' ' GLN . 39.7 t -104.75 143.33 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.931 -0.481 . . . . 0.0 109.967 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 68.4 mt -134.95 139.92 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.311 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.794 HG12 ' HB3' ' A' ' 68' ' ' GLU . 8.4 p . . . . . 0 N--CA 1.5 2.045 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.76 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 45.3 t . . . . . 0 N--CA 1.504 2.256 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.437 ' CG ' ' HB ' ' A' ' 26' ' ' VAL . 17.1 ptm -119.09 123.31 44.13 Favored 'General case' 0 N--CA 1.508 2.456 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -74.17 133.29 42.74 Favored 'General case' 0 N--CA 1.511 2.606 0 CA-C-O 120.974 0.416 . . . . 0.0 112.045 -176.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.517 ' HG2' HG23 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -135.37 163.38 30.15 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-O 121.367 0.603 . . . . 0.0 111.093 179.34 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.5 t30 27.78 70.24 0.06 Allowed 'General case' 0 N--CA 1.523 3.205 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -135.76 82.85 37.09 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.736 -0.603 . . . . 0.0 110.619 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -65.44 110.0 1.51 Allowed 'Trans proline' 0 N--CA 1.491 1.366 0 N-CA-C 109.02 -1.185 . . . . 0.0 109.02 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.586 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.1 OUTLIER -60.64 -59.05 15.09 Favored Pre-proline 0 N--CA 1.502 2.151 0 CA-C-O 117.113 -1.422 . . . . 0.0 112.161 -177.777 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.528 ' HD3' ' OG1' ' A' ' 9' ' ' THR . 1.4 Cg_endo -80.11 91.44 1.17 Allowed 'Trans proline' 0 CA--C 1.554 1.488 0 CA-C-N 121.055 1.413 . . . . 0.0 111.557 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.533 HE21 HG13 ' A' ' 90' ' ' VAL . 15.7 pt20 -101.38 173.5 6.41 Favored 'General case' 0 N--CA 1.509 2.504 0 O-C-N 120.973 -1.079 . . . . 0.0 110.521 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -158.37 121.13 3.76 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.783 -0.573 . . . . 0.0 111.478 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -116.68 -170.02 1.74 Allowed 'General case' 0 N--CA 1.503 2.203 0 O-C-N 122.06 -0.4 . . . . 0.0 109.943 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -103.48 137.52 41.46 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.527 0.68 . . . . 0.0 111.444 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -61.08 116.67 4.71 Favored 'General case' 0 N--CA 1.508 2.466 0 CA-C-O 121.051 0.453 . . . . 0.0 110.333 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.13 22.46 29.96 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -117.48 165.41 13.56 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 118.567 1.183 . . . . 0.0 111.085 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -80.62 99.85 8.34 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 177.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.29 165.85 11.49 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.968 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.677 HG22 ' HG2' ' A' ' 59' ' ' GLN . 99.2 t -141.68 139.47 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 177.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.746 HD12 HD23 ' A' ' 58' ' ' LEU . 42.6 mt -97.15 113.47 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 178.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.557 HG13 ' CE2' ' A' ' 57' ' ' TYR . 48.4 t -76.43 117.47 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 CA-C-O 121.558 0.694 . . . . 0.0 110.401 -177.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.3 t -157.94 91.26 1.11 Allowed 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.01 138.95 31.0 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -178.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.804 HG21 HD12 ' A' ' 33' ' ' ILE . 44.3 t -143.87 131.11 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 C-N-CA 120.283 -0.567 . . . . 0.0 109.476 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.517 HG23 ' HG2' ' A' ' 5' ' ' LYS . 93.3 t -97.63 83.21 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.8 m -84.62 171.18 12.65 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 177.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.5 t -46.18 -81.49 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.091 0 O-C-N 121.594 -0.691 . . . . 0.0 111.261 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.431 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 0.9 OUTLIER -165.93 -64.01 0.01 OUTLIER Pre-proline 0 N--CA 1.514 2.758 0 CA-C-O 117.706 -1.14 . . . . 0.0 111.752 177.687 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.431 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 3.0 Cg_endo -61.13 -53.07 2.76 Favored 'Trans proline' 0 CA--C 1.563 1.939 0 CA-C-N 120.189 1.103 . . . . 0.0 113.013 -179.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.404 ' C ' ' HG1' ' A' ' 32' ' ' THR . 3.2 Cg_exo -61.14 -163.83 0.03 OUTLIER 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 120.549 0.832 . . . . 0.0 113.108 -178.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.404 ' HG1' ' C ' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -168.97 -162.81 0.39 Allowed 'General case' 0 N--CA 1.517 2.915 0 O-C-N 121.966 -0.459 . . . . 0.0 109.768 -179.293 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.804 HD12 HG21 ' A' ' 25' ' ' VAL . 14.0 tt -101.23 167.35 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.879 -0.513 . . . . 0.0 110.195 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.435 HD12 ' NE ' ' A' ' 76' ' ' ARG . 96.7 mt -131.89 134.35 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.539 ' HB2' HG22 ' A' ' 42' ' ' VAL . 85.4 m95 -95.9 114.88 26.64 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.5 tttt . . . . . 0 N--CA 1.503 2.213 0 O-C-N 121.814 -0.554 . . . . 0.0 111.129 -178.72 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.539 HG22 ' HB2' ' A' ' 35' ' ' TRP . 3.3 m . . . . . 0 N--CA 1.505 2.323 0 CA-C-O 121.192 0.52 . . . . 0.0 109.663 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.48 HD11 HG21 ' A' ' 52' ' ' VAL . 47.8 mm -58.35 -19.36 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.795 0 O-C-N 121.867 -0.52 . . . . 0.0 111.558 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.525 ' N ' HD12 ' A' ' 44' ' ' LEU . 8.2 mp -93.03 -22.78 18.94 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.478 -0.764 . . . . 0.0 111.126 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.421 ' HG2' ' HA ' ' A' ' 42' ' ' VAL . 31.2 pttt -97.96 -38.57 9.34 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.4 mmmt 49.14 54.86 10.22 Favored 'General case' 0 N--CA 1.507 2.395 0 CA-C-O 121.487 0.66 . . . . 0.0 111.726 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.75 161.47 0.74 Allowed 'General case' 0 N--CA 1.514 2.764 0 O-C-N 121.731 -0.605 . . . . 0.0 110.916 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.9 m -58.42 -21.1 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.666 0 O-C-N 121.909 -0.494 . . . . 0.0 111.876 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.1 ptp85 -111.53 46.11 1.14 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.78 -0.575 . . . . 0.0 111.633 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -146.24 106.36 4.02 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.72 -0.613 . . . . 0.0 109.836 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 81.1 mt -129.03 107.5 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.523 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.1 t -74.94 139.32 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.466 HD11 ' CG ' ' A' ' 59' ' ' GLN . 43.1 mt -94.82 167.84 11.18 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 121.224 0.535 . . . . 0.0 111.963 -178.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.4 p -61.76 -23.22 66.03 Favored 'General case' 0 N--CA 1.509 2.484 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.072 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 35.6 p-10 -90.03 16.93 7.49 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.659 -0.651 . . . . 0.0 111.414 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.5 m120 69.43 32.18 3.55 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 121.558 -0.714 . . . . 0.0 112.283 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.557 ' CE2' HG13 ' A' ' 22' ' ' VAL . 4.0 m-85 -103.24 157.97 16.64 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.746 HD23 HD12 ' A' ' 21' ' ' ILE . 17.8 tp -114.13 98.92 7.26 Favored 'General case' 0 N--CA 1.517 2.897 0 C-N-CA 119.487 -0.885 . . . . 0.0 111.624 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.677 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -76.97 98.96 5.1 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 120.325 -0.55 . . . . 0.0 111.075 179.609 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.58 HD11 HD11 ' A' ' 21' ' ' ILE . 98.2 mt -89.58 119.56 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 177.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.2 tpt85 -81.45 114.12 19.98 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-O 121.443 0.639 . . . . 0.0 111.247 -178.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.17 -36.73 3.75 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.507 ' CG1' HG21 ' A' ' 92' ' ' VAL . 3.1 tp 42.3 93.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.826 0 CA-C-N 118.14 0.97 . . . . 0.0 112.237 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -80.36 154.68 27.59 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.377 -0.827 . . . . 0.0 112.004 -177.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.7 tttm -62.04 -25.07 67.45 Favored 'General case' 0 N--CA 1.509 2.517 0 O-C-N 122.174 -0.329 . . . . 0.0 111.002 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 56.3 p -82.22 -16.62 48.98 Favored 'General case' 0 N--CA 1.505 2.325 0 O-C-N 121.848 -0.532 . . . . 0.0 110.978 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.88 -12.42 36.26 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.622 -0.674 . . . . 0.0 111.732 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.551 ' HB3' HG12 ' A' ' 92' ' ' VAL . 8.2 pt-20 -73.42 142.87 46.92 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.385 -0.822 . . . . 0.0 109.792 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 171.85 -104.27 0.2 Allowed Glycine 0 N--CA 1.498 2.792 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.4 m -147.77 102.13 3.39 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 122.055 -0.674 . . . . 0.0 110.45 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -81.97 139.61 34.46 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.8 ttt180 -102.46 116.79 33.34 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.02 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.482 ' HB3' HD11 ' A' ' 33' ' ' ILE . 7.0 m -79.04 133.43 36.81 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 177.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -133.71 91.58 2.86 Favored 'General case' 0 N--CA 1.504 2.243 0 CA-C-N 118.711 0.687 . . . . 0.0 110.452 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.36 109.6 2.96 Favored Glycine 0 N--CA 1.504 3.185 0 N-CA-C 107.631 -2.187 . . . . 0.0 107.631 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.435 ' NE ' HD12 ' A' ' 34' ' ' ILE . 5.9 ttm180 . . . . . 0 N--CA 1.505 2.284 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -176.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.2 m120 . . . . . 0 N--CA 1.505 2.292 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -164.83 -178.6 5.34 Favored 'General case' 0 N--CA 1.506 2.348 0 C-N-CA 119.723 -0.791 . . . . 0.0 112.937 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.9 mttm -168.72 159.52 9.9 Favored 'General case' 0 N--CA 1.505 2.294 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.586 ' O ' HG22 ' A' ' 9' ' ' THR . 4.0 p-10 -103.66 112.75 25.82 Favored 'General case' 0 N--CA 1.512 2.642 0 O-C-N 121.847 -0.533 . . . . 0.0 110.644 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.572 ' N ' HD12 ' A' ' 88' ' ' ILE . 2.8 mp -98.85 115.23 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -82.87 110.87 18.24 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.533 HG13 HE21 ' A' ' 11' ' ' GLN . 44.4 t -105.54 135.69 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.032 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.41 ' N ' HD12 ' A' ' 91' ' ' ILE . 5.1 mp -124.71 159.76 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.551 HG12 ' HB3' ' A' ' 68' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.503 2.205 0 CA-C-O 117.937 -1.03 . . . . 0.0 110.35 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 43.3 t . . . . . 0 N--CA 1.502 2.129 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.512 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 0.8 OUTLIER -108.31 112.89 25.58 Favored 'General case' 0 N--CA 1.507 2.42 0 C-N-CA 120.251 -0.579 . . . . 0.0 109.56 179.289 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -69.91 120.43 15.63 Favored 'General case' 0 N--CA 1.504 2.242 0 CA-C-O 120.926 0.393 . . . . 0.0 110.485 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.438 ' HG2' HG23 ' A' ' 26' ' ' VAL . 3.0 pttt -130.92 161.55 31.63 Favored 'General case' 0 N--CA 1.502 2.133 0 CA-C-O 121.624 0.726 . . . . 0.0 111.068 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.405 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.4 OUTLIER 32.55 72.38 0.08 Allowed 'General case' 0 N--CA 1.518 2.942 0 C-N-CA 124.213 1.005 . . . . 0.0 113.31 179.602 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -136.5 80.79 37.87 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.739 -0.601 . . . . 0.0 110.972 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -66.08 102.32 0.54 Allowed 'Trans proline' 0 N--CA 1.491 1.378 0 N-CA-C 108.455 -1.402 . . . . 0.0 108.455 178.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.589 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.3 OUTLIER -53.15 -67.82 0.53 Allowed Pre-proline 0 N--CA 1.509 2.5 0 CA-C-O 116.732 -1.604 . . . . 0.0 112.401 -177.219 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.497 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.4 Cg_endo -74.88 95.14 0.96 Allowed 'Trans proline' 0 N--CA 1.498 1.749 0 CA-C-N 121.54 1.586 . . . . 0.0 111.123 178.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.436 HE21 HG13 ' A' ' 90' ' ' VAL . 16.3 pt20 -100.49 179.51 4.42 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.96 -1.087 . . . . 0.0 110.389 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -159.61 124.68 4.06 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.852 -0.53 . . . . 0.0 111.921 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -124.18 -169.04 1.89 Allowed 'General case' 0 N--CA 1.505 2.315 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.0 tttt -106.04 137.18 44.41 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.598 0.713 . . . . 0.0 111.542 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -62.18 115.87 4.5 Favored 'General case' 0 N--CA 1.508 2.471 0 CA-C-O 121.105 0.478 . . . . 0.0 110.168 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.0 22.4 23.12 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.436 ' O ' HG22 ' A' ' 63' ' ' ILE . 15.8 tt0 -118.3 165.31 14.0 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 118.371 1.086 . . . . 0.0 110.851 -179.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -83.3 99.34 9.94 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 177.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.26 169.07 9.38 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.315 0.579 . . . . 0.0 112.197 -177.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.683 HG22 ' HG2' ' A' ' 59' ' ' GLN . 88.5 t -142.01 141.05 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 177.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.801 HD12 HD23 ' A' ' 58' ' ' LEU . 29.2 mt -97.01 114.18 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 178.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.503 HG13 ' CE2' ' A' ' 57' ' ' TYR . 46.8 t -75.41 120.41 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.64 -176.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.0 t -162.4 89.91 0.71 Allowed 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.405 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -88.88 142.88 27.28 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.313 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.781 HG21 HD12 ' A' ' 33' ' ' ILE . 48.0 t -147.34 132.61 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.512 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 48.9 t -93.63 75.54 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.1 m -77.6 163.96 25.78 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.5 t -45.44 -83.58 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.145 0 O-C-N 121.895 -0.503 . . . . 0.0 111.189 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.405 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 0.3 OUTLIER -167.06 -64.37 0.01 OUTLIER Pre-proline 0 N--CA 1.513 2.712 0 CA-C-O 117.61 -1.186 . . . . 0.0 111.686 177.592 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.405 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 2.9 Cg_endo -59.6 -53.15 3.61 Favored 'Trans proline' 0 CA--C 1.563 1.969 0 CA-C-N 120.235 1.12 . . . . 0.0 112.682 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.73 -163.73 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 120.601 0.867 . . . . 0.0 112.611 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.411 HG22 ' H ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -169.94 -168.76 0.79 Allowed 'General case' 0 N--CA 1.518 2.95 0 O-C-N 121.932 -0.48 . . . . 0.0 110.283 -179.576 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.781 HD12 HG21 ' A' ' 25' ' ' VAL . 14.8 tt -97.52 164.24 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 86.6 mt -129.34 129.66 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.563 ' HB2' HG22 ' A' ' 42' ' ' VAL . 84.6 m95 -91.95 101.03 13.59 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.8 tttt . . . . . 0 N--CA 1.5 2.068 0 CA-C-O 121.065 0.46 . . . . 0.0 110.493 -179.134 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.563 HG22 ' HB2' ' A' ' 35' ' ' TRP . 4.1 m . . . . . 0 N--CA 1.509 2.494 0 CA-C-O 120.77 0.319 . . . . 0.0 110.618 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.3 mm -58.91 -17.76 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.757 0 O-C-N 121.578 -0.702 . . . . 0.0 111.679 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.505 ' N ' HD12 ' A' ' 44' ' ' LEU . 8.9 mp -92.53 -22.47 19.53 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.48 -0.762 . . . . 0.0 110.986 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.6 pttt -98.03 -42.27 7.57 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.574 -0.704 . . . . 0.0 109.635 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 20.1 mmmt 46.37 56.49 6.28 Favored 'General case' 0 N--CA 1.51 2.55 0 CA-C-O 121.457 0.646 . . . . 0.0 112.038 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -52.19 169.58 0.07 Allowed 'General case' 0 N--CA 1.515 2.798 0 O-C-N 121.694 -0.628 . . . . 0.0 110.968 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.8 m -61.99 -19.25 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.638 0 O-C-N 121.975 -0.453 . . . . 0.0 111.893 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.1 ptt-85 -116.93 46.49 1.65 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.678 -0.639 . . . . 0.0 111.703 -179.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -143.8 102.99 4.0 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.609 -0.682 . . . . 0.0 109.501 178.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 71.3 mt -128.17 113.22 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.47 HG22 ' CD1' ' A' ' 58' ' ' LEU . 2.4 t -78.62 127.37 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.524 HD11 ' CG ' ' A' ' 59' ' ' GLN . 65.1 mt -78.82 165.51 23.47 Favored 'General case' 0 N--CA 1.508 2.473 0 CA-C-O 121.224 0.535 . . . . 0.0 112.169 -177.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.2 p -60.16 -21.59 61.84 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 122.196 -0.315 . . . . 0.0 111.505 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -91.39 19.04 6.42 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.676 -0.64 . . . . 0.0 111.526 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.0 m120 68.11 31.48 5.38 Favored 'General case' 0 N--CA 1.516 2.851 0 O-C-N 121.661 -0.649 . . . . 0.0 112.145 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.503 ' CE2' HG13 ' A' ' 22' ' ' VAL . 4.0 m-85 -102.12 165.21 11.28 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.801 HD23 HD12 ' A' ' 21' ' ' ILE . 21.9 tp -120.65 98.68 6.14 Favored 'General case' 0 N--CA 1.517 2.908 0 C-N-CA 119.341 -0.944 . . . . 0.0 112.008 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.683 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -76.18 104.97 6.96 Favored 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.991 179.486 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.716 HD11 HD11 ' A' ' 21' ' ' ILE . 98.9 mt -96.56 113.63 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 177.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -77.08 115.95 17.32 Favored 'General case' 0 N--CA 1.503 2.224 0 CA-C-O 121.394 0.616 . . . . 0.0 111.287 -178.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.53 -37.02 3.65 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.588 ' CG1' HG21 ' A' ' 92' ' ' VAL . 3.6 tp 40.11 84.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.521 3.095 0 CA-C-O 122.133 0.968 . . . . 0.0 112.44 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 45.6 mttt -75.99 160.08 30.2 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 121.631 -0.668 . . . . 0.0 112.151 -178.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.8 tttm -60.86 -25.6 66.79 Favored 'General case' 0 N--CA 1.51 2.564 0 O-C-N 122.022 -0.424 . . . . 0.0 110.974 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 63.9 p -80.14 -16.9 53.92 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 121.859 -0.525 . . . . 0.0 111.56 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.25 -29.47 26.46 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.51 -0.743 . . . . 0.0 110.509 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.438 ' HB3' HG12 ' A' ' 92' ' ' VAL . 5.7 pt-20 -61.72 140.68 58.17 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.884 -0.51 . . . . 0.0 111.18 -178.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 169.06 -101.39 0.17 Allowed Glycine 0 N--CA 1.497 2.765 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.3 m -151.23 100.6 2.77 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 122.079 -0.659 . . . . 0.0 110.382 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -81.64 140.05 34.63 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.2 ttm-85 -102.44 121.09 41.64 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 120.059 -0.656 . . . . 0.0 111.511 -179.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.501 ' HB3' HD11 ' A' ' 33' ' ' ILE . 9.8 m -86.1 130.1 34.64 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 177.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -131.38 90.47 2.87 Favored 'General case' 0 N--CA 1.506 2.331 0 CA-C-N 118.783 0.719 . . . . 0.0 110.526 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.2 106.27 1.74 Allowed Glycine 0 N--CA 1.504 3.208 0 N-CA-C 107.827 -2.109 . . . . 0.0 107.827 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 . . . . . 0 N--CA 1.504 2.24 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -177.12 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.8 m120 . . . . . 0 N--CA 1.498 1.952 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -161.9 -179.25 7.02 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 120.009 -0.676 . . . . 0.0 112.221 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.0 mttt -165.76 160.39 17.11 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.589 ' O ' HG22 ' A' ' 9' ' ' THR . 6.9 p-10 -104.17 113.36 26.86 Favored 'General case' 0 N--CA 1.511 2.612 0 O-C-N 121.896 -0.502 . . . . 0.0 110.213 178.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.582 ' N ' HD12 ' A' ' 88' ' ' ILE . 3.0 mp -100.89 116.74 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -82.96 122.09 27.84 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.436 HG13 HE21 ' A' ' 11' ' ' GLN . 44.6 t -116.01 126.5 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.16 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 71.0 mt -115.68 155.75 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.588 HG21 ' CG1' ' A' ' 63' ' ' ILE . 0.9 OUTLIER . . . . . 0 N--CA 1.499 1.975 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.71 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 48.4 t . . . . . 0 N--CA 1.504 2.243 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.427 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 16.3 mtp -114.81 106.56 14.33 Favored 'General case' 0 N--CA 1.513 2.698 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -66.38 119.16 11.11 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.959 -0.463 . . . . 0.0 110.747 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.401 ' HG2' HG23 ' A' ' 26' ' ' VAL . 0.4 OUTLIER -130.87 156.2 45.44 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-O 121.578 0.704 . . . . 0.0 110.558 179.768 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.422 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 1.6 t30 39.13 87.75 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.051 0 C-N-CA 123.404 0.682 . . . . 0.0 112.193 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -143.04 61.36 10.32 Favored Pre-proline 0 N--CA 1.497 1.917 0 C-N-CA 119.91 -0.716 . . . . 0.0 112.332 -178.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -64.68 93.34 0.2 Allowed 'Trans proline' 0 N--CA 1.494 1.506 0 N-CA-C 107.972 -1.588 . . . . 0.0 107.972 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.502 HG22 HD13 ' A' ' 88' ' ' ILE . 18.3 p -53.04 -42.79 92.53 Favored Pre-proline 0 N--CA 1.508 2.472 0 CA-C-O 117.343 -1.313 . . . . 0.0 113.631 -176.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.494 ' HD3' ' OG1' ' A' ' 9' ' ' THR . 1.6 Cg_endo -82.83 86.55 1.46 Allowed 'Trans proline' 0 CA--C 1.548 1.203 0 CA-C-N 120.785 1.316 . . . . 0.0 111.051 -177.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.491 HE21 HG13 ' A' ' 90' ' ' VAL . 17.8 pt20 -100.16 171.17 7.97 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 121.15 -0.969 . . . . 0.0 111.068 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -155.92 119.9 4.48 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 122.089 -0.382 . . . . 0.0 110.975 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -116.28 -171.09 1.93 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.871 -0.518 . . . . 0.0 110.196 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.0 tttm -103.68 139.58 38.76 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.492 0.663 . . . . 0.0 111.633 -178.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -59.83 125.83 25.2 Favored 'General case' 0 N--CA 1.508 2.442 0 O-C-N 121.767 -0.583 . . . . 0.0 110.815 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.24 22.04 66.16 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -113.59 160.9 18.06 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-N 118.829 1.314 . . . . 0.0 111.094 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -78.29 98.38 5.91 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.39 174.0 6.49 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.125 0.488 . . . . 0.0 111.875 -177.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.702 HG22 ' HG2' ' A' ' 59' ' ' GLN . 85.9 t -145.57 141.52 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.889 HD12 HD23 ' A' ' 58' ' ' LEU . 21.9 mt -95.95 116.77 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 178.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.417 ' HA ' ' CE2' ' A' ' 57' ' ' TYR . 55.6 t -75.98 121.02 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 CA-C-O 121.446 0.641 . . . . 0.0 111.42 -176.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.8 t -165.2 93.75 0.61 Allowed 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.422 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -91.4 139.11 31.03 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.044 -179.582 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.694 HG21 HD12 ' A' ' 33' ' ' ILE . 47.8 t -147.08 131.95 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.427 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 48.2 t -94.09 74.06 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.1 m -76.18 165.93 24.2 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.1 t -47.65 -82.75 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.085 0 O-C-N 121.877 -0.515 . . . . 0.0 111.206 -179.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.414 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 0.7 OUTLIER -166.59 -63.22 0.01 OUTLIER Pre-proline 0 N--CA 1.513 2.694 0 CA-C-O 117.661 -1.161 . . . . 0.0 111.696 178.173 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.414 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 2.9 Cg_endo -60.22 -53.19 3.2 Favored 'Trans proline' 0 CA--C 1.561 1.852 0 CA-C-N 120.203 1.108 . . . . 0.0 112.503 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.44 ' C ' ' HG1' ' A' ' 32' ' ' THR . 2.8 Cg_endo -63.45 -164.58 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.715 0 CA-C-N 119.211 0.754 . . . . 0.0 112.51 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.44 ' HG1' ' C ' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -171.79 -164.5 0.32 Allowed 'General case' 0 N--CA 1.52 3.037 0 O-C-N 121.925 -0.484 . . . . 0.0 110.206 -179.842 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.716 HD11 ' HB3' ' A' ' 73' ' ' CYS . 18.8 tt -103.49 136.32 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 122.038 -0.414 . . . . 0.0 110.069 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.507 ' N ' HD12 ' A' ' 34' ' ' ILE . 5.0 mp -100.79 130.03 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.579 ' CG ' HD22 ' A' ' 58' ' ' LEU . 74.7 m95 -89.73 107.34 19.04 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 48.2 mttt . . . . . 0 N--CA 1.496 1.841 0 O-C-N 122.02 -0.425 . . . . 0.0 110.618 -178.732 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.493 HG22 ' HB2' ' A' ' 35' ' ' TRP . 4.8 m . . . . . 0 N--CA 1.506 2.332 0 CA-C-O 120.877 0.37 . . . . 0.0 110.28 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 77.9 mt -60.61 -16.87 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.829 0 O-C-N 121.943 -0.473 . . . . 0.0 111.658 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.449 ' N ' HD12 ' A' ' 44' ' ' LEU . 10.3 mp -91.43 -22.29 20.52 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.469 -0.769 . . . . 0.0 110.731 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.5 pttt -98.55 -36.43 9.91 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.71 -0.619 . . . . 0.0 109.411 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.4 mmmt 47.92 55.0 9.19 Favored 'General case' 0 N--CA 1.507 2.379 0 CA-C-O 121.405 0.622 . . . . 0.0 112.035 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.52 169.39 0.13 Allowed 'General case' 0 N--CA 1.513 2.685 0 O-C-N 121.705 -0.622 . . . . 0.0 110.81 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.7 m -63.78 -16.02 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.612 0 O-C-N 121.891 -0.506 . . . . 0.0 111.872 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.5 ptt-85 -120.07 45.05 2.27 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.585 -0.697 . . . . 0.0 111.956 -178.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -145.49 101.59 3.6 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.56 -0.712 . . . . 0.0 110.418 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.9 mm -125.96 113.79 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.439 HG22 ' CD1' ' A' ' 58' ' ' LEU . 2.5 t -80.02 139.4 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.411 HD11 ' CG ' ' A' ' 59' ' ' GLN . 31.8 mt -92.92 165.51 12.85 Favored 'General case' 0 N--CA 1.506 2.327 0 CA-C-O 121.335 0.588 . . . . 0.0 112.0 -178.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.1 p -61.09 -21.25 63.51 Favored 'General case' 0 N--CA 1.509 2.493 0 O-C-N 122.097 -0.377 . . . . 0.0 111.212 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 46.5 p-10 -89.67 16.97 6.99 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.573 -0.704 . . . . 0.0 111.503 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.6 m120 68.14 31.49 5.33 Favored 'General case' 0 N--CA 1.517 2.896 0 O-C-N 121.559 -0.713 . . . . 0.0 112.278 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.417 ' CE2' ' HA ' ' A' ' 22' ' ' VAL . 4.2 m-85 -103.68 165.64 10.91 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 177.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.889 HD23 HD12 ' A' ' 21' ' ' ILE . 23.4 tp -121.48 99.42 6.46 Favored 'General case' 0 N--CA 1.516 2.833 0 C-N-CA 119.404 -0.918 . . . . 0.0 111.901 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.702 ' HG2' HG22 ' A' ' 20' ' ' VAL . 1.3 mt-30 -76.0 105.16 6.89 Favored 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.089 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.843 HD11 HD11 ' A' ' 21' ' ' ILE . 96.5 mt -95.26 115.08 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.45 113.32 12.72 Favored 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.642 -177.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.66 -35.12 4.69 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 178.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.652 HG23 HG21 ' A' ' 92' ' ' VAL . 3.1 tp 41.07 76.65 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.519 2.98 0 CA-C-N 118.15 0.975 . . . . 0.0 112.116 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.6 mtpp -59.65 147.63 36.74 Favored 'General case' 0 N--CA 1.508 2.444 0 O-C-N 121.411 -0.805 . . . . 0.0 111.769 -178.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.551 ' HA ' HG13 ' A' ' 92' ' ' VAL . 38.2 tttt -62.22 -17.46 58.34 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 122.23 -0.294 . . . . 0.0 111.037 178.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.8 p -90.81 -16.72 27.82 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.6 -0.688 . . . . 0.0 111.116 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.2 12.44 20.13 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.573 -0.704 . . . . 0.0 112.039 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.795 ' HB3' HG12 ' A' ' 92' ' ' VAL . 0.4 OUTLIER -92.78 160.93 14.73 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.33 -0.856 . . . . 0.0 109.368 179.342 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 157.12 -98.68 0.18 Allowed Glycine 0 N--CA 1.495 2.625 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.7 m -153.67 102.49 2.55 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 117.52 0.66 . . . . 0.0 111.292 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -82.38 139.38 34.09 Favored 'General case' 0 N--CA 1.506 2.33 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.9 ttp180 -101.25 119.61 39.01 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.282 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.716 ' HB3' HD11 ' A' ' 33' ' ' ILE . 37.8 m -79.56 127.85 32.66 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 177.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.71 85.11 2.35 Favored 'General case' 0 N--CA 1.505 2.321 0 CA-C-N 119.312 0.96 . . . . 0.0 110.549 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.88 105.12 1.31 Allowed Glycine 0 N--CA 1.504 3.231 0 N-CA-C 107.688 -2.165 . . . . 0.0 107.688 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 34.4 ttp85 . . . . . 0 N--CA 1.497 1.905 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -176.823 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 N--CA 1.499 1.994 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -159.2 176.07 12.66 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 119.544 -0.862 . . . . 0.0 112.9 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.8 mttp -165.74 158.68 15.49 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -96.92 138.52 34.34 Favored 'General case' 0 N--CA 1.506 2.351 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.212 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.502 HD13 HG22 ' A' ' 9' ' ' THR . 46.4 mm -121.04 104.73 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -71.17 113.32 8.09 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.491 HG13 HE21 ' A' ' 11' ' ' GLN . 43.5 t -110.72 132.48 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.621 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 71.7 mt -124.76 143.83 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.365 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.795 HG12 ' HB3' ' A' ' 68' ' ' GLU . 9.9 p . . . . . 0 N--CA 1.503 2.194 0 CA-C-O 118.043 -0.98 . . . . 0.0 110.863 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 44.3 t . . . . . 0 N--CA 1.5 2.06 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.503 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 12.0 mmt -110.16 123.14 49.21 Favored 'General case' 0 N--CA 1.51 2.54 0 O-C-N 121.85 -0.531 . . . . 0.0 111.868 -178.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -77.26 122.11 24.62 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 120.927 0.394 . . . . 0.0 110.585 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.44 ' HG2' HG23 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -132.83 157.06 45.96 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.427 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.1 OUTLIER 40.17 70.67 0.22 Allowed 'General case' 0 N--CA 1.517 2.913 0 C-N-CA 123.178 0.591 . . . . 0.0 111.956 -179.493 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -130.16 71.47 82.22 Favored Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.599 -0.688 . . . . 0.0 111.017 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -64.52 108.36 1.01 Allowed 'Trans proline' 0 N--CA 1.492 1.406 0 N-CA-C 109.161 -1.13 . . . . 0.0 109.161 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.636 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.3 OUTLIER -63.2 -69.18 0.63 Allowed Pre-proline 0 N--CA 1.503 2.189 0 CA-C-O 116.767 -1.587 . . . . 0.0 111.5 -178.101 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.496 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.4 Cg_endo -71.52 88.34 0.75 Allowed 'Trans proline' 0 N--CA 1.492 1.432 0 CA-C-N 121.392 1.533 . . . . 0.0 111.706 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.507 HE21 HG13 ' A' ' 90' ' ' VAL . 12.0 pt20 -100.66 169.45 9.02 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 120.99 -1.069 . . . . 0.0 109.192 177.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -157.01 122.35 4.64 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.708 -0.62 . . . . 0.0 111.277 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -115.21 -173.78 2.38 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.948 -0.47 . . . . 0.0 110.033 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -102.54 140.51 36.72 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.536 0.684 . . . . 0.0 111.404 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -60.16 117.78 5.55 Favored 'General case' 0 N--CA 1.51 2.535 0 O-C-N 121.985 -0.447 . . . . 0.0 110.855 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.27 22.05 36.25 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.407 ' O ' HG22 ' A' ' 63' ' ' ILE . 15.4 tt0 -113.81 159.69 19.52 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 118.465 1.132 . . . . 0.0 111.465 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -79.55 100.31 7.7 Favored 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 177.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -101.86 168.61 9.32 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.59 0.709 . . . . 0.0 112.386 -177.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.656 HG22 ' HG2' ' A' ' 59' ' ' GLN . 98.6 t -144.16 137.33 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 178.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.759 HD12 HD23 ' A' ' 58' ' ' LEU . 53.7 mt -93.89 115.85 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 178.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.518 HG13 ' CZ ' ' A' ' 57' ' ' TYR . 43.0 t -76.41 115.49 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-O 121.492 0.663 . . . . 0.0 110.903 -176.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.1 t -161.16 81.38 0.62 Allowed 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.427 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.4 OUTLIER -80.37 147.74 30.92 Favored 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.878 -178.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.4 HG21 HD12 ' A' ' 33' ' ' ILE . 44.7 t -147.64 137.73 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.503 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 25.8 t -97.7 88.95 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.52 138.58 31.66 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.7 t -94.86 14.76 20.46 Favored 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -177.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.445 ' HB3' ' HD2' ' A' ' 31' ' ' PRO . 17.3 mt -140.59 168.18 15.37 Favored Pre-proline 0 N--CA 1.503 2.22 0 O-C-N 121.164 -0.96 . . . . 0.0 111.677 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.435 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 3.9 Cg_exo -48.2 -47.37 19.82 Favored 'Trans proline' 0 N--CA 1.502 2.029 0 C-N-CA 121.616 1.544 . . . . 0.0 114.516 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 29' ' ' LEU . 4.6 Cg_exo -55.13 -165.43 0.01 OUTLIER 'Trans proline' 0 N--CA 1.504 2.116 0 CA-C-N 120.004 1.037 . . . . 0.0 112.794 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.648 HG22 ' ND2' ' A' ' 56' ' ' ASN . 0.2 OUTLIER -169.65 -157.29 0.16 Allowed 'General case' 0 N--CA 1.518 2.935 0 O-C-N 120.556 -1.34 . . . . 0.0 111.02 -176.937 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.488 HD11 ' HB3' ' A' ' 73' ' ' CYS . 20.2 tt -78.98 166.75 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.876 -0.515 . . . . 0.0 110.796 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.452 HD13 ' O ' ' A' ' 33' ' ' ILE . 38.2 mm -128.85 128.51 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.592 ' HB2' HG22 ' A' ' 42' ' ' VAL . 81.5 m95 -93.89 99.18 11.58 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 120.191 -0.604 . . . . 0.0 109.44 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.4 tttm . . . . . 0 N--CA 1.497 1.892 0 O-C-N 121.922 -0.486 . . . . 0.0 110.285 -179.217 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.592 HG22 ' HB2' ' A' ' 35' ' ' TRP . 7.7 m . . . . . 0 N--CA 1.51 2.527 0 CA-C-O 120.897 0.38 . . . . 0.0 110.342 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 50.6 mt -59.24 -17.24 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.812 0 O-C-N 121.746 -0.596 . . . . 0.0 111.651 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.484 ' N ' HD12 ' A' ' 44' ' ' LEU . 9.7 mp -90.82 -23.27 20.64 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.504 -0.748 . . . . 0.0 110.882 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 53.9 pttt -97.89 -37.06 9.96 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.696 -0.627 . . . . 0.0 109.595 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm 46.49 55.26 7.72 Favored 'General case' 0 N--CA 1.51 2.529 0 CA-C-O 121.335 0.588 . . . . 0.0 112.229 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.3 163.71 0.55 Allowed 'General case' 0 N--CA 1.515 2.778 0 O-C-N 121.657 -0.652 . . . . 0.0 110.736 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.8 m -58.6 -20.77 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.779 0 O-C-N 121.868 -0.52 . . . . 0.0 111.823 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 16.8 ptt-85 -113.95 46.05 1.38 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.757 -0.59 . . . . 0.0 111.684 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -146.25 108.33 4.39 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.67 -0.644 . . . . 0.0 110.138 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 71.6 mt -130.85 107.8 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.422 HG22 ' CD1' ' A' ' 58' ' ' LEU . 2.6 t -74.76 134.17 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.0 mt -89.23 160.43 16.94 Favored 'General case' 0 N--CA 1.505 2.307 0 CA-C-O 121.223 0.535 . . . . 0.0 111.364 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 90.5 p -60.2 -19.74 55.56 Favored 'General case' 0 N--CA 1.508 2.459 0 O-C-N 122.091 -0.381 . . . . 0.0 111.194 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 49.8 p-10 -91.87 19.21 6.81 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.673 -0.642 . . . . 0.0 111.653 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.648 ' ND2' HG22 ' A' ' 32' ' ' THR . 6.2 m120 70.51 29.68 3.36 Favored 'General case' 0 N--CA 1.524 3.23 0 O-C-N 121.615 -0.678 . . . . 0.0 112.681 178.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.518 ' CZ ' HG13 ' A' ' 22' ' ' VAL . 4.6 m-85 -105.74 157.85 17.15 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.759 HD23 HD12 ' A' ' 21' ' ' ILE . 20.5 tp -115.61 98.94 6.99 Favored 'General case' 0 N--CA 1.517 2.912 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.164 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.656 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -75.96 100.18 4.78 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.099 179.719 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.58 HD11 HD11 ' A' ' 21' ' ' ILE . 88.3 mt -92.1 120.72 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 177.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -83.71 114.59 21.69 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 121.299 0.571 . . . . 0.0 111.308 -178.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 100.25 -37.32 3.62 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 178.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.751 ' CG1' HG21 ' A' ' 92' ' ' VAL . 4.1 tp 38.21 97.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.139 0 CA-C-O 121.862 0.839 . . . . 0.0 112.8 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.538 ' HB3' HG22 ' A' ' 66' ' ' THR . 20.7 mmtp -90.7 150.02 21.82 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.26 -0.9 . . . . 0.0 111.172 -178.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.6 ptmt -59.48 -28.25 66.84 Favored 'General case' 0 N--CA 1.512 2.637 0 O-C-N 122.002 -0.436 . . . . 0.0 110.271 178.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.538 HG22 ' HB3' ' A' ' 64' ' ' LYS . 7.3 t -72.12 -14.97 61.98 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.897 -0.502 . . . . 0.0 110.603 178.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -99.12 -6.48 28.25 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.638 -0.664 . . . . 0.0 111.579 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -71.94 162.21 29.8 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.319 -0.863 . . . . 0.0 109.144 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 155.02 -111.97 0.51 Allowed Glycine 0 N--CA 1.496 2.691 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 16.9 m -143.62 99.16 3.37 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 122.108 -0.642 . . . . 0.0 110.867 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -79.3 133.47 36.63 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -95.4 119.41 33.85 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.671 -0.812 . . . . 0.0 111.5 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.488 ' HB3' HD11 ' A' ' 33' ' ' ILE . 9.1 m -81.97 129.15 34.69 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 177.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -132.36 85.99 2.29 Favored 'General case' 0 N--CA 1.507 2.409 0 CA-C-N 119.155 0.889 . . . . 0.0 110.791 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' A' ' 33' ' ' ILE . . . -58.55 103.6 0.38 Allowed Glycine 0 N--CA 1.508 3.492 0 N-CA-C 108.507 -1.837 . . . . 0.0 108.507 178.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.8 ttm-85 . . . . . 0 N--CA 1.499 1.984 0 CA-C-O 122.255 1.026 . . . . 0.0 113.752 -176.744 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.7 m120 . . . . . 0 N--CA 1.505 2.3 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 43.8 p90 -160.63 175.5 12.59 Favored 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 119.507 -0.877 . . . . 0.0 112.918 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 8.1 mttp -166.58 154.8 10.21 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.636 ' O ' HG22 ' A' ' 9' ' ' THR . 4.9 p-10 -99.66 114.01 26.82 Favored 'General case' 0 N--CA 1.51 2.559 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.007 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.583 ' N ' HD12 ' A' ' 88' ' ' ILE . 2.1 mp -102.45 123.38 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -91.96 120.32 32.51 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.507 HG13 HE21 ' A' ' 11' ' ' GLN . 48.3 t -107.73 140.53 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 C-N-CA 120.658 -0.417 . . . . 0.0 109.907 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.618 ' O ' HG23 ' A' ' 92' ' ' VAL . 32.2 mm -126.18 147.52 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.41 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.751 HG21 ' CG1' ' A' ' 63' ' ' ILE . 2.1 t . . . . . 0 N--CA 1.502 2.174 0 CA-C-O 117.962 -1.018 . . . . 0.0 108.553 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 48.0 t . . . . . 0 N--CA 1.502 2.139 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.508 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 3.1 mmt -112.54 110.65 20.96 Favored 'General case' 0 N--CA 1.509 2.494 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.242 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -69.35 115.41 8.58 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 122.114 -0.366 . . . . 0.0 110.901 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.34 160.33 32.52 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 121.723 0.773 . . . . 0.0 111.283 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.406 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.3 OUTLIER 32.92 79.39 0.03 OUTLIER 'General case' 0 N--CA 1.52 3.049 0 C-N-CA 123.975 0.91 . . . . 0.0 113.35 179.398 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -142.1 78.68 16.89 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.726 -0.609 . . . . 0.0 111.103 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -66.62 104.48 0.79 Allowed 'Trans proline' 0 N--CA 1.489 1.263 0 N-CA-C 108.535 -1.371 . . . . 0.0 108.535 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.579 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.2 OUTLIER -55.46 -61.03 6.8 Favored Pre-proline 0 N--CA 1.505 2.304 0 CA-C-O 116.974 -1.489 . . . . 0.0 112.361 -177.586 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.547 ' HD3' ' OG1' ' A' ' 9' ' ' THR . 1.4 Cg_endo -78.66 93.75 1.09 Allowed 'Trans proline' 0 N--CA 1.493 1.443 0 CA-C-N 121.134 1.441 . . . . 0.0 111.552 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.496 HE21 HG13 ' A' ' 90' ' ' VAL . 16.6 pt20 -101.2 172.17 7.16 Favored 'General case' 0 N--CA 1.508 2.445 0 O-C-N 120.911 -1.118 . . . . 0.0 109.864 178.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -148.47 125.72 11.51 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.822 -0.549 . . . . 0.0 111.587 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -127.14 -165.54 1.48 Allowed 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.07 147.59 52.64 Favored 'General case' 0 N--CA 1.517 2.897 0 CA-C-O 121.92 0.866 . . . . 0.0 111.906 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -57.96 130.47 46.68 Favored 'General case' 0 N--CA 1.507 2.411 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.209 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.3 17.8 77.34 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.662 ' O ' HG22 ' A' ' 63' ' ' ILE . 7.7 tp10 -109.38 155.11 21.64 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 119.182 1.491 . . . . 0.0 111.434 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -79.77 98.54 7.06 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -104.69 169.49 8.42 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.626 0.727 . . . . 0.0 112.586 -177.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.675 HG22 ' HG2' ' A' ' 59' ' ' GLN . 87.9 t -144.53 140.82 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.867 HD12 HD23 ' A' ' 58' ' ' LEU . 48.5 mt -96.84 114.95 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 178.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.513 HG13 ' CZ ' ' A' ' 57' ' ' TYR . 47.4 t -75.5 119.35 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 CA-C-O 121.61 0.719 . . . . 0.0 110.842 -176.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.6 t -161.71 89.01 0.72 Allowed 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.406 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -88.41 138.77 31.14 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.193 -179.016 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.718 HG21 HD12 ' A' ' 33' ' ' ILE . 43.4 t -147.04 126.55 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.508 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 48.1 t -90.87 77.76 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.5 m -78.74 165.85 23.13 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 t -43.96 -85.51 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.177 0 O-C-N 121.753 -0.592 . . . . 0.0 111.443 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.417 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 1.1 mt -165.48 -63.06 0.01 OUTLIER Pre-proline 0 N--CA 1.512 2.657 0 CA-C-O 117.677 -1.154 . . . . 0.0 111.52 177.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.417 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 2.9 Cg_endo -60.55 -53.37 2.88 Favored 'Trans proline' 0 CA--C 1.564 1.987 0 CA-C-N 120.102 1.072 . . . . 0.0 112.524 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.409 ' HD3' ' CG ' ' A' ' 30' ' ' PRO . 2.9 Cg_endo -62.68 -163.66 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 120.541 0.827 . . . . 0.0 112.418 -179.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -171.75 -166.15 0.42 Allowed 'General case' 0 N--CA 1.518 2.937 0 O-C-N 121.861 -0.525 . . . . 0.0 110.304 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.718 HD12 HG21 ' A' ' 25' ' ' VAL . 16.9 tt -99.54 147.98 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 78.0 mt -111.23 127.3 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.573 ' HB2' HG22 ' A' ' 42' ' ' VAL . 76.8 m95 -89.9 109.69 20.69 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.0 tttm . . . . . 0 N--CA 1.502 2.146 0 CA-C-O 121.072 0.463 . . . . 0.0 110.572 -178.561 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.573 HG22 ' HB2' ' A' ' 35' ' ' TRP . 9.7 m . . . . . 0 N--CA 1.51 2.527 0 CA-C-O 121.054 0.454 . . . . 0.0 110.494 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 66.8 mt -60.56 -15.7 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.781 0 O-C-N 121.817 -0.552 . . . . 0.0 111.768 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.442 ' N ' HD12 ' A' ' 44' ' ' LEU . 10.9 mp -90.68 -21.79 21.46 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.527 -0.733 . . . . 0.0 110.666 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.1 pttt -97.77 -35.48 10.53 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.598 -0.689 . . . . 0.0 109.733 178.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.1 mmmt 46.35 56.5 6.25 Favored 'General case' 0 N--CA 1.509 2.525 0 CA-C-O 121.382 0.61 . . . . 0.0 112.134 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -50.32 171.59 0.03 OUTLIER 'General case' 0 N--CA 1.516 2.84 0 O-C-N 121.732 -0.605 . . . . 0.0 111.491 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.5 t -65.57 -14.9 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.539 0 O-C-N 121.952 -0.468 . . . . 0.0 111.415 -179.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -115.85 -4.6 12.09 Favored 'General case' 0 N--CA 1.506 2.364 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.438 ' C ' HD12 ' A' ' 51' ' ' ILE . 12.1 m-85 -94.14 115.22 27.48 Favored 'General case' 0 N--CA 1.503 2.182 0 CA-C-N 119.075 0.852 . . . . 0.0 110.616 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.438 HD12 ' C ' ' A' ' 50' ' ' PHE . 5.2 mp -137.19 106.25 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.442 HG22 ' CD1' ' A' ' 58' ' ' LEU . 2.8 t -73.74 128.18 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.502 HD11 ' CG ' ' A' ' 59' ' ' GLN . 52.6 mt -81.93 166.84 19.53 Favored 'General case' 0 N--CA 1.506 2.357 0 CA-C-O 121.377 0.608 . . . . 0.0 112.022 -178.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.6 p -60.66 -21.69 63.07 Favored 'General case' 0 N--CA 1.509 2.51 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.229 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 42.1 p-10 -91.55 19.03 6.61 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.665 -0.647 . . . . 0.0 111.403 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.5 m120 66.63 32.72 6.91 Favored 'General case' 0 N--CA 1.515 2.798 0 O-C-N 121.627 -0.67 . . . . 0.0 112.223 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.513 ' CZ ' HG13 ' A' ' 22' ' ' VAL . 3.5 m-85 -101.69 168.34 9.53 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.867 HD23 HD12 ' A' ' 21' ' ' ILE . 17.1 tp -121.43 96.99 5.3 Favored 'General case' 0 N--CA 1.517 2.912 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.621 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.675 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -76.4 104.2 6.8 Favored 'General case' 0 N--CA 1.502 2.174 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.919 179.49 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.549 HD11 HD11 ' A' ' 21' ' ' ILE . 96.5 mt -97.55 101.37 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 177.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.35 114.77 7.91 Favored 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 121.252 0.549 . . . . 0.0 110.97 -178.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 101.39 -34.18 5.87 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 109.971 -1.251 . . . . 0.0 109.971 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.662 HG22 ' O ' ' A' ' 17' ' ' GLU . 1.8 tp 32.92 92.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.523 3.212 0 CA-C-N 117.925 0.863 . . . . 0.0 113.251 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.549 ' HB3' HG22 ' A' ' 66' ' ' THR . 3.2 mmmm -74.23 148.25 41.72 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.697 -0.627 . . . . 0.0 110.834 -178.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -63.4 -19.13 64.42 Favored 'General case' 0 N--CA 1.508 2.455 0 C-N-CA 120.571 -0.451 . . . . 0.0 110.711 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.549 HG22 ' HB3' ' A' ' 64' ' ' LYS . 10.1 t -83.76 -12.85 55.15 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.441 -0.787 . . . . 0.0 111.105 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.43 11.03 36.36 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.49 -0.756 . . . . 0.0 111.571 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -88.0 152.73 21.83 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.286 -0.884 . . . . 0.0 109.533 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 163.95 -106.15 0.27 Allowed Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.2 m -146.51 103.85 3.71 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 122.156 -0.614 . . . . 0.0 110.654 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -83.61 128.72 34.74 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.4 tpp180 -91.77 118.37 30.62 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.179 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.567 ' HB3' HD11 ' A' ' 33' ' ' ILE . 5.1 m -83.77 122.59 28.86 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 177.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -123.27 88.27 2.89 Favored 'General case' 0 N--CA 1.506 2.349 0 CA-C-N 118.738 0.699 . . . . 0.0 110.643 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.7 103.03 0.9 Allowed Glycine 0 N--CA 1.503 3.161 0 N-CA-C 107.653 -2.179 . . . . 0.0 107.653 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 . . . . . 0 N--CA 1.5 2.054 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -176.808 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.9 m120 . . . . . 0 N--CA 1.503 2.208 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.403 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 42.7 p90 -162.06 -179.21 6.93 Favored 'General case' 0 N--CA 1.503 2.191 0 C-N-CA 119.612 -0.835 . . . . 0.0 113.142 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.6 mttt -167.16 161.54 14.64 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.579 ' O ' HG22 ' A' ' 9' ' ' THR . 4.7 p-10 -103.27 112.35 25.18 Favored 'General case' 0 N--CA 1.51 2.545 0 O-C-N 121.782 -0.574 . . . . 0.0 111.221 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.582 ' N ' HD12 ' A' ' 88' ' ' ILE . 3.0 mp -97.06 115.62 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -85.22 117.27 24.06 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.496 HG13 HE21 ' A' ' 11' ' ' GLN . 42.7 t -111.05 135.27 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 CA-C-O 121.058 0.456 . . . . 0.0 110.045 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 47.7 mt -121.76 135.02 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.44 HG21 ' CG1' ' A' ' 63' ' ' ILE . 54.7 t . . . . . 0 N--CA 1.504 2.27 0 CA-C-O 118.308 -0.853 . . . . 0.0 109.782 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.2 t . . . . . 0 N--CA 1.503 2.204 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.544 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 4.7 mmt -111.38 116.86 31.66 Favored 'General case' 0 N--CA 1.51 2.556 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.142 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -73.44 119.63 17.94 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 122.039 -0.413 . . . . 0.0 110.485 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.401 ' HG2' HG23 ' A' ' 26' ' ' VAL . 0.8 OUTLIER -132.82 160.15 37.73 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 121.495 0.664 . . . . 0.0 111.076 -179.388 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.407 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.4 OUTLIER 33.31 88.85 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.107 0 C-N-CA 124.013 0.925 . . . . 0.0 113.423 179.474 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -157.25 81.23 3.27 Favored Pre-proline 0 N--CA 1.495 1.806 0 C-N-CA 120.084 -0.646 . . . . 0.0 111.55 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -64.97 105.61 0.69 Allowed 'Trans proline' 0 N--CA 1.492 1.416 0 N-CA-C 108.588 -1.351 . . . . 0.0 108.588 177.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.544 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.2 OUTLIER -53.88 -66.91 0.71 Allowed Pre-proline 0 N--CA 1.508 2.468 0 CA-C-O 116.91 -1.519 . . . . 0.0 112.245 -177.593 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.486 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.4 Cg_endo -73.13 92.47 0.82 Allowed 'Trans proline' 0 N--CA 1.495 1.591 0 CA-C-N 121.242 1.479 . . . . 0.0 110.978 178.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.458 HE21 HG13 ' A' ' 90' ' ' VAL . 13.1 pt20 -100.18 173.05 6.8 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 120.917 -1.114 . . . . 0.0 110.192 178.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -155.1 125.3 6.72 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.937 -0.477 . . . . 0.0 111.304 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -122.98 -169.73 1.98 Allowed 'General case' 0 N--CA 1.504 2.246 0 O-C-N 122.025 -0.422 . . . . 0.0 110.04 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -106.05 138.65 41.87 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.578 0.704 . . . . 0.0 111.507 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -60.13 126.6 28.13 Favored 'General case' 0 N--CA 1.509 2.498 0 O-C-N 121.717 -0.614 . . . . 0.0 110.739 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.36 21.14 62.96 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.434 ' O ' HG22 ' A' ' 63' ' ' ILE . 7.5 tp10 -112.85 161.63 16.72 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 118.811 1.306 . . . . 0.0 111.31 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.88 98.66 7.2 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 177.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -101.56 169.02 9.12 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 120.15 -0.62 . . . . 0.0 112.109 -177.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.656 HG22 ' HG2' ' A' ' 59' ' ' GLN . 84.1 t -142.23 140.68 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 178.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.718 HD12 HD23 ' A' ' 58' ' ' LEU . 43.9 mt -96.62 115.34 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 178.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.426 ' HA ' ' CE2' ' A' ' 57' ' ' TYR . 57.3 t -76.41 116.98 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 CA-C-O 121.355 0.598 . . . . 0.0 110.536 -177.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.2 t -160.67 89.82 0.83 Allowed 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.407 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -87.53 141.56 28.52 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.212 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.689 HG21 HD12 ' A' ' 33' ' ' ILE . 44.5 t -147.11 129.18 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.544 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 26.4 t -90.41 75.17 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.8 m -79.53 162.22 25.52 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 178.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 t -43.18 -85.04 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.25 0 O-C-N 121.844 -0.535 . . . . 0.0 111.433 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.4 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 1.3 mt -166.77 -63.56 0.01 OUTLIER Pre-proline 0 N--CA 1.512 2.658 0 CA-C-O 117.747 -1.121 . . . . 0.0 111.1 177.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.4 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 3.0 Cg_endo -59.65 -53.37 3.39 Favored 'Trans proline' 0 CA--C 1.565 2.05 0 CA-C-N 120.113 1.076 . . . . 0.0 112.347 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -61.02 -165.65 0.04 OUTLIER 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 120.685 0.923 . . . . 0.0 112.358 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -170.64 -161.3 0.23 Allowed 'General case' 0 N--CA 1.523 3.197 0 C-N-CA 120.134 -0.626 . . . . 0.0 111.045 -179.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.835 HD11 ' HB3' ' A' ' 73' ' ' CYS . 21.2 tt -111.3 137.39 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.978 -0.451 . . . . 0.0 110.249 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.45 HD11 ' NE ' ' A' ' 76' ' ' ARG . 70.6 mt -94.56 129.98 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.506 ' HB2' HG22 ' A' ' 42' ' ' VAL . 48.1 m95 -94.66 103.46 15.39 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.181 -178.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.6 tptm . . . . . 0 N--CA 1.497 1.888 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 177.54 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.506 HG22 ' HB2' ' A' ' 35' ' ' TRP . 12.8 m . . . . . 0 N--CA 1.508 2.437 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.746 HD11 HG21 ' A' ' 52' ' ' VAL . 46.9 mm -57.7 -18.92 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.778 0 O-C-N 121.889 -0.507 . . . . 0.0 111.854 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.467 ' N ' HD12 ' A' ' 44' ' ' LEU . 10.8 mp -89.05 -25.34 22.0 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.581 -0.699 . . . . 0.0 110.767 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.5 pttt -98.67 -39.82 8.49 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.775 -0.578 . . . . 0.0 109.957 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.5 mmmt 47.75 55.01 9.05 Favored 'General case' 0 N--CA 1.511 2.623 0 CA-C-O 121.593 0.711 . . . . 0.0 111.569 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.15 169.47 0.17 Allowed 'General case' 0 N--CA 1.511 2.61 0 O-C-N 121.724 -0.61 . . . . 0.0 110.81 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 29.4 m -62.55 -20.55 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.534 0 O-C-N 122.052 -0.405 . . . . 0.0 111.601 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.9 ptp85 -113.51 46.6 1.25 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.735 -0.603 . . . . 0.0 112.055 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.405 ' HE2' HD21 ' A' ' 58' ' ' LEU . 7.8 m-85 -144.93 107.02 4.31 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.685 -0.634 . . . . 0.0 109.778 178.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 66.3 mt -128.93 104.82 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.746 HG21 HD11 ' A' ' 43' ' ' ILE . 3.1 t -73.95 132.16 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.9 mt -85.91 166.66 15.79 Favored 'General case' 0 N--CA 1.508 2.431 0 O-C-N 121.786 -0.571 . . . . 0.0 111.699 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.8 p -61.57 -21.43 64.3 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 122.204 -0.31 . . . . 0.0 111.137 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -90.93 18.15 6.99 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.614 -0.679 . . . . 0.0 111.46 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.443 ' HB3' HG21 ' A' ' 33' ' ' ILE . 4.0 m120 67.98 32.54 5.03 Favored 'General case' 0 N--CA 1.517 2.899 0 O-C-N 121.596 -0.69 . . . . 0.0 112.189 178.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.426 ' CE2' ' HA ' ' A' ' 22' ' ' VAL . 4.0 m-85 -102.75 162.79 12.64 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 177.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.718 HD23 HD12 ' A' ' 21' ' ' ILE . 17.4 tp -118.2 98.37 6.26 Favored 'General case' 0 N--CA 1.517 2.913 0 C-N-CA 119.276 -0.97 . . . . 0.0 111.591 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.656 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -77.01 97.98 4.82 Favored 'General case' 0 N--CA 1.501 2.12 0 C-N-CA 120.391 -0.523 . . . . 0.0 110.84 179.439 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.548 HD11 HD11 ' A' ' 21' ' ' ILE . 96.0 mt -89.09 119.64 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 177.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.0 tpp180 -80.14 115.43 19.69 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 121.369 0.604 . . . . 0.0 110.707 -178.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.04 -33.28 5.87 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.501 HG23 HG21 ' A' ' 92' ' ' VAL . 1.9 tp 37.85 72.02 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.521 3.108 0 CA-C-N 118.155 0.978 . . . . 0.0 112.861 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.6 mtpp -62.77 158.34 18.96 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 121.751 -0.593 . . . . 0.0 112.187 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 45.2 tttt -62.35 -24.14 67.18 Favored 'General case' 0 N--CA 1.509 2.521 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.908 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 48.0 p -82.86 -15.91 49.67 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.894 -0.504 . . . . 0.0 111.056 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -88.69 -21.67 23.78 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.672 -0.642 . . . . 0.0 110.998 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.464 ' HB3' HG12 ' A' ' 92' ' ' VAL . 7.2 pt-20 -66.74 151.14 48.03 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.519 -0.738 . . . . 0.0 110.312 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 164.24 -115.73 0.66 Allowed Glycine 0 N--CA 1.498 2.787 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.6 m -138.4 100.55 4.14 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.94 -0.741 . . . . 0.0 110.431 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -83.22 135.68 34.69 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.6 ttm105 -103.81 119.61 39.28 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.749 -0.78 . . . . 0.0 111.003 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.835 ' HB3' HD11 ' A' ' 33' ' ' ILE . 19.6 m -78.51 122.64 26.12 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 177.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -121.43 84.26 2.21 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 121.216 0.532 . . . . 0.0 110.695 -178.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.44 117.27 8.74 Favored Glycine 0 N--CA 1.504 3.178 0 N-CA-C 108.062 -2.015 . . . . 0.0 108.062 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.45 ' NE ' HD11 ' A' ' 34' ' ' ILE . 11.6 ttp180 . . . . . 0 N--CA 1.498 1.938 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -177.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 N--CA 1.499 2.016 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -167.26 174.96 7.68 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.538 -0.726 . . . . 0.0 112.556 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.508 ' HD2' HD11 ' A' ' 88' ' ' ILE . 1.0 OUTLIER -166.71 155.1 10.2 Favored 'General case' 0 N--CA 1.503 2.221 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.461 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.544 ' O ' HG22 ' A' ' 9' ' ' THR . 5.3 p-10 -91.78 120.38 32.45 Favored 'General case' 0 N--CA 1.512 2.669 0 O-C-N 121.839 -0.538 . . . . 0.0 111.933 -178.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.574 ' N ' HD12 ' A' ' 88' ' ' ILE . 3.1 mp -102.91 120.51 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 178.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -87.69 114.81 24.66 Favored 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.458 HG13 HE21 ' A' ' 11' ' ' GLN . 32.5 t -107.96 133.88 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.07 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 74.0 mt -125.62 156.72 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.501 HG21 HG23 ' A' ' 63' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.498 1.937 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.578 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 62.3 t . . . . . 0 N--CA 1.505 2.297 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.449 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 11.5 mmm -107.52 114.72 28.9 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 122.032 -0.418 . . . . 0.0 109.953 -178.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -68.45 119.2 12.55 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.935 -0.478 . . . . 0.0 109.892 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.691 ' HG2' HG23 ' A' ' 26' ' ' VAL . 3.2 pttt -129.43 161.54 30.14 Favored 'General case' 0 N--CA 1.503 2.201 0 CA-C-O 121.693 0.758 . . . . 0.0 111.482 -178.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.418 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.4 OUTLIER 32.85 51.39 0.26 Allowed 'General case' 0 N--CA 1.517 2.917 0 C-N-CA 124.134 0.974 . . . . 0.0 113.243 179.423 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -116.64 81.89 12.02 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.725 -0.61 . . . . 0.0 110.645 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -65.54 107.33 1.01 Allowed 'Trans proline' 0 N--CA 1.491 1.373 0 N-CA-C 109.142 -1.138 . . . . 0.0 109.142 178.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.58 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.3 OUTLIER -60.19 -67.84 0.93 Allowed Pre-proline 0 N--CA 1.505 2.311 0 CA-C-O 116.802 -1.57 . . . . 0.0 110.985 -178.336 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.496 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.5 Cg_endo -73.8 89.63 0.99 Allowed 'Trans proline' 0 CA--C 1.559 1.739 0 CA-C-N 121.385 1.53 . . . . 0.0 110.67 177.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -98.44 178.65 4.96 Favored 'General case' 0 N--CA 1.508 2.45 0 O-C-N 120.675 -1.266 . . . . 0.0 110.193 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -159.38 124.53 4.13 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 120.294 -0.562 . . . . 0.0 112.03 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -122.54 -165.21 1.26 Allowed 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.49 137.43 53.2 Favored 'General case' 0 N--CA 1.514 2.765 0 CA-C-O 121.734 0.778 . . . . 0.0 110.941 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -55.32 140.2 40.23 Favored 'General case' 0 N--CA 1.511 2.604 0 O-C-N 121.707 -0.62 . . . . 0.0 111.352 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.13 12.27 81.59 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -106.93 157.47 17.76 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 119.332 1.566 . . . . 0.0 111.821 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -80.07 95.15 6.11 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 176.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.09 169.73 9.2 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.191 0.519 . . . . 0.0 112.204 -176.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.631 HG22 ' HG2' ' A' ' 59' ' ' GLN . 85.3 t -139.75 140.73 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.936 HD12 HD23 ' A' ' 58' ' ' LEU . 27.7 mt -93.17 115.64 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 105.969 -1.864 . . . . 0.0 105.969 177.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.46 HG13 ' CE2' ' A' ' 57' ' ' TYR . 48.1 t -77.54 119.68 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 CA-C-O 121.446 0.641 . . . . 0.0 110.618 -176.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.6 t -161.33 92.18 0.89 Allowed 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.418 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -90.04 145.43 25.09 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 -179.501 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.606 HG21 HD12 ' A' ' 33' ' ' ILE . 23.6 t -146.42 119.92 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.691 HG23 ' HG2' ' A' ' 5' ' ' LYS . 21.2 t -75.9 73.46 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 178.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.4 m -84.09 157.24 21.82 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.6 t -47.46 -79.4 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.078 0 O-C-N 121.762 -0.586 . . . . 0.0 111.385 -178.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -172.94 -61.02 0.0 OUTLIER Pre-proline 0 N--CA 1.514 2.758 0 CA-C-O 117.918 -1.039 . . . . 0.0 111.018 177.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.09 -53.97 3.13 Favored 'Trans proline' 0 CA--C 1.563 1.935 0 CA-C-N 119.7 0.928 . . . . 0.0 112.634 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -61.99 -166.41 0.05 OUTLIER 'Trans proline' 0 N--CA 1.501 1.936 0 CA-C-N 119.322 0.794 . . . . 0.0 111.545 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -170.7 -164.93 0.4 Allowed 'General case' 0 N--CA 1.518 2.966 0 O-C-N 121.7 -0.625 . . . . 0.0 110.078 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.606 HD12 HG21 ' A' ' 25' ' ' VAL . 17.9 tt -105.1 158.22 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.992 -0.443 . . . . 0.0 110.023 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 68.8 mt -125.58 118.89 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.558 ' HB2' HG22 ' A' ' 42' ' ' VAL . 83.0 m95 -81.6 102.15 10.46 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.2 tttt . . . . . 0 N--CA 1.499 1.978 0 CA-C-O 121.222 0.534 . . . . 0.0 110.906 -178.785 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.558 HG22 ' HB2' ' A' ' 35' ' ' TRP . 4.5 m . . . . . 0 N--CA 1.509 2.519 0 CA-C-O 120.792 0.33 . . . . 0.0 110.769 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 73.5 mt -59.79 -16.6 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.83 0 O-C-N 121.624 -0.673 . . . . 0.0 111.656 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.495 ' N ' HD12 ' A' ' 44' ' ' LEU . 10.6 mp -91.45 -23.39 20.02 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.433 -0.792 . . . . 0.0 110.732 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -97.86 -38.95 9.24 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.697 -0.627 . . . . 0.0 109.379 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 17.5 mmmt 46.35 55.55 7.27 Favored 'General case' 0 N--CA 1.51 2.559 0 CA-C-O 121.438 0.637 . . . . 0.0 112.228 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.33 165.76 0.33 Allowed 'General case' 0 N--CA 1.513 2.688 0 O-C-N 121.782 -0.574 . . . . 0.0 111.106 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.5 m -58.85 -20.88 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.699 0 O-C-N 122.018 -0.426 . . . . 0.0 111.856 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 5.0 ptt-85 -115.79 47.22 1.39 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.791 -0.568 . . . . 0.0 111.886 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -146.26 101.56 3.51 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.645 -0.659 . . . . 0.0 109.796 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 62.5 mt -125.92 113.42 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.439 HG22 ' CD1' ' A' ' 58' ' ' LEU . 2.4 t -79.49 128.05 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.411 HD11 ' CG ' ' A' ' 59' ' ' GLN . 15.5 mt -80.56 164.1 23.19 Favored 'General case' 0 N--CA 1.506 2.354 0 CA-C-O 121.195 0.521 . . . . 0.0 111.601 -178.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 96.6 p -60.0 -20.63 58.76 Favored 'General case' 0 N--CA 1.511 2.618 0 O-C-N 122.139 -0.351 . . . . 0.0 111.336 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.7 p-10 -91.19 19.44 5.87 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.721 -0.612 . . . . 0.0 111.43 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.8 m120 66.64 32.87 6.81 Favored 'General case' 0 N--CA 1.515 2.806 0 O-C-N 121.607 -0.683 . . . . 0.0 112.165 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.46 ' CE2' HG13 ' A' ' 22' ' ' VAL . 3.9 m-85 -103.4 168.82 8.92 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.936 HD23 HD12 ' A' ' 21' ' ' ILE . 18.0 tp -124.77 98.47 5.72 Favored 'General case' 0 N--CA 1.515 2.788 0 C-N-CA 119.29 -0.964 . . . . 0.0 112.241 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.631 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -74.79 100.16 3.96 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 120.77 0.319 . . . . 0.0 110.825 179.338 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.849 HD11 HD11 ' A' ' 21' ' ' ILE . 97.3 mt -92.7 110.9 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 178.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.27 113.89 9.8 Favored 'General case' 0 N--CA 1.504 2.261 0 CA-C-O 121.386 0.612 . . . . 0.0 111.343 -178.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.36 -38.3 3.15 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.506 HG12 HG21 ' A' ' 92' ' ' VAL . 1.5 tp 41.84 67.24 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.927 0 CA-C-O 122.145 0.974 . . . . 0.0 112.544 -178.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.5 mttm -58.35 157.38 8.71 Favored 'General case' 0 N--CA 1.51 2.557 0 CA-C-O 121.398 0.618 . . . . 0.0 112.611 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.8 ttmm -62.06 -21.81 65.24 Favored 'General case' 0 N--CA 1.509 2.486 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.97 178.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.1 p -83.78 -18.86 36.31 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.802 -0.561 . . . . 0.0 110.96 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.75 -5.7 56.72 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.653 -0.655 . . . . 0.0 111.607 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.529 ' HB3' HG12 ' A' ' 92' ' ' VAL . 8.2 pt-20 -81.7 137.01 35.46 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 119.006 0.821 . . . . 0.0 109.619 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 176.97 -111.39 0.33 Allowed Glycine 0 N--CA 1.499 2.863 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.0 m -138.8 104.1 5.0 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 122.034 -0.686 . . . . 0.0 110.708 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -86.8 135.89 33.19 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -93.72 118.62 31.65 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.21 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 85' ' ' PHE . 3.4 m -86.48 91.33 8.51 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 178.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -91.53 88.45 6.78 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.842 -0.536 . . . . 0.0 109.929 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.47 96.3 0.82 Allowed Glycine 0 N--CA 1.5 2.95 0 N-CA-C 107.311 -2.315 . . . . 0.0 107.311 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.7 ttm180 . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 122.031 0.919 . . . . 0.0 113.198 -176.921 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.9 m120 . . . . . 0 N--CA 1.507 2.401 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.474 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 36.1 p90 -161.1 171.93 17.68 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.534 -0.729 . . . . 0.0 112.4 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.9 mttp -165.78 159.0 15.7 Favored 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.58 ' O ' HG22 ' A' ' 9' ' ' THR . 6.9 p-10 -103.94 121.29 42.81 Favored 'General case' 0 N--CA 1.512 2.662 0 O-C-N 121.757 -0.589 . . . . 0.0 110.756 179.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.521 ' N ' HD12 ' A' ' 88' ' ' ILE . 1.8 mp -105.46 121.49 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -85.26 111.46 19.87 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.7 t -104.73 127.75 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.097 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 72.2 mt -117.17 159.71 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.529 HG12 ' HB3' ' A' ' 68' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.501 2.092 0 CA-C-O 117.922 -1.037 . . . . 0.0 110.496 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 49.0 t . . . . . 0 N--CA 1.501 2.105 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.493 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 17.8 mmm -112.53 111.22 21.89 Favored 'General case' 0 N--CA 1.506 2.371 0 C-N-CA 120.501 -0.479 . . . . 0.0 110.475 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -70.91 116.5 11.28 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 122.041 -0.412 . . . . 0.0 110.841 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -124.8 155.3 39.6 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 121.531 0.681 . . . . 0.0 110.133 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 41.85 86.04 0.02 OUTLIER 'General case' 0 N--CA 1.52 3.044 0 C-N-CA 123.073 0.549 . . . . 0.0 111.803 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -131.95 62.9 66.62 Favored Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 121.696 -0.627 . . . . 0.0 112.155 -178.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.408 ' HD2' HG12 ' A' ' 22' ' ' VAL . 2.5 Cg_endo -66.28 89.83 0.26 Allowed 'Trans proline' 0 N--CA 1.494 1.543 0 N-CA-C 108.162 -1.514 . . . . 0.0 108.162 177.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.489 ' OG1' ' HD3' ' A' ' 10' ' ' PRO . 13.6 p -59.47 -43.34 95.89 Favored Pre-proline 0 N--CA 1.508 2.459 0 CA-C-O 117.382 -1.294 . . . . 0.0 113.156 -177.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.489 ' HD3' ' OG1' ' A' ' 9' ' ' THR . 1.7 Cg_endo -81.8 82.88 2.23 Favored 'Trans proline' 0 CA--C 1.549 1.251 0 CA-C-N 120.651 1.268 . . . . 0.0 111.332 -177.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.477 HE21 HG13 ' A' ' 90' ' ' VAL . 15.7 pt20 -100.73 170.52 8.29 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.163 -0.96 . . . . 0.0 110.978 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -155.3 124.34 6.2 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 122.002 -0.436 . . . . 0.0 110.996 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -122.49 -169.59 1.93 Allowed 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.912 -0.493 . . . . 0.0 109.778 179.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -115.96 145.61 42.79 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.479 0.657 . . . . 0.0 111.67 -178.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -61.44 121.24 12.18 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 121.947 -0.471 . . . . 0.0 110.399 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.35 20.61 51.6 Favored Glycine 0 N--CA 1.497 2.714 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -179.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.506 ' O ' HG22 ' A' ' 63' ' ' ILE . 7.7 tp10 -112.37 158.1 20.22 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 118.619 1.21 . . . . 0.0 111.212 -179.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -80.45 98.09 7.38 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 177.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -102.9 165.5 11.0 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 120.169 -0.612 . . . . 0.0 112.398 -177.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.699 HG22 ' HG2' ' A' ' 59' ' ' GLN . 93.8 t -140.0 143.26 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 178.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.895 HD12 HD23 ' A' ' 58' ' ' LEU . 47.1 mt -99.96 113.24 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 178.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.411 HG13 ' CE2' ' A' ' 57' ' ' TYR . 58.4 t -73.22 120.15 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 CA-C-O 121.513 0.673 . . . . 0.0 111.057 -176.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.0 t -165.09 93.12 0.6 Allowed 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.15 140.79 29.11 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.314 -179.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.627 HG21 HD12 ' A' ' 33' ' ' ILE . 43.7 t -148.83 133.24 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.493 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 59.5 t -99.85 78.71 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.8 m -79.23 165.71 22.95 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.9 t -43.56 -82.31 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.19 0 O-C-N 121.899 -0.501 . . . . 0.0 111.509 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.416 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 1.0 OUTLIER -167.73 -63.27 0.01 OUTLIER Pre-proline 0 N--CA 1.513 2.708 0 CA-C-O 117.778 -1.106 . . . . 0.0 111.661 177.642 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.416 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 2.9 Cg_endo -60.1 -53.13 3.32 Favored 'Trans proline' 0 CA--C 1.563 1.939 0 CA-C-N 120.107 1.074 . . . . 0.0 112.676 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.403 ' HD3' ' CG ' ' A' ' 30' ' ' PRO . 2.8 Cg_endo -62.57 -163.98 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.794 0 CA-C-N 119.268 0.774 . . . . 0.0 112.634 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -169.95 -160.13 0.22 Allowed 'General case' 0 N--CA 1.519 3.017 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.21 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.847 HD11 ' HB3' ' A' ' 73' ' ' CYS . 20.7 tt -107.98 145.19 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.924 -0.485 . . . . 0.0 110.036 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.0 mt -104.59 130.43 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.533 ' HB2' HG22 ' A' ' 42' ' ' VAL . 55.8 m95 -96.02 119.37 34.38 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.217 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.6 tptt . . . . . 0 N--CA 1.498 1.935 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.274 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.533 HG22 ' HB2' ' A' ' 35' ' ' TRP . 8.4 m . . . . . 0 N--CA 1.505 2.307 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.6 mm -57.95 -19.41 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.683 0 O-C-N 122.028 -0.42 . . . . 0.0 111.796 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.472 ' N ' HD12 ' A' ' 44' ' ' LEU . 9.9 mp -90.59 -24.96 20.41 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.562 -0.711 . . . . 0.0 110.843 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 41.6 pttt -99.03 -39.97 8.26 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.665 -0.647 . . . . 0.0 109.802 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm 49.6 54.51 10.89 Favored 'General case' 0 N--CA 1.509 2.523 0 CA-C-O 121.464 0.649 . . . . 0.0 111.744 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -53.49 164.21 0.53 Allowed 'General case' 0 N--CA 1.514 2.771 0 O-C-N 121.698 -0.626 . . . . 0.0 110.715 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.8 m -60.83 -21.0 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.728 0 O-C-N 121.943 -0.473 . . . . 0.0 111.767 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.8 ptt-85 -100.87 -8.89 22.14 Favored 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -93.47 107.61 19.43 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-N 118.852 0.751 . . . . 0.0 110.272 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 71.7 mt -128.64 105.68 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.478 HG22 ' CD1' ' A' ' 58' ' ' LEU . 2.9 t -75.17 131.51 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.51 HD11 ' CG ' ' A' ' 59' ' ' GLN . 37.8 mt -84.15 168.1 16.11 Favored 'General case' 0 N--CA 1.508 2.452 0 CA-C-O 121.172 0.511 . . . . 0.0 111.717 -178.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 55.3 p -61.58 -22.87 65.58 Favored 'General case' 0 N--CA 1.509 2.522 0 O-C-N 122.182 -0.324 . . . . 0.0 111.074 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 50.9 p-10 -91.25 18.42 7.03 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.825 -0.547 . . . . 0.0 111.345 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.441 ' HB3' HG21 ' A' ' 33' ' ' ILE . 4.3 m120 66.82 34.63 5.38 Favored 'General case' 0 N--CA 1.515 2.795 0 O-C-N 121.542 -0.724 . . . . 0.0 112.406 178.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.411 ' CE2' HG13 ' A' ' 22' ' ' VAL . 4.0 m-85 -102.67 159.21 15.66 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.895 HD23 HD12 ' A' ' 21' ' ' ILE . 17.8 tp -114.01 98.31 6.9 Favored 'General case' 0 N--CA 1.515 2.815 0 C-N-CA 119.353 -0.939 . . . . 0.0 112.026 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.699 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -78.76 101.42 7.57 Favored 'General case' 0 N--CA 1.503 2.205 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.088 179.439 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.581 HD11 HD11 ' A' ' 21' ' ' ILE . 91.1 mt -93.58 102.43 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 177.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -68.98 114.19 7.05 Favored 'General case' 0 N--CA 1.506 2.371 0 CA-C-O 121.24 0.543 . . . . 0.0 111.378 -178.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 100.4 -34.8 5.26 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 110.079 -1.209 . . . . 0.0 110.079 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.506 HG22 ' O ' ' A' ' 17' ' ' GLU . 1.9 tp 35.98 95.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.13 0 CA-C-N 118.001 0.901 . . . . 0.0 113.205 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -72.88 146.78 45.93 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.626 -0.671 . . . . 0.0 111.116 -178.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -63.28 -18.71 63.87 Favored 'General case' 0 N--CA 1.51 2.545 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.676 178.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 58.5 p -86.14 -16.43 37.94 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.422 -0.798 . . . . 0.0 110.859 179.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -93.18 17.45 11.02 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.601 -0.687 . . . . 0.0 111.479 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -95.72 145.03 25.62 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.581 -0.699 . . . . 0.0 109.737 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 169.6 -105.36 0.22 Allowed Glycine 0 N--CA 1.497 2.757 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.0 m -142.89 101.38 3.83 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.99 -0.712 . . . . 0.0 111.277 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -83.11 127.55 33.69 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.0 ttt180 -95.71 122.21 38.23 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 120.087 -0.645 . . . . 0.0 111.407 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.847 ' HB3' HD11 ' A' ' 33' ' ' ILE . 65.1 m -79.85 127.34 32.11 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 177.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -126.16 84.63 2.29 Favored 'General case' 0 N--CA 1.506 2.344 0 CA-C-N 119.245 0.929 . . . . 0.0 110.36 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.09 102.35 0.71 Allowed Glycine 0 N--CA 1.506 3.307 0 N-CA-C 107.898 -2.081 . . . . 0.0 107.898 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 . . . . . 0 N--CA 1.497 1.919 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -176.814 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 . . . . . 0 N--CA 1.503 2.186 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -159.47 -178.2 6.96 Favored 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 119.419 -0.912 . . . . 0.0 113.429 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -168.24 163.18 13.07 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -104.22 144.86 31.03 Favored 'General case' 0 N--CA 1.511 2.58 0 O-C-N 121.771 -0.581 . . . . 0.0 111.442 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.519 HG21 ' CG2' ' A' ' 21' ' ' ILE . 50.8 mm -126.48 106.24 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -72.52 101.1 2.89 Favored 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.477 HG13 HE21 ' A' ' 11' ' ' GLN . 25.7 t -100.25 133.51 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.438 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 72.8 mt -119.68 144.72 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 43.5 t . . . . . 0 N--CA 1.505 2.281 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.625 -179.176 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 62.4 t . . . . . 0 N--CA 1.504 2.266 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.462 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 61.4 mmm -104.16 120.21 40.63 Favored 'General case' 0 N--CA 1.509 2.484 0 O-C-N 121.831 -0.543 . . . . 0.0 110.741 -178.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -78.1 113.59 16.18 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 122.053 -0.404 . . . . 0.0 110.192 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.6 ptpt -127.61 165.93 19.02 Favored 'General case' 0 N--CA 1.503 2.182 0 CA-C-O 121.748 0.785 . . . . 0.0 112.235 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.432 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.3 OUTLIER 31.26 80.27 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.959 0 C-N-CA 124.442 1.097 . . . . 0.0 113.226 179.077 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.418 ' HB2' ' HA ' ' A' ' 23' ' ' CYS . . . -154.4 81.44 4.48 Favored Pre-proline 0 N--CA 1.489 1.505 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.864 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.6 105.49 0.63 Allowed 'Trans proline' 0 N--CA 1.491 1.339 0 N-CA-C 108.58 -1.354 . . . . 0.0 108.58 178.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.583 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.2 OUTLIER -51.41 -64.6 1.31 Allowed Pre-proline 0 N--CA 1.509 2.481 0 CA-C-O 117.139 -1.41 . . . . 0.0 111.909 -177.563 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.491 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.6 Cg_endo -74.6 90.56 1.03 Allowed 'Trans proline' 0 CA--C 1.557 1.67 0 CA-C-N 120.974 1.384 . . . . 0.0 110.545 177.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.409 HE21 HG13 ' A' ' 90' ' ' VAL . 13.3 pt20 -99.03 177.04 5.36 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 120.805 -1.185 . . . . 0.0 110.2 179.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -159.81 121.29 3.22 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.855 -0.528 . . . . 0.0 111.856 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -116.2 -169.89 1.7 Allowed 'General case' 0 N--CA 1.504 2.259 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -103.43 137.12 41.95 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.553 0.692 . . . . 0.0 111.524 -178.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -61.06 113.97 2.85 Favored 'General case' 0 N--CA 1.509 2.484 0 O-C-N 121.897 -0.502 . . . . 0.0 110.539 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.16 23.33 22.61 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.526 -1.029 . . . . 0.0 110.526 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -117.88 164.83 14.46 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 118.335 1.068 . . . . 0.0 110.998 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -80.47 99.31 7.95 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 177.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.77 167.44 10.77 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.454 0.645 . . . . 0.0 112.119 -177.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.631 HG22 ' HG2' ' A' ' 59' ' ' GLN . 87.5 t -143.72 133.84 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 178.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.736 HD12 HD23 ' A' ' 58' ' ' LEU . 42.1 mt -90.35 115.18 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 178.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.426 ' HA ' ' CE2' ' A' ' 57' ' ' TYR . 54.4 t -74.83 120.99 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.852 -176.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.418 ' HA ' ' HB2' ' A' ' 7' ' ' ALA . 0.7 OUTLIER -162.19 91.74 0.8 Allowed 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.406 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.432 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -90.59 140.6 29.6 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.651 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.605 HG21 HD12 ' A' ' 33' ' ' ILE . 14.5 t -146.35 124.0 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.462 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 45.3 t -82.45 77.51 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.1 m -87.47 154.64 20.48 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.6 t -43.88 -85.69 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.255 0 O-C-N 121.919 -0.488 . . . . 0.0 112.294 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.402 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 1.2 mt -165.4 -62.51 0.01 OUTLIER Pre-proline 0 N--CA 1.51 2.555 0 CA-C-O 117.711 -1.137 . . . . 0.0 111.24 178.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.402 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 2.9 Cg_endo -59.4 -53.45 3.46 Favored 'Trans proline' 0 CA--C 1.561 1.864 0 CA-C-N 120.091 1.068 . . . . 0.0 112.307 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.412 ' C ' ' HG1' ' A' ' 32' ' ' THR . 2.7 Cg_endo -62.91 -170.07 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.668 0 CA-C-N 119.286 0.781 . . . . 0.0 111.467 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.412 ' HG1' ' C ' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -171.17 -165.41 0.41 Allowed 'General case' 0 N--CA 1.519 2.979 0 O-C-N 121.767 -0.583 . . . . 0.0 109.647 179.808 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.605 HD12 HG21 ' A' ' 25' ' ' VAL . 16.3 tt -99.11 161.03 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 66.2 mt -128.74 121.04 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.597 ' HB2' HG22 ' A' ' 42' ' ' VAL . 83.5 m95 -85.51 113.13 21.53 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 120.49 -0.484 . . . . 0.0 109.778 -179.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 50.9 mttt . . . . . 0 N--CA 1.502 2.16 0 O-C-N 121.79 -0.569 . . . . 0.0 111.539 -178.929 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.597 HG22 ' HB2' ' A' ' 35' ' ' TRP . 13.6 m . . . . . 0 N--CA 1.509 2.491 0 CA-C-O 121.022 0.439 . . . . 0.0 110.695 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 71.1 mt -59.43 -18.08 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.769 0 O-C-N 121.711 -0.618 . . . . 0.0 111.738 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.476 ' N ' HD12 ' A' ' 44' ' ' LEU . 10.4 mp -92.57 -21.35 20.14 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.455 -0.778 . . . . 0.0 111.119 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.41 ' HG2' ' HA ' ' A' ' 42' ' ' VAL . 42.8 pttt -98.06 -37.43 9.75 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.633 -0.667 . . . . 0.0 109.233 178.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.4 mmmt 48.05 54.75 9.65 Favored 'General case' 0 N--CA 1.509 2.493 0 CA-C-O 121.421 0.629 . . . . 0.0 111.824 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -51.83 168.29 0.09 Allowed 'General case' 0 N--CA 1.515 2.789 0 O-C-N 121.867 -0.521 . . . . 0.0 110.943 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.8 m -61.16 -18.77 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.689 0 O-C-N 121.976 -0.452 . . . . 0.0 111.799 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 29.6 ptt-85 -121.26 46.82 1.96 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.728 -0.607 . . . . 0.0 111.973 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.426 ' HE2' HD21 ' A' ' 58' ' ' LEU . 6.8 m-85 -145.36 106.97 4.23 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.574 -0.704 . . . . 0.0 110.156 178.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 82.7 mt -129.66 107.99 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.556 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.0 t -76.17 131.66 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.5 mt -85.02 164.43 18.25 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.909 -0.494 . . . . 0.0 111.49 -178.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.3 p -62.03 -20.68 64.19 Favored 'General case' 0 N--CA 1.509 2.48 0 O-C-N 122.102 -0.374 . . . . 0.0 110.812 178.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 50.3 p30 -88.17 13.58 11.06 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.721 -0.612 . . . . 0.0 111.528 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.3 m120 71.09 33.94 1.94 Allowed 'General case' 0 N--CA 1.518 2.968 0 O-C-N 121.547 -0.72 . . . . 0.0 112.493 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.426 ' CE2' ' HA ' ' A' ' 22' ' ' VAL . 5.3 m-85 -106.0 163.77 12.5 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 177.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.736 HD23 HD12 ' A' ' 21' ' ' ILE . 18.1 tp -118.07 97.54 5.86 Favored 'General case' 0 N--CA 1.519 3.005 0 C-N-CA 119.381 -0.928 . . . . 0.0 111.218 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.631 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -75.39 99.49 4.16 Favored 'General case' 0 N--CA 1.501 2.081 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.763 179.651 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.597 HD11 HD11 ' A' ' 21' ' ' ILE . 92.6 mt -90.75 118.95 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 177.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.8 tpt85 -81.2 113.06 19.09 Favored 'General case' 0 N--CA 1.501 2.092 0 CA-C-O 121.29 0.566 . . . . 0.0 111.012 -178.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.55 -37.28 3.6 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.585 ' CG1' HG21 ' A' ' 92' ' ' VAL . 3.2 tp 41.6 94.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.521 3.08 0 CA-C-N 118.126 0.963 . . . . 0.0 112.253 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.2 mttm -86.87 157.45 19.53 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 121.233 -0.917 . . . . 0.0 112.693 -177.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.6 tttp -61.68 -27.38 68.65 Favored 'General case' 0 N--CA 1.508 2.453 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.12 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.5 t -81.11 -11.74 59.41 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 121.896 -0.503 . . . . 0.0 111.601 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.64 -17.54 20.31 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.534 -0.729 . . . . 0.0 111.482 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.475 ' HB3' HG12 ' A' ' 92' ' ' VAL . 8.4 pt-20 -68.75 148.28 50.58 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.36 -0.837 . . . . 0.0 109.933 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 167.01 -107.15 0.28 Allowed Glycine 0 N--CA 1.496 2.695 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.9 m -145.26 104.2 3.92 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 122.023 -0.692 . . . . 0.0 110.864 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -85.44 138.02 32.53 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -97.42 120.29 37.52 Favored 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.447 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 85' ' ' PHE . 2.9 m -87.31 105.73 17.45 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -104.63 85.97 2.41 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.298 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.29 87.96 0.25 Allowed Glycine 0 N--CA 1.499 2.899 0 N-CA-C 107.674 -2.17 . . . . 0.0 107.674 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.706 0.765 . . . . 0.0 112.967 -176.961 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 N--CA 1.504 2.266 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.451 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 35.4 p90 -164.12 176.69 9.04 Favored 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.2 pttt -170.53 167.13 8.17 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.583 ' O ' HG22 ' A' ' 9' ' ' THR . 5.8 p-10 -105.54 123.96 48.77 Favored 'General case' 0 N--CA 1.513 2.677 0 O-C-N 121.801 -0.562 . . . . 0.0 111.703 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.537 ' N ' HD12 ' A' ' 88' ' ' ILE . 1.9 mp -104.85 119.24 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -83.54 114.83 21.79 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.409 HG13 HE21 ' A' ' 11' ' ' GLN . 46.5 t -108.52 132.92 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.235 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 50.2 mt -121.95 159.25 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.585 HG21 ' CG1' ' A' ' 63' ' ' ILE . 1.4 p . . . . . 0 N--CA 1.498 1.943 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.699 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 44.5 t . . . . . 0 N--CA 1.505 2.276 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.527 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 12.5 mmt -119.85 116.23 25.44 Favored 'General case' 0 N--CA 1.507 2.396 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.803 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -72.88 115.71 12.5 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 122.118 -0.364 . . . . 0.0 111.101 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -124.49 156.56 37.05 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.566 0.698 . . . . 0.0 110.357 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.426 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.2 OUTLIER 41.07 81.82 0.03 OUTLIER 'General case' 0 N--CA 1.518 2.94 0 C-N-CA 123.479 0.712 . . . . 0.0 111.919 -179.47 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -131.92 68.54 80.49 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.711 -0.618 . . . . 0.0 111.68 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -67.12 88.85 0.31 Allowed 'Trans proline' 0 N--CA 1.492 1.397 0 N-CA-C 107.966 -1.59 . . . . 0.0 107.966 177.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.544 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.6 OUTLIER -48.69 -68.27 0.34 Allowed Pre-proline 0 N--CA 1.509 2.496 0 CA-C-O 116.795 -1.574 . . . . 0.0 113.069 -176.702 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.487 ' HD3' ' OG1' ' A' ' 9' ' ' THR . 1.5 Cg_endo -71.31 93.88 0.66 Allowed 'Trans proline' 0 N--CA 1.497 1.686 0 CA-C-N 121.516 1.577 . . . . 0.0 111.441 178.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.498 HE21 HG13 ' A' ' 90' ' ' VAL . 16.1 pt20 -101.0 173.98 6.22 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.02 -1.05 . . . . 0.0 110.26 178.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 15.5 tt0 -158.79 120.39 3.45 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.238 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -116.72 -169.76 1.69 Allowed 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.945 -0.472 . . . . 0.0 109.94 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -102.01 137.46 40.25 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.597 0.713 . . . . 0.0 111.705 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -60.79 118.78 7.07 Favored 'General case' 0 N--CA 1.508 2.444 0 O-C-N 121.964 -0.46 . . . . 0.0 110.494 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.3 23.54 37.01 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.422 ' O ' HG22 ' A' ' 63' ' ' ILE . 15.4 tt0 -118.26 165.17 14.14 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 118.412 1.106 . . . . 0.0 110.867 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.71 97.74 8.08 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 178.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.19 169.96 9.23 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.729 -177.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.681 HG22 ' HG2' ' A' ' 59' ' ' GLN . 93.2 t -142.88 140.76 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 178.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.873 HD12 HD23 ' A' ' 58' ' ' LEU . 20.8 mt -96.02 113.32 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 178.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.437 HG13 ' CE2' ' A' ' 57' ' ' TYR . 45.2 t -73.66 122.04 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.21 -176.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -164.92 89.81 0.5 Allowed 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.426 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -88.6 141.3 28.64 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.056 -179.374 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.675 HG21 HD12 ' A' ' 33' ' ' ILE . 38.3 t -148.16 132.08 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.527 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 53.8 t -95.32 78.57 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.6 m -81.52 163.48 22.65 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 178.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 t -43.04 -85.06 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.329 0 O-C-N 121.825 -0.547 . . . . 0.0 111.582 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.401 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 0.5 OUTLIER -167.29 -63.15 0.01 OUTLIER Pre-proline 0 N--CA 1.514 2.768 0 CA-C-O 117.707 -1.14 . . . . 0.0 111.663 177.783 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.401 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 2.9 Cg_endo -59.76 -53.23 3.45 Favored 'Trans proline' 0 CA--C 1.564 1.999 0 CA-C-N 120.209 1.11 . . . . 0.0 112.446 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.55 -164.4 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 120.55 0.833 . . . . 0.0 112.185 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -171.12 -166.69 0.49 Allowed 'General case' 0 N--CA 1.519 3.019 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.443 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.675 HD12 HG21 ' A' ' 25' ' ' VAL . 15.1 tt -97.96 165.45 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 81.1 mt -128.65 133.9 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.55 ' HB2' HG22 ' A' ' 42' ' ' VAL . 82.7 m95 -97.55 115.49 27.95 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.7 tttt . . . . . 0 N--CA 1.505 2.3 0 CA-C-O 121.334 0.588 . . . . 0.0 111.295 -178.623 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.55 HG22 ' HB2' ' A' ' 35' ' ' TRP . 5.7 m . . . . . 0 N--CA 1.507 2.421 0 CA-C-O 120.831 0.348 . . . . 0.0 110.626 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.5 mm -58.44 -18.41 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.806 0 O-C-N 121.623 -0.673 . . . . 0.0 111.77 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.47 ' N ' HD12 ' A' ' 44' ' ' LEU . 10.4 mp -91.66 -23.02 19.96 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.527 -0.733 . . . . 0.0 111.133 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -98.9 -42.28 7.23 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.753 -0.592 . . . . 0.0 110.034 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt 48.05 56.91 6.65 Favored 'General case' 0 N--CA 1.509 2.499 0 CA-C-O 121.492 0.663 . . . . 0.0 111.892 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -50.9 170.14 0.04 OUTLIER 'General case' 0 N--CA 1.517 2.893 0 O-C-N 121.689 -0.632 . . . . 0.0 111.506 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 36.0 m -63.21 -19.5 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.64 0 O-C-N 122.054 -0.404 . . . . 0.0 111.985 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.1 ptp85 -109.42 0.16 19.23 Favored 'General case' 0 N--CA 1.506 2.349 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -99.33 106.1 18.16 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.35 -0.844 . . . . 0.0 110.562 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 74.5 mt -129.64 110.49 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.478 HG22 ' CD1' ' A' ' 58' ' ' LEU . 2.5 t -77.62 137.88 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.51 HD11 ' CG ' ' A' ' 59' ' ' GLN . 45.0 mt -89.97 167.44 12.8 Favored 'General case' 0 N--CA 1.505 2.321 0 CA-C-O 121.387 0.613 . . . . 0.0 112.01 -178.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.7 p -60.92 -22.41 64.33 Favored 'General case' 0 N--CA 1.51 2.554 0 O-C-N 122.137 -0.352 . . . . 0.0 111.229 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 35.5 p-10 -91.29 18.54 6.92 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.735 -0.603 . . . . 0.0 111.48 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.6 m120 67.48 33.21 5.3 Favored 'General case' 0 N--CA 1.516 2.86 0 O-C-N 121.544 -0.722 . . . . 0.0 111.999 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.437 ' CE2' HG13 ' A' ' 22' ' ' VAL . 4.1 m-85 -103.06 163.84 11.97 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 177.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.873 HD23 HD12 ' A' ' 21' ' ' ILE . 20.8 tp -120.11 100.6 7.3 Favored 'General case' 0 N--CA 1.516 2.859 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.968 -179.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.681 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -78.69 105.32 9.9 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.328 179.672 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.755 HD11 HD11 ' A' ' 21' ' ' ILE . 96.4 mt -97.47 102.81 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 177.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -67.55 118.17 10.49 Favored 'General case' 0 N--CA 1.506 2.33 0 CA-C-O 121.155 0.503 . . . . 0.0 111.221 -178.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.57 -39.14 2.85 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.582 HG23 HG21 ' A' ' 92' ' ' VAL . 2.8 tp 40.13 85.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.52 3.042 0 CA-C-O 122.023 0.916 . . . . 0.0 112.308 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.452 ' HB3' HG22 ' A' ' 66' ' ' THR . 28.2 mtpt -68.95 151.28 46.74 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 121.548 -0.72 . . . . 0.0 111.347 -178.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.619 ' HA ' HG13 ' A' ' 92' ' ' VAL . 0.1 OUTLIER -63.24 -17.99 63.06 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 122.15 -0.344 . . . . 0.0 110.956 179.023 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.452 HG22 ' HB3' ' A' ' 64' ' ' LYS . 10.0 t -90.98 -12.37 36.11 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.551 -0.718 . . . . 0.0 111.246 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.81 14.71 18.51 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.454 -0.779 . . . . 0.0 111.532 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.813 ' HB3' HG12 ' A' ' 92' ' ' VAL . 0.7 OUTLIER -97.41 148.07 23.56 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.416 -0.802 . . . . 0.0 109.946 179.674 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 169.52 -102.1 0.18 Allowed Glycine 0 N--CA 1.498 2.769 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.6 m -148.38 100.76 3.18 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 122.025 -0.691 . . . . 0.0 110.994 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -80.76 133.41 35.64 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.8 tpt180 -96.32 116.56 29.22 Favored 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.651 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 7.1 m -79.29 132.89 36.6 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -134.82 91.13 2.72 Favored 'General case' 0 N--CA 1.503 2.178 0 CA-C-N 118.719 0.69 . . . . 0.0 110.724 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.76 121.21 10.56 Favored Glycine 0 N--CA 1.501 3.03 0 N-CA-C 107.598 -2.201 . . . . 0.0 107.598 178.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 . . . . . 0 N--CA 1.503 2.188 0 CA-C-N 118.308 1.054 . . . . 0.0 113.581 -177.251 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.8 m120 . . . . . 0 N--CA 1.501 2.124 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -161.37 -177.92 6.31 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.797 -0.761 . . . . 0.0 112.035 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.5 tptp -169.17 166.07 10.87 Favored 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.544 ' O ' HG22 ' A' ' 9' ' ' THR . 4.4 p-10 -111.03 112.86 24.98 Favored 'General case' 0 N--CA 1.51 2.544 0 CA-C-O 121.071 0.462 . . . . 0.0 110.46 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.57 ' N ' HD12 ' A' ' 88' ' ' ILE . 2.2 mp -101.07 118.99 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -83.52 127.32 33.63 Favored 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.498 HG13 HE21 ' A' ' 11' ' ' GLN . 40.7 t -121.11 132.7 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 O-C-N 121.808 -0.558 . . . . 0.0 109.905 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 72.1 mt -126.05 146.34 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.813 HG12 ' HB3' ' A' ' 68' ' ' GLU . 9.8 p . . . . . 0 N--CA 1.501 2.103 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.714 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.603 HG12 ' HA ' ' A' ' 27' ' ' SER . 14.5 m . . . . . 0 N--CA 1.504 2.272 0 CA-C-O 121.335 0.588 . . . . 0.0 109.464 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.514 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 0.7 OUTLIER -87.8 106.81 18.33 Favored 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.907 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -67.13 119.9 12.83 Favored 'General case' 0 N--CA 1.506 2.346 0 CA-C-O 120.812 0.339 . . . . 0.0 110.738 -178.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.408 ' HG2' HG23 ' A' ' 26' ' ' VAL . 3.2 pttt -135.13 163.84 29.03 Favored 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 121.88 0.847 . . . . 0.0 112.26 -179.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.4 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.3 OUTLIER 28.59 95.58 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.134 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 179.133 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.429 ' HB2' ' HA ' ' A' ' 23' ' ' CYS . . . -164.82 84.0 1.16 Allowed Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.953 -0.467 . . . . 0.0 111.154 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -65.2 106.04 0.77 Allowed 'Trans proline' 0 N--CA 1.492 1.392 0 N-CA-C 108.419 -1.416 . . . . 0.0 108.419 177.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.558 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.2 OUTLIER -51.04 -65.64 0.88 Allowed Pre-proline 0 N--CA 1.508 2.45 0 CA-C-O 116.91 -1.519 . . . . 0.0 112.594 -177.02 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.488 ' HD3' ' OG1' ' A' ' 9' ' ' THR . 1.4 Cg_endo -75.1 94.55 0.96 Allowed 'Trans proline' 0 N--CA 1.495 1.59 0 CA-C-N 121.182 1.458 . . . . 0.0 111.019 178.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.434 HE21 HG13 ' A' ' 90' ' ' VAL . 16.1 pt20 -99.96 179.35 4.53 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 120.949 -1.095 . . . . 0.0 110.276 178.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -160.6 121.75 2.99 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.825 -0.547 . . . . 0.0 111.82 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -118.95 -170.95 2.01 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.929 -0.482 . . . . 0.0 109.988 178.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.1 tttp -102.33 135.95 43.04 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.505 0.669 . . . . 0.0 111.339 -178.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -60.66 112.42 2.0 Allowed 'General case' 0 N--CA 1.508 2.47 0 O-C-N 121.929 -0.482 . . . . 0.0 110.533 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.02 23.89 16.42 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.417 ' O ' HG22 ' A' ' 63' ' ' ILE . 18.3 tt0 -118.4 165.79 13.44 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-N 118.397 1.099 . . . . 0.0 110.676 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -81.72 98.98 8.68 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 177.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.03 166.67 10.92 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 120.24 -0.584 . . . . 0.0 112.116 -177.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.679 HG22 ' HG2' ' A' ' 59' ' ' GLN . 89.6 t -141.19 139.7 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 178.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.772 HD12 HD23 ' A' ' 58' ' ' LEU . 42.7 mt -95.38 119.11 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 106.563 -1.644 . . . . 0.0 106.563 178.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.412 ' HA ' ' CE2' ' A' ' 57' ' ' TYR . 54.1 t -78.59 118.87 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 CA-C-O 121.415 0.626 . . . . 0.0 110.922 -176.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.429 ' HA ' ' HB2' ' A' ' 7' ' ' ALA . 1.6 t -159.91 91.56 0.97 Allowed 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.4 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -90.12 138.29 31.64 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.103 -179.051 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.708 HG21 HD12 ' A' ' 33' ' ' ILE . 43.6 t -147.51 124.17 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.514 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 29.0 t -85.51 75.01 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.603 ' HA ' HG12 ' A' ' 2' ' ' VAL . 3.4 m -75.48 158.22 32.9 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.5 t -40.45 -77.97 0.02 OUTLIER 'General case' 0 N--CA 1.525 3.323 0 CA-C-N 118.158 0.435 . . . . 0.0 111.597 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.404 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 1.2 mt -173.27 -63.47 0.0 OUTLIER Pre-proline 0 N--CA 1.515 2.789 0 CA-C-O 117.719 -1.134 . . . . 0.0 111.064 177.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.404 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 2.9 Cg_endo -60.13 -53.35 3.13 Favored 'Trans proline' 0 CA--C 1.564 1.98 0 CA-C-N 120.105 1.073 . . . . 0.0 112.473 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -62.11 -164.83 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 120.503 0.802 . . . . 0.0 112.558 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -170.34 -167.37 0.61 Allowed 'General case' 0 N--CA 1.519 3.003 0 O-C-N 121.921 -0.487 . . . . 0.0 110.434 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.708 HD12 HG21 ' A' ' 25' ' ' VAL . 17.8 tt -103.59 139.42 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.539 ' N ' HD12 ' A' ' 34' ' ' ILE . 4.0 mp -102.13 130.57 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.528 ' HB2' HG22 ' A' ' 42' ' ' VAL . 72.3 m95 -92.68 114.78 27.43 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt . . . . . 0 N--CA 1.501 2.115 0 O-C-N 121.903 -0.498 . . . . 0.0 111.035 -178.981 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.528 HG22 ' HB2' ' A' ' 35' ' ' TRP . 8.7 m . . . . . 0 N--CA 1.507 2.387 0 CA-C-O 121.282 0.563 . . . . 0.0 109.739 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.579 HG12 HG21 ' A' ' 52' ' ' VAL . 58.5 mt -60.94 -17.48 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.718 0 O-C-N 121.964 -0.46 . . . . 0.0 111.423 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.476 ' N ' HD12 ' A' ' 44' ' ' LEU . 10.1 mp -90.08 -23.64 21.35 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.473 -0.767 . . . . 0.0 110.451 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -99.06 -35.45 10.03 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.721 -0.612 . . . . 0.0 109.544 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.5 mmmt 49.27 54.85 10.25 Favored 'General case' 0 N--CA 1.506 2.351 0 CA-C-O 121.359 0.6 . . . . 0.0 111.978 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.0 167.24 0.12 Allowed 'General case' 0 N--CA 1.517 2.888 0 O-C-N 121.895 -0.503 . . . . 0.0 110.729 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.9 m -60.81 -19.38 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.741 0 O-C-N 121.874 -0.516 . . . . 0.0 111.843 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 25.6 ptt-85 -118.52 45.41 2.04 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.676 -0.64 . . . . 0.0 111.915 -179.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -146.51 104.84 3.8 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.604 -0.685 . . . . 0.0 109.752 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 76.1 mt -129.87 108.32 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.579 HG21 HG12 ' A' ' 43' ' ' ILE . 2.7 t -74.65 140.88 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.422 HD11 ' OE1' ' A' ' 59' ' ' GLN . 17.0 mt -95.49 169.59 9.95 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.821 -0.549 . . . . 0.0 111.899 -178.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.6 p -61.88 -23.11 66.09 Favored 'General case' 0 N--CA 1.509 2.521 0 O-C-N 122.183 -0.323 . . . . 0.0 111.007 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 44.6 p-10 -88.19 15.15 7.93 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.768 -0.582 . . . . 0.0 111.412 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.424 ' HB3' HG21 ' A' ' 33' ' ' ILE . 7.6 m120 68.13 33.47 4.43 Favored 'General case' 0 N--CA 1.516 2.834 0 O-C-N 121.577 -0.702 . . . . 0.0 112.023 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.412 ' CE2' ' HA ' ' A' ' 22' ' ' VAL . 3.8 m-85 -102.85 166.83 10.25 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.772 HD23 HD12 ' A' ' 21' ' ' ILE . 19.2 tp -120.83 98.03 5.81 Favored 'General case' 0 N--CA 1.519 2.991 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.666 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.679 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.7 OUTLIER -75.65 101.11 4.85 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.917 179.464 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.599 HD11 HD11 ' A' ' 21' ' ' ILE . 95.5 mt -92.12 115.37 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 177.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -77.58 112.23 14.16 Favored 'General case' 0 N--CA 1.505 2.298 0 CA-C-O 121.521 0.677 . . . . 0.0 111.467 -178.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 100.16 -36.44 4.12 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 179.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.587 ' CG1' HG21 ' A' ' 92' ' ' VAL . 2.6 tp 41.77 74.47 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.519 3.003 0 CA-C-O 122.249 1.024 . . . . 0.0 112.454 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.9 mmtp -62.8 158.6 18.39 Favored 'General case' 0 N--CA 1.509 2.483 0 O-C-N 121.488 -0.758 . . . . 0.0 112.336 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.3 tptt -61.97 -24.55 67.08 Favored 'General case' 0 N--CA 1.51 2.557 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.833 178.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.3 t -83.61 -15.1 50.31 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.773 -0.579 . . . . 0.0 111.109 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -94.12 11.09 31.22 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.635 -0.666 . . . . 0.0 111.595 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.512 ' HB3' HG12 ' A' ' 92' ' ' VAL . 9.1 pt-20 -98.74 137.3 37.55 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.275 -0.891 . . . . 0.0 109.593 179.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 174.7 -106.37 0.22 Allowed Glycine 0 N--CA 1.499 2.886 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.3 m -143.33 102.2 3.93 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.946 -0.737 . . . . 0.0 110.901 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -83.61 132.55 34.89 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.7 tpp85 -96.42 118.18 32.4 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.459 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.692 ' HB3' HD11 ' A' ' 33' ' ' ILE . 9.0 m -81.04 126.4 31.38 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 177.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -125.26 87.28 2.68 Favored 'General case' 0 N--CA 1.503 2.178 0 CA-C-N 118.605 0.639 . . . . 0.0 110.681 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.83 101.0 0.6 Allowed Glycine 0 N--CA 1.501 3.021 0 N-CA-C 107.921 -2.071 . . . . 0.0 107.921 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 30.3 ttp85 . . . . . 0 N--CA 1.495 1.797 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -176.961 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 . . . . . 0 N--CA 1.502 2.134 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -164.51 177.64 7.99 Favored 'General case' 0 N--CA 1.503 2.22 0 C-N-CA 119.861 -0.736 . . . . 0.0 112.744 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.48 ' HG3' HD11 ' A' ' 88' ' ' ILE . 1.3 pttt -167.42 163.6 14.99 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 177.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.558 ' O ' HG22 ' A' ' 9' ' ' THR . 10.2 p-10 -99.79 119.34 38.01 Favored 'General case' 0 N--CA 1.511 2.618 0 O-C-N 121.884 -0.51 . . . . 0.0 111.698 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.579 ' N ' HD12 ' A' ' 88' ' ' ILE . 3.1 mp -104.17 118.47 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -84.06 125.65 32.31 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.434 HG13 HE21 ' A' ' 11' ' ' GLN . 47.6 t -119.26 126.08 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 O-C-N 121.719 -0.613 . . . . 0.0 109.792 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 51.1 mt -116.4 157.97 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.587 HG21 ' CG1' ' A' ' 63' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.5 2.053 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.394 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 37.6 t . . . . . 0 N--CA 1.501 2.123 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.49 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 1.6 mmm -108.43 111.54 23.49 Favored 'General case' 0 N--CA 1.508 2.468 0 C-N-CA 120.144 -0.622 . . . . 0.0 109.821 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -67.65 119.87 13.11 Favored 'General case' 0 N--CA 1.505 2.319 0 CA-C-O 120.786 0.327 . . . . 0.0 110.783 -178.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.462 ' HG2' HG23 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -132.56 160.29 36.99 Favored 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 121.553 0.692 . . . . 0.0 111.114 -179.821 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.415 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.4 OUTLIER 31.41 58.81 0.29 Allowed 'General case' 0 N--CA 1.519 2.994 0 C-N-CA 124.148 0.979 . . . . 0.0 113.561 179.411 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -121.37 79.14 36.43 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.697 -0.627 . . . . 0.0 110.74 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -65.75 114.12 2.82 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 N-CA-C 109.189 -1.12 . . . . 0.0 109.189 178.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.581 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.2 OUTLIER -67.75 -66.76 1.02 Allowed Pre-proline 0 N--CA 1.498 1.956 0 CA-C-O 117.059 -1.448 . . . . 0.0 111.208 -178.335 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.485 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.4 Cg_endo -72.17 89.22 0.8 Allowed 'Trans proline' 0 N--CA 1.498 1.763 0 CA-C-N 121.108 1.432 . . . . 0.0 111.199 178.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.421 HE21 HG13 ' A' ' 90' ' ' VAL . 10.5 pt20 -100.36 171.75 7.57 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 120.715 -1.24 . . . . 0.0 110.088 178.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -154.4 127.44 8.31 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.816 -0.552 . . . . 0.0 111.646 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -125.73 -164.0 1.26 Allowed 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.36 142.63 51.13 Favored 'General case' 0 N--CA 1.513 2.694 0 CA-C-O 121.856 0.836 . . . . 0.0 111.455 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -56.26 141.86 39.73 Favored 'General case' 0 N--CA 1.51 2.536 0 O-C-N 121.831 -0.543 . . . . 0.0 111.082 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.15 12.73 72.38 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -104.87 156.09 18.33 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 119.116 1.458 . . . . 0.0 111.34 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -81.12 95.45 6.88 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 176.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.15 166.34 11.46 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.996 -0.682 . . . . 0.0 112.203 -176.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.713 HG22 ' HG2' ' A' ' 59' ' ' GLN . 94.3 t -140.04 140.05 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 178.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.816 HD12 HD23 ' A' ' 58' ' ' LEU . 47.9 mt -94.87 117.0 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 178.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.497 HG13 ' CE2' ' A' ' 57' ' ' TYR . 39.2 t -77.08 119.48 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 CA-C-O 121.431 0.634 . . . . 0.0 110.98 -176.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.4 t -161.34 92.03 0.88 Allowed 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.415 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.2 OUTLIER -92.09 140.59 29.49 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.905 -0.718 . . . . 0.0 109.314 -179.131 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.687 HG21 HD12 ' A' ' 33' ' ' ILE . 43.7 t -146.79 128.19 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.49 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 45.9 t -89.42 74.09 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.0 m -78.44 161.79 26.86 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 178.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 t -41.96 -78.29 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.199 0 CA-C-N 118.191 0.451 . . . . 0.0 111.566 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -174.0 -62.54 0.0 OUTLIER Pre-proline 0 N--CA 1.515 2.809 0 CA-C-O 117.873 -1.06 . . . . 0.0 111.498 177.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.68 -53.44 3.31 Favored 'Trans proline' 0 CA--C 1.562 1.913 0 CA-C-N 119.845 0.981 . . . . 0.0 112.519 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -61.4 -165.28 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 120.535 0.823 . . . . 0.0 112.61 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -170.35 -170.13 0.92 Allowed 'General case' 0 N--CA 1.521 3.114 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.717 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.687 HD12 HG21 ' A' ' 25' ' ' VAL . 18.3 tt -100.92 140.22 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.535 ' N ' HD12 ' A' ' 34' ' ' ILE . 5.1 mp -102.91 128.36 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.009 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.527 ' HB2' HG22 ' A' ' 42' ' ' VAL . 73.6 m95 -90.56 112.88 24.73 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.0 ttpt . . . . . 0 N--CA 1.504 2.251 0 O-C-N 121.783 -0.573 . . . . 0.0 111.059 -178.685 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.527 HG22 ' HB2' ' A' ' 35' ' ' TRP . 6.4 m . . . . . 0 N--CA 1.503 2.208 0 CA-C-O 121.111 0.481 . . . . 0.0 109.791 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 77.3 mt -60.24 -17.61 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.855 0 O-C-N 122.071 -0.393 . . . . 0.0 111.418 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.463 ' N ' HD12 ' A' ' 44' ' ' LEU . 10.7 mp -90.16 -23.65 21.27 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.511 -0.743 . . . . 0.0 110.617 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.403 ' HG2' ' HA ' ' A' ' 42' ' ' VAL . 45.0 pttt -99.15 -36.91 9.52 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.719 -0.613 . . . . 0.0 109.572 178.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.7 mmmt 47.97 56.72 6.87 Favored 'General case' 0 N--CA 1.508 2.426 0 CA-C-O 121.503 0.668 . . . . 0.0 111.88 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.67 168.45 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.811 0 O-C-N 121.863 -0.523 . . . . 0.0 111.638 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.9 m -59.91 -20.04 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.68 0 O-C-N 121.923 -0.485 . . . . 0.0 112.268 -178.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.9 ptp85 -114.68 4.37 15.03 Favored 'General case' 0 N--CA 1.507 2.42 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -102.32 111.3 23.53 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.143 -0.973 . . . . 0.0 110.916 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 82.6 mt -132.87 105.96 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.531 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.2 t -73.39 136.73 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.417 HD11 ' CG ' ' A' ' 59' ' ' GLN . 14.4 mt -90.22 166.83 13.13 Favored 'General case' 0 N--CA 1.507 2.386 0 CA-C-O 121.319 0.58 . . . . 0.0 111.845 -178.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 92.9 p -60.87 -21.7 63.54 Favored 'General case' 0 N--CA 1.509 2.487 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.249 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 42.0 p-10 -90.32 17.92 6.67 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.629 -0.67 . . . . 0.0 111.475 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.416 ' HB3' HG21 ' A' ' 33' ' ' ILE . 4.5 m120 68.26 30.72 5.49 Favored 'General case' 0 N--CA 1.518 2.948 0 O-C-N 121.605 -0.685 . . . . 0.0 112.051 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.497 ' CE2' HG13 ' A' ' 22' ' ' VAL . 3.6 m-85 -101.71 165.2 11.34 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.816 HD23 HD12 ' A' ' 21' ' ' ILE . 17.1 tp -120.06 102.61 8.65 Favored 'General case' 0 N--CA 1.518 2.942 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.751 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.713 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.7 OUTLIER -80.0 103.42 9.87 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.368 179.653 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.522 HD11 HD11 ' A' ' 21' ' ' ILE . 95.1 mt -95.89 104.7 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 177.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -68.01 113.22 5.51 Favored 'General case' 0 N--CA 1.505 2.289 0 CA-C-O 121.07 0.462 . . . . 0.0 110.756 -178.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.402 ' O ' HG22 ' A' ' 63' ' ' ILE . . . 100.92 -40.17 2.51 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 179.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.55 ' CG1' HG21 ' A' ' 92' ' ' VAL . 1.7 tp 42.91 72.14 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.961 0 CA-C-O 122.228 1.013 . . . . 0.0 112.446 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 59.9 mttt -62.33 158.62 16.95 Favored 'General case' 0 N--CA 1.51 2.527 0 O-C-N 121.63 -0.669 . . . . 0.0 112.154 -178.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.5 mtmt -62.84 -23.65 67.39 Favored 'General case' 0 N--CA 1.508 2.473 0 O-C-N 122.134 -0.354 . . . . 0.0 110.879 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.0 p -80.77 -17.28 51.44 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.741 -0.6 . . . . 0.0 110.774 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -94.23 10.02 35.7 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.701 -0.624 . . . . 0.0 111.725 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.542 ' HB3' HG12 ' A' ' 92' ' ' VAL . 8.2 pt-20 -98.18 144.57 27.49 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-N 119.209 0.913 . . . . 0.0 110.156 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 167.94 -102.93 0.19 Allowed Glycine 0 N--CA 1.499 2.878 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.7 m -145.98 102.87 3.69 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 122.123 -0.634 . . . . 0.0 111.122 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -83.97 133.73 34.68 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -95.41 120.68 36.07 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.405 -179.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.681 ' HB3' HD11 ' A' ' 33' ' ' ILE . 7.3 m -85.21 122.57 29.6 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 177.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -125.06 88.39 2.88 Favored 'General case' 0 N--CA 1.505 2.293 0 CA-C-N 119.021 0.828 . . . . 0.0 111.061 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.39 110.52 3.46 Favored Glycine 0 N--CA 1.502 3.071 0 N-CA-C 107.911 -2.076 . . . . 0.0 107.911 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.7 ttp85 . . . . . 0 N--CA 1.499 2.004 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -177.096 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.6 m120 . . . . . 0 N--CA 1.501 2.083 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.422 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 30.7 p90 -157.24 -177.25 6.46 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 119.497 -0.881 . . . . 0.0 112.669 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 9.6 tptt -168.4 165.36 12.73 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.581 ' O ' HG22 ' A' ' 9' ' ' THR . 7.5 p-10 -110.31 108.74 18.92 Favored 'General case' 0 N--CA 1.509 2.494 0 CA-C-O 120.974 0.416 . . . . 0.0 110.245 178.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.588 ' N ' HD12 ' A' ' 88' ' ' ILE . 2.2 mp -92.76 113.78 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -80.68 105.08 11.65 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.421 HG13 HE21 ' A' ' 11' ' ' GLN . 39.3 t -99.97 136.5 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.156 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 63.4 mt -126.92 156.95 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.55 HG21 ' CG1' ' A' ' 63' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.498 1.948 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.594 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.9 t . . . . . 0 N--CA 1.501 2.117 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.499 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 6.3 mmt -116.46 113.37 22.74 Favored 'General case' 0 N--CA 1.507 2.413 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.416 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -70.31 116.5 10.73 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 122.103 -0.373 . . . . 0.0 111.1 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt -119.9 155.98 31.65 Favored 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.423 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.1 OUTLIER 44.48 81.24 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.747 0 C-N-CA 122.718 0.407 . . . . 0.0 111.517 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -126.35 56.86 17.8 Favored Pre-proline 0 N--CA 1.497 1.907 0 O-C-N 121.64 -0.663 . . . . 0.0 112.425 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.02 90.67 0.16 Allowed 'Trans proline' 0 N--CA 1.496 1.62 0 N-CA-C 107.983 -1.583 . . . . 0.0 107.983 176.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.551 ' OG1' ' HD3' ' A' ' 10' ' ' PRO . 0.5 OUTLIER -52.93 -54.87 39.19 Favored Pre-proline 0 N--CA 1.503 2.194 0 CA-C-O 117.119 -1.419 . . . . 0.0 113.575 -176.268 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.551 ' HD3' ' OG1' ' A' ' 9' ' ' THR . 1.6 Cg_endo -80.27 92.84 1.07 Allowed 'Trans proline' 0 CA--C 1.549 1.242 0 CA-C-N 120.892 1.354 . . . . 0.0 111.584 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.544 HE21 HG13 ' A' ' 90' ' ' VAL . 16.7 pt20 -100.99 171.04 7.88 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.088 -1.007 . . . . 0.0 110.197 178.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -156.76 118.1 3.77 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.635 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -114.47 -170.0 1.64 Allowed 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.901 -0.499 . . . . 0.0 110.024 179.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -101.79 139.71 37.07 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.517 0.675 . . . . 0.0 111.452 -178.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -59.87 119.03 6.93 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 121.015 0.436 . . . . 0.0 110.842 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.69 23.49 46.26 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -114.57 164.31 14.18 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 118.621 1.211 . . . . 0.0 110.907 -179.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -79.72 98.88 7.17 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 177.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.78 170.64 8.41 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 120.218 -0.593 . . . . 0.0 111.731 -177.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.692 HG22 ' HG2' ' A' ' 59' ' ' GLN . 87.5 t -143.47 141.11 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 178.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.923 HD11 HD11 ' A' ' 60' ' ' ILE . 18.9 mt -96.11 115.25 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 178.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.414 HG13 ' CE2' ' A' ' 57' ' ' TYR . 46.0 t -74.94 122.0 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 CA-C-O 121.371 0.605 . . . . 0.0 111.205 -176.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -164.94 88.6 0.47 Allowed 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.423 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -87.79 145.01 26.3 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 119.785 -0.766 . . . . 0.0 108.995 -179.612 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.649 HG21 HD12 ' A' ' 33' ' ' ILE . 39.9 t -151.64 137.17 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.499 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 62.2 t -99.49 78.45 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 108.174 -1.046 . . . . 0.0 108.174 178.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.2 m -80.1 163.13 24.38 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 178.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.8 t -42.11 -79.83 0.01 OUTLIER 'General case' 0 N--CA 1.524 3.237 0 O-C-N 121.87 -0.519 . . . . 0.0 111.595 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.418 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 0.2 OUTLIER -171.13 -63.29 0.0 OUTLIER Pre-proline 0 N--CA 1.514 2.768 0 CA-C-O 117.715 -1.136 . . . . 0.0 111.593 177.675 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.418 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 2.8 Cg_endo -60.26 -53.21 3.17 Favored 'Trans proline' 0 CA--C 1.562 1.914 0 CA-C-N 120.045 1.052 . . . . 0.0 112.812 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.4 ' HD3' ' CG ' ' A' ' 30' ' ' PRO . 3.0 Cg_endo -62.04 -163.99 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 120.456 0.771 . . . . 0.0 112.716 -178.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -170.53 -168.12 0.67 Allowed 'General case' 0 N--CA 1.518 2.931 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.134 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.649 HD12 HG21 ' A' ' 25' ' ' VAL . 15.4 tt -100.24 155.28 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.529 ' N ' HD12 ' A' ' 34' ' ' ILE . 4.7 mp -117.65 132.35 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.577 ' CG ' HD22 ' A' ' 58' ' ' LEU . 79.4 m95 -94.54 104.67 16.62 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.2 tttt . . . . . 0 N--CA 1.498 1.969 0 CA-C-O 121.192 0.52 . . . . 0.0 110.609 -178.848 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.563 HG22 ' HB2' ' A' ' 35' ' ' TRP . 8.5 m . . . . . 0 N--CA 1.508 2.461 0 CA-C-O 120.896 0.379 . . . . 0.0 110.605 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 57.7 mt -59.21 -17.51 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.796 0 O-C-N 121.551 -0.718 . . . . 0.0 111.546 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.499 ' N ' HD12 ' A' ' 44' ' ' LEU . 8.8 mp -92.13 -21.82 20.21 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.491 -0.756 . . . . 0.0 111.122 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 39.9 pttt -97.25 -38.55 9.64 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.54 -0.725 . . . . 0.0 109.584 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.8 mmmt 46.31 55.05 7.77 Favored 'General case' 0 N--CA 1.51 2.54 0 CA-C-O 121.533 0.682 . . . . 0.0 112.116 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.05 169.86 0.09 Allowed 'General case' 0 N--CA 1.514 2.761 0 O-C-N 121.734 -0.604 . . . . 0.0 110.819 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.4 m -60.79 -19.57 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.621 0 O-C-N 121.965 -0.459 . . . . 0.0 111.664 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 8.9 ptp85 -119.32 46.82 1.81 Allowed 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.662 -0.649 . . . . 0.0 112.174 -178.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -145.62 99.21 3.25 Favored 'General case' 0 N--CA 1.508 2.431 0 O-C-N 121.556 -0.715 . . . . 0.0 110.081 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.485 ' N ' HD12 ' A' ' 51' ' ' ILE . 5.3 mp -125.8 114.44 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.509 HG22 ' CD1' ' A' ' 58' ' ' LEU . 2.5 t -79.99 131.69 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.9 mt -82.1 163.97 21.66 Favored 'General case' 0 N--CA 1.507 2.409 0 CA-C-O 121.328 0.585 . . . . 0.0 111.774 -178.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 92.4 p -60.4 -20.2 58.81 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 122.171 -0.331 . . . . 0.0 111.221 179.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 48.7 p-10 -91.33 19.23 6.18 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.609 -0.682 . . . . 0.0 111.389 179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.9 m120 67.23 32.17 6.19 Favored 'General case' 0 N--CA 1.516 2.835 0 O-C-N 121.613 -0.68 . . . . 0.0 112.401 178.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.414 ' CE2' HG13 ' A' ' 22' ' ' VAL . 4.0 m-85 -103.39 166.61 10.32 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.914 HD23 HD12 ' A' ' 21' ' ' ILE . 19.7 tp -121.72 97.99 5.75 Favored 'General case' 0 N--CA 1.515 2.791 0 C-N-CA 119.407 -0.917 . . . . 0.0 111.748 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.692 ' HG2' HG22 ' A' ' 20' ' ' VAL . 1.3 mt-30 -74.91 105.44 5.94 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.861 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.923 HD11 HD11 ' A' ' 21' ' ' ILE . 97.0 mt -96.44 112.1 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 178.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -73.1 112.66 9.35 Favored 'General case' 0 N--CA 1.506 2.336 0 CA-C-O 121.384 0.611 . . . . 0.0 111.423 -177.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.65 -36.08 4.15 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 178.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.506 HG23 HG21 ' A' ' 92' ' ' VAL . 1.7 tp 41.97 69.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.808 0 CA-C-O 122.185 0.993 . . . . 0.0 112.379 -178.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 55.3 mttt -57.55 158.9 5.42 Favored 'General case' 0 N--CA 1.51 2.56 0 O-C-N 121.615 -0.678 . . . . 0.0 112.209 -178.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 45.4 tttt -62.33 -23.63 66.88 Favored 'General case' 0 N--CA 1.508 2.452 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.895 178.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.7 t -83.15 -15.85 49.03 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.794 -0.566 . . . . 0.0 111.184 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -93.95 9.57 36.92 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.714 -0.616 . . . . 0.0 111.653 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -98.45 142.63 29.83 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.33 -0.856 . . . . 0.0 109.626 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 168.0 -103.81 0.2 Allowed Glycine 0 N--CA 1.498 2.815 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.4 m -145.93 102.78 3.69 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.974 -0.721 . . . . 0.0 111.21 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.4 ' CG ' HD13 ' A' ' 21' ' ' ILE . 24.9 m-85 -83.91 135.28 34.55 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.8 ttt85 -97.51 117.64 32.22 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.103 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.2 m -80.47 133.11 35.81 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 177.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -134.59 91.33 2.77 Favored 'General case' 0 N--CA 1.505 2.297 0 CA-C-N 118.686 0.676 . . . . 0.0 110.396 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.47 118.83 8.78 Favored Glycine 0 N--CA 1.503 3.141 0 N-CA-C 107.746 -2.142 . . . . 0.0 107.746 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.1 ttm180 . . . . . 0 N--CA 1.501 2.104 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -177.238 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.9 m120 . . . . . 0 N--CA 1.505 2.322 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -162.42 -175.21 4.4 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 119.684 -0.806 . . . . 0.0 112.715 -179.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.4 tptt -171.1 167.5 7.12 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.519 ' O ' HG22 ' A' ' 9' ' ' THR . 2.7 p-10 -115.37 108.09 16.07 Favored 'General case' 0 N--CA 1.513 2.723 0 O-C-N 121.844 -0.535 . . . . 0.0 110.222 178.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.606 ' N ' HD12 ' A' ' 88' ' ' ILE . 2.4 mp -96.16 115.71 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -84.63 111.02 19.17 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.544 HG13 HE21 ' A' ' 11' ' ' GLN . 42.5 t -105.48 138.05 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.917 -0.489 . . . . 0.0 110.291 -179.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 82.3 mt -128.23 157.31 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.506 HG21 HG23 ' A' ' 63' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.916 0 CA-C-O 118.062 -0.971 . . . . 0.0 110.458 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.2 t . . . . . 0 N--CA 1.506 2.332 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.542 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 6.5 mmt -110.27 110.9 21.89 Favored 'General case' 0 N--CA 1.506 2.348 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.18 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -71.24 113.71 8.56 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 122.086 -0.384 . . . . 0.0 110.239 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.6 ptpt -129.03 163.7 24.83 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 122.013 0.911 . . . . 0.0 112.301 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 29.69 95.49 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.014 0 C-N-CA 124.654 1.182 . . . . 0.0 114.185 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.403 ' HB2' ' HA ' ' A' ' 23' ' ' CYS . . . -164.47 84.67 1.19 Allowed Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.8 -0.562 . . . . 0.0 111.263 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -66.17 104.38 0.72 Allowed 'Trans proline' 0 N--CA 1.49 1.309 0 N-CA-C 108.288 -1.466 . . . . 0.0 108.288 177.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.548 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.2 OUTLIER -50.61 -66.01 0.76 Allowed Pre-proline 0 N--CA 1.51 2.56 0 CA-C-O 116.932 -1.509 . . . . 0.0 112.54 -176.973 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.485 ' HD3' ' OG1' ' A' ' 9' ' ' THR . 1.6 Cg_endo -73.99 94.5 0.88 Allowed 'Trans proline' 0 N--CA 1.494 1.542 0 CA-C-N 121.203 1.465 . . . . 0.0 110.937 178.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.441 HE21 HG13 ' A' ' 90' ' ' VAL . 17.1 pt20 -99.66 173.47 6.7 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.047 -1.033 . . . . 0.0 110.091 178.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -155.23 121.25 5.15 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 120.373 -0.531 . . . . 0.0 112.01 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -120.2 -170.5 1.98 Allowed 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 178.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 30.7 ttpt -104.92 139.32 39.81 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.339 0.59 . . . . 0.0 111.489 -179.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -62.1 111.6 2.01 Favored 'General case' 0 N--CA 1.508 2.447 0 CA-C-O 121.062 0.458 . . . . 0.0 110.359 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.51 22.31 16.93 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -117.16 164.83 14.18 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 118.474 1.137 . . . . 0.0 110.668 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -82.62 100.1 9.96 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 178.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -102.42 167.42 9.96 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.955 -177.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.666 HG22 ' HG2' ' A' ' 59' ' ' GLN . 95.7 t -138.99 141.2 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 178.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.894 HD12 HD23 ' A' ' 58' ' ' LEU . 22.5 mt -95.76 112.39 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 178.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.477 HG13 ' CE2' ' A' ' 57' ' ' TYR . 57.8 t -74.12 122.35 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 CA-C-O 121.551 0.691 . . . . 0.0 110.682 -176.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.403 ' HA ' ' HB2' ' A' ' 7' ' ' ALA . 1.2 t -163.7 92.55 0.7 Allowed 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.02 137.87 32.01 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.373 -179.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.432 HG21 HD13 ' A' ' 33' ' ' ILE . 41.1 t -147.18 125.71 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.542 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 40.8 t -91.06 79.43 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.3 m -78.06 167.14 21.9 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 178.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 t -45.49 -80.23 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.165 0 O-C-N 121.761 -0.587 . . . . 0.0 111.09 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.428 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 0.6 OUTLIER -166.98 -64.56 0.01 OUTLIER Pre-proline 0 N--CA 1.512 2.635 0 CA-C-O 117.566 -1.207 . . . . 0.0 111.697 177.529 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.428 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 2.8 Cg_endo -60.36 -53.49 2.89 Favored 'Trans proline' 0 CA--C 1.562 1.916 0 CA-C-N 120.233 1.119 . . . . 0.0 112.847 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.4 ' HD3' ' CG ' ' A' ' 30' ' ' PRO . 3.2 Cg_exo -61.15 -165.72 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 120.498 0.798 . . . . 0.0 113.223 -178.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -172.83 -161.36 0.15 Allowed 'General case' 0 N--CA 1.52 3.051 0 O-C-N 121.927 -0.483 . . . . 0.0 109.906 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.574 HD12 ' N ' ' A' ' 75' ' ' GLY . 0.6 OUTLIER -106.04 148.63 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.896 -0.503 . . . . 0.0 110.415 179.502 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.538 ' N ' HD12 ' A' ' 34' ' ' ILE . 5.3 mp -109.53 125.19 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.546 ' CG ' HD22 ' A' ' 58' ' ' LEU . 77.1 m95 -85.21 120.53 26.8 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.6 mmmt . . . . . 0 N--CA 1.503 2.184 0 CA-C-O 121.439 0.637 . . . . 0.0 111.71 -177.75 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.518 HG22 ' HB2' ' A' ' 35' ' ' TRP . 4.3 m . . . . . 0 N--CA 1.509 2.511 0 CA-C-O 121.13 0.49 . . . . 0.0 109.99 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.821 ' CD1' HG21 ' A' ' 52' ' ' VAL . 47.9 mm -59.57 -18.25 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.702 0 O-C-N 121.92 -0.487 . . . . 0.0 111.76 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.435 ' N ' HD12 ' A' ' 44' ' ' LEU . 10.7 mp -92.32 -21.4 20.3 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.509 -0.744 . . . . 0.0 111.195 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 35.1 pttt -98.55 -37.87 9.38 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.625 -0.672 . . . . 0.0 109.408 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.4 mmmt 47.61 54.25 10.03 Favored 'General case' 0 N--CA 1.51 2.551 0 CA-C-O 121.498 0.666 . . . . 0.0 111.859 179.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.99 161.43 2.32 Favored 'General case' 0 N--CA 1.512 2.661 0 O-C-N 121.754 -0.591 . . . . 0.0 110.404 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.4 m -58.42 -20.3 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.77 0 O-C-N 121.924 -0.485 . . . . 0.0 111.613 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -108.0 37.86 2.35 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.78 -0.575 . . . . 0.0 111.806 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -144.86 106.75 4.29 Favored 'General case' 0 N--CA 1.506 2.375 0 O-C-N 121.767 -0.583 . . . . 0.0 109.598 178.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 72.9 mt -126.21 102.14 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.821 HG21 ' CD1' ' A' ' 43' ' ' ILE . 4.2 t -74.33 132.08 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.4 mt -88.15 162.45 16.71 Favored 'General case' 0 N--CA 1.504 2.272 0 CA-C-O 121.272 0.558 . . . . 0.0 111.571 -178.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.6 p -60.24 -19.64 55.44 Favored 'General case' 0 N--CA 1.511 2.598 0 O-C-N 122.141 -0.35 . . . . 0.0 111.427 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 43.2 p-10 -91.74 19.5 6.4 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.565 -0.71 . . . . 0.0 111.374 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.43 ' HB3' HG21 ' A' ' 33' ' ' ILE . 4.7 m120 67.93 32.05 5.34 Favored 'General case' 0 N--CA 1.518 2.93 0 O-C-N 121.783 -0.573 . . . . 0.0 112.356 178.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.477 ' CE2' HG13 ' A' ' 22' ' ' VAL . 4.3 m-85 -103.59 163.37 12.35 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.894 HD23 HD12 ' A' ' 21' ' ' ILE . 16.8 tp -122.14 97.51 5.51 Favored 'General case' 0 N--CA 1.513 2.722 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.715 -179.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.666 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -75.53 98.48 3.97 Favored 'General case' 0 N--CA 1.501 2.082 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.825 179.512 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.801 HD11 HD11 ' A' ' 21' ' ' ILE . 98.0 mt -90.73 115.94 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.17 115.08 15.55 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 121.265 0.555 . . . . 0.0 110.991 -178.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.31 -37.5 3.46 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.447 ' CG1' HG21 ' A' ' 92' ' ' VAL . 2.5 tp 41.7 70.57 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.517 2.897 0 CA-C-O 122.237 1.018 . . . . 0.0 112.246 -178.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.533 ' HB3' HG22 ' A' ' 66' ' ' THR . 39.7 mtpt -67.04 149.89 49.97 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.589 -0.694 . . . . 0.0 111.472 -178.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.618 ' HA ' HG12 ' A' ' 92' ' ' VAL . 22.6 pttt -60.96 -24.29 65.97 Favored 'General case' 0 N--CA 1.511 2.582 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.493 178.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.533 HG22 ' HB3' ' A' ' 64' ' ' LYS . 9.4 t -71.17 -18.15 62.5 Favored 'General case' 0 N--CA 1.502 2.144 0 C-N-CA 120.261 -0.575 . . . . 0.0 110.134 177.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -102.67 -1.03 30.87 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.644 -0.66 . . . . 0.0 111.842 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -79.23 153.5 29.91 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.163 -0.961 . . . . 0.0 109.606 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 161.74 -102.66 0.21 Allowed Glycine 0 N--CA 1.497 2.733 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.5 m -152.97 104.18 2.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 122.084 -0.656 . . . . 0.0 110.305 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -82.82 135.37 34.97 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -96.77 119.8 35.93 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.762 -0.586 . . . . 0.0 110.99 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.481 ' HB3' HD11 ' A' ' 33' ' ' ILE . 7.4 m -83.85 116.66 22.85 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 177.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.449 ' O ' HD12 ' A' ' 34' ' ' ILE . 26.2 mt-10 -115.94 88.16 2.83 Favored 'General case' 0 N--CA 1.503 2.185 0 CA-C-N 118.637 0.653 . . . . 0.0 110.928 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.574 ' N ' HD12 ' A' ' 33' ' ' ILE . . . -68.76 113.64 5.38 Favored Glycine 0 N--CA 1.504 3.184 0 N-CA-C 107.883 -2.087 . . . . 0.0 107.883 178.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.3 ttm-85 . . . . . 0 N--CA 1.499 1.998 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -177.411 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 N--CA 1.503 2.213 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.415 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 30.7 p90 -163.97 177.9 8.15 Favored 'General case' 0 N--CA 1.503 2.197 0 C-N-CA 119.765 -0.774 . . . . 0.0 112.833 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.4 pttt -166.85 165.59 16.08 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.548 ' O ' HG22 ' A' ' 9' ' ' THR . 8.8 p-10 -101.42 119.09 38.23 Favored 'General case' 0 N--CA 1.511 2.606 0 O-C-N 121.857 -0.527 . . . . 0.0 111.956 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.565 ' N ' HD12 ' A' ' 88' ' ' ILE . 2.6 mp -102.28 117.01 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 178.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -83.47 123.11 29.38 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -179.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.441 HG13 HE21 ' A' ' 11' ' ' GLN . 37.5 t -118.15 131.23 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 121.775 -0.578 . . . . 0.0 109.721 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 69.3 mt -127.34 152.94 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.618 HG12 ' HA ' ' A' ' 65' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.502 2.15 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.042 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 36.0 t . . . . . 0 N--CA 1.505 2.32 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.565 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 73.1 mtp -119.09 112.59 19.73 Favored 'General case' 0 N--CA 1.511 2.579 0 O-C-N 121.752 -0.592 . . . . 0.0 111.19 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -72.48 107.11 4.86 Favored 'General case' 0 N--CA 1.508 2.432 0 CA-C-O 121.01 0.433 . . . . 0.0 110.454 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -118.75 170.98 8.53 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-O 121.221 0.534 . . . . 0.0 110.669 -179.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.412 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.9 OUTLIER 25.43 63.23 0.06 Allowed 'General case' 0 N--CA 1.526 3.342 0 C-N-CA 124.291 1.037 . . . . 0.0 113.753 178.424 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -128.33 66.79 74.2 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 121.627 -0.671 . . . . 0.0 111.646 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.73 108.25 1.03 Allowed 'Trans proline' 0 N--CA 1.493 1.48 0 N-CA-C 108.218 -1.493 . . . . 0.0 108.218 177.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.516 HG22 HD13 ' A' ' 88' ' ' ILE . 11.4 p -62.24 -43.9 86.97 Favored Pre-proline 0 N--CA 1.503 2.208 0 CA-C-O 117.287 -1.339 . . . . 0.0 113.178 -176.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.487 ' HD3' ' OG1' ' A' ' 9' ' ' THR . 1.6 Cg_endo -84.11 84.79 1.49 Allowed 'Trans proline' 0 CA--C 1.551 1.329 0 CA-C-N 120.677 1.277 . . . . 0.0 111.513 -177.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.449 HE21 HG13 ' A' ' 90' ' ' VAL . 15.8 pt20 -100.49 172.74 6.93 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 121.085 -1.009 . . . . 0.0 110.748 179.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -158.03 120.52 3.77 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.897 -0.502 . . . . 0.0 111.342 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -116.41 -169.73 1.67 Allowed 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.965 -0.459 . . . . 0.0 110.196 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 49.5 tttm -101.85 135.77 42.83 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.378 0.609 . . . . 0.0 111.256 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -60.74 116.86 4.73 Favored 'General case' 0 N--CA 1.509 2.498 0 CA-C-O 121.082 0.468 . . . . 0.0 110.582 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.88 22.81 29.58 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.419 ' O ' HG22 ' A' ' 63' ' ' ILE . 16.9 tt0 -117.26 164.58 14.6 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 118.471 1.135 . . . . 0.0 110.93 -179.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -81.08 98.41 7.99 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 177.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.11 167.22 10.6 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 120.291 -0.564 . . . . 0.0 111.911 -177.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.662 HG22 ' HG2' ' A' ' 59' ' ' GLN . 98.5 t -140.55 139.98 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 178.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.703 HD12 HD23 ' A' ' 58' ' ' LEU . 38.4 mt -95.2 116.73 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 178.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.498 HG13 ' CE2' ' A' ' 57' ' ' TYR . 44.6 t -78.87 117.02 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-O 121.321 0.581 . . . . 0.0 110.781 -176.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -154.47 95.01 1.76 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.412 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 1.7 m-20 -90.05 137.79 32.05 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.48 HG21 HD12 ' A' ' 33' ' ' ILE . 13.9 t -147.81 122.26 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.565 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 14.8 t -85.15 81.53 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.9 m -87.38 155.2 20.14 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.6 t -44.94 -84.03 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.15 0 O-C-N 121.884 -0.51 . . . . 0.0 111.909 -178.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.404 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 0.8 OUTLIER -166.94 -62.23 0.01 OUTLIER Pre-proline 0 N--CA 1.511 2.576 0 CA-C-O 117.76 -1.114 . . . . 0.0 112.094 178.568 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.404 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 2.7 Cg_endo -59.37 -53.87 3.09 Favored 'Trans proline' 0 CA--C 1.559 1.741 0 CA-C-N 120.082 1.065 . . . . 0.0 112.336 -178.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.414 ' C ' ' HG1' ' A' ' 32' ' ' THR . 2.4 Cg_endo -64.46 -168.97 0.11 Allowed 'Trans proline' 0 N--CA 1.496 1.663 0 CA-C-N 119.399 0.821 . . . . 0.0 110.984 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.414 ' HG1' ' C ' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -172.04 -165.29 0.34 Allowed 'General case' 0 N--CA 1.521 3.086 0 O-C-N 121.723 -0.611 . . . . 0.0 109.844 179.838 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.48 HD12 HG21 ' A' ' 25' ' ' VAL . 20.3 tt -99.39 150.73 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 122.053 -0.405 . . . . 0.0 109.925 179.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.6 mt -115.56 115.42 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.553 ' HB2' HG22 ' A' ' 42' ' ' VAL . 72.7 m95 -81.18 104.96 12.02 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.7 tttt . . . . . 0 N--CA 1.502 2.142 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.885 -178.78 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.553 HG22 ' HB2' ' A' ' 35' ' ' TRP . 7.0 m . . . . . 0 N--CA 1.507 2.386 0 CA-C-O 121.312 0.577 . . . . 0.0 109.675 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.571 HG12 HG21 ' A' ' 52' ' ' VAL . 64.5 mt -60.66 -18.44 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.72 0 O-C-N 121.951 -0.468 . . . . 0.0 111.167 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.493 ' N ' HD12 ' A' ' 44' ' ' LEU . 9.6 mp -90.95 -22.56 20.79 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.52 -0.737 . . . . 0.0 110.823 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.414 ' HG2' ' HA ' ' A' ' 42' ' ' VAL . 30.6 pttt -99.18 -36.83 9.53 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.577 -0.702 . . . . 0.0 109.716 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 17.2 mmmt 48.92 54.77 10.28 Favored 'General case' 0 N--CA 1.51 2.563 0 CA-C-O 121.507 0.67 . . . . 0.0 111.562 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.61 172.14 0.05 OUTLIER 'General case' 0 N--CA 1.514 2.741 0 O-C-N 121.836 -0.54 . . . . 0.0 111.067 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.6 m -61.22 -19.19 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.605 0 O-C-N 121.982 -0.449 . . . . 0.0 111.954 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.402 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 26.6 ptt-85 -121.78 47.46 1.88 Allowed 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.757 -0.59 . . . . 0.0 112.356 -178.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -145.04 108.52 4.63 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 121.521 -0.737 . . . . 0.0 110.094 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 71.3 mt -129.12 102.01 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.645 HG22 ' CD1' ' A' ' 58' ' ' LEU . 4.8 t -73.84 128.1 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.42 HD11 ' OE1' ' A' ' 59' ' ' GLN . 18.8 mt -82.56 165.43 20.11 Favored 'General case' 0 N--CA 1.508 2.445 0 CA-C-O 121.299 0.571 . . . . 0.0 111.828 -178.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 93.7 p -59.94 -20.84 59.71 Favored 'General case' 0 N--CA 1.51 2.534 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.39 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 36.2 p-10 -92.38 21.2 5.45 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.699 -0.626 . . . . 0.0 111.343 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.412 ' HB3' HG21 ' A' ' 33' ' ' ILE . 5.5 m120 65.18 33.53 9.27 Favored 'General case' 0 N--CA 1.514 2.727 0 O-C-N 121.756 -0.59 . . . . 0.0 112.496 178.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.498 ' CE2' HG13 ' A' ' 22' ' ' VAL . 3.9 m-85 -102.15 164.77 11.52 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 177.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.703 HD23 HD12 ' A' ' 21' ' ' ILE . 15.5 tp -120.61 97.07 5.39 Favored 'General case' 0 N--CA 1.517 2.887 0 C-N-CA 119.327 -0.949 . . . . 0.0 111.651 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.662 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -75.83 95.97 3.59 Favored 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.799 179.499 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.551 HD11 HD11 ' A' ' 21' ' ' ILE . 93.1 mt -86.95 117.0 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -78.3 111.72 14.56 Favored 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 121.393 0.616 . . . . 0.0 111.663 -178.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 100.13 -35.65 4.64 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.499 HG23 HG21 ' A' ' 92' ' ' VAL . 1.6 tp 40.96 69.65 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.842 0 CA-C-O 122.201 1.0 . . . . 0.0 112.657 -179.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -57.75 157.75 7.03 Favored 'General case' 0 N--CA 1.513 2.684 0 O-C-N 121.638 -0.663 . . . . 0.0 112.417 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 35.7 tttm -61.47 -22.53 65.15 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 122.218 -0.301 . . . . 0.0 110.876 178.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.7 p -83.36 -19.96 35.16 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.772 -0.58 . . . . 0.0 110.74 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.76 7.7 35.53 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.61 -0.681 . . . . 0.0 111.678 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.438 ' HB3' HG12 ' A' ' 92' ' ' VAL . 8.4 pt-20 -96.79 141.12 30.38 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.35 -0.844 . . . . 0.0 109.365 179.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 169.98 -105.72 0.23 Allowed Glycine 0 N--CA 1.498 2.831 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.2 m -144.12 103.65 4.03 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 122.031 -0.688 . . . . 0.0 111.206 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -84.57 134.43 34.4 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.7 tpp85 -91.64 119.54 31.62 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.743 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 85' ' ' PHE . 1.8 m -87.83 90.26 8.31 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -91.57 88.64 6.84 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.276 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.55 91.31 0.56 Allowed Glycine 0 N--CA 1.499 2.873 0 N-CA-C 107.531 -2.227 . . . . 0.0 107.531 178.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.1 ttm180 . . . . . 0 N--CA 1.496 1.859 0 CA-C-O 121.923 0.868 . . . . 0.0 113.043 -177.257 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 . . . . . 0 N--CA 1.506 2.336 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.484 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 25.5 p90 -157.06 175.78 13.63 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.658 -0.817 . . . . 0.0 112.583 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 20.0 tttt -165.25 169.61 15.73 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -116.75 134.4 54.85 Favored 'General case' 0 N--CA 1.51 2.557 0 O-C-N 121.829 -0.544 . . . . 0.0 110.654 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.516 HD13 HG22 ' A' ' 9' ' ' THR . 47.9 mm -117.47 109.24 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -77.09 100.41 5.7 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.449 HG13 HE21 ' A' ' 11' ' ' GLN . 46.6 t -96.27 136.99 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.915 -179.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 65.9 mt -125.51 159.1 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.499 HG21 HG23 ' A' ' 63' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.5 2.056 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.539 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 26.2 t . . . . . 0 N--CA 1.508 2.427 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.535 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 7.9 mmm -121.17 117.31 26.79 Favored 'General case' 0 N--CA 1.511 2.575 0 O-C-N 121.879 -0.513 . . . . 0.0 110.551 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -74.33 114.41 12.67 Favored 'General case' 0 N--CA 1.507 2.415 0 CA-C-O 120.98 0.419 . . . . 0.0 111.099 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.21 162.32 26.45 Favored 'General case' 0 N--CA 1.503 2.22 0 CA-C-O 121.758 0.79 . . . . 0.0 111.594 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.416 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.3 OUTLIER 32.02 80.56 0.02 OUTLIER 'General case' 0 N--CA 1.52 3.057 0 C-N-CA 124.177 0.991 . . . . 0.0 113.274 179.266 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -138.41 79.97 28.8 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.954 -0.466 . . . . 0.0 110.727 -179.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -65.44 96.89 0.3 Allowed 'Trans proline' 0 N--CA 1.491 1.336 0 N-CA-C 108.503 -1.383 . . . . 0.0 108.503 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.582 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.6 OUTLIER -51.25 -72.29 0.17 Allowed Pre-proline 0 N--CA 1.506 2.331 0 CA-C-O 116.437 -1.744 . . . . 0.0 112.485 -177.172 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.492 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.5 Cg_endo -71.48 97.1 0.76 Allowed 'Trans proline' 0 N--CA 1.498 1.755 0 CA-C-N 121.921 1.722 . . . . 0.0 111.719 178.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -101.59 178.11 4.73 Favored 'General case' 0 N--CA 1.507 2.41 0 O-C-N 120.974 -1.079 . . . . 0.0 110.055 178.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -156.23 127.5 7.07 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.833 -0.542 . . . . 0.0 111.568 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -127.84 -169.2 2.01 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.847 -0.533 . . . . 0.0 109.802 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -115.49 145.42 42.62 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.838 0.827 . . . . 0.0 111.841 -178.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -61.82 121.24 12.39 Favored 'General case' 0 N--CA 1.508 2.442 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.45 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.74 22.83 48.66 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.513 ' O ' HG22 ' A' ' 63' ' ' ILE . 18.4 tt0 -112.98 159.84 18.71 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 118.478 1.139 . . . . 0.0 111.186 -179.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.36 97.65 8.44 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 177.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -103.4 164.2 11.79 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.528 0.68 . . . . 0.0 112.498 -177.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.695 HG22 ' HG2' ' A' ' 59' ' ' GLN . 95.3 t -139.31 141.82 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 178.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.903 HD12 HD23 ' A' ' 58' ' ' LEU . 55.3 mt -97.42 115.29 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 178.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.483 HG13 ' CE2' ' A' ' 57' ' ' TYR . 46.8 t -76.32 120.86 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 121.505 0.669 . . . . 0.0 111.055 -176.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.7 t -161.68 94.85 0.97 Allowed 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.416 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -92.88 141.44 28.42 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 120.121 -0.632 . . . . 0.0 109.684 -178.767 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.643 HG21 HD12 ' A' ' 33' ' ' ILE . 32.9 t -149.52 123.46 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.535 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 21.6 t -81.7 80.42 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.6 m -87.61 154.09 20.88 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.2 t -44.09 -83.11 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.216 0 O-C-N 121.956 -0.465 . . . . 0.0 111.953 -178.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.417 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 0.3 OUTLIER -168.96 -61.29 0.01 OUTLIER Pre-proline 0 N--CA 1.51 2.566 0 CA-C-O 117.731 -1.128 . . . . 0.0 111.785 178.532 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.417 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 2.7 Cg_endo -60.74 -54.13 2.21 Favored 'Trans proline' 0 CA--C 1.561 1.86 0 CA-C-N 120.028 1.046 . . . . 0.0 112.519 -179.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.409 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 2.7 Cg_endo -63.66 -166.83 0.07 OUTLIER 'Trans proline' 0 N--CA 1.498 1.765 0 CA-C-N 119.539 0.871 . . . . 0.0 111.678 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -170.97 -166.62 0.49 Allowed 'General case' 0 N--CA 1.523 3.188 0 O-C-N 121.813 -0.554 . . . . 0.0 110.36 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.643 HD12 HG21 ' A' ' 25' ' ' VAL . 18.7 tt -104.1 136.73 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.546 ' N ' HD12 ' A' ' 34' ' ' ILE . 4.9 mp -101.17 124.37 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.568 ' HB2' HG22 ' A' ' 42' ' ' VAL . 75.1 m95 -84.64 109.69 18.18 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.2 tttt . . . . . 0 N--CA 1.501 2.095 0 CA-C-O 121.48 0.657 . . . . 0.0 111.625 -178.05 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.568 HG22 ' HB2' ' A' ' 35' ' ' TRP . 6.3 m . . . . . 0 N--CA 1.508 2.438 0 CA-C-O 120.804 0.335 . . . . 0.0 110.823 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.7 mm -59.26 -17.95 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.819 0 O-C-N 121.577 -0.702 . . . . 0.0 111.572 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.489 ' N ' HD12 ' A' ' 44' ' ' LEU . 10.0 mp -91.38 -22.84 20.28 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.457 -0.777 . . . . 0.0 110.978 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -98.66 -40.44 8.19 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.764 -0.585 . . . . 0.0 109.478 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm 47.26 56.02 7.42 Favored 'General case' 0 N--CA 1.509 2.517 0 CA-C-O 121.473 0.654 . . . . 0.0 112.04 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.58 155.19 1.64 Allowed 'General case' 0 N--CA 1.515 2.796 0 O-C-N 121.649 -0.657 . . . . 0.0 111.013 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.7 m -54.32 -24.36 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.816 0 O-C-N 121.907 -0.496 . . . . 0.0 112.125 -178.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.95 -3.67 31.81 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.484 ' HE2' HD21 ' A' ' 58' ' ' LEU . 7.5 m-85 -95.79 109.41 21.73 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.388 -0.82 . . . . 0.0 110.18 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 71.8 mt -129.44 104.27 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.524 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.2 t -73.76 128.59 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.494 HD11 ' CG ' ' A' ' 59' ' ' GLN . 39.5 mt -82.11 166.3 19.83 Favored 'General case' 0 N--CA 1.508 2.466 0 CA-C-O 121.308 0.575 . . . . 0.0 111.806 -178.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.4 p -61.19 -21.55 63.91 Favored 'General case' 0 N--CA 1.51 2.532 0 O-C-N 122.106 -0.371 . . . . 0.0 111.211 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -90.87 19.12 5.81 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.577 -0.702 . . . . 0.0 111.338 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.408 ' HB3' HG21 ' A' ' 33' ' ' ILE . 6.1 m120 67.42 33.21 5.36 Favored 'General case' 0 N--CA 1.516 2.862 0 O-C-N 121.57 -0.706 . . . . 0.0 112.524 178.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.483 ' CE2' HG13 ' A' ' 22' ' ' VAL . 3.9 m-85 -103.3 166.77 10.23 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 177.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.903 HD23 HD12 ' A' ' 21' ' ' ILE . 16.8 tp -120.69 98.24 5.93 Favored 'General case' 0 N--CA 1.519 2.995 0 C-N-CA 119.356 -0.938 . . . . 0.0 111.919 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.695 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -78.45 101.62 7.4 Favored 'General case' 0 N--CA 1.504 2.263 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.364 179.66 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.509 HD11 HD11 ' A' ' 21' ' ' ILE . 96.8 mt -93.82 103.4 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 177.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 19.3 tpp85 -70.3 116.6 10.84 Favored 'General case' 0 N--CA 1.504 2.233 0 CA-C-O 121.317 0.58 . . . . 0.0 110.865 -178.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.64 -35.1 4.83 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.513 HG22 ' O ' ' A' ' 17' ' ' GLU . 1.8 tp 35.27 94.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.519 2.999 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 59.0 mmtt -73.4 148.71 43.09 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.613 -0.68 . . . . 0.0 110.656 -178.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -62.58 -18.89 63.04 Favored 'General case' 0 N--CA 1.51 2.559 0 O-C-N 122.072 -0.393 . . . . 0.0 110.978 178.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.8 t -87.83 -13.5 41.98 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.686 -0.634 . . . . 0.0 111.376 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -91.67 14.36 15.39 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.53 -0.731 . . . . 0.0 111.491 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.78 150.3 20.55 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.433 -0.792 . . . . 0.0 109.792 179.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 166.06 -101.25 0.18 Allowed Glycine 0 N--CA 1.499 2.887 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.6 m -149.02 101.13 3.13 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.953 -0.734 . . . . 0.0 111.239 179.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -81.47 133.56 35.42 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 177.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.8 ttm105 -97.29 120.3 37.4 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.11 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.624 ' HB3' HD11 ' A' ' 33' ' ' ILE . 9.3 m -83.46 113.33 20.7 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 177.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -111.5 85.63 2.17 Favored 'General case' 0 N--CA 1.504 2.272 0 CA-C-N 118.537 0.608 . . . . 0.0 109.609 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.68 96.67 0.31 Allowed Glycine 0 N--CA 1.502 3.057 0 N-CA-C 108.475 -1.85 . . . . 0.0 108.475 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.409 ' O ' ' HB2' ' A' ' 31' ' ' PRO . 2.1 ttp85 . . . . . 0 N--CA 1.494 1.736 0 O-C-N 122.059 -0.671 . . . . 0.0 112.212 -177.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 . . . . . 0 N--CA 1.505 2.29 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.418 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 39.1 p90 -166.73 175.8 7.61 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 121.352 -0.843 . . . . 0.0 113.158 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.538 ' HD2' HD11 ' A' ' 88' ' ' ILE . 3.2 ptpt -167.78 161.27 13.14 Favored 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.582 ' O ' HG22 ' A' ' 9' ' ' THR . 7.7 p-10 -98.06 122.93 41.79 Favored 'General case' 0 N--CA 1.512 2.635 0 O-C-N 121.736 -0.602 . . . . 0.0 112.107 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.55 ' N ' HD12 ' A' ' 88' ' ' ILE . 2.3 mp -106.72 122.55 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 178.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -87.25 134.82 33.5 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.2 t -127.52 129.08 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 O-C-N 121.673 -0.642 . . . . 0.0 110.22 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 74.6 mt -116.26 139.63 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.426 HG21 ' CG1' ' A' ' 63' ' ' ILE . 44.6 t . . . . . 0 N--CA 1.503 2.18 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.364 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 36.6 t . . . . . 0 N--CA 1.504 2.228 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.52 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 7.1 mmt -122.73 115.92 22.88 Favored 'General case' 0 N--CA 1.51 2.565 0 O-C-N 121.783 -0.573 . . . . 0.0 110.482 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -74.38 113.1 11.22 Favored 'General case' 0 N--CA 1.506 2.374 0 O-C-N 122.005 -0.434 . . . . 0.0 110.538 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.435 ' HG2' HG23 ' A' ' 26' ' ' VAL . 5.0 ptpt -127.16 163.7 23.26 Favored 'General case' 0 N--CA 1.503 2.215 0 CA-C-O 121.712 0.768 . . . . 0.0 111.753 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.419 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.3 OUTLIER 31.88 72.68 0.07 Allowed 'General case' 0 N--CA 1.52 3.048 0 C-N-CA 124.188 0.995 . . . . 0.0 113.342 179.317 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -136.81 81.01 35.31 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.802 -0.561 . . . . 0.0 110.721 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -65.58 102.09 0.48 Allowed 'Trans proline' 0 N--CA 1.49 1.294 0 N-CA-C 108.62 -1.339 . . . . 0.0 108.62 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.581 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.2 OUTLIER -55.86 -66.62 1.0 Allowed Pre-proline 0 N--CA 1.503 2.213 0 CA-C-O 116.93 -1.509 . . . . 0.0 112.216 -177.314 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.499 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.5 Cg_endo -74.18 91.4 0.94 Allowed 'Trans proline' 0 CA--C 1.556 1.609 0 CA-C-N 121.258 1.485 . . . . 0.0 111.148 178.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.525 HE21 HG13 ' A' ' 90' ' ' VAL . 15.9 pt20 -100.0 176.49 5.4 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 120.871 -1.143 . . . . 0.0 110.006 178.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -160.62 122.76 3.17 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.741 -0.599 . . . . 0.0 111.374 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -119.26 -170.64 1.96 Allowed 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.963 -0.461 . . . . 0.0 110.205 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 15.8 tptm -104.71 138.8 40.46 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.567 0.699 . . . . 0.0 111.413 -178.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -59.19 118.61 6.1 Favored 'General case' 0 N--CA 1.509 2.522 0 O-C-N 121.933 -0.479 . . . . 0.0 110.88 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.33 23.47 40.24 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.43 ' O ' HG22 ' A' ' 63' ' ' ILE . 13.0 tt0 -114.98 164.6 13.92 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 118.411 1.105 . . . . 0.0 110.531 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -82.85 98.46 9.17 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 178.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.17 168.27 9.92 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 120.365 -0.534 . . . . 0.0 112.053 -177.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.658 HG22 ' HG2' ' A' ' 59' ' ' GLN . 99.6 t -142.75 141.09 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.82 HD12 HD23 ' A' ' 58' ' ' LEU . 43.5 mt -97.02 111.96 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 178.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.442 HG13 ' CE2' ' A' ' 57' ' ' TYR . 57.8 t -75.17 119.93 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 CA-C-O 121.47 0.652 . . . . 0.0 110.493 -176.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -160.83 92.68 0.95 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.419 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.2 OUTLIER -91.16 140.75 29.52 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.529 -179.198 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.596 HG21 HD12 ' A' ' 33' ' ' ILE . 13.5 t -147.53 121.67 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.52 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 16.0 t -81.2 80.68 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.4 m -87.83 154.75 20.3 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.6 t -43.66 -84.0 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.18 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.407 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 0.9 OUTLIER -166.32 -62.21 0.01 OUTLIER Pre-proline 0 N--CA 1.509 2.475 0 CA-C-O 117.675 -1.155 . . . . 0.0 111.584 178.639 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.407 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 2.8 Cg_endo -60.2 -53.81 2.72 Favored 'Trans proline' 0 CA--C 1.561 1.844 0 CA-C-N 120.086 1.066 . . . . 0.0 112.552 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.414 ' C ' ' HG1' ' A' ' 32' ' ' THR . 2.6 Cg_endo -63.02 -168.53 0.08 OUTLIER 'Trans proline' 0 N--CA 1.496 1.668 0 CA-C-N 119.425 0.83 . . . . 0.0 111.746 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.414 ' HG1' ' C ' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -171.58 -164.77 0.34 Allowed 'General case' 0 N--CA 1.52 3.067 0 O-C-N 121.92 -0.488 . . . . 0.0 109.78 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.596 HD12 HG21 ' A' ' 25' ' ' VAL . 17.1 tt -102.53 147.31 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.925 -0.484 . . . . 0.0 110.056 179.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.553 ' N ' HD12 ' A' ' 34' ' ' ILE . 5.2 mp -114.5 121.07 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.56 ' HB2' HG22 ' A' ' 42' ' ' VAL . 83.6 m95 -82.77 104.4 12.99 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.1 tttm . . . . . 0 N--CA 1.506 2.359 0 CA-C-O 121.322 0.582 . . . . 0.0 111.494 -177.995 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.56 HG22 ' HB2' ' A' ' 35' ' ' TRP . 4.4 m . . . . . 0 N--CA 1.51 2.562 0 CA-C-O 121.019 0.438 . . . . 0.0 110.421 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.7 mm -58.42 -18.11 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.688 0 O-C-N 121.71 -0.618 . . . . 0.0 111.864 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.475 ' N ' HD12 ' A' ' 44' ' ' LEU . 9.3 mp -92.47 -22.18 19.74 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.492 -0.755 . . . . 0.0 111.106 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.1 pttt -97.88 -41.04 8.21 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.8 mmmt 46.91 56.91 6.14 Favored 'General case' 0 N--CA 1.509 2.505 0 CA-C-O 121.166 0.507 . . . . 0.0 112.308 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -49.69 161.17 0.24 Allowed 'General case' 0 N--CA 1.519 2.987 0 O-C-N 121.804 -0.56 . . . . 0.0 111.081 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 36.0 m -56.83 -21.92 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.779 0 O-C-N 121.911 -0.493 . . . . 0.0 112.172 -178.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 24.1 ptt-85 -104.22 -2.44 25.7 Favored 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.404 ' HE2' HD21 ' A' ' 58' ' ' LEU . 7.6 m-85 -96.24 108.28 20.74 Favored 'General case' 0 N--CA 1.503 2.18 0 CA-C-N 119.145 0.884 . . . . 0.0 110.166 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 75.6 mt -129.36 104.84 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.677 HG22 ' CD1' ' A' ' 58' ' ' LEU . 4.8 t -74.78 127.89 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.513 HD11 ' CG ' ' A' ' 59' ' ' GLN . 42.7 mt -80.63 165.54 21.94 Favored 'General case' 0 N--CA 1.509 2.477 0 CA-C-O 121.34 0.591 . . . . 0.0 111.905 -178.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 89.9 p -60.19 -20.92 60.83 Favored 'General case' 0 N--CA 1.51 2.547 0 O-C-N 122.07 -0.394 . . . . 0.0 111.484 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 42.8 p-10 -91.74 19.83 6.11 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.658 -0.652 . . . . 0.0 111.392 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.3 m120 67.24 32.13 6.2 Favored 'General case' 0 N--CA 1.516 2.846 0 O-C-N 121.594 -0.691 . . . . 0.0 112.39 178.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.442 ' CE2' HG13 ' A' ' 22' ' ' VAL . 3.7 m-85 -102.06 167.64 9.9 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.82 HD23 HD12 ' A' ' 21' ' ' ILE . 15.2 tp -121.99 98.8 6.11 Favored 'General case' 0 N--CA 1.519 2.978 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.954 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.658 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -78.72 101.15 7.39 Favored 'General case' 0 N--CA 1.503 2.202 0 C-N-CA 120.479 -0.489 . . . . 0.0 111.12 179.413 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.557 HD11 HD11 ' A' ' 21' ' ' ILE . 97.2 mt -94.68 104.31 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 177.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.85 115.65 8.42 Favored 'General case' 0 N--CA 1.505 2.301 0 CA-C-O 121.187 0.517 . . . . 0.0 110.721 -178.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 100.31 -39.26 2.8 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.577 ' CG1' HG21 ' A' ' 92' ' ' VAL . 3.0 tp 42.52 83.58 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.517 2.901 0 CA-C-O 122.225 1.012 . . . . 0.0 112.117 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -72.11 158.42 35.97 Favored 'General case' 0 N--CA 1.508 2.454 0 O-C-N 121.751 -0.593 . . . . 0.0 111.984 -178.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt -61.27 -24.55 66.47 Favored 'General case' 0 N--CA 1.51 2.558 0 O-C-N 121.941 -0.474 . . . . 0.0 110.918 178.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.9 t -79.32 -15.0 58.63 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.893 -0.505 . . . . 0.0 111.691 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -87.37 -27.77 22.6 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.502 -0.749 . . . . 0.0 110.718 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.402 ' HB3' HG12 ' A' ' 92' ' ' VAL . 5.1 pt-20 -62.0 140.56 58.34 Favored 'General case' 0 N--CA 1.507 2.406 0 O-C-N 121.691 -0.631 . . . . 0.0 110.752 -179.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 167.09 -104.88 0.23 Allowed Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.7 m -146.72 102.28 3.54 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 122.03 -0.688 . . . . 0.0 110.543 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -83.52 134.65 34.83 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 -94.0 115.65 28.01 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.85 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 85' ' ' PHE . 1.9 m -85.68 90.58 8.05 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -92.08 88.65 6.62 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.317 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.85 90.24 0.57 Allowed Glycine 0 N--CA 1.499 2.855 0 N-CA-C 107.44 -2.264 . . . . 0.0 107.44 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.406 ' HB2' HD13 ' A' ' 34' ' ' ILE . 30.1 ttm-85 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.805 0.812 . . . . 0.0 112.823 -177.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 . . . . . 0 N--CA 1.506 2.365 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.494 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 29.7 p90 -159.02 171.5 19.9 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 119.505 -0.878 . . . . 0.0 113.09 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 10.8 mttp -160.55 159.25 30.42 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.581 ' O ' HG22 ' A' ' 9' ' ' THR . 3.6 p30 -106.02 120.08 40.84 Favored 'General case' 0 N--CA 1.513 2.697 0 O-C-N 121.84 -0.538 . . . . 0.0 110.769 179.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.523 ' N ' HD12 ' A' ' 88' ' ' ILE . 1.8 mp -104.74 121.6 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -85.32 115.61 23.17 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.525 HG13 HE21 ' A' ' 11' ' ' GLN . 46.5 t -110.33 131.93 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.171 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 67.0 mt -120.38 157.57 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.577 HG21 ' CG1' ' A' ' 63' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.503 2.196 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.382 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 47.3 p90 . . . . . 0 N--CA 1.498 1.932 0 CA-C-O 120.752 0.31 . . . . 0.0 110.438 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.674 ' CG2' HD11 ' A' ' 77' ' ' ILE . 47.0 t -146.85 107.63 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.524 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 7.6 mmt -114.33 116.84 29.61 Favored 'General case' 0 N--CA 1.507 2.386 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.137 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -75.37 115.16 14.72 Favored 'General case' 0 N--CA 1.504 2.248 0 CA-C-O 120.9 0.381 . . . . 0.0 110.479 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.5 ptpt -127.22 163.71 23.28 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.649 0.738 . . . . 0.0 111.529 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 32.36 76.97 0.04 OUTLIER 'General case' 0 N--CA 1.517 2.901 0 C-N-CA 124.266 1.026 . . . . 0.0 113.49 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -145.03 78.45 12.48 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.812 -0.555 . . . . 0.0 110.916 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -64.37 104.39 0.51 Allowed 'Trans proline' 0 N--CA 1.492 1.412 0 N-CA-C 108.532 -1.372 . . . . 0.0 108.532 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.61 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.5 OUTLIER -50.92 -69.69 0.28 Allowed Pre-proline 0 N--CA 1.509 2.5 0 CA-C-O 116.625 -1.655 . . . . 0.0 112.802 -176.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.487 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.6 Cg_endo -72.62 96.72 0.84 Allowed 'Trans proline' 0 N--CA 1.498 1.741 0 CA-C-N 121.69 1.639 . . . . 0.0 111.518 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.441 HE21 HG13 ' A' ' 90' ' ' VAL . 16.1 pt20 -101.3 177.5 4.91 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 120.951 -1.093 . . . . 0.0 110.319 178.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -158.57 125.16 4.72 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.897 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -123.17 -170.65 2.15 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.953 -0.467 . . . . 0.0 109.876 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -104.67 143.86 32.51 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.617 0.722 . . . . 0.0 111.519 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -60.27 125.0 22.0 Favored 'General case' 0 N--CA 1.508 2.431 0 O-C-N 121.965 -0.459 . . . . 0.0 111.049 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.29 22.24 68.32 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 110.889 -0.885 . . . . 0.0 110.889 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -110.21 164.44 12.65 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 118.714 1.257 . . . . 0.0 110.61 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.43 98.62 8.98 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 177.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.78 165.82 11.4 Favored 'General case' 0 N--CA 1.497 1.925 0 C-N-CA 120.121 -0.631 . . . . 0.0 111.991 -177.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.671 HG22 ' HG2' ' A' ' 59' ' ' GLN . 85.1 t -138.94 139.68 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.737 HD12 HD23 ' A' ' 58' ' ' LEU . 40.9 mt -95.47 115.62 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 178.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.495 HG13 ' CE2' ' A' ' 57' ' ' TYR . 47.4 t -76.9 118.19 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-O 121.544 0.687 . . . . 0.0 110.507 -177.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.1 t -160.08 87.11 0.78 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.03 142.11 28.17 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 119.946 -0.702 . . . . 0.0 109.269 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.666 HG21 HD12 ' A' ' 33' ' ' ILE . 39.3 t -147.7 129.28 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.524 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 60.1 t -92.71 78.28 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.2 m -79.45 164.62 23.82 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.9 t -42.13 -80.52 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.224 0 CA-C-N 118.283 0.492 . . . . 0.0 111.607 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.416 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 0.4 OUTLIER -170.69 -63.43 0.0 OUTLIER Pre-proline 0 N--CA 1.515 2.786 0 CA-C-O 117.658 -1.163 . . . . 0.0 111.467 177.5 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.416 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 2.9 Cg_endo -60.84 -53.29 2.77 Favored 'Trans proline' 0 CA--C 1.563 1.97 0 CA-C-N 120.1 1.071 . . . . 0.0 112.805 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.515 ' HG3' HG23 ' A' ' 77' ' ' ILE . 2.9 Cg_endo -61.71 -162.94 0.03 OUTLIER 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 120.516 0.811 . . . . 0.0 112.666 -178.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -170.16 -165.67 0.49 Allowed 'General case' 0 N--CA 1.518 2.936 0 O-C-N 121.849 -0.532 . . . . 0.0 110.403 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.677 HD11 ' HB3' ' A' ' 73' ' ' CYS . 17.5 tt -100.82 162.79 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.1 mt -125.23 126.77 71.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.567 ' HB2' HG22 ' A' ' 42' ' ' VAL . 78.5 m95 -90.44 110.65 21.75 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.0 tttt -112.78 -178.05 3.29 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.941 -0.475 . . . . 0.0 110.594 -179.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 24.8 t-80 63.76 150.58 0.03 OUTLIER 'General case' 0 N--CA 1.512 2.671 0 O-C-N 121.769 -0.582 . . . . 0.0 110.053 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.9 tppt? 54.33 43.73 30.04 Favored 'General case' 0 N--CA 1.515 2.796 0 O-C-N 121.538 -0.726 . . . . 0.0 110.415 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 150.37 -17.94 1.02 Allowed Glycine 0 N--CA 1.491 2.35 0 C-N-CA 120.337 -0.935 . . . . 0.0 111.099 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.75 88.35 0.05 Allowed 'General case' 0 N--CA 1.516 2.828 0 CA-C-N 118.797 1.299 . . . . 0.0 110.051 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 55.06 84.61 0.07 Allowed 'General case' 0 N--CA 1.514 2.773 0 O-C-N 121.727 -0.608 . . . . 0.0 110.217 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.567 HG22 ' HB2' ' A' ' 35' ' ' TRP . 4.4 m -69.19 -32.35 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.364 0 O-C-N 121.869 -0.519 . . . . 0.0 110.052 -178.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.652 HD11 HG21 ' A' ' 52' ' ' VAL . 47.8 mm -58.27 -18.75 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.825 0 O-C-N 121.807 -0.558 . . . . 0.0 111.87 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.435 ' N ' HD12 ' A' ' 44' ' ' LEU . 10.3 mp -93.2 -20.71 20.19 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.47 -0.769 . . . . 0.0 111.531 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 42.2 pttt -98.97 -37.89 9.21 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.531 -0.731 . . . . 0.0 109.802 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt 48.61 55.19 9.41 Favored 'General case' 0 N--CA 1.509 2.513 0 CA-C-O 121.581 0.705 . . . . 0.0 111.766 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -53.11 171.3 0.07 Allowed 'General case' 0 N--CA 1.513 2.682 0 O-C-N 121.755 -0.591 . . . . 0.0 110.876 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.6 t -66.9 -19.41 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.467 0 O-C-N 122.007 -0.433 . . . . 0.0 110.996 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 10.0 ptt-85 -115.64 45.7 1.64 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.504 -0.747 . . . . 0.0 112.1 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -145.28 105.33 4.04 Favored 'General case' 0 N--CA 1.506 2.346 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 177.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 45.2 mt -126.0 102.45 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.652 HG21 HD11 ' A' ' 43' ' ' ILE . 3.5 t -73.37 129.04 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.55 HD11 ' CG ' ' A' ' 59' ' ' GLN . 29.8 mt -82.71 167.6 18.05 Favored 'General case' 0 N--CA 1.509 2.498 0 CA-C-O 121.358 0.599 . . . . 0.0 112.143 -178.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.4 p -61.63 -22.02 64.89 Favored 'General case' 0 N--CA 1.509 2.496 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.985 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 52.4 p30 -91.49 18.85 6.76 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.749 -0.595 . . . . 0.0 111.337 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.8 m120 66.88 34.44 5.4 Favored 'General case' 0 N--CA 1.517 2.921 0 O-C-N 121.534 -0.728 . . . . 0.0 112.832 178.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.495 ' CE2' HG13 ' A' ' 22' ' ' VAL . 3.7 m-85 -103.06 166.03 10.67 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 177.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.737 HD23 HD12 ' A' ' 21' ' ' ILE . 15.2 tp -119.51 97.19 5.53 Favored 'General case' 0 N--CA 1.519 2.993 0 C-N-CA 119.371 -0.932 . . . . 0.0 111.505 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.671 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -76.67 95.39 3.97 Favored 'General case' 0 N--CA 1.502 2.166 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.857 179.609 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.584 HD11 HD11 ' A' ' 21' ' ' ILE . 99.4 mt -87.04 119.74 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 177.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 32.9 tpt85 -80.3 117.39 21.03 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-O 121.324 0.583 . . . . 0.0 110.638 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.26 -39.59 2.75 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.628 HG23 HG21 ' A' ' 92' ' ' VAL . 2.8 tp 42.3 73.59 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.776 0 CA-C-O 122.16 0.981 . . . . 0.0 112.581 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.406 ' HB3' HG22 ' A' ' 66' ' ' THR . 37.5 mmtt -59.8 150.61 27.71 Favored 'General case' 0 N--CA 1.51 2.573 0 O-C-N 121.377 -0.827 . . . . 0.0 111.661 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.619 ' HA ' HG13 ' A' ' 92' ' ' VAL . 20.7 ttmt -62.52 -17.59 60.11 Favored 'General case' 0 N--CA 1.506 2.374 0 O-C-N 122.087 -0.383 . . . . 0.0 111.213 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.406 HG22 ' HB3' ' A' ' 64' ' ' LYS . 8.8 t -89.32 -15.95 32.23 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.651 -0.656 . . . . 0.0 111.127 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -92.47 15.03 14.98 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.502 -0.748 . . . . 0.0 111.536 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.74 ' HB3' HG12 ' A' ' 92' ' ' VAL . 0.5 OUTLIER -96.73 160.98 14.07 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.422 -0.798 . . . . 0.0 109.283 179.294 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 154.99 -99.4 0.19 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.371 -1.491 . . . . 0.0 109.371 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.8 m -151.05 101.35 2.87 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 122.016 -0.696 . . . . 0.0 111.988 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -82.17 131.74 35.24 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.1 tpp85 -98.11 117.02 31.53 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 120.087 -0.645 . . . . 0.0 111.212 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.677 ' HB3' HD11 ' A' ' 33' ' ' ILE . 14.4 m -79.43 129.84 34.85 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 177.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -128.03 88.63 2.79 Favored 'General case' 0 N--CA 1.502 2.15 0 CA-C-N 118.581 0.628 . . . . 0.0 110.265 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.47 111.11 3.84 Favored Glycine 0 N--CA 1.504 3.178 0 N-CA-C 107.915 -2.074 . . . . 0.0 107.915 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.2 ttm180 -125.28 141.08 52.3 Favored 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 121.959 0.885 . . . . 0.0 113.366 -177.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.674 HD11 ' CG2' ' A' ' 2' ' ' VAL . 87.6 mt -120.61 134.7 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.283 177.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.5 mt -93.4 -36.09 12.67 Favored 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.622 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.83 -54.85 28.61 Favored 'General case' 0 N--CA 1.514 2.731 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.442 ' H ' HG22 ' A' ' 77' ' ' ILE . 68.9 mtt180 -107.98 63.59 0.62 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 177.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -13.71 80.77 0.0 OUTLIER Glycine 1 N--CA 1.527 4.714 0 C-N-CA 125.098 1.332 . . . . 0.0 114.879 -178.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -116.83 143.7 45.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 122.161 -0.611 . . . . 0.0 109.772 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.1 pt -136.23 81.11 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 CA-C-O 121.316 0.579 . . . . 0.0 111.459 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -97.3 154.04 17.67 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -167.76 176.19 6.49 Favored 'General case' 0 N--CA 1.508 2.475 0 O-C-N 121.455 -0.778 . . . . 0.0 112.692 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.547 ' CD ' HD11 ' A' ' 88' ' ' ILE . 3.3 ptpt -168.13 155.95 8.45 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.61 ' O ' HG22 ' A' ' 9' ' ' THR . 4.5 p30 -93.16 120.53 33.55 Favored 'General case' 0 N--CA 1.51 2.55 0 O-C-N 121.713 -0.617 . . . . 0.0 111.796 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.57 ' N ' HD12 ' A' ' 88' ' ' ILE . 3.6 mp -106.04 119.47 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -85.11 130.84 34.54 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.441 HG13 HE21 ' A' ' 11' ' ' GLN . 46.1 t -123.25 128.76 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 54.7 mt -121.07 142.29 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.74 HG12 ' HB3' ' A' ' 68' ' ' GLU . 6.7 p . . . . . 0 N--CA 1.5 2.056 0 CA-C-O 117.876 -1.059 . . . . 0.0 110.469 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 37.4 p90 . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 121.368 0.604 . . . . 0.0 111.268 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.662 ' CG2' HD13 ' A' ' 77' ' ' ILE . 11.4 t -142.39 96.99 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.502 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 7.3 mmm -96.56 113.92 25.53 Favored 'General case' 0 N--CA 1.506 2.354 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.907 -178.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -72.13 115.06 10.91 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.421 ' HG2' HG23 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -125.22 158.01 35.11 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 121.323 0.582 . . . . 0.0 110.354 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.439 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.1 OUTLIER 38.88 70.92 0.18 Allowed 'General case' 0 N--CA 1.518 2.954 0 C-N-CA 123.374 0.67 . . . . 0.0 112.151 -179.654 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.03 72.01 72.69 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.748 -0.595 . . . . 0.0 111.258 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -65.09 102.07 0.43 Allowed 'Trans proline' 0 N--CA 1.49 1.323 0 N-CA-C 108.886 -1.236 . . . . 0.0 108.886 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.576 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.4 OUTLIER -54.28 -68.3 0.51 Allowed Pre-proline 0 N--CA 1.508 2.461 0 CA-C-O 116.782 -1.58 . . . . 0.0 112.25 -177.636 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.491 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.4 Cg_endo -72.43 90.5 0.79 Allowed 'Trans proline' 0 N--CA 1.496 1.676 0 CA-C-N 121.52 1.579 . . . . 0.0 111.353 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -100.85 173.93 6.27 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 120.785 -1.197 . . . . 0.0 110.352 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -157.16 122.88 4.71 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.803 -0.561 . . . . 0.0 111.003 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -117.16 -170.09 1.78 Allowed 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.963 -0.46 . . . . 0.0 110.552 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -103.31 140.45 37.4 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.862 0.839 . . . . 0.0 111.907 -178.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -60.79 126.96 29.32 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.822 -0.548 . . . . 0.0 111.017 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.07 21.82 72.83 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -110.91 161.5 15.77 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 118.652 1.226 . . . . 0.0 111.018 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -79.79 95.8 6.11 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 177.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.66 169.68 9.86 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.851 -177.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.651 HG22 ' HG2' ' A' ' 59' ' ' GLN . 84.5 t -142.98 141.3 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.771 HD12 HD23 ' A' ' 58' ' ' LEU . 26.0 mt -96.36 114.4 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 178.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.63 HG13 ' CZ ' ' A' ' 57' ' ' TYR . 38.8 t -75.51 118.33 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 CA-C-O 121.477 0.656 . . . . 0.0 110.735 -176.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.9 t -163.61 80.49 0.44 Allowed 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.439 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.4 OUTLIER -80.06 146.21 32.06 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.149 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.488 HG21 HD12 ' A' ' 33' ' ' ILE . 60.4 t -148.88 133.84 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.502 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 60.6 t -94.88 88.49 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -88.29 140.2 29.72 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.0 t -97.97 30.57 3.0 Favored 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -177.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.664 HD22 ' CB ' ' A' ' 79' ' ' ALA . 0.2 OUTLIER -161.79 170.41 8.12 Favored Pre-proline 0 N--CA 1.513 2.693 0 O-C-N 120.896 -1.127 . . . . 0.0 111.12 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.632 ' HD2' HD23 ' A' ' 29' ' ' LEU . 4.0 Cg_exo -49.81 -47.93 21.32 Favored 'Trans proline' 0 N--CA 1.502 1.973 0 C-N-CA 121.639 1.559 . . . . 0.0 114.491 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 29' ' ' LEU . 4.5 Cg_exo -52.66 -170.02 0.01 OUTLIER 'Trans proline' 0 N--CA 1.506 2.235 0 CA-C-N 120.044 1.051 . . . . 0.0 112.896 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.549 HG22 ' ND2' ' A' ' 56' ' ' ASN . 0.2 OUTLIER -168.93 -156.21 0.16 Allowed 'General case' 0 N--CA 1.522 3.154 0 O-C-N 120.381 -1.45 . . . . 0.0 111.634 -176.915 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.563 HD11 ' HB3' ' A' ' 73' ' ' CYS . 19.5 tt -88.02 143.04 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 O-C-N 121.897 -0.502 . . . . 0.0 111.906 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.546 ' N ' HD12 ' A' ' 34' ' ' ILE . 3.6 mp -109.47 130.44 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 177.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.529 ' CG ' HD22 ' A' ' 58' ' ' LEU . 79.3 m95 -90.28 110.61 21.66 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -110.37 -170.18 1.6 Allowed 'General case' 0 N--CA 1.501 2.1 0 CA-C-O 121.394 0.616 . . . . 0.0 111.199 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 64.06 163.79 0.13 Allowed 'General case' 0 N--CA 1.511 2.621 0 O-C-N 121.87 -0.519 . . . . 0.0 110.24 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.404 ' HG3' ' CE1' ' A' ' 71' ' ' TYR . 0.0 OUTLIER 76.87 -51.71 0.57 Allowed 'General case' 0 N--CA 1.522 3.13 0 C-N-CA 123.873 0.869 . . . . 0.0 110.575 -178.754 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -144.94 30.37 1.8 Allowed Glycine 0 N--CA 1.498 2.818 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.61 89.06 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.791 0 O-C-N 121.496 -1.003 . . . . 0.0 111.625 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.36 105.89 0.01 OUTLIER 'General case' 0 N--CA 1.518 2.932 0 O-C-N 121.807 -0.558 . . . . 0.0 110.865 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.527 HG22 ' HB2' ' A' ' 35' ' ' TRP . 5.6 m -76.99 -31.38 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.394 0 O-C-N 121.715 -0.616 . . . . 0.0 110.646 -179.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 79.6 mt -59.27 -17.33 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.87 0 O-C-N 121.754 -0.591 . . . . 0.0 111.803 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.495 ' N ' HD12 ' A' ' 44' ' ' LEU . 9.8 mp -89.47 -25.22 21.59 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.599 -0.688 . . . . 0.0 110.55 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.0 pttt -98.6 -38.87 8.97 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.756 -0.59 . . . . 0.0 109.655 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.5 mmmt 47.06 55.64 7.79 Favored 'General case' 0 N--CA 1.51 2.55 0 CA-C-O 121.399 0.618 . . . . 0.0 111.959 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.8 169.46 0.07 Allowed 'General case' 0 N--CA 1.515 2.778 0 O-C-N 121.792 -0.567 . . . . 0.0 111.116 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 31.4 m -63.54 -21.59 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.591 0 O-C-N 121.985 -0.447 . . . . 0.0 111.649 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 16.4 ptt-85 -113.67 48.5 1.06 Allowed 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.648 -0.658 . . . . 0.0 111.747 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.411 ' O ' HD13 ' A' ' 51' ' ' ILE . 7.6 m-85 -144.73 102.97 3.87 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.553 -0.717 . . . . 0.0 109.895 178.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.411 HD13 ' O ' ' A' ' 50' ' ' PHE . 48.0 mm -127.74 114.05 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.474 HG22 ' CD1' ' A' ' 58' ' ' LEU . 2.6 t -80.13 146.64 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 24.6 mt -102.71 162.99 12.48 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 121.244 0.545 . . . . 0.0 111.605 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 81.8 p -59.88 -20.58 57.96 Favored 'General case' 0 N--CA 1.51 2.552 0 O-C-N 122.098 -0.376 . . . . 0.0 111.689 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 38.5 p-10 -91.36 17.74 8.06 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.662 -0.649 . . . . 0.0 111.736 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.549 ' ND2' HG22 ' A' ' 32' ' ' THR . 8.1 m120 70.21 29.54 3.67 Favored 'General case' 0 N--CA 1.52 3.046 0 O-C-N 121.635 -0.666 . . . . 0.0 111.931 179.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.63 ' CZ ' HG13 ' A' ' 22' ' ' VAL . 4.3 m-85 -103.18 159.92 15.11 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.771 HD23 HD12 ' A' ' 21' ' ' ILE . 26.9 tp -120.85 100.81 7.3 Favored 'General case' 0 N--CA 1.514 2.743 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.814 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.651 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.7 OUTLIER -75.48 103.47 5.62 Favored 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 120.759 -0.377 . . . . 0.0 111.244 179.717 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.739 HD11 HD11 ' A' ' 21' ' ' ILE . 99.8 mt -95.53 114.09 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 177.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -74.59 115.55 14.28 Favored 'General case' 0 N--CA 1.503 2.175 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.229 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.401 ' O ' HG22 ' A' ' 63' ' ' ILE . . . 97.04 -39.02 2.89 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 178.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.5 ' CG1' HG21 ' A' ' 92' ' ' VAL . 1.9 tp 42.92 71.79 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.843 0 CA-C-O 122.256 1.027 . . . . 0.0 112.241 -178.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.1 mtpp -63.32 158.01 21.46 Favored 'General case' 0 N--CA 1.506 2.374 0 O-C-N 121.59 -0.694 . . . . 0.0 112.333 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -62.02 -23.63 66.56 Favored 'General case' 0 N--CA 1.508 2.441 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.933 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.7 p -83.78 -16.56 44.24 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.74 -0.6 . . . . 0.0 111.015 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.91 -19.47 25.77 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.704 -0.623 . . . . 0.0 111.042 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.497 ' HB3' HG12 ' A' ' 92' ' ' VAL . 7.6 pt-20 -67.6 150.1 49.23 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.445 -0.785 . . . . 0.0 109.916 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 166.31 -111.69 0.46 Allowed Glycine 0 N--CA 1.498 2.822 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.4 m -144.57 101.59 3.7 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.941 -0.74 . . . . 0.0 110.034 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.404 ' CE1' ' HG3' ' A' ' 38' ' ' LYS . 24.3 m-85 -82.16 133.52 35.27 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -94.64 117.94 30.92 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 120.002 -0.679 . . . . 0.0 111.143 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.563 ' HB3' HD11 ' A' ' 33' ' ' ILE . 12.0 m -80.3 120.82 24.87 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 177.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.82 82.59 1.97 Allowed 'General case' 0 N--CA 1.509 2.512 0 CA-C-N 118.962 0.801 . . . . 0.0 110.556 -179.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.61 100.79 0.29 Allowed Glycine 0 N--CA 1.508 3.493 0 N-CA-C 108.779 -1.729 . . . . 0.0 108.779 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.604 ' C ' HD12 ' A' ' 77' ' ' ILE . 25.1 ttp85 -116.62 128.75 55.68 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -177.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.662 HD13 ' CG2' ' A' ' 2' ' ' VAL . 4.6 mp -136.22 119.45 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 177.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.7 mt -91.38 52.54 2.11 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.42 0.629 . . . . 0.0 111.531 -178.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.664 ' CB ' HD22 ' A' ' 29' ' ' LEU . . . -152.2 -60.01 0.16 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 178.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 45.7 mtp85 -135.37 -43.33 0.7 Allowed 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -63.63 -18.45 61.49 Favored Glycine 0 N--CA 1.496 2.696 0 CA-C-O 119.538 -0.59 . . . . 0.0 111.956 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 45.79 -150.06 0.08 Allowed 'General case' 0 N--CA 1.515 2.813 0 CA-C-N 118.613 1.206 . . . . 0.0 112.842 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.589 HG22 ' HG3' ' A' ' 76' ' ' ARG . 1.1 pt -105.5 112.48 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.493 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -177.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -118.89 150.63 39.55 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 177.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.417 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 39.0 p90 -159.51 178.38 9.95 Favored 'General case' 0 N--CA 1.504 2.248 0 CA-C-N 119.773 1.17 . . . . 0.0 113.752 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -171.3 159.61 5.83 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.576 ' O ' HG22 ' A' ' 9' ' ' THR . 7.1 p-10 -102.39 118.15 36.25 Favored 'General case' 0 N--CA 1.512 2.656 0 O-C-N 121.795 -0.566 . . . . 0.0 110.773 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.552 ' N ' HD12 ' A' ' 88' ' ' ILE . 1.9 mp -101.99 119.73 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 179.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.06 112.83 21.63 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -179.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.9 t -106.74 133.26 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.13 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.9 mt -124.64 158.53 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.5 HG21 ' CG1' ' A' ' 63' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.499 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 10.4 t80 . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 120.759 0.314 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.721 ' CG2' HD11 ' A' ' 77' ' ' ILE . 42.2 t -150.19 105.27 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 O-C-N 122.063 -0.398 . . . . 0.0 110.383 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.417 ' CG ' ' HB ' ' A' ' 26' ' ' VAL . 25.6 ptm -119.29 122.87 42.87 Favored 'General case' 0 N--CA 1.509 2.485 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 177.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -73.71 136.87 43.75 Favored 'General case' 0 N--CA 1.511 2.603 0 O-C-N 122.031 -0.418 . . . . 0.0 111.992 -176.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.606 ' HG2' HG23 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -136.47 158.15 45.11 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 121.424 0.631 . . . . 0.0 110.823 179.287 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.414 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.6 OUTLIER 32.93 84.1 0.02 OUTLIER 'General case' 0 N--CA 1.521 3.103 0 C-N-CA 123.998 0.919 . . . . 0.0 113.347 179.635 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -145.19 80.86 10.81 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.7 -0.625 . . . . 0.0 111.23 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -67.07 105.3 0.96 Allowed 'Trans proline' 0 N--CA 1.49 1.32 0 N-CA-C 108.693 -1.31 . . . . 0.0 108.693 178.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.563 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.4 OUTLIER -57.88 -67.25 0.95 Allowed Pre-proline 0 N--CA 1.507 2.415 0 CA-C-O 116.905 -1.521 . . . . 0.0 111.828 -177.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.486 ' HD3' ' OG1' ' A' ' 9' ' ' THR . 1.6 Cg_endo -71.46 92.02 0.68 Allowed 'Trans proline' 0 N--CA 1.493 1.445 0 CA-C-N 121.32 1.507 . . . . 0.0 111.604 178.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.52 HE21 HG13 ' A' ' 90' ' ' VAL . 14.7 pt20 -101.27 166.31 10.83 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.068 -1.02 . . . . 0.0 110.141 178.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -152.37 120.62 6.3 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 120.196 -0.601 . . . . 0.0 111.844 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -116.12 -172.03 2.1 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 122.028 -0.42 . . . . 0.0 110.056 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 62.2 tttt -101.2 140.77 35.04 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.477 0.656 . . . . 0.0 111.468 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -59.52 122.17 13.37 Favored 'General case' 0 N--CA 1.51 2.541 0 O-C-N 121.99 -0.443 . . . . 0.0 111.041 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.26 21.97 59.71 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.418 ' O ' HG22 ' A' ' 63' ' ' ILE . 14.3 tt0 -111.76 164.43 13.06 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 118.738 1.269 . . . . 0.0 110.628 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -82.81 99.85 9.95 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -101.62 171.06 7.78 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.772 -177.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.669 HG22 ' HG2' ' A' ' 59' ' ' GLN . 84.5 t -141.96 141.26 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 178.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.788 HD12 HD23 ' A' ' 58' ' ' LEU . 19.0 mt -95.18 112.35 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 178.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.504 HG13 ' CE2' ' A' ' 57' ' ' TYR . 43.6 t -74.1 121.49 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.546 -176.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.6 t -164.85 93.56 0.64 Allowed 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.414 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -90.95 142.53 27.67 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -179.569 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.888 HG21 HD12 ' A' ' 33' ' ' ILE . 44.9 t -144.41 138.2 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 C-N-CA 120.311 -0.556 . . . . 0.0 109.541 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.606 HG23 ' HG2' ' A' ' 5' ' ' LYS . 90.0 t -106.08 79.46 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.8 m -84.37 169.38 14.67 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.4 t -45.46 -76.31 0.02 OUTLIER 'General case' 0 N--CA 1.521 3.091 0 O-C-N 121.689 -0.632 . . . . 0.0 111.458 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.411 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 0.3 OUTLIER -173.04 -62.52 0.0 OUTLIER Pre-proline 0 N--CA 1.518 2.953 0 CA-C-O 117.832 -1.08 . . . . 0.0 111.987 177.608 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.411 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 2.9 Cg_endo -60.19 -53.31 3.13 Favored 'Trans proline' 0 CA--C 1.562 1.909 0 CA-C-N 119.939 1.014 . . . . 0.0 112.897 -179.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.514 ' HG3' HG23 ' A' ' 77' ' ' ILE . 2.8 Cg_endo -62.48 -163.63 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.745 0 CA-C-N 119.275 0.777 . . . . 0.0 112.676 -178.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.428 ' HG1' ' C ' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -170.25 -166.37 0.53 Allowed 'General case' 0 N--CA 1.519 3.001 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.203 -179.534 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.888 HD12 HG21 ' A' ' 25' ' ' VAL . 15.1 tt -97.61 161.11 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 122.065 -0.397 . . . . 0.0 110.056 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 90.4 mt -126.3 124.69 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.597 ' HB2' HG22 ' A' ' 42' ' ' VAL . 78.2 m95 -87.56 105.95 17.67 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 24.9 tttt -112.31 -172.9 2.13 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 122.052 -0.405 . . . . 0.0 110.617 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 30.5 t-80 63.78 147.2 0.03 OUTLIER 'General case' 0 N--CA 1.511 2.599 0 O-C-N 121.802 -0.561 . . . . 0.0 109.938 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.6 tptt 54.87 28.3 10.25 Favored 'General case' 0 N--CA 1.514 2.773 0 O-C-N 121.537 -0.727 . . . . 0.0 111.218 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 162.29 -29.15 0.27 Allowed Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? 56.14 104.77 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.788 0 O-C-N 121.607 -0.937 . . . . 0.0 111.179 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 54.97 70.35 0.63 Allowed 'General case' 0 N--CA 1.511 2.588 0 O-C-N 121.732 -0.605 . . . . 0.0 110.668 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.597 HG22 ' HB2' ' A' ' 35' ' ' TRP . 9.6 m -68.25 -35.06 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.325 0 O-C-N 121.677 -0.64 . . . . 0.0 109.375 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.694 HG12 HG21 ' A' ' 52' ' ' VAL . 50.6 mt -60.51 -18.62 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.68 0 O-C-N 121.877 -0.515 . . . . 0.0 111.173 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.496 ' N ' HD12 ' A' ' 44' ' ' LEU . 9.0 mp -91.73 -20.94 21.02 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.608 -0.682 . . . . 0.0 110.975 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.416 ' HG2' ' HA ' ' A' ' 42' ' ' VAL . 51.5 pttt -98.88 -38.14 9.14 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt 48.35 56.69 7.1 Favored 'General case' 0 N--CA 1.508 2.463 0 CA-C-O 121.508 0.671 . . . . 0.0 111.649 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -50.57 173.71 0.02 OUTLIER 'General case' 0 N--CA 1.516 2.842 0 O-C-N 121.895 -0.503 . . . . 0.0 111.421 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.3 m -61.33 -18.47 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.636 0 O-C-N 121.882 -0.511 . . . . 0.0 111.804 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -126.05 48.33 2.12 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.6 -0.687 . . . . 0.0 112.337 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -144.47 106.47 4.32 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 121.56 -0.712 . . . . 0.0 109.689 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 65.8 mt -128.05 106.84 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.694 HG21 HG12 ' A' ' 43' ' ' ILE . 3.3 t -75.67 136.73 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.287 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.446 HD11 ' OE1' ' A' ' 59' ' ' GLN . 14.5 mt -91.16 165.26 13.58 Favored 'General case' 0 N--CA 1.506 2.338 0 CA-C-O 121.309 0.576 . . . . 0.0 111.724 -178.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.8 p -60.55 -21.22 62.29 Favored 'General case' 0 N--CA 1.511 2.576 0 O-C-N 122.114 -0.366 . . . . 0.0 111.453 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 40.4 p-10 -90.57 17.23 7.72 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.627 -0.671 . . . . 0.0 111.505 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.5 m120 69.38 31.58 3.79 Favored 'General case' 0 N--CA 1.516 2.856 0 O-C-N 121.594 -0.691 . . . . 0.0 111.846 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.504 ' CE2' HG13 ' A' ' 22' ' ' VAL . 4.3 m-85 -102.41 166.03 10.78 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 177.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.788 HD23 HD12 ' A' ' 21' ' ' ILE . 18.5 tp -123.62 99.92 6.54 Favored 'General case' 0 N--CA 1.515 2.818 0 C-N-CA 119.333 -0.947 . . . . 0.0 111.808 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.669 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -77.28 101.5 6.29 Favored 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 120.805 0.336 . . . . 0.0 111.107 179.647 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.776 HD11 HD11 ' A' ' 21' ' ' ILE . 97.6 mt -92.78 115.97 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.51 115.24 17.12 Favored 'General case' 0 N--CA 1.505 2.302 0 CA-C-O 121.299 0.571 . . . . 0.0 111.306 -178.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.31 -38.81 2.95 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 179.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.727 HG23 HG21 ' A' ' 92' ' ' VAL . 1.7 tp 41.47 72.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.846 0 CA-C-O 121.995 0.903 . . . . 0.0 112.624 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -62.72 155.37 26.72 Favored 'General case' 0 N--CA 1.509 2.508 0 O-C-N 121.391 -0.818 . . . . 0.0 111.687 -178.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.413 ' HA ' HG13 ' A' ' 92' ' ' VAL . 33.9 tttt -62.82 -21.45 65.92 Favored 'General case' 0 N--CA 1.51 2.542 0 O-C-N 122.119 -0.363 . . . . 0.0 110.772 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 50.7 p -85.17 -13.97 48.39 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.79 -0.569 . . . . 0.0 111.106 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.88 -6.38 48.83 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.607 -0.683 . . . . 0.0 111.452 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.794 ' HB3' HG12 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -80.04 172.74 13.38 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-N 119.005 0.82 . . . . 0.0 110.067 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 145.33 -108.16 0.46 Allowed Glycine 0 N--CA 1.496 2.646 0 N-CA-C 108.991 -1.643 . . . . 0.0 108.991 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.7 m -143.17 100.99 3.74 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 122.041 -0.682 . . . . 0.0 111.418 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -83.72 129.46 34.95 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 29.4 ttp180 -94.84 119.21 33.03 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.324 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.506 ' HB3' HD11 ' A' ' 33' ' ' ILE . 5.5 m -81.88 124.12 29.44 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 177.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -125.12 89.94 3.15 Favored 'General case' 0 N--CA 1.503 2.201 0 CA-C-N 118.995 0.816 . . . . 0.0 111.021 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.44 107.89 2.28 Favored Glycine 0 N--CA 1.502 3.045 0 N-CA-C 107.336 -2.306 . . . . 0.0 107.336 178.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -122.83 142.85 50.31 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -176.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.721 HD11 ' CG2' ' A' ' 2' ' ' VAL . 90.4 mt -115.74 137.63 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.104 177.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 14.2 mt -90.97 -47.35 7.63 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.119 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.19 -56.69 18.94 Favored 'General case' 0 N--CA 1.516 2.872 0 O-C-N 121.639 -0.663 . . . . 0.0 109.99 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 78.4 mtt180 -101.92 61.67 0.88 Allowed 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -14.62 81.72 0.0 OUTLIER Glycine 1 N--CA 1.525 4.599 0 C-N-CA 125.011 1.291 . . . . 0.0 114.867 -178.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -115.17 145.46 42.36 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 122.222 -0.575 . . . . 0.0 109.471 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.7 pt -135.41 70.68 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 CA-C-O 121.183 0.516 . . . . 0.0 111.534 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -85.79 150.37 24.61 Favored 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -163.01 -175.94 4.62 Favored 'General case' 0 N--CA 1.503 2.19 0 C-N-CA 119.551 -0.86 . . . . 0.0 112.979 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 9.1 tttt -167.6 162.27 14.12 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.563 ' O ' HG22 ' A' ' 9' ' ' THR . 4.5 p-10 -106.71 110.5 22.7 Favored 'General case' 0 N--CA 1.51 2.531 0 O-C-N 121.764 -0.585 . . . . 0.0 111.0 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.589 ' N ' HD12 ' A' ' 88' ' ' ILE . 2.6 mp -95.74 120.13 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 10.6 tm0? -91.63 113.53 25.82 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.046 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.52 HG13 HE21 ' A' ' 11' ' ' GLN . 39.7 t -104.75 143.33 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.931 -0.481 . . . . 0.0 109.967 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 68.4 mt -134.95 139.92 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.311 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.794 HG12 ' HB3' ' A' ' 68' ' ' GLU . 8.4 p . . . . . 0 N--CA 1.5 2.045 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.76 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 2.1 t80 . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.701 ' CG2' HD11 ' A' ' 77' ' ' ILE . 45.3 t -150.89 104.52 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 O-C-N 122.055 -0.403 . . . . 0.0 110.045 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.437 ' CG ' ' HB ' ' A' ' 26' ' ' VAL . 17.1 ptm -119.09 123.31 44.13 Favored 'General case' 0 N--CA 1.508 2.456 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -74.17 133.29 42.74 Favored 'General case' 0 N--CA 1.511 2.606 0 CA-C-O 120.974 0.416 . . . . 0.0 112.045 -176.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.517 ' HG2' HG23 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -135.37 163.38 30.15 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-O 121.367 0.603 . . . . 0.0 111.093 179.34 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.5 t30 27.78 70.24 0.06 Allowed 'General case' 0 N--CA 1.523 3.205 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -135.76 82.85 37.09 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.736 -0.603 . . . . 0.0 110.619 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -65.44 110.0 1.51 Allowed 'Trans proline' 0 N--CA 1.491 1.366 0 N-CA-C 109.02 -1.185 . . . . 0.0 109.02 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.586 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.1 OUTLIER -60.64 -59.05 15.09 Favored Pre-proline 0 N--CA 1.502 2.151 0 CA-C-O 117.113 -1.422 . . . . 0.0 112.161 -177.777 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.528 ' HD3' ' OG1' ' A' ' 9' ' ' THR . 1.4 Cg_endo -80.11 91.44 1.17 Allowed 'Trans proline' 0 CA--C 1.554 1.488 0 CA-C-N 121.055 1.413 . . . . 0.0 111.557 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.533 HE21 HG13 ' A' ' 90' ' ' VAL . 15.7 pt20 -101.38 173.5 6.41 Favored 'General case' 0 N--CA 1.509 2.504 0 O-C-N 120.973 -1.079 . . . . 0.0 110.521 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -158.37 121.13 3.76 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.783 -0.573 . . . . 0.0 111.478 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -116.68 -170.02 1.74 Allowed 'General case' 0 N--CA 1.503 2.203 0 O-C-N 122.06 -0.4 . . . . 0.0 109.943 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -103.48 137.52 41.46 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.527 0.68 . . . . 0.0 111.444 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -61.08 116.67 4.71 Favored 'General case' 0 N--CA 1.508 2.466 0 CA-C-O 121.051 0.453 . . . . 0.0 110.333 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.13 22.46 29.96 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -117.48 165.41 13.56 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 118.567 1.183 . . . . 0.0 111.085 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -80.62 99.85 8.34 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 177.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.29 165.85 11.49 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.968 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.677 HG22 ' HG2' ' A' ' 59' ' ' GLN . 99.2 t -141.68 139.47 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 177.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.746 HD12 HD23 ' A' ' 58' ' ' LEU . 42.6 mt -97.15 113.47 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 178.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.557 HG13 ' CE2' ' A' ' 57' ' ' TYR . 48.4 t -76.43 117.47 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 CA-C-O 121.558 0.694 . . . . 0.0 110.401 -177.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.3 t -157.94 91.26 1.11 Allowed 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.01 138.95 31.0 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -178.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.804 HG21 HD12 ' A' ' 33' ' ' ILE . 44.3 t -143.87 131.11 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 C-N-CA 120.283 -0.567 . . . . 0.0 109.476 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.517 HG23 ' HG2' ' A' ' 5' ' ' LYS . 93.3 t -97.63 83.21 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.8 m -84.62 171.18 12.65 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 177.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.5 t -46.18 -81.49 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.091 0 O-C-N 121.594 -0.691 . . . . 0.0 111.261 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.431 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 0.9 OUTLIER -165.93 -64.01 0.01 OUTLIER Pre-proline 0 N--CA 1.514 2.758 0 CA-C-O 117.706 -1.14 . . . . 0.0 111.752 177.687 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.431 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 3.0 Cg_endo -61.13 -53.07 2.76 Favored 'Trans proline' 0 CA--C 1.563 1.939 0 CA-C-N 120.189 1.103 . . . . 0.0 113.013 -179.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.498 ' HG3' HG23 ' A' ' 77' ' ' ILE . 3.2 Cg_exo -61.14 -163.83 0.03 OUTLIER 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 120.549 0.832 . . . . 0.0 113.108 -178.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.404 ' HG1' ' C ' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -168.97 -162.81 0.39 Allowed 'General case' 0 N--CA 1.517 2.915 0 O-C-N 121.966 -0.459 . . . . 0.0 109.768 -179.293 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.804 HD12 HG21 ' A' ' 25' ' ' VAL . 14.0 tt -101.23 167.35 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.879 -0.513 . . . . 0.0 110.195 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.435 HD12 ' NE ' ' A' ' 76' ' ' ARG . 96.7 mt -131.89 134.35 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.539 ' HB2' HG22 ' A' ' 42' ' ' VAL . 85.4 m95 -95.9 114.88 26.64 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.5 tttt -121.65 -162.68 0.99 Allowed 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.814 -0.554 . . . . 0.0 111.129 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.8 t60 69.35 -166.38 0.18 Allowed 'General case' 0 N--CA 1.509 2.524 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.27 19.51 6.34 Favored 'General case' 0 N--CA 1.516 2.863 0 O-C-N 121.493 -0.755 . . . . 0.0 111.14 -178.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 121.91 -46.9 1.06 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.29 -173.45 0.66 Allowed 'General case' 0 N--CA 1.51 2.547 0 O-C-N 121.895 -0.768 . . . . 0.0 109.773 -178.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -70.77 146.48 49.76 Favored 'General case' 0 N--CA 1.506 2.36 0 C-N-CA 120.708 -0.397 . . . . 0.0 109.973 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.539 HG22 ' HB2' ' A' ' 35' ' ' TRP . 3.3 m -95.1 -34.21 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 CA-C-O 121.192 0.52 . . . . 0.0 109.663 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.48 HD11 HG21 ' A' ' 52' ' ' VAL . 47.8 mm -58.35 -19.36 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.795 0 O-C-N 121.867 -0.52 . . . . 0.0 111.558 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.525 ' N ' HD12 ' A' ' 44' ' ' LEU . 8.2 mp -93.03 -22.78 18.94 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.478 -0.764 . . . . 0.0 111.126 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.421 ' HG2' ' HA ' ' A' ' 42' ' ' VAL . 31.2 pttt -97.96 -38.57 9.34 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.4 mmmt 49.14 54.86 10.22 Favored 'General case' 0 N--CA 1.507 2.395 0 CA-C-O 121.487 0.66 . . . . 0.0 111.726 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.75 161.47 0.74 Allowed 'General case' 0 N--CA 1.514 2.764 0 O-C-N 121.731 -0.605 . . . . 0.0 110.916 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.9 m -58.42 -21.1 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.666 0 O-C-N 121.909 -0.494 . . . . 0.0 111.876 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.1 ptp85 -111.53 46.11 1.14 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.78 -0.575 . . . . 0.0 111.633 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -146.24 106.36 4.02 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.72 -0.613 . . . . 0.0 109.836 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 81.1 mt -129.03 107.5 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.523 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.1 t -74.94 139.32 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.466 HD11 ' CG ' ' A' ' 59' ' ' GLN . 43.1 mt -94.82 167.84 11.18 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 121.224 0.535 . . . . 0.0 111.963 -178.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.4 p -61.76 -23.22 66.03 Favored 'General case' 0 N--CA 1.509 2.484 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.072 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 35.6 p-10 -90.03 16.93 7.49 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.659 -0.651 . . . . 0.0 111.414 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.5 m120 69.43 32.18 3.55 Favored 'General case' 0 N--CA 1.518 2.956 0 O-C-N 121.558 -0.714 . . . . 0.0 112.283 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.557 ' CE2' HG13 ' A' ' 22' ' ' VAL . 4.0 m-85 -103.24 157.97 16.64 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.746 HD23 HD12 ' A' ' 21' ' ' ILE . 17.8 tp -114.13 98.92 7.26 Favored 'General case' 0 N--CA 1.517 2.897 0 C-N-CA 119.487 -0.885 . . . . 0.0 111.624 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.677 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -76.97 98.96 5.1 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 120.325 -0.55 . . . . 0.0 111.075 179.609 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.58 HD11 HD11 ' A' ' 21' ' ' ILE . 98.2 mt -89.58 119.56 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 177.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.2 tpt85 -81.45 114.12 19.98 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-O 121.443 0.639 . . . . 0.0 111.247 -178.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.17 -36.73 3.75 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.507 ' CG1' HG21 ' A' ' 92' ' ' VAL . 3.1 tp 42.3 93.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.826 0 CA-C-N 118.14 0.97 . . . . 0.0 112.237 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -80.36 154.68 27.59 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.377 -0.827 . . . . 0.0 112.004 -177.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.7 tttm -62.04 -25.07 67.45 Favored 'General case' 0 N--CA 1.509 2.517 0 O-C-N 122.174 -0.329 . . . . 0.0 111.002 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 56.3 p -82.22 -16.62 48.98 Favored 'General case' 0 N--CA 1.505 2.325 0 O-C-N 121.848 -0.532 . . . . 0.0 110.978 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.88 -12.42 36.26 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.622 -0.674 . . . . 0.0 111.732 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.551 ' HB3' HG12 ' A' ' 92' ' ' VAL . 8.2 pt-20 -73.42 142.87 46.92 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.385 -0.822 . . . . 0.0 109.792 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 171.85 -104.27 0.2 Allowed Glycine 0 N--CA 1.498 2.792 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.4 m -147.77 102.13 3.39 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 122.055 -0.674 . . . . 0.0 110.45 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -81.97 139.61 34.46 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.8 ttt180 -102.46 116.79 33.34 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.02 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.482 ' HB3' HD11 ' A' ' 33' ' ' ILE . 7.0 m -79.04 133.43 36.81 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 177.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -133.71 91.58 2.86 Favored 'General case' 0 N--CA 1.504 2.243 0 CA-C-N 118.711 0.687 . . . . 0.0 110.452 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.36 109.6 2.96 Favored Glycine 0 N--CA 1.504 3.185 0 N-CA-C 107.631 -2.187 . . . . 0.0 107.631 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.435 ' NE ' HD12 ' A' ' 34' ' ' ILE . 5.9 ttm180 -120.54 140.2 51.83 Favored 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -176.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.701 HD11 ' CG2' ' A' ' 2' ' ' VAL . 85.1 mt -118.89 137.76 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-N 114.933 -1.03 . . . . 0.0 108.505 177.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.5 mt -92.18 -44.29 8.87 Favored 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 121.071 -0.252 . . . . 0.0 110.886 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.07 -57.36 12.89 Favored 'General case' 0 N--CA 1.515 2.806 0 O-C-N 121.645 -0.659 . . . . 0.0 109.797 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 60.1 mtt85 -102.14 61.99 0.87 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -14.31 82.1 0.0 OUTLIER Glycine 1 N--CA 1.526 4.685 0 C-N-CA 124.946 1.26 . . . . 0.0 114.733 -178.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.464 ' OE1' HD12 ' A' ' 77' ' ' ILE . 2.1 tt0 -116.8 148.59 41.07 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 122.146 -0.62 . . . . 0.0 109.636 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.9 pt -138.26 65.93 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 CA-C-O 121.111 0.482 . . . . 0.0 111.169 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -79.42 155.36 28.38 Favored 'General case' 0 N--CA 1.505 2.292 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -164.83 -178.6 5.34 Favored 'General case' 0 N--CA 1.506 2.348 0 C-N-CA 119.723 -0.791 . . . . 0.0 112.937 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.9 mttm -168.72 159.52 9.9 Favored 'General case' 0 N--CA 1.505 2.294 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.586 ' O ' HG22 ' A' ' 9' ' ' THR . 4.0 p-10 -103.66 112.75 25.82 Favored 'General case' 0 N--CA 1.512 2.642 0 O-C-N 121.847 -0.533 . . . . 0.0 110.644 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.572 ' N ' HD12 ' A' ' 88' ' ' ILE . 2.8 mp -98.85 115.23 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -82.87 110.87 18.24 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.533 HG13 HE21 ' A' ' 11' ' ' GLN . 44.4 t -105.54 135.69 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.032 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.41 ' N ' HD12 ' A' ' 91' ' ' ILE . 5.1 mp -124.71 159.76 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.551 HG12 ' HB3' ' A' ' 68' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.503 2.205 0 CA-C-O 117.937 -1.03 . . . . 0.0 110.35 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 45.2 p90 . . . . . 0 N--CA 1.499 1.976 0 CA-C-O 120.704 0.287 . . . . 0.0 110.451 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.642 ' CG2' HD11 ' A' ' 77' ' ' ILE . 43.3 t -148.11 104.03 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.512 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 0.8 OUTLIER -108.31 112.89 25.58 Favored 'General case' 0 N--CA 1.507 2.42 0 C-N-CA 120.251 -0.579 . . . . 0.0 109.56 179.289 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -69.91 120.43 15.63 Favored 'General case' 0 N--CA 1.504 2.242 0 CA-C-O 120.926 0.393 . . . . 0.0 110.485 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.438 ' HG2' HG23 ' A' ' 26' ' ' VAL . 3.0 pttt -130.92 161.55 31.63 Favored 'General case' 0 N--CA 1.502 2.133 0 CA-C-O 121.624 0.726 . . . . 0.0 111.068 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.405 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.4 OUTLIER 32.55 72.38 0.08 Allowed 'General case' 0 N--CA 1.518 2.942 0 C-N-CA 124.213 1.005 . . . . 0.0 113.31 179.602 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -136.5 80.79 37.87 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.739 -0.601 . . . . 0.0 110.972 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -66.08 102.32 0.54 Allowed 'Trans proline' 0 N--CA 1.491 1.378 0 N-CA-C 108.455 -1.402 . . . . 0.0 108.455 178.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.589 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.3 OUTLIER -53.15 -67.82 0.53 Allowed Pre-proline 0 N--CA 1.509 2.5 0 CA-C-O 116.732 -1.604 . . . . 0.0 112.401 -177.219 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.497 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.4 Cg_endo -74.88 95.14 0.96 Allowed 'Trans proline' 0 N--CA 1.498 1.749 0 CA-C-N 121.54 1.586 . . . . 0.0 111.123 178.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.436 HE21 HG13 ' A' ' 90' ' ' VAL . 16.3 pt20 -100.49 179.51 4.42 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.96 -1.087 . . . . 0.0 110.389 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -159.61 124.68 4.06 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.852 -0.53 . . . . 0.0 111.921 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -124.18 -169.04 1.89 Allowed 'General case' 0 N--CA 1.505 2.315 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.0 tttt -106.04 137.18 44.41 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.598 0.713 . . . . 0.0 111.542 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -62.18 115.87 4.5 Favored 'General case' 0 N--CA 1.508 2.471 0 CA-C-O 121.105 0.478 . . . . 0.0 110.168 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.0 22.4 23.12 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.436 ' O ' HG22 ' A' ' 63' ' ' ILE . 15.8 tt0 -118.3 165.31 14.0 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 118.371 1.086 . . . . 0.0 110.851 -179.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -83.3 99.34 9.94 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 177.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.26 169.07 9.38 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.315 0.579 . . . . 0.0 112.197 -177.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.683 HG22 ' HG2' ' A' ' 59' ' ' GLN . 88.5 t -142.01 141.05 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 177.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.801 HD12 HD23 ' A' ' 58' ' ' LEU . 29.2 mt -97.01 114.18 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 178.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.503 HG13 ' CE2' ' A' ' 57' ' ' TYR . 46.8 t -75.41 120.41 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.64 -176.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.0 t -162.4 89.91 0.71 Allowed 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.405 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -88.88 142.88 27.28 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.313 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.781 HG21 HD12 ' A' ' 33' ' ' ILE . 48.0 t -147.34 132.61 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.512 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 48.9 t -93.63 75.54 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.1 m -77.6 163.96 25.78 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.5 t -45.44 -83.58 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.145 0 O-C-N 121.895 -0.503 . . . . 0.0 111.189 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.405 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 0.3 OUTLIER -167.06 -64.37 0.01 OUTLIER Pre-proline 0 N--CA 1.513 2.712 0 CA-C-O 117.61 -1.186 . . . . 0.0 111.686 177.592 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.405 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 2.9 Cg_endo -59.6 -53.15 3.61 Favored 'Trans proline' 0 CA--C 1.563 1.969 0 CA-C-N 120.235 1.12 . . . . 0.0 112.682 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.599 ' HG3' HG23 ' A' ' 77' ' ' ILE . 3.0 Cg_endo -61.73 -163.73 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 120.601 0.867 . . . . 0.0 112.611 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.411 HG22 ' H ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -169.94 -168.76 0.79 Allowed 'General case' 0 N--CA 1.518 2.95 0 O-C-N 121.932 -0.48 . . . . 0.0 110.283 -179.576 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.781 HD12 HG21 ' A' ' 25' ' ' VAL . 14.8 tt -97.52 164.24 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 86.6 mt -129.34 129.66 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.563 ' HB2' HG22 ' A' ' 42' ' ' VAL . 84.6 m95 -91.95 101.03 13.59 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -99.87 -170.14 1.84 Allowed 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.065 0.46 . . . . 0.0 110.493 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 61.78 161.71 0.07 Allowed 'General case' 0 N--CA 1.512 2.642 0 O-C-N 121.809 -0.557 . . . . 0.0 110.339 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.3 tppm? 56.55 40.45 29.45 Favored 'General case' 0 N--CA 1.517 2.919 0 O-C-N 121.492 -0.755 . . . . 0.0 110.682 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 133.83 8.13 2.22 Favored Glycine 0 N--CA 1.497 2.741 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.991 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? 52.59 90.58 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.786 0 CA-C-N 119.376 1.588 . . . . 0.0 111.18 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.2 t0 53.95 100.02 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.904 0 O-C-N 121.85 -0.531 . . . . 0.0 110.94 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.563 HG22 ' HB2' ' A' ' 35' ' ' TRP . 4.1 m -71.72 -26.25 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.494 0 O-C-N 121.794 -0.567 . . . . 0.0 110.618 -179.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.3 mm -58.91 -17.76 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.757 0 O-C-N 121.578 -0.702 . . . . 0.0 111.679 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.505 ' N ' HD12 ' A' ' 44' ' ' LEU . 8.9 mp -92.53 -22.47 19.53 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.48 -0.762 . . . . 0.0 110.986 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.6 pttt -98.03 -42.27 7.57 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.574 -0.704 . . . . 0.0 109.635 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 20.1 mmmt 46.37 56.49 6.28 Favored 'General case' 0 N--CA 1.51 2.55 0 CA-C-O 121.457 0.646 . . . . 0.0 112.038 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -52.19 169.58 0.07 Allowed 'General case' 0 N--CA 1.515 2.798 0 O-C-N 121.694 -0.628 . . . . 0.0 110.968 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.8 m -61.99 -19.25 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.638 0 O-C-N 121.975 -0.453 . . . . 0.0 111.893 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.1 ptt-85 -116.93 46.49 1.65 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.678 -0.639 . . . . 0.0 111.703 -179.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -143.8 102.99 4.0 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.609 -0.682 . . . . 0.0 109.501 178.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 71.3 mt -128.17 113.22 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.47 HG22 ' CD1' ' A' ' 58' ' ' LEU . 2.4 t -78.62 127.37 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.524 HD11 ' CG ' ' A' ' 59' ' ' GLN . 65.1 mt -78.82 165.51 23.47 Favored 'General case' 0 N--CA 1.508 2.473 0 CA-C-O 121.224 0.535 . . . . 0.0 112.169 -177.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.2 p -60.16 -21.59 61.84 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 122.196 -0.315 . . . . 0.0 111.505 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -91.39 19.04 6.42 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.676 -0.64 . . . . 0.0 111.526 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.0 m120 68.11 31.48 5.38 Favored 'General case' 0 N--CA 1.516 2.851 0 O-C-N 121.661 -0.649 . . . . 0.0 112.145 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.503 ' CE2' HG13 ' A' ' 22' ' ' VAL . 4.0 m-85 -102.12 165.21 11.28 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.801 HD23 HD12 ' A' ' 21' ' ' ILE . 21.9 tp -120.65 98.68 6.14 Favored 'General case' 0 N--CA 1.517 2.908 0 C-N-CA 119.341 -0.944 . . . . 0.0 112.008 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.683 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -76.18 104.97 6.96 Favored 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.991 179.486 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.716 HD11 HD11 ' A' ' 21' ' ' ILE . 98.9 mt -96.56 113.63 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 177.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -77.08 115.95 17.32 Favored 'General case' 0 N--CA 1.503 2.224 0 CA-C-O 121.394 0.616 . . . . 0.0 111.287 -178.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.53 -37.02 3.65 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.588 ' CG1' HG21 ' A' ' 92' ' ' VAL . 3.6 tp 40.11 84.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.521 3.095 0 CA-C-O 122.133 0.968 . . . . 0.0 112.44 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 45.6 mttt -75.99 160.08 30.2 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 121.631 -0.668 . . . . 0.0 112.151 -178.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.8 tttm -60.86 -25.6 66.79 Favored 'General case' 0 N--CA 1.51 2.564 0 O-C-N 122.022 -0.424 . . . . 0.0 110.974 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 63.9 p -80.14 -16.9 53.92 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 121.859 -0.525 . . . . 0.0 111.56 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.25 -29.47 26.46 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.51 -0.743 . . . . 0.0 110.509 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.438 ' HB3' HG12 ' A' ' 92' ' ' VAL . 5.7 pt-20 -61.72 140.68 58.17 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.884 -0.51 . . . . 0.0 111.18 -178.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 169.06 -101.39 0.17 Allowed Glycine 0 N--CA 1.497 2.765 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.3 m -151.23 100.6 2.77 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 122.079 -0.659 . . . . 0.0 110.382 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -81.64 140.05 34.63 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.2 ttm-85 -102.44 121.09 41.64 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 120.059 -0.656 . . . . 0.0 111.511 -179.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.501 ' HB3' HD11 ' A' ' 33' ' ' ILE . 9.8 m -86.1 130.1 34.64 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 177.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -131.38 90.47 2.87 Favored 'General case' 0 N--CA 1.506 2.331 0 CA-C-N 118.783 0.719 . . . . 0.0 110.526 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.2 106.27 1.74 Allowed Glycine 0 N--CA 1.504 3.208 0 N-CA-C 107.827 -2.109 . . . . 0.0 107.827 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 -118.85 138.74 52.51 Favored 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -177.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.642 HD11 ' CG2' ' A' ' 2' ' ' VAL . 74.2 mt -124.21 135.9 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.569 177.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 35.6 mt -94.95 -39.97 9.92 Favored 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 121.044 -0.263 . . . . 0.0 110.684 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.83 -58.96 5.96 Favored 'General case' 0 N--CA 1.515 2.812 0 O-C-N 121.788 -0.57 . . . . 0.0 109.509 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 81.4 mtt-85 -100.83 61.23 0.98 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 177.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -14.41 81.8 0.0 OUTLIER Glycine 1 N--CA 1.525 4.618 0 C-N-CA 125.012 1.291 . . . . 0.0 114.92 -178.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -120.29 142.98 48.59 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 122.271 -0.546 . . . . 0.0 109.978 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.1 pt -135.48 81.81 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 CA-C-O 121.275 0.559 . . . . 0.0 111.129 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -100.15 153.54 19.16 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -161.9 -179.25 7.02 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 120.009 -0.676 . . . . 0.0 112.221 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.0 mttt -165.76 160.39 17.11 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.589 ' O ' HG22 ' A' ' 9' ' ' THR . 6.9 p-10 -104.17 113.36 26.86 Favored 'General case' 0 N--CA 1.511 2.612 0 O-C-N 121.896 -0.502 . . . . 0.0 110.213 178.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.582 ' N ' HD12 ' A' ' 88' ' ' ILE . 3.0 mp -100.89 116.74 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -82.96 122.09 27.84 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.436 HG13 HE21 ' A' ' 11' ' ' GLN . 44.6 t -116.01 126.5 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.16 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 71.0 mt -115.68 155.75 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.588 HG21 ' CG1' ' A' ' 63' ' ' ILE . 0.9 OUTLIER . . . . . 0 N--CA 1.499 1.975 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.71 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 39.6 p90 . . . . . 0 N--CA 1.5 2.052 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.637 ' CG2' HD11 ' A' ' 77' ' ' ILE . 48.4 t -147.44 114.02 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.427 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 16.3 mtp -114.81 106.56 14.33 Favored 'General case' 0 N--CA 1.513 2.698 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -66.38 119.16 11.11 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.959 -0.463 . . . . 0.0 110.747 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.401 ' HG2' HG23 ' A' ' 26' ' ' VAL . 0.4 OUTLIER -130.87 156.2 45.44 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-O 121.578 0.704 . . . . 0.0 110.558 179.768 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.422 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 1.6 t30 39.13 87.75 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.051 0 C-N-CA 123.404 0.682 . . . . 0.0 112.193 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -143.04 61.36 10.32 Favored Pre-proline 0 N--CA 1.497 1.917 0 C-N-CA 119.91 -0.716 . . . . 0.0 112.332 -178.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -64.68 93.34 0.2 Allowed 'Trans proline' 0 N--CA 1.494 1.506 0 N-CA-C 107.972 -1.588 . . . . 0.0 107.972 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.502 HG22 HD13 ' A' ' 88' ' ' ILE . 18.3 p -53.04 -42.79 92.53 Favored Pre-proline 0 N--CA 1.508 2.472 0 CA-C-O 117.343 -1.313 . . . . 0.0 113.631 -176.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.494 ' HD3' ' OG1' ' A' ' 9' ' ' THR . 1.6 Cg_endo -82.83 86.55 1.46 Allowed 'Trans proline' 0 CA--C 1.548 1.203 0 CA-C-N 120.785 1.316 . . . . 0.0 111.051 -177.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.491 HE21 HG13 ' A' ' 90' ' ' VAL . 17.8 pt20 -100.16 171.17 7.97 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 121.15 -0.969 . . . . 0.0 111.068 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -155.92 119.9 4.48 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 122.089 -0.382 . . . . 0.0 110.975 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -116.28 -171.09 1.93 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.871 -0.518 . . . . 0.0 110.196 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.0 tttm -103.68 139.58 38.76 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.492 0.663 . . . . 0.0 111.633 -178.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -59.83 125.83 25.2 Favored 'General case' 0 N--CA 1.508 2.442 0 O-C-N 121.767 -0.583 . . . . 0.0 110.815 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.24 22.04 66.16 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -113.59 160.9 18.06 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-N 118.829 1.314 . . . . 0.0 111.094 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -78.29 98.38 5.91 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.39 174.0 6.49 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.125 0.488 . . . . 0.0 111.875 -177.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.702 HG22 ' HG2' ' A' ' 59' ' ' GLN . 85.9 t -145.57 141.52 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.889 HD12 HD23 ' A' ' 58' ' ' LEU . 21.9 mt -95.95 116.77 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 178.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.417 ' HA ' ' CE2' ' A' ' 57' ' ' TYR . 55.6 t -75.98 121.02 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 CA-C-O 121.446 0.641 . . . . 0.0 111.42 -176.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.8 t -165.2 93.75 0.61 Allowed 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.422 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -91.4 139.11 31.03 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.044 -179.582 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.694 HG21 HD12 ' A' ' 33' ' ' ILE . 47.8 t -147.08 131.95 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.427 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 48.2 t -94.09 74.06 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.1 m -76.18 165.93 24.2 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.1 t -47.65 -82.75 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.085 0 O-C-N 121.877 -0.515 . . . . 0.0 111.206 -179.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.414 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 0.7 OUTLIER -166.59 -63.22 0.01 OUTLIER Pre-proline 0 N--CA 1.513 2.694 0 CA-C-O 117.661 -1.161 . . . . 0.0 111.696 178.173 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.414 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 2.9 Cg_endo -60.22 -53.19 3.2 Favored 'Trans proline' 0 CA--C 1.561 1.852 0 CA-C-N 120.203 1.108 . . . . 0.0 112.503 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.511 ' CB ' ' HA ' ' A' ' 77' ' ' ILE . 2.8 Cg_endo -63.45 -164.58 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.715 0 CA-C-N 119.211 0.754 . . . . 0.0 112.51 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.44 ' HG1' ' C ' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -171.79 -164.5 0.32 Allowed 'General case' 0 N--CA 1.52 3.037 0 O-C-N 121.925 -0.484 . . . . 0.0 110.206 -179.842 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.716 HD11 ' HB3' ' A' ' 73' ' ' CYS . 18.8 tt -103.49 136.32 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 122.038 -0.414 . . . . 0.0 110.069 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.507 ' N ' HD12 ' A' ' 34' ' ' ILE . 5.0 mp -100.79 130.03 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.579 ' CG ' HD22 ' A' ' 58' ' ' LEU . 74.7 m95 -89.73 107.34 19.04 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 48.2 mttt -108.88 -165.44 1.02 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 122.02 -0.425 . . . . 0.0 110.618 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 66.2 162.78 0.16 Allowed 'General case' 0 N--CA 1.511 2.609 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -178.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.7 tppm? 55.48 23.14 5.61 Favored 'General case' 0 N--CA 1.515 2.789 0 O-C-N 121.613 -0.679 . . . . 0.0 111.534 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 142.28 36.21 0.09 OUTLIER Glycine 0 N--CA 1.498 2.812 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.582 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 60.86 -75.39 0.03 OUTLIER 'General case' 0 N--CA 1.518 2.973 0 CA-C-N 118.42 1.11 . . . . 0.0 111.102 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -144.62 140.4 28.69 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.493 HG22 ' HB2' ' A' ' 35' ' ' TRP . 4.8 m -95.93 -36.68 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.332 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.28 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 77.9 mt -60.61 -16.87 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.829 0 O-C-N 121.943 -0.473 . . . . 0.0 111.658 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.449 ' N ' HD12 ' A' ' 44' ' ' LEU . 10.3 mp -91.43 -22.29 20.52 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.469 -0.769 . . . . 0.0 110.731 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.5 pttt -98.55 -36.43 9.91 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.71 -0.619 . . . . 0.0 109.411 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.4 mmmt 47.92 55.0 9.19 Favored 'General case' 0 N--CA 1.507 2.379 0 CA-C-O 121.405 0.622 . . . . 0.0 112.035 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.52 169.39 0.13 Allowed 'General case' 0 N--CA 1.513 2.685 0 O-C-N 121.705 -0.622 . . . . 0.0 110.81 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.7 m -63.78 -16.02 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.612 0 O-C-N 121.891 -0.506 . . . . 0.0 111.872 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.5 ptt-85 -120.07 45.05 2.27 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.585 -0.697 . . . . 0.0 111.956 -178.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -145.49 101.59 3.6 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.56 -0.712 . . . . 0.0 110.418 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.9 mm -125.96 113.79 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.439 HG22 ' CD1' ' A' ' 58' ' ' LEU . 2.5 t -80.02 139.4 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.411 HD11 ' CG ' ' A' ' 59' ' ' GLN . 31.8 mt -92.92 165.51 12.85 Favored 'General case' 0 N--CA 1.506 2.327 0 CA-C-O 121.335 0.588 . . . . 0.0 112.0 -178.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.1 p -61.09 -21.25 63.51 Favored 'General case' 0 N--CA 1.509 2.493 0 O-C-N 122.097 -0.377 . . . . 0.0 111.212 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 46.5 p-10 -89.67 16.97 6.99 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.573 -0.704 . . . . 0.0 111.503 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.6 m120 68.14 31.49 5.33 Favored 'General case' 0 N--CA 1.517 2.896 0 O-C-N 121.559 -0.713 . . . . 0.0 112.278 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.417 ' CE2' ' HA ' ' A' ' 22' ' ' VAL . 4.2 m-85 -103.68 165.64 10.91 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 177.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.889 HD23 HD12 ' A' ' 21' ' ' ILE . 23.4 tp -121.48 99.42 6.46 Favored 'General case' 0 N--CA 1.516 2.833 0 C-N-CA 119.404 -0.918 . . . . 0.0 111.901 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.702 ' HG2' HG22 ' A' ' 20' ' ' VAL . 1.3 mt-30 -76.0 105.16 6.89 Favored 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.089 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.843 HD11 HD11 ' A' ' 21' ' ' ILE . 96.5 mt -95.26 115.08 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.45 113.32 12.72 Favored 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.642 -177.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.66 -35.12 4.69 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 178.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.652 HG23 HG21 ' A' ' 92' ' ' VAL . 3.1 tp 41.07 76.65 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.519 2.98 0 CA-C-N 118.15 0.975 . . . . 0.0 112.116 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.6 mtpp -59.65 147.63 36.74 Favored 'General case' 0 N--CA 1.508 2.444 0 O-C-N 121.411 -0.805 . . . . 0.0 111.769 -178.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.551 ' HA ' HG13 ' A' ' 92' ' ' VAL . 38.2 tttt -62.22 -17.46 58.34 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 122.23 -0.294 . . . . 0.0 111.037 178.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.8 p -90.81 -16.72 27.82 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.6 -0.688 . . . . 0.0 111.116 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.2 12.44 20.13 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.573 -0.704 . . . . 0.0 112.039 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.795 ' HB3' HG12 ' A' ' 92' ' ' VAL . 0.4 OUTLIER -92.78 160.93 14.73 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.33 -0.856 . . . . 0.0 109.368 179.342 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 157.12 -98.68 0.18 Allowed Glycine 0 N--CA 1.495 2.625 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.7 m -153.67 102.49 2.55 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 117.52 0.66 . . . . 0.0 111.292 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -82.38 139.38 34.09 Favored 'General case' 0 N--CA 1.506 2.33 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.9 ttp180 -101.25 119.61 39.01 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.282 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.716 ' HB3' HD11 ' A' ' 33' ' ' ILE . 37.8 m -79.56 127.85 32.66 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 177.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.71 85.11 2.35 Favored 'General case' 0 N--CA 1.505 2.321 0 CA-C-N 119.312 0.96 . . . . 0.0 110.549 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.88 105.12 1.31 Allowed Glycine 0 N--CA 1.504 3.231 0 N-CA-C 107.688 -2.165 . . . . 0.0 107.688 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 34.4 ttp85 -122.13 140.74 52.19 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -176.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.637 HD11 ' CG2' ' A' ' 2' ' ' VAL . 91.0 mt -118.62 133.68 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.137 177.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 17.3 mt -92.26 -33.86 14.48 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.005 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.97 -57.15 8.46 Favored 'General case' 0 N--CA 1.512 2.661 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 38.2 mtp85 -103.66 61.72 0.76 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 177.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -14.09 81.16 0.0 OUTLIER Glycine 1 N--CA 1.526 4.657 0 C-N-CA 124.999 1.285 . . . . 0.0 114.952 -178.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -121.64 141.79 50.77 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 122.229 -0.571 . . . . 0.0 109.803 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.1 pt -132.85 86.21 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.374 0 CA-C-O 121.391 0.615 . . . . 0.0 111.803 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -98.27 148.65 23.42 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -159.2 176.07 12.66 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 119.544 -0.862 . . . . 0.0 112.9 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.8 mttp -165.74 158.68 15.49 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -96.92 138.52 34.34 Favored 'General case' 0 N--CA 1.506 2.351 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.212 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.502 HD13 HG22 ' A' ' 9' ' ' THR . 46.4 mm -121.04 104.73 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -71.17 113.32 8.09 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.491 HG13 HE21 ' A' ' 11' ' ' GLN . 43.5 t -110.72 132.48 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.621 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 71.7 mt -124.76 143.83 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.365 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.795 HG12 ' HB3' ' A' ' 68' ' ' GLU . 9.9 p . . . . . 0 N--CA 1.503 2.194 0 CA-C-O 118.043 -0.98 . . . . 0.0 110.863 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 42.3 p90 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.26 0.552 . . . . 0.0 110.999 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.662 HG21 HD13 ' A' ' 77' ' ' ILE . 44.3 t -143.05 102.67 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.503 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 12.0 mmt -110.16 123.14 49.21 Favored 'General case' 0 N--CA 1.51 2.54 0 O-C-N 121.85 -0.531 . . . . 0.0 111.868 -178.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -77.26 122.11 24.62 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 120.927 0.394 . . . . 0.0 110.585 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.44 ' HG2' HG23 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -132.83 157.06 45.96 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.427 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.1 OUTLIER 40.17 70.67 0.22 Allowed 'General case' 0 N--CA 1.517 2.913 0 C-N-CA 123.178 0.591 . . . . 0.0 111.956 -179.493 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -130.16 71.47 82.22 Favored Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.599 -0.688 . . . . 0.0 111.017 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -64.52 108.36 1.01 Allowed 'Trans proline' 0 N--CA 1.492 1.406 0 N-CA-C 109.161 -1.13 . . . . 0.0 109.161 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.636 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.3 OUTLIER -63.2 -69.18 0.63 Allowed Pre-proline 0 N--CA 1.503 2.189 0 CA-C-O 116.767 -1.587 . . . . 0.0 111.5 -178.101 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.496 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.4 Cg_endo -71.52 88.34 0.75 Allowed 'Trans proline' 0 N--CA 1.492 1.432 0 CA-C-N 121.392 1.533 . . . . 0.0 111.706 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.507 HE21 HG13 ' A' ' 90' ' ' VAL . 12.0 pt20 -100.66 169.45 9.02 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 120.99 -1.069 . . . . 0.0 109.192 177.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -157.01 122.35 4.64 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.708 -0.62 . . . . 0.0 111.277 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -115.21 -173.78 2.38 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.948 -0.47 . . . . 0.0 110.033 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -102.54 140.51 36.72 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.536 0.684 . . . . 0.0 111.404 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -60.16 117.78 5.55 Favored 'General case' 0 N--CA 1.51 2.535 0 O-C-N 121.985 -0.447 . . . . 0.0 110.855 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.27 22.05 36.25 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.407 ' O ' HG22 ' A' ' 63' ' ' ILE . 15.4 tt0 -113.81 159.69 19.52 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 118.465 1.132 . . . . 0.0 111.465 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -79.55 100.31 7.7 Favored 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 177.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -101.86 168.61 9.32 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.59 0.709 . . . . 0.0 112.386 -177.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.656 HG22 ' HG2' ' A' ' 59' ' ' GLN . 98.6 t -144.16 137.33 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 178.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.759 HD12 HD23 ' A' ' 58' ' ' LEU . 53.7 mt -93.89 115.85 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 178.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.518 HG13 ' CZ ' ' A' ' 57' ' ' TYR . 43.0 t -76.41 115.49 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-O 121.492 0.663 . . . . 0.0 110.903 -176.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.1 t -161.16 81.38 0.62 Allowed 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.427 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.4 OUTLIER -80.37 147.74 30.92 Favored 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.878 -178.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.4 HG21 HD12 ' A' ' 33' ' ' ILE . 44.7 t -147.64 137.73 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.503 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 25.8 t -97.7 88.95 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.52 138.58 31.66 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.7 t -94.86 14.76 20.46 Favored 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -177.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.026 HD13 ' HB3' ' A' ' 79' ' ' ALA . 17.3 mt -140.59 168.18 15.37 Favored Pre-proline 0 N--CA 1.503 2.22 0 O-C-N 121.164 -0.96 . . . . 0.0 111.677 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.435 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 3.9 Cg_exo -48.2 -47.37 19.82 Favored 'Trans proline' 0 N--CA 1.502 2.029 0 C-N-CA 121.616 1.544 . . . . 0.0 114.516 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 29' ' ' LEU . 4.6 Cg_exo -55.13 -165.43 0.01 OUTLIER 'Trans proline' 0 N--CA 1.504 2.116 0 CA-C-N 120.004 1.037 . . . . 0.0 112.794 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.648 HG22 ' ND2' ' A' ' 56' ' ' ASN . 0.2 OUTLIER -169.65 -157.29 0.16 Allowed 'General case' 0 N--CA 1.518 2.935 0 O-C-N 120.556 -1.34 . . . . 0.0 111.02 -176.937 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.488 HD11 ' HB3' ' A' ' 73' ' ' CYS . 20.2 tt -78.98 166.75 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.876 -0.515 . . . . 0.0 110.796 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.452 HD13 ' O ' ' A' ' 33' ' ' ILE . 38.2 mm -128.85 128.51 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.592 ' HB2' HG22 ' A' ' 42' ' ' VAL . 81.5 m95 -93.89 99.18 11.58 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 120.191 -0.604 . . . . 0.0 109.44 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.4 tttm -102.63 -167.07 1.35 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.922 -0.486 . . . . 0.0 110.285 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 66.77 165.36 0.21 Allowed 'General case' 0 N--CA 1.509 2.515 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 56.29 28.88 14.01 Favored 'General case' 0 N--CA 1.515 2.786 0 O-C-N 121.643 -0.661 . . . . 0.0 110.871 -178.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.07 40.99 0.49 Allowed Glycine 0 N--CA 1.497 2.746 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 17.1 mmt180 54.8 -161.39 0.15 Allowed 'General case' 0 N--CA 1.517 2.891 0 O-C-N 121.628 -0.925 . . . . 0.0 110.579 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -62.03 120.27 10.51 Favored 'General case' 0 N--CA 1.512 2.658 0 O-C-N 121.636 -0.665 . . . . 0.0 110.463 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.592 HG22 ' HB2' ' A' ' 35' ' ' TRP . 7.7 m -71.97 -28.42 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.527 0 O-C-N 122.011 -0.43 . . . . 0.0 110.342 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 50.6 mt -59.24 -17.24 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.812 0 O-C-N 121.746 -0.596 . . . . 0.0 111.651 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.484 ' N ' HD12 ' A' ' 44' ' ' LEU . 9.7 mp -90.82 -23.27 20.64 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.504 -0.748 . . . . 0.0 110.882 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 53.9 pttt -97.89 -37.06 9.96 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.696 -0.627 . . . . 0.0 109.595 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm 46.49 55.26 7.72 Favored 'General case' 0 N--CA 1.51 2.529 0 CA-C-O 121.335 0.588 . . . . 0.0 112.229 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.3 163.71 0.55 Allowed 'General case' 0 N--CA 1.515 2.778 0 O-C-N 121.657 -0.652 . . . . 0.0 110.736 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.8 m -58.6 -20.77 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.779 0 O-C-N 121.868 -0.52 . . . . 0.0 111.823 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 16.8 ptt-85 -113.95 46.05 1.38 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.757 -0.59 . . . . 0.0 111.684 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -146.25 108.33 4.39 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.67 -0.644 . . . . 0.0 110.138 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 71.6 mt -130.85 107.8 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.422 HG22 ' CD1' ' A' ' 58' ' ' LEU . 2.6 t -74.76 134.17 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.0 mt -89.23 160.43 16.94 Favored 'General case' 0 N--CA 1.505 2.307 0 CA-C-O 121.223 0.535 . . . . 0.0 111.364 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 90.5 p -60.2 -19.74 55.56 Favored 'General case' 0 N--CA 1.508 2.459 0 O-C-N 122.091 -0.381 . . . . 0.0 111.194 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 49.8 p-10 -91.87 19.21 6.81 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.673 -0.642 . . . . 0.0 111.653 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.648 ' ND2' HG22 ' A' ' 32' ' ' THR . 6.2 m120 70.51 29.68 3.36 Favored 'General case' 0 N--CA 1.524 3.23 0 O-C-N 121.615 -0.678 . . . . 0.0 112.681 178.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.518 ' CZ ' HG13 ' A' ' 22' ' ' VAL . 4.6 m-85 -105.74 157.85 17.15 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.759 HD23 HD12 ' A' ' 21' ' ' ILE . 20.5 tp -115.61 98.94 6.99 Favored 'General case' 0 N--CA 1.517 2.912 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.164 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.656 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -75.96 100.18 4.78 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.099 179.719 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.58 HD11 HD11 ' A' ' 21' ' ' ILE . 88.3 mt -92.1 120.72 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 177.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -83.71 114.59 21.69 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 121.299 0.571 . . . . 0.0 111.308 -178.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 100.25 -37.32 3.62 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 178.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.751 ' CG1' HG21 ' A' ' 92' ' ' VAL . 4.1 tp 38.21 97.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.139 0 CA-C-O 121.862 0.839 . . . . 0.0 112.8 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.538 ' HB3' HG22 ' A' ' 66' ' ' THR . 20.7 mmtp -90.7 150.02 21.82 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.26 -0.9 . . . . 0.0 111.172 -178.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.6 ptmt -59.48 -28.25 66.84 Favored 'General case' 0 N--CA 1.512 2.637 0 O-C-N 122.002 -0.436 . . . . 0.0 110.271 178.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.538 HG22 ' HB3' ' A' ' 64' ' ' LYS . 7.3 t -72.12 -14.97 61.98 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.897 -0.502 . . . . 0.0 110.603 178.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -99.12 -6.48 28.25 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.638 -0.664 . . . . 0.0 111.579 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -71.94 162.21 29.8 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.319 -0.863 . . . . 0.0 109.144 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 155.02 -111.97 0.51 Allowed Glycine 0 N--CA 1.496 2.691 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 16.9 m -143.62 99.16 3.37 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 122.108 -0.642 . . . . 0.0 110.867 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -79.3 133.47 36.63 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -95.4 119.41 33.85 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.671 -0.812 . . . . 0.0 111.5 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.488 ' HB3' HD11 ' A' ' 33' ' ' ILE . 9.1 m -81.97 129.15 34.69 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 177.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -132.36 85.99 2.29 Favored 'General case' 0 N--CA 1.507 2.409 0 CA-C-N 119.155 0.889 . . . . 0.0 110.791 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' A' ' 33' ' ' ILE . . . -58.55 103.6 0.38 Allowed Glycine 0 N--CA 1.508 3.492 0 N-CA-C 108.507 -1.837 . . . . 0.0 108.507 178.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.624 ' C ' HD12 ' A' ' 77' ' ' ILE . 6.8 ttm-85 -120.88 129.8 53.65 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 122.255 1.026 . . . . 0.0 113.752 -176.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.662 HD13 HG21 ' A' ' 2' ' ' VAL . 3.5 mp -131.27 140.2 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.5 mt -95.06 -46.27 6.88 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.842 -0.536 . . . . 0.0 111.898 -178.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 1.026 ' HB3' HD13 ' A' ' 29' ' ' LEU . . . -54.11 -55.13 30.63 Favored 'General case' 0 N--CA 1.523 3.219 0 O-C-N 121.442 -0.786 . . . . 0.0 109.896 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.419 ' CG ' HD11 ' A' ' 29' ' ' LEU . 28.4 mmm-85 -100.5 59.28 0.97 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 177.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -14.33 81.46 0.0 OUTLIER Glycine 1 N--CA 1.526 4.688 0 C-N-CA 125.042 1.306 . . . . 0.0 114.665 -178.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -125.26 141.85 51.84 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 122.183 -0.599 . . . . 0.0 109.449 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.0 pt -137.48 64.66 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 CA-C-O 121.188 0.518 . . . . 0.0 109.999 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -79.75 155.88 27.74 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 43.8 p90 -160.63 175.5 12.59 Favored 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 119.507 -0.877 . . . . 0.0 112.918 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 8.1 mttp -166.58 154.8 10.21 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.636 ' O ' HG22 ' A' ' 9' ' ' THR . 4.9 p-10 -99.66 114.01 26.82 Favored 'General case' 0 N--CA 1.51 2.559 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.007 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.583 ' N ' HD12 ' A' ' 88' ' ' ILE . 2.1 mp -102.45 123.38 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -91.96 120.32 32.51 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.507 HG13 HE21 ' A' ' 11' ' ' GLN . 48.3 t -107.73 140.53 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 C-N-CA 120.658 -0.417 . . . . 0.0 109.907 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.618 ' O ' HG23 ' A' ' 92' ' ' VAL . 32.2 mm -126.18 147.52 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.41 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.751 HG21 ' CG1' ' A' ' 63' ' ' ILE . 2.1 t . . . . . 0 N--CA 1.502 2.174 0 CA-C-O 117.962 -1.018 . . . . 0.0 108.553 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 44.1 p90 . . . . . 0 N--CA 1.498 1.963 0 CA-C-O 120.78 0.324 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.65 ' CG2' HD11 ' A' ' 77' ' ' ILE . 48.0 t -148.03 106.78 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.508 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 3.1 mmt -112.54 110.65 20.96 Favored 'General case' 0 N--CA 1.509 2.494 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.242 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -69.35 115.41 8.58 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 122.114 -0.366 . . . . 0.0 110.901 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.34 160.33 32.52 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 121.723 0.773 . . . . 0.0 111.283 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.406 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.3 OUTLIER 32.92 79.39 0.03 OUTLIER 'General case' 0 N--CA 1.52 3.049 0 C-N-CA 123.975 0.91 . . . . 0.0 113.35 179.398 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -142.1 78.68 16.89 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.726 -0.609 . . . . 0.0 111.103 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -66.62 104.48 0.79 Allowed 'Trans proline' 0 N--CA 1.489 1.263 0 N-CA-C 108.535 -1.371 . . . . 0.0 108.535 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.579 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.2 OUTLIER -55.46 -61.03 6.8 Favored Pre-proline 0 N--CA 1.505 2.304 0 CA-C-O 116.974 -1.489 . . . . 0.0 112.361 -177.586 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.547 ' HD3' ' OG1' ' A' ' 9' ' ' THR . 1.4 Cg_endo -78.66 93.75 1.09 Allowed 'Trans proline' 0 N--CA 1.493 1.443 0 CA-C-N 121.134 1.441 . . . . 0.0 111.552 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.496 HE21 HG13 ' A' ' 90' ' ' VAL . 16.6 pt20 -101.2 172.17 7.16 Favored 'General case' 0 N--CA 1.508 2.445 0 O-C-N 120.911 -1.118 . . . . 0.0 109.864 178.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -148.47 125.72 11.51 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.822 -0.549 . . . . 0.0 111.587 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -127.14 -165.54 1.48 Allowed 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.07 147.59 52.64 Favored 'General case' 0 N--CA 1.517 2.897 0 CA-C-O 121.92 0.866 . . . . 0.0 111.906 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -57.96 130.47 46.68 Favored 'General case' 0 N--CA 1.507 2.411 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.209 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.3 17.8 77.34 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.662 ' O ' HG22 ' A' ' 63' ' ' ILE . 7.7 tp10 -109.38 155.11 21.64 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 119.182 1.491 . . . . 0.0 111.434 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -79.77 98.54 7.06 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -104.69 169.49 8.42 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.626 0.727 . . . . 0.0 112.586 -177.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.675 HG22 ' HG2' ' A' ' 59' ' ' GLN . 87.9 t -144.53 140.82 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.867 HD12 HD23 ' A' ' 58' ' ' LEU . 48.5 mt -96.84 114.95 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 178.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.513 HG13 ' CZ ' ' A' ' 57' ' ' TYR . 47.4 t -75.5 119.35 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 CA-C-O 121.61 0.719 . . . . 0.0 110.842 -176.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.6 t -161.71 89.01 0.72 Allowed 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.406 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -88.41 138.77 31.14 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.193 -179.016 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.718 HG21 HD12 ' A' ' 33' ' ' ILE . 43.4 t -147.04 126.55 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.508 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 48.1 t -90.87 77.76 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.5 m -78.74 165.85 23.13 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 t -43.96 -85.51 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.177 0 O-C-N 121.753 -0.592 . . . . 0.0 111.443 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.417 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 1.1 mt -165.48 -63.06 0.01 OUTLIER Pre-proline 0 N--CA 1.512 2.657 0 CA-C-O 117.677 -1.154 . . . . 0.0 111.52 177.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.417 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 2.9 Cg_endo -60.55 -53.37 2.88 Favored 'Trans proline' 0 CA--C 1.564 1.987 0 CA-C-N 120.102 1.072 . . . . 0.0 112.524 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.502 ' CB ' ' HA ' ' A' ' 77' ' ' ILE . 2.9 Cg_endo -62.68 -163.66 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 120.541 0.827 . . . . 0.0 112.418 -179.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -171.75 -166.15 0.42 Allowed 'General case' 0 N--CA 1.518 2.937 0 O-C-N 121.861 -0.525 . . . . 0.0 110.304 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.718 HD12 HG21 ' A' ' 25' ' ' VAL . 16.9 tt -99.54 147.98 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 78.0 mt -111.23 127.3 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.573 ' HB2' HG22 ' A' ' 42' ' ' VAL . 76.8 m95 -89.9 109.69 20.69 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.0 tttm -116.77 -165.54 1.07 Allowed 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.072 0.463 . . . . 0.0 110.572 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 58.6 60.65 2.47 Favored 'General case' 0 N--CA 1.51 2.542 0 CA-C-O 121.484 0.659 . . . . 0.0 111.129 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.9 ttpp -170.94 -42.3 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.398 0 O-C-N 121.718 -0.613 . . . . 0.0 109.995 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -169.51 39.74 0.2 Allowed Glycine 0 N--CA 1.497 2.746 0 N-CA-C 108.641 -1.784 . . . . 0.0 108.641 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 58.59 80.39 0.18 Allowed 'General case' 0 N--CA 1.512 2.663 0 O-C-N 122.005 -0.703 . . . . 0.0 110.463 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.423 ' HB3' HD13 ' A' ' 44' ' ' LEU . 2.7 m-20 58.48 107.98 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.823 0 O-C-N 121.912 -0.492 . . . . 0.0 110.845 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.573 HG22 ' HB2' ' A' ' 35' ' ' TRP . 9.7 m -72.99 -30.98 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.527 0 O-C-N 121.963 -0.461 . . . . 0.0 110.494 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 66.8 mt -60.56 -15.7 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.781 0 O-C-N 121.817 -0.552 . . . . 0.0 111.768 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.442 ' N ' HD12 ' A' ' 44' ' ' LEU . 10.9 mp -90.68 -21.79 21.46 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.527 -0.733 . . . . 0.0 110.666 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.1 pttt -97.77 -35.48 10.53 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.598 -0.689 . . . . 0.0 109.733 178.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.1 mmmt 46.35 56.5 6.25 Favored 'General case' 0 N--CA 1.509 2.525 0 CA-C-O 121.382 0.61 . . . . 0.0 112.134 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -50.32 171.59 0.03 OUTLIER 'General case' 0 N--CA 1.516 2.84 0 O-C-N 121.732 -0.605 . . . . 0.0 111.491 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.5 t -65.57 -14.9 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.539 0 O-C-N 121.952 -0.468 . . . . 0.0 111.415 -179.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -115.85 -4.6 12.09 Favored 'General case' 0 N--CA 1.506 2.364 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.438 ' C ' HD12 ' A' ' 51' ' ' ILE . 12.1 m-85 -94.14 115.22 27.48 Favored 'General case' 0 N--CA 1.503 2.182 0 CA-C-N 119.075 0.852 . . . . 0.0 110.616 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.438 HD12 ' C ' ' A' ' 50' ' ' PHE . 5.2 mp -137.19 106.25 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.442 HG22 ' CD1' ' A' ' 58' ' ' LEU . 2.8 t -73.74 128.18 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.502 HD11 ' CG ' ' A' ' 59' ' ' GLN . 52.6 mt -81.93 166.84 19.53 Favored 'General case' 0 N--CA 1.506 2.357 0 CA-C-O 121.377 0.608 . . . . 0.0 112.022 -178.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.6 p -60.66 -21.69 63.07 Favored 'General case' 0 N--CA 1.509 2.51 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.229 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 42.1 p-10 -91.55 19.03 6.61 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.665 -0.647 . . . . 0.0 111.403 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.5 m120 66.63 32.72 6.91 Favored 'General case' 0 N--CA 1.515 2.798 0 O-C-N 121.627 -0.67 . . . . 0.0 112.223 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.513 ' CZ ' HG13 ' A' ' 22' ' ' VAL . 3.5 m-85 -101.69 168.34 9.53 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.867 HD23 HD12 ' A' ' 21' ' ' ILE . 17.1 tp -121.43 96.99 5.3 Favored 'General case' 0 N--CA 1.517 2.912 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.621 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.675 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -76.4 104.2 6.8 Favored 'General case' 0 N--CA 1.502 2.174 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.919 179.49 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.549 HD11 HD11 ' A' ' 21' ' ' ILE . 96.5 mt -97.55 101.37 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 177.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.35 114.77 7.91 Favored 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 121.252 0.549 . . . . 0.0 110.97 -178.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 101.39 -34.18 5.87 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 109.971 -1.251 . . . . 0.0 109.971 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.662 HG22 ' O ' ' A' ' 17' ' ' GLU . 1.8 tp 32.92 92.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.523 3.212 0 CA-C-N 117.925 0.863 . . . . 0.0 113.251 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.549 ' HB3' HG22 ' A' ' 66' ' ' THR . 3.2 mmmm -74.23 148.25 41.72 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.697 -0.627 . . . . 0.0 110.834 -178.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -63.4 -19.13 64.42 Favored 'General case' 0 N--CA 1.508 2.455 0 C-N-CA 120.571 -0.451 . . . . 0.0 110.711 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.549 HG22 ' HB3' ' A' ' 64' ' ' LYS . 10.1 t -83.76 -12.85 55.15 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.441 -0.787 . . . . 0.0 111.105 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.43 11.03 36.36 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.49 -0.756 . . . . 0.0 111.571 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -88.0 152.73 21.83 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.286 -0.884 . . . . 0.0 109.533 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 163.95 -106.15 0.27 Allowed Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.2 m -146.51 103.85 3.71 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 122.156 -0.614 . . . . 0.0 110.654 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -83.61 128.72 34.74 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.4 tpp180 -91.77 118.37 30.62 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.179 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.567 ' HB3' HD11 ' A' ' 33' ' ' ILE . 5.1 m -83.77 122.59 28.86 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 177.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -123.27 88.27 2.89 Favored 'General case' 0 N--CA 1.506 2.349 0 CA-C-N 118.738 0.699 . . . . 0.0 110.643 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.7 103.03 0.9 Allowed Glycine 0 N--CA 1.503 3.161 0 N-CA-C 107.653 -2.179 . . . . 0.0 107.653 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 -118.73 141.64 48.42 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -176.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.65 HD11 ' CG2' ' A' ' 2' ' ' VAL . 88.1 mt -121.63 137.02 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.553 177.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 30.6 mt -92.7 -39.87 11.03 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 121.074 -0.25 . . . . 0.0 110.652 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.82 -58.21 7.53 Favored 'General case' 0 N--CA 1.515 2.776 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.8 mtt180 -101.02 61.72 0.96 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 177.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -14.48 81.68 0.0 OUTLIER Glycine 1 N--CA 1.526 4.696 0 C-N-CA 125.079 1.323 . . . . 0.0 114.73 -178.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -117.69 144.51 45.18 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 122.162 -0.611 . . . . 0.0 110.25 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.1 pt -136.73 74.82 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 CA-C-O 121.132 0.491 . . . . 0.0 110.689 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -93.77 149.57 21.12 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.403 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 42.7 p90 -162.06 -179.21 6.93 Favored 'General case' 0 N--CA 1.503 2.191 0 C-N-CA 119.612 -0.835 . . . . 0.0 113.142 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.6 mttt -167.16 161.54 14.64 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.579 ' O ' HG22 ' A' ' 9' ' ' THR . 4.7 p-10 -103.27 112.35 25.18 Favored 'General case' 0 N--CA 1.51 2.545 0 O-C-N 121.782 -0.574 . . . . 0.0 111.221 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.582 ' N ' HD12 ' A' ' 88' ' ' ILE . 3.0 mp -97.06 115.62 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -85.22 117.27 24.06 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.496 HG13 HE21 ' A' ' 11' ' ' GLN . 42.7 t -111.05 135.27 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 CA-C-O 121.058 0.456 . . . . 0.0 110.045 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 47.7 mt -121.76 135.02 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.44 HG21 ' CG1' ' A' ' 63' ' ' ILE . 54.7 t . . . . . 0 N--CA 1.504 2.27 0 CA-C-O 118.308 -0.853 . . . . 0.0 109.782 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 43.5 p90 . . . . . 0 N--CA 1.499 2.008 0 CA-C-O 120.668 0.27 . . . . 0.0 110.438 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.505 ' CG2' HD11 ' A' ' 77' ' ' ILE . 47.2 t -147.9 105.71 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.544 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 4.7 mmt -111.38 116.86 31.66 Favored 'General case' 0 N--CA 1.51 2.556 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.142 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -73.44 119.63 17.94 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 122.039 -0.413 . . . . 0.0 110.485 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.401 ' HG2' HG23 ' A' ' 26' ' ' VAL . 0.8 OUTLIER -132.82 160.15 37.73 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 121.495 0.664 . . . . 0.0 111.076 -179.388 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.407 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.4 OUTLIER 33.31 88.85 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.107 0 C-N-CA 124.013 0.925 . . . . 0.0 113.423 179.474 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -157.25 81.23 3.27 Favored Pre-proline 0 N--CA 1.495 1.806 0 C-N-CA 120.084 -0.646 . . . . 0.0 111.55 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -64.97 105.61 0.69 Allowed 'Trans proline' 0 N--CA 1.492 1.416 0 N-CA-C 108.588 -1.351 . . . . 0.0 108.588 177.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.544 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.2 OUTLIER -53.88 -66.91 0.71 Allowed Pre-proline 0 N--CA 1.508 2.468 0 CA-C-O 116.91 -1.519 . . . . 0.0 112.245 -177.593 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.486 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.4 Cg_endo -73.13 92.47 0.82 Allowed 'Trans proline' 0 N--CA 1.495 1.591 0 CA-C-N 121.242 1.479 . . . . 0.0 110.978 178.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.458 HE21 HG13 ' A' ' 90' ' ' VAL . 13.1 pt20 -100.18 173.05 6.8 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 120.917 -1.114 . . . . 0.0 110.192 178.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -155.1 125.3 6.72 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.937 -0.477 . . . . 0.0 111.304 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -122.98 -169.73 1.98 Allowed 'General case' 0 N--CA 1.504 2.246 0 O-C-N 122.025 -0.422 . . . . 0.0 110.04 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -106.05 138.65 41.87 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.578 0.704 . . . . 0.0 111.507 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -60.13 126.6 28.13 Favored 'General case' 0 N--CA 1.509 2.498 0 O-C-N 121.717 -0.614 . . . . 0.0 110.739 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.36 21.14 62.96 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.434 ' O ' HG22 ' A' ' 63' ' ' ILE . 7.5 tp10 -112.85 161.63 16.72 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 118.811 1.306 . . . . 0.0 111.31 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.88 98.66 7.2 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 177.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -101.56 169.02 9.12 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 120.15 -0.62 . . . . 0.0 112.109 -177.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.656 HG22 ' HG2' ' A' ' 59' ' ' GLN . 84.1 t -142.23 140.68 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 178.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.718 HD12 HD23 ' A' ' 58' ' ' LEU . 43.9 mt -96.62 115.34 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 178.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.426 ' HA ' ' CE2' ' A' ' 57' ' ' TYR . 57.3 t -76.41 116.98 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 CA-C-O 121.355 0.598 . . . . 0.0 110.536 -177.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.2 t -160.67 89.82 0.83 Allowed 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.407 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -87.53 141.56 28.52 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.212 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.689 HG21 HD12 ' A' ' 33' ' ' ILE . 44.5 t -147.11 129.18 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.544 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 26.4 t -90.41 75.17 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.8 m -79.53 162.22 25.52 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 178.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 t -43.18 -85.04 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.25 0 O-C-N 121.844 -0.535 . . . . 0.0 111.433 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.4 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 1.3 mt -166.77 -63.56 0.01 OUTLIER Pre-proline 0 N--CA 1.512 2.658 0 CA-C-O 117.747 -1.121 . . . . 0.0 111.1 177.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.4 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 3.0 Cg_endo -59.65 -53.37 3.39 Favored 'Trans proline' 0 CA--C 1.565 2.05 0 CA-C-N 120.113 1.076 . . . . 0.0 112.347 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.459 ' HG3' HG23 ' A' ' 77' ' ' ILE . 3.3 Cg_exo -61.02 -165.65 0.04 OUTLIER 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 120.685 0.923 . . . . 0.0 112.358 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -170.64 -161.3 0.23 Allowed 'General case' 0 N--CA 1.523 3.197 0 C-N-CA 120.134 -0.626 . . . . 0.0 111.045 -179.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.835 HD11 ' HB3' ' A' ' 73' ' ' CYS . 21.2 tt -111.3 137.39 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.978 -0.451 . . . . 0.0 110.249 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.45 HD11 ' NE ' ' A' ' 76' ' ' ARG . 70.6 mt -94.56 129.98 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.506 ' HB2' HG22 ' A' ' 42' ' ' VAL . 48.1 m95 -94.66 103.46 15.39 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.181 -178.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.6 tptm -81.52 142.97 32.37 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 177.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.617 ' CG ' HG12 ' A' ' 42' ' ' VAL . 15.4 p-80 -142.04 -146.37 0.19 Allowed 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 120.063 -0.655 . . . . 0.0 111.518 -178.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 5.1 mmpt? -78.55 -0.89 31.43 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.864 -0.523 . . . . 0.0 111.331 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -136.26 34.2 2.28 Favored Glycine 0 N--CA 1.499 2.886 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? 54.58 101.87 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.627 0 O-C-N 121.704 -0.88 . . . . 0.0 112.147 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.8 t0 61.05 133.89 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.712 0 CA-C-O 121.199 0.523 . . . . 0.0 111.744 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.617 HG12 ' CG ' ' A' ' 37' ' ' HIS . 12.8 m -101.95 -32.68 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.437 0 O-C-N 121.755 -0.59 . . . . 0.0 109.758 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.746 HD11 HG21 ' A' ' 52' ' ' VAL . 46.9 mm -57.7 -18.92 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.778 0 O-C-N 121.889 -0.507 . . . . 0.0 111.854 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.467 ' N ' HD12 ' A' ' 44' ' ' LEU . 10.8 mp -89.05 -25.34 22.0 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.581 -0.699 . . . . 0.0 110.767 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.5 pttt -98.67 -39.82 8.49 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.775 -0.578 . . . . 0.0 109.957 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.5 mmmt 47.75 55.01 9.05 Favored 'General case' 0 N--CA 1.511 2.623 0 CA-C-O 121.593 0.711 . . . . 0.0 111.569 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.15 169.47 0.17 Allowed 'General case' 0 N--CA 1.511 2.61 0 O-C-N 121.724 -0.61 . . . . 0.0 110.81 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 29.4 m -62.55 -20.55 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.534 0 O-C-N 122.052 -0.405 . . . . 0.0 111.601 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.9 ptp85 -113.51 46.6 1.25 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.735 -0.603 . . . . 0.0 112.055 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.405 ' HE2' HD21 ' A' ' 58' ' ' LEU . 7.8 m-85 -144.93 107.02 4.31 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.685 -0.634 . . . . 0.0 109.778 178.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 66.3 mt -128.93 104.82 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.746 HG21 HD11 ' A' ' 43' ' ' ILE . 3.1 t -73.95 132.16 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.9 mt -85.91 166.66 15.79 Favored 'General case' 0 N--CA 1.508 2.431 0 O-C-N 121.786 -0.571 . . . . 0.0 111.699 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.8 p -61.57 -21.43 64.3 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 122.204 -0.31 . . . . 0.0 111.137 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -90.93 18.15 6.99 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.614 -0.679 . . . . 0.0 111.46 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.443 ' HB3' HG21 ' A' ' 33' ' ' ILE . 4.0 m120 67.98 32.54 5.03 Favored 'General case' 0 N--CA 1.517 2.899 0 O-C-N 121.596 -0.69 . . . . 0.0 112.189 178.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.426 ' CE2' ' HA ' ' A' ' 22' ' ' VAL . 4.0 m-85 -102.75 162.79 12.64 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 177.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.718 HD23 HD12 ' A' ' 21' ' ' ILE . 17.4 tp -118.2 98.37 6.26 Favored 'General case' 0 N--CA 1.517 2.913 0 C-N-CA 119.276 -0.97 . . . . 0.0 111.591 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.656 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -77.01 97.98 4.82 Favored 'General case' 0 N--CA 1.501 2.12 0 C-N-CA 120.391 -0.523 . . . . 0.0 110.84 179.439 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.548 HD11 HD11 ' A' ' 21' ' ' ILE . 96.0 mt -89.09 119.64 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 177.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.0 tpp180 -80.14 115.43 19.69 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 121.369 0.604 . . . . 0.0 110.707 -178.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.04 -33.28 5.87 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.501 HG23 HG21 ' A' ' 92' ' ' VAL . 1.9 tp 37.85 72.02 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.521 3.108 0 CA-C-N 118.155 0.978 . . . . 0.0 112.861 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.6 mtpp -62.77 158.34 18.96 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 121.751 -0.593 . . . . 0.0 112.187 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 45.2 tttt -62.35 -24.14 67.18 Favored 'General case' 0 N--CA 1.509 2.521 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.908 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 48.0 p -82.86 -15.91 49.67 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.894 -0.504 . . . . 0.0 111.056 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -88.69 -21.67 23.78 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.672 -0.642 . . . . 0.0 110.998 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.464 ' HB3' HG12 ' A' ' 92' ' ' VAL . 7.2 pt-20 -66.74 151.14 48.03 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.519 -0.738 . . . . 0.0 110.312 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 164.24 -115.73 0.66 Allowed Glycine 0 N--CA 1.498 2.787 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.6 m -138.4 100.55 4.14 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.94 -0.741 . . . . 0.0 110.431 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -83.22 135.68 34.69 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.6 ttm105 -103.81 119.61 39.28 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.749 -0.78 . . . . 0.0 111.003 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.835 ' HB3' HD11 ' A' ' 33' ' ' ILE . 19.6 m -78.51 122.64 26.12 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 177.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -121.43 84.26 2.21 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 121.216 0.532 . . . . 0.0 110.695 -178.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.44 117.27 8.74 Favored Glycine 0 N--CA 1.504 3.178 0 N-CA-C 108.062 -2.015 . . . . 0.0 108.062 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.45 ' NE ' HD11 ' A' ' 34' ' ' ILE . 11.6 ttp180 -134.74 140.88 46.28 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -177.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.505 HD11 ' CG2' ' A' ' 2' ' ' VAL . 78.7 mt -122.52 137.57 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-N 114.545 -1.207 . . . . 0.0 108.015 177.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 15.1 mt -91.67 -45.85 8.24 Favored 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.107 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.09 -57.81 11.42 Favored 'General case' 0 N--CA 1.517 2.888 0 O-C-N 121.584 -0.697 . . . . 0.0 109.672 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 70.8 mtt-85 -98.62 59.27 1.25 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 177.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -15.18 81.97 0.0 OUTLIER Glycine 1 N--CA 1.524 4.561 0 C-N-CA 125.037 1.303 . . . . 0.0 114.931 -178.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -120.41 143.72 48.31 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 122.295 -0.532 . . . . 0.0 109.66 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.6 pt -138.01 80.17 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.275 0 CA-C-O 121.483 0.659 . . . . 0.0 111.279 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -96.77 151.17 19.91 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -167.26 174.96 7.68 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.538 -0.726 . . . . 0.0 112.556 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.508 ' HD2' HD11 ' A' ' 88' ' ' ILE . 1.0 OUTLIER -166.71 155.1 10.2 Favored 'General case' 0 N--CA 1.503 2.221 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.461 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.544 ' O ' HG22 ' A' ' 9' ' ' THR . 5.3 p-10 -91.78 120.38 32.45 Favored 'General case' 0 N--CA 1.512 2.669 0 O-C-N 121.839 -0.538 . . . . 0.0 111.933 -178.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.574 ' N ' HD12 ' A' ' 88' ' ' ILE . 3.1 mp -102.91 120.51 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 178.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -87.69 114.81 24.66 Favored 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.458 HG13 HE21 ' A' ' 11' ' ' GLN . 32.5 t -107.96 133.88 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.07 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 74.0 mt -125.62 156.72 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.501 HG21 HG23 ' A' ' 63' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.498 1.937 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.578 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.767 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.634 ' CG2' HD13 ' A' ' 77' ' ' ILE . 62.3 t -151.48 80.13 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.297 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.449 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 11.5 mmm -107.52 114.72 28.9 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 122.032 -0.418 . . . . 0.0 109.953 -178.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -68.45 119.2 12.55 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.935 -0.478 . . . . 0.0 109.892 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.691 ' HG2' HG23 ' A' ' 26' ' ' VAL . 3.2 pttt -129.43 161.54 30.14 Favored 'General case' 0 N--CA 1.503 2.201 0 CA-C-O 121.693 0.758 . . . . 0.0 111.482 -178.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.418 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.4 OUTLIER 32.85 51.39 0.26 Allowed 'General case' 0 N--CA 1.517 2.917 0 C-N-CA 124.134 0.974 . . . . 0.0 113.243 179.423 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -116.64 81.89 12.02 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.725 -0.61 . . . . 0.0 110.645 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -65.54 107.33 1.01 Allowed 'Trans proline' 0 N--CA 1.491 1.373 0 N-CA-C 109.142 -1.138 . . . . 0.0 109.142 178.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.58 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.3 OUTLIER -60.19 -67.84 0.93 Allowed Pre-proline 0 N--CA 1.505 2.311 0 CA-C-O 116.802 -1.57 . . . . 0.0 110.985 -178.336 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.496 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.5 Cg_endo -73.8 89.63 0.99 Allowed 'Trans proline' 0 CA--C 1.559 1.739 0 CA-C-N 121.385 1.53 . . . . 0.0 110.67 177.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -98.44 178.65 4.96 Favored 'General case' 0 N--CA 1.508 2.45 0 O-C-N 120.675 -1.266 . . . . 0.0 110.193 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -159.38 124.53 4.13 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 120.294 -0.562 . . . . 0.0 112.03 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -122.54 -165.21 1.26 Allowed 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.49 137.43 53.2 Favored 'General case' 0 N--CA 1.514 2.765 0 CA-C-O 121.734 0.778 . . . . 0.0 110.941 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -55.32 140.2 40.23 Favored 'General case' 0 N--CA 1.511 2.604 0 O-C-N 121.707 -0.62 . . . . 0.0 111.352 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.13 12.27 81.59 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -106.93 157.47 17.76 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 119.332 1.566 . . . . 0.0 111.821 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -80.07 95.15 6.11 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 176.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.09 169.73 9.2 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.191 0.519 . . . . 0.0 112.204 -176.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.631 HG22 ' HG2' ' A' ' 59' ' ' GLN . 85.3 t -139.75 140.73 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.936 HD12 HD23 ' A' ' 58' ' ' LEU . 27.7 mt -93.17 115.64 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 105.969 -1.864 . . . . 0.0 105.969 177.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.46 HG13 ' CE2' ' A' ' 57' ' ' TYR . 48.1 t -77.54 119.68 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 CA-C-O 121.446 0.641 . . . . 0.0 110.618 -176.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.6 t -161.33 92.18 0.89 Allowed 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.418 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -90.04 145.43 25.09 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 -179.501 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.606 HG21 HD12 ' A' ' 33' ' ' ILE . 23.6 t -146.42 119.92 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.691 HG23 ' HG2' ' A' ' 5' ' ' LYS . 21.2 t -75.9 73.46 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 178.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.4 m -84.09 157.24 21.82 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.6 t -47.46 -79.4 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.078 0 O-C-N 121.762 -0.586 . . . . 0.0 111.385 -178.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -172.94 -61.02 0.0 OUTLIER Pre-proline 0 N--CA 1.514 2.758 0 CA-C-O 117.918 -1.039 . . . . 0.0 111.018 177.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.09 -53.97 3.13 Favored 'Trans proline' 0 CA--C 1.563 1.935 0 CA-C-N 119.7 0.928 . . . . 0.0 112.634 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.451 ' HB2' HG13 ' A' ' 77' ' ' ILE . 2.2 Cg_endo -61.99 -166.41 0.05 OUTLIER 'Trans proline' 0 N--CA 1.501 1.936 0 CA-C-N 119.322 0.794 . . . . 0.0 111.545 -179.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -170.7 -164.93 0.4 Allowed 'General case' 0 N--CA 1.518 2.966 0 O-C-N 121.7 -0.625 . . . . 0.0 110.078 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.606 HD12 HG21 ' A' ' 25' ' ' VAL . 17.9 tt -105.1 158.22 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.992 -0.443 . . . . 0.0 110.023 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 68.8 mt -125.58 118.89 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.558 ' HB2' HG22 ' A' ' 42' ' ' VAL . 83.0 m95 -81.6 102.15 10.46 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.2 tttt -102.18 -172.39 2.13 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 121.222 0.534 . . . . 0.0 110.906 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 63.76 157.86 0.08 Allowed 'General case' 0 N--CA 1.511 2.603 0 O-C-N 121.89 -0.506 . . . . 0.0 110.173 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.3 tptt 57.03 44.6 22.49 Favored 'General case' 0 N--CA 1.514 2.738 0 O-C-N 121.67 -0.644 . . . . 0.0 110.771 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 133.76 2.88 3.42 Favored Glycine 0 N--CA 1.497 2.757 0 C-N-CA 120.371 -0.919 . . . . 0.0 111.84 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 54.38 90.49 0.03 OUTLIER 'General case' 0 N--CA 1.516 2.847 0 CA-C-N 119.247 1.524 . . . . 0.0 110.739 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 t0 54.54 97.88 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.963 0 O-C-N 121.783 -0.573 . . . . 0.0 110.431 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.558 HG22 ' HB2' ' A' ' 35' ' ' TRP . 4.5 m -69.32 -28.97 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.519 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.769 -178.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 73.5 mt -59.79 -16.6 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.83 0 O-C-N 121.624 -0.673 . . . . 0.0 111.656 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.495 ' N ' HD12 ' A' ' 44' ' ' LEU . 10.6 mp -91.45 -23.39 20.02 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.433 -0.792 . . . . 0.0 110.732 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -97.86 -38.95 9.24 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.697 -0.627 . . . . 0.0 109.379 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 17.5 mmmt 46.35 55.55 7.27 Favored 'General case' 0 N--CA 1.51 2.559 0 CA-C-O 121.438 0.637 . . . . 0.0 112.228 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.33 165.76 0.33 Allowed 'General case' 0 N--CA 1.513 2.688 0 O-C-N 121.782 -0.574 . . . . 0.0 111.106 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.5 m -58.85 -20.88 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.699 0 O-C-N 122.018 -0.426 . . . . 0.0 111.856 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 5.0 ptt-85 -115.79 47.22 1.39 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.791 -0.568 . . . . 0.0 111.886 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -146.26 101.56 3.51 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.645 -0.659 . . . . 0.0 109.796 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 62.5 mt -125.92 113.42 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.439 HG22 ' CD1' ' A' ' 58' ' ' LEU . 2.4 t -79.49 128.05 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.411 HD11 ' CG ' ' A' ' 59' ' ' GLN . 15.5 mt -80.56 164.1 23.19 Favored 'General case' 0 N--CA 1.506 2.354 0 CA-C-O 121.195 0.521 . . . . 0.0 111.601 -178.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 96.6 p -60.0 -20.63 58.76 Favored 'General case' 0 N--CA 1.511 2.618 0 O-C-N 122.139 -0.351 . . . . 0.0 111.336 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.7 p-10 -91.19 19.44 5.87 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.721 -0.612 . . . . 0.0 111.43 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.8 m120 66.64 32.87 6.81 Favored 'General case' 0 N--CA 1.515 2.806 0 O-C-N 121.607 -0.683 . . . . 0.0 112.165 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.46 ' CE2' HG13 ' A' ' 22' ' ' VAL . 3.9 m-85 -103.4 168.82 8.92 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.936 HD23 HD12 ' A' ' 21' ' ' ILE . 18.0 tp -124.77 98.47 5.72 Favored 'General case' 0 N--CA 1.515 2.788 0 C-N-CA 119.29 -0.964 . . . . 0.0 112.241 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.631 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -74.79 100.16 3.96 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 120.77 0.319 . . . . 0.0 110.825 179.338 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.849 HD11 HD11 ' A' ' 21' ' ' ILE . 97.3 mt -92.7 110.9 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 178.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.27 113.89 9.8 Favored 'General case' 0 N--CA 1.504 2.261 0 CA-C-O 121.386 0.612 . . . . 0.0 111.343 -178.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.36 -38.3 3.15 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.506 HG12 HG21 ' A' ' 92' ' ' VAL . 1.5 tp 41.84 67.24 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.927 0 CA-C-O 122.145 0.974 . . . . 0.0 112.544 -178.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.5 mttm -58.35 157.38 8.71 Favored 'General case' 0 N--CA 1.51 2.557 0 CA-C-O 121.398 0.618 . . . . 0.0 112.611 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.8 ttmm -62.06 -21.81 65.24 Favored 'General case' 0 N--CA 1.509 2.486 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.97 178.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.1 p -83.78 -18.86 36.31 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.802 -0.561 . . . . 0.0 110.96 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.75 -5.7 56.72 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.653 -0.655 . . . . 0.0 111.607 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.529 ' HB3' HG12 ' A' ' 92' ' ' VAL . 8.2 pt-20 -81.7 137.01 35.46 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 119.006 0.821 . . . . 0.0 109.619 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 176.97 -111.39 0.33 Allowed Glycine 0 N--CA 1.499 2.863 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.0 m -138.8 104.1 5.0 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 122.034 -0.686 . . . . 0.0 110.708 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -86.8 135.89 33.19 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -93.72 118.62 31.65 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.21 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 85' ' ' PHE . 3.4 m -86.48 91.33 8.51 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 178.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -91.53 88.45 6.78 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.842 -0.536 . . . . 0.0 109.929 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.47 96.3 0.82 Allowed Glycine 0 N--CA 1.5 2.95 0 N-CA-C 107.311 -2.315 . . . . 0.0 107.311 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.593 ' HG3' HG22 ' A' ' 83' ' ' ILE . 3.7 ttm180 -99.5 127.23 45.56 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 122.031 0.919 . . . . 0.0 113.198 -176.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.634 HD13 ' CG2' ' A' ' 2' ' ' VAL . 4.8 mp -143.09 89.55 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 CA-C-N 114.387 -1.279 . . . . 0.0 107.693 178.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 28.2 mt -95.39 20.05 9.97 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.954 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -113.3 -31.85 6.46 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.665 -0.647 . . . . 0.0 110.692 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -115.84 -63.56 1.43 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.919 -0.488 . . . . 0.0 110.784 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -98.55 -81.74 1.62 Allowed Glycine 0 N--CA 1.49 2.279 0 C-N-CA 121.056 -0.592 . . . . 0.0 111.808 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 179.33 -160.03 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.76 0 O-C-N 122.038 -0.683 . . . . 0.0 110.281 -178.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.593 HG22 ' HG3' ' A' ' 76' ' ' ARG . 1.1 pp -99.93 103.62 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.424 0 O-C-N 121.717 -0.615 . . . . 0.0 110.944 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -100.71 158.72 15.74 Favored 'General case' 0 N--CA 1.507 2.401 0 O-C-N 121.444 -0.785 . . . . 0.0 110.026 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.474 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 36.1 p90 -161.1 171.93 17.68 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.534 -0.729 . . . . 0.0 112.4 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.9 mttp -165.78 159.0 15.7 Favored 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.58 ' O ' HG22 ' A' ' 9' ' ' THR . 6.9 p-10 -103.94 121.29 42.81 Favored 'General case' 0 N--CA 1.512 2.662 0 O-C-N 121.757 -0.589 . . . . 0.0 110.756 179.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.521 ' N ' HD12 ' A' ' 88' ' ' ILE . 1.8 mp -105.46 121.49 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -85.26 111.46 19.87 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.7 t -104.73 127.75 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.097 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 72.2 mt -117.17 159.71 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.529 HG12 ' HB3' ' A' ' 68' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.501 2.092 0 CA-C-O 117.922 -1.037 . . . . 0.0 110.496 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 45.9 p90 . . . . . 0 N--CA 1.498 1.941 0 CA-C-O 120.679 0.276 . . . . 0.0 110.494 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.683 ' CG2' HD11 ' A' ' 77' ' ' ILE . 49.0 t -146.95 106.06 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.493 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 17.8 mmm -112.53 111.22 21.89 Favored 'General case' 0 N--CA 1.506 2.371 0 C-N-CA 120.501 -0.479 . . . . 0.0 110.475 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -70.91 116.5 11.28 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 122.041 -0.412 . . . . 0.0 110.841 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -124.8 155.3 39.6 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 121.531 0.681 . . . . 0.0 110.133 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 41.85 86.04 0.02 OUTLIER 'General case' 0 N--CA 1.52 3.044 0 C-N-CA 123.073 0.549 . . . . 0.0 111.803 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -131.95 62.9 66.62 Favored Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 121.696 -0.627 . . . . 0.0 112.155 -178.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.408 ' HD2' HG12 ' A' ' 22' ' ' VAL . 2.5 Cg_endo -66.28 89.83 0.26 Allowed 'Trans proline' 0 N--CA 1.494 1.543 0 N-CA-C 108.162 -1.514 . . . . 0.0 108.162 177.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.489 ' OG1' ' HD3' ' A' ' 10' ' ' PRO . 13.6 p -59.47 -43.34 95.89 Favored Pre-proline 0 N--CA 1.508 2.459 0 CA-C-O 117.382 -1.294 . . . . 0.0 113.156 -177.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.489 ' HD3' ' OG1' ' A' ' 9' ' ' THR . 1.7 Cg_endo -81.8 82.88 2.23 Favored 'Trans proline' 0 CA--C 1.549 1.251 0 CA-C-N 120.651 1.268 . . . . 0.0 111.332 -177.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.477 HE21 HG13 ' A' ' 90' ' ' VAL . 15.7 pt20 -100.73 170.52 8.29 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.163 -0.96 . . . . 0.0 110.978 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -155.3 124.34 6.2 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 122.002 -0.436 . . . . 0.0 110.996 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -122.49 -169.59 1.93 Allowed 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.912 -0.493 . . . . 0.0 109.778 179.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -115.96 145.61 42.79 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.479 0.657 . . . . 0.0 111.67 -178.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -61.44 121.24 12.18 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 121.947 -0.471 . . . . 0.0 110.399 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.35 20.61 51.6 Favored Glycine 0 N--CA 1.497 2.714 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -179.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.506 ' O ' HG22 ' A' ' 63' ' ' ILE . 7.7 tp10 -112.37 158.1 20.22 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 118.619 1.21 . . . . 0.0 111.212 -179.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -80.45 98.09 7.38 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 177.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -102.9 165.5 11.0 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 120.169 -0.612 . . . . 0.0 112.398 -177.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.699 HG22 ' HG2' ' A' ' 59' ' ' GLN . 93.8 t -140.0 143.26 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 178.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.895 HD12 HD23 ' A' ' 58' ' ' LEU . 47.1 mt -99.96 113.24 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 178.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.411 HG13 ' CE2' ' A' ' 57' ' ' TYR . 58.4 t -73.22 120.15 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 CA-C-O 121.513 0.673 . . . . 0.0 111.057 -176.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.0 t -165.09 93.12 0.6 Allowed 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.15 140.79 29.11 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.314 -179.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.627 HG21 HD12 ' A' ' 33' ' ' ILE . 43.7 t -148.83 133.24 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.493 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 59.5 t -99.85 78.71 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.8 m -79.23 165.71 22.95 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.9 t -43.56 -82.31 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.19 0 O-C-N 121.899 -0.501 . . . . 0.0 111.509 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.416 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 1.0 OUTLIER -167.73 -63.27 0.01 OUTLIER Pre-proline 0 N--CA 1.513 2.708 0 CA-C-O 117.778 -1.106 . . . . 0.0 111.661 177.642 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.416 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 2.9 Cg_endo -60.1 -53.13 3.32 Favored 'Trans proline' 0 CA--C 1.563 1.939 0 CA-C-N 120.107 1.074 . . . . 0.0 112.676 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.532 ' CB ' ' HA ' ' A' ' 77' ' ' ILE . 2.8 Cg_endo -62.57 -163.98 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.794 0 CA-C-N 119.268 0.774 . . . . 0.0 112.634 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -169.95 -160.13 0.22 Allowed 'General case' 0 N--CA 1.519 3.017 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.21 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.847 HD11 ' HB3' ' A' ' 73' ' ' CYS . 20.7 tt -107.98 145.19 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.924 -0.485 . . . . 0.0 110.036 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.0 mt -104.59 130.43 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.533 ' HB2' HG22 ' A' ' 42' ' ' VAL . 55.8 m95 -96.02 119.37 34.38 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.217 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.6 tptt -100.4 103.6 14.99 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 32.3 p-80 -93.32 125.6 38.01 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.256 0.551 . . . . 0.0 111.569 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.6 mmtt 49.23 23.64 0.84 Allowed 'General case' 0 N--CA 1.514 2.74 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 178.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.96 -31.99 7.06 Favored Glycine 0 N--CA 1.5 2.909 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.2 -179.56 4.98 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-N 117.824 0.812 . . . . 0.0 110.307 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -109.02 147.35 32.46 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.962 -0.461 . . . . 0.0 110.196 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.533 HG22 ' HB2' ' A' ' 35' ' ' TRP . 8.4 m -93.26 -35.46 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.705 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.6 mm -57.95 -19.41 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.683 0 O-C-N 122.028 -0.42 . . . . 0.0 111.796 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.472 ' N ' HD12 ' A' ' 44' ' ' LEU . 9.9 mp -90.59 -24.96 20.41 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.562 -0.711 . . . . 0.0 110.843 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 41.6 pttt -99.03 -39.97 8.26 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.665 -0.647 . . . . 0.0 109.802 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm 49.6 54.51 10.89 Favored 'General case' 0 N--CA 1.509 2.523 0 CA-C-O 121.464 0.649 . . . . 0.0 111.744 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -53.49 164.21 0.53 Allowed 'General case' 0 N--CA 1.514 2.771 0 O-C-N 121.698 -0.626 . . . . 0.0 110.715 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.8 m -60.83 -21.0 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.728 0 O-C-N 121.943 -0.473 . . . . 0.0 111.767 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.8 ptt-85 -100.87 -8.89 22.14 Favored 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -93.47 107.61 19.43 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-N 118.852 0.751 . . . . 0.0 110.272 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 71.7 mt -128.64 105.68 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.478 HG22 ' CD1' ' A' ' 58' ' ' LEU . 2.9 t -75.17 131.51 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.51 HD11 ' CG ' ' A' ' 59' ' ' GLN . 37.8 mt -84.15 168.1 16.11 Favored 'General case' 0 N--CA 1.508 2.452 0 CA-C-O 121.172 0.511 . . . . 0.0 111.717 -178.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 55.3 p -61.58 -22.87 65.58 Favored 'General case' 0 N--CA 1.509 2.522 0 O-C-N 122.182 -0.324 . . . . 0.0 111.074 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 50.9 p-10 -91.25 18.42 7.03 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.825 -0.547 . . . . 0.0 111.345 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.441 ' HB3' HG21 ' A' ' 33' ' ' ILE . 4.3 m120 66.82 34.63 5.38 Favored 'General case' 0 N--CA 1.515 2.795 0 O-C-N 121.542 -0.724 . . . . 0.0 112.406 178.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.411 ' CE2' HG13 ' A' ' 22' ' ' VAL . 4.0 m-85 -102.67 159.21 15.66 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.895 HD23 HD12 ' A' ' 21' ' ' ILE . 17.8 tp -114.01 98.31 6.9 Favored 'General case' 0 N--CA 1.515 2.815 0 C-N-CA 119.353 -0.939 . . . . 0.0 112.026 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.699 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -78.76 101.42 7.57 Favored 'General case' 0 N--CA 1.503 2.205 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.088 179.439 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.581 HD11 HD11 ' A' ' 21' ' ' ILE . 91.1 mt -93.58 102.43 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 177.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -68.98 114.19 7.05 Favored 'General case' 0 N--CA 1.506 2.371 0 CA-C-O 121.24 0.543 . . . . 0.0 111.378 -178.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 100.4 -34.8 5.26 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 110.079 -1.209 . . . . 0.0 110.079 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.506 HG22 ' O ' ' A' ' 17' ' ' GLU . 1.9 tp 35.98 95.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.13 0 CA-C-N 118.001 0.901 . . . . 0.0 113.205 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -72.88 146.78 45.93 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.626 -0.671 . . . . 0.0 111.116 -178.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -63.28 -18.71 63.87 Favored 'General case' 0 N--CA 1.51 2.545 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.676 178.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 58.5 p -86.14 -16.43 37.94 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.422 -0.798 . . . . 0.0 110.859 179.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -93.18 17.45 11.02 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.601 -0.687 . . . . 0.0 111.479 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -95.72 145.03 25.62 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.581 -0.699 . . . . 0.0 109.737 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 169.6 -105.36 0.22 Allowed Glycine 0 N--CA 1.497 2.757 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.0 m -142.89 101.38 3.83 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.99 -0.712 . . . . 0.0 111.277 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -83.11 127.55 33.69 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.0 ttt180 -95.71 122.21 38.23 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 120.087 -0.645 . . . . 0.0 111.407 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.847 ' HB3' HD11 ' A' ' 33' ' ' ILE . 65.1 m -79.85 127.34 32.11 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 177.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -126.16 84.63 2.29 Favored 'General case' 0 N--CA 1.506 2.344 0 CA-C-N 119.245 0.929 . . . . 0.0 110.36 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.09 102.35 0.71 Allowed Glycine 0 N--CA 1.506 3.307 0 N-CA-C 107.898 -2.081 . . . . 0.0 107.898 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -117.59 140.49 49.56 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -176.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.683 HD11 ' CG2' ' A' ' 2' ' ' VAL . 96.4 mt -114.86 138.28 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.19 177.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 52.2 mt -88.93 -58.01 2.7 Favored 'General case' 0 N--CA 1.503 2.188 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.357 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.08 -57.1 12.35 Favored 'General case' 0 N--CA 1.519 2.991 0 O-C-N 121.677 -0.639 . . . . 0.0 110.502 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -98.66 60.59 1.31 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -16.06 82.18 0.0 OUTLIER Glycine 1 N--CA 1.524 4.55 0 C-N-CA 125.06 1.314 . . . . 0.0 114.872 -178.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -114.0 147.49 38.54 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 122.109 -0.642 . . . . 0.0 109.844 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.1 pt -138.35 72.62 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 CA-C-O 121.225 0.536 . . . . 0.0 111.562 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -91.72 150.4 21.14 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -159.47 -178.2 6.96 Favored 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 119.419 -0.912 . . . . 0.0 113.429 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -168.24 163.18 13.07 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -104.22 144.86 31.03 Favored 'General case' 0 N--CA 1.511 2.58 0 O-C-N 121.771 -0.581 . . . . 0.0 111.442 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.519 HG21 ' CG2' ' A' ' 21' ' ' ILE . 50.8 mm -126.48 106.24 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -72.52 101.1 2.89 Favored 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.477 HG13 HE21 ' A' ' 11' ' ' GLN . 25.7 t -100.25 133.51 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.438 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 72.8 mt -119.68 144.72 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 43.5 t . . . . . 0 N--CA 1.505 2.281 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.625 -179.176 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.78 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.665 ' CG2' HD13 ' A' ' 77' ' ' ILE . 62.4 t -152.19 78.11 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.462 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 61.4 mmm -104.16 120.21 40.63 Favored 'General case' 0 N--CA 1.509 2.484 0 O-C-N 121.831 -0.543 . . . . 0.0 110.741 -178.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -78.1 113.59 16.18 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 122.053 -0.404 . . . . 0.0 110.192 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.6 ptpt -127.61 165.93 19.02 Favored 'General case' 0 N--CA 1.503 2.182 0 CA-C-O 121.748 0.785 . . . . 0.0 112.235 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.432 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.3 OUTLIER 31.26 80.27 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.959 0 C-N-CA 124.442 1.097 . . . . 0.0 113.226 179.077 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.418 ' HB2' ' HA ' ' A' ' 23' ' ' CYS . . . -154.4 81.44 4.48 Favored Pre-proline 0 N--CA 1.489 1.505 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.864 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.6 105.49 0.63 Allowed 'Trans proline' 0 N--CA 1.491 1.339 0 N-CA-C 108.58 -1.354 . . . . 0.0 108.58 178.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.583 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.2 OUTLIER -51.41 -64.6 1.31 Allowed Pre-proline 0 N--CA 1.509 2.481 0 CA-C-O 117.139 -1.41 . . . . 0.0 111.909 -177.563 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.491 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.6 Cg_endo -74.6 90.56 1.03 Allowed 'Trans proline' 0 CA--C 1.557 1.67 0 CA-C-N 120.974 1.384 . . . . 0.0 110.545 177.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.409 HE21 HG13 ' A' ' 90' ' ' VAL . 13.3 pt20 -99.03 177.04 5.36 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 120.805 -1.185 . . . . 0.0 110.2 179.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -159.81 121.29 3.22 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.855 -0.528 . . . . 0.0 111.856 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -116.2 -169.89 1.7 Allowed 'General case' 0 N--CA 1.504 2.259 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -103.43 137.12 41.95 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.553 0.692 . . . . 0.0 111.524 -178.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -61.06 113.97 2.85 Favored 'General case' 0 N--CA 1.509 2.484 0 O-C-N 121.897 -0.502 . . . . 0.0 110.539 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.16 23.33 22.61 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.526 -1.029 . . . . 0.0 110.526 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -117.88 164.83 14.46 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 118.335 1.068 . . . . 0.0 110.998 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -80.47 99.31 7.95 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 177.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.77 167.44 10.77 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.454 0.645 . . . . 0.0 112.119 -177.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.631 HG22 ' HG2' ' A' ' 59' ' ' GLN . 87.5 t -143.72 133.84 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 178.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.736 HD12 HD23 ' A' ' 58' ' ' LEU . 42.1 mt -90.35 115.18 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 178.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.426 ' HA ' ' CE2' ' A' ' 57' ' ' TYR . 54.4 t -74.83 120.99 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.852 -176.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.418 ' HA ' ' HB2' ' A' ' 7' ' ' ALA . 0.7 OUTLIER -162.19 91.74 0.8 Allowed 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.406 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.432 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -90.59 140.6 29.6 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.651 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.605 HG21 HD12 ' A' ' 33' ' ' ILE . 14.5 t -146.35 124.0 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.462 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 45.3 t -82.45 77.51 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.1 m -87.47 154.64 20.48 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.6 t -43.88 -85.69 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.255 0 O-C-N 121.919 -0.488 . . . . 0.0 112.294 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.402 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 1.2 mt -165.4 -62.51 0.01 OUTLIER Pre-proline 0 N--CA 1.51 2.555 0 CA-C-O 117.711 -1.137 . . . . 0.0 111.24 178.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.402 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 2.9 Cg_endo -59.4 -53.45 3.46 Favored 'Trans proline' 0 CA--C 1.561 1.864 0 CA-C-N 120.091 1.068 . . . . 0.0 112.307 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.556 ' HG2' HG23 ' A' ' 77' ' ' ILE . 2.7 Cg_endo -62.91 -170.07 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.668 0 CA-C-N 119.286 0.781 . . . . 0.0 111.467 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.412 ' HG1' ' C ' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -171.17 -165.41 0.41 Allowed 'General case' 0 N--CA 1.519 2.979 0 O-C-N 121.767 -0.583 . . . . 0.0 109.647 179.808 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.605 HD12 HG21 ' A' ' 25' ' ' VAL . 16.3 tt -99.11 161.03 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 66.2 mt -128.74 121.04 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.597 ' HB2' HG22 ' A' ' 42' ' ' VAL . 83.5 m95 -85.51 113.13 21.53 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 120.49 -0.484 . . . . 0.0 109.778 -179.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 50.9 mttt -128.07 -166.4 1.62 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.79 -0.569 . . . . 0.0 111.539 -178.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 66.14 49.77 1.49 Allowed 'General case' 0 N--CA 1.513 2.719 0 O-C-N 121.698 -0.626 . . . . 0.0 111.296 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -171.73 -43.09 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.591 -0.693 . . . . 0.0 109.488 178.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -153.94 34.82 0.73 Allowed Glycine 0 N--CA 1.495 2.633 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? 51.72 85.03 0.04 OUTLIER 'General case' 0 N--CA 1.514 2.76 0 O-C-N 121.575 -0.956 . . . . 0.0 110.997 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.424 ' CG ' HD13 ' A' ' 44' ' ' LEU . 3.4 t0 55.17 96.39 0.02 OUTLIER 'General case' 0 N--CA 1.516 2.826 0 O-C-N 121.634 -0.666 . . . . 0.0 110.276 -179.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.597 HG22 ' HB2' ' A' ' 35' ' ' TRP . 13.6 m -64.3 -30.35 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.491 0 O-C-N 121.919 -0.488 . . . . 0.0 110.695 -178.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 71.1 mt -59.43 -18.08 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.769 0 O-C-N 121.711 -0.618 . . . . 0.0 111.738 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.476 ' N ' HD12 ' A' ' 44' ' ' LEU . 10.4 mp -92.57 -21.35 20.14 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.455 -0.778 . . . . 0.0 111.119 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.41 ' HG2' ' HA ' ' A' ' 42' ' ' VAL . 42.8 pttt -98.06 -37.43 9.75 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.633 -0.667 . . . . 0.0 109.233 178.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.4 mmmt 48.05 54.75 9.65 Favored 'General case' 0 N--CA 1.509 2.493 0 CA-C-O 121.421 0.629 . . . . 0.0 111.824 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -51.83 168.29 0.09 Allowed 'General case' 0 N--CA 1.515 2.789 0 O-C-N 121.867 -0.521 . . . . 0.0 110.943 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.8 m -61.16 -18.77 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.689 0 O-C-N 121.976 -0.452 . . . . 0.0 111.799 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 29.6 ptt-85 -121.26 46.82 1.96 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.728 -0.607 . . . . 0.0 111.973 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.426 ' HE2' HD21 ' A' ' 58' ' ' LEU . 6.8 m-85 -145.36 106.97 4.23 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.574 -0.704 . . . . 0.0 110.156 178.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 82.7 mt -129.66 107.99 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.556 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.0 t -76.17 131.66 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.5 mt -85.02 164.43 18.25 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.909 -0.494 . . . . 0.0 111.49 -178.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.3 p -62.03 -20.68 64.19 Favored 'General case' 0 N--CA 1.509 2.48 0 O-C-N 122.102 -0.374 . . . . 0.0 110.812 178.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 50.3 p30 -88.17 13.58 11.06 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.721 -0.612 . . . . 0.0 111.528 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.3 m120 71.09 33.94 1.94 Allowed 'General case' 0 N--CA 1.518 2.968 0 O-C-N 121.547 -0.72 . . . . 0.0 112.493 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.426 ' CE2' ' HA ' ' A' ' 22' ' ' VAL . 5.3 m-85 -106.0 163.77 12.5 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 177.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.736 HD23 HD12 ' A' ' 21' ' ' ILE . 18.1 tp -118.07 97.54 5.86 Favored 'General case' 0 N--CA 1.519 3.005 0 C-N-CA 119.381 -0.928 . . . . 0.0 111.218 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.631 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -75.39 99.49 4.16 Favored 'General case' 0 N--CA 1.501 2.081 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.763 179.651 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.597 HD11 HD11 ' A' ' 21' ' ' ILE . 92.6 mt -90.75 118.95 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 177.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.8 tpt85 -81.2 113.06 19.09 Favored 'General case' 0 N--CA 1.501 2.092 0 CA-C-O 121.29 0.566 . . . . 0.0 111.012 -178.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.55 -37.28 3.6 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.585 ' CG1' HG21 ' A' ' 92' ' ' VAL . 3.2 tp 41.6 94.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.521 3.08 0 CA-C-N 118.126 0.963 . . . . 0.0 112.253 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.2 mttm -86.87 157.45 19.53 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 121.233 -0.917 . . . . 0.0 112.693 -177.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.6 tttp -61.68 -27.38 68.65 Favored 'General case' 0 N--CA 1.508 2.453 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.12 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.5 t -81.11 -11.74 59.41 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 121.896 -0.503 . . . . 0.0 111.601 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.64 -17.54 20.31 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.534 -0.729 . . . . 0.0 111.482 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.475 ' HB3' HG12 ' A' ' 92' ' ' VAL . 8.4 pt-20 -68.75 148.28 50.58 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.36 -0.837 . . . . 0.0 109.933 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 167.01 -107.15 0.28 Allowed Glycine 0 N--CA 1.496 2.695 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.9 m -145.26 104.2 3.92 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 122.023 -0.692 . . . . 0.0 110.864 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -85.44 138.02 32.53 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -97.42 120.29 37.52 Favored 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.447 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 85' ' ' PHE . 2.9 m -87.31 105.73 17.45 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -104.63 85.97 2.41 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.298 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.29 87.96 0.25 Allowed Glycine 0 N--CA 1.499 2.899 0 N-CA-C 107.674 -2.17 . . . . 0.0 107.674 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.592 ' HG3' HG22 ' A' ' 83' ' ' ILE . 2.6 ttm180 -92.91 125.69 37.64 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.706 0.765 . . . . 0.0 112.967 -176.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.665 HD13 ' CG2' ' A' ' 2' ' ' VAL . 5.2 mp -141.43 91.55 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.469 HD21 HG23 ' A' ' 83' ' ' ILE . 18.6 mt -96.94 19.11 13.24 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.009 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -112.59 -26.2 8.77 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.717 -0.614 . . . . 0.0 110.847 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 78.2 mmt-85 -121.22 -62.9 1.38 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.777 -0.577 . . . . 0.0 110.753 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.58 -81.71 1.62 Allowed Glycine 0 N--CA 1.491 2.305 0 C-N-CA 121.02 -0.61 . . . . 0.0 111.645 -178.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 178.09 -159.83 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.765 0 O-C-N 122.204 -0.586 . . . . 0.0 109.827 -178.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.592 HG22 ' HG3' ' A' ' 76' ' ' ARG . 1.7 pp -98.16 115.06 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 O-C-N 121.743 -0.598 . . . . 0.0 110.42 179.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -113.61 155.95 24.55 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.539 -0.725 . . . . 0.0 109.869 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.451 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 35.4 p90 -164.12 176.69 9.04 Favored 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.2 pttt -170.53 167.13 8.17 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.583 ' O ' HG22 ' A' ' 9' ' ' THR . 5.8 p-10 -105.54 123.96 48.77 Favored 'General case' 0 N--CA 1.513 2.677 0 O-C-N 121.801 -0.562 . . . . 0.0 111.703 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.537 ' N ' HD12 ' A' ' 88' ' ' ILE . 1.9 mp -104.85 119.24 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -83.54 114.83 21.79 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.409 HG13 HE21 ' A' ' 11' ' ' GLN . 46.5 t -108.52 132.92 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.235 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 50.2 mt -121.95 159.25 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.585 HG21 ' CG1' ' A' ' 63' ' ' ILE . 1.4 p . . . . . 0 N--CA 1.498 1.943 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.699 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 47.9 p90 . . . . . 0 N--CA 1.499 1.999 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.532 ' CG2' HD11 ' A' ' 77' ' ' ILE . 44.5 t -147.17 109.26 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.527 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 12.5 mmt -119.85 116.23 25.44 Favored 'General case' 0 N--CA 1.507 2.396 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.803 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -72.88 115.71 12.5 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 122.118 -0.364 . . . . 0.0 111.101 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -124.49 156.56 37.05 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.566 0.698 . . . . 0.0 110.357 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.426 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.2 OUTLIER 41.07 81.82 0.03 OUTLIER 'General case' 0 N--CA 1.518 2.94 0 C-N-CA 123.479 0.712 . . . . 0.0 111.919 -179.47 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -131.92 68.54 80.49 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.711 -0.618 . . . . 0.0 111.68 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -67.12 88.85 0.31 Allowed 'Trans proline' 0 N--CA 1.492 1.397 0 N-CA-C 107.966 -1.59 . . . . 0.0 107.966 177.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.544 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.6 OUTLIER -48.69 -68.27 0.34 Allowed Pre-proline 0 N--CA 1.509 2.496 0 CA-C-O 116.795 -1.574 . . . . 0.0 113.069 -176.702 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.487 ' HD3' ' OG1' ' A' ' 9' ' ' THR . 1.5 Cg_endo -71.31 93.88 0.66 Allowed 'Trans proline' 0 N--CA 1.497 1.686 0 CA-C-N 121.516 1.577 . . . . 0.0 111.441 178.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.498 HE21 HG13 ' A' ' 90' ' ' VAL . 16.1 pt20 -101.0 173.98 6.22 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.02 -1.05 . . . . 0.0 110.26 178.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 15.5 tt0 -158.79 120.39 3.45 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.238 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -116.72 -169.76 1.69 Allowed 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.945 -0.472 . . . . 0.0 109.94 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -102.01 137.46 40.25 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.597 0.713 . . . . 0.0 111.705 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -60.79 118.78 7.07 Favored 'General case' 0 N--CA 1.508 2.444 0 O-C-N 121.964 -0.46 . . . . 0.0 110.494 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.3 23.54 37.01 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.422 ' O ' HG22 ' A' ' 63' ' ' ILE . 15.4 tt0 -118.26 165.17 14.14 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 118.412 1.106 . . . . 0.0 110.867 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.71 97.74 8.08 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 178.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.19 169.96 9.23 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.729 -177.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.681 HG22 ' HG2' ' A' ' 59' ' ' GLN . 93.2 t -142.88 140.76 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 178.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.873 HD12 HD23 ' A' ' 58' ' ' LEU . 20.8 mt -96.02 113.32 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 178.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.437 HG13 ' CE2' ' A' ' 57' ' ' TYR . 45.2 t -73.66 122.04 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.21 -176.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -164.92 89.81 0.5 Allowed 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.426 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -88.6 141.3 28.64 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.056 -179.374 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.675 HG21 HD12 ' A' ' 33' ' ' ILE . 38.3 t -148.16 132.08 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.527 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 53.8 t -95.32 78.57 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.6 m -81.52 163.48 22.65 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 178.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 t -43.04 -85.06 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.329 0 O-C-N 121.825 -0.547 . . . . 0.0 111.582 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.401 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 0.5 OUTLIER -167.29 -63.15 0.01 OUTLIER Pre-proline 0 N--CA 1.514 2.768 0 CA-C-O 117.707 -1.14 . . . . 0.0 111.663 177.783 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.401 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 2.9 Cg_endo -59.76 -53.23 3.45 Favored 'Trans proline' 0 CA--C 1.564 1.999 0 CA-C-N 120.209 1.11 . . . . 0.0 112.446 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.468 ' HG3' HG23 ' A' ' 77' ' ' ILE . 3.0 Cg_endo -62.55 -164.4 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 120.55 0.833 . . . . 0.0 112.185 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -171.12 -166.69 0.49 Allowed 'General case' 0 N--CA 1.519 3.019 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.443 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.675 HD12 HG21 ' A' ' 25' ' ' VAL . 15.1 tt -97.96 165.45 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 81.1 mt -128.65 133.9 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.55 ' HB2' HG22 ' A' ' 42' ' ' VAL . 82.7 m95 -97.55 115.49 27.95 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -114.98 -172.72 2.18 Favored 'General case' 0 N--CA 1.505 2.3 0 CA-C-O 121.334 0.588 . . . . 0.0 111.295 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 9.0 t60 63.66 153.08 0.04 OUTLIER 'General case' 0 N--CA 1.51 2.563 0 CA-C-O 121.08 0.467 . . . . 0.0 110.468 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 26.1 tptt 55.28 53.63 9.76 Favored 'General case' 0 N--CA 1.515 2.796 0 O-C-N 121.732 -0.605 . . . . 0.0 110.783 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 133.34 -7.26 5.02 Favored Glycine 0 N--CA 1.496 2.651 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.229 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 56.4 89.61 0.04 OUTLIER 'General case' 0 N--CA 1.514 2.748 0 CA-C-N 118.902 1.351 . . . . 0.0 110.553 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 55.2 98.03 0.02 OUTLIER 'General case' 0 N--CA 1.514 2.77 0 O-C-N 121.766 -0.584 . . . . 0.0 110.775 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.55 HG22 ' HB2' ' A' ' 35' ' ' TRP . 5.7 m -73.05 -26.29 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.421 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.626 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.5 mm -58.44 -18.41 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.806 0 O-C-N 121.623 -0.673 . . . . 0.0 111.77 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.47 ' N ' HD12 ' A' ' 44' ' ' LEU . 10.4 mp -91.66 -23.02 19.96 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.527 -0.733 . . . . 0.0 111.133 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -98.9 -42.28 7.23 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.753 -0.592 . . . . 0.0 110.034 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt 48.05 56.91 6.65 Favored 'General case' 0 N--CA 1.509 2.499 0 CA-C-O 121.492 0.663 . . . . 0.0 111.892 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -50.9 170.14 0.04 OUTLIER 'General case' 0 N--CA 1.517 2.893 0 O-C-N 121.689 -0.632 . . . . 0.0 111.506 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 36.0 m -63.21 -19.5 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.64 0 O-C-N 122.054 -0.404 . . . . 0.0 111.985 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.1 ptp85 -109.42 0.16 19.23 Favored 'General case' 0 N--CA 1.506 2.349 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -99.33 106.1 18.16 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.35 -0.844 . . . . 0.0 110.562 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 74.5 mt -129.64 110.49 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.478 HG22 ' CD1' ' A' ' 58' ' ' LEU . 2.5 t -77.62 137.88 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.51 HD11 ' CG ' ' A' ' 59' ' ' GLN . 45.0 mt -89.97 167.44 12.8 Favored 'General case' 0 N--CA 1.505 2.321 0 CA-C-O 121.387 0.613 . . . . 0.0 112.01 -178.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.7 p -60.92 -22.41 64.33 Favored 'General case' 0 N--CA 1.51 2.554 0 O-C-N 122.137 -0.352 . . . . 0.0 111.229 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 35.5 p-10 -91.29 18.54 6.92 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.735 -0.603 . . . . 0.0 111.48 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.6 m120 67.48 33.21 5.3 Favored 'General case' 0 N--CA 1.516 2.86 0 O-C-N 121.544 -0.722 . . . . 0.0 111.999 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.437 ' CE2' HG13 ' A' ' 22' ' ' VAL . 4.1 m-85 -103.06 163.84 11.97 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 177.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.873 HD23 HD12 ' A' ' 21' ' ' ILE . 20.8 tp -120.11 100.6 7.3 Favored 'General case' 0 N--CA 1.516 2.859 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.968 -179.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.681 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -78.69 105.32 9.9 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.328 179.672 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.755 HD11 HD11 ' A' ' 21' ' ' ILE . 96.4 mt -97.47 102.81 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 177.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -67.55 118.17 10.49 Favored 'General case' 0 N--CA 1.506 2.33 0 CA-C-O 121.155 0.503 . . . . 0.0 111.221 -178.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.57 -39.14 2.85 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.582 HG23 HG21 ' A' ' 92' ' ' VAL . 2.8 tp 40.13 85.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.52 3.042 0 CA-C-O 122.023 0.916 . . . . 0.0 112.308 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.452 ' HB3' HG22 ' A' ' 66' ' ' THR . 28.2 mtpt -68.95 151.28 46.74 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 121.548 -0.72 . . . . 0.0 111.347 -178.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.619 ' HA ' HG13 ' A' ' 92' ' ' VAL . 0.1 OUTLIER -63.24 -17.99 63.06 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 122.15 -0.344 . . . . 0.0 110.956 179.023 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.452 HG22 ' HB3' ' A' ' 64' ' ' LYS . 10.0 t -90.98 -12.37 36.11 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.551 -0.718 . . . . 0.0 111.246 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.81 14.71 18.51 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.454 -0.779 . . . . 0.0 111.532 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.813 ' HB3' HG12 ' A' ' 92' ' ' VAL . 0.7 OUTLIER -97.41 148.07 23.56 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.416 -0.802 . . . . 0.0 109.946 179.674 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 169.52 -102.1 0.18 Allowed Glycine 0 N--CA 1.498 2.769 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.6 m -148.38 100.76 3.18 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 122.025 -0.691 . . . . 0.0 110.994 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -80.76 133.41 35.64 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.8 tpt180 -96.32 116.56 29.22 Favored 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.651 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 7.1 m -79.29 132.89 36.6 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -134.82 91.13 2.72 Favored 'General case' 0 N--CA 1.503 2.178 0 CA-C-N 118.719 0.69 . . . . 0.0 110.724 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.76 121.21 10.56 Favored Glycine 0 N--CA 1.501 3.03 0 N-CA-C 107.598 -2.201 . . . . 0.0 107.598 178.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 -136.29 139.23 42.49 Favored 'General case' 0 N--CA 1.503 2.188 0 CA-C-N 118.308 1.054 . . . . 0.0 113.581 -177.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.532 HD11 ' CG2' ' A' ' 2' ' ' VAL . 81.0 mt -122.41 139.54 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.34 177.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 37.1 mt -92.7 -43.13 9.23 Favored 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 121.113 -0.235 . . . . 0.0 110.775 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.34 -57.81 10.79 Favored 'General case' 0 N--CA 1.514 2.774 0 O-C-N 121.63 -0.669 . . . . 0.0 109.583 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 23.2 mtm180 -100.58 61.34 1.01 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 177.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -15.33 82.21 0.0 OUTLIER Glycine 1 N--CA 1.524 4.535 0 C-N-CA 124.961 1.267 . . . . 0.0 114.845 -178.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -116.85 144.7 44.2 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.5 pt -137.82 68.26 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 CA-C-O 121.197 0.522 . . . . 0.0 111.033 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -85.19 154.83 21.73 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -161.37 -177.92 6.31 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.797 -0.761 . . . . 0.0 112.035 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.5 tptp -169.17 166.07 10.87 Favored 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.544 ' O ' HG22 ' A' ' 9' ' ' THR . 4.4 p-10 -111.03 112.86 24.98 Favored 'General case' 0 N--CA 1.51 2.544 0 CA-C-O 121.071 0.462 . . . . 0.0 110.46 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.57 ' N ' HD12 ' A' ' 88' ' ' ILE . 2.2 mp -101.07 118.99 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -83.52 127.32 33.63 Favored 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.498 HG13 HE21 ' A' ' 11' ' ' GLN . 40.7 t -121.11 132.7 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 O-C-N 121.808 -0.558 . . . . 0.0 109.905 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 72.1 mt -126.05 146.34 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.813 HG12 ' HB3' ' A' ' 68' ' ' GLU . 9.8 p . . . . . 0 N--CA 1.501 2.103 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.714 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 53.5 p90 . . . . . 0 N--CA 1.496 1.851 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 1.097 HG13 HD11 ' A' ' 77' ' ' ILE . 14.5 m -136.9 93.0 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 CA-C-O 121.335 0.588 . . . . 0.0 109.464 178.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.514 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 0.7 OUTLIER -87.8 106.81 18.33 Favored 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.907 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -67.13 119.9 12.83 Favored 'General case' 0 N--CA 1.506 2.346 0 CA-C-O 120.812 0.339 . . . . 0.0 110.738 -178.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.408 ' HG2' HG23 ' A' ' 26' ' ' VAL . 3.2 pttt -135.13 163.84 29.03 Favored 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 121.88 0.847 . . . . 0.0 112.26 -179.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.4 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.3 OUTLIER 28.59 95.58 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.134 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 179.133 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.429 ' HB2' ' HA ' ' A' ' 23' ' ' CYS . . . -164.82 84.0 1.16 Allowed Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.953 -0.467 . . . . 0.0 111.154 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -65.2 106.04 0.77 Allowed 'Trans proline' 0 N--CA 1.492 1.392 0 N-CA-C 108.419 -1.416 . . . . 0.0 108.419 177.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.558 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.2 OUTLIER -51.04 -65.64 0.88 Allowed Pre-proline 0 N--CA 1.508 2.45 0 CA-C-O 116.91 -1.519 . . . . 0.0 112.594 -177.02 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.488 ' HD3' ' OG1' ' A' ' 9' ' ' THR . 1.4 Cg_endo -75.1 94.55 0.96 Allowed 'Trans proline' 0 N--CA 1.495 1.59 0 CA-C-N 121.182 1.458 . . . . 0.0 111.019 178.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.434 HE21 HG13 ' A' ' 90' ' ' VAL . 16.1 pt20 -99.96 179.35 4.53 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 120.949 -1.095 . . . . 0.0 110.276 178.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -160.6 121.75 2.99 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.825 -0.547 . . . . 0.0 111.82 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -118.95 -170.95 2.01 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.929 -0.482 . . . . 0.0 109.988 178.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.1 tttp -102.33 135.95 43.04 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.505 0.669 . . . . 0.0 111.339 -178.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -60.66 112.42 2.0 Allowed 'General case' 0 N--CA 1.508 2.47 0 O-C-N 121.929 -0.482 . . . . 0.0 110.533 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.02 23.89 16.42 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.417 ' O ' HG22 ' A' ' 63' ' ' ILE . 18.3 tt0 -118.4 165.79 13.44 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-N 118.397 1.099 . . . . 0.0 110.676 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -81.72 98.98 8.68 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 177.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.03 166.67 10.92 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 120.24 -0.584 . . . . 0.0 112.116 -177.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.679 HG22 ' HG2' ' A' ' 59' ' ' GLN . 89.6 t -141.19 139.7 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 178.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.772 HD12 HD23 ' A' ' 58' ' ' LEU . 42.7 mt -95.38 119.11 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 106.563 -1.644 . . . . 0.0 106.563 178.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.412 ' HA ' ' CE2' ' A' ' 57' ' ' TYR . 54.1 t -78.59 118.87 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 CA-C-O 121.415 0.626 . . . . 0.0 110.922 -176.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.429 ' HA ' ' HB2' ' A' ' 7' ' ' ALA . 1.6 t -159.91 91.56 0.97 Allowed 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.4 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -90.12 138.29 31.64 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.103 -179.051 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.708 HG21 HD12 ' A' ' 33' ' ' ILE . 43.6 t -147.51 124.17 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.514 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 29.0 t -85.51 75.01 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.603 ' HA ' HG12 ' A' ' 2' ' ' VAL . 3.4 m -75.48 158.22 32.9 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.5 t -40.45 -77.97 0.02 OUTLIER 'General case' 0 N--CA 1.525 3.323 0 CA-C-N 118.158 0.435 . . . . 0.0 111.597 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.404 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 1.2 mt -173.27 -63.47 0.0 OUTLIER Pre-proline 0 N--CA 1.515 2.789 0 CA-C-O 117.719 -1.134 . . . . 0.0 111.064 177.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.404 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 2.9 Cg_endo -60.13 -53.35 3.13 Favored 'Trans proline' 0 CA--C 1.564 1.98 0 CA-C-N 120.105 1.073 . . . . 0.0 112.473 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.52 ' CB ' ' HA ' ' A' ' 77' ' ' ILE . 3.0 Cg_exo -62.11 -164.83 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 120.503 0.802 . . . . 0.0 112.558 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -170.34 -167.37 0.61 Allowed 'General case' 0 N--CA 1.519 3.003 0 O-C-N 121.921 -0.487 . . . . 0.0 110.434 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.708 HD12 HG21 ' A' ' 25' ' ' VAL . 17.8 tt -103.59 139.42 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.539 ' N ' HD12 ' A' ' 34' ' ' ILE . 4.0 mp -102.13 130.57 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.528 ' HB2' HG22 ' A' ' 42' ' ' VAL . 72.3 m95 -92.68 114.78 27.43 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt -115.04 -175.17 2.63 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.903 -0.498 . . . . 0.0 111.035 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 60.99 150.22 0.02 OUTLIER 'General case' 0 N--CA 1.511 2.596 0 CA-C-O 121.264 0.554 . . . . 0.0 110.812 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? 54.96 33.97 21.29 Favored 'General case' 0 N--CA 1.517 2.903 0 O-C-N 121.483 -0.761 . . . . 0.0 110.536 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 159.93 -25.92 0.32 Allowed Glycine 0 N--CA 1.491 2.323 0 C-N-CA 120.266 -0.968 . . . . 0.0 110.906 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.47 97.22 0.02 OUTLIER 'General case' 0 N--CA 1.516 2.837 0 O-C-N 121.238 -1.154 . . . . 0.0 110.0 -179.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 54.3 75.76 0.27 Allowed 'General case' 0 N--CA 1.513 2.721 0 O-C-N 121.675 -0.641 . . . . 0.0 110.376 -179.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.528 HG22 ' HB2' ' A' ' 35' ' ' TRP . 8.7 m -67.53 -38.93 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 O-C-N 121.793 -0.567 . . . . 0.0 109.739 -178.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.579 HG12 HG21 ' A' ' 52' ' ' VAL . 58.5 mt -60.94 -17.48 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.718 0 O-C-N 121.964 -0.46 . . . . 0.0 111.423 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.476 ' N ' HD12 ' A' ' 44' ' ' LEU . 10.1 mp -90.08 -23.64 21.35 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.473 -0.767 . . . . 0.0 110.451 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -99.06 -35.45 10.03 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.721 -0.612 . . . . 0.0 109.544 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.5 mmmt 49.27 54.85 10.25 Favored 'General case' 0 N--CA 1.506 2.351 0 CA-C-O 121.359 0.6 . . . . 0.0 111.978 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.0 167.24 0.12 Allowed 'General case' 0 N--CA 1.517 2.888 0 O-C-N 121.895 -0.503 . . . . 0.0 110.729 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.9 m -60.81 -19.38 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.741 0 O-C-N 121.874 -0.516 . . . . 0.0 111.843 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 25.6 ptt-85 -118.52 45.41 2.04 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.676 -0.64 . . . . 0.0 111.915 -179.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -146.51 104.84 3.8 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.604 -0.685 . . . . 0.0 109.752 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 76.1 mt -129.87 108.32 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.579 HG21 HG12 ' A' ' 43' ' ' ILE . 2.7 t -74.65 140.88 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.422 HD11 ' OE1' ' A' ' 59' ' ' GLN . 17.0 mt -95.49 169.59 9.95 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.821 -0.549 . . . . 0.0 111.899 -178.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.6 p -61.88 -23.11 66.09 Favored 'General case' 0 N--CA 1.509 2.521 0 O-C-N 122.183 -0.323 . . . . 0.0 111.007 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 44.6 p-10 -88.19 15.15 7.93 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.768 -0.582 . . . . 0.0 111.412 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.424 ' HB3' HG21 ' A' ' 33' ' ' ILE . 7.6 m120 68.13 33.47 4.43 Favored 'General case' 0 N--CA 1.516 2.834 0 O-C-N 121.577 -0.702 . . . . 0.0 112.023 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.412 ' CE2' ' HA ' ' A' ' 22' ' ' VAL . 3.8 m-85 -102.85 166.83 10.25 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.772 HD23 HD12 ' A' ' 21' ' ' ILE . 19.2 tp -120.83 98.03 5.81 Favored 'General case' 0 N--CA 1.519 2.991 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.666 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.679 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.7 OUTLIER -75.65 101.11 4.85 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.917 179.464 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.599 HD11 HD11 ' A' ' 21' ' ' ILE . 95.5 mt -92.12 115.37 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 177.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -77.58 112.23 14.16 Favored 'General case' 0 N--CA 1.505 2.298 0 CA-C-O 121.521 0.677 . . . . 0.0 111.467 -178.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 100.16 -36.44 4.12 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 179.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.587 ' CG1' HG21 ' A' ' 92' ' ' VAL . 2.6 tp 41.77 74.47 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.519 3.003 0 CA-C-O 122.249 1.024 . . . . 0.0 112.454 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.9 mmtp -62.8 158.6 18.39 Favored 'General case' 0 N--CA 1.509 2.483 0 O-C-N 121.488 -0.758 . . . . 0.0 112.336 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.3 tptt -61.97 -24.55 67.08 Favored 'General case' 0 N--CA 1.51 2.557 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.833 178.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.3 t -83.61 -15.1 50.31 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.773 -0.579 . . . . 0.0 111.109 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -94.12 11.09 31.22 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.635 -0.666 . . . . 0.0 111.595 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.512 ' HB3' HG12 ' A' ' 92' ' ' VAL . 9.1 pt-20 -98.74 137.3 37.55 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.275 -0.891 . . . . 0.0 109.593 179.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 174.7 -106.37 0.22 Allowed Glycine 0 N--CA 1.499 2.886 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.3 m -143.33 102.2 3.93 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.946 -0.737 . . . . 0.0 110.901 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -83.61 132.55 34.89 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.7 tpp85 -96.42 118.18 32.4 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.459 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.692 ' HB3' HD11 ' A' ' 33' ' ' ILE . 9.0 m -81.04 126.4 31.38 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 177.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -125.26 87.28 2.68 Favored 'General case' 0 N--CA 1.503 2.178 0 CA-C-N 118.605 0.639 . . . . 0.0 110.681 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.83 101.0 0.6 Allowed Glycine 0 N--CA 1.501 3.021 0 N-CA-C 107.921 -2.071 . . . . 0.0 107.921 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 30.3 ttp85 -112.72 135.4 53.51 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -176.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 1.097 HD11 HG13 ' A' ' 2' ' ' VAL . 95.8 mt -117.35 135.98 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 18.9 mt -90.71 -45.74 8.68 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.338 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.29 -58.89 6.49 Favored 'General case' 0 N--CA 1.516 2.87 0 O-C-N 121.574 -0.704 . . . . 0.0 109.652 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 20.9 mtt180 -96.87 58.26 1.6 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 177.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -15.02 82.3 0.0 OUTLIER Glycine 1 N--CA 1.524 4.541 0 C-N-CA 125.016 1.293 . . . . 0.0 114.66 -178.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -127.15 149.97 49.72 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 122.312 -0.522 . . . . 0.0 109.676 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.4 pt -137.25 74.17 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 CA-C-O 121.385 0.612 . . . . 0.0 110.834 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -82.31 151.04 26.91 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -164.51 177.64 7.99 Favored 'General case' 0 N--CA 1.503 2.22 0 C-N-CA 119.861 -0.736 . . . . 0.0 112.744 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.48 ' HG3' HD11 ' A' ' 88' ' ' ILE . 1.3 pttt -167.42 163.6 14.99 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 177.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.558 ' O ' HG22 ' A' ' 9' ' ' THR . 10.2 p-10 -99.79 119.34 38.01 Favored 'General case' 0 N--CA 1.511 2.618 0 O-C-N 121.884 -0.51 . . . . 0.0 111.698 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.579 ' N ' HD12 ' A' ' 88' ' ' ILE . 3.1 mp -104.17 118.47 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -84.06 125.65 32.31 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.434 HG13 HE21 ' A' ' 11' ' ' GLN . 47.6 t -119.26 126.08 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 O-C-N 121.719 -0.613 . . . . 0.0 109.792 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 51.1 mt -116.4 157.97 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.587 HG21 ' CG1' ' A' ' 63' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.5 2.053 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.394 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 45.0 p90 . . . . . 0 N--CA 1.499 2.005 0 CA-C-O 120.779 0.323 . . . . 0.0 110.413 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.694 ' CG2' HD11 ' A' ' 77' ' ' ILE . 37.6 t -146.1 105.34 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.49 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 1.6 mmm -108.43 111.54 23.49 Favored 'General case' 0 N--CA 1.508 2.468 0 C-N-CA 120.144 -0.622 . . . . 0.0 109.821 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -67.65 119.87 13.11 Favored 'General case' 0 N--CA 1.505 2.319 0 CA-C-O 120.786 0.327 . . . . 0.0 110.783 -178.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.462 ' HG2' HG23 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -132.56 160.29 36.99 Favored 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 121.553 0.692 . . . . 0.0 111.114 -179.821 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.415 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.4 OUTLIER 31.41 58.81 0.29 Allowed 'General case' 0 N--CA 1.519 2.994 0 C-N-CA 124.148 0.979 . . . . 0.0 113.561 179.411 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -121.37 79.14 36.43 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.697 -0.627 . . . . 0.0 110.74 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -65.75 114.12 2.82 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 N-CA-C 109.189 -1.12 . . . . 0.0 109.189 178.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.581 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.2 OUTLIER -67.75 -66.76 1.02 Allowed Pre-proline 0 N--CA 1.498 1.956 0 CA-C-O 117.059 -1.448 . . . . 0.0 111.208 -178.335 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.485 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.4 Cg_endo -72.17 89.22 0.8 Allowed 'Trans proline' 0 N--CA 1.498 1.763 0 CA-C-N 121.108 1.432 . . . . 0.0 111.199 178.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.421 HE21 HG13 ' A' ' 90' ' ' VAL . 10.5 pt20 -100.36 171.75 7.57 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 120.715 -1.24 . . . . 0.0 110.088 178.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -154.4 127.44 8.31 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.816 -0.552 . . . . 0.0 111.646 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -125.73 -164.0 1.26 Allowed 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.36 142.63 51.13 Favored 'General case' 0 N--CA 1.513 2.694 0 CA-C-O 121.856 0.836 . . . . 0.0 111.455 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -56.26 141.86 39.73 Favored 'General case' 0 N--CA 1.51 2.536 0 O-C-N 121.831 -0.543 . . . . 0.0 111.082 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.15 12.73 72.38 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -104.87 156.09 18.33 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 119.116 1.458 . . . . 0.0 111.34 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -81.12 95.45 6.88 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 176.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.15 166.34 11.46 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.996 -0.682 . . . . 0.0 112.203 -176.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.713 HG22 ' HG2' ' A' ' 59' ' ' GLN . 94.3 t -140.04 140.05 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 178.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.816 HD12 HD23 ' A' ' 58' ' ' LEU . 47.9 mt -94.87 117.0 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 178.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.497 HG13 ' CE2' ' A' ' 57' ' ' TYR . 39.2 t -77.08 119.48 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 CA-C-O 121.431 0.634 . . . . 0.0 110.98 -176.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.4 t -161.34 92.03 0.88 Allowed 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.415 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.2 OUTLIER -92.09 140.59 29.49 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.905 -0.718 . . . . 0.0 109.314 -179.131 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.687 HG21 HD12 ' A' ' 33' ' ' ILE . 43.7 t -146.79 128.19 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.49 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 45.9 t -89.42 74.09 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.0 m -78.44 161.79 26.86 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 178.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 t -41.96 -78.29 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.199 0 CA-C-N 118.191 0.451 . . . . 0.0 111.566 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -174.0 -62.54 0.0 OUTLIER Pre-proline 0 N--CA 1.515 2.809 0 CA-C-O 117.873 -1.06 . . . . 0.0 111.498 177.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.68 -53.44 3.31 Favored 'Trans proline' 0 CA--C 1.562 1.913 0 CA-C-N 119.845 0.981 . . . . 0.0 112.519 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.498 ' HG3' HG23 ' A' ' 77' ' ' ILE . 3.3 Cg_exo -61.4 -165.28 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 120.535 0.823 . . . . 0.0 112.61 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -170.35 -170.13 0.92 Allowed 'General case' 0 N--CA 1.521 3.114 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.717 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.687 HD12 HG21 ' A' ' 25' ' ' VAL . 18.3 tt -100.92 140.22 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.535 ' N ' HD12 ' A' ' 34' ' ' ILE . 5.1 mp -102.91 128.36 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.009 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.527 ' HB2' HG22 ' A' ' 42' ' ' VAL . 73.6 m95 -90.56 112.88 24.73 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.0 ttpt -114.25 -176.32 2.87 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.783 -0.573 . . . . 0.0 111.059 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 62.06 153.5 0.03 OUTLIER 'General case' 0 N--CA 1.512 2.641 0 O-C-N 121.915 -0.491 . . . . 0.0 110.788 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.5 tppt? 53.4 37.03 24.54 Favored 'General case' 0 N--CA 1.516 2.861 0 O-C-N 121.677 -0.64 . . . . 0.0 110.578 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 154.73 -23.77 0.63 Allowed Glycine 0 N--CA 1.488 2.112 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.34 98.45 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.689 0 O-C-N 121.374 -1.074 . . . . 0.0 110.458 -179.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 54.96 79.34 0.15 Allowed 'General case' 0 N--CA 1.513 2.711 0 O-C-N 121.721 -0.612 . . . . 0.0 110.298 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.527 HG22 ' HB2' ' A' ' 35' ' ' TRP . 6.4 m -70.97 -36.95 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 O-C-N 121.79 -0.569 . . . . 0.0 109.791 -178.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 77.3 mt -60.24 -17.61 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.855 0 O-C-N 122.071 -0.393 . . . . 0.0 111.418 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.463 ' N ' HD12 ' A' ' 44' ' ' LEU . 10.7 mp -90.16 -23.65 21.27 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.511 -0.743 . . . . 0.0 110.617 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.403 ' HG2' ' HA ' ' A' ' 42' ' ' VAL . 45.0 pttt -99.15 -36.91 9.52 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.719 -0.613 . . . . 0.0 109.572 178.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.7 mmmt 47.97 56.72 6.87 Favored 'General case' 0 N--CA 1.508 2.426 0 CA-C-O 121.503 0.668 . . . . 0.0 111.88 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.67 168.45 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.811 0 O-C-N 121.863 -0.523 . . . . 0.0 111.638 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.9 m -59.91 -20.04 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.68 0 O-C-N 121.923 -0.485 . . . . 0.0 112.268 -178.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.9 ptp85 -114.68 4.37 15.03 Favored 'General case' 0 N--CA 1.507 2.42 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -102.32 111.3 23.53 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.143 -0.973 . . . . 0.0 110.916 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 82.6 mt -132.87 105.96 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.531 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.2 t -73.39 136.73 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.417 HD11 ' CG ' ' A' ' 59' ' ' GLN . 14.4 mt -90.22 166.83 13.13 Favored 'General case' 0 N--CA 1.507 2.386 0 CA-C-O 121.319 0.58 . . . . 0.0 111.845 -178.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 92.9 p -60.87 -21.7 63.54 Favored 'General case' 0 N--CA 1.509 2.487 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.249 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 42.0 p-10 -90.32 17.92 6.67 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.629 -0.67 . . . . 0.0 111.475 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.416 ' HB3' HG21 ' A' ' 33' ' ' ILE . 4.5 m120 68.26 30.72 5.49 Favored 'General case' 0 N--CA 1.518 2.948 0 O-C-N 121.605 -0.685 . . . . 0.0 112.051 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.497 ' CE2' HG13 ' A' ' 22' ' ' VAL . 3.6 m-85 -101.71 165.2 11.34 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.816 HD23 HD12 ' A' ' 21' ' ' ILE . 17.1 tp -120.06 102.61 8.65 Favored 'General case' 0 N--CA 1.518 2.942 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.751 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.713 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.7 OUTLIER -80.0 103.42 9.87 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.368 179.653 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.522 HD11 HD11 ' A' ' 21' ' ' ILE . 95.1 mt -95.89 104.7 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 177.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -68.01 113.22 5.51 Favored 'General case' 0 N--CA 1.505 2.289 0 CA-C-O 121.07 0.462 . . . . 0.0 110.756 -178.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.402 ' O ' HG22 ' A' ' 63' ' ' ILE . . . 100.92 -40.17 2.51 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 179.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.55 ' CG1' HG21 ' A' ' 92' ' ' VAL . 1.7 tp 42.91 72.14 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.961 0 CA-C-O 122.228 1.013 . . . . 0.0 112.446 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 59.9 mttt -62.33 158.62 16.95 Favored 'General case' 0 N--CA 1.51 2.527 0 O-C-N 121.63 -0.669 . . . . 0.0 112.154 -178.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.5 mtmt -62.84 -23.65 67.39 Favored 'General case' 0 N--CA 1.508 2.473 0 O-C-N 122.134 -0.354 . . . . 0.0 110.879 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.0 p -80.77 -17.28 51.44 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.741 -0.6 . . . . 0.0 110.774 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -94.23 10.02 35.7 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.701 -0.624 . . . . 0.0 111.725 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.542 ' HB3' HG12 ' A' ' 92' ' ' VAL . 8.2 pt-20 -98.18 144.57 27.49 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-N 119.209 0.913 . . . . 0.0 110.156 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 167.94 -102.93 0.19 Allowed Glycine 0 N--CA 1.499 2.878 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.7 m -145.98 102.87 3.69 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 122.123 -0.634 . . . . 0.0 111.122 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -83.97 133.73 34.68 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -95.41 120.68 36.07 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.405 -179.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.681 ' HB3' HD11 ' A' ' 33' ' ' ILE . 7.3 m -85.21 122.57 29.6 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 177.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -125.06 88.39 2.88 Favored 'General case' 0 N--CA 1.505 2.293 0 CA-C-N 119.021 0.828 . . . . 0.0 111.061 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.39 110.52 3.46 Favored Glycine 0 N--CA 1.502 3.071 0 N-CA-C 107.911 -2.076 . . . . 0.0 107.911 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.7 ttp85 -124.92 138.9 54.23 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -177.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.694 HD11 ' CG2' ' A' ' 2' ' ' VAL . 84.2 mt -119.6 137.84 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.273 177.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 46.9 mt -92.84 -45.67 7.89 Favored 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.865 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.48 -56.95 15.47 Favored 'General case' 0 N--CA 1.515 2.813 0 O-C-N 121.538 -0.726 . . . . 0.0 109.819 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 23.1 mtp85 -102.06 61.01 0.86 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 177.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -14.81 81.56 0.0 OUTLIER Glycine 1 N--CA 1.526 4.673 0 C-N-CA 125.07 1.319 . . . . 0.0 114.9 -178.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -117.81 143.93 45.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 122.273 -0.545 . . . . 0.0 109.718 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.1 pt -137.08 73.24 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.345 0 CA-C-O 121.319 0.58 . . . . 0.0 111.153 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -90.13 147.61 23.5 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.422 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 30.7 p90 -157.24 -177.25 6.46 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 119.497 -0.881 . . . . 0.0 112.669 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 9.6 tptt -168.4 165.36 12.73 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.581 ' O ' HG22 ' A' ' 9' ' ' THR . 7.5 p-10 -110.31 108.74 18.92 Favored 'General case' 0 N--CA 1.509 2.494 0 CA-C-O 120.974 0.416 . . . . 0.0 110.245 178.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.588 ' N ' HD12 ' A' ' 88' ' ' ILE . 2.2 mp -92.76 113.78 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -80.68 105.08 11.65 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.421 HG13 HE21 ' A' ' 11' ' ' GLN . 39.3 t -99.97 136.5 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.156 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 63.4 mt -126.92 156.95 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.55 HG21 ' CG1' ' A' ' 63' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.498 1.948 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.594 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 48.4 p90 . . . . . 0 N--CA 1.497 1.921 0 CA-C-O 120.636 0.255 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.692 ' CG2' HD11 ' A' ' 77' ' ' ILE . 47.9 t -146.72 108.46 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.499 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 6.3 mmt -116.46 113.37 22.74 Favored 'General case' 0 N--CA 1.507 2.413 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.416 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -70.31 116.5 10.73 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 122.103 -0.373 . . . . 0.0 111.1 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt -119.9 155.98 31.65 Favored 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.423 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.1 OUTLIER 44.48 81.24 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.747 0 C-N-CA 122.718 0.407 . . . . 0.0 111.517 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -126.35 56.86 17.8 Favored Pre-proline 0 N--CA 1.497 1.907 0 O-C-N 121.64 -0.663 . . . . 0.0 112.425 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.02 90.67 0.16 Allowed 'Trans proline' 0 N--CA 1.496 1.62 0 N-CA-C 107.983 -1.583 . . . . 0.0 107.983 176.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.551 ' OG1' ' HD3' ' A' ' 10' ' ' PRO . 0.5 OUTLIER -52.93 -54.87 39.19 Favored Pre-proline 0 N--CA 1.503 2.194 0 CA-C-O 117.119 -1.419 . . . . 0.0 113.575 -176.268 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.551 ' HD3' ' OG1' ' A' ' 9' ' ' THR . 1.6 Cg_endo -80.27 92.84 1.07 Allowed 'Trans proline' 0 CA--C 1.549 1.242 0 CA-C-N 120.892 1.354 . . . . 0.0 111.584 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.544 HE21 HG13 ' A' ' 90' ' ' VAL . 16.7 pt20 -100.99 171.04 7.88 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.088 -1.007 . . . . 0.0 110.197 178.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -156.76 118.1 3.77 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.635 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -114.47 -170.0 1.64 Allowed 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.901 -0.499 . . . . 0.0 110.024 179.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -101.79 139.71 37.07 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.517 0.675 . . . . 0.0 111.452 -178.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -59.87 119.03 6.93 Favored 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 121.015 0.436 . . . . 0.0 110.842 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.69 23.49 46.26 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -114.57 164.31 14.18 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 118.621 1.211 . . . . 0.0 110.907 -179.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -79.72 98.88 7.17 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 177.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.78 170.64 8.41 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 120.218 -0.593 . . . . 0.0 111.731 -177.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.692 HG22 ' HG2' ' A' ' 59' ' ' GLN . 87.5 t -143.47 141.11 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 178.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.923 HD11 HD11 ' A' ' 60' ' ' ILE . 18.9 mt -96.11 115.25 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 178.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.414 HG13 ' CE2' ' A' ' 57' ' ' TYR . 46.0 t -74.94 122.0 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 CA-C-O 121.371 0.605 . . . . 0.0 111.205 -176.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -164.94 88.6 0.47 Allowed 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.423 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -87.79 145.01 26.3 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 119.785 -0.766 . . . . 0.0 108.995 -179.612 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.649 HG21 HD12 ' A' ' 33' ' ' ILE . 39.9 t -151.64 137.17 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.499 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 62.2 t -99.49 78.45 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 108.174 -1.046 . . . . 0.0 108.174 178.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.2 m -80.1 163.13 24.38 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 178.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.8 t -42.11 -79.83 0.01 OUTLIER 'General case' 0 N--CA 1.524 3.237 0 O-C-N 121.87 -0.519 . . . . 0.0 111.595 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.418 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 0.2 OUTLIER -171.13 -63.29 0.0 OUTLIER Pre-proline 0 N--CA 1.514 2.768 0 CA-C-O 117.715 -1.136 . . . . 0.0 111.593 177.675 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.418 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 2.8 Cg_endo -60.26 -53.21 3.17 Favored 'Trans proline' 0 CA--C 1.562 1.914 0 CA-C-N 120.045 1.052 . . . . 0.0 112.812 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.502 ' HG3' HG23 ' A' ' 77' ' ' ILE . 3.0 Cg_endo -62.04 -163.99 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 120.456 0.771 . . . . 0.0 112.716 -178.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -170.53 -168.12 0.67 Allowed 'General case' 0 N--CA 1.518 2.931 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.134 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.649 HD12 HG21 ' A' ' 25' ' ' VAL . 15.4 tt -100.24 155.28 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.529 ' N ' HD12 ' A' ' 34' ' ' ILE . 4.7 mp -117.65 132.35 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.577 ' CG ' HD22 ' A' ' 58' ' ' LEU . 79.4 m95 -94.54 104.67 16.62 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.2 tttt -105.1 -171.99 2.02 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.192 0.52 . . . . 0.0 110.609 -178.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 65.64 167.19 0.19 Allowed 'General case' 0 N--CA 1.511 2.593 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.53 26.63 11.2 Favored 'General case' 0 N--CA 1.515 2.82 0 O-C-N 121.68 -0.637 . . . . 0.0 111.154 -178.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.34 40.58 0.43 Allowed Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 51.84 -161.55 0.09 Allowed 'General case' 0 N--CA 1.516 2.875 0 O-C-N 121.576 -0.955 . . . . 0.0 110.871 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -60.33 111.94 1.75 Allowed 'General case' 0 N--CA 1.513 2.711 0 O-C-N 121.644 -0.66 . . . . 0.0 110.109 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.563 HG22 ' HB2' ' A' ' 35' ' ' TRP . 8.5 m -67.64 -27.69 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.461 0 O-C-N 122.057 -0.402 . . . . 0.0 110.605 -178.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 57.7 mt -59.21 -17.51 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.796 0 O-C-N 121.551 -0.718 . . . . 0.0 111.546 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.499 ' N ' HD12 ' A' ' 44' ' ' LEU . 8.8 mp -92.13 -21.82 20.21 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.491 -0.756 . . . . 0.0 111.122 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 39.9 pttt -97.25 -38.55 9.64 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.54 -0.725 . . . . 0.0 109.584 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.8 mmmt 46.31 55.05 7.77 Favored 'General case' 0 N--CA 1.51 2.54 0 CA-C-O 121.533 0.682 . . . . 0.0 112.116 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.05 169.86 0.09 Allowed 'General case' 0 N--CA 1.514 2.761 0 O-C-N 121.734 -0.604 . . . . 0.0 110.819 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.4 m -60.79 -19.57 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.621 0 O-C-N 121.965 -0.459 . . . . 0.0 111.664 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 8.9 ptp85 -119.32 46.82 1.81 Allowed 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.662 -0.649 . . . . 0.0 112.174 -178.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -145.62 99.21 3.25 Favored 'General case' 0 N--CA 1.508 2.431 0 O-C-N 121.556 -0.715 . . . . 0.0 110.081 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.485 ' N ' HD12 ' A' ' 51' ' ' ILE . 5.3 mp -125.8 114.44 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.509 HG22 ' CD1' ' A' ' 58' ' ' LEU . 2.5 t -79.99 131.69 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.9 mt -82.1 163.97 21.66 Favored 'General case' 0 N--CA 1.507 2.409 0 CA-C-O 121.328 0.585 . . . . 0.0 111.774 -178.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 92.4 p -60.4 -20.2 58.81 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 122.171 -0.331 . . . . 0.0 111.221 179.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 48.7 p-10 -91.33 19.23 6.18 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.609 -0.682 . . . . 0.0 111.389 179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.9 m120 67.23 32.17 6.19 Favored 'General case' 0 N--CA 1.516 2.835 0 O-C-N 121.613 -0.68 . . . . 0.0 112.401 178.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.414 ' CE2' HG13 ' A' ' 22' ' ' VAL . 4.0 m-85 -103.39 166.61 10.32 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.914 HD23 HD12 ' A' ' 21' ' ' ILE . 19.7 tp -121.72 97.99 5.75 Favored 'General case' 0 N--CA 1.515 2.791 0 C-N-CA 119.407 -0.917 . . . . 0.0 111.748 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.692 ' HG2' HG22 ' A' ' 20' ' ' VAL . 1.3 mt-30 -74.91 105.44 5.94 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.861 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.923 HD11 HD11 ' A' ' 21' ' ' ILE . 97.0 mt -96.44 112.1 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 178.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -73.1 112.66 9.35 Favored 'General case' 0 N--CA 1.506 2.336 0 CA-C-O 121.384 0.611 . . . . 0.0 111.423 -177.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.65 -36.08 4.15 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 178.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.506 HG23 HG21 ' A' ' 92' ' ' VAL . 1.7 tp 41.97 69.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.808 0 CA-C-O 122.185 0.993 . . . . 0.0 112.379 -178.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 55.3 mttt -57.55 158.9 5.42 Favored 'General case' 0 N--CA 1.51 2.56 0 O-C-N 121.615 -0.678 . . . . 0.0 112.209 -178.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 45.4 tttt -62.33 -23.63 66.88 Favored 'General case' 0 N--CA 1.508 2.452 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.895 178.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.7 t -83.15 -15.85 49.03 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.794 -0.566 . . . . 0.0 111.184 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -93.95 9.57 36.92 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.714 -0.616 . . . . 0.0 111.653 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -98.45 142.63 29.83 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.33 -0.856 . . . . 0.0 109.626 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 168.0 -103.81 0.2 Allowed Glycine 0 N--CA 1.498 2.815 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.4 m -145.93 102.78 3.69 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.974 -0.721 . . . . 0.0 111.21 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.4 ' CG ' HD13 ' A' ' 21' ' ' ILE . 24.9 m-85 -83.91 135.28 34.55 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.8 ttt85 -97.51 117.64 32.22 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.103 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.2 m -80.47 133.11 35.81 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 177.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -134.59 91.33 2.77 Favored 'General case' 0 N--CA 1.505 2.297 0 CA-C-N 118.686 0.676 . . . . 0.0 110.396 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.47 118.83 8.78 Favored Glycine 0 N--CA 1.503 3.141 0 N-CA-C 107.746 -2.142 . . . . 0.0 107.746 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.1 ttm180 -132.14 138.79 48.19 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -177.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.692 HD11 ' CG2' ' A' ' 2' ' ' VAL . 87.4 mt -118.78 138.12 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-N 114.968 -1.015 . . . . 0.0 108.33 177.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.3 mt -92.88 -39.4 11.2 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.889 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.1 -56.23 14.22 Favored 'General case' 0 N--CA 1.512 2.673 0 O-C-N 121.7 -0.625 . . . . 0.0 109.383 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 57.9 mtt180 -103.7 63.39 0.78 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 177.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -14.07 80.95 0.0 OUTLIER Glycine 1 N--CA 1.526 4.659 0 C-N-CA 125.14 1.353 . . . . 0.0 114.714 -178.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -112.6 146.62 38.26 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.9 pt -140.75 63.2 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.151 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -79.17 157.89 27.79 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 178.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -162.42 -175.21 4.4 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 119.684 -0.806 . . . . 0.0 112.715 -179.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.4 tptt -171.1 167.5 7.12 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.519 ' O ' HG22 ' A' ' 9' ' ' THR . 2.7 p-10 -115.37 108.09 16.07 Favored 'General case' 0 N--CA 1.513 2.723 0 O-C-N 121.844 -0.535 . . . . 0.0 110.222 178.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.606 ' N ' HD12 ' A' ' 88' ' ' ILE . 2.4 mp -96.16 115.71 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -84.63 111.02 19.17 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.544 HG13 HE21 ' A' ' 11' ' ' GLN . 42.5 t -105.48 138.05 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.917 -0.489 . . . . 0.0 110.291 -179.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 82.3 mt -128.23 157.31 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.506 HG21 HG23 ' A' ' 63' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.916 0 CA-C-O 118.062 -0.971 . . . . 0.0 110.458 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 38.4 p90 . . . . . 0 N--CA 1.5 2.06 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.705 ' CG2' HD11 ' A' ' 77' ' ' ILE . 47.2 t -148.8 105.35 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.332 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.542 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 6.5 mmt -110.27 110.9 21.89 Favored 'General case' 0 N--CA 1.506 2.348 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.18 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -71.24 113.71 8.56 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 122.086 -0.384 . . . . 0.0 110.239 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.6 ptpt -129.03 163.7 24.83 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 122.013 0.911 . . . . 0.0 112.301 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 29.69 95.49 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.014 0 C-N-CA 124.654 1.182 . . . . 0.0 114.185 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.403 ' HB2' ' HA ' ' A' ' 23' ' ' CYS . . . -164.47 84.67 1.19 Allowed Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.8 -0.562 . . . . 0.0 111.263 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -66.17 104.38 0.72 Allowed 'Trans proline' 0 N--CA 1.49 1.309 0 N-CA-C 108.288 -1.466 . . . . 0.0 108.288 177.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.548 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.2 OUTLIER -50.61 -66.01 0.76 Allowed Pre-proline 0 N--CA 1.51 2.56 0 CA-C-O 116.932 -1.509 . . . . 0.0 112.54 -176.973 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.485 ' HD3' ' OG1' ' A' ' 9' ' ' THR . 1.6 Cg_endo -73.99 94.5 0.88 Allowed 'Trans proline' 0 N--CA 1.494 1.542 0 CA-C-N 121.203 1.465 . . . . 0.0 110.937 178.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.441 HE21 HG13 ' A' ' 90' ' ' VAL . 17.1 pt20 -99.66 173.47 6.7 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.047 -1.033 . . . . 0.0 110.091 178.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -155.23 121.25 5.15 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 120.373 -0.531 . . . . 0.0 112.01 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -120.2 -170.5 1.98 Allowed 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 178.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 30.7 ttpt -104.92 139.32 39.81 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.339 0.59 . . . . 0.0 111.489 -179.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -62.1 111.6 2.01 Favored 'General case' 0 N--CA 1.508 2.447 0 CA-C-O 121.062 0.458 . . . . 0.0 110.359 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.51 22.31 16.93 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -117.16 164.83 14.18 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 118.474 1.137 . . . . 0.0 110.668 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -82.62 100.1 9.96 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 178.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -102.42 167.42 9.96 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.955 -177.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.666 HG22 ' HG2' ' A' ' 59' ' ' GLN . 95.7 t -138.99 141.2 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 178.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.894 HD12 HD23 ' A' ' 58' ' ' LEU . 22.5 mt -95.76 112.39 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 178.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.477 HG13 ' CE2' ' A' ' 57' ' ' TYR . 57.8 t -74.12 122.35 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 CA-C-O 121.551 0.691 . . . . 0.0 110.682 -176.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.403 ' HA ' ' HB2' ' A' ' 7' ' ' ALA . 1.2 t -163.7 92.55 0.7 Allowed 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.02 137.87 32.01 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.373 -179.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.432 HG21 HD13 ' A' ' 33' ' ' ILE . 41.1 t -147.18 125.71 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.542 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 40.8 t -91.06 79.43 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.3 m -78.06 167.14 21.9 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 178.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 t -45.49 -80.23 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.165 0 O-C-N 121.761 -0.587 . . . . 0.0 111.09 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.428 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 0.6 OUTLIER -166.98 -64.56 0.01 OUTLIER Pre-proline 0 N--CA 1.512 2.635 0 CA-C-O 117.566 -1.207 . . . . 0.0 111.697 177.529 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.428 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 2.8 Cg_endo -60.36 -53.49 2.89 Favored 'Trans proline' 0 CA--C 1.562 1.916 0 CA-C-N 120.233 1.119 . . . . 0.0 112.847 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.483 ' HG3' HG23 ' A' ' 77' ' ' ILE . 3.2 Cg_exo -61.15 -165.72 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 120.498 0.798 . . . . 0.0 113.223 -178.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -172.83 -161.36 0.15 Allowed 'General case' 0 N--CA 1.52 3.051 0 O-C-N 121.927 -0.483 . . . . 0.0 109.906 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.574 HD12 ' N ' ' A' ' 75' ' ' GLY . 0.6 OUTLIER -106.04 148.63 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.896 -0.503 . . . . 0.0 110.415 179.502 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.538 ' N ' HD12 ' A' ' 34' ' ' ILE . 5.3 mp -109.53 125.19 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.546 ' CG ' HD22 ' A' ' 58' ' ' LEU . 77.1 m95 -85.21 120.53 26.8 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.6 mmmt -131.25 -166.99 1.78 Allowed 'General case' 0 N--CA 1.503 2.184 0 CA-C-O 121.439 0.637 . . . . 0.0 111.71 -177.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 67.24 52.0 0.87 Allowed 'General case' 0 N--CA 1.511 2.603 0 CA-C-O 121.608 0.718 . . . . 0.0 111.525 179.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -162.64 29.75 0.1 Allowed 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.841 -0.537 . . . . 0.0 109.912 178.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 116.13 -53.71 0.61 Allowed Glycine 0 N--CA 1.486 2.02 0 N-CA-C 108.176 -1.97 . . . . 0.0 108.176 -178.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.97 -164.91 0.66 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 122.223 -0.575 . . . . 0.0 109.487 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -74.61 119.3 18.61 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.518 HG22 ' HB2' ' A' ' 35' ' ' TRP . 4.3 m -66.15 -34.12 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.511 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.99 -178.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.821 ' CD1' HG21 ' A' ' 52' ' ' VAL . 47.9 mm -59.57 -18.25 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.702 0 O-C-N 121.92 -0.487 . . . . 0.0 111.76 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.435 ' N ' HD12 ' A' ' 44' ' ' LEU . 10.7 mp -92.32 -21.4 20.3 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.509 -0.744 . . . . 0.0 111.195 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 35.1 pttt -98.55 -37.87 9.38 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.625 -0.672 . . . . 0.0 109.408 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.4 mmmt 47.61 54.25 10.03 Favored 'General case' 0 N--CA 1.51 2.551 0 CA-C-O 121.498 0.666 . . . . 0.0 111.859 179.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.99 161.43 2.32 Favored 'General case' 0 N--CA 1.512 2.661 0 O-C-N 121.754 -0.591 . . . . 0.0 110.404 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.4 m -58.42 -20.3 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.77 0 O-C-N 121.924 -0.485 . . . . 0.0 111.613 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -108.0 37.86 2.35 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.78 -0.575 . . . . 0.0 111.806 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -144.86 106.75 4.29 Favored 'General case' 0 N--CA 1.506 2.375 0 O-C-N 121.767 -0.583 . . . . 0.0 109.598 178.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 72.9 mt -126.21 102.14 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.821 HG21 ' CD1' ' A' ' 43' ' ' ILE . 4.2 t -74.33 132.08 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.4 mt -88.15 162.45 16.71 Favored 'General case' 0 N--CA 1.504 2.272 0 CA-C-O 121.272 0.558 . . . . 0.0 111.571 -178.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.6 p -60.24 -19.64 55.44 Favored 'General case' 0 N--CA 1.511 2.598 0 O-C-N 122.141 -0.35 . . . . 0.0 111.427 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 43.2 p-10 -91.74 19.5 6.4 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.565 -0.71 . . . . 0.0 111.374 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.43 ' HB3' HG21 ' A' ' 33' ' ' ILE . 4.7 m120 67.93 32.05 5.34 Favored 'General case' 0 N--CA 1.518 2.93 0 O-C-N 121.783 -0.573 . . . . 0.0 112.356 178.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.477 ' CE2' HG13 ' A' ' 22' ' ' VAL . 4.3 m-85 -103.59 163.37 12.35 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.894 HD23 HD12 ' A' ' 21' ' ' ILE . 16.8 tp -122.14 97.51 5.51 Favored 'General case' 0 N--CA 1.513 2.722 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.715 -179.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.666 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -75.53 98.48 3.97 Favored 'General case' 0 N--CA 1.501 2.082 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.825 179.512 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.801 HD11 HD11 ' A' ' 21' ' ' ILE . 98.0 mt -90.73 115.94 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.17 115.08 15.55 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 121.265 0.555 . . . . 0.0 110.991 -178.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.31 -37.5 3.46 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.447 ' CG1' HG21 ' A' ' 92' ' ' VAL . 2.5 tp 41.7 70.57 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.517 2.897 0 CA-C-O 122.237 1.018 . . . . 0.0 112.246 -178.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.533 ' HB3' HG22 ' A' ' 66' ' ' THR . 39.7 mtpt -67.04 149.89 49.97 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.589 -0.694 . . . . 0.0 111.472 -178.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.618 ' HA ' HG12 ' A' ' 92' ' ' VAL . 22.6 pttt -60.96 -24.29 65.97 Favored 'General case' 0 N--CA 1.511 2.582 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.493 178.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.533 HG22 ' HB3' ' A' ' 64' ' ' LYS . 9.4 t -71.17 -18.15 62.5 Favored 'General case' 0 N--CA 1.502 2.144 0 C-N-CA 120.261 -0.575 . . . . 0.0 110.134 177.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -102.67 -1.03 30.87 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.644 -0.66 . . . . 0.0 111.842 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -79.23 153.5 29.91 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.163 -0.961 . . . . 0.0 109.606 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 161.74 -102.66 0.21 Allowed Glycine 0 N--CA 1.497 2.733 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.5 m -152.97 104.18 2.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 122.084 -0.656 . . . . 0.0 110.305 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -82.82 135.37 34.97 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -96.77 119.8 35.93 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.762 -0.586 . . . . 0.0 110.99 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.481 ' HB3' HD11 ' A' ' 33' ' ' ILE . 7.4 m -83.85 116.66 22.85 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 177.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.449 ' O ' HD12 ' A' ' 34' ' ' ILE . 26.2 mt-10 -115.94 88.16 2.83 Favored 'General case' 0 N--CA 1.503 2.185 0 CA-C-N 118.637 0.653 . . . . 0.0 110.928 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.574 ' N ' HD12 ' A' ' 33' ' ' ILE . . . -68.76 113.64 5.38 Favored Glycine 0 N--CA 1.504 3.184 0 N-CA-C 107.883 -2.087 . . . . 0.0 107.883 178.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.3 ttm-85 -130.51 143.71 50.93 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -177.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.705 HD11 ' CG2' ' A' ' 2' ' ' VAL . 85.1 mt -120.58 137.88 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.37 177.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 56.8 mt -93.17 -38.2 11.7 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.762 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.53 -58.26 6.89 Favored 'General case' 0 N--CA 1.512 2.663 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 26.3 mtt85 -100.07 60.39 1.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 177.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -14.2 81.24 0.0 OUTLIER Glycine 1 N--CA 1.526 4.682 0 C-N-CA 125.046 1.308 . . . . 0.0 114.805 -178.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -117.89 144.18 45.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 122.218 -0.577 . . . . 0.0 110.075 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.1 pt -134.8 75.41 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 CA-C-O 121.191 0.519 . . . . 0.0 110.839 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -92.8 148.96 21.6 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.415 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 30.7 p90 -163.97 177.9 8.15 Favored 'General case' 0 N--CA 1.503 2.197 0 C-N-CA 119.765 -0.774 . . . . 0.0 112.833 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.4 pttt -166.85 165.59 16.08 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.548 ' O ' HG22 ' A' ' 9' ' ' THR . 8.8 p-10 -101.42 119.09 38.23 Favored 'General case' 0 N--CA 1.511 2.606 0 O-C-N 121.857 -0.527 . . . . 0.0 111.956 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.565 ' N ' HD12 ' A' ' 88' ' ' ILE . 2.6 mp -102.28 117.01 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 178.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -83.47 123.11 29.38 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -179.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.441 HG13 HE21 ' A' ' 11' ' ' GLN . 37.5 t -118.15 131.23 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 121.775 -0.578 . . . . 0.0 109.721 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 69.3 mt -127.34 152.94 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.618 HG12 ' HA ' ' A' ' 65' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.502 2.15 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.042 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 42.4 p90 . . . . . 0 N--CA 1.499 1.992 0 CA-C-O 120.634 0.255 . . . . 0.0 110.357 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.709 ' CG2' HD13 ' A' ' 77' ' ' ILE . 36.0 t -143.0 107.13 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.32 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.565 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 73.1 mtp -119.09 112.59 19.73 Favored 'General case' 0 N--CA 1.511 2.579 0 O-C-N 121.752 -0.592 . . . . 0.0 111.19 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -72.48 107.11 4.86 Favored 'General case' 0 N--CA 1.508 2.432 0 CA-C-O 121.01 0.433 . . . . 0.0 110.454 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -118.75 170.98 8.53 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-O 121.221 0.534 . . . . 0.0 110.669 -179.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.412 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.9 OUTLIER 25.43 63.23 0.06 Allowed 'General case' 0 N--CA 1.526 3.342 0 C-N-CA 124.291 1.037 . . . . 0.0 113.753 178.424 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -128.33 66.79 74.2 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 121.627 -0.671 . . . . 0.0 111.646 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.73 108.25 1.03 Allowed 'Trans proline' 0 N--CA 1.493 1.48 0 N-CA-C 108.218 -1.493 . . . . 0.0 108.218 177.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.516 HG22 HD13 ' A' ' 88' ' ' ILE . 11.4 p -62.24 -43.9 86.97 Favored Pre-proline 0 N--CA 1.503 2.208 0 CA-C-O 117.287 -1.339 . . . . 0.0 113.178 -176.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.487 ' HD3' ' OG1' ' A' ' 9' ' ' THR . 1.6 Cg_endo -84.11 84.79 1.49 Allowed 'Trans proline' 0 CA--C 1.551 1.329 0 CA-C-N 120.677 1.277 . . . . 0.0 111.513 -177.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.449 HE21 HG13 ' A' ' 90' ' ' VAL . 15.8 pt20 -100.49 172.74 6.93 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 121.085 -1.009 . . . . 0.0 110.748 179.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -158.03 120.52 3.77 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.897 -0.502 . . . . 0.0 111.342 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -116.41 -169.73 1.67 Allowed 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.965 -0.459 . . . . 0.0 110.196 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 49.5 tttm -101.85 135.77 42.83 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.378 0.609 . . . . 0.0 111.256 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -60.74 116.86 4.73 Favored 'General case' 0 N--CA 1.509 2.498 0 CA-C-O 121.082 0.468 . . . . 0.0 110.582 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.88 22.81 29.58 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.419 ' O ' HG22 ' A' ' 63' ' ' ILE . 16.9 tt0 -117.26 164.58 14.6 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 118.471 1.135 . . . . 0.0 110.93 -179.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -81.08 98.41 7.99 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 177.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.11 167.22 10.6 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 120.291 -0.564 . . . . 0.0 111.911 -177.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.662 HG22 ' HG2' ' A' ' 59' ' ' GLN . 98.5 t -140.55 139.98 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 178.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.703 HD12 HD23 ' A' ' 58' ' ' LEU . 38.4 mt -95.2 116.73 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 178.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.498 HG13 ' CE2' ' A' ' 57' ' ' TYR . 44.6 t -78.87 117.02 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-O 121.321 0.581 . . . . 0.0 110.781 -176.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -154.47 95.01 1.76 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.412 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 1.7 m-20 -90.05 137.79 32.05 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.48 HG21 HD12 ' A' ' 33' ' ' ILE . 13.9 t -147.81 122.26 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.565 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 14.8 t -85.15 81.53 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.9 m -87.38 155.2 20.14 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.6 t -44.94 -84.03 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.15 0 O-C-N 121.884 -0.51 . . . . 0.0 111.909 -178.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.404 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 0.8 OUTLIER -166.94 -62.23 0.01 OUTLIER Pre-proline 0 N--CA 1.511 2.576 0 CA-C-O 117.76 -1.114 . . . . 0.0 112.094 178.568 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.404 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 2.7 Cg_endo -59.37 -53.87 3.09 Favored 'Trans proline' 0 CA--C 1.559 1.741 0 CA-C-N 120.082 1.065 . . . . 0.0 112.336 -178.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.653 ' HG2' HG23 ' A' ' 77' ' ' ILE . 2.4 Cg_endo -64.46 -168.97 0.11 Allowed 'Trans proline' 0 N--CA 1.496 1.663 0 CA-C-N 119.399 0.821 . . . . 0.0 110.984 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.414 ' HG1' ' C ' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -172.04 -165.29 0.34 Allowed 'General case' 0 N--CA 1.521 3.086 0 O-C-N 121.723 -0.611 . . . . 0.0 109.844 179.838 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.48 HD12 HG21 ' A' ' 25' ' ' VAL . 20.3 tt -99.39 150.73 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 122.053 -0.405 . . . . 0.0 109.925 179.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.6 mt -115.56 115.42 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.553 ' HB2' HG22 ' A' ' 42' ' ' VAL . 72.7 m95 -81.18 104.96 12.02 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -109.21 -175.31 2.73 Favored 'General case' 0 N--CA 1.502 2.142 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.885 -178.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 2.4 t60 62.7 153.24 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.669 0 O-C-N 121.876 -0.515 . . . . 0.0 110.146 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.6 tppm? 52.35 29.86 7.36 Favored 'General case' 0 N--CA 1.519 2.979 0 O-C-N 121.566 -0.709 . . . . 0.0 110.869 -179.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 160.84 -28.31 0.31 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 56.9 101.15 0.02 OUTLIER 'General case' 0 N--CA 1.517 2.888 0 O-C-N 121.528 -0.984 . . . . 0.0 110.472 -179.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 55.14 70.93 0.58 Allowed 'General case' 0 N--CA 1.511 2.623 0 O-C-N 121.646 -0.659 . . . . 0.0 109.934 -178.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.553 HG22 ' HB2' ' A' ' 35' ' ' TRP . 7.0 m -65.77 -37.24 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.386 0 CA-C-O 121.312 0.577 . . . . 0.0 109.675 -178.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.571 HG12 HG21 ' A' ' 52' ' ' VAL . 64.5 mt -60.66 -18.44 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.72 0 O-C-N 121.951 -0.468 . . . . 0.0 111.167 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.493 ' N ' HD12 ' A' ' 44' ' ' LEU . 9.6 mp -90.95 -22.56 20.79 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.52 -0.737 . . . . 0.0 110.823 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.414 ' HG2' ' HA ' ' A' ' 42' ' ' VAL . 30.6 pttt -99.18 -36.83 9.53 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.577 -0.702 . . . . 0.0 109.716 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 17.2 mmmt 48.92 54.77 10.28 Favored 'General case' 0 N--CA 1.51 2.563 0 CA-C-O 121.507 0.67 . . . . 0.0 111.562 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.61 172.14 0.05 OUTLIER 'General case' 0 N--CA 1.514 2.741 0 O-C-N 121.836 -0.54 . . . . 0.0 111.067 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.6 m -61.22 -19.19 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.605 0 O-C-N 121.982 -0.449 . . . . 0.0 111.954 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.402 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 26.6 ptt-85 -121.78 47.46 1.88 Allowed 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.757 -0.59 . . . . 0.0 112.356 -178.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -145.04 108.52 4.63 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 121.521 -0.737 . . . . 0.0 110.094 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 71.3 mt -129.12 102.01 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.645 HG22 ' CD1' ' A' ' 58' ' ' LEU . 4.8 t -73.84 128.1 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.42 HD11 ' OE1' ' A' ' 59' ' ' GLN . 18.8 mt -82.56 165.43 20.11 Favored 'General case' 0 N--CA 1.508 2.445 0 CA-C-O 121.299 0.571 . . . . 0.0 111.828 -178.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 93.7 p -59.94 -20.84 59.71 Favored 'General case' 0 N--CA 1.51 2.534 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.39 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 36.2 p-10 -92.38 21.2 5.45 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.699 -0.626 . . . . 0.0 111.343 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.412 ' HB3' HG21 ' A' ' 33' ' ' ILE . 5.5 m120 65.18 33.53 9.27 Favored 'General case' 0 N--CA 1.514 2.727 0 O-C-N 121.756 -0.59 . . . . 0.0 112.496 178.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.498 ' CE2' HG13 ' A' ' 22' ' ' VAL . 3.9 m-85 -102.15 164.77 11.52 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 177.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.703 HD23 HD12 ' A' ' 21' ' ' ILE . 15.5 tp -120.61 97.07 5.39 Favored 'General case' 0 N--CA 1.517 2.887 0 C-N-CA 119.327 -0.949 . . . . 0.0 111.651 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.662 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -75.83 95.97 3.59 Favored 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.799 179.499 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.551 HD11 HD11 ' A' ' 21' ' ' ILE . 93.1 mt -86.95 117.0 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -78.3 111.72 14.56 Favored 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 121.393 0.616 . . . . 0.0 111.663 -178.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 100.13 -35.65 4.64 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.499 HG23 HG21 ' A' ' 92' ' ' VAL . 1.6 tp 40.96 69.65 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.842 0 CA-C-O 122.201 1.0 . . . . 0.0 112.657 -179.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -57.75 157.75 7.03 Favored 'General case' 0 N--CA 1.513 2.684 0 O-C-N 121.638 -0.663 . . . . 0.0 112.417 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 35.7 tttm -61.47 -22.53 65.15 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 122.218 -0.301 . . . . 0.0 110.876 178.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.7 p -83.36 -19.96 35.16 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.772 -0.58 . . . . 0.0 110.74 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.76 7.7 35.53 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.61 -0.681 . . . . 0.0 111.678 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.438 ' HB3' HG12 ' A' ' 92' ' ' VAL . 8.4 pt-20 -96.79 141.12 30.38 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.35 -0.844 . . . . 0.0 109.365 179.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 169.98 -105.72 0.23 Allowed Glycine 0 N--CA 1.498 2.831 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.2 m -144.12 103.65 4.03 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 122.031 -0.688 . . . . 0.0 111.206 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -84.57 134.43 34.4 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.7 tpp85 -91.64 119.54 31.62 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.743 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 85' ' ' PHE . 1.8 m -87.83 90.26 8.31 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -91.57 88.64 6.84 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.276 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.55 91.31 0.56 Allowed Glycine 0 N--CA 1.499 2.873 0 N-CA-C 107.531 -2.227 . . . . 0.0 107.531 178.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.594 ' CG ' HG22 ' A' ' 83' ' ' ILE . 4.1 ttm180 -98.05 125.24 42.94 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.923 0.868 . . . . 0.0 113.043 -177.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.709 HD13 ' CG2' ' A' ' 2' ' ' VAL . 5.1 mp -142.03 90.16 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-N 114.506 -1.224 . . . . 0.0 107.899 178.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.414 ' HG ' HG23 ' A' ' 83' ' ' ILE . 8.8 mt -97.38 20.42 11.64 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.671 178.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -110.71 -22.53 11.54 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.777 -0.577 . . . . 0.0 110.601 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -127.05 -62.39 1.11 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.781 -0.574 . . . . 0.0 110.649 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.24 -81.35 1.59 Allowed Glycine 0 N--CA 1.49 2.29 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.864 -178.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 179.72 -161.99 0.04 OUTLIER 'General case' 0 N--CA 1.516 2.832 0 O-C-N 122.09 -0.653 . . . . 0.0 110.408 -177.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.594 HG22 ' CG ' ' A' ' 76' ' ' ARG . 1.5 pp -99.98 116.59 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.321 0 O-C-N 121.776 -0.577 . . . . 0.0 110.333 178.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -117.53 159.68 22.46 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.65 -0.656 . . . . 0.0 109.663 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.484 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 25.5 p90 -157.06 175.78 13.63 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.658 -0.817 . . . . 0.0 112.583 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 20.0 tttt -165.25 169.61 15.73 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -116.75 134.4 54.85 Favored 'General case' 0 N--CA 1.51 2.557 0 O-C-N 121.829 -0.544 . . . . 0.0 110.654 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.516 HD13 HG22 ' A' ' 9' ' ' THR . 47.9 mm -117.47 109.24 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -77.09 100.41 5.7 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.449 HG13 HE21 ' A' ' 11' ' ' GLN . 46.6 t -96.27 136.99 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.915 -179.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 65.9 mt -125.51 159.1 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.499 HG21 HG23 ' A' ' 63' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.5 2.056 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.539 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 28.6 p90 . . . . . 0 N--CA 1.499 2.021 0 N-CA-C 110.372 -0.233 . . . . 0.0 110.372 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.719 ' CG2' HD13 ' A' ' 77' ' ' ILE . 26.2 t -141.51 106.55 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.427 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.535 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 7.9 mmm -121.17 117.31 26.79 Favored 'General case' 0 N--CA 1.511 2.575 0 O-C-N 121.879 -0.513 . . . . 0.0 110.551 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -74.33 114.41 12.67 Favored 'General case' 0 N--CA 1.507 2.415 0 CA-C-O 120.98 0.419 . . . . 0.0 111.099 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.21 162.32 26.45 Favored 'General case' 0 N--CA 1.503 2.22 0 CA-C-O 121.758 0.79 . . . . 0.0 111.594 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.416 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.3 OUTLIER 32.02 80.56 0.02 OUTLIER 'General case' 0 N--CA 1.52 3.057 0 C-N-CA 124.177 0.991 . . . . 0.0 113.274 179.266 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -138.41 79.97 28.8 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.954 -0.466 . . . . 0.0 110.727 -179.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -65.44 96.89 0.3 Allowed 'Trans proline' 0 N--CA 1.491 1.336 0 N-CA-C 108.503 -1.383 . . . . 0.0 108.503 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.582 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.6 OUTLIER -51.25 -72.29 0.17 Allowed Pre-proline 0 N--CA 1.506 2.331 0 CA-C-O 116.437 -1.744 . . . . 0.0 112.485 -177.172 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.492 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.5 Cg_endo -71.48 97.1 0.76 Allowed 'Trans proline' 0 N--CA 1.498 1.755 0 CA-C-N 121.921 1.722 . . . . 0.0 111.719 178.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -101.59 178.11 4.73 Favored 'General case' 0 N--CA 1.507 2.41 0 O-C-N 120.974 -1.079 . . . . 0.0 110.055 178.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -156.23 127.5 7.07 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.833 -0.542 . . . . 0.0 111.568 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -127.84 -169.2 2.01 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.847 -0.533 . . . . 0.0 109.802 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -115.49 145.42 42.62 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.838 0.827 . . . . 0.0 111.841 -178.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -61.82 121.24 12.39 Favored 'General case' 0 N--CA 1.508 2.442 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.45 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.74 22.83 48.66 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.513 ' O ' HG22 ' A' ' 63' ' ' ILE . 18.4 tt0 -112.98 159.84 18.71 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 118.478 1.139 . . . . 0.0 111.186 -179.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.36 97.65 8.44 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 177.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -103.4 164.2 11.79 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.528 0.68 . . . . 0.0 112.498 -177.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.695 HG22 ' HG2' ' A' ' 59' ' ' GLN . 95.3 t -139.31 141.82 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 178.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.903 HD12 HD23 ' A' ' 58' ' ' LEU . 55.3 mt -97.42 115.29 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 178.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.483 HG13 ' CE2' ' A' ' 57' ' ' TYR . 46.8 t -76.32 120.86 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 121.505 0.669 . . . . 0.0 111.055 -176.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.7 t -161.68 94.85 0.97 Allowed 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.416 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -92.88 141.44 28.42 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 120.121 -0.632 . . . . 0.0 109.684 -178.767 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.643 HG21 HD12 ' A' ' 33' ' ' ILE . 32.9 t -149.52 123.46 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.535 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 21.6 t -81.7 80.42 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.6 m -87.61 154.09 20.88 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.2 t -44.09 -83.11 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.216 0 O-C-N 121.956 -0.465 . . . . 0.0 111.953 -178.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.417 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 0.3 OUTLIER -168.96 -61.29 0.01 OUTLIER Pre-proline 0 N--CA 1.51 2.566 0 CA-C-O 117.731 -1.128 . . . . 0.0 111.785 178.532 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.417 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 2.7 Cg_endo -60.74 -54.13 2.21 Favored 'Trans proline' 0 CA--C 1.561 1.86 0 CA-C-N 120.028 1.046 . . . . 0.0 112.519 -179.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.696 ' HG2' HG23 ' A' ' 77' ' ' ILE . 2.7 Cg_endo -63.66 -166.83 0.07 OUTLIER 'Trans proline' 0 N--CA 1.498 1.765 0 CA-C-N 119.539 0.871 . . . . 0.0 111.678 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -170.97 -166.62 0.49 Allowed 'General case' 0 N--CA 1.523 3.188 0 O-C-N 121.813 -0.554 . . . . 0.0 110.36 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.643 HD12 HG21 ' A' ' 25' ' ' VAL . 18.7 tt -104.1 136.73 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.546 ' N ' HD12 ' A' ' 34' ' ' ILE . 4.9 mp -101.17 124.37 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.568 ' HB2' HG22 ' A' ' 42' ' ' VAL . 75.1 m95 -84.64 109.69 18.18 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.2 tttt -108.81 -174.84 2.61 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 121.48 0.657 . . . . 0.0 111.625 -178.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 27.8 t-80 66.36 153.04 0.07 Allowed 'General case' 0 N--CA 1.511 2.584 0 CA-C-O 121.023 0.44 . . . . 0.0 110.111 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 19.9 tptt 57.97 50.7 9.87 Favored 'General case' 0 N--CA 1.513 2.723 0 O-C-N 121.838 -0.539 . . . . 0.0 110.727 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 131.5 -0.85 5.17 Favored Glycine 0 N--CA 1.498 2.774 0 C-N-CA 120.545 -0.836 . . . . 0.0 111.582 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 54.77 89.81 0.03 OUTLIER 'General case' 0 N--CA 1.513 2.715 0 CA-C-N 119.184 1.492 . . . . 0.0 110.768 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.5 t0 55.66 97.96 0.02 OUTLIER 'General case' 0 N--CA 1.516 2.827 0 O-C-N 121.713 -0.617 . . . . 0.0 110.587 -179.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.568 HG22 ' HB2' ' A' ' 35' ' ' TRP . 6.3 m -67.95 -24.55 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.438 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.823 -179.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.7 mm -59.26 -17.95 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.819 0 O-C-N 121.577 -0.702 . . . . 0.0 111.572 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.489 ' N ' HD12 ' A' ' 44' ' ' LEU . 10.0 mp -91.38 -22.84 20.28 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.457 -0.777 . . . . 0.0 110.978 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -98.66 -40.44 8.19 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.764 -0.585 . . . . 0.0 109.478 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm 47.26 56.02 7.42 Favored 'General case' 0 N--CA 1.509 2.517 0 CA-C-O 121.473 0.654 . . . . 0.0 112.04 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.58 155.19 1.64 Allowed 'General case' 0 N--CA 1.515 2.796 0 O-C-N 121.649 -0.657 . . . . 0.0 111.013 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.7 m -54.32 -24.36 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.816 0 O-C-N 121.907 -0.496 . . . . 0.0 112.125 -178.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.95 -3.67 31.81 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.484 ' HE2' HD21 ' A' ' 58' ' ' LEU . 7.5 m-85 -95.79 109.41 21.73 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.388 -0.82 . . . . 0.0 110.18 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 71.8 mt -129.44 104.27 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.524 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.2 t -73.76 128.59 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.494 HD11 ' CG ' ' A' ' 59' ' ' GLN . 39.5 mt -82.11 166.3 19.83 Favored 'General case' 0 N--CA 1.508 2.466 0 CA-C-O 121.308 0.575 . . . . 0.0 111.806 -178.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.4 p -61.19 -21.55 63.91 Favored 'General case' 0 N--CA 1.51 2.532 0 O-C-N 122.106 -0.371 . . . . 0.0 111.211 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -90.87 19.12 5.81 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.577 -0.702 . . . . 0.0 111.338 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.408 ' HB3' HG21 ' A' ' 33' ' ' ILE . 6.1 m120 67.42 33.21 5.36 Favored 'General case' 0 N--CA 1.516 2.862 0 O-C-N 121.57 -0.706 . . . . 0.0 112.524 178.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.483 ' CE2' HG13 ' A' ' 22' ' ' VAL . 3.9 m-85 -103.3 166.77 10.23 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 177.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.903 HD23 HD12 ' A' ' 21' ' ' ILE . 16.8 tp -120.69 98.24 5.93 Favored 'General case' 0 N--CA 1.519 2.995 0 C-N-CA 119.356 -0.938 . . . . 0.0 111.919 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.695 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -78.45 101.62 7.4 Favored 'General case' 0 N--CA 1.504 2.263 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.364 179.66 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.509 HD11 HD11 ' A' ' 21' ' ' ILE . 96.8 mt -93.82 103.4 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 177.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 19.3 tpp85 -70.3 116.6 10.84 Favored 'General case' 0 N--CA 1.504 2.233 0 CA-C-O 121.317 0.58 . . . . 0.0 110.865 -178.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.64 -35.1 4.83 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.513 HG22 ' O ' ' A' ' 17' ' ' GLU . 1.8 tp 35.27 94.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.519 2.999 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 59.0 mmtt -73.4 148.71 43.09 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.613 -0.68 . . . . 0.0 110.656 -178.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -62.58 -18.89 63.04 Favored 'General case' 0 N--CA 1.51 2.559 0 O-C-N 122.072 -0.393 . . . . 0.0 110.978 178.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.8 t -87.83 -13.5 41.98 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.686 -0.634 . . . . 0.0 111.376 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -91.67 14.36 15.39 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.53 -0.731 . . . . 0.0 111.491 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.78 150.3 20.55 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.433 -0.792 . . . . 0.0 109.792 179.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 166.06 -101.25 0.18 Allowed Glycine 0 N--CA 1.499 2.887 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.6 m -149.02 101.13 3.13 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.953 -0.734 . . . . 0.0 111.239 179.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -81.47 133.56 35.42 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 177.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.8 ttm105 -97.29 120.3 37.4 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.11 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.624 ' HB3' HD11 ' A' ' 33' ' ' ILE . 9.3 m -83.46 113.33 20.7 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 177.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -111.5 85.63 2.17 Favored 'General case' 0 N--CA 1.504 2.272 0 CA-C-N 118.537 0.608 . . . . 0.0 109.609 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.68 96.67 0.31 Allowed Glycine 0 N--CA 1.502 3.057 0 N-CA-C 108.475 -1.85 . . . . 0.0 108.475 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.64 ' HG3' HG22 ' A' ' 83' ' ' ILE . 2.1 ttp85 -102.4 117.83 35.57 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 122.059 -0.671 . . . . 0.0 112.212 -177.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.719 HD13 ' CG2' ' A' ' 2' ' ' VAL . 5.3 mp -141.3 90.77 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.539 179.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 21.8 mt -99.87 26.75 6.01 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.286 178.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -111.61 -34.29 6.11 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.875 -0.515 . . . . 0.0 110.003 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -118.06 -62.56 1.53 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 122.036 -0.415 . . . . 0.0 110.811 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.405 ' O ' ' HB3' ' A' ' 82' ' ' GLU . . . -98.54 -82.78 1.68 Allowed Glycine 0 N--CA 1.489 2.183 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.956 -178.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.405 ' HB3' ' O ' ' A' ' 81' ' ' GLY . 9.9 pt-20 176.53 -155.29 0.02 OUTLIER 'General case' 0 N--CA 1.517 2.89 0 O-C-N 122.182 -0.599 . . . . 0.0 109.719 -177.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.64 HG22 ' HG3' ' A' ' 76' ' ' ARG . 8.4 pt -104.13 153.84 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 121.436 -0.79 . . . . 0.0 110.868 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -155.24 162.13 40.99 Favored 'General case' 0 N--CA 1.505 2.29 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.418 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 39.1 p90 -166.73 175.8 7.61 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 121.352 -0.843 . . . . 0.0 113.158 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.538 ' HD2' HD11 ' A' ' 88' ' ' ILE . 3.2 ptpt -167.78 161.27 13.14 Favored 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.582 ' O ' HG22 ' A' ' 9' ' ' THR . 7.7 p-10 -98.06 122.93 41.79 Favored 'General case' 0 N--CA 1.512 2.635 0 O-C-N 121.736 -0.602 . . . . 0.0 112.107 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.55 ' N ' HD12 ' A' ' 88' ' ' ILE . 2.3 mp -106.72 122.55 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 178.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -87.25 134.82 33.5 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.2 t -127.52 129.08 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 O-C-N 121.673 -0.642 . . . . 0.0 110.22 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 74.6 mt -116.26 139.63 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.426 HG21 ' CG1' ' A' ' 63' ' ' ILE . 44.6 t . . . . . 0 N--CA 1.503 2.18 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.364 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 41.0 p90 . . . . . 0 N--CA 1.497 1.896 0 CA-C-O 120.624 0.249 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.722 ' CG2' HD13 ' A' ' 77' ' ' ILE . 36.6 t -143.07 108.97 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.52 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 7.1 mmt -122.73 115.92 22.88 Favored 'General case' 0 N--CA 1.51 2.565 0 O-C-N 121.783 -0.573 . . . . 0.0 110.482 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -74.38 113.1 11.22 Favored 'General case' 0 N--CA 1.506 2.374 0 O-C-N 122.005 -0.434 . . . . 0.0 110.538 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.435 ' HG2' HG23 ' A' ' 26' ' ' VAL . 5.0 ptpt -127.16 163.7 23.26 Favored 'General case' 0 N--CA 1.503 2.215 0 CA-C-O 121.712 0.768 . . . . 0.0 111.753 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.419 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . 0.3 OUTLIER 31.88 72.68 0.07 Allowed 'General case' 0 N--CA 1.52 3.048 0 C-N-CA 124.188 0.995 . . . . 0.0 113.342 179.317 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -136.81 81.01 35.31 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.802 -0.561 . . . . 0.0 110.721 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -65.58 102.09 0.48 Allowed 'Trans proline' 0 N--CA 1.49 1.294 0 N-CA-C 108.62 -1.339 . . . . 0.0 108.62 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.581 HG22 ' O ' ' A' ' 87' ' ' ASP . 0.2 OUTLIER -55.86 -66.62 1.0 Allowed Pre-proline 0 N--CA 1.503 2.213 0 CA-C-O 116.93 -1.509 . . . . 0.0 112.216 -177.314 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.499 ' HD3' ' CB ' ' A' ' 9' ' ' THR . 1.5 Cg_endo -74.18 91.4 0.94 Allowed 'Trans proline' 0 CA--C 1.556 1.609 0 CA-C-N 121.258 1.485 . . . . 0.0 111.148 178.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.525 HE21 HG13 ' A' ' 90' ' ' VAL . 15.9 pt20 -100.0 176.49 5.4 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 120.871 -1.143 . . . . 0.0 110.006 178.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -160.62 122.76 3.17 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.741 -0.599 . . . . 0.0 111.374 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -119.26 -170.64 1.96 Allowed 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.963 -0.461 . . . . 0.0 110.205 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 15.8 tptm -104.71 138.8 40.46 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.567 0.699 . . . . 0.0 111.413 -178.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -59.19 118.61 6.1 Favored 'General case' 0 N--CA 1.509 2.522 0 O-C-N 121.933 -0.479 . . . . 0.0 110.88 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.33 23.47 40.24 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.43 ' O ' HG22 ' A' ' 63' ' ' ILE . 13.0 tt0 -114.98 164.6 13.92 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 118.411 1.105 . . . . 0.0 110.531 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -82.85 98.46 9.17 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 178.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.17 168.27 9.92 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 120.365 -0.534 . . . . 0.0 112.053 -177.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.658 HG22 ' HG2' ' A' ' 59' ' ' GLN . 99.6 t -142.75 141.09 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.82 HD12 HD23 ' A' ' 58' ' ' LEU . 43.5 mt -97.02 111.96 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 178.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.442 HG13 ' CE2' ' A' ' 57' ' ' TYR . 57.8 t -75.17 119.93 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 CA-C-O 121.47 0.652 . . . . 0.0 110.493 -176.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -160.83 92.68 0.95 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.419 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.2 OUTLIER -91.16 140.75 29.52 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.529 -179.198 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.596 HG21 HD12 ' A' ' 33' ' ' ILE . 13.5 t -147.53 121.67 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.52 ' HB ' ' HB2' ' A' ' 3' ' ' MET . 16.0 t -81.2 80.68 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.4 m -87.83 154.75 20.3 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.6 t -43.66 -84.0 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.18 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.407 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 0.9 OUTLIER -166.32 -62.21 0.01 OUTLIER Pre-proline 0 N--CA 1.509 2.475 0 CA-C-O 117.675 -1.155 . . . . 0.0 111.584 178.639 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.407 ' HD3' ' CB ' ' A' ' 29' ' ' LEU . 2.8 Cg_endo -60.2 -53.81 2.72 Favored 'Trans proline' 0 CA--C 1.561 1.844 0 CA-C-N 120.086 1.066 . . . . 0.0 112.552 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.68 ' HG2' HG23 ' A' ' 77' ' ' ILE . 2.6 Cg_endo -63.02 -168.53 0.08 OUTLIER 'Trans proline' 0 N--CA 1.496 1.668 0 CA-C-N 119.425 0.83 . . . . 0.0 111.746 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.414 ' HG1' ' C ' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -171.58 -164.77 0.34 Allowed 'General case' 0 N--CA 1.52 3.067 0 O-C-N 121.92 -0.488 . . . . 0.0 109.78 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.596 HD12 HG21 ' A' ' 25' ' ' VAL . 17.1 tt -102.53 147.31 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.925 -0.484 . . . . 0.0 110.056 179.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.553 ' N ' HD12 ' A' ' 34' ' ' ILE . 5.2 mp -114.5 121.07 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.56 ' HB2' HG22 ' A' ' 42' ' ' VAL . 83.6 m95 -82.77 104.4 12.99 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -118.04 -165.7 1.13 Allowed 'General case' 0 N--CA 1.506 2.359 0 CA-C-O 121.322 0.582 . . . . 0.0 111.494 -177.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 56.32 58.83 3.99 Favored 'General case' 0 N--CA 1.511 2.58 0 CA-C-O 121.598 0.713 . . . . 0.0 111.461 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.407 ' HD3' ' CE1' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -166.12 -48.06 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.733 -0.604 . . . . 0.0 109.403 179.363 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -158.58 44.62 0.47 Allowed Glycine 0 N--CA 1.494 2.538 0 N-CA-C 108.522 -1.831 . . . . 0.0 108.522 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? 55.88 75.81 0.31 Allowed 'General case' 0 N--CA 1.511 2.587 0 O-C-N 121.903 -0.763 . . . . 0.0 110.725 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.0 t0 57.59 105.53 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.815 0 O-C-N 121.678 -0.639 . . . . 0.0 111.007 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.56 HG22 ' HB2' ' A' ' 35' ' ' TRP . 4.4 m -68.1 -28.53 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.562 0 O-C-N 121.876 -0.515 . . . . 0.0 110.421 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.7 mm -58.42 -18.11 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.688 0 O-C-N 121.71 -0.618 . . . . 0.0 111.864 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.475 ' N ' HD12 ' A' ' 44' ' ' LEU . 9.3 mp -92.47 -22.18 19.74 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.492 -0.755 . . . . 0.0 111.106 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.1 pttt -97.88 -41.04 8.21 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.8 mmmt 46.91 56.91 6.14 Favored 'General case' 0 N--CA 1.509 2.505 0 CA-C-O 121.166 0.507 . . . . 0.0 112.308 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -49.69 161.17 0.24 Allowed 'General case' 0 N--CA 1.519 2.987 0 O-C-N 121.804 -0.56 . . . . 0.0 111.081 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 36.0 m -56.83 -21.92 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.779 0 O-C-N 121.911 -0.493 . . . . 0.0 112.172 -178.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 24.1 ptt-85 -104.22 -2.44 25.7 Favored 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.404 ' HE2' HD21 ' A' ' 58' ' ' LEU . 7.6 m-85 -96.24 108.28 20.74 Favored 'General case' 0 N--CA 1.503 2.18 0 CA-C-N 119.145 0.884 . . . . 0.0 110.166 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 75.6 mt -129.36 104.84 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.677 HG22 ' CD1' ' A' ' 58' ' ' LEU . 4.8 t -74.78 127.89 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.513 HD11 ' CG ' ' A' ' 59' ' ' GLN . 42.7 mt -80.63 165.54 21.94 Favored 'General case' 0 N--CA 1.509 2.477 0 CA-C-O 121.34 0.591 . . . . 0.0 111.905 -178.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 89.9 p -60.19 -20.92 60.83 Favored 'General case' 0 N--CA 1.51 2.547 0 O-C-N 122.07 -0.394 . . . . 0.0 111.484 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 42.8 p-10 -91.74 19.83 6.11 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.658 -0.652 . . . . 0.0 111.392 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.3 m120 67.24 32.13 6.2 Favored 'General case' 0 N--CA 1.516 2.846 0 O-C-N 121.594 -0.691 . . . . 0.0 112.39 178.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.442 ' CE2' HG13 ' A' ' 22' ' ' VAL . 3.7 m-85 -102.06 167.64 9.9 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.82 HD23 HD12 ' A' ' 21' ' ' ILE . 15.2 tp -121.99 98.8 6.11 Favored 'General case' 0 N--CA 1.519 2.978 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.954 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.658 ' HG2' HG22 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -78.72 101.15 7.39 Favored 'General case' 0 N--CA 1.503 2.202 0 C-N-CA 120.479 -0.489 . . . . 0.0 111.12 179.413 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.557 HD11 HD11 ' A' ' 21' ' ' ILE . 97.2 mt -94.68 104.31 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 177.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.85 115.65 8.42 Favored 'General case' 0 N--CA 1.505 2.301 0 CA-C-O 121.187 0.517 . . . . 0.0 110.721 -178.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 100.31 -39.26 2.8 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.577 ' CG1' HG21 ' A' ' 92' ' ' VAL . 3.0 tp 42.52 83.58 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.517 2.901 0 CA-C-O 122.225 1.012 . . . . 0.0 112.117 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -72.11 158.42 35.97 Favored 'General case' 0 N--CA 1.508 2.454 0 O-C-N 121.751 -0.593 . . . . 0.0 111.984 -178.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt -61.27 -24.55 66.47 Favored 'General case' 0 N--CA 1.51 2.558 0 O-C-N 121.941 -0.474 . . . . 0.0 110.918 178.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.9 t -79.32 -15.0 58.63 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.893 -0.505 . . . . 0.0 111.691 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -87.37 -27.77 22.6 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.502 -0.749 . . . . 0.0 110.718 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.402 ' HB3' HG12 ' A' ' 92' ' ' VAL . 5.1 pt-20 -62.0 140.56 58.34 Favored 'General case' 0 N--CA 1.507 2.406 0 O-C-N 121.691 -0.631 . . . . 0.0 110.752 -179.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 167.09 -104.88 0.23 Allowed Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.7 m -146.72 102.28 3.54 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 122.03 -0.688 . . . . 0.0 110.543 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.407 ' CE1' ' HD3' ' A' ' 38' ' ' LYS . 26.1 m-85 -83.52 134.65 34.83 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 -94.0 115.65 28.01 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.85 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 85' ' ' PHE . 1.9 m -85.68 90.58 8.05 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -92.08 88.65 6.62 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.317 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.85 90.24 0.57 Allowed Glycine 0 N--CA 1.499 2.855 0 N-CA-C 107.44 -2.264 . . . . 0.0 107.44 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.633 ' CG ' HG22 ' A' ' 83' ' ' ILE . 30.1 ttm-85 -96.49 125.63 41.11 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.805 0.812 . . . . 0.0 112.823 -177.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.722 HD13 ' CG2' ' A' ' 2' ' ' VAL . 5.2 mp -142.05 91.01 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.183 178.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 14.1 mt -99.09 24.12 8.23 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.591 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -111.15 -28.87 8.09 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.866 -0.521 . . . . 0.0 110.592 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 11.1 mmt85 -123.2 -61.53 1.41 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.909 -0.494 . . . . 0.0 110.733 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -98.54 -81.85 1.62 Allowed Glycine 0 N--CA 1.489 2.203 0 C-N-CA 120.995 -0.621 . . . . 0.0 111.708 -178.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 178.14 -164.04 0.04 OUTLIER 'General case' 0 N--CA 1.518 2.967 0 O-C-N 122.059 -0.671 . . . . 0.0 110.57 -178.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.633 HG22 ' CG ' ' A' ' 76' ' ' ARG . 1.5 pp -96.03 129.25 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.449 0 O-C-N 121.784 -0.572 . . . . 0.0 110.392 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -130.29 159.44 36.93 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 121.702 -0.624 . . . . 0.0 109.617 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.494 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 29.7 p90 -159.02 171.5 19.9 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 119.505 -0.878 . . . . 0.0 113.09 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 10.8 mttp -160.55 159.25 30.42 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.581 ' O ' HG22 ' A' ' 9' ' ' THR . 3.6 p30 -106.02 120.08 40.84 Favored 'General case' 0 N--CA 1.513 2.697 0 O-C-N 121.84 -0.538 . . . . 0.0 110.769 179.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.523 ' N ' HD12 ' A' ' 88' ' ' ILE . 1.8 mp -104.74 121.6 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -85.32 115.61 23.17 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.525 HG13 HE21 ' A' ' 11' ' ' GLN . 46.5 t -110.33 131.93 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.171 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 67.0 mt -120.38 157.57 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.577 HG21 ' CG1' ' A' ' 63' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.503 2.196 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.382 179.613 . . . . . . . . 2 2 . 1 stop_ save_